{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "import spacy\n",
    "import scispacy\n",
    "import deplacy\n",
    "from spacy import displacy\n",
    "import stanza\n",
    "import re\n",
    "import pandas as pd\n",
    "from scispacy.abbreviation import AbbreviationDetector\n",
    "from scispacy.hyponym_detector import HyponymDetector\n",
    "from spacy.matcher import Matcher\n",
    "import matplotlib.pyplot as plt\n",
    "import networkx as nx"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "#loading the data\n",
    "with open (\"/Users/abhinavshinow/Documents/GitHub/KG-Genaration-from-Biomedical-Text-Using-NER/Data_Collection/heart_basic-data.txt\",\"r\") as f:\n",
    "    text=f.read().replace(\"\\n\\n\",\" \").replace(\"\\n\",\" \")\n",
    "text=text[:100000]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "100000"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-12-11 07:40:47 INFO: Loading these models for language: en (English):\n",
      "=======================\n",
      "| Processor | Package |\n",
      "-----------------------\n",
      "| tokenize  | mimic   |\n",
      "| pos       | mimic   |\n",
      "| lemma     | mimic   |\n",
      "| depparse  | mimic   |\n",
      "| ner       | i2b2    |\n",
      "=======================\n",
      "\n",
      "2021-12-11 07:40:47 INFO: Use device: cpu\n",
      "2021-12-11 07:40:47 INFO: Loading: tokenize\n",
      "2021-12-11 07:40:47 INFO: Loading: pos\n",
      "2021-12-11 07:40:47 INFO: Loading: lemma\n",
      "2021-12-11 07:40:47 INFO: Loading: depparse\n",
      "2021-12-11 07:40:48 INFO: Loading: ner\n",
      "2021-12-11 07:40:48 INFO: Done loading processors!\n"
     ]
    }
   ],
   "source": [
    "#loading the scispacy core model\n",
    "nlp_core = spacy.load(\"en_core_sci_lg\")\n",
    "nlp_core.add_pipe(\"abbreviation_detector\")\n",
    "nlp_core.add_pipe(\"hyponym_detector\", last=True, config={\"extended\": False})\n",
    "\n",
    "#loading the scispacy ner models\n",
    "nlp_jnlpba = spacy.load('en_ner_jnlpba_md')\n",
    "nlp_craft = spacy.load('en_ner_craft_md')\n",
    "nlp_bionlp = spacy.load('en_ner_bionlp13cg_md')\n",
    "nlp_bc5cdr = spacy.load('en_ner_bc5cdr_md')\n",
    "\n",
    "#loading the stanza model\n",
    "nlp_stanza = stanza.Pipeline('en', package='mimic', processors={'ner': 'i2b2'})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['ENTITY']"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "nlp_core.pipe_labels['ner']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "doc=nlp_core(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "heart\n",
      "muscular organ\n",
      "animals\n",
      "pumps blood\n",
      "blood vessels\n",
      "circulatory system\n",
      "pumped blood carries oxygen\n",
      "nutrients\n",
      "body\n",
      "metabolic\n",
      "waste\n",
      "carbon dioxide\n",
      "lungs\n",
      "humans\n",
      "heart\n",
      "size\n",
      "closed fist\n",
      "lungs\n",
      "middle compartment\n",
      "chest\n",
      "humans\n",
      "mammals\n",
      "birds\n",
      "heart\n",
      "chambers\n",
      "upper left\n",
      "right atria\n",
      "lower left\n",
      "right ventricles\n",
      "right atrium\n",
      "ventricle\n",
      "right heart\n",
      "left counterparts\n",
      "left heart\n",
      "Fish\n",
      "chambers\n",
      "atrium\n",
      "ventricle\n",
      "reptiles\n",
      "chambers\n",
      "healthy\n",
      "heart blood\n",
      "heart\n",
      "heart valves\n",
      "prevent\n",
      "backflow\n",
      "heart\n",
      "enclosed\n",
      "protective sac\n",
      "pericardium\n",
      "amount\n",
      "fluid\n",
      "heart\n",
      "layers\n",
      "epicardium\n",
      "myocardium\n",
      "endocardium\n",
      "heart pumps\n",
      "blood\n",
      "rhythm\n",
      "group\n",
      "pacemaker cells\n",
      "sinoatrial node\n",
      "contraction\n",
      "heart\n",
      "traveling\n",
      "atrioventricular node\n",
      "conduction system\n",
      "heart\n",
      "heart\n",
      "blood low\n",
      "oxygen\n",
      "systemic\n",
      "circulation\n",
      "right atrium\n",
      "superior\n",
      "inferior venae cavae\n",
      "right ventricle\n",
      "pumped\n",
      "pulmonary circulation\n",
      "lungs\n",
      "oxygen\n",
      "carbon dioxide\n",
      "Oxygenated blood\n",
      "left atrium\n",
      "left ventricle\n",
      "aorta\n",
      "systemic\n",
      "circulation−where the oxygen\n",
      "metabolized\n",
      "carbon dioxide\n",
      "heart beats\n",
      "resting rate\n",
      "beats\n",
      "Exercise\n",
      "increases\n",
      "rate\n",
      "resting heart rate\n",
      "long term\n",
      "heart health\n",
      "Cardiovascular diseases\n",
      "CVD\n",
      "death\n",
      "deaths\n",
      "coronary artery disease\n",
      "stroke\n",
      "Risk factors\n",
      "smoking\n",
      "overweight\n",
      "exercise\n",
      "high cholesterol\n",
      "high blood pressure\n",
      "poorly controlled diabetes\n",
      "Cardiovascular diseases\n",
      "symptoms\n",
      "chest pain\n",
      "shortness of breath\n",
      "Diagnosis\n",
      "heart disease\n",
      "medical history\n",
      "listening\n",
      "heart-sounds\n",
      "stethoscope\n",
      "ECG\n",
      "echocardiogram\n",
      "ultrasound\n",
      "Specialists\n",
      "diseases\n",
      "heart\n",
      "cardiologists\n",
      "specialties\n",
      "medicine\n",
      "treatment\n",
      "Structure Location\n",
      "shape\n",
      "human heart\n",
      "mediastinum\n",
      "level\n",
      "thoracic vertebrae\n",
      "T5-T8\n",
      "double-membraned sac\n",
      "pericardium\n",
      "heart\n",
      "mediastinum\n",
      "surface\n",
      "heart\n",
      "near\n",
      "vertebral column\n",
      "surface\n",
      "sternum\n",
      "rib cartilages\n",
      "upper part\n",
      "heart\n",
      "attachment\n",
      "blood vessels\n",
      "venae cavae\n",
      "aorta\n",
      "pulmonary trunk\n",
      "upper part\n",
      "heart\n",
      "level\n",
      "tip\n",
      "heart\n",
      "apex\n",
      "left\n",
      "sternum\n",
      "midsternal line\n",
      "junction\n",
      "ribs\n",
      "near\n",
      "articulation\n",
      "costal cartilages\n",
      "heart\n",
      "left side\n",
      "chest\n",
      "right\n",
      "left\n",
      "left heart\n",
      "stronger\n",
      "larger\n",
      "pumps\n",
      "body parts\n",
      "heart\n",
      "lungs\n",
      "left lung\n",
      "right lung\n",
      "cardiac notch\n",
      "heart\n",
      "heart\n",
      "cone-shaped\n",
      "base\n",
      "tapering\n",
      "apex\n",
      "adult\n",
      "heart\n",
      "mass\n",
      "grams\n",
      "heart\n",
      "size\n",
      "fist\n",
      "length\n",
      "thickness\n",
      "description\n",
      "heart\n",
      "Well-trained\n",
      "athletes\n",
      "hearts\n",
      "effects of\n",
      "exercise\n",
      "heart muscle\n",
      "response\n",
      "skeletal muscle\n",
      "Chambers\n",
      "heart\n",
      "chambers\n",
      "upper atria\n",
      "chambers\n",
      "ventricles\n",
      "discharging chambers\n",
      "atria\n",
      "ventricles\n",
      "atrioventricular valves\n",
      "atrioventricular septum\n",
      "surface\n",
      "heart\n",
      "coronary sulcus\n",
      "ear-shaped structure\n",
      "upper right atrium\n",
      "right atrial appendage\n",
      "auricle\n",
      "upper left atrium\n",
      "left atrial appendage\n",
      "right atrium\n",
      "right ventricle\n",
      "right heart\n",
      "left atrium\n",
      "left ventricle\n",
      "left heart\n",
      "ventricles\n",
      "interventricular septum\n",
      "visible\n",
      "surface\n",
      "heart\n",
      "anterior\n",
      "longitudinal sulcus\n",
      "posterior interventricular sulcus\n",
      "cardiac skeleton\n",
      "dense\n",
      "connective tissue\n",
      "structure\n",
      "heart\n",
      "atrioventricular septum\n",
      "atria\n",
      "ventricles\n",
      "fibrous rings\n",
      "bases\n",
      "heart valves\n",
      "cardiac skeleton\n",
      "boundary\n",
      "heart's\n",
      "electrical conduction system\n",
      "collagen\n",
      "electricity\n",
      "interatrial septum\n",
      "atria\n",
      "interventricular septum\n",
      "ventricles\n",
      "interventricular septum\n",
      "thicker\n",
      "interatrial septum\n",
      "ventricles\n",
      "pressure\n",
      "contract\n",
      "Valves\n",
      "heart\n",
      "valves\n",
      "chambers\n",
      "valve\n",
      "atrium\n",
      "ventricle\n",
      "valve\n",
      "exit\n",
      "ventricle\n",
      "valves\n",
      "atria\n",
      "ventricles\n",
      "atrioventricular valves\n",
      "right atrium\n",
      "right ventricle\n",
      "tricuspid valve\n",
      "tricuspid valve\n",
      "cusps\n",
      "chordae tendinae\n",
      "papillary muscles\n",
      "anterior\n",
      "posterior\n",
      "septal muscles\n",
      "positions\n",
      "mitral valve\n",
      "left atrium\n",
      "left ventricle\n",
      "bicuspid valve\n",
      "cusps\n",
      "anterior\n",
      "posterior\n",
      "cusp\n",
      "cusps\n",
      "chordae tendinae\n",
      "papillary muscles\n",
      "ventricular wall\n",
      "papillary muscles\n",
      "walls\n",
      "heart\n",
      "valves\n",
      "cartilaginous\n",
      "connections\n",
      "chordae tendinae\n",
      "muscles\n",
      "prevent\n",
      "valves\n",
      "relaxation\n",
      "phase\n",
      "cardiac cycle\n",
      "papillary muscles\n",
      "tension\n",
      "chordae\n",
      "tendineae\n",
      "heart chambers\n",
      "contract\n",
      "papillary muscles\n",
      "tension\n",
      "chordae\n",
      "tendineae\n",
      "cusps\n",
      "atrioventricular valves\n",
      "preventing\n",
      "blown back\n",
      "atria\n",
      "semilunar valves\n",
      "exit\n",
      "ventricles\n",
      "pulmonary valve\n",
      "base\n",
      "pulmonary artery\n",
      "cusps\n",
      "papillary muscles\n",
      "ventricle\n",
      "blood flows\n",
      "ventricle\n",
      "artery\n",
      "flow\n",
      "blood\n",
      "pocket-like valve\n",
      "cusps\n",
      "seal\n",
      "valve\n",
      "semilunar aortic valve\n",
      "base\n",
      "aorta\n",
      "papillary muscles\n",
      "cusps\n",
      "pressure\n",
      "blood flowing back\n",
      "aorta\n",
      "Right heart\n",
      "right heart\n",
      "chambers\n",
      "right atrium\n",
      "right ventricle\n",
      "valve\n",
      "tricuspid valve\n",
      "right atrium receives blood\n",
      "body's\n",
      "veins\n",
      "superior\n",
      "inferior venae cavae\n",
      "amount\n",
      "blood\n",
      "coronary circulation\n",
      "drains\n",
      "right atrium\n",
      "coronary sinus\n",
      "opening\n",
      "inferior vena cava\n",
      "right atrium\n",
      "oval-shaped depression\n",
      "fossa ovalis\n",
      "remnant\n",
      "opening\n",
      "fetal heart\n",
      "foramen ovale\n",
      "internal surface\n",
      "right atrium\n",
      "smooth\n",
      "depression\n",
      "fossa ovalis\n",
      "medial\n",
      "anterior\n",
      "surface\n",
      "ridges\n",
      "pectinate muscles\n",
      "right atrial appendage\n",
      "right atrium\n",
      "right ventricle\n",
      "tricuspid valve\n",
      "walls\n",
      "right ventricle\n",
      "trabeculae\n",
      "carneae\n",
      "ridges\n",
      "cardiac muscle\n",
      "endocardium\n",
      "muscular\n",
      "ridges\n",
      "cardiac muscle\n",
      "endocardium\n",
      "moderator\n",
      "thin walls\n",
      "right ventricle\n",
      "cardiac conduction\n",
      "interventricular septum\n",
      "crosses\n",
      "interior space\n",
      "right ventricle\n",
      "inferior papillary muscle\n",
      "right ventricle tapers\n",
      "pulmonary trunk\n",
      "blood\n",
      "contracting\n",
      "pulmonary trunk branches\n",
      "left\n",
      "right pulmonary arteries\n",
      "blood\n",
      "lung\n",
      "pulmonary valve\n",
      "right heart\n",
      "pulmonary trunk\n",
      "Left heart\n",
      "left heart\n",
      "chambers\n",
      "left atrium\n",
      "left ventricle\n",
      "mitral valve\n",
      "left atrium\n",
      "oxygenated blood back\n",
      "lungs\n",
      "pulmonary veins\n",
      "left atrium\n",
      "outpouching\n",
      "left atrial appendage\n",
      "right atrium\n",
      "left atrium\n",
      "pectinate muscles\n",
      "left atrium\n",
      "left ventricle\n",
      "mitral valve\n",
      "left ventricle\n",
      "thicker\n",
      "right\n",
      "force\n",
      "pump\n",
      "blood\n",
      "entire body\n",
      "right ventricle\n",
      "left\n",
      "trabeculae\n",
      "carneae\n",
      "left ventricle pumps\n",
      "body\n",
      "aortic valve\n",
      "aorta\n",
      "openings\n",
      "aortic valve\n",
      "blood\n",
      "heart muscle\n",
      "left coronary artery\n",
      "left cusp\n",
      "valve\n",
      "right coronary artery\n",
      "right cusp\n",
      "heart wall\n",
      "layers\n",
      "inner endocardium\n",
      "middle myocardium\n",
      "outer\n",
      "epicardium\n",
      "surrounded\n",
      "double-membraned sac\n",
      "pericardium\n",
      "innermost layer\n",
      "heart\n",
      "endocardium\n",
      "lining\n",
      "squamous epithelium\n",
      "heart chambers\n",
      "valves\n",
      "continuous\n",
      "endothelium\n",
      "veins\n",
      "arteries\n",
      "heart\n",
      "myocardium\n",
      "layer\n",
      "connective tissue\n",
      "endocardium\n",
      "secreting\n",
      "endothelins\n",
      "regulating\n",
      "contraction\n",
      "myocardium\n",
      "middle layer\n",
      "heart wall\n",
      "myocardium\n",
      "cardiac muscle\n",
      "layer\n",
      "involuntary\n",
      "striated muscle\n",
      "surrounded\n",
      "framework\n",
      "collagen\n",
      "cardiac muscle\n",
      "elegant\n",
      "complex\n",
      "muscle cells\n",
      "swirl\n",
      "spiral\n",
      "chambers\n",
      "heart\n",
      "outer muscles\n",
      "pattern\n",
      "atria\n",
      "bases\n",
      "vessels\n",
      "inner muscles\n",
      "ventricles\n",
      "apex\n",
      "complex\n",
      "heart\n",
      "pump\n",
      "blood\n",
      "effectively\n",
      "cells\n",
      "cardiac muscle\n",
      "muscle cells\n",
      "contract\n",
      "pacemaker cells\n",
      "conducting system\n",
      "muscle cells\n",
      "cells\n",
      "atria\n",
      "ventricles\n",
      "contractile cells\n",
      "intercalated\n",
      "discs\n",
      "response\n",
      "impulses\n",
      "action\n",
      "potential\n",
      "pacemaker cells\n",
      "intercalated\n",
      "discs\n",
      "cells\n",
      "syncytium\n",
      "contractions\n",
      "pump\n",
      "blood\n",
      "heart\n",
      "arteries\n",
      "pacemaker cells\n",
      "cells\n",
      "conduction system\n",
      "heart\n",
      "contractile cells\n",
      "myofibrils\n",
      "contractibility\n",
      "function\n",
      "neurons\n",
      "Cardiac muscle\n",
      "autorhythmicity\n",
      "initiate\n",
      "cardiac action\n",
      "potential\n",
      "fixed rate\n",
      "spreading\n",
      "impulse\n",
      "cell\n",
      "cell\n",
      "contraction\n",
      "entire heart\n",
      "proteins\n",
      "expressed\n",
      "cardiac muscle cells\n",
      "associated with\n",
      "muscle contraction\n",
      "bind\n",
      "actin\n",
      "myosin\n",
      "tropomyosin\n",
      "troponin\n",
      "MYH6\n",
      "ACTC1\n",
      "TNNI3\n",
      "CDH2\n",
      "PKP2\n",
      "proteins\n",
      "expressed\n",
      "MYH7\n",
      "LDB3\n",
      "expressed\n",
      "skeletal muscle\n",
      "Pericardium\n",
      "pericardium\n",
      "sac\n",
      "heart\n",
      "outer\n",
      "surface\n",
      "pericardium\n",
      "fibrous membrane\n",
      "double inner membrane\n",
      "serous membrane\n",
      "pericardial fluid\n",
      "lubricate\n",
      "surface\n",
      "heart\n",
      "serous membrane\n",
      "fibrous membrane\n",
      "parietal pericardium\n",
      "serous membrane\n",
      "heart\n",
      "visceral pericardium\n",
      "pericardium\n",
      "lubricate\n",
      "movement\n",
      "structures\n",
      "chest\n",
      "heart's\n",
      "stabilised\n",
      "chest\n",
      "heart\n",
      "infection\n",
      "Coronary circulation\n",
      "Heart tissue\n",
      "cells\n",
      "body\n",
      "oxygen\n",
      "nutrients\n",
      "metabolic\n",
      "wastes\n",
      "coronary circulation\n",
      "arteries\n",
      "veins\n",
      "lymphatic vessels\n",
      "Blood flow\n",
      "coronary vessels\n",
      "peaks\n",
      "troughs\n",
      "heart muscle's\n",
      "relaxation\n",
      "contraction\n",
      "Heart tissue\n",
      "blood\n",
      "arteries\n",
      "aortic valve\n",
      "left main coronary artery\n",
      "right coronary artery\n",
      "aorta\n",
      "vessels\n",
      "left anterior descending\n",
      "left circumflex artery\n",
      "left anterior descending artery supplies\n",
      "heart tissue\n",
      "front\n",
      "outer side\n",
      "septum\n",
      "left ventricle\n",
      "branching\n",
      "arteries\n",
      "diagonal\n",
      "septal branches\n",
      "left circumflex\n",
      "supplies\n",
      "back\n",
      "underneath\n",
      "left ventricle\n",
      "right coronary artery supplies\n",
      "right atrium\n",
      "right ventricle\n",
      "sections\n",
      "left ventricle\n",
      "right coronary artery\n",
      "supplies\n",
      "blood\n",
      "atrioventricular node\n",
      "people\n",
      "sinoatrial node\n",
      "people\n",
      "right coronary artery runs\n",
      "groove\n",
      "heart\n",
      "left anterior descending artery runs\n",
      "groove\n",
      "front\n",
      "variation\n",
      "people\n",
      "anatomy\n",
      "arteries\n",
      "supply\n",
      "heart  \n",
      "arteries\n",
      "branches\n",
      "edges\n",
      "arterial\n",
      "distribution\n",
      "coronary sinus\n",
      "vein\n",
      "drains\n",
      "right atrium\n",
      "venous drainage\n",
      "heart\n",
      "blood\n",
      "cardiac vein\n",
      "left atrium\n",
      "ventricles\n",
      "posterior cardiac vein\n",
      "draining\n",
      "left ventricle\n",
      "middle cardiac vein\n",
      "draining\n",
      "left\n",
      "right ventricles\n",
      "small cardiac veins\n",
      "anterior\n",
      "cardiac veins\n",
      "drain\n",
      "right ventricle\n",
      "drain\n",
      "right atrium\n",
      "lymphatic networks\n",
      "plexuses\n",
      "layers\n",
      "heart\n",
      "networks\n",
      "left\n",
      "right trunk\n",
      "travel\n",
      "groove\n",
      "ventricles\n",
      "heart's\n",
      "surface\n",
      "vessels\n",
      "travel\n",
      "vessels\n",
      "travel\n",
      "atrioventricular groove\n",
      "third vessel\n",
      "drains\n",
      "section\n",
      "left ventricle sitting\n",
      "diaphragm\n",
      "left vessel\n",
      "third vessel\n",
      "pulmonary artery\n",
      "left atrium\n",
      "inferior tracheobronchial node\n",
      "right vessel\n",
      "right atrium\n",
      "right ventricle sitting\n",
      "diaphragm\n",
      "ascending aorta\n",
      "ends\n",
      "brachiocephalic node\n",
      "Nerve\n",
      "supply\n",
      "heart\n",
      "signals\n",
      "vagus nerve\n",
      "nerves\n",
      "sympathetic trunk\n",
      "nerves\n",
      "influence\n",
      "heart rate\n",
      "Sympathetic nerves\n",
      "influence\n",
      "force\n",
      "heart contraction\n",
      "Signals\n",
      "travel\n",
      "nerves\n",
      "cardiovascular centres\n",
      "medulla oblongata\n",
      "vagus nerve\n",
      "parasympathetic nervous system\n",
      "decrease\n",
      "heart rate\n",
      "nerves\n",
      "sympathetic trunk\n",
      "increase\n",
      "heart rate\n",
      "nerves\n",
      "network\n",
      "nerves\n",
      "heart\n",
      "cardiac plexus\n",
      "vagus nerve\n",
      "wandering nerve\n",
      "brainstem\n",
      "parasympathetic stimulation\n",
      "organs\n",
      "thorax\n",
      "abdomen\n",
      "heart\n",
      "nerves\n",
      "sympathetic trunk\n",
      "emerge\n",
      "T1-T4 thoracic ganglia\n",
      "travel\n",
      "sinoatrial\n",
      "atrioventricular nodes\n",
      "atria\n",
      "ventricles\n",
      "ventricles\n",
      "richly\n",
      "innervated\n",
      "sympathetic fibers\n",
      "parasympathetic fibers\n",
      "Sympathetic stimulation\n",
      "release\n",
      "neurotransmitter\n",
      "norepinephrine\n",
      "noradrenaline\n",
      "neuromuscular junction\n",
      "cardiac nerves\n",
      "repolarization\n",
      "period\n",
      "rate\n",
      "depolarization\n",
      "contraction\n",
      "results\n",
      "increased\n",
      "heart rate\n",
      "chemical\n",
      "ligand-gated sodium\n",
      "calcium ion channels\n",
      "influx\n",
      "positively charged ions\n",
      "Norepinephrine\n",
      "binds\n",
      "beta–1 receptor\n",
      "Development\n",
      "heart\n",
      "functional\n",
      "organ\n",
      "beat\n",
      "pump\n",
      "blood\n",
      "weeks\n",
      "embryogenesis\n",
      "early\n",
      "embryonic\n",
      "prenatal development\n",
      "heart\n",
      "splanchnopleuric mesenchyme\n",
      "neural plate\n",
      "cardiogenic region\n",
      "endocardial tubes\n",
      "fuse\n",
      "primitive\n",
      "heart tube\n",
      "tubular heart\n",
      "week\n",
      "heart tube\n",
      "lengthens\n",
      "S-shape\n",
      "pericardium\n",
      "chambers\n",
      "vessels\n",
      "correct\n",
      "alignment\n",
      "heart\n",
      "development\n",
      "formation\n",
      "septa\n",
      "valves\n",
      "remodeling\n",
      "heart chambers\n",
      "week\n",
      "septa\n",
      "complete\n",
      "ninth\n",
      "week\n",
      "heart valves\n",
      "complete\n",
      "week\n",
      "opening\n",
      "fetal heart\n",
      "foramen ovale\n",
      "foramen ovale\n",
      "blood\n",
      "fetal heart\n",
      "right atrium\n",
      "left atrium\n",
      "blood\n",
      "bypass\n",
      "lungs\n",
      "birth\n",
      "flap\n",
      "tissue\n",
      "septum primum\n",
      "valve\n",
      "foramen ovale\n",
      "cardiac circulation\n",
      "pattern\n",
      "depression\n",
      "surface\n",
      "right atrium\n",
      "foramen ovale\n",
      "fossa ovalis\n",
      "embryonic heart\n",
      "beating\n",
      "days\n",
      "conception\n",
      "weeks\n",
      "normal\n",
      "menstrual\n",
      "period\n",
      "LMP\n",
      "beat\n",
      "rate\n",
      "near\n",
      "mother's\n",
      "beats\n",
      "bpm\n",
      "embryonic heart rate\n",
      "accelerates\n",
      "peak rate\n",
      "bpm\n",
      "early\n",
      "week\n",
      "early\n",
      "week\n",
      "LMP\n",
      "weeks\n",
      "fetal stage\n",
      "decelerate\n",
      "birth\n",
      "female\n",
      "male\n",
      "heart rates\n",
      "birth\n",
      "Physiology Blood flow\n",
      "heart functions\n",
      "pump\n",
      "circulatory system\n",
      "continuous\n",
      "blood\n",
      "body\n",
      "circulation\n",
      "systemic\n",
      "circulation\n",
      "body\n",
      "pulmonary circulation\n",
      "lungs\n",
      "Blood\n",
      "pulmonary circulation\n",
      "carbon dioxide\n",
      "oxygen\n",
      "lungs\n",
      "process\n",
      "respiration\n",
      "systemic\n",
      "circulation\n",
      "transports oxygen\n",
      "body\n",
      "returns\n",
      "carbon dioxide\n",
      "deoxygenated blood\n",
      "heart\n",
      "transfer\n",
      "lungs\n",
      "right heart collects\n",
      "deoxygenated blood\n",
      "veins\n",
      "superior\n",
      "inferior venae cavae\n",
      "Blood\n",
      "right\n",
      "left atrium\n",
      "superior vena cava\n",
      "blood\n",
      "diaphragm\n",
      "empties\n",
      "upper back part\n",
      "right atrium\n",
      "inferior vena cava\n",
      "drains\n",
      "blood\n",
      "diaphragm\n",
      "empties\n",
      "atrium\n",
      "opening\n",
      "superior vena cava\n",
      "opening\n",
      "inferior vena cava\n",
      "opening\n",
      "thin-walled coronary sinus\n",
      "coronary sinus\n",
      "deoxygenated blood\n",
      "myocardium\n",
      "right atrium\n",
      "blood\n",
      "right atrium\n",
      "right atrium contracts\n",
      "blood\n",
      "pumped\n",
      "tricuspid valve\n",
      "right ventricle\n",
      "right ventricle contracts\n",
      "tricuspid valve\n",
      "blood\n",
      "pumped\n",
      "pulmonary trunk\n",
      "pulmonary valve\n",
      "pulmonary trunk\n",
      "pulmonary arteries\n",
      "arteries\n",
      "lungs\n",
      "capillaries\n",
      "alveoli carbon dioxide\n",
      "oxygen\n",
      "passive process\n",
      "diffusion\n",
      "left heart\n",
      "oxygenated blood\n",
      "left atrium\n",
      "pulmonary veins\n",
      "pumped\n",
      "left ventricle\n",
      "mitral valve\n",
      "aorta\n",
      "aortic valve\n",
      "systemic\n",
      "circulation\n",
      "aorta\n",
      "artery\n",
      "branches\n",
      "arteries\n",
      "arterioles\n",
      "capillaries\n",
      "capillaries\n",
      "oxygen\n",
      "nutrients\n",
      "blood\n",
      "body cells\n",
      "metabolism\n",
      "carbon dioxide\n",
      "waste products\n",
      "Capillary blood\n",
      "deoxygenated\n",
      "venules\n",
      "veins\n",
      "collect\n",
      "superior\n",
      "inferior vena cavae\n",
      "right heart\n",
      "Cardiac cycle\n",
      "cardiac cycle\n",
      "sequence\n",
      "events\n",
      "heart contracts\n",
      "relaxes\n",
      "heartbeat\n",
      "period\n",
      "time\n",
      "ventricles\n",
      "contract\n",
      "forcing blood\n",
      "aorta\n",
      "pulmonary artery\n",
      "systole\n",
      "period\n",
      "ventricles\n",
      "refill\n",
      "blood\n",
      "diastole\n",
      "atria\n",
      "ventricles\n",
      "concert\n",
      "systole\n",
      "ventricles\n",
      "contracting\n",
      "atria\n",
      "collecting blood\n",
      "ventricles\n",
      "diastole\n",
      "atria\n",
      "contract\n",
      "pump\n",
      "blood\n",
      "ventricles\n",
      "coordination\n",
      "blood\n",
      "pumped\n",
      "body\n",
      "cardiac cycle\n",
      "ventricles\n",
      "relaxing\n",
      "blood passing\n",
      "open mitral\n",
      "tricuspid valves\n",
      "ventricles\n",
      "filling\n",
      "atria\n",
      "contract\n",
      "blood\n",
      "ventricles\n",
      "priming\n",
      "pump\n",
      "ventricles\n",
      "contract\n",
      "pressure\n",
      "rises\n",
      "cavities\n",
      "ventricles\n",
      "mitral\n",
      "tricuspid valves\n",
      "pressure\n",
      "ventricles\n",
      "rises\n",
      "pressure\n",
      "aorta\n",
      "pulmonary arteries\n",
      "aortic\n",
      "pulmonary valves open\n",
      "Blood\n",
      "ejected\n",
      "heart\n",
      "pressure\n",
      "ventricles\n",
      "fall\n",
      "Simultaneously\n",
      "atria\n",
      "refill\n",
      "blood flows\n",
      "right atrium\n",
      "superior\n",
      "inferior vena cavae\n",
      "left atrium\n",
      "pulmonary veins\n",
      "pressure\n",
      "ventricles\n",
      "falls\n",
      "pressure\n",
      "aorta\n",
      "pulmonary arteries\n",
      "aortic\n",
      "pulmonary valves\n",
      "ventricles\n",
      "mitral\n",
      "tricuspid valves\n",
      "open\n",
      "cycle\n",
      "Cardiac output\n",
      "Cardiac output\n",
      "CO\n",
      "measurement\n",
      "amount\n",
      "blood pumped\n",
      "ventricle\n",
      "stroke\n",
      "volume\n",
      "minute\n",
      "multiplying\n",
      "stroke\n",
      "volume\n",
      "SV\n",
      "beats\n",
      "heart rate\n",
      "HR\n",
      "CO\n",
      "SV\n",
      "HR\n",
      "cardiac output\n",
      "body size\n",
      "body surface area\n",
      "cardiac index\n",
      "average\n",
      "cardiac output\n",
      "average\n",
      "stroke\n",
      "volume\n",
      "stroke\n",
      "volume\n",
      "measured\n",
      "echocardiogram\n",
      "influenced\n",
      "size\n",
      "heart\n",
      "physical\n",
      "mental condition\n",
      "individual\n",
      "sex\n",
      "contractility\n",
      "duration\n",
      "contraction\n",
      "preload\n",
      "afterload\n",
      "Preload\n",
      "filling pressure\n",
      "atria\n",
      "diastole\n",
      "ventricles\n",
      "ventricles\n",
      "ventricles\n",
      "contract\n",
      "preload\n",
      "Preload\n",
      "affected\n",
      "person's\n",
      "blood volume\n",
      "force\n",
      "contraction\n",
      "heart muscle\n",
      "proportional\n",
      "preload\n",
      "Frank-Starling\n",
      "mechanism\n",
      "states\n",
      "force\n",
      "contraction\n",
      "proportional\n",
      "length\n",
      "muscle fiber\n",
      "ventricle\n",
      "contract\n",
      "stretched\n",
      "Afterload\n",
      "pressure\n",
      "heart\n",
      "blood\n",
      "systole\n",
      "vascular resistance\n",
      "influenced\n",
      "narrowing\n",
      "heart valves\n",
      "stenosis\n",
      "contraction\n",
      "relaxation\n",
      "peripheral blood vessels\n",
      "strength\n",
      "heart muscle\n",
      "contractions\n",
      "stroke\n",
      "volume\n",
      "influenced\n",
      "positively\n",
      "negatively\n",
      "agents\n",
      "inotropes\n",
      "agents\n",
      "changes\n",
      "body\n",
      "drugs\n",
      "treatment\n",
      "medical disorder\n",
      "life support\n",
      "intensive care units\n",
      "Inotropes\n",
      "increase\n",
      "force\n",
      "contraction\n",
      "positive\n",
      "inotropes\n",
      "sympathetic agents\n",
      "adrenaline\n",
      "noradrenaline\n",
      "dopamine\n",
      "Negative\n",
      "inotropes\n",
      "decrease\n",
      "force\n",
      "contraction\n",
      "calcium channel blockers\n",
      "Electrical conduction\n",
      "normal rhythmical heart beat\n",
      "sinus rhythm\n",
      "heart's\n",
      "pacemaker\n",
      "sinoatrial node\n",
      "sinus node\n",
      "SA\n",
      "node\n",
      "electrical signal\n",
      "heart\n",
      "heart muscle\n",
      "contract\n",
      "sinoatrial node\n",
      "upper part\n",
      "right atrium\n",
      "junction\n",
      "superior vena cava\n",
      "electrical signal\n",
      "sinoatrial node\n",
      "right atrium\n",
      "radial\n",
      "left atrium\n",
      "Bachmann's bundle\n",
      "muscles\n",
      "left\n",
      "right atria\n",
      "contract\n",
      "signal\n",
      "atrioventricular node\n",
      "right atrium\n",
      "atrioventricular septum\n",
      "right atrium\n",
      "left ventricle\n",
      "septum\n",
      "cardiac skeleton\n",
      "tissue\n",
      "heart\n",
      "electrical signal\n",
      "forces\n",
      "signal\n",
      "atrioventricular node\n",
      "signal\n",
      "bundle\n",
      "right bundle branches\n",
      "ventricles\n",
      "heart\n",
      "ventricles\n",
      "signal\n",
      "specialized tissue\n",
      "Purkinje fibers\n",
      "transmit\n",
      "electric charge\n",
      "heart muscle\n",
      "Heart rate\n",
      "normal resting heart rate\n",
      "sinus rhythm\n",
      "sustained\n",
      "sinoatrial node\n",
      "group\n",
      "pacemaking cells\n",
      "wall\n",
      "right atrium\n",
      "Cells\n",
      "sinoatrial node\n",
      "action\n",
      "potential\n",
      "cardiac action\n",
      "potential\n",
      "movement\n",
      "electrolytes\n",
      "pacemaker cells\n",
      "action\n",
      "potential\n",
      "spreads\n",
      "nearby cells\n",
      "sinoatrial cells\n",
      "resting\n",
      "negative\n",
      "membranes\n",
      "influx\n",
      "sodium ions\n",
      "membrane's charge\n",
      "positive\n",
      "depolarisation\n",
      "spontaneously\n",
      "cell\n",
      "sodium channels\n",
      "calcium ions\n",
      "cell\n",
      "potassium\n",
      "ions\n",
      "travel\n",
      "ion channels\n",
      "membrane\n",
      "sinoatrial cells\n",
      "potassium\n",
      "calcium\n",
      "cell\n",
      "voltage-gated\n",
      "calcium channels\n",
      "potassium channels open\n",
      "potassium\n",
      "cell\n",
      "cell\n",
      "negative\n",
      "repolarization\n",
      "membrane\n",
      "potential\n",
      "−60 mV\n",
      "potassium channels\n",
      "process\n",
      "ions\n",
      "areas\n",
      "sodium\n",
      "cell\n",
      "outside\n",
      "potassium\n",
      "cell\n",
      "cell\n",
      "Calcium\n",
      "influx\n",
      "slow channels\n",
      "sinoatrial cells\n",
      "prolonged\n",
      "plateau\n",
      "phase\n",
      "positive charge\n",
      "absolute\n",
      "refractory\n",
      "period\n",
      "Calcium ions\n",
      "regulatory protein troponin C\n",
      "troponin complex\n",
      "contraction\n",
      "cardiac muscle\n",
      "protein\n",
      "relaxation\n",
      "adult\n",
      "resting heart rate ranges\n",
      "bpm\n",
      "resting heart rate\n",
      "newborn\n",
      "beats\n",
      "bpm\n",
      "decreases\n",
      "maturity\n",
      "athlete's\n",
      "heart rate\n",
      "bpm\n",
      "exercise\n",
      "rate\n",
      "maximum\n",
      "rates\n",
      "bpm\n",
      "Influences\n",
      "normal sinus rhythm\n",
      "heart\n",
      "resting heart rate\n",
      "factors\n",
      "cardiovascular centres\n",
      "brainstem control\n",
      "sympathetic\n",
      "parasympathetic\n",
      "influences\n",
      "heart\n",
      "vagus nerve\n",
      "sympathetic trunk\n",
      "cardiovascular centres\n",
      "receptors\n",
      "baroreceptors\n",
      "sensing stretch\n",
      "stretching\n",
      "blood vessels\n",
      "chemoreceptors\n",
      "sensing\n",
      "amount\n",
      "oxygen\n",
      "carbon dioxide\n",
      "blood\n",
      "pH.\n",
      "reflexes\n",
      "regulate\n",
      "sustain\n",
      "blood flow\n",
      "Baroreceptors\n",
      "stretch receptors\n",
      "aortic sinus\n",
      "carotid bodies\n",
      "venae cavae\n",
      "locations\n",
      "pulmonary vessels\n",
      "right side\n",
      "heart\n",
      "Baroreceptors\n",
      "fire\n",
      "rate\n",
      "stretched\n",
      "influenced\n",
      "blood pressure\n",
      "level\n",
      "physical activity\n",
      "distribution\n",
      "blood\n",
      "increased\n",
      "pressure\n",
      "stretch\n",
      "rate\n",
      "baroreceptor\n",
      "firing\n",
      "increases\n",
      "cardiac centers\n",
      "decrease\n",
      "sympathetic stimulation\n",
      "increase\n",
      "parasympathetic stimulation\n",
      "pressure\n",
      "stretch\n",
      "decrease\n",
      "rate\n",
      "baroreceptor\n",
      "firing\n",
      "decreases\n",
      "cardiac centers\n",
      "increase\n",
      "sympathetic stimulation\n",
      "decrease\n",
      "parasympathetic stimulation\n",
      "reflex\n",
      "atrial reflex\n",
      "Bainbridge reflex\n",
      "associated with\n",
      "rates\n",
      "blood flow\n",
      "atria\n",
      "Increased\n",
      "venous return stretches\n",
      "walls\n",
      "atria\n",
      "specialized baroreceptors\n",
      "atrial baroreceptors\n",
      "increase\n",
      "rate\n",
      "firing\n",
      "stretch\n",
      "increased\n",
      "blood pressure\n",
      "cardiac center\n",
      "sympathetic stimulation\n",
      "inhibiting\n",
      "parasympathetic stimulation\n",
      "increase\n",
      "heart rate\n",
      "Chemoreceptors\n",
      "carotid body\n",
      "adjacent\n",
      "aorta\n",
      "aortic body\n",
      "blood's oxygen\n",
      "carbon dioxide\n",
      "levels\n",
      "Low oxygen\n",
      "stimulate\n",
      "firing\n",
      "receptors\n",
      "Exercise\n",
      "fitness\n",
      "levels\n",
      "age\n",
      "body temperature\n",
      "basal\n",
      "metabolic\n",
      "rate\n",
      "person's\n",
      "emotional state\n",
      "heart rate\n",
      "levels\n",
      "hormones\n",
      "epinephrine\n",
      "norepinephrine\n",
      "thyroid hormones\n",
      "increase\n",
      "heart rate\n",
      "levels\n",
      "electrolytes\n",
      "calcium\n",
      "potassium\n",
      "sodium\n",
      "influence\n",
      "speed\n",
      "regularity\n",
      "heart rate\n",
      "low blood oxygen\n",
      "low blood pressure\n",
      "dehydration\n",
      "increase\n",
      "Clinical significance Diseases\n",
      "Cardiovascular diseases\n",
      "diseases\n",
      "heart\n",
      "death\n",
      "worldwide\n",
      "cardiovascular disease\n",
      "noncommunicable\n",
      "lifestyle\n",
      "factors\n",
      "prevalent\n",
      "ageing\n",
      "Heart disease\n",
      "death\n",
      "average\n",
      "deaths\n",
      "rate\n",
      "high-income countries\n",
      "Doctors\n",
      "heart\n",
      "cardiologists\n",
      "medical professionals\n",
      "treating\n",
      "diseases\n",
      "heart\n",
      "doctors\n",
      "cardiothoracic surgeons\n",
      "intensivists\n",
      "allied health practitioners\n",
      "physiotherapists\n",
      "dieticians\n",
      "Ischaemic heart disease\n",
      "Coronary artery disease\n",
      "ischaemic heart disease\n",
      "atherosclerosis\n",
      "build-up\n",
      "fatty material\n",
      "inner walls\n",
      "arteries\n",
      "fatty deposits\n",
      "atherosclerotic\n",
      "plaques\n",
      "narrow\n",
      "coronary arteries\n",
      "severe\n",
      "reduce\n",
      "blood flow\n",
      "heart\n",
      "narrowing\n",
      "stenosis\n",
      "patient\n",
      "symptoms\n",
      "Severe\n",
      "narrowings\n",
      "chest pain\n",
      "angina\n",
      "breathlessness\n",
      "exercise\n",
      "rest\n",
      "atherosclerotic plaque\n",
      "rupture\n",
      "fatty centre\n",
      "circulating blood\n",
      "clot\n",
      "thrombus\n",
      "blocking\n",
      "artery\n",
      "restricting\n",
      "blood flow\n",
      "area\n",
      "heart muscle\n",
      "myocardial infarction\n",
      "heart attack\n",
      "unstable angina\n",
      "case\n",
      "cardiac arrest\n",
      "sudden\n",
      "utter loss\n",
      "output\n",
      "heart\n",
      "Obesity\n",
      "high blood pressure\n",
      "uncontrolled\n",
      "diabetes\n",
      "smoking\n",
      "high cholesterol\n",
      "increase\n",
      "risk\n",
      "atherosclerosis\n",
      "coronary artery disease\n",
      "Heart failure\n",
      "Heart failure\n",
      "condition\n",
      "heart\n",
      "pump\n",
      "blood\n",
      "demands\n",
      "body\n",
      "Patients\n",
      "heart failure\n",
      "breathlessness\n",
      "flat\n",
      "ankle swelling\n",
      "peripheral oedema\n",
      "Heart failure\n",
      "diseases\n",
      "affecting\n",
      "heart\n",
      "associated with\n",
      "ischaemic heart disease\n",
      "valvular heart disease\n",
      "high blood pressure\n",
      "cardiomyopathies\n",
      "Heart failure\n",
      "associated with\n",
      "weakness\n",
      "heart muscle\n",
      "ventricles\n",
      "systolic heart failure\n",
      "patients\n",
      "heart muscle\n",
      "stiff\n",
      "diastolic heart failure\n",
      "condition\n",
      "left ventricle\n",
      "breathlessness\n",
      "right ventricle\n",
      "swelling\n",
      "legs\n",
      "elevated\n",
      "jugular\n",
      "venous pressure\n",
      "ventricles\n",
      "Patients\n",
      "heart failure\n",
      "risk\n",
      "heart rhythm\n",
      "disturbances\n",
      "arrhythmias\n",
      "Cardiomyopathies Cardiomyopathies\n",
      "diseases\n",
      "affecting\n",
      "muscle\n",
      "heart\n",
      "abnormal\n",
      "thickening\n",
      "heart muscle\n",
      "hypertrophic cardiomyopathy\n",
      "heart\n",
      "dilated cardiomyopathy\n",
      "heart muscle\n",
      "stiff\n",
      "contractions\n",
      "restrictive cardiomyopathy\n",
      "heart\n",
      "abnormal\n",
      "arrhythmogenic cardiomyopathy\n",
      "conditions\n",
      "genetic\n",
      "inherited\n",
      "dilated cardiomyopathy\n",
      "damage\n",
      "toxins\n",
      "alcohol\n",
      "cardiomyopathies\n",
      "hypertrophic cardiomopathy\n",
      "risk\n",
      "sudden cardiac death\n",
      "athletes\n",
      "cardiomyopathies\n",
      "heart failure\n",
      "stages\n",
      "disease\n",
      "Valvular heart disease\n",
      "Healthy heart valves\n",
      "blood\n",
      "flow\n",
      "direction\n",
      "prevent\n",
      "flowing\n",
      "direction\n",
      "Diseased heart valves\n",
      "opening\n",
      "flow\n",
      "blood\n",
      "forward direction\n",
      "stenotic valve\n",
      "blood\n",
      "leak\n",
      "reverse direction\n",
      "valvular regurgitation\n",
      "Valvular heart disease\n",
      "breathlessness\n",
      "blackouts\n",
      "chest pain\n",
      "asymptomatic\n",
      "detected\n",
      "routine\n",
      "examination\n",
      "hearing\n",
      "abnormal\n",
      "heart sounds\n",
      "heart murmur\n",
      "valvular heart disease\n",
      "degeneration\n",
      "secondary to old age\n",
      "infection\n",
      "heart valves\n",
      "endocarditis\n",
      "parts\n",
      "world\n",
      "rheumatic heart disease\n",
      "valvular heart disease\n",
      "mitral\n",
      "aortic stenosis\n",
      "body's\n",
      "immune system\n",
      "streptococcal throat infection\n",
      "Cardiac arrhythmias\n",
      "healthy heart\n",
      "waves\n",
      "electrical impulses\n",
      "sinus node\n",
      "spreading\n",
      "atria\n",
      "atrioventricular node\n",
      "ventricles\n",
      "normal sinus rhythm\n",
      "normal rhythm\n",
      "disrupted\n",
      "Abnormal\n",
      "heart rhythms\n",
      "arrhythmias\n",
      "asymptomatic\n",
      "palpitations\n",
      "blackouts\n",
      "breathlessness\n",
      "arrhythmia\n",
      "atrial fibrillation\n",
      "increase\n",
      "long term\n",
      "risk\n",
      "stroke\n",
      "arrhythmias\n",
      "heart\n",
      "beat\n",
      "bradycardia\n",
      "bradyarrhythmia\n",
      "damage\n",
      "cardiac conduction system\n",
      "heart block\n",
      "arrhythmias\n",
      "heart\n",
      "beat\n",
      "abnormally\n",
      "tachycardia\n",
      "tachyarrhythmia\n",
      "arrhythmias\n",
      "structures\n",
      "heart\n",
      "atria\n",
      "atrial flutter\n",
      "atrioventricular node\n",
      "AV nodal re-entrant tachycardia\n",
      "ventricles\n",
      "ventricular tachycardia\n",
      "tachyarrhythmias\n",
      "scarring\n",
      "heart\n",
      "ventricular tachycardia\n",
      "irritable focus\n",
      "focal atrial tachycardia\n",
      "abnormal\n",
      "conduction tissue\n",
      "birth\n",
      "Wolff-Parkinson-White syndrome\n",
      "heart racing\n",
      "ventricular fibrillation\n",
      "ventricles\n",
      "quiver\n",
      "contract\n",
      "untreated\n",
      "fatal\n",
      "Pericardial disease\n",
      "sac\n",
      "heart\n",
      "pericardium\n",
      "inflamed\n",
      "condition\n",
      "pericarditis\n",
      "condition\n",
      "chest pain\n",
      "spread\n",
      "back\n",
      "viral infection\n",
      "glandular fever\n",
      "cytomegalovirus\n",
      "coxsackievirus\n",
      "Fluid\n",
      "pericardial sac\n",
      "pericardial effusion\n",
      "Pericardial effusions\n",
      "secondary to\n",
      "pericarditis\n",
      "kidney failure\n",
      "tumours\n",
      "symptoms\n",
      "effusions\n",
      "effusions\n",
      "accumulate\n",
      "compress\n",
      "heart\n",
      "condition\n",
      "cardiac tamponade\n",
      "breathlessness\n",
      "fatal\n",
      "low blood pressure\n",
      "Fluid\n",
      "removed\n",
      "pericardial space\n",
      "diagnosis\n",
      "tamponade\n",
      "syringe\n",
      "procedure\n",
      "pericardiocentesis\n",
      "Congenital heart disease\n",
      "people\n",
      "born\n",
      "hearts\n",
      "abnormal\n",
      "abnormalities\n",
      "congenital heart defects\n",
      "minor\n",
      "patent foramen ovale\n",
      "variant\n",
      "normal\n",
      "life-threatening abnormalities\n",
      "hypoplastic left heart syndrome\n",
      "abnormalities\n",
      "heart muscle\n",
      "heart\n",
      "heart\n",
      "ventricular septal defect\n",
      "defects\n",
      "affecting\n",
      "heart valves\n",
      "congenital aortic stenosis\n",
      "blood vessels\n",
      "heart\n",
      "coarctation\n",
      "aorta\n",
      "complex syndromes\n",
      "heart\n",
      "Tetralogy\n",
      "Fallot\n",
      "congenital heart defects\n",
      "blood\n",
      "low\n",
      "oxygen\n",
      "lungs\n",
      "pumped back\n",
      "body\n",
      "cyanotic congenital heart defects\n",
      "serious\n",
      "congenital heart defects\n",
      "childhood\n",
      "birth\n",
      "child\n",
      "born\n",
      "transposition\n",
      "arteries\n",
      "breathlessness\n",
      "rate\n",
      "growth\n",
      "congenital heart disease\n",
      "years\n",
      "adult\n",
      "life\n",
      "atrial septal defect\n",
      "Diagnosis Heart disease\n",
      "diagnosed\n",
      "medical history\n",
      "cardiac examination\n",
      "investigations\n",
      "blood tests\n",
      "echocardiograms\n",
      "ECGs\n",
      "imaging\n",
      "invasive procedures\n",
      "cardiac catheterisation\n",
      "Examination\n",
      "cardiac examination\n",
      "inspection\n",
      "feeling\n",
      "chest\n",
      "hands\n",
      "palpation\n",
      "listening\n",
      "stethoscope\n",
      "auscultation\n",
      "assessment\n",
      "signs\n",
      "person's hands\n",
      "splinter haemorrhages\n",
      "joints\n",
      "person's\n",
      "pulse\n",
      "radial artery\n",
      "wrist\n",
      "assess\n",
      "rhythm\n",
      "strength\n",
      "pulse\n",
      "blood pressure\n",
      "manual\n",
      "automatic sphygmomanometer\n",
      "invasive\n",
      "measurement\n",
      "artery\n",
      "elevation\n",
      "jugular\n",
      "venous pulse\n",
      "person's\n",
      "chest\n",
      "transmitted\n",
      "vibrations\n",
      "heart\n",
      "listened\n",
      "stethoscope\n",
      "Heart sounds\n",
      "healthy\n",
      "hearts\n",
      "audible\n",
      "heart sounds\n",
      "S1\n",
      "S2\n",
      "heart sound S1\n",
      "sound\n",
      "closing\n",
      "atrioventricular valves\n",
      "ventricular contraction\n",
      "heart sound\n",
      "S2\n",
      "sound\n",
      "semilunar valves\n",
      "closing\n",
      "ventricular diastole\n",
      "sound\n",
      "components\n",
      "valves\n",
      "S2\n",
      "sounds\n",
      "inspiration\n",
      "valvular\n",
      "cardiac problems\n",
      "heart sounds\n",
      "gallop rhythms\n",
      "third heart sound\n",
      "S3\n",
      "increase\n",
      "ventricular blood volume\n",
      "atrial gallop\n",
      "sound\n",
      "forced\n",
      "stiff ventricle\n",
      "presence\n",
      "S3\n",
      "quadruple gallop\n",
      "Heart murmurs\n",
      "abnormal\n",
      "heart sounds\n",
      "disease\n",
      "benign\n",
      "heart sounds\n",
      "abnormal\n",
      "heart sounds\n",
      "extra sounds\n",
      "murmurs\n",
      "flow\n",
      "blood\n",
      "sounds\n",
      "Murmurs\n",
      "volume\n",
      "quietest\n",
      "loudest\n",
      "evaluated\n",
      "relationship\n",
      "heart sounds\n",
      "position\n",
      "cardiac cycle\n",
      "features\n",
      "radiation\n",
      "sites\n",
      "changes\n",
      "person's\n",
      "position\n",
      "frequency\n",
      "sound\n",
      "stethoscope\n",
      "site\n",
      "Murmurs\n",
      "damaged\n",
      "heart valves\n",
      "congenital heart disease\n",
      "ventricular septal defects\n",
      "normal\n",
      "hearts\n",
      "pericardial friction rub\n",
      "cases\n",
      "pericarditis\n",
      "inflamed\n",
      "membranes\n",
      "rub\n",
      "Blood tests\n",
      "Blood tests\n",
      "diagnosis\n",
      "treatment\n",
      "cardiovascular conditions\n",
      "Troponin\n",
      "sensitive\n",
      "biomarker\n",
      "heart\n",
      "insufficient\n",
      "blood supply\n",
      "4–6 hours\n",
      "injury\n",
      "peaks\n",
      "hours\n",
      "tests\n",
      "troponin\n",
      "time\n",
      "initial\n",
      "presentation\n",
      "3–6\n",
      "hours\n",
      "level\n",
      "significant\n",
      "diagnostic\n",
      "brain natriuretic peptide\n",
      "BNP\n",
      "evaluate\n",
      "presence\n",
      "heart failure\n",
      "rises\n",
      "increased\n",
      "left ventricle\n",
      "tests\n",
      "biomarkers\n",
      "cardiac disease\n",
      "Testing\n",
      "MB\n",
      "creatine kinase\n",
      "information\n",
      "heart's\n",
      "blood supply\n",
      "specific\n",
      "sensitive\n",
      "blood tests\n",
      "person's\n",
      "general health\n",
      "risk factors\n",
      "heart disease\n",
      "investigating\n",
      "anaemia\n",
      "metabolic panel\n",
      "disturbances\n",
      "electrolytes\n",
      "coagulation\n",
      "right level\n",
      "anticoagulation\n",
      "Fasting\n",
      "lipids\n",
      "fasting blood glucose\n",
      "HbA1c\n",
      "level\n",
      "evaluate\n",
      "person's\n",
      "cholesterol\n",
      "diabetes status\n",
      "Electrocardiogram\n",
      "surface\n",
      "electrodes\n",
      "body\n",
      "record\n",
      "electrical activity\n",
      "heart\n",
      "electrical signal\n",
      "electrocardiogram\n",
      "ECG\n",
      "EKG\n",
      "ECG\n",
      "bedside test\n",
      "placement\n",
      "body\n",
      "ECG\n",
      "calculated\n",
      "ground).There\n",
      "features\n",
      "ECG\n",
      "P wave\n",
      "atrial depolarisation\n",
      "QRS complex\n",
      "ventricular depolarisation\n",
      "T wave\n",
      "ventricular repolarisation\n",
      "heart cells\n",
      "contract\n",
      "heart\n",
      "downward deflection\n",
      "ECG\n",
      "cells\n",
      "positive\n",
      "charge\n",
      "direction\n",
      "inflection\n",
      "cells\n",
      "negative\n",
      "repolarising\n",
      "direction\n",
      "position\n",
      "lead\n",
      "wave\n",
      "moved\n",
      "left\n",
      "negative deflection\n",
      "right\n",
      "positive deflection\n",
      "ECG\n",
      "tool\n",
      "detecting\n",
      "rhythm\n",
      "disturbances\n",
      "insufficient\n",
      "blood supply\n",
      "heart\n",
      "abnormalities\n",
      "suspected\n",
      "visible\n",
      "ECG\n",
      "Testing\n",
      "exercising\n",
      "abnormality\n",
      "ECG\n",
      "worn\n",
      "period\n",
      "24-hour Holter\n",
      "monitor\n",
      "suspected\n",
      "rhythm\n",
      "abnormality\n",
      "time\n",
      "assessment\n",
      "Imaging\n",
      "imaging methods\n",
      "assess\n",
      "anatomy\n",
      "function\n",
      "heart\n",
      "ultrasound (echocardiography\n",
      "angiography\n",
      "CT scans\n",
      "MRI\n",
      "PET\n",
      "echocardiogram\n",
      "ultrasound\n",
      "heart\n",
      "measure\n",
      "heart's function\n",
      "assess\n",
      "valve disease\n",
      "abnormalities\n",
      "Echocardiography\n",
      "probe\n",
      "chest\n",
      "transthoracic\n",
      "probe\n",
      "esophagus\n",
      "transoesophageal\n",
      "echocardiography\n",
      "report\n",
      "information\n",
      "width\n",
      "valves\n",
      "stenosis\n",
      "backflow of blood\n",
      "regurgitation\n",
      "information\n",
      "blood volumes\n",
      "systole\n",
      "diastole\n",
      "ejection fraction\n",
      "blood\n",
      "ejected\n",
      "left\n",
      "right ventricles\n",
      "systole\n",
      "Ejection fraction\n",
      "dividing\n",
      "volume\n",
      "ejected\n",
      "heart\n",
      "stroke\n",
      "volume\n",
      "volume\n",
      "filled heart\n",
      "end-diastolic volume\n",
      "Echocardiograms\n",
      "body\n",
      "stressed\n",
      "signs\n",
      "lack\n",
      "blood supply\n",
      "cardiac stress test\n",
      "exercise\n",
      "injection\n",
      "drug\n",
      "dobutamine\n",
      "CT scans\n",
      "chest X-rays\n",
      "imaging\n",
      "evaluate\n",
      "heart's\n",
      "size\n",
      "evaluate\n",
      "signs\n",
      "pulmonary oedema\n",
      "fluid\n",
      "heart\n",
      "evaluating\n",
      "aorta\n",
      "blood vessel\n",
      "leaves\n",
      "heart\n",
      "Treatment Diseases\n",
      "affecting\n",
      "heart\n",
      "treated\n",
      "methods\n",
      "lifestyle\n",
      "modification\n",
      "drug treatment\n",
      "surgery\n",
      "Ischaemic heart disease\n",
      "Narrowings\n",
      "coronary arteries\n",
      "ischaemic heart disease\n",
      "treated\n",
      "symptoms\n",
      "chest pain\n",
      "angina pectoris\n",
      "heart muscle\n",
      "damage\n",
      "artery\n",
      "myocardial infarction\n",
      "prevent\n",
      "myocardial infarction\n",
      "occurring\n",
      "Medications\n",
      "angina\n",
      "symptoms\n",
      "nitroglycerin\n",
      "beta blockers\n",
      "calcium channel blockers\n",
      "preventative\n",
      "treatments\n",
      "antiplatelets\n",
      "aspirin\n",
      "statins\n",
      "lifestyle\n",
      "measures\n",
      "smoking\n",
      "weight loss\n",
      "treatment\n",
      "risk factors\n",
      "high blood pressure\n",
      "diabetes\n",
      "medications\n",
      "heart arteries\n",
      "treated\n",
      "narrowings\n",
      "flow\n",
      "blood\n",
      "bypass\n",
      "obstruction\n",
      "percutaneous coronary intervention\n",
      "narrowings\n",
      "coronary arteries\n",
      "inflating\n",
      "balloon\n",
      "narrowing\n",
      "metal\n",
      "scaffold\n",
      "stent\n",
      "artery open\n",
      "narrowings\n",
      "coronary arteries\n",
      "treatment\n",
      "percutaneous coronary intervention\n",
      "open surgery\n",
      "coronary artery bypass graft\n",
      "blood vessel\n",
      "body\n",
      "saphenous vein\n",
      "radial artery\n",
      "internal mammary artery\n",
      "blood\n",
      "narrowing\n",
      "aorta\n",
      "obstruction\n",
      "Valvular heart disease\n",
      "Diseased heart valves\n",
      "narrow\n",
      "abnormally\n",
      "leaky\n",
      "surgery\n",
      "damaged\n",
      "heart valve\n",
      "tissue\n",
      "metallic\n",
      "tricuspid\n",
      "mitral valves\n",
      "repaired surgically\n",
      "valve replacement\n",
      "Heart valves\n",
      "treated percutaneously\n",
      "techniques\n",
      "similarities\n",
      "percutaneous coronary intervention\n",
      "Transcatheter aortic valve replacement\n",
      "patients\n",
      "risk\n",
      "open valve replacement\n",
      "Cardiac arrhythmias\n",
      "Abnormal heart rhythms\n",
      "arrhythmias\n",
      "treated\n",
      "antiarrhythmic drugs\n",
      "flow\n",
      "electrolytes\n",
      "cell membrane\n",
      "calcium channel blockers\n",
      "sodium channel blockers\n",
      "amiodarone\n",
      "digoxin\n",
      "modify\n",
      "autonomic nervous system's\n",
      "effect\n",
      "heart\n",
      "beta blockers\n",
      "atropine\n",
      "arrhythmias\n",
      "atrial fibrillation\n",
      "increase\n",
      "risk\n",
      "stroke\n",
      "risk\n",
      "reduced\n",
      "anticoagulants\n",
      "warfarin\n",
      "oral anticoagulants\n",
      "medications\n",
      "fail\n",
      "control\n",
      "arrhythmia\n",
      "treatment\n",
      "catheter ablation\n",
      "procedures\n",
      "wires\n",
      "vein\n",
      "artery\n",
      "leg\n",
      "heart\n",
      "abnormal area\n",
      "tissue\n",
      "arrhythmia\n",
      "abnormal\n",
      "tissue\n",
      "damaged\n",
      "ablated\n",
      "heating\n",
      "freezing\n",
      "heart rhythm\n",
      "disturbances\n",
      "arrhythmias\n",
      "treated\n",
      "minimally invasive\n",
      "catheter techniques\n",
      "arrhythmias\n",
      "atrial fibrillation\n",
      "treated\n",
      "open\n",
      "thoracoscopic surgery\n",
      "time\n",
      "cardiac surgery\n",
      "standalone procedure\n",
      "cardioversion\n",
      "electric shock\n",
      "stun\n",
      "heart\n",
      "abnormal rhythm\n",
      "Cardiac devices\n",
      "pacemakers\n",
      "implantable defibrillators\n",
      "treat\n",
      "arrhythmias\n",
      "Pacemakers\n",
      "small battery powered generator\n",
      "implanted\n",
      "skin\n",
      "heart\n",
      "treat\n",
      "Implantable defibrillators\n",
      "treat\n",
      "life-threatening\n",
      "devices monitor\n",
      "heart\n",
      "heart racing\n",
      "detected\n",
      "shock\n",
      "heart\n",
      "normal rhythm\n",
      "Implantable defibrillators\n",
      "patients\n",
      "heart failure\n",
      "cardiomyopathies\n",
      "inherited\n",
      "arrhythmia syndromes\n",
      "Heart failure\n",
      "patient's\n",
      "heart failure\n",
      "ischaemic heart disease\n",
      "hypertension\n",
      "heart failure\n",
      "treatment\n",
      "medication\n",
      "drugs\n",
      "prevent\n",
      "fluid\n",
      "lungs\n",
      "increasing\n",
      "amount\n",
      "urine\n",
      "patient\n",
      "diuretics\n",
      "drugs\n",
      "pumping function\n",
      "heart\n",
      "beta blockers\n",
      "ACE inhibitors\n",
      "mineralocorticoid receptor\n",
      "antagonists).In\n",
      "patients\n",
      "heart failure\n",
      "specialised pacemaker\n",
      "cardiac resynchronisation therapy\n",
      "improve\n",
      "heart's\n",
      "pumping\n",
      "efficiency\n",
      "devices\n",
      "defibrillator\n",
      "cases\n",
      "heart failure\n",
      "ventricular assist device\n",
      "implanted\n",
      "supplements\n",
      "heart's\n",
      "pumping\n",
      "severe\n",
      "cases\n",
      "cardiac transplant\n",
      "History\n",
      "Humans\n",
      "heart\n",
      "function\n",
      "anatomy\n",
      "religious\n",
      "societies\n",
      "heart\n",
      "Greeks\n",
      "primary seat\n",
      "scientific\n",
      "heart\n",
      "ancient world\n",
      "Aristotle\n",
      "heart\n",
      "organ\n",
      "blood\n",
      "Plato\n",
      "heart\n",
      "source\n",
      "circulating blood\n",
      "Hippocrates\n",
      "blood circulating\n",
      "body\n",
      "heart\n",
      "lungs\n",
      "Erasistratos\n",
      "BCE\n",
      "heart\n",
      "pump\n",
      "dilation\n",
      "blood vessels\n",
      "arteries\n",
      "veins\n",
      "heart\n",
      "distance\n",
      "air\n",
      "not blood\n",
      "heart valves\n",
      "Greek physician\n",
      "Galen\n",
      "CE\n",
      "blood vessels\n",
      "blood\n",
      "identified\n",
      "venous (dark red\n",
      "arterial\n",
      "thinner\n",
      "blood\n",
      "functions\n",
      "Galen\n",
      "heart\n",
      "hottest\n",
      "organ\n",
      "body\n",
      "heat\n",
      "body\n",
      "heart\n",
      "pump\n",
      "blood\n",
      "heart's motion\n",
      "blood\n",
      "diastole\n",
      "blood\n",
      "moved\n",
      "pulsation\n",
      "arteries\n",
      "Galen\n",
      "arterial blood\n",
      "venous blood\n",
      "left ventricle\n",
      "right\n",
      "pores\n",
      "ventricles\n",
      "Air\n",
      "lungs\n",
      "lungs\n",
      "pulmonary artery\n",
      "left side\n",
      "heart\n",
      "arterial blood\n",
      "unchallenged\n",
      "years\n",
      "Pre-modern\n",
      "descriptions\n",
      "coronary\n",
      "pulmonary circulation systems\n",
      "Commentary\n",
      "Anatomy\n",
      "Avicenna's Canon\n",
      "published\n",
      "manuscript\n",
      "al-Nafis\n",
      "wrote\n",
      "blood passes\n",
      "pulmonary circulation\n",
      "moving\n",
      "left ventricle\n",
      "Galen\n",
      "translated\n",
      "Latin\n",
      "Andrea Alpago\n",
      "Europe\n",
      "teachings\n",
      "Galen\n",
      "academic community\n",
      "doctrines\n",
      "official\n",
      "canon\n",
      "Church\n",
      "Galen's beliefs\n",
      "heart\n",
      "De humani corporis fabrica\n",
      "magnum opus\n",
      "authorities\n",
      "attacks\n",
      "Michael Servetus\n",
      "Christianismi Restitutio\n",
      "blood flows\n",
      "heart\n",
      "lungs\n",
      "flow\n",
      "blood\n",
      "heart\n",
      "body\n",
      "publication\n",
      "De Motu Cordis\n",
      "English physician\n",
      "William Harvey\n",
      "Harvey's book\n",
      "systemic\n",
      "circulation\n",
      "mechanical force\n",
      "heart\n",
      "overhaul\n",
      "Galenic doctrines\n",
      "Otto Frank\n",
      "German physiologist\n",
      "published works\n",
      "studies\n",
      "heart relationship\n",
      "Ernest Starling\n",
      "English physiologist\n",
      "heart\n",
      "conclusions\n",
      "Purkinje fibers\n",
      "bundle of His\n",
      "early\n",
      "electrical conduction system\n",
      "heart\n",
      "Sunao Tawara published his monograph\n",
      "Tawara's discovery\n",
      "atrioventricular node prompted Arthur Keith\n",
      "structures\n",
      "heart\n",
      "discovery\n",
      "sinoatrial node\n",
      "months\n",
      "structures\n",
      "anatomical\n",
      "electrocardiogram\n",
      "inventor\n",
      "Willem Einthoven\n",
      "Nobel Prize\n",
      "Medicine\n",
      "Physiology\n",
      "heart transplantation\n",
      "South African surgeon\n",
      "Christiaan Barnard\n",
      "Groote Schuur Hospital\n",
      "Cape Town\n",
      "milestone\n",
      "cardiac surgery\n",
      "attention\n",
      "medical profession\n",
      "world\n",
      "long-term\n",
      "survival rates\n",
      "patients\n",
      "Louis Washkansky\n",
      "recipient\n",
      "donated heart\n",
      "died\n",
      "days\n",
      "operation\n",
      "patients\n",
      "survive\n",
      "weeks\n",
      "American surgeon\n",
      "Norman Shumway\n",
      "transplantation techniques\n",
      "pioneers Richard\n",
      "Lower\n",
      "Vladimir Demikhov\n",
      "Adrian Kantrowitz\n",
      "heart transplantations\n",
      "heart disease\n",
      "infectious disease\n",
      "death\n",
      "United States\n",
      "deaths\n",
      "worldwide\n",
      "Framingham Heart Study\n",
      "effects\n",
      "influences\n",
      "heart\n",
      "diet\n",
      "exercise\n",
      "medications\n",
      "aspirin\n",
      "introduction\n",
      "ACE inhibitors\n",
      "beta blockers\n",
      "improved\n",
      "management\n",
      "chronic heart failure\n",
      "disease\n",
      "medical\n",
      "societal burden\n",
      "patients\n",
      "dying\n",
      "year\n",
      "diagnosis\n",
      "Society\n",
      "culture Symbolism\n",
      "vital organs\n",
      "heart\n",
      "entire body\n",
      "seat of life\n",
      "emotion\n",
      "reason\n",
      "intellect\n",
      "purpose\n",
      "heart\n",
      "emblematic symbol\n",
      "religions\n",
      "conscience\n",
      "moral courage\n",
      "religions\n",
      "temple\n",
      "throne\n",
      "God\n",
      "Islamic\n",
      "Judeo-Christian\n",
      "divine centre\n",
      "atman\n",
      "transcendent\n",
      "Hinduism\n",
      "diamond\n",
      "purity\n",
      "Buddha\n",
      "Taoist centre\n",
      "understanding.\"\"In\n",
      "Hebrew\n",
      "Bible\n",
      "word\n",
      "heart\n",
      "lev\n",
      "seat\n",
      "emotion\n",
      "anatomical organ\n",
      "function\n",
      "symbolism\n",
      "stomach\n",
      "concept\n",
      "soul\n",
      "Ancient\n",
      "Egyptian\n",
      "religion\n",
      "heart\n",
      "metaphysical heart\n",
      "drop\n",
      "blood\n",
      "child's\n",
      "mother's heart\n",
      "conception\n",
      "Egyptians\n",
      "heart\n",
      "seat\n",
      "emotion\n",
      "intention\n",
      "Egyptian\n",
      "expressions\n",
      "word ib\n",
      "Awi-ib\n",
      "Xak-ib\n",
      "Egyptian\n",
      "religion\n",
      "heart\n",
      "afterlife\n",
      "death\n",
      "nether world\n",
      "evidence\n",
      "possessor\n",
      "heart\n",
      "Anubis\n",
      "deities\n",
      "Weighing\n",
      "Heart ceremony\n",
      "heart\n",
      "weighed\n",
      "feather\n",
      "Maat\n",
      "behavior\n",
      "scales\n",
      "balanced\n",
      "heart's possessor\n",
      "life\n",
      "afterlife\n",
      "heart\n",
      "monster Ammit\n",
      "Chinese\n",
      "character\n",
      "heart\n",
      "心\n",
      "depiction\n",
      "heart\n",
      "heart chambers\n",
      "seal script\n",
      "Chinese\n",
      "word xīn\n",
      "metaphorical meanings\n",
      "intention\n",
      "Chinese medicine\n",
      "heart\n",
      "shén\n",
      "consciousness\n",
      "heart\n",
      "associated with\n",
      "small intestine\n",
      "tongue\n",
      "organs\n",
      "viscera\n",
      "fire\n",
      "elements\n",
      "Sanskrit\n",
      "word\n",
      "heart\n",
      "hṛd\n",
      "hṛdaya\n",
      "Sanskrit text\n",
      "Rigveda\n",
      "Sanskrit\n",
      "anatomical object\n",
      "seat\n",
      "emotion\n",
      "Hrd\n",
      "cognate\n",
      "word\n",
      "heart\n",
      "Greek\n",
      "Latin\n",
      "English\n",
      "philosophers\n",
      "scientists\n",
      "Aristotle\n",
      "heart\n",
      "seat\n",
      "emotion\n",
      "brain\n",
      "functions\n",
      "identification\n",
      "heart\n",
      "seat\n",
      "emotions\n",
      "Roman physician\n",
      "Galen\n",
      "seat\n",
      "passions\n",
      "liver\n",
      "seat\n",
      "brain\n",
      "heart\n",
      "Aztec system\n",
      "belief\n",
      "human\n",
      "sacrifice\n",
      "Aztecs\n",
      "heart-extraction\n",
      "Aztec\n",
      "heart\n",
      "tona\n",
      "seat\n",
      "individual\n",
      "fragment\n",
      "Sun's heat\n",
      "istli\n",
      "day\n",
      "Nahua\n",
      "heart-soul\n",
      "tona-tiuh\n",
      "hot\n",
      "Catholicism\n",
      "heart\n",
      "worship\n",
      "wounds\n",
      "Jesus Christ\n",
      "tradition\n",
      "influenced\n",
      "development\n",
      "Christian\n",
      "Sacred Heart of Jesus\n",
      "Immaculate Heart of Mary\n",
      "John Eudes\n",
      "expression\n",
      "heart\n",
      "cross-cultural\n",
      "grief\n",
      "lost\n",
      "romantic love\n",
      "Cupid's arrows\n",
      "Ovid\n",
      "Ovid\n",
      "Cupid\n",
      "wounding\n",
      "victims\n",
      "explicit\n",
      "heart\n",
      "wounded\n",
      "iconography\n",
      "Cupid shooting little heart symbols\n",
      "Renaissance\n",
      "Valentine's\n",
      "day\n",
      "Food Animal\n",
      "hearts\n",
      "food\n",
      "muscle\n",
      "protein\n",
      "dishes\n",
      "offal\n",
      "pan-Ottoman kokoretsi\n",
      "Chicken\n",
      "hearts\n",
      "giblets\n",
      "grilled\n",
      "skewers\n",
      "Japanese\n",
      "hāto\n",
      "yakitori\n",
      "Brazilian churrasco de coração\n",
      "Indonesian\n",
      "chicken\n",
      "heart satay\n",
      "pan-fried\n",
      "Jerusalem\n",
      "Egyptian\n",
      "cuisine\n",
      "finely chopped\n",
      "stuffing\n",
      "chicken\n",
      "recipes\n",
      "combined\n",
      "giblets\n",
      "Mexican pollo en menudencias\n",
      "Russian ragu\n",
      "kurinyikh\n",
      "potrokhov\n",
      "hearts\n",
      "beef\n",
      "pork\n",
      "mutton\n",
      "interchanged\n",
      "recipes\n",
      "heart\n",
      "hard-working muscle\n",
      "firm\n",
      "dry\n",
      "meat\n",
      "slow-cooked\n",
      "toughness\n",
      "julienne\n",
      "meat\n",
      "Chinese stir-fried heart\n",
      "Beef heart\n",
      "grilled\n",
      "braised\n",
      "Peruvian\n",
      "anticuchos de corazón\n",
      "barbecued beef\n",
      "hearts\n",
      "grilled\n",
      "tenderized\n",
      "long marination\n",
      "spice\n",
      "vinegar mixture\n",
      "Australian recipe\n",
      "mock goose\n",
      "braised\n",
      "Pig heart\n",
      "stewed\n",
      "poached\n",
      "braised\n",
      "sausage\n",
      "Balinese\n",
      "oret\n",
      "blood sausage\n",
      "pig\n",
      "heart\n",
      "blood\n",
      "French recipe\n",
      "cœur de porc à l'orange\n",
      "braised heart\n",
      "orange sauce\n",
      "animals\n",
      "Vertebrates\n",
      "size\n",
      "heart\n",
      "animal groups\n",
      "hearts\n",
      "vertebrates\n",
      "mice\n",
      "blue whale\n",
      "vertebrates\n",
      "heart\n",
      "ventral part\n",
      "body\n",
      "surrounded\n",
      "pericardium\n",
      "fish\n",
      "peritoneum\n",
      "SA\n",
      "node\n",
      "amniotes\n",
      "primitive\n",
      "vertebrates\n",
      "animals\n",
      "muscles\n",
      "heart\n",
      "continuous\n",
      "sinus\n",
      "beat\n",
      "wave\n",
      "chambers\n",
      "sinus venosus\n",
      "right atrium\n",
      "amniotes\n",
      "homologous\n",
      "SA\n",
      "node\n",
      "teleosts\n",
      "sinus\n",
      "coordination\n",
      "atrium\n",
      "rate\n",
      "heartbeat\n",
      "species\n",
      "beats\n",
      "codfish\n",
      "hummingbirds\n",
      "bpm\n",
      "ruby-throated hummingbird\n",
      "Double circulatory systems\n",
      "Adult\n",
      "amphibians\n",
      "reptiles\n",
      "circulatory system\n",
      "arterial\n",
      "venous parts\n",
      "heart\n",
      "sides\n",
      "chambers\n",
      "atria\n",
      "ventricle\n",
      "Blood\n",
      "systemic\n",
      "circulation\n",
      "lungs\n",
      "blood\n",
      "pumped simultaneously\n",
      "systemic\n",
      "circulation\n",
      "lungs\n",
      "double system\n",
      "blood\n",
      "circulate\n",
      "lungs\n",
      "oxygenated blood\n",
      "heart\n",
      "reptiles\n",
      "heart\n",
      "thorax\n",
      "snakes\n",
      "junction\n",
      "upper first\n",
      "heart\n",
      "chambers\n",
      "atria\n",
      "ventricle\n",
      "function\n",
      "hearts\n",
      "mammalian\n",
      "hearts\n",
      "snakes\n",
      "elongated\n",
      "affected\n",
      "environmental factors\n",
      "snake's heart\n",
      "position\n",
      "body\n",
      "influenced\n",
      "gravity\n",
      "snakes\n",
      "size\n",
      "blood pressure\n",
      "gravitational change\n",
      "results\n",
      "heart\n",
      "regions\n",
      "body\n",
      "snake's body length\n",
      "ventricle\n",
      "wall\n",
      "septum\n",
      "near\n",
      "pulmonary artery\n",
      "aortic\n",
      "openings\n",
      "reptilian\n",
      "species\n",
      "mixing\n",
      "bloodstreams\n",
      "aorta\n",
      "oxygenated blood\n",
      "crocodiles\n",
      "four-chambered heart\n",
      "heart\n",
      "lungfish\n",
      "septum\n",
      "ventricle\n",
      "degree\n",
      "separation\n",
      "de-oxygenated bloodstream\n",
      "lungs\n",
      "oxygenated stream\n",
      "body\n",
      "absence\n",
      "division\n",
      "living amphibian\n",
      "species\n",
      "amount\n",
      "respiration\n",
      "skin\n",
      "blood\n",
      "heart\n",
      "venae cavae\n",
      "oxygenated\n",
      "result\n",
      "finer division\n",
      "bloodstreams\n",
      "lungfish\n",
      "tetrapods\n",
      "species\n",
      "amphibian\n",
      "spongy\n",
      "nature\n",
      "ventricle\n",
      "separation\n",
      "bloodstreams\n",
      "original\n",
      "valves\n",
      "conus arteriosus\n",
      "spiral valve\n",
      "parallel parts\n",
      "bloodstreams\n",
      "separate\n",
      "division\n",
      "Archosaurs\n",
      "crocodilians\n",
      "birds\n",
      "mammals\n",
      "separation\n",
      "heart\n",
      "pumps\n",
      "heart chambers\n",
      "four-chambered heart\n",
      "archosaurs\n",
      "mammals\n",
      "crocodilians\n",
      "opening\n",
      "foramen\n",
      "Panizza\n",
      "base\n",
      "arterial trunks\n",
      "degree\n",
      "mixing\n",
      "blood\n",
      "heart\n",
      "dive\n",
      "underwater\n",
      "birds\n",
      "mammals\n",
      "streams\n",
      "blood\n",
      "pulmonary\n",
      "systemic\n",
      "circulations\n",
      "permanently\n",
      "physical barrier\n",
      "Fish Fish\n",
      "two-chambered heart\n",
      "atrium\n",
      "blood\n",
      "ventricle\n",
      "pump\n",
      "fish heart\n",
      "entry\n",
      "exit\n",
      "compartments\n",
      "chambers\n",
      "three-chambered\n",
      "four-chambered\n",
      "chamber\n",
      "atrium\n",
      "ventricle\n",
      "true chambers\n",
      "accessory chambers\"\".Primitive fish\n",
      "four-chambered heart\n",
      "chambers\n",
      "heart\n",
      "four-chambered hearts\n",
      "mammals\n",
      "birds\n",
      "sinus venosus\n",
      "deoxygenated blood\n",
      "body\n",
      "hepatic\n",
      "cardinal\n",
      "veins\n",
      "blood flows\n",
      "atrium\n",
      "muscular ventricle\n",
      "pumping action\n",
      "chamber\n",
      "conus arteriosus\n",
      "valves\n",
      "blood\n",
      "ventral aorta\n",
      "ventral aorta\n",
      "blood\n",
      "gills\n",
      "oxygenated\n",
      "flows\n",
      "dorsal aorta\n",
      "body\n",
      "tetrapods\n",
      "ventral aorta\n",
      "ascending aorta\n",
      "pulmonary artery).In\n",
      "adult\n",
      "fish\n",
      "chambers\n",
      "straight row\n",
      "S-shape\n",
      "chambers\n",
      "lying\n",
      "pattern\n",
      "cartilaginous fish\n",
      "ray-finned fish\n",
      "teleosts\n",
      "conus arteriosus\n",
      "aorta\n",
      "heart\n",
      "conus arteriosus\n",
      "amniotes\n",
      "absorbed\n",
      "ventricles\n",
      "course\n",
      "evolution\n",
      "sinus venosus\n",
      "structure\n",
      "reptiles\n",
      "birds\n",
      "absorbed\n",
      "right atrium\n",
      "Invertebrates\n",
      "Arthropods\n",
      "mollusks\n",
      "open circulatory system\n",
      "system\n",
      "deoxygenated blood\n",
      "heart\n",
      "cavities\n",
      "sinuses\n",
      "blood slowly\n",
      "heart\n",
      "one-way channels\n",
      "heart\n",
      "pumps\n",
      "blood\n",
      "hemocoel\n",
      "cavity\n",
      "organs\n",
      "heart\n",
      "arthropods\n",
      "muscular tube\n",
      "length\n",
      "body\n",
      "base\n",
      "head\n",
      "blood\n",
      "circulatory fluid\n",
      "haemolymph\n",
      "respiratory pigment\n",
      "copper-based haemocyanin\n",
      "oxygen transporter\n",
      "Haemoglobin\n",
      "arthropods\n",
      "invertebrates\n",
      "earthworms\n",
      "circulatory system\n",
      "transport oxygen\n",
      "reduced\n",
      "no veins\n",
      "arteries\n",
      "tubes\n",
      "Oxygen travels\n",
      "diffusion\n",
      "muscular vessels\n",
      "vessels\n",
      "contract\n",
      "animals\n",
      "hearts\"\".Squids\n",
      "cephalopods\n",
      "gill\n",
      "hearts\n",
      "branchial\n",
      "hearts\n",
      "systemic heart\n",
      "branchial\n",
      "hearts\n",
      "atria\n",
      "ventricle\n",
      "pump\n",
      "gills\n",
      "systemic heart pumps\n",
      "body\n",
      "chordates\n",
      "vertebrates\n",
      "hemichordates\n",
      "vesicle\n",
      "thickening\n",
      "aorta\n",
      "contracts\n",
      "pump\n",
      "blood\n",
      "presence\n",
      "ancestor\n",
      "groups\n",
      "lost\n",
      "echinoderms\n",
      "images\n",
      "References\n",
      "text\n",
      "CC-BY\n",
      "OpenStax College\n",
      "OpenStax CNX\n",
      "Bibliography Hall\n",
      "John\n",
      "Guyton\n",
      "medical physiology\n",
      "Philadelphia\n",
      "Fauci\n",
      "Anthony\n",
      "Jameson\n",
      "Joseph\n",
      "Harrison's Principles\n",
      "Internal Medicine\n",
      "McGraw-Hill Professional\n",
      "Susan Standring\n",
      "Gray's\n",
      "anatomy\n",
      "anatomical\n",
      "clinical practice\n",
      "London\n",
      "Churchill\n",
      "Livingstone\n",
      "ISBN\n",
      "Davidson's principles\n",
      "practice\n",
      "medicine\n",
      "Edinburgh\n",
      "Churchill\n",
      "External links\n",
      "Heart\n",
      "NIH\n",
      "Atlas\n",
      "Human Cardiac Anatomy\n",
      "Dissection\n",
      "review\n",
      "anatomy\n",
      "Human Heart\n",
      "vessels\n",
      "internal\n",
      "Prenatal\n",
      "human\n",
      "Animal\n",
      "hearts\n",
      "fish\n",
      "squid\n",
      "Heart\n",
      "Radio 4\n",
      "interdisciplinary\n",
      "David Wootton, Fay Bound Alberti & Jonathan Sawday\n",
      "Time\n",
      "ACTC1\n",
      "cardiac muscle alpha actin\n",
      "isoform\n",
      "alpha actin\n",
      "expressed\n",
      "skeletal muscle\n",
      "ACTA1\n",
      "Alpha cardiac actin\n",
      "protein\n",
      "thin\n",
      "filament\n",
      "cardiac sarcomeres\n",
      "muscle contraction\n",
      "generation\n",
      "force\n",
      "pump\n",
      "function\n",
      "heart\n",
      "Structure Cardiac alpha actin\n",
      "amino acids\n",
      "Cardiac alpha actin\n",
      "filamentous protein\n",
      "complex\n",
      "mesh\n",
      "cardiac alpha-actinin\n",
      "ACTN2\n",
      "Z-lines\n",
      "center\n",
      "sarcomere\n",
      "Polymerization\n",
      "globular actin\n",
      "G-actin\n",
      "structural filament\n",
      "F-actin\n",
      "two-stranded helix\n",
      "actin\n",
      "bind\n",
      "atomic structure\n",
      "monomeric actin\n",
      "Kabsch et al.\n",
      "group\n",
      "published\n",
      "structure\n",
      "actin filament\n",
      "Actins\n",
      "conserved proteins\n",
      "alpha actins\n",
      "muscle tissues\n",
      "contractile apparatus\n",
      "Cardiac\n",
      "ACTC1\n",
      "skeletal\n",
      "ACTA1\n",
      "amino acids\n",
      "Asp4Glu\n",
      "Glu5Asp\n",
      "Leu301Met\n",
      "Ser360Thr\n",
      "cardiac/skeletal\n",
      "actin monomer\n",
      "asymmetric domains\n",
      "inner domain\n",
      "sub-domains\n",
      "outer domain\n",
      "sub-domains\n",
      "amino\n",
      "carboxy-termini\n",
      "outer domain\n",
      "Function Actin\n",
      "dynamic structure\n",
      "states\n",
      "flexibility\n",
      "states\n",
      "movement\n",
      "sub-domain 2\n",
      "Myosin binding\n",
      "increases\n",
      "flexibility\n",
      "actin\n",
      "cross-linking studies\n",
      "myosin subfragment-1\n",
      "binds\n",
      "actin\n",
      "amino acid residues\n",
      "actin sub-domain 2\n",
      "effect\n",
      "ACTC1 gene\n",
      "development\n",
      "Experiments\n",
      "chick\n",
      "embryos\n",
      "association\n",
      "ACTC1\n",
      "knockdown\n",
      "reduction\n",
      "atrial septa\n",
      "Clinical significance\n",
      "Polymorphisms\n",
      "ACTC1\n",
      "Dilated Cardiomyopathy\n",
      "Japanese\n",
      "patients\n",
      "studies\n",
      "patients\n",
      "South Africa\n",
      "association\n",
      "E101K missense mutation\n",
      "associated with\n",
      "Hypertrophic Cardiomyopathy\n",
      "Left Ventricular Noncompaction\n",
      "mutation\n",
      "ACTC1 gene\n",
      "associated with\n",
      "atrial septal defects\n",
      "References\n",
      "reading\n",
      "characterization\n",
      "human\n",
      "ACTC1\n",
      "COPaKB\n",
      "GeneReviews/NIH/NCBI/UW\n",
      "entry\n",
      "Familial Hypertrophic Cardiomyopathy\n",
      "Human\n",
      "ACTC1\n",
      "genome\n",
      "location\n",
      "ACTC1 gene\n",
      "page\n",
      "UCSC Genome Browser\n",
      "Refractoriness\n",
      "object\n",
      "autowave\n",
      "nature\n",
      "excitable medium\n",
      "stimuli\n",
      "object stays\n",
      "refractory state\n",
      "refractory\n",
      "period\n",
      "recovery\n",
      "period\n",
      "associated with\n",
      "motion\n",
      "image\n",
      "left branch\n",
      "isocline                                                                u               ˙                                          \n",
      "details\n",
      "Reaction\n",
      "diffusion\n",
      "Parabolic partial differential equation\n",
      "physiology\n",
      "refractory\n",
      "period\n",
      "period\n",
      "time\n",
      "organ\n",
      "cell\n",
      "action\n",
      "amount\n",
      "excitable membrane\n",
      "stimulus\n",
      "resting state\n",
      "excitation\n",
      "electrically excitable muscle cells\n",
      "neurons\n",
      "Absolute\n",
      "refractory\n",
      "period\n",
      "depolarization\n",
      "repolarization\n",
      "period\n",
      "hyperpolarization\n",
      "Electrochemical usage\n",
      "initiation\n",
      "action\n",
      "potential\n",
      "refractory\n",
      "period\n",
      "absolute\n",
      "refractory\n",
      "period\n",
      "duration\n",
      "action\n",
      "potential\n",
      "neurons\n",
      "inactivation\n",
      "Na+ channels\n",
      "depolarize\n",
      "membrane\n",
      "channels\n",
      "inactivated\n",
      "membrane hyperpolarizes\n",
      "channels\n",
      "de-inactivate\n",
      "regain\n",
      "response\n",
      "stimulus\n",
      "period\n",
      "absolute\n",
      "voltage-gated potassium channels\n",
      "terminate\n",
      "action\n",
      "potential\n",
      "repolarizing\n",
      "membrane\n",
      "potassium conductance\n",
      "membrane\n",
      "increases\n",
      "K+ ions\n",
      "moving\n",
      "cell\n",
      "membrane\n",
      "potential\n",
      "equilibrium\n",
      "potential\n",
      "potassium\n",
      "hyperpolarization\n",
      "membrane\n",
      "membrane\n",
      "potential\n",
      "negative\n",
      "normal resting potential\n",
      "potassium conductance\n",
      "resting value\n",
      "stimulus\n",
      "initiation\n",
      "threshold\n",
      "depolarization\n",
      "equilibrium resting potential\n",
      "period\n",
      "Cardiac refractory\n",
      "period\n",
      "refractory\n",
      "period\n",
      "cardiac physiology\n",
      "ion currents\n",
      "cardiac cells\n",
      "nerve cells\n",
      "flow\n",
      "cell freely\n",
      "flow\n",
      "ions\n",
      "change\n",
      "voltage\n",
      "inside\n",
      "cell\n",
      "extracellular space\n",
      "nerve cells\n",
      "voltage\n",
      "action\n",
      "potential\n",
      "nerve cells\n",
      "cardiac action potential\n",
      "duration\n",
      "variations\n",
      "cell type\n",
      "autonomic tone\n",
      "action\n",
      "initiates\n",
      "cardiac cell\n",
      "initiate\n",
      "action\n",
      "potential\n",
      "duration of time\n",
      "shorter\n",
      "duration\n",
      "period\n",
      "refractory\n",
      "period\n",
      "duration\n",
      "heart\n",
      "cardiac refractory\n",
      "period\n",
      "absolute\n",
      "refractory\n",
      "period\n",
      "period\n",
      "absolute\n",
      "refractory\n",
      "period\n",
      "action\n",
      "potential\n",
      "period\n",
      "action\n",
      "potential\n",
      "circumstances\n",
      "cardiac refractory\n",
      "period\n",
      "re-entry\n",
      "tachycardia\n",
      "Vortices\n",
      "excitation\n",
      "myocardium\n",
      "autowave\n",
      "vortices\n",
      "re-entry\n",
      "vortices\n",
      "mechanism\n",
      "life-threatening\n",
      "cardiac arrhythmias\n",
      "autowave reverberator\n",
      "spiral waves\n",
      "rotors\n",
      "atria\n",
      "atrial fibrillation\n",
      "Neuronal refractory\n",
      "period\n",
      "refractory\n",
      "period\n",
      "neuron\n",
      "action\n",
      "potential\n",
      "millisecond\n",
      "action\n",
      "potential\n",
      "phases\n",
      "Phase\n",
      "depolarization\n",
      "depolarization\n",
      "voltage-gated sodium ion channels open\n",
      "increasing\n",
      "neuron's\n",
      "membrane conductance\n",
      "sodium ions\n",
      "depolarizing\n",
      "cell's membrane\n",
      "potential\n",
      "mV\n",
      "positive\n",
      "potential\n",
      "words\n",
      "membrane\n",
      "negative\n",
      "potential\n",
      "activation\n",
      "threshold\n",
      "depolarization\n",
      "neuron\n",
      "overshoots\n",
      "equilibrium\n",
      "potential\n",
      "activated membrane\n",
      "Phase\n",
      "repolarization\n",
      "repolarization\n",
      "voltage-gated sodium ion channels\n",
      "inactivate\n",
      "closed state\n",
      "now-depolarized membrane\n",
      "voltage-gated potassium channels activate\n",
      "inactivation\n",
      "sodium ion channels\n",
      "opening\n",
      "potassium ion channels\n",
      "repolarize\n",
      "cell's membrane\n",
      "potential\n",
      "resting membrane potential\n",
      "cell's membrane\n",
      "resting membrane potential\n",
      "near\n",
      "cell\n",
      "phase\n",
      "hyperpolarization\n",
      "larger-than-resting potassium conductance\n",
      "cell membrane\n",
      "potassium conductance\n",
      "drops\n",
      "cell\n",
      "resting membrane potential\n",
      "refractory\n",
      "periods\n",
      "inactivation\n",
      "voltage-gated sodium channels\n",
      "potassium channels\n",
      "closing\n",
      "Voltage-gated sodium channels\n",
      "gating\n",
      "mechanisms\n",
      "activation\n",
      "mechanism\n",
      "channel\n",
      "depolarization\n",
      "inactivation\n",
      "mechanism\n",
      "channel\n",
      "repolarization\n",
      "channel\n",
      "inactive state\n",
      "response\n",
      "depolarization\n",
      "period\n",
      "sodium channels\n",
      "inactive state\n",
      "absolute\n",
      "refractory\n",
      "period\n",
      "period\n",
      "voltage-activated sodium channels\n",
      "closed\n",
      "depolarization\n",
      "voltage-gated potassium channels\n",
      "response\n",
      "repolarization\n",
      "voltage-gated sodium channels\n",
      "active closed state\n",
      "time\n",
      "potassium conductance\n",
      "membrane\n",
      "threshold\n",
      "stimulus\n",
      "action potentials\n",
      "fire\n",
      "words\n",
      "membrane\n",
      "potential\n",
      "axon\n",
      "negative\n",
      "membrane\n",
      "stronger\n",
      "stimulus\n",
      "threshold\n",
      "voltage\n",
      "initiate\n",
      "action\n",
      "potential\n",
      "period\n",
      "period\n",
      "Skeletal muscle\n",
      "period\n",
      "muscle action\n",
      "potential\n",
      "absolute\n",
      "refractory\n",
      "period\n",
      "1–3 ms\n",
      "shorter\n",
      "cells\n",
      "References\n",
      "Books Papers\n",
      "heart beats\n",
      "rhythm set\n",
      "sinus node\n",
      "pacemaker\n",
      "nervous system\n",
      "hormones\n",
      "blood\n",
      "venous return\n",
      "amount\n",
      "blood\n",
      "heart\n",
      "nerves\n",
      "heart\n",
      "vagus nerve\n",
      "slows\n",
      "heart rate\n",
      "acetylcholine\n",
      "accelerans nerve\n",
      "speeds\n",
      "noradrenaline\n",
      "results\n",
      "increased\n",
      "bloodflow\n",
      "body\n",
      "sudden\n",
      "increase\n",
      "activity\n",
      "nerve fibres\n",
      "autonomic nervous system\n",
      "fight\n",
      "flight' system\n",
      "References\n",
      "AV-nodal reentrant tachycardia\n",
      "AVNRT\n",
      "abnormal\n",
      "supraventricular tachycardia\n",
      "SVT\n",
      "location\n",
      "heart\n",
      "bundle of His\n",
      "supraventricular tachycardia\n",
      "women\n",
      "men\n",
      "cases\n",
      "females\n",
      "symptom\n",
      "palpitations\n",
      "Treatment\n",
      "physical maneuvers\n",
      "medications\n",
      "rarely\n",
      "synchronized cardioversion\n",
      "Frequent\n",
      "attacks\n",
      "radiofrequency ablation\n",
      "tissue\n",
      "heart\n",
      "destroyed\n",
      "AVNRT\n",
      "reentrant circuit forms\n",
      "atrioventricular node\n",
      "circuit\n",
      "anatomical pathways\n",
      "fast pathway\n",
      "slow pathway\n",
      "right atrium\n",
      "slow pathway\n",
      "targeted\n",
      "ablation\n",
      "inferior\n",
      "posterior\n",
      "AV node\n",
      "anterior\n",
      "margin\n",
      "coronary sinus\n",
      "fast pathway\n",
      "superior\n",
      "posterior\n",
      "AV node\n",
      "pathways\n",
      "tissue\n",
      "behaves\n",
      "AV node\n",
      "authors\n",
      "AV node\n",
      "fast\n",
      "slow pathways\n",
      "accessory pathways\n",
      "Wolff-Parkinson-White syndrome\n",
      "WPW syndrome\n",
      "atrioventricular reciprocating tachycardia (AVRT\n",
      "AVNRT\n",
      "fast\n",
      "slow pathways\n",
      "right atrium\n",
      "AV node\n",
      "electrophysiologic\n",
      "properties\n",
      "AV\n",
      "Accessory pathways\n",
      "WPW syndrome\n",
      "AVRT\n",
      "atrioventricular valvular rings\n",
      "connection\n",
      "atria\n",
      "ventricles\n",
      "electrophysiologic\n",
      "properties\n",
      "muscular heart tissue\n",
      "heart's\n",
      "ventricles\n",
      "Signs and\n",
      "symptoms\n",
      "symptom\n",
      "AVNRT\n",
      "sudden development\n",
      "palpitations\n",
      "palpitations\n",
      "associated with\n",
      "fluttering\n",
      "sensation\n",
      "neck\n",
      "near-simultaneous\n",
      "contraction\n",
      "atria\n",
      "ventricles\n",
      "closed\n",
      "tricuspid valve\n",
      "pressure\n",
      "atrial contraction\n",
      "transmitted\n",
      "venous system\n",
      "heart rate\n",
      "feelings\n",
      "anxiety\n",
      "panic\n",
      "attacks\n",
      "cases\n",
      "fast heart\n",
      "associated with\n",
      "drop\n",
      "blood pressure\n",
      "someone\n",
      "dizziness\n",
      "rarely lose consciousness\n",
      "faint\n",
      "coronary artery disease\n",
      "narrowing\n",
      "arteries\n",
      "heart\n",
      "atherosclerosis\n",
      "heart rate\n",
      "chest pain\n",
      "angina\n",
      "pain\n",
      "pressure-like\n",
      "chest\n",
      "radiates\n",
      "left arm\n",
      "angle\n",
      "left jaw\n",
      "Symptoms\n",
      "trigger\n",
      "palpitations\n",
      "lifting heavy items\n",
      "bending forwards\n",
      "palpitations\n",
      "sudden\n",
      "acceleration\n",
      "heart rate\n",
      "heart skipping\n",
      "beat\n",
      "heart\n",
      "race\n",
      "minutes\n",
      "hours\n",
      "termination\n",
      "arrhythmia\n",
      "AVNRT\n",
      "heart rate\n",
      "beats\n",
      "inspection\n",
      "neck\n",
      "pulsation\n",
      "jugular vein\n",
      "cannon A-waves\n",
      "right atrium contracts\n",
      "closed\n",
      "Mechanisms\n",
      "mechanism\n",
      "AVNRT\n",
      "re-entrant circuit\n",
      "atrioventricular node\n",
      "AVNRT\n",
      "slow AV nodal pathway\n",
      "ventricle\n",
      "anterograde limb\n",
      "circuit\n",
      "fast AV nodal pathway\n",
      "atria\n",
      "retrograde\n",
      "limb\n",
      "re-entrant circuit\n",
      "reversed\n",
      "fast AV nodal pathway\n",
      "anterograde limb\n",
      "slow AV nodal pathway\n",
      "retrograde\n",
      "limb\n",
      "atypical\n",
      "AVNRT\n",
      "Atypical AVNRT\n",
      "slow AV nodal pathway\n",
      "anterograde limb\n",
      "left atrial fibres\n",
      "AV node\n",
      "left side\n",
      "inter-atrial septum\n",
      "retrograde\n",
      "limb\n",
      "AVNRT\n",
      "AVNRT\n",
      "AVNRT\n",
      "anterograde\n",
      "conduction\n",
      "slow pathway\n",
      "retrograde\n",
      "conduction\n",
      "fast pathway\n",
      "retrograde\n",
      "conduction\n",
      "fast pathway\n",
      "stimulation\n",
      "atria\n",
      "inverted P wave\n",
      "stimulation\n",
      "ventricles\n",
      "QRS complex\n",
      "result\n",
      "time\n",
      "QRS complex\n",
      "P wave\n",
      "RP interval\n",
      "time\n",
      "consecutive\n",
      "QRS complexes\n",
      "RP\n",
      "interval\n",
      "inverted P waves\n",
      "surface electrocardiogram\n",
      "ECG\n",
      "buried\n",
      "QRS complexes\n",
      "lead V1\n",
      "inferior\n",
      "Atypical\n",
      "AVNRT\n",
      "atypical\n",
      "AVNRT\n",
      "anterograde\n",
      "conduction\n",
      "fast pathway\n",
      "retrograde\n",
      "conduction\n",
      "slow pathway\n",
      "AVNRT).Multiple slow pathways\n",
      "anterograde\n",
      "retrograde\n",
      "conduction\n",
      "slow pathways\n",
      "retrograde\n",
      "conduction\n",
      "slow pathway\n",
      "stimulation\n",
      "atria\n",
      "delayed\n",
      "slow conduction tissue\n",
      "inverted P wave\n",
      "falls\n",
      "QRS complex\n",
      "surface\n",
      "ECG\n",
      "Diagnosis\n",
      "symptoms\n",
      "person\n",
      "medical care\n",
      "emergency department\n",
      "ECG\n",
      "changes\n",
      "confirm\n",
      "diagnosis\n",
      "QRS duration\n",
      "heart block\n",
      "suspected\n",
      "palpitations\n",
      "recurrent\n",
      "doctor\n",
      "Holter monitor\n",
      "portable\n",
      "wearable ECG recorder\n",
      "diagnosis\n",
      "recorder\n",
      "time\n",
      "symptoms\n",
      "cases\n",
      "disabling\n",
      "infrequent\n",
      "episodes\n",
      "palpitations\n",
      "insertion\n",
      "small device\n",
      "skin\n",
      "record\n",
      "heart activity\n",
      "implantable loop recorder\n",
      "ECG-based\n",
      "technologies\n",
      "AVNRT\n",
      "abnormal\n",
      "fast heart rhythms\n",
      "atrial fibrillation\n",
      "atrial flutter\n",
      "sinus tachycardia\n",
      "ventricular tachycardia\n",
      "tachyarrhythmias\n",
      "Wolff-Parkinson-White syndrome\n",
      "symptoms\n",
      "AVNRT.Blood tests\n",
      "people\n",
      "palpitations\n",
      "thyroid function tests\n",
      "TFTs\n",
      "overactive thyroid\n",
      "increases\n",
      "risk\n",
      "AVNRT\n",
      "electrolytes\n",
      "disturbances\n",
      "potassium\n",
      "calcium\n",
      "magnesium\n",
      "AVNRT\n",
      "cardiac\n",
      "markers\n",
      "–\n",
      "myocardial infarction\n",
      "heart attack\n",
      "cause\n",
      "AVNRT\n",
      "case\n",
      "patient\n",
      "chest pain\n",
      "Treatment\n",
      "Treatments\n",
      "AVNRT\n",
      "episodes\n",
      "tachycardia\n",
      "prevent\n",
      "episodes\n",
      "future\n",
      "treatments\n",
      "physical manoeuvres\n",
      "medication\n",
      "invasive procedures\n",
      "ablation\n",
      "Arrhythmia\n",
      "termination\n",
      "episode\n",
      "supraventricular tachycardia\n",
      "AVNRT\n",
      "action\n",
      "transiently blocks\n",
      "AV node\n",
      "AVNRT\n",
      "stop\n",
      "attack\n",
      "physical manoeuvres\n",
      "increase\n",
      "activity\n",
      "vagus nerve\n",
      "heart\n",
      "atrioventricular node\n",
      "manoeuvres\n",
      "carotid sinus massage\n",
      "pressure\n",
      "carotid sinus\n",
      "neck\n",
      "Valsalva manoeuvre\n",
      "increasing\n",
      "pressure\n",
      "chest\n",
      "exhale\n",
      "closed\n",
      "airway\n",
      "breath).Medications\n",
      "slow\n",
      "electrical conduction\n",
      "AV node\n",
      "AVNRT\n",
      "adenosine\n",
      "beta blockers\n",
      "non-dihydropyridine calcium channel blockers\n",
      "verapamil\n",
      "diltiazem\n",
      "adenosine\n",
      "beta blockers\n",
      "airways\n",
      "caution\n",
      "people\n",
      "asthma\n",
      "drugs\n",
      "antiarrhythmic drugs\n",
      "flecainide\n",
      "amiodarone\n",
      "fast heart rate\n",
      "tolerated\n",
      "development\n",
      "heart failure\n",
      "symptoms\n",
      "low blood pressure\n",
      "coma\n",
      "AVNRT\n",
      "electrically\n",
      "cardioversion\n",
      "procedure\n",
      "administering\n",
      "sedative\n",
      "general anaesthetic\n",
      "electric shock\n",
      "heart\n",
      "normal rhythm\n",
      "Arrhythmia\n",
      "prevention\n",
      "preventative\n",
      "treatment\n",
      "unpleasant\n",
      "symptoms\n",
      "associated with\n",
      "AVNRT\n",
      "arrhythmia\n",
      "benign condition\n",
      "preventative\n",
      "treatment\n",
      "treatment\n",
      "asymptomatic\n",
      "treatment\n",
      "long term\n",
      "antiarrhythmic medication\n",
      "drugs\n",
      "calcium channel antagonists\n",
      "beta blockers\n",
      "flecainide\n",
      "amiodarone\n",
      "digoxin\n",
      "drugs\n",
      "effective\n",
      "preventing\n",
      "episodes\n",
      "long term\n",
      "invasive procedure\n",
      "electrophysiology\n",
      "EP\n",
      "study\n",
      "catheter ablation\n",
      "confirm\n",
      "diagnosis\n",
      "cure\n",
      "procedure\n",
      "wires\n",
      "catheters\n",
      "heart\n",
      "vein\n",
      "leg\n",
      "tip\n",
      "catheters\n",
      "heat\n",
      "freeze\n",
      "slow pathway\n",
      "AV node\n",
      "electrical impulses\n",
      "preventing\n",
      "AVNRT\n",
      "risks\n",
      "benefits\n",
      "weighed\n",
      "Catheter ablation\n",
      "slow pathway\n",
      "cure\n",
      "AVNRT\n",
      "success rates\n",
      "small risk\n",
      "complications\n",
      "AV node\n",
      "pacemaker\n",
      "External links\n",
      "Angiotensin-converting-enzyme inhibitors\n",
      "ACE inhibitors\n",
      "medication\n",
      "treatment\n",
      "high blood pressure\n",
      "heart failure\n",
      "relaxation\n",
      "blood vessels\n",
      "decrease\n",
      "blood volume\n",
      "lower blood pressure\n",
      "decreased\n",
      "oxygen demand\n",
      "heart\n",
      "ACE inhibitors\n",
      "inhibit\n",
      "activity\n",
      "angiotensin-converting enzyme\n",
      "renin\n",
      "angiotensin system\n",
      "angiotensin I\n",
      "angiotensin II\n",
      "hydrolyses\n",
      "bradykinin\n",
      "ACE inhibitors\n",
      "decrease\n",
      "formation\n",
      "angiotensin II\n",
      "vasoconstrictor\n",
      "increase\n",
      "level\n",
      "bradykinin\n",
      "peptide vasodilator\n",
      "combination\n",
      "synergistic\n",
      "lowering\n",
      "blood pressure\n",
      "inhibiting\n",
      "ACE\n",
      "enzyme\n",
      "bradykinin system\n",
      "ACE inhibitor\n",
      "drugs\n",
      "increased\n",
      "levels\n",
      "bradykinin\n",
      "degraded\n",
      "mechanism\n",
      "side effects\n",
      "ACE Inhibitors\n",
      "angioedema\n",
      "cough\n",
      "Bradykinin\n",
      "prostaglandin\n",
      "prescribed\n",
      "ACE inhibitors\n",
      "benazepril\n",
      "zofenopril\n",
      "perindopril\n",
      "trandolapril\n",
      "captopril\n",
      "enalapril\n",
      "lisinopril\n",
      "ramipril\n",
      "ACE\n",
      "inhibitors\n",
      "treatment\n",
      "hypertension\n",
      "combination\n",
      "anti-hypertensive medications\n",
      "cardiovascular\n",
      "kidney diseases\n",
      "Acute myocardial infarction\n",
      "heart attack\n",
      "left ventricular systolic dysfunction\n",
      "Kidney\n",
      "complications\n",
      "diabetes mellitus\n",
      "diabetic nephropathy\n",
      "decreasing\n",
      "blood pressure\n",
      "increasing\n",
      "perfusion\n",
      "glomerular arterioles\n",
      "treating\n",
      "high blood pressure\n",
      "ACE inhibitors\n",
      "drug choice\n",
      "diabetes\n",
      "age\n",
      "choices\n",
      "drug\n",
      "improvement\n",
      "fixed-dose combination drugs\n",
      "ACE inhibitor\n",
      "thiazide combinations\n",
      "ACE inhibitors\n",
      "chronic kidney failure\n",
      "kidney\n",
      "involvement\n",
      "systemic sclerosis\n",
      "hardening\n",
      "tissues\n",
      "scleroderma renal crisis\n",
      "stable\n",
      "heart failure\n",
      "benefits\n",
      "treatments\n",
      "meta-analysis\n",
      "published\n",
      "BMJ\n",
      "ACE inhibitors\n",
      "reducing\n",
      "risk\n",
      "pneumonia\n",
      "ARBs\n",
      "Angiotensin II Receptor Blockers\n",
      "authors\n",
      "decreased\n",
      "risk\n",
      "patients\n",
      "stroke\n",
      "risk reduction\n",
      "heart failure\n",
      "risk reduction\n",
      "Asian descent\n",
      "risk reduction\n",
      "risk reduction\n",
      "non-Asian population\n",
      "pneumonia\n",
      "mortality\n",
      "observed\n",
      "ACE inhibitors\n",
      "decrease\n",
      "excessive\n",
      "water\n",
      "consumption\n",
      "people\n",
      "schizophrenia\n",
      "psychogenic polydipsia\n",
      "double-blind\n",
      "placebo-controlled trial\n",
      "enalapril\n",
      "decreased\n",
      "consumption\n",
      "urine output\n",
      "osmolality\n",
      "people\n",
      "effect\n",
      "ACE inhibitors\n",
      "ACEi\n",
      "renal transplant\n",
      "post-transplant erythrocytosis\n",
      "condition\n",
      "characterised\n",
      "persistently\n",
      "months\n",
      "transplantation\n",
      "ACEi\n",
      "decrease\n",
      "erythropoietin\n",
      "production\n",
      "Adverse effects\n",
      "side effects\n",
      "low blood pressure\n",
      "cough\n",
      "hyperkalemia\n",
      "headache\n",
      "dizziness\n",
      "fatigue\n",
      "nausea\n",
      "kidney impairment\n",
      "adverse effects\n",
      "ACE\n",
      "inhibition\n",
      "pharmacological action\n",
      "adverse effects\n",
      "liver problems\n",
      "effects\n",
      "fetus\n",
      "Kidney problems\n",
      "ACE inhibitors\n",
      "mechanism\n",
      "action\n",
      "Patients\n",
      "ACE inhibitor\n",
      "reduction\n",
      "glomerular filtration rate\n",
      "GFR\n",
      "decrease\n",
      "significant\n",
      "conditions\n",
      "decreased\n",
      "renal perfusions\n",
      "renal artery stenosis\n",
      "heart failure\n",
      "polycystic kidney disease\n",
      "volume depletion\n",
      "patients\n",
      "maintenance\n",
      "GFR\n",
      "angiotensin-II-dependent efferent\n",
      "vasomotor tone\n",
      "renal function\n",
      "monitored\n",
      "days\n",
      "initiation\n",
      "treatment\n",
      "ACE inhibitor\n",
      "patients\n",
      "decreased\n",
      "renal perfusion\n",
      "moderate\n",
      "reduction\n",
      "renal function\n",
      "serum creatinine\n",
      "stabilized\n",
      "week\n",
      "treatment\n",
      "therapeutic effect\n",
      "residual renal function\n",
      "Reduced\n",
      "GFR\n",
      "problem\n",
      "patient\n",
      "NSAID\n",
      "diuretic\n",
      "drugs\n",
      "risk\n",
      "renal failure\n",
      "increased\n",
      "High blood potassium\n",
      "complication\n",
      "treatment\n",
      "ACE inhibitor\n",
      "effect\n",
      "aldosterone\n",
      "Suppression\n",
      "angiotensin II\n",
      "decrease\n",
      "aldosterone\n",
      "levels\n",
      "aldosterone\n",
      "increasing\n",
      "excretion\n",
      "potassium\n",
      "ACE inhibitors\n",
      "retention\n",
      "potassium\n",
      "people\n",
      "potassium\n",
      "ACE inhibitor\n",
      "Hyperkalemia\n",
      "decrease\n",
      "velocity\n",
      "impulse conduction\n",
      "nerves\n",
      "muscles\n",
      "cardiac tissues\n",
      "cardiac dysfunction\n",
      "neuromuscular\n",
      "consequences\n",
      "muscle weakness\n",
      "paresthesia\n",
      "nausea\n",
      "diarrhea\n",
      "monitoring\n",
      "potassium\n",
      "levels\n",
      "patients\n",
      "treatment\n",
      "ACE inhibitors\n",
      "risk\n",
      "hyperkalemia\n",
      "adverse effect\n",
      "ACE inhibitors\n",
      "RAAS bloc\n"
     ]
    }
   ],
   "source": [
    "for ent in doc.ents:\n",
    "    print(ent)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('such_as', waste, carbon dioxide),\n",
       " ('include', They, MYH6),\n",
       " ('include', They, ACTC1),\n",
       " ('include', They, TNNI3),\n",
       " ('include', They, CDH2),\n",
       " ('include', They, PKP2),\n",
       " ('such_as', agents, adrenaline),\n",
       " ('such_as', agents, noradrenaline),\n",
       " ('such_as', agents, dopamine),\n",
       " ('include', receptors, baroreceptors),\n",
       " ('other', locations, cavae),\n",
       " ('other', locations, stretch receptors),\n",
       " ('other', locations, side),\n",
       " ('include', electrolytes, calcium),\n",
       " ('include', electrolytes, potassium),\n",
       " ('include', electrolytes, sodium),\n",
       " ('other', factors, lifestyle),\n",
       " ('include', heart, doctors),\n",
       " ('include', heart, surgeons),\n",
       " ('include', heart, intensivists),\n",
       " ('include', heart, health practitioners),\n",
       " ('include', health practitioners, physiotherapists),\n",
       " ('include', health practitioners, dieticians),\n",
       " ('such_as', toxins, alcohol),\n",
       " ('include', investigations, blood tests),\n",
       " ('include', investigations, echocardiograms),\n",
       " ('include', investigations, ECGs),\n",
       " ('include', investigations, imaging),\n",
       " ('include', examination, inspection),\n",
       " ('such_as', hands, splinter haemorrhages),\n",
       " ('other', areas, joints),\n",
       " ('other', areas, It involves assessment),\n",
       " ('such_as', features, their radiation),\n",
       " ('include', heart, ultrasound),\n",
       " ('include', heart, angiography),\n",
       " ('include', heart, CT scans),\n",
       " ('include', heart, MRI),\n",
       " ('include', heart, PET),\n",
       " ('such_as', drug, dobutamine),\n",
       " ('other', forms, X-rays),\n",
       " ('other', forms, CT scans),\n",
       " ('include', methods, lifestyle modification),\n",
       " ('include', methods, drug treatment),\n",
       " ('include', methods, surgery),\n",
       " ('include', symptoms, nitroglycerin),\n",
       " ('include', symptoms, beta blockers),\n",
       " ('include', treatments, antiplatelets),\n",
       " ('such_as', antiplatelets, aspirin),\n",
       " ('such_as', antiplatelets, statins),\n",
       " ('such_as', antiplatelets, lifestyle measures),\n",
       " ('such_as', cell membrane, calcium channel blockers),\n",
       " ('such_as', anticoagulants, warfarin),\n",
       " ('such_as', anticoagulants, anticoagulants),\n",
       " ('include', heart, diet),\n",
       " ('include', heart, exercise),\n",
       " ('include', heart, medications),\n",
       " ('such_as', medications, aspirin),\n",
       " ('such_as', word ib, Awi-ib),\n",
       " ('include', scientists, Aristotle),\n",
       " ('other', tetrapods, lungfish),\n",
       " ('such_as', invertebrates, earthworms),\n",
       " ('other', cephalopods, hearts\"\".Squids),\n",
       " ('include', chordates, vertebrates),\n",
       " ('include', Human Heart, vessels),\n",
       " ('such_as', procedures, ablation),\n",
       " ('include', manoeuvres, pressure),\n",
       " ('include', AVNRT, adenosine),\n",
       " ('include', AVNRT, beta blockers),\n",
       " ('include', AVNRT, calcium channel blockers),\n",
       " ('such_as', calcium channel blockers, verapamil),\n",
       " ('such_as', calcium channel blockers, diltiazem),\n",
       " ('such_as', drugs, flecainide),\n",
       " ('such_as', drugs, amiodarone),\n",
       " ('include', line agents, flecainide),\n",
       " ('include', line agents, amiodarone),\n",
       " ('include', line agents, digoxin),\n",
       " ('include', ACE inhibitors, benazepril),\n",
       " ('include', ACE inhibitors, zofenopril),\n",
       " ('include', ACE inhibitors, perindopril),\n",
       " ('include', ACE inhibitors, trandolapril),\n",
       " ('include', ACE inhibitors, captopril),\n",
       " ('include', ACE inhibitors, enalapril),\n",
       " ('include', ACE inhibitors, lisinopril),\n",
       " ('include', ACE inhibitors, ramipril),\n",
       " ('such_as', combination drugs, ACE inhibitor),\n",
       " ('such_as', combination drugs, thiazide combinations),\n",
       " ('such_as', consequences, muscle weakness),\n",
       " ('such_as', consequences, paresthesia),\n",
       " ('such_as', consequences, nausea),\n",
       " ('such_as', consequences, diarrhea),\n",
       " ('such_as', consequences, others)]"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Hearst Patterns\n",
    "doc._.hearst_patterns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CVD Cardiovascular diseases\n",
      "bpm beats per minute\n",
      "bpm beats per minute\n",
      "bpm beats per minute\n",
      "bpm beats per minute\n",
      "bpm beats per minute\n",
      "bpm beats per minute\n",
      "bpm beats per minute\n",
      "bpm beats per minute\n",
      "bpm beats per minute\n",
      "week week after the LMP\n",
      "week week after the LMP\n",
      "week week after the LMP\n",
      "week week after the LMP\n",
      "week week after the LMP\n",
      "week week after the LMP\n",
      "week week after the LMP\n",
      "CO Cardiac output\n",
      "CO Cardiac output\n",
      "SV stroke volume\n",
      "SV stroke volume\n",
      "HR heart rate\n",
      "HR heart rate\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "node nodal re-entrant tachycardia\n",
      "BNP brain natriuretic peptide\n",
      "ECG electrocardiogram\n",
      "ECG electrocardiogram\n",
      "ECG electrocardiogram\n",
      "ECG electrocardiogram\n",
      "ECG electrocardiogram\n",
      "ECG electrocardiogram\n",
      "ECG electrocardiogram\n",
      "ECG electrocardiogram\n",
      "ECG electrocardiogram\n",
      "ECG electrocardiogram\n",
      "ECG electrocardiogram\n",
      "ECG electrocardiogram\n",
      "ECG electrocardiogram\n",
      "ischaemic heart disease Ischaemic heart disease Narrowings of the coronary arteries\n",
      "ischaemic heart disease Ischaemic heart disease Narrowings of the coronary arteries\n",
      "ischaemic heart disease Ischaemic heart disease Narrowings of the coronary arteries\n",
      "ischaemic heart disease Ischaemic heart disease Narrowings of the coronary arteries\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "heart heart chambers\n",
      "G-actin globular actin\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "potential potential\n",
      "active voltage-activated sodium channels in the closed\n",
      "active voltage-activated sodium channels in the closed\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "AVNRT AV-nodal reentrant tachycardia\n",
      "SVT supraventricular tachycardia\n",
      "WPW syndrome Wolff-Parkinson-White syndrome\n",
      "WPW syndrome Wolff-Parkinson-White syndrome\n",
      "AVRT atrioventricular reciprocating tachycardia\n",
      "AVRT atrioventricular reciprocating tachycardia\n",
      "TFTs thyroid function tests\n",
      "EP electrophysiology\n",
      "sclerosis scleroderma renal crisis\n",
      "ARBs Angiotensin II Receptor Blockers\n",
      "GFR glomerular filtration rate\n",
      "GFR glomerular filtration rate\n",
      "GFR glomerular filtration rate\n"
     ]
    }
   ],
   "source": [
    "#Abbreviations\n",
    "for abrv in doc._.abbreviations:\n",
    "\tprint(str(abrv),str(abrv._.long_form))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "abbreviations=[]\n",
    "long_form=[]\n",
    "for abrv in doc._.abbreviations:\n",
    "    if str(abrv) not in abbreviations:\n",
    "        if str(abrv)!=str(abrv._.long_form):\n",
    "            abbreviations.append(str(abrv))\n",
    "            long_form.append(str(abrv._.long_form))\n",
    "\n",
    "hyponyms=list(doc._.hearst_patterns)\n",
    "sources=[str(source[1]) for source in hyponyms]\n",
    "targets=[str(target[2]) for target in hyponyms]\n",
    "relations=[str(relation[0]) for relation in hyponyms]\n",
    "\n",
    "for abrv,abrv_long in zip(abbreviations,long_form):\n",
    "    sources.append(abrv)\n",
    "    targets.append(abrv_long)\n",
    "    relations.append('abbreviated-as')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Pos Tagging and Dependency parsing\n",
    "def extract(sent):\n",
    "\n",
    "  doc=nlp_core(sent)\n",
    "  matcher = Matcher(nlp_core.vocab)\n",
    "  pattern = [{'DEP':'ROOT'}, \n",
    "            {'DEP':'prep','OP':\"?\"},\n",
    "            {'DEP':'agent','OP':\"?\"},  \n",
    "            {'POS':'ADJ','OP':\"?\"}] \n",
    "  matcher.add(\"relation\",[pattern]) \n",
    "  matches = matcher(doc)\n",
    "  k = len(matches) - 1\n",
    "  span = doc[matches[k][1]:matches[k][2]] \n",
    "\n",
    "  ent1,ent2,prv_tok_dep,prv_tok_text,prefix,modifier = \"\",\"\",\"\",\"\",\"\",\"\"\n",
    "  for tok in nlp_core(sent):\n",
    "    if tok.dep_ != \"punct\":\n",
    "      if tok.dep_ == \"compound\":\n",
    "        prefix = tok.text\n",
    "        if prv_tok_dep == \"compound\":\n",
    "          prefix = prv_tok_text + \" \"+ tok.text\n",
    "      \n",
    "      if tok.dep_.endswith(\"mod\") == True:\n",
    "        modifier = tok.text\n",
    "        if prv_tok_dep == \"compound\":\n",
    "          modifier = prv_tok_text + \" \"+ tok.text\n",
    "\n",
    "      if tok.dep_.find(\"subj\") == True:\n",
    "        ent1 = modifier +\" \"+ prefix + \" \"+ tok.text\n",
    "        prefix = \"\"\n",
    "        modifier = \"\"\n",
    "        prv_tok_dep = \"\"\n",
    "        prv_tok_text = \"\"   \n",
    "\n",
    "      if tok.dep_.find(\"obj\") == True:\n",
    "        ent2 = modifier +\" \"+ prefix +\" \"+ tok.text\n",
    "      prv_tok_dep = tok.dep_\n",
    "      prv_tok_text = tok.text\n",
    "      \n",
    "  return [ent1.strip(),span.text,ent2.strip()]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/opt/homebrew/Caskroom/miniforge/base/lib/python3.9/site-packages/scispacy/abbreviation.py:216: UserWarning: [W036] The component 'matcher' does not have any patterns defined.\n",
      "  global_matches = self.global_matcher(doc)\n"
     ]
    }
   ],
   "source": [
    "ner_core=[]\n",
    "for sent in doc.sents:\n",
    "    source=extract(str(sent))[0]\n",
    "    relation=extract(str(sent))[1]\n",
    "    target=extract(str(sent))[2]\n",
    "    if not any(re.search(\"^\\s*$\",s) for s in [source,target,relation]):\n",
    "        ner_core.append(extract(str(sent)))\n",
    "        sources.append(source)\n",
    "        relations.append(relation)\n",
    "        targets.append(target)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['animals  which', 'organ', 'blood']\n",
      "['pumped  blood', 'carries', 'metabolic  waste']\n",
      "['two  reptiles', 'have', 'three  chambers']\n",
      "['heart valves heart which', 'flows', 'backflow']\n",
      "['sac  which', 'enclosed', 'small  amount']\n",
      "['heart', 'pumps', 'blood']\n",
      "['that', 'generate', 'contraction']\n",
      "['circulation  which', 'receives', 'right  atrium']\n",
      "['where  it', 'pumped', 'carbon dioxide']\n",
      "['Exercise', 'increases', 'resting heart rate']\n",
      "['Cardiovascular  diseases', 'have', 'chest  pain']\n",
      "['Structure Location', 'situated', 'human  heart']\n",
      "['double-membraned  sac', 'surrounds', 'heart']\n",
      "['left  lung', 'smaller', 'border  heart']\n",
      "['adult  heart', 'has', 'mass']\n",
      "['Well-trained  athletes', 'have', 'larger  hearts']\n",
      "['Chambers', 'has', 'four  chambers']\n",
      "['tissue  this', 'made', 'structure']\n",
      "['fibrous  which', 'forms', 'atria']\n",
      "['conduction system conduction collagen', 'provides', 'electricity']\n",
      "['interventricular  septum', 'separates', 'ventricles']\n",
      "['when  they', 'thicker', 'greater  pressure']\n",
      "['four  which', 'has', 'chambers']\n",
      "['three  which', 'has', 'three  cusps']\n",
      "['mitral  valve', 'lies', 'atrium  ventricle']\n",
      "['bicuspid valve bicuspid its', 'known', 'two  cusps']\n",
      "['when  they', 'prevent', 'valves']\n",
      "['This', 'creates', 'place chordae them']\n",
      "['three  which', 'has', 'three  cusps']\n",
      "['cusps  which', 'flows', 'valve']\n",
      "['three  which', 'has', 'three  cusps']\n",
      "['right  atrium', 'receives', 'blood']\n",
      "['muscles  which', 'smooth', 'prominent  ridges']\n",
      "['endocardium moderator band', 'addition', 'crucial  role']\n",
      "['It', 'arises', 'interior  space']\n",
      "['which  it', 'tapers', 'blood']\n",
      "['arteries trunk that', 'branches', 'blood']\n",
      "['left  heart', 'has', 'left  atrium']\n",
      "['left  atrium', 'receives', 'oxygenated  blood']\n",
      "['left  atrium', 'has', 'outpouching']\n",
      "['left  ventricle', 'thicker', 'force  blood']\n",
      "['ventricle  left', 'has', 'trabeculae  carneae']\n",
      "['left  ventricle', 'pumps', 'blood']\n",
      "['coronary heart artery', 'carry', 'valve  blood']\n",
      "['It', 'made', 'epithelium heart chambers']\n",
      "['endocardium', 'play', 'also  contraction']\n",
      "['muscle cells', 'elegant', 'inner figure figure']\n",
      "['swirling  pattern', 'allows', 'blood']\n",
      "['muscle muscle which', 'are', 'ability']\n",
      "['muscle cells', 'make', 'bulk']\n",
      "['discs  which', 'connected', 'rapid  response']\n",
      "['syncytium  that', 'allow', 'blood']\n",
      "['pacemaker cells', 'make', 'cells conduction system']\n",
      "['few  which', 'smaller', 'limited  contractibility']\n",
      "['Cardiac muscle tissue', 'has', 'cell rate contraction']\n",
      "['They', 'include', 'MYH6']\n",
      "['that', 'sac', 'heart']\n",
      "['serous  that', 'lined', 'pericardial  surface']\n",
      "['pericardium', 'present', 'chest  heart']\n",
      "['Coronary circulation Heart tissue', 'needs', 'metabolic  wastes']\n",
      "['circulation  which', 'achieved', 'arteries']\n",
      "['arteries  which', 'receives', 'blood']\n",
      "['coronary  artery', 'splits', 'shortly  aorta']\n",
      "['It', 'does', 'this']\n",
      "['coronary  artery', 'supplies', 'posterior  sections']\n",
      "['coronary  artery', 'supplies', 'also  blood']\n",
      "['large  that', 'vein', 'atrium  most']\n",
      "['It', 'receives', 'cardiac  bottom']\n",
      "['cardiac  veins', 'drain', 'front']\n",
      "['smaller  they', 'collect', 'smaller  vessels']\n",
      "['third  which', 'travel', 'section']\n",
      "['left  vessel', 'joins', 'artery  atrium']\n",
      "['Nerve supply heart', 'receives', 'nerve signals']\n",
      "['nerves', 'act', 'heart rate']\n",
      "['Sympathetic  nerves', 'influence', 'also  force']\n",
      "['vagus  nerve', 'acts', 'trunk act heart rate']\n",
      "['nerves  that', 'form', 'network']\n",
      "['wandering  that', 'nerve', 'parasympathetic  stimulation']\n",
      "['Sympathetic  stimulation', 'causes', 'release']\n",
      "['depolarization repolarization which', 'shortens', 'thus repolarization rate']\n",
      "['It', 'opens', 'chemical ion influx']\n",
      "['Development heart', 'organ', 'functional  blood']\n",
      "['plate  which', 'derives', 'cardiogenic  region']\n",
      "['here  that', 'form', 'primitive heart tube']\n",
      "['week heart tube', 'lengthens', 'S-shape']\n",
      "['Further  development', 'include', 'formation']\n",
      "['atrium  blood', 'allowed', 'lungs']\n",
      "['septum primum septum that', 'closes', 'cardiac circulation pattern']\n",
      "['embryonic heart rate', 'accelerates', 'peak  rate']\n",
      "['Physiology Blood flow', 'functions', 'continuous heart flow']\n",
      "['systemic  circulation', 'transports', 'deoxygenated carbon blood']\n",
      "['right  heart', 'collects deoxygenated', 'deoxygenated  blood']\n",
      "['Blood', 'collects', 'right  atrium']\n",
      "['inferior vena cava', 'drains', 'blood']\n",
      "['lungs  it', 'divides', 'capillaries']\n",
      "['which  ventricles', 'period', 'blood']\n",
      "['atria', 'relaxed', 'blood']\n",
      "['When  ventricles', 'contract', 'diastole atria blood']\n",
      "['ventricles', 'completed most', 'ventricles atria pump']\n",
      "['aortic aorta valves', 'open', 'further  pressure']\n",
      "['Blood', 'ejected', 'heart  pressure']\n",
      "['This', 'calculated', 'stroke volume']\n",
      "['So  CO', '=', 'SV HR']\n",
      "['cardiac  output', 'L/min', 'average stroke volume']\n",
      "['stroke volume', 'measured', 'normally  echocardiogram']\n",
      "['less  preload', 'is', 'ventricles']\n",
      "['much  heart', 'influenced', 'blood']\n",
      "['strength', 'controls', 'muscle contractions stroke volume']\n",
      "['adrenaline  inotropes', 'decrease', 'contraction calcium channel blockers']\n",
      "['that', 'created', 'heart heart muscle']\n",
      "['which', 'part', 'signal']\n",
      "['signal', 'travels', 'right bundle branches']\n",
      "['tissue Purkinje which', 'carried', 'electric  charge']\n",
      "['Cells', 'do', 'node action potential']\n",
      "['they', 'have', 'negative  charge']\n",
      "['rapid  influx', 'causes', 'sodium ions sodium charge']\n",
      "['potassium', 'close', 'it']\n",
      "['only  it', 'has', 'high  charge']\n",
      "['potassium', 'close', 'cell']\n",
      "['This', 'causes', 'resting  charge']\n",
      "['process', 'close', '−60  mV']\n",
      "['Calcium', 'plays', 'critical  role']\n",
      "['when plateau they', 'means', 'positive  charge']\n",
      "['Calcium ions', 'combine', 'protein troponin relaxation']\n",
      "['Influences', 'influenced', 'resting heart rate']\n",
      "['cardiovascular  centres', 'control', 'sympathetic  influences']\n",
      "['reflexes carbon help', 'receive', 'blood flow']\n",
      "['cardiac baroreceptor firing centers', 'decrease sympathetic', 'parasympathetic  stimulation']\n",
      "['pressure  rate', 'increase sympathetic', 'parasympathetic baroreceptor firing stimulation']\n",
      "['specialized  baroreceptors', 'stretches', 'walls']\n",
      "['cardiac blood center', 'responds', 'parasympathetic heart rate']\n",
      "['Low  oxygen', 'stimulate', 'high carbon firing']\n",
      "['Exercise levels', 'affect', 'all heart rate']\n",
      "['High  levels', 'increase', 'hormones heart rate']\n",
      "['low blood oxygen', 'increase', 'low blood it']\n",
      "['which', 'cause', 'diseases']\n",
      "['medical  professionals', 'involved', 'diseases']\n",
      "['coronary  severe', 'narrow', 'blood flow']\n",
      "['then  patient', 'experience', 'symptoms']\n",
      "['Severe  narrowings', 'cause chest', 'chest  pain']\n",
      "['thin  covering', 'rupture', 'fatty  centre']\n",
      "['case  clot', 'form', 'myocardial heart infarction']\n",
      "['case  this', 'cause cardiac', 'cardiac  arrest']\n",
      "['Obesity', 'increase', 'all blood atherosclerosis']\n",
      "['which  heart', 'defined', 'enough  demands']\n",
      "['Patients', 'experience', 'heart failure heart breathlessness']\n",
      "['Heart failure', 'result', 'diseases end heart']\n",
      "['common  causes', 'include various', 'various  cardiomyopathies']\n",
      "['condition', 'affect', 'right  ventricle']\n",
      "['Patients', 'risk', 'dangerous heart rhythm disturbances']\n",
      "['Cardiomyopathies Cardiomyopathies', 'diseases', 'muscle']\n",
      "['heart', 'cause', 'dilated  cardiomyopathy']\n",
      "['blood', 'allow', 'direction  it']\n",
      "['Diseased heart valves', 'have', 'valve  blood']\n",
      "['Valvular heart disease', 'cause', 'abnormal  heart']\n",
      "['Abnormal heart rhythms', 'asymptomatic', 'palpitations']\n",
      "['types', 'increase', 'long term risk']\n",
      "['re-entrant AV others', 'take many', 'heart  arise']\n",
      "['which', 'become inflamed', 'heart']\n",
      "['chest  that', 'causes chest', 'chest  pain']\n",
      "['Pericardial  effusions', 'occur secondary', 'frequently kidney symptoms']\n",
      "['which', 'compress', 'tamponade  breathlessness']\n",
      "['Fluid', 'removed', 'diagnosis  syringe']\n",
      "['heart that', 'include', 'heart  hole']\n",
      "['main blood that', 'include', 'e.g.  coarctation']\n",
      "['that', 'seen', 'one  part']\n",
      "['oxygen  that', 'allow', 'blood']\n",
      "['transposition', 'picked', 'arteries  breathlessness']\n",
      "['minor  forms', 'remain undetected', 'only heart themselves']\n",
      "['invasive  procedures', 'play', 'also  role']\n",
      "['cardiac Examination examination', 'includes', 'chest']\n",
      "['signs  that', 'involves', 'assessment']\n",
      "['blood pressure', 'taken', 'invasive  measurement']\n",
      "['healthy  hearts', 'sounds', 'audible heart sounds']\n",
      "['two  valves', 'consists', 'slight  difference']\n",
      "['also  these', 'present', 'rise']\n",
      "['S3', 'indicates', 'usually  increase']\n",
      "['combined  presence', 'give', 'quadruple  gallop']\n",
      "['tests Blood tests', 'play', 'important  role']\n",
      "['It', 'released', '4–6 hours']\n",
      "['significant  rise', 'taken', 'often  one']\n",
      "['frequently blood it', 'provides', 'creatine kinase creatine information']\n",
      "['general health that', 'taken', 'general health factors']\n",
      "['metabolic blood that', 'include', 'disturbances']\n",
      "['Fasting  lipids', 'ordered', 'often cholesterol status']\n",
      "['body surface it', 'possible', 'electrical  activity']\n",
      "['ECG', 'test', 'bedside placement']\n",
      "['ground).There', 'produces', '12  lead']\n",
      "['that', 'create', 'current']\n",
      "['negative  lead', 'depends', 'positive  deflection']\n",
      "['ECG', 'tool', 'insufficient blood supply']\n",
      "['suspected rhythm abnormality', 'worn', 'abnormality']\n",
      "['Several imaging methods', 'used', 'anatomy']\n",
      "['echocardiogram', 'ultrasound', 'heart  function']\n",
      "['much  blood', 'include', 'valves  stenosis']\n",
      "['Ejection fraction', 'obtained', 'then  volume']\n",
      "['where  this', 'involves', 'injection']\n",
      "['CT scans', 'help', 'imaging  size']\n",
      "['major blood which', 'useful', 'heart']\n",
      "['Treatment Diseases', 'treated', 'heart']\n",
      "['when heart muscle artery', 'treated', 'myocardial  infarction']\n",
      "['preventative calcium channel treatments', 'include', 'aspirin lifestyle smoking']\n",
      "['narrowed heart arteries', 'treated', 'blood  obstruction']\n",
      "['which  narrowings', 'performed', 'stent artery open']\n",
      "['whereby blood vessel', 'performed', 'mammary  blood']\n",
      "['that', 'require', 'abnormally  surgery']\n",
      "['This', 'performed', 'damaged heart valve']\n",
      "['circumstances tricuspid valves', 'repaired', 'surgically  need']\n",
      "['percutaneously  that', 'treated', 'many  similarities']\n",
      "['Transcatheter aortic valve replacement', 'used', 'high  risk']\n",
      "['Cardiac  arrhythmias', 'treated', 'antiarrhythmic heart drugs']\n",
      "['These', 'work', 'nervous sodium channel effect']\n",
      "['stroke  risk', 'reduced', 'anticoagulants']\n",
      "['treatment option', 'ablation', 'arrhythmia']\n",
      "['tissue  that', 'passed', 'arrhythmia']\n",
      "['abnormal  tissue', 'damaged', 'further heart rhythm disturbances']\n",
      "['invasive catheter arrhythmias', 'treated', 'open  surgery']\n",
      "['electric  shock', 'used', 'heart']\n",
      "['Cardiac  devices', 'required', 'also  arrhythmias']\n",
      "['skin  that', 'leads', 'slow heart rhythms']\n",
      "['Implantable  defibrillators', 'used', 'rapid heart rhythms']\n",
      "['dangerous heart racing', 'monitor', 'automatically  heart']\n",
      "['Heart failure', 'medication', 'underlying  cause']\n",
      "['that', 'include', 'resynchronisation therapy pumping efficiency']\n",
      "['which', 'implanted', 'own pumping ability']\n",
      "['blood  Hippocrates', 'considered', 'blood']\n",
      "['they', 'noted', 'pump  dilation']\n",
      "['He', 'discovered', 'also heart valves']\n",
      "['Greek physician Galen', 'knew', 'brighter blood blood']\n",
      "['body  it', 'concluded', 'heat']\n",
      "['diastole  blood', 'pump', 'blood']\n",
      "['academic  doctrines', 'continued', 'academic  community']\n",
      "['authorities  he', 'questioned', 'some']\n",
      "['Christianismi Restitutio Christianismi blood', 'wrote', 'Christianismi Restitutio Christianismi that']\n",
      "['William Harvey physician William book', 'came', 'systemic  circulation']\n",
      "['English  who', 'physiologist', 'also  heart']\n",
      "['heart Sunao Tawara', 'recognized', 'Reizleitungssystem des Säugetierherzens']\n",
      "['discovery', 'prompted', 'node Arthur Keith']\n",
      "['electrocardiogram  inventor', 'form', 'Nobel Prize']\n",
      "['This', 'marked', 'surgery  attention']\n",
      "['American surgeon Norman Shumway', 'credited', 'efforts transplantation techniques']\n",
      "['United States United it', 'surpassed infectious', 'infectious  disease']\n",
      "['ongoing Framingham Heart Study', 'shed', 'light']\n",
      "['heart failure heart disease', 'continues', 'year 30 diagnosis']\n",
      "['heart', 'symbol', 'religions  temple']\n",
      "['expressions  which', 'evidenced', 'ib']\n",
      "['where nether it', 'conceived', 'evidence']\n",
      "['Maat  which', 'weighed more', 'ideal  standard']\n",
      "['it', 'devoured', 'just  afterlife']\n",
      "['Chinese  character', 'derives', 'heart heart chambers']\n",
      "['Chinese  word', 'takes', 'metaphorical  meanings']\n",
      "['heart', 'associated', 'six  organs']\n",
      "['Sanskrit  it', 'mean', 'anatomical  seat']\n",
      "['classical  philosophers', 'considered', 'often  brain']\n",
      "['physician Galen physician who', 'due', 'also  seat']\n",
      "['heart', 'played', 'also  role']\n",
      "['Jesus Christ Jesus which', 'consider', 'prominence']\n",
      "['tradition', 'influenced', 'development']\n",
      "['that', 'ancient', 'explicit']\n",
      "['little Renaissance that', 'theme', 'little heart symbols']\n",
      "['Many  recipes', 'combined', 'them']\n",
      "['Australian  recipe', 'braised', 'stuffed beef heart']\n",
      "['Other  animals', 'Vertebrates', 'size']\n",
      "['which', 'continuous', 'beat']\n",
      "['systems Adult systems amphibians', 'have', 'circulatory  system']\n",
      "['lungs  which', 'allows', 'oxygenated  blood']\n",
      "['fact  snakes', 'different', 'elongated  body']\n",
      "['that', 'tend', 'higher blood pressure']\n",
      "['rule  which', 'crocodiles', 'four-chambered  heart']\n",
      "['spongy  nature', 'seem', 'ventricle  more']\n",
      "['valve  that', 'replaced', 'two  bloodstreams']\n",
      "['four-chambered  heart', 'thought', 'complete  separation']\n",
      "['what', 'have', 'one  it']\n",
      "['sometimes  what', 'has', 'entry compartments']\n",
      "['primitive  heart', 'considered', 'four-chambered  heart']\n",
      "['sinus which', 'venosus', 'deoxygenated  blood']\n",
      "['main pumping action', 'flows', 'place']\n",
      "['conus  which', 'arteriosus', 'several  blood']\n",
      "['two  chambers', 'delivers', 'instead  S-shape']\n",
      "['Invertebrates Arthropods', 'have', 'circulatory  system']\n",
      "['blood', 'permeates', 'slowly  heart']\n",
      "['heart', 'pumps', 'then  blood']\n",
      "['muscular  that', 'tube', 'length']\n",
      "['which', 'haemolymph', 'pigment copper-based pigment haemocyanin']\n",
      "['circulatory  system', 'used', 'much  veins']\n",
      "['animals  that', 'travels', 'two gill hearts']\n",
      "['systemic  heart', 'have', 'two  atria']\n",
      "['central  which', 'have', 'aorta  blood']\n",
      "['This', 'suggests', 'presence']\n",
      "['article', 'Notes', 'text']\n",
      "['– NIH Atlas', 'discussion', 'human development Animal Heart']\n",
      "['ACTC1', 'encodes cardiac', 'cardiac muscle alpha actin']\n",
      "['sarcomeres  which', 'protein', 'force pump function']\n",
      "['same Kabsch et group', 'solved', 'structure']\n",
      "['actin monomer', 'has', 'asymmetric  domains']\n",
      "['dynamic  that', 'structure', 'two  states']\n",
      "['2 actin which', 'increases', 'flexibility']\n",
      "['ACTC1 gene', 'suggested', 'role']\n",
      "['Experiments', 'found', 'chick embryos chick association']\n",
      "['Further  studies', 'found', 'South Africa South association']\n",
      "['stimuli  object', 'reading External', 'genome location gene details']\n",
      "['characteristic recovery that', 'time', '–          diffusion']\n",
      "['stimulus   it', 'period', 'particular  action']\n",
      "['refractory  period', 'defined', 'two  ways']\n",
      "['Na+ channels Na+ that', 'caused', 'originally  membrane']\n",
      "['channels', 'close', 'then  ability']\n",
      "['refractory  period', 'follows', 'immediately  absolute']\n",
      "['potassium conductance', 'increases', 'action membrane']\n",
      "['K+ ions', 'bring', 'cell membrane potential']\n",
      "['that membrane potential', 'becomes', 'brief  hyperpolarization']\n",
      "['greater  stimulus', 'required', 'initiation threshold']\n",
      "['return', 'marks', 'potential  end']\n",
      "['time action which', 'unable', 'action potential']\n",
      "['period  which', 'referred to', 'duration  heart']\n",
      "['refractory  period', 'occurs', 'one action millisecond']\n",
      "['voltage-gated sodium ion channels', 'open', 'sodium ions membrane potential']\n",
      "['-55 activation depolarization', 'driven', 'equilibrium   potential']\n",
      "['inactivation', 'act', 'ion channels membrane potential']\n",
      "['resting membrane cell', 'enters', 'phase']\n",
      "['depolarization inactivation that', 'have', 'channel']\n",
      "['membrane', 'means', 'greater action potentials']\n",
      "['stronger  stimulus', 'required', 'thus action potential']\n",
      "['refractory  period', 'lasts', '2–4  ms']\n",
      "['References Books heart', 'See', 'References Books Papers']\n",
      "['accelerans which', 'nerve', 'it']\n",
      "['conducting radiofrequency tissue', 'require', 'radiofrequency ablation']\n",
      "['slow  which', 'involves', 'anatomical  pathways']\n",
      "['AV node AV authors', 'formed', 'them']\n",
      "['accessory pathways accessory that', 'confused', 'rise']\n",
      "['fast  pathways', 'located', 'electrophysiologic AV properties']\n",
      "['that', 'located', 'rise']\n",
      "['They', 'provide', 'electrophysiologic  properties']\n",
      "['someone', 'experience', 'rarely  consciousness']\n",
      "['angina heart pain', 'band-', 'chest heart pain']\n",
      "['palpitations', 'occur', 'heavy  forwards']\n",
      "['feeling heart heart', 'sudden', 'beat']\n",
      "['Close  inspection', 'reveal', 'neck  pulsation']\n",
      "['Mechanisms', 'circuit', 'fundamental  mechanism']\n",
      "['Typical  AVNRT', 'take several', 'AV nodal AV pathway']\n",
      "['atrial anterograde that', 'use', 'AV node']\n",
      "['ventricles P which', 'occurs', 'QRS complex']\n",
      "['inverted P that', 'delayed', 'inverted P wave']\n",
      "['120 heart block', 'show typical', 'diagnosis']\n",
      "['doctor', 'request', 'Holter monitor']\n",
      "['recorder', 'show', 'diagnosis']\n",
      "['skin  that', 'require', 'continuously heart activity']\n",
      "['only  patient', 'case', 'further pain Treatment episodes']\n",
      "['treatments', 'include physical', 'physical  manoeuvres']\n",
      "['action  that', 'terminated', 'transiently AV node']\n",
      "['physical  that', 'able', 'activity']\n",
      "['airway Valsalva slow', 'include', 'AV node AV AVNRT']\n",
      "['people  who', 'cause', 'asthma']\n",
      "['used  drugs', 'include antiarrhythmic', 'antiarrhythmic  drugs']\n",
      "['then blood AVNRT', 'terminated', 'electrically  cardioversion']\n",
      "['electric  shock', 'applied', 'normal  rhythm']\n",
      "['preventative  treatment', 'helpful', 'unpleasant  symptoms']\n",
      "['those  who', 'become asymptomatic', 'further  treatment']\n",
      "['who', 'choose', 'term antiarrhythmic term medication']\n",
      "['drugs', 'effective', 'long  term']\n",
      "['invasive  procedure', 'used', 'potentially catheter cure']\n",
      "['procedure', 'involves', 'wires']\n",
      "['tip', 'used', 'electrical AV AVNRT']\n",
      "['Catheter  ablation', 'cure', 'subsequently AV pacemaker']\n",
      "['Angiotensin-converting-enzyme  inhibitors', 'class', 'External  links']\n",
      "['blood volume blood which', 'work', 'blood pressure oxygen demand']\n",
      "['angiotensin system angiotensin which', 'inhibit', 'II angiotensin bradykinin']\n",
      "['Therefore ACE inhibitors', 'decrease', 'II  level']\n",
      "['bradykinin  which', 'allow', 'result ACE enzyme']\n",
      "['mechanism', 'explain', 'side  effects']\n",
      "['Bradykinin', 'produces', 'prostaglandin']\n",
      "['prescribed ACE inhibitors', 'include', 'benazepril']\n",
      "['use', 'approved', 'ACE inhibitors']\n",
      "['Later  they', 'found useful', 'means blood pressure']\n",
      "['choices  it', 'lead', 'desired  improvement']\n",
      "['BMJ  that', 'was', 'ACE inhibitors ACE risk']\n",
      "['authors', 'found', 'decreased  risk']\n",
      "['Other ACE inhibitors', 'used', 'excessive water consumption']\n",
      "['transplantation  ACEi', 'used', 'erythropoietin production']\n",
      "['side  effects', 'effects Common', 'low blood pressure']\n",
      "['Patients', 'have', 'modest ACE reduction']\n",
      "['serum creatinine serum that', 'deemed acceptable', 'renal  function']\n",
      "['especially  patient', 'problem', 'concomitantly  NSAID']\n",
      "['together   risk', 'increased', 'renal  failure']\n",
      "['potassium ACE inhibitors', 'cause', 'retention']\n",
      "['people', 'continue', 'however  potassium']\n",
      "['Hyperkalemia', 'decrease', 'velocity']\n",
      "['ACE inhibitors ACE who', 'required', 'patients potassium treatment']\n",
      "['ACE inhibitors ACE role', 'effect', 'bradykinin  symptoms']\n",
      "['who', 'switched', 'cough']\n",
      "['Some', 'develop', '0.7  angioedema']\n",
      "['allergic  reaction', 'affect', 'abdominal bowel pain']\n",
      "['women ACE inhibitors', 'reported', 'congenital  malformations']\n",
      "['fetal  abnormalities', 'include', 'hypotension']\n",
      "['use', 'associated', 'nervous  systems']\n",
      "['Treatment', 'symptomatic', 'further volume absorption']\n",
      "['ACE inhibitors', 'contraindicated', 'drugs ACE effects']\n",
      "['Concomitant  use', 'tends', 'hypotensive ACE effect']\n",
      "['Mechanism', 'reduce', 'ACE inhibitors action ACE activity']\n",
      "['Markers', 'decreased', 'sympathetic blood release']\n",
      "['Renin', 'activates', 'two angiotensin converting angiotensin']\n",
      "['very blood vessels', 'increases', 'potent  vasoconstrictor']\n",
      "['Effects ACE inhibitors', 'block', 'conversion']\n",
      "['They', 'lower arteriolar', 'cardiac  output']\n",
      "['II  Vasoconstriction', 'has', 'II  effects']\n",
      "['cortex  that', 'causes', 'kidney tubules sodium retention']\n",
      "['Stimulation', 'acts', 'kidneys water retention']\n",
      "['ATII  which', 'decreased', 'aldosterone release']\n",
      "['This', 'allows', 'water potassium ions']\n",
      "['This', 'decreases', 'blood volume']\n",
      "['ACE inhibitors', 'shown', 'progress']\n",
      "['events heart it', 'justified', 'clinical  outcomes']\n",
      "['Such  therapy', 'requires careful', 'dose  effects']\n",
      "['ACE inhibitors', 'shown', 'central  enhancement']\n",
      "['action', 'reduce', 'prevalence']\n",
      "['system activation angiotensin system which', 'reduce', 'cardiac ACE inhibitor cachexia']\n",
      "['ZofenoprilThese agents', 'appear', 'antioxidative  properties']\n",
      "['only Inhibace member', 'available', 'comprehensive  resource']\n",
      "['It', 'contains', 'antihypertensive  peptides']\n",
      "['Val-Pro-Pro', 'shown', 'ACE-inhibiting Lactobacillus functions']\n",
      "['equivalent  doses', 'have similar', 'antihypertensive  efficacy']\n",
      "['Captopril', 'has', 'shorter  duration']\n",
      "['brain barrier brain significance', 'inhibitor capable', 'clinical  effects']\n",
      "['study  one', 'demonstrated', 'subsequent mortality development']\n",
      "['regular  use', 'made', 'ramipril mortality rates']\n",
      "['effective  treatment', 'expect', 'broad  spectrum']\n",
      "['hypertension ACE inhibitors', 'have different', 'different  strengths']\n",
      "['when  patients', 'possess many', 'common  characteristics']\n",
      "['AT2 receptor AT2 latter', 'have', 'further  study']\n",
      "['combination', 'increase', 'bradykinin  generation']\n",
      "['alone ACE angiotensin', 'effective', 'more ACE inhibitor']\n",
      "['Preliminary  studies', 'suggest', 'combination']\n",
      "['recent ONTARGET study', 'showed', 'agents']\n",
      "['clinical  significance', 'lacking', 'role  hypertension']\n",
      "['Patients', 'benefit', 'terms heart morbidity']\n",
      "['nephropathy combination therapy', 'found', 'renoprotective  effect']\n",
      "['Leonard T. Skeggs', 'discovered', 'Norman Shumway Norman ACE']\n",
      "['Brazilian Sérgio Henrique Ferreira', 'reported', 'bradykinin-potentiating  factor']\n",
      "['conversion', 'thought', 'II  place']\n",
      "['Subsequent  investigation', 'showed rapid', 'rapid  conversion']\n",
      "['Ferreira  conversion', 'showed', 'BPF']\n",
      "['20,881 BPF which', 'yielded', 'greatest ACE inhibition potency']\n",
      "['Teprotide', 'limited clinical', 'clinical  value']\n",
      "['David Cushman', 'used', 'ACE carboxypeptidase A']\n",
      "['Japanese  scientists', 'created', 'specific tripeptide isoleucine-proline-proline']\n",
      "['human  study', 'confirmed', 'blood pressure-lowering blood effect']\n",
      "['IPP  VPP', 'assumed', 'ACE-inhibiting  activity']\n",
      "['Note', 'See', 'receptor blockers angiotensin receptor Loop']\n",
      "['Citation Reports Journal Citation it', 'has', '2017 impact factor']\n",
      "['journal', 'established', 'current Acta Physiologica name']\n",
      "['second Christiaan Barnard', 'surgeon', 'second heart transplant attempt']\n",
      "['Kantrowitz', 'invented', 'intra-aortic balloon pump']\n",
      "['costume designer', 'ran', 'clinic']\n",
      "['three-year-old  he', 'told', 'child  electrocardiograph']\n",
      "['origin  he', 'has', 'Polish  ancestry']\n",
      "['He', 'graduated', '1940 New York majored']\n",
      "['He', 'attended', 'effort Downstate Medical availability']\n",
      "['which Galea he', 'developed', 'clamp  craniotomy']\n",
      "['16 New York he', 'screened', 'sequential  opening']\n",
      "['which blood vessels', 'developed', 'left  heart']\n",
      "['bladders', 'developed', 'individuals']\n",
      "['1970  he', 'held surgical', 'surgical  posts']\n",
      "['heart  that', 'used', 'one-inch  hole']\n",
      "['which  portion', 'reported', '25 booster %']\n",
      "['1960s  Kantrowitz', 'developed', 'artificial  pacemaker']\n",
      "['minute pacing patient', 'included', 'physical  stress']\n",
      "['team  that', 'collaborated', 'brother']\n",
      "['patient', 'performed', '24  hours']\n",
      "['13  patient', 'lasted', '13  days']\n",
      "['electrical valveless impulses', 'used', 'heart  action']\n",
      "['heart transplantation Dr. James Hardy', 'performed', 'first heart transplant attempt']\n",
      "['brain death brain Hardy', 'acquired', 'four  chimpanzees']\n",
      "['surgery  Hardy', 'brought', 'fellow  doctors']\n",
      "['Rush', 'proceeded', 'consciousness']\n",
      "['newspaper articles newspaper donor', 'put', 'newspaper articles newspaper assumption']\n",
      "['disdain   Hardy', 'treated', 'International Transplantation Conference']\n",
      "['surgeon Richard Kantrowitz', 'prepared', 'heart transplant heart hearts']\n",
      "['infant  who', 'completed', 'new  heart']\n",
      "['her', 'located', 'anencephalic  baby']\n",
      "['brain death donor which', 'forced', 'brain death donor heart']\n",
      "['Barnard', 'performed', 'human-to-human heart transplant']\n",
      "['100 December transplants', 'were more', 'December 1967 December transplant']\n",
      "['pediatric heart transplant attempt', 'performed', 'pediatric heart transplant attempt']\n",
      "['grossly  who', 'Bashaw', 'startle Moro reflex response']\n",
      "['However  infant', 'move', 'feeble  cry']\n",
      "['then donor heart', 'had', 'beating']\n",
      "['19-day-old Jamie who', 'Scudero', 'heart conditions']\n",
      "['Jordan Haller', 'flat-lined', 'heart']\n",
      "['He', 'sutured', 'heart']\n",
      "['This', 'took', '40  minutes']\n",
      "['Scudero  which', 'relying', 'entire  operation']\n",
      "['heart  it', 'warmed', 'electrical  shock']\n",
      "['he', 'emphasized', 'operation']\n",
      "['Alex Faltine', 'technician', 'head Scudero']\n",
      "['Faltine', 'held', 'hands  anything']\n",
      "['long  he', 'astonished', 'pipes']\n",
      "['fifties  who', 'shrugged', 'simply  it']\n",
      "['intra-aortic balloon pump', 'invented', 'heart']\n",
      "['thigh  it', 'directed', 'order  strain']\n",
      "['when  heart', 'inflated', 'blood']\n",
      "['pump', 'require', 'local  anesthetic']\n",
      "['woman  who', 'used', 'heart attack']\n",
      "['where Sinai-Grace he', 'relocated', 'surgeon']\n",
      "['weakened heart heart', 'implanted', 'oxygenated  blood']\n",
      "['Personal  life', 'married', 'Jean Rosensaft']\n",
      "['1983  they', 'co-founded', 'L.VAD Technology']\n",
      "['Achievement American References', 'contains', 'high-definition State University images']\n",
      "['epinephrine National which', 'aid', 'visceral  functions']\n",
      "['It', 'plays', 'muscles blood output']\n",
      "['It', 'does', 'this']\n",
      "['medication  it', 'used', 'number']\n",
      "['Inhaled  adrenaline', 'used', 'symptoms']\n",
      "['Common side effects', 'include shakiness', 'shakiness']\n",
      "['conclusively  infusions', 'needed', 'successfully  rates']\n",
      "['plasma  it', 'concentration', '90  %']\n",
      "['neurons  which', 'found', 'adrenaline']\n",
      "['Pharmacological  doses', 'stimulate', 'adrenaline  α1']\n",
      "['neural  connection', 'have', 'adrenoceptor-mediated  effect']\n",
      "['This', 'demonstrated', 'biological  assay']\n",
      "['Biochemical  methods', 'published', 'catecholamines']\n",
      "['total catecholamine method', 'non-specific', 'small  quantities']\n",
      "['development', 'transformed', 'derivate radio-enzymatic derivate analysis']\n",
      "['Infusion', 'has little', 'haemodynamic exercise effect']\n",
      "['Infusion', 'suppresses human', 'sufficiently constrictor effects']\n",
      "['stimulation', 'shown', 'muscarine-induced airway constriction']\n",
      "['patients  those', 'reported', 'asthma  protection']\n",
      "['subjects airway that', 'induces progressive', 'progressive airway dilation']\n",
      "['time course time bronchoconstriction', 'causes', 'propranolol  rebound']\n",
      "['reduction', 'reduces', 'exercise airway work']\n",
      "['emotional  response', 'has', 'behavioral  component']\n",
      "['stress  that', 'includes', 'release']\n",
      "['who', 'expressed', 'facial  films']\n",
      "['subjects', 'reported', 'intense  fear']\n",
      "['heart rate knee which', 'effect', 'sympathetic  responses']\n",
      "['other  emotions', 'had such', 'such  results']\n",
      "['study  subjects', 'express', 'greater  amusement']\n",
      "['rodent  that', 'supported', 'either  adrenaline']\n",
      "['adrenaline', 'support', 'encoding']\n",
      "['adrenergic  hormones', 'found', 'adrenaline retrograde enhancement']\n",
      "['events memory that', 'modulate', 'events memory strength']\n",
      "['adrenaline', 'is', 'role']\n",
      "['Adrenaline', 'play', 'arousal  memory']\n",
      "['epinephrine', 'indicates', 'memory consolidation']\n",
      "['mechanism  that', 'found', 'adrenaline']\n",
      "['blood – brain effects', 'cross', 'blood – brain barrier']\n",
      "['β adrenoceptor that', 'found', 'enhancing  effects']\n",
      "['β adrenoceptors', 'suggest', 'adrenaline  effect']\n",
      "['familial  tremor', 'responsive', 'blockers β tremor']\n",
      "['Patients', 'found', 'increased plasma adrenaline']\n",
      "['cortisol adrenaline that', 'suppress', 'disease adrenaline secretion']\n",
      "['glands  which', 'patented', 'purified  extract']\n",
      "['However  pharmacologist', 'prepared', '1897 name it']\n",
      "['International name adrenaline', 'became', 'Adopted  Name']\n",
      "['preferentially term converse', 'true', 'preferentially term adrenaline']\n",
      "['that', 'called adrenergic', 'effects']\n",
      "['muscle muscle that', 'causes smooth', 'most  arterioles']\n",
      "['binding', 'triggers', 'receptors  number']\n",
      "['Binding', 'inhibits', 'insulin-mediated insulin glycogenesis']\n",
      "['β adrenergic receptor binding', 'triggers', 'adrenocorticotropic hormone secretion']\n",
      "['Together  effects', 'lead', 'fatty blood substrates']\n",
      "['Adrenaline', 'causes', 'adrenergic alpha glycogenolysis']\n",
      "['liver cells liver which', 'binds', 'heterotrimeric G GDP']\n",
      "['Gs alpha', 'stimulates adenylyl', 'thus adenosine triphosphate']\n",
      "['Cyclic  AMP', 'activates', 'partially phosphorylase kinase']\n",
      "['Adrenaline', 'binds', 'inositol trisphosphate calcium cytoplasm']\n",
      "['glycogen which', 'phosphorylates', 'then  glycogen']\n",
      "['Adrenaline', 'has significant', 'significant  effects']\n",
      "['It', 'increases peripheral', 'cardiac  output']\n",
      "['goal', 'is', 'therefore oxygen exchange']\n",
      "['carotid circulation it', 'lowers', 'carotid blood flow']\n",
      "['actual  perfusion', 'appears', 'place']\n",
      "['fluids  Adrenaline', 'quantified', 'causative  agent']\n",
      "['terms 100,000 adrenaline', 'have', 'patients plasma concentrations']\n",
      "['pathway medulla that', 'synthesized', 'amino acids']\n",
      "['Then  it', 'decarboxylated', 'subsequently  dopamine']\n",
      "['dopamine beta-hydroxylase dopamine which', 'converted', 'ascorbic  acid']\n",
      "['phenylethanolamine N-methyltransferase enzyme phenylethanolamine which', 'catalyzed', 'S-adenosyl  methionine']\n",
      "['Adrenocorticotropic  hormone', 'stimulate', 'key dopamine enzymes']\n",
      "['adrenal  which', 'stimulates', 'cells adrenaline synthesis']\n",
      "['nervous  system', 'stimulates', 'medulla  release']\n",
      "['Acetylcholine', 'acts', 'acetylcholine receptors cell depolarization']\n",
      "['Calcium', 'triggers', 'thus  release']\n",
      "['VMAT1', 'responsible', 'synthesized  adrenaline']\n",
      "['he', 'contained', 'adrenaline']\n",
      "['American William H. Bates', 'discovered', 'usage']\n",
      "['glands  he', 'finds', 'epinephrine']\n",
      "['it', 'remains', 'crucial firstline treatment']\n",
      "['Japanese chemist Jōkichi Takamine', 'discovered', 'independently assistant Keizo adrenaline']\n",
      "['1901  Takamine', 'isolated', 'successfully  hormone']\n",
      "['1895 George Oliver', 'published', 'gland extract gland increase']\n",
      "['1897 John Jacob Abel', 'found', 'pharmacology U.S compound']\n",
      "['Abel', 'claimed', 'principle']\n",
      "['Japanese  chemist', 'worked', 'active Keizo principle']\n",
      "['Takamine', 'got', '1901  patent']\n",
      "['Such  activities', 'include extreme', 'extreme  sports']\n",
      "['adrenal  gland', 'secondary', 'adrenal  medulla']\n",
      "['it', 'activates many', 'behavior']\n",
      "['Nevertheless adrenaline infusion', 'increase', 'alone  roles']\n",
      "['when  child', 'are', 'parent  part']\n",
      "['rapidly cell depolarization', 'causes adjacent', 'adjacent  locations']\n",
      "['excitable  which', 'occur', 'neurons']\n",
      "['axon  signals', 'connect', 'conduction  propagation']\n",
      "['main  function', 'is', 'intracellular  processes']\n",
      "['pancreas beta they', 'provoke', 'release']\n",
      "['that', 'said', 'action potential']\n",
      "['rapidly membrane potential', 'shut', 'transmembrane  potential']\n",
      "['electrochemical  which', 'allow', 'further  rise']\n",
      "['This', 'causes more', 'electric  current']\n",
      "['plasma membrane ion channels', 'causes', 'sodium ions sodium polarity']\n",
      "['longer  they', 'enter', 'longer  neuron']\n",
      "['state action potential', 'activated', 'electrochemical potassium gradient']\n",
      "['slow calcium spikes', 'provide', 'driving force']\n",
      "['calcium spike calcium which', 'provides', 'then muscle contraction']\n",
      "['Nearly cell membranes', 'maintain', 'animals voltage difference']\n",
      "['interior', 'mV.', 'negative  voltage']\n",
      "['neurons voltage fluctuations', 'take', 'frequently  form']\n",
      "['up-and-down  cycle', 'takes', 'place']\n",
      "['cells action potential', 'last', 'three  seconds']\n",
      "['membrane  that', 'determined', 'it']\n",
      "['which  ions', 'provide', 'contrast  channels']\n",
      "['words  they', 'maintain', 'voltage difference']\n",
      "['neurons  types', 'vary', 'cell ion dendrites']\n",
      "['neuron action others', 'excitable', 'neuron action potentials']\n",
      "['initial  axon', 'shown', 'cell body']\n",
      "['long membrane nothing', 'has', 'cell']\n",
      "['enough  depolarization', 'triggered', 'membrane potential']\n",
      "['rise', 'stereotyped', 'same  amplitude']\n",
      "['entire  process', 'takes', 'place']\n",
      "['Many  types', 'emit', 'neurons action potentials']\n",
      "['However  types', 'quieter', 'minutes action potentials']\n",
      "['key  It', 'protein', 'one  conformation']\n",
      "['membrane  that', 'creates', 'conformations  channel']\n",
      "['however  relationship', 'probabilistic', 'membrane potential time delay']\n",
      "['times membrane potential', 'switch', 'rate']\n",
      "['ion channels ion state', 'capable', 'ion channels membrane potential']\n",
      "['situations  rise', 'cause', 'further ion rise']\n",
      "['ion channels ion that', 'determined', 'it']\n",
      "['Several  types', 'exist', 'necessary action potential']\n",
      "['studied  type', 'comprises', 'ion channels sodium channels']\n",
      "['voltage NaV channel', 'stands', 'possible  states']\n",
      "['channel', 'spends most', 'most']\n",
      "['level  channel', 'shows', 'increased  probability']\n",
      "['individual  channel', 'make', 'principle  transition']\n",
      "['global  dynamics', 'difficult', 'major  voltage']\n",
      "['parameters  that', 'approached', 'ion channel states']\n",
      "['equations', 'modified', 'research starting point']\n",
      "['sodium ion channels', 'open', 'entry']\n",
      "['ion channels potassium ion that', 'followed', 'exit']\n",
      "['where sodium potential', 'increases', 'cell sodium depolarization']\n",
      "['action potential action potassium', 'close', 'cell']\n",
      "['efflux', 'decreases', 'potassium ions membrane cell']\n",
      "['However voltage voltage', 'exceeds', 'sodium current sodium dominates']\n",
      "['positive runaway feedback', 'results', 'more sodium channels']\n",
      "['which  neuron', 'referred to', 'action potentials']\n",
      "['synaptic membrane which', 'property', 'sets action it']\n",
      "['potassium ions', 'enter', 'equilibrium']\n",
      "['few  ions', 'need', 'membrane']\n",
      "['ions', 'exchanged', 'negligible action change']\n",
      "['potassium pump potassium which', 'pumped', 'normal ion ratio']\n",
      "['resulting  currents', 'trigger', 'domino-like neighboring propagation']\n",
      "['axons action signal', 'excitable', 'axons action potentials']\n",
      "['unmyelinated  patches', 'generate', 'Ranvier action signal']\n",
      "['conduction  type', 'provides', 'favorable signal tradeoff']\n",
      "['Depolarization', 'triggers', 'general axon release']\n",
      "['These', 'thought', 'role']\n",
      "['contradictory  measurements', 'disputed', 'entropy changes capacitance model']\n",
      "['more  channels', 'added', 'membrane  decrease']\n",
      "['mature  neuron', 'undergoes shorter', 'shorter  changes']\n",
      "['P0 voltage they', 'have', 'constant voltage deflection']\n",
      "['Immature  neurons', 'prone', 'more  depression']\n",
      "['sodium channels sodium that', 'slower', 'action potential']\n",
      "['initially action that', 'have', '60–90  ms']\n",
      "['delayed  rectifier', 'increases', 'initial potassium channel strength']\n",
      "['electrical  activity', 'play', 'cell  role']\n",
      "['heart muscle which', 'support', 'cardiac action potential']\n",
      "['which', 'neuron', 'simplest  mechanism']\n",
      "['primary  function', 'projections', 'synaptic  signals']\n",
      "['protrusions', 'designed', 'spines  neurotransmitters']\n",
      "['They', 'have', 'high  concentration']\n",
      "['spines', 'have', 'bulbous  protrusion']\n",
      "['changes', 'ensures', 'less neighboring spines']\n",
      "['dendritic  spine', 'see', 'exception  LTP']\n",
      "['soma  which', 'extend', 'nucleus']\n",
      "['channels', 'help', 'signals']\n",
      "['region', 'characterized', 'high  concentration']\n",
      "['signals  they', 'communicate', 'biochemical  support']\n",
      "['fatty myelin that', 'wraps multiple', 'axon']\n",
      "['insulation', 'prevents significant', 'faster signal speed']\n",
      "['however  channels', 'has', 'however  restriction']\n",
      "['membrane  which', 'are', 'insulation']\n",
      "['Ranvier mini axon purpose', 'considered', 'significant signal decay']\n",
      "['end  axon', 'loses', 'insulation']\n",
      "['cell  that', 'area', 'neurotransmitters']\n",
      "['which action potentials', 'helpful', 'methods']\n",
      "['binding', 'opens various', 'various  types']\n",
      "['opening', 'has', 'local  permeability']\n",
      "['synapse', 'excitatory', 'membrane']\n",
      "['it', 'inhibitory', 'membrane']\n",
      "['fraction', 'reach', 'new action potential']\n",
      "['excitatory  potentials', 'work', 'new action potential']\n",
      "['free  flow', 'enables rapid', 'non-chemical-mediated  transmission']\n",
      "['current action that', 'found', 'it']\n",
      "['larger  currents', 'create larger', 'larger action potentials']\n",
      "['ion channels ion which', 'coupled', 'ionic  permeabilities']\n",
      "['combined  effects', 'excitatory', 'enough action potentials']\n",
      "['olfactory receptor which', 'include', 'olfactory receptor neuron']\n",
      "['action potentials action some', 'have', 'even  axon']\n",
      "['potentials  either', 'convert', 'subsequent action potential']\n",
      "['neurotransmitter  molecules', 'convert', 'incoming sound']\n",
      "['third action which', 'produce', 'optic  nerve']\n",
      "['such  They', 'depolarize', 'spontaneously axon hillock']\n",
      "['cardiac pacemaker cells', 'provide', 'good  example']\n",
      "['instance heart rate', 'altered', 'natural  rhythm']\n",
      "['external  stimuli', 'cause', 'merely  timing']\n",
      "['stage membrane potential', 'reaches', 'maximum']\n",
      "['This', 'changes', 'permeability']\n",
      "['Goldman equation Goldman change', 'changes', 'potential  Em']\n",
      "['which', 'affects', 'further membrane potential']\n",
      "['feedback  which', 'sets', 'possibility']\n",
      "['internal  that', 'is', 'internal  gates']\n",
      "['sodium channel sodium it', 'closes', 'also inactivation gate']\n",
      "['which Andrew they', 'modeled', 'Nobel Prize']\n",
      "['internal ion gates', 'considers', 'several ion assumptions']\n",
      "['depolarization axon that', 'begins', 'Vm']\n",
      "['concentrations  which', 'responsible', 'ions']\n",
      "['inside', 'has', 'negative  charge']\n",
      "['Na+  channels', 'drive', 'them']\n",
      "['membrane sodium ions', 'opens', 'sodium channels']\n",
      "['which', 'overwhelms', 'inward  current']\n",
      "['more sodium which', 'causes', 'Vm']\n",
      "['immediately Na+ channels', 'fire', 'just action one']\n",
      "['which action potentials', 'stimulated', 'stronger action depolarization']\n",
      "['slowly sodium channels', 'shuts', 'slowly sodium pores']\n",
      "['This', 'lowers', 'potassium membrane voltage']\n",
      "['voltage-sensitive potassium increase', 'opens voltage-sensitive', 'potassium permeability potassium Vm']\n",
      "['permeability sodium Vm', 'cause', 'falling  phase']\n",
      "['voltage-dependent potassium some', 'opens additional', 'voltage-dependent potassium channels']\n",
      "['Hence  that', 'is', 'value membrane potential']\n",
      "['stronger-than-usual action stimulus', 'followed', 'action potential']\n",
      "['membrane potential membrane this', 'enter', 'rise']\n",
      "['potassium channels potassium it', 'transitioned', 'thereby membrane rise']\n",
      "['currents', 'spread', 'adjacent action sections']\n",
      "['sufficiently  depolarization', 'provokes', 'similar action potential']\n",
      "['blocked action segment', 'showed', 'block action potential']\n",
      "['even  some', 'inactivate fast', 'A-type  currents']\n",
      "['action potential action moves', 'ensures', 'frequency']\n",
      "['just action potential', 'respond', 'range  part']\n",
      "['neuronal  axons', 'covered', 'fast  transduction']\n",
      "['multilamellar  that', 'membrane', 'axon']\n",
      "['Myelin  sheath', 'reduces', 'saltatory membrane movement']\n",
      "['example  axons', 'myelinated', 'nervous  system']\n",
      "['Myelin', 'prevents', 'axon']\n",
      "['action potentials action them', 'increases', 'conduction velocity']\n",
      "['cytoplasm  which', 'carried', 'subsequent  node']\n",
      "['apparent action hopping', 'provokes', 'Ranvier action potential']\n",
      "['axons action potential', 'provokes', 'another']\n",
      "['Myelin', 'has', 'important  advantages']\n",
      "['1  myelination', 'increases', 'conduction velocity']\n",
      "['giant frog axon', 'move', 'cross-sectional  area']\n",
      "['ionic  currents', 'confined', 'metabolic  energy']\n",
      "['nervous  system', 'advantage', '20  %']\n",
      "['arriving  signal', 'long as possible', 'too action potential']\n",
      "['propagated  signal', 'enough', 'enough action potential']\n",
      "['Thus safety factor', 'high', 'conduction  transmission']\n",
      "['diseases', 'degrade', 'saltatory conduction velocity']\n",
      "['which  breakdown', 'sclerosis', 'coordinated  movement']\n",
      "['Cable theory', 'developed', 'transatlantic telegraph cable']\n",
      "['which length voltages', 'treated', '\\\\partial ^{2}V}{\\\\partial']\n",
      "['τ', '=', 'time \\\\lambda dependence']\n",
      "['unit time unit equilibration', 'transferred', '= equation CV']\n",
      "['likewise  λ', 'increased', 'conduction velocity']\n",
      "['synaptic  neurotransmitter', 'cause', 'synaptic  knobs']\n",
      "['most ion axons', 'have', 'same  neurotransmitter']\n",
      "['membrane calcium influx', 'opens voltage-sensitive', 'surface  contents']\n",
      "['Electrical  synapses', 'synapses', 'presynaptic  cells']\n",
      "['ionic  currents', 'cross', 'postsynaptic cell cell']\n",
      "['ionic  currents', 'stimulate', 'postsynaptic action cell']\n",
      "['transmission  they', 'allow', 'slow  diffusion']\n",
      "['which  axon', 'junctions', 'special  case']\n",
      "['muscle  which', 'reduces', 'degree']\n",
      "['poisons', 'inactivate', 'control']\n",
      "['which action membrane', 'potentials', 'extended action plateau']\n",
      "['even sodium channels', 'due', 'calcium channels membrane voltage']\n",
      "['cardiac action potential', 'plays', 'important  contraction']\n",
      "['node pacemaker that', 'provide', 'heart']\n",
      "['Muscular  action', 'potentials', 'action potential']\n",
      "['membrane', 'result', 'voltage-sensitive sodium channels']\n",
      "['1–3 conduction velocity', 'lasts', '2–4  ms']\n",
      "['muscle', 'releases', 'tropomyosin']\n",
      "['plants action which', 'published', 'first  measurements']\n",
      "['This', 'makes', 'calcium precursor']\n",
      "['full  depolarization', 'poses', 'cellular calcium depolarization']\n",
      "['plants', 'use sodium-gated', 'sodium-gated Dionaea movements']\n",
      "['how action they', 'done', 'movement']\n",
      "['it', 'makes', 'action potential']\n",
      "['plant  it', 'triggers', 'hair-like  mechanoreceptor']\n",
      "['then action which', 'activates', '1.5  ms']\n",
      "['Ultimately  this', 'causes', 'slightly Calcium it']\n",
      "['Instead  it', 'requires', 'activation']\n",
      "['it', 'throws', 'activation']\n",
      "['time interval time it', 'reaches', 'Calcium trap']\n",
      "['subsequent  release', 'involves', 'osmotic action loss']\n",
      "['equal  amounts', 'neutral', 'other']\n",
      "['interaction', 'appears', 'plants salinity conditions']\n",
      "['cell', 'requires', 'movement']\n",
      "['fully plant cell', 'differs', 'cell – cell transporter']\n",
      "['organisms', 'seem', 'form']\n",
      "['evolution conduction velocity', 'varied', 'action potential action much']\n",
      "['evolution action potential', 'seems', 'evolutionary  advantages']\n",
      "['110  which', 'rapid', '110  m/s']\n",
      "['transmission distance action potential', 'has similar', 'similar  advantages']\n",
      "['computation action that', 'form', 'central pattern generators']\n",
      "['which', 'believed', 'voltage-gated four channels']\n",
      "['functionality', 'likely', 'point communication mechanism']\n",
      "['single-celled  bacteria', 'utilize', 'action potentials']\n",
      "['study', 'required', 'action potentials action development']\n",
      "['Lloyd Hodgkin Andrew Fielding who', 'carried', '1963 Nobel Prize']\n",
      "['first  problem', 'solved', 'giant  axons']\n",
      "['voltage clamp voltage which', 'addressed', 'key action source']\n",
      "['that', 'design', 'zero  rate']\n",
      "['Thus  current', 'reflection', 'Vm']\n",
      "['voltage', 'included', 'use']\n",
      "['micropipette electrode glass micropipette which', 'solved', 'axon  it']\n",
      "['10 100 which', 'able', 'high input impedance']\n",
      "['glass micropipette electrodes', 'became possible', 'electrical ion properties']\n",
      "['discovery  they', 'awarded', 'Nobel Prize']\n",
      "['ionic  channels', 'verified', 'discrete  states']\n",
      "['Optical imaging technologies', 'developed', 'years action potentials']\n",
      "['voltage-sensitive action potentials', 'recorded', 'voltage-sensitive  dyes']\n",
      "['Neurotoxins Several Neurotoxins neurotoxins', 'designed', 'action potential']\n",
      "['similarly sodium dendrotoxin', 'inhibits', 'voltage-sensitive potassium channel']\n",
      "['other  they', 'serve', 'affinity chromatography affinity concentration']\n",
      "['such  inhibitors', 'make effective', 'effective  neurotoxins']\n",
      "['synthetic  which', 'insecticides', 'activation']\n",
      "['Luigi Galvani Luigi who', 'observed', 'it']\n",
      "['which pile he', 'stimulated', 'animal electricity']\n",
      "['nervous  tissue', 'studied', 'century  propagation']\n",
      "['cell membranes', 'followed', 'direct  current']\n",
      "['German Emil du who', 'inspired', 'action potential']\n",
      "['neurons Camillo they', 'used', 'neurons Camillo which']\n",
      "['discoveries  Golgi', 'awarded', '1906 Nobel Prize']\n",
      "['century  Golgi', 'argued', 'long-standing  controversy']\n",
      "['action potential', 'advanced', 'hypothesis']\n",
      "['particular  they', 'refined', 'crucial  role']\n",
      "['membrane  that', 'made', 'action potential']\n",
      "['which sodium they', 'line', 'action potential']\n",
      "['ion channels ion that', 'correlated', 'properties']\n",
      "['Erwin Neher Bert who', 'confirmed', 'patch clamping conductance states']\n",
      "['century  researchers', 'beginning', 'structural  basis']\n",
      "['membrane Nernst this', 'generalized', 'also Nernst equation']\n",
      "['molecular  machines', 'solved', 'broader  view']\n",
      "['action that', 'essential', 'stringent  test']\n",
      "['Hodgkin – Huxley which', 'model', 'action potential']\n",
      "['FitzHugh – Nagumo both', 'inspired several', 'coupled  ODEs']\n",
      "['simple  models', 'fail', 'spike rate shape']\n",
      "['dendrites  researchers', 'focused', 'neural  computation']\n",
      "['proteins  that', 'simulate neuronal', 'microfilaments']\n",
      "['diverse  range', 'believed', 'large  range']\n",
      "['it', 'provides', 'order cell tissue']\n",
      "['cell membrane cell which', 'anchored', 'endocytosis']\n",
      "['It', 'produce', 'also  movement']\n",
      "['It', 'plays', 'embryogenesis  healing']\n",
      "['cells  which', 'traced', 'equivalent  proteins']\n",
      "['Lastly  actin', 'plays', 'important  role']\n",
      "['genes  that', 'caused', 'production']\n",
      "['genes  that', 'cause muscular', 'muscular actin variations']\n",
      "['make-up', 'related', 'related  actions']\n",
      "['myosin  he', 'observed', 'myosin  that']\n",
      "['further  discovery', 'unable', 'further  findings']\n",
      "['novel muscle that', 'developed', 'substantial  amounts']\n",
      "['myosin  it', 'dubbed', 'coagulation']\n",
      "['well  Szent-Györgyi', 'called', 'actin']\n",
      "['War II World War Szent-Gyorgyi', 'meant', 'work']\n",
      "['inorganic  which', 'continued', 'bound  ATP']\n",
      "['transformation', 'suggested', 'actin  role']\n",
      "['year  model', 'proposed', 'experiments  co-crystallization']\n",
      "['rhodamine conjugate rhodamine that', 'possible due', 'amino acid cys-374']\n",
      "['actin dimers actin that', 'able', 'exact  model']\n",
      "['Other  approaches', 'allowed', 'increasing synchrotron resolution']\n",
      "['proteins  it', 'one', 'little']\n",
      "['It', 'considered', 'optimised  structure']\n",
      "['that', 'is', 'universal energy currency']\n",
      "['However  ATP', 'required', 'structural  integrity']\n",
      "['protein  which', 'able', 'wider  variety']\n",
      "['which', 'villin', 'bundles  filaments']\n",
      "['muscle fibres muscle it', 'comprises', '20  %']\n",
      "['actin  that', 'is', '60 gene elements']\n",
      "['called actin that', 'means', 'different  functions']\n",
      "['mobility  which', 'means', 'projection']\n",
      "['that  filaments', 'has', 'two  forms']\n",
      "['parallel F-actin strands', 'rotate', '166  degrees']\n",
      "['This', 'creates', 'double helix structure']\n",
      "['Microfilaments', 'measure', '37  nm']\n",
      "['each', 'indicate', 'globular  structure']\n",
      "['catalysis  that', 'represents', 'former']\n",
      "['energy metabolism protein that', 'motif', 'important  part']\n",
      "['when  actin', 'functional', 'ADP']\n",
      "['67  Å', 'has', 'molecular  mass']\n",
      "['Primary  structureElzinga', 'determined', 'further peptide detail']\n",
      "['It', 'contains', '374 amino acid residues']\n",
      "['cysteine  which', 'alkaline', 'degree']\n",
      "['names  both', 'have', 'comparable  depth']\n",
      "['larger  domain', 'divided', 'III  residues']\n",
      "['domains  “', 'referred to', 'subdomains “ ends']\n",
      "['authors', 'call', 'subdomains']\n",
      "['nucleotide  that', 'form', 'movements']\n",
      "['protein  withdrawal', 'maintains', 'actin monomer']\n",
      "['centres', 'suggested', 'role']\n",
      "['domain  which', 'has', 'appearance']\n",
      "['filamentous  that', 'F-actin', 'filamentous  structure']\n",
      "['that', 'have', 'cryo-electron electron crystallization']\n",
      "['27.5 Å subunit rotation data', 'talk', 'considerable  variability']\n",
      "['again  this', 'appear', 'cofilin  angle']\n",
      "['Å. X-ray diffraction studies', 'is less', 'precise contact points']\n",
      "['monomers', 'make lateral', 'bodies  residues']\n",
      "['fact MreB.The F-actin subunits', 'suggests', 'structural MreB.The F-actin polarity']\n",
      "['where  cleft', 'called', 'ATP binding site']\n",
      "['where  shaft', 'forms polar', 'actin monomers actin rise']\n",
      "['long  that', 'contains', 'also tropomyosin molecule']\n",
      "['actin-myosin  interaction', 'covers', 'muscular  contraction']\n",
      "['three  troponin', 'are other', 'large C. Folding part']\n",
      "['it', 'special', 'functional  form']\n",
      "['they', 'need', 'route  presence']\n",
      "['additionally  it', 'key', 'essential cell cycle']\n",
      "['order  folding', 'required', 'place']\n",
      "['organelles  it', 'formed', 'co-chaperone']\n",
      "['changes  that', 'acts', 'order  reaction']\n",
      "['so  molecules', 'complete', 'successfully  need']\n",
      "['actin', 'recognized', 'prefoldin  image']\n",
      "['tertiary  complex', 'brief', 'immediately  prefoldin']\n",
      "['CCT', 'causes', 'simply  it']\n",
      "['why  it', 'is', 'specific recognition areas']\n",
      "['other  determinants', 'establish', 'contact']\n",
      "['change tubulin binding', 'bound', 'place']\n",
      "['binding  which', 'has specific', 'binding  sequences']\n",
      "['protein', 'understood', 'phosducin  activity']\n",
      "['that', 'ATPase', 'ATP']\n",
      "['when  actin', 'known', 'part']\n",
      "['γ-phosphate bond γ-phosphate nucleotide', 'is', 'nucleophilic  attack']\n",
      "['conformational  change', 'likely', 'closer  hydrolysis']\n",
      "['It', 'has', '% Saccharomyces conservation']\n",
      "['most  yeasts', 'express several', 'several actin isoforms']\n",
      "['genes actin which', 'have', 'six actin isoforms']\n",
      "['typical actin gene', 'has', '5  UTR']\n",
      "['family  actin', 'makes', 'introns-early  models']\n",
      "['shape', 'appear', 'homologues']\n",
      "['polymerized  form', 'encodes', 'dynamically plasmid DNA']\n",
      "['polymerization Nucleating factors', 'necessary', 'actin polymerization']\n",
      "['Arp2/3 which', 'complex', 'order G-actin formation']\n",
      "['Arp2/3 complex', 'binds', 'new actin branches']\n",
      "['hydrolysis', 'bind', 'ATP  destabilization']\n",
      "['polymerizing  profilin', 'binds', 'monomeric  addition']\n",
      "['theory  they', 'resolve', 'theory  structure']\n",
      "['filament', 'give', 'easily  monomers']\n",
      "['filaments', 'means', 'cellular  structure']\n",
      "['In  studiesStudies', 'carried', 'actin in rise']\n",
      "['it', 'makes', 'basic  conditions']\n",
      "['G-actin  which', 'is', 'place']\n",
      "['units  that', 'produces', 'sometimes  monomer']\n",
      "['F-actin  that', 'prepares', 'rise']\n",
      "['where dissociation dynamic', 'defined', 'dimers  change']\n",
      "['hand  ADP', 'indicated', 'also  polymerization']\n",
      "['unfavourable  process', 'poses', 'prodigious  expenditure']\n",
      "['where actin ADP', 'consists', 'thereby  cycle']\n",
      "['filament', 'depends', 'equal  amount']\n",
      "['situation', 'reverses', 'only + ADP+Pi']\n",
      "['less  elongation', 'similar', 'rise']\n",
      "['equilibrium  that', 'possible', '“ stationary “ state']\n",
      "['energy  it', 'justifies', 'biological  functions']\n",
      "['binding proteins actin binding which', 'detected', 'also  dynamism']\n",
      "['that', 'such', 'part']\n",
      "['that', 'exist', 'incorporation']\n",
      "['that', 'are', 'complexity']\n",
      "['role', 'is', 'incorporation']\n",
      "['different  it', 'protein', 'replacement']\n",
      "['microfilaments  which', 'regulate', 'rise']\n",
      "['new  situation', 'favors', 'dynamics']\n",
      "['polymer actin they', 'achieve', 'then actin conformation']\n",
      "['This', 'has', 'addition']\n",
      "['order  they', 'cover', 'them']\n",
      "['protein  which', 'CapZ', 'ends']\n",
      "['muscle sarcomeres muscle which', 'acts', 'basically  F-actin']\n",
      "['function  two', 'composed', 'subunits  structure']\n",
      "['homology', 'allows', 'units']\n",
      "['structures  that', 'required', 'dendritic  structures']\n",
      "['either phalloidin Latrunculin', 'are', 'either cytochalasin it']\n",
      "['It', 'binds', 'G-actin  it']\n",
      "['fungi  that', 'alkaloid', 'F-actin + addition']\n",
      "['Cytochalasin D', 'found', 'protein p53']\n",
      "['It', 'binds', 'F-actin polymer F-actin depolymerization']\n",
      "['forms filaments', 'elements', 'fast  polymerization']\n",
      "['Various  types', 'give mechanical', 'cytoplasm signal transduction']\n",
      "['Rapid  assembly', 'enables', 'actin network Cell migration']\n",
      "['which myosin proteins', 'scaffold', 'muscle contraction']\n",
      "['Nonconventional  myosins', 'use', 'ATP cargo']\n",
      "['cell', 'regulated', 'restructuring']\n",
      "['that', 'involved', 'cytochalasins F-actin activity']\n",
      "['Actin', 'comprises', '10  %']\n",
      "['high turnover majority', 'found', 'high turnover rate']\n",
      "['microfilaments  which', 'means', 'presence']\n",
      "['receptor cells receptor that', 'connected', 'signals']\n",
      "['cohesive actin that', 'form', 'axon membrane']\n",
      "['structure periodicity', 'regulate', 'also sodium ion channels']\n",
      "['all', 'involve', 'high  degree']\n",
      "['modulated  that', 'allow', 'response']\n",
      "['patches  that', 'contain', 'main  elements']\n",
      "['kDa cyclase that', 'possess', 'disassembly']\n",
      "['Plant genome studies', 'revealed', 'existence']\n",
      "['necessity  that', 'explained', 'necessity  variants']\n",
      "['microfilaments', 'generate sufficient', 'sufficient  number']\n",
      "['cellular  which', 'involved', 'as cell elongation']\n",
      "['that', 'include', 'role']\n",
      "['laevis oocytes Xenopus laevis which', 'describe', 'same  features']\n",
      "['controlled  level', 'allows', 'important  role']\n",
      "['Transport', 'contain', 'nuclear localization signal']\n",
      "['small  size', 'allows', '43  nucleus']\n",
      "['quickly  which', 'shuttles', 'existence']\n",
      "['very protein importin actin', 'facilitated', 'nuclear export signals']\n",
      "['mutation', 'demonstrated', 'rapid  export']\n",
      "['general  mechanism', 'proposed', 'cytoplasm cofilin ADP-actin monomers']\n",
      "['Higher  concentration', 'promote', 'cytoplasm  ADP']\n",
      "['This', 'weakens', 'strength']\n",
      "['Actin', 'form', 'profilin  nucleus']\n",
      "['organization', 'exists', 'dynamic actin oligomers']\n",
      "['which', 'cells', 'nucleus architecture']\n",
      "['however actin filaments', 'observed', 'technique']\n",
      "['nuclear  actin', 'revealed', 'quantification']\n",
      "['controlled  level', 'lower', 'cytoplasm cell formation']\n",
      "['Actin isoforms', 'have different', 'biochemical sequence properties']\n",
      "['They', 'show different', 'different  localization']\n",
      "['especially fibroblastThe level', 'allows', 'significant fibroblastThe effect']\n",
      "['functions', 'associated', 'Functions']\n",
      "['Nuclear  actin', 'involved', 'proper alpha shape']\n",
      "['Actin', 'takes', 'part']\n",
      "['transcription Pol which', 'act', 'DNA']\n",
      "['Pol', 'contains', 'III  β-actin']\n",
      "['differentiated  cells', 'used', 'gene activity']\n",
      "['movement', 'requires', 'interaction']\n",
      "['that', 'molecule', 'cytoplasmic signal transduction pathways']\n",
      "['proteins  actin', 'acts', 'conformational  changes']\n",
      "['muscle cells actomyosin myofibrils', 'make', 'much']\n",
      "['myofibrils', 'use', 'ATP  movements']\n",
      "['load power that', 'undergo', 'past  muscle']\n",
      "['actin-bundling protein alpha-actinin', 'separates', 'thin  filament']\n",
      "['increase', 'allows thick', 'thick  deformation']\n",
      "['This', 'pulls', 'membrane']\n",
      "['filaments  both', 'bound', 'filament actin filaments']\n",
      "['40-nanometre tropomyosin that', 'contains', 'also tropomyosin molecule']\n",
      "['it', 'gives', 'times  contraction']\n",
      "['that', 'depends', 'three  polymers']\n",
      "['muscle contraction muscle they', 'involved', '90  %']\n",
      "['specialized  interiors', 'initiated', 'specialized  cells']\n",
      "['contraction-relaxation  cycle', 'comprises', 'following  steps']\n",
      "['cross-links  latter', 'alters', 'active  formation']\n",
      "['filaments  this', 'involve', 'ATP']\n",
      "['former  mechanism', 'causes', 'myosin heads myosin movement']\n",
      "['tropomyosin  that', 'causing', 'actin-myosin  interaction']\n",
      "['biological  processes', 'relates', 'therefore  organization']\n",
      "['However  actin', 'has', 'wider  role']\n",
      "['Cell division', 'involves', 'normally  separation']\n",
      "['process', 'involves', 'constricting  ring']\n",
      "['in vivo in one', 'degrade', 'interleukin-1β-converter proteases interleukin-1β-converter actin']\n",
      "['mechanisms cell that', 'represents', 'basis']\n",
      "['just cell use', 'shown', 'calpain inhibitors actin proteolysis']\n",
      "['structures stress this', 'causes', 'also  rise']\n",
      "['organisms  that', 'characteristic', 'therefore cell complexity']\n",
      "['Adhesion', 'involves', 'cell epithelia actin cytoskeleton']\n",
      "['element  systems', 'has', 'actin dynamics actin repercussions']\n",
      "['fact Dictyostelium each', 'show', 'proteins  function']\n",
      "['state', 'affects', 'polymerization  pattern']\n",
      "['D-mediated  depolymerization', 'discovered', 'specific Schwann pattern']\n",
      "['F-actin', 'shown', 'transcriptome']\n",
      "['actin-like  proteins', 'play', 'role']\n",
      "['surface  that', 'develop fine', 'mechanosensory  function']\n",
      "['molecular  architecture', 'includes', 'paracrystalline actin core']\n",
      "['Actomyosin  networks', 'implicated', 'intrinsic  chirality']\n",
      "['left/right  that', 'show', 'left/right  bias']\n",
      "['majority', 'possess', 'different actin genes']\n",
      "['point that', 'mutations', 'dominant  effect']\n",
      "['cases  mutant', 'acts', '“ cap “ elongation']\n",
      "['exons  that', 'consists', 'known  transcripts']\n",
      "['phenotype  that', 'cases', 'severity']\n",
      "['mutation', 'alters', 'muscles  one']\n",
      "['also  that', 'found', 'core myopathies']\n",
      "['myopathy  specialists', 'distinguish', 'type']\n",
      "['patient', 'important', 'more  one']\n",
      "['common  symptoms', 'consist', 'muscular  delay']\n",
      "['non-pathognomonic  that', 'structures', 'similar  composition']\n",
      "['clumps  that', 'goes', 'great  variety']\n",
      "['exportation signal protein exportation accumulation', 'found', 'changes']\n",
      "['ACTA1  that', 'appears', 'greater  effect']\n",
      "['apparent  which', 'tried', 'apparent  paradox']\n",
      "['mutations', 'appears', 'greater apoptosis rate']\n",
      "['actin isoform actin which', 'are', 'nine  exons']\n",
      "['cases  that', 'found', 'chemotherapy  cisplatin']\n",
      "['mutated  variant', 'produces', 'filamentary  assembly']\n",
      "['certain  mutations', 'related', 'heterozygosis  predisposition']\n",
      "['α-actin', 'found', 'interesting  progress']\n",
      "['protein domains protein that', 'studied', 'cardiomyopathy  substitution']\n",
      "['that', 'appears', 'mechanical  behaviour']\n",
      "['ACTC1 that', 'discovered', 'ACTC1 mutations']\n",
      "['splicing  which', 'exist', 'rise']\n",
      "['addition cell they', 'found', 'part']\n",
      "['translocational gene mutation', 'discovered', 'fusion']\n",
      "['eosinophilic  inclusions', 'affects', 'areas']\n",
      "['affected  individuals', 'represent', 'phenotype']\n",
      "['which amino acid', 'caused', 'arginine']\n",
      "['ADF/cofilin system ADF/cofilin which', 'alters', 'dynamics']\n",
      "['also  that', 'discovered', 'neutrophil granulocyte dysfunction']\n",
      "['mutation', 'appears', 'domain']\n",
      "['tissue  they', 'contains', 'complete  isoforms']\n",
      "['It', 'has', 'different DNA promoters']\n",
      "['ancestral  that', 'noted', 'duplication']\n",
      "['autosomal-dominant point mutations', 'found', 'sensorineural hearing loss']\n",
      "['they', 'seems', 'stereocilia']\n",
      "['cells  which', 'protein', 'location']\n",
      "['majority', 'appears', 'mutations  areas']\n",
      "['pathological  mechanism', 'suggested', 'type  loss']\n",
      "['absence', 'known', 'rise']\n",
      "['infectious  agents', 'use', 'actin']\n",
      "['basic  forms', 'present', 'vacuoles Shigella themselves']\n",
      "['comet tail comet that', 'generate', 'mobility']\n",
      "['species', 'exhibits small', 'small  differences']\n",
      "['Many  experiments', 'demonstrated', 'mechanism']\n",
      "['polymerization  that', 'indicates', 'place']\n",
      "['minimum  covering', 'surrounded', 'Arp2/3 complex']\n",
      "['immune neighbouring system', 'form', 'only  infection']\n",
      "['mechanism Burkholderia that', 'capable', 'actin Burkholderia movement']\n",
      "['addition vaccine virus Vaccinia', 'uses', 'also  elements']\n",
      "['Pseudomonas aeruginosa', 'able', 'white blood cells']\n",
      "['biofilm', 'constructed', 'DNA']\n",
      "['example actin polymerization', 'stimulated', 'example cofilin complex']\n",
      "['actin', 'determined', 'that']\n",
      "['eukaryotic Evolution cytoskeleton', 'have similar', 'similar  components']\n",
      "['that', 'suggest', 'actin  proteins']\n",
      "['behaviour', 'point', 'ability  advantage']\n",
      "['also  they', 'suggested', 'common  ancestor']\n",
      "['molecules  that', 'resulted', 'biological  processes']\n",
      "['that', 'contains', 'proteins']\n",
      "['also FtsZ which', 'contains', 'also FtsZ proteins']\n",
      "['even amino acid sequence', 'possess', 'therefore  cytoskeleton']\n",
      "['such  proteins', 'have', 'high  degree']\n",
      "['ParMs', 'form', 'faithful plasmid inheritance']\n",
      "['motors  that', 'act', 'transport']\n",
      "['molecular  that', 'is', 'given  load']\n",
      "['which  load', 'used', 'circuit']\n",
      "['locations  which', 'used', 'controlled  assembly']\n",
      "['mechanics  that', 'applied', 'mechanical  energy']\n",
      "['assumption  expression', 'reacted', 'blot anti-β-actin reference']\n",
      "['whenever  expression', 'possible', 'relative  quantity']\n",
      "['actin', 'worth', 'desired  stability']\n",
      "['pathology  it', 'used', 'variations']\n",
      "['It', 'possible', 'sausages  amount']\n",
      "['heart', 'include', 'blood']\n",
      "['Afterload', 'proportional', 'systolic blood pressure']\n",
      "['wall thickness wall ratio', 'determinant', 'other  afterload']\n",
      "['aortic  it', 'create', 'internal  radius']\n",
      "['dilated  heart', 'has', 'higher  afterload']\n",
      "['left  ventricle', 'have', 'lower  afterload']\n",
      "['afterload', 'rises', 'output']\n",
      "['oxygen requirements', 'start', 'vicious  circle']\n",
      "['heart  this', 'described', 'heart  blood']\n",
      "['pressure', 'greater', 'aortic  valves']\n",
      "['ventricle  h', 'calculated', 'pulmonary artery wedge pressure']\n",
      "['Disease processes that', 'include elevated', 'elevated blood pressure']\n",
      "['ventricular LV LV', 'increases', 'harder  blood']\n",
      "['PH', 'indicates', 'applied  increase']\n",
      "['left  ventricle', 'increases', 'blood pressure blood blood']\n",
      "['left  ventricle', 'has', 'aortic  blood']\n",
      "['afterload  ventricle', 'has', 'harder  goal']\n",
      "['blood  that', 'increases', 'Aortic afterload']\n",
      "['This', 'increases', 'pulse pressure']\n",
      "['Mitral  regurgitation', 'decreases', 'afterload']\n",
      "['regurgitant  blood', 'flows', 'backwards/retrograde']\n",
      "['left blood ventricle', 'have', 'hard  blood']\n",
      "['Cardiac Hemodynamics Preload References', 'See', 'conceptual Afterload mismatch framework']\n",
      "['Avolio A. Nitroglycerin', 'P.', 'favourable  effects']\n",
      "['They', 'provide', 'range']\n",
      "['health professionals health who', 'defined', 'disease people']\n",
      "['staff  they', 'deliver direct', 'physical health functions']\n",
      "['Service Act Health Service who', 'professions', 'Service Act Health Service those']\n",
      "['allied health professions', 'those', 'degrees']\n",
      "['Often  they', 'prove', 'skills']\n",
      "['training  which', 'require', 'then  them']\n",
      "['Allied health professions', 'include', 'use']\n",
      "['profession  these', 'include basic', 'interpersonal healthcare information']\n",
      "['knowledge  that', 'brought', 'medical World War procedures']\n",
      "['Increasing', 'provoked', 'care costs health care trend']\n",
      "['international development assistance', 'led', 'essential health care services']\n",
      "['Changes', 'continue', 'care delivery health care expansion']\n",
      "['World Health Organization', 'estimates', 'global health goals']\n",
      "['2008 health version', 'increased', 'Occupations International Standard number']\n",
      "['new  categories', 'created', 'paramedical \"\"— grouping professions']\n",
      "['Employment projections Projections', 'shown', 'allied health positions']\n",
      "['health workers health need', 'due', 'training programs training pace']\n",
      "['Studies', 'pointed', 'competent health system']\n",
      "['Classification System health care industry', 'provides inpatient', 'outpatient health services']\n",
      "['Ambulatory health care settings', 'provides outpatient', 'outpatient  services']\n",
      "['residential Nursing facilities', 'provides residential', 'residential  care']\n",
      "['Social Assistance', 'provides', 'elderly  services']\n",
      "['One  source', 'reported allied', '60 health percent']\n",
      "['which 2 services', 'amounted', 'quality']\n",
      "['services  that', 'allow', 'expensive  hospital']\n",
      "['California  research', 'predicted', 'total  consumption']\n",
      "['human  resources', 'focusing', 'preventive community health services']\n",
      "['professions  that', 'expect', 'allied  health']\n",
      "['NHS Careers American Journal', 'See', 'scientific  journal']\n",
      "['4.406 AJP-Cell Physiology AJP-Endocrinology', 'rendered', 'seven  subjournals']\n",
      "['titles', 'included', 'Devourer']\n",
      "['feather  feather', 'weighed', 'heart']\n",
      "['person', 'devour', 'voyage']\n",
      "['forever  this', 'called', 'second  time']\n",
      "['scholars', 'believe', 'same  concept']\n",
      "['restlessness  they', 'embodied', 'principle']\n",
      "['Wikimedia Commons Wikimedia Amiodarone', 'See', 'antiarrhythmic  number']\n",
      "['This', 'includes ventricular', 'ventricular  tachycardia']\n",
      "['few  effects', 'take', 'few  weeks']\n",
      "['side  it', 'recommended', 'side  effects']\n",
      "['side  effects', 'include', 'lung toxicity']\n",
      "['pregnancy  it', 'cause', 'problems']\n",
      "['partly heart cell', 'works', 'partly  time']\n",
      "['Amiodarone', 'uses', 'long term suppression']\n",
      "['It', 'used', 'both']\n",
      "['those  who', 'appear', 'cardiac  arrest']\n",
      "['Individuals', 'receive', 'initially  amiodarone']\n",
      "['who', 'risk', 'atrial heart fibrillation']\n",
      "['clinical  studies', 'failed', 'side  effects']\n",
      "['which  five', 'demonstrated', 'placebo  arm']\n",
      "['who', 'advised', 'strongly  amiodarone']\n",
      "['breast milk breast women', 'advised', 'nursing']\n",
      "['second degree heart who', 'contraindicated', 'artificial  pacemaker']\n",
      "['gasping  syndrome\"\".Amiodarone', 'given', 'cardiac  arrhythmia']\n",
      "['Side effects Amiodarone', 'has numerous', 'side  effects']\n",
      "['Most  individuals', 'administered', 'side  effect']\n",
      "['Lung Side Lung effects', 'include various', 'pulmonary  effects']\n",
      "['Risk factors', 'include high', 'cumulative  dose']\n",
      "['treatment  others', 'noted', 'it']\n",
      "['Common   practice', 'avoid', 'agent']\n",
      "['Amiodarone', 'similar', 'also  iodine']\n",
      "['molecule – Chaikoff which', 'causes', 'cardiac  hypothyroidism']\n",
      "['SAFE trial SAFE which', 'occurs', 'group 4.5 placebo']\n",
      "['patients  who', 'based', 'amiodarone']\n",
      "['amiodarone thyroid gland', 'saturated', 'further  uptake']\n",
      "['Eye Corneal micro-deposits', 'present', 'individuals cornea amiodarone']\n",
      "['deposits', 'cause', 'typically  symptoms']\n",
      "['liver inflammation', 'reported', 'pseudo-alcoholic liver).Low-dose cirrhosis']\n",
      "['however skin color', 'associated', 'sun  sunscreen']\n",
      "['Pregnancy', 'result', 'Use']\n",
      "['Amiodarone', 'accumulates', 'unilateral  inflammation']\n",
      "['study', 'showed', 'possible  association']\n",
      "['many  that', 'affected', 'pharmacokinetics']\n",
      "['Particularly  doses', 'halved', 'individuals  amiodarone']\n",
      "['Amiodarone', 'potentiates', 'warfarin  clearance']\n",
      "['Individuals', 'have', 'anticoagulation warfarin status']\n",
      "['200 mg amiodarone dose', 'follows', '30 % reduction']\n",
      "['Amiodarone', 'inhibits', 'action']\n",
      "['amiodarone hepatitis C who', 'warned', 'slow  heartbeats']\n",
      "['Metabolism Amiodarone', 'metabolized', 'P450 3A4 cytochrome P450 metabolism']\n",
      "['amiodarone  which', 'desethylamiodarone', 'antiarrhythmic  properties']\n",
      "['when kidney simvastatin', 'issued', 'warning']\n",
      "['interaction', 'dose-dependent', '20 simvastatin mg']\n",
      "['it', 'occurs', 'amiodarone']\n",
      "['Pharmacology Amiodarone', 'categorized', 'agent class phase']\n",
      "['gated calcium channels', 'blocker', 'refractory conduction period']\n",
      "['It', 'prolongs', 'His Purkinje effects']\n",
      "['Amiodarone', 'shown', 'action potential cell action duration']\n",
      "['It', 'shows', 'intra-cardiac SA conduction']\n",
      "['amiodarone', 'suggested', 'QT-3 syndrome QT-3 mutations']\n",
      "['effect', 'combination', 'peak sodium current']\n",
      "['original progenitor molecule', 'made', 'cardioactive  properties']\n",
      "['one', 'noticed', 'symptoms  khellin']\n",
      "['chemists Labaz who', 'developed', 'chemists Labaz Tondeur']\n",
      "['agents  what', 'determined', 'antiarrhythmic  properties']\n",
      "['drugs', 'demonstrated', 'refractory action period']\n",
      "['who', 'began', 'patients']\n",
      "['Rosenbaum  physicians', 'began', 'United States United amiodarone']\n",
      "['Administration Food physicians', 'prescribed', 'directly  amiodarone']\n",
      "['initial  reports', 'reluctant', 'increased  incidence']\n",
      "['physicians  it', 'began', 'FDA  supply']\n",
      "['This', 'makes', 'amiodarone one']\n",
      "['It', 'has', 'pH']\n",
      "['mg/500mL  it', 'administered', '0.22 micron patient']\n",
      "['References', 'reading', '2003 Amiodarone guidelines']\n",
      "['vertebrates  that', 'clade', 'sauropsids']\n",
      "['They', 'distinguished', 'membrane  embryo']\n",
      "['anamniotes  which', 'lay', 'typically  eggs']\n",
      "['lamb\"\".The   amnion', 'comes', 'extensive  membranes']\n",
      "['amniotic  that', 'include', 'fetus']\n",
      "['vertebrates  that', 'divergence', 'embryos']\n",
      "['This', 'free', 'enabled  amniotes']\n",
      "['eggs', 'breathe', 'wastes  eggs']\n",
      "['first   amniotes', 'resembled small', 'small  lizards']\n",
      "['development  that', 'characterize', 'formation']\n",
      "['metamorphosis larval tadpole amphibians', 'develop', 'first larval tadpole stage']\n",
      "['drier  increase', 'reflect', 'drier  environments']\n",
      "['hard  that', 'include', 'reservoir']\n",
      "['corresponding  structures', 'lay', 'eggs']\n",
      "['Casineria kiddi Casineria which', 'evolved', 'small 340 lizards']\n",
      "['dry Carboniferous conditions', 'laid', 'amniotes  eggs']\n",
      "['modern-day  amniotes', 'require', 'eggs']\n",
      "['land  amphibians', 'lack advanced', 'advanced  traits']\n",
      "['major amniote breakthrough', 'appears', 'amphibian  egg']\n",
      "['egg', 'allowed', 'full gas development']\n",
      "['carbon dioxide carbon egg', 'suggested', 'terrestrial  eggs']\n",
      "['posthatching  growth', 'limit', 'juveniles  size']\n",
      "['snout-vent  length', 'supported', 'diameter  adults']\n",
      "['eggs', 'develop new', 'internal  structures']\n",
      "['they', 'affect', 'adulthood']\n",
      "['egg membranes', 'have', 'inner  membrane']\n",
      "['Evolution', 'required', 'increased amniote exchange']\n",
      "['further  that', 'permit', 'feasible  size']\n",
      "['increased  size', 'permitted', 'eggs  increase']\n",
      "['only  invertebrates', 'limited', 'level two']\n",
      "['ecological  niches', 'experience adaptive', 'larger  body-size']\n",
      "['key  difference', 'resembled', 'amphibian  ancestors']\n",
      "['ancestors  notch', 'held', 'spiracle']\n",
      "['descent  they', 'classified', 'secondarily  fenestrae']\n",
      "['girdle Labyrinthodont amniotes', 'identified', 'it']\n",
      "['orderly Subclass scheme', 'recognised', 'flightless Subclass Ichthyornithes']\n",
      "['it', 'come', 'rise']\n",
      "['writers  who', 'adopted', 'paraphyletic  groupings']\n",
      "['other birds researchers', 'attempted', 'physiological  unity']\n",
      "['example Jacques Gauthier', 'forwarded', 'definition']\n",
      "['group definition crown group Amniota', 'has', 'different  content']\n",
      "['Cladogram cladogram', 'illustrates', 'simplified family version']\n",
      "['cladogram', 'covers', 'group']\n",
      "['quickly  symptoms', 'include', 'consciousness  thirst']\n",
      "['pre-operative  anemia', 'increase', 'blood transfusion']\n",
      "['Causes', 'include', 'bleeding  trauma']\n",
      "['Causes', 'include', 'production iron deficiency']\n",
      "['Causes', 'include genetic', 'cell anemia cell infections']\n",
      "['Further  testing', 'required', 'then  cause']\n",
      "['Dietary  supplementation', 'recommended', 'specific  cause']\n",
      "['Iron-deficiency anemia', 'affects', '1 billion 1 people']\n",
      "['Anemia', 'increases', 'care  productivity']\n",
      "['ἀν- Greek ἀναιμία blood\"\".Anemia', 'derived', 'ἀν- Greek ἀναιμία haima']\n",
      "['Efforts', 'contribute', 'Sustainable Development Goals']\n",
      "['They', 'report', 'also  shortness']\n",
      "['severe muscle body', 'include', 'cardiac  output']\n",
      "['pre-existing heart disease', 'symptoms', 'symptoms']\n",
      "['pale  this', 'exhibited', 'pallor']\n",
      "['those  who', 'symptom', 'normal  levels']\n",
      "['Chronic  anemia', 'result', 'academic  performance']\n",
      "['Several', 'interplay', 'these  anemia']\n",
      "['impaired RBC production', 'loss', 'lasting  symptoms']\n",
      "['Impaired production Disturbance', 'affects', 'anemia cell kinds']\n",
      "['Fanconi  anemia', 'disorder', 'aplastic  anemia']\n",
      "['Lack', 'causes non-pernicious', 'megaloblastic  anemia']\n",
      "['Anemia', 'causes megaloblastic', 'megaloblastic anemia Anemia']\n",
      "['Other stem cell mechanisms', 'type', 'also stem cell dysfunction']\n",
      "['bone marrow bone that', 'caused', 'normal  production']\n",
      "['These', 'featuring', 'generally  jaundice']\n",
      "['intracorpuscular  abnormalities', 'cause premature', 'premature  destruction']\n",
      "['hereditary  that', 'defect', 'cell membrane RBC cell erythrocytes']\n",
      "['IgG. blood It', 'common', 'hemoglobinuria Extrinsic hemoglobinuria abnormalities']\n",
      "['older blood who', 'causing chronic', 'stages blood Infection']\n",
      "['either', 'implies widespread', 'widespread  effects']\n",
      "['Thus  ischemia', 'cause localized', 'anemic body effects']\n",
      "['General hemoglobin causes', 'causes', 'excessive sodium intake']\n",
      "['hormonal  changes', 'cause', 'increase']\n",
      "['gastrointestinal inflammation disorders', 'cause', 'anemia']\n",
      "['hepcidin  that', 'multifactorial', 'dysregulation']\n",
      "['anemia  reviews', 'are', 'comparison']\n",
      "['broader blood cell definition', 'decrease', 'blood  oxygen']\n",
      "['It', 'difficult', 'indirectly hematocrit value']\n",
      "['flow cytometry flow which', 'measure', 'also  size']\n",
      "['automated  analysis', 'helpful', 'blood smear blood microscope']\n",
      "['blood test', 'provide', 'counts']\n",
      "['it', 'determine', 'serious  cause']\n",
      "['complete blood CBC', 'include', 'number']\n",
      "['blood cells blood some', 'determine', 'size']\n",
      "['protein', 'helps', 'low store levels']\n",
      "['red blood which', 'develop', 'oxygen']\n",
      "['automatic United counters', 'become', 'now reticulocyte counts']\n",
      "['normal reticulocyte count', 'reflect', 'inadequate  response']\n",
      "['formed  RBCs', 'larger', 'RBCs  polychromasia']\n",
      "['hypothesis  that', 'use other', 'other  tests']\n",
      "['severe  pathology', 'allows direct', 'direct  examination']\n",
      "['microcytic  anemia', 'exposes', 'quickly  some']\n",
      "['philosophically  morphology', 'one', 'kinetic  approach']\n",
      "['net vitamin B12 result', 'include', 'iron deficiency iron cause']\n",
      "['Production', 'yields', 'relevant  classification']\n",
      "['This', 'yields', 'then  classification']\n",
      "['Clinical  signs', 'include abnormal', 'elevated cell destruction']\n",
      "['ongoing reticulocyte combination', 'seen', 'cause reticulocyte count']\n",
      "['white blood cells', 'point', 'valuable  clues']\n",
      "['overall  it', 'result', 'many  causes']\n",
      "['Iron deficiency anemia', 'due', 'iron  needs']\n",
      "['Infants', 'have higher', 'pregnant  higher']\n",
      "['Increased iron intake', 'needed', 'also blood losses']\n",
      "['girls school this', 'shown', 'poor school performance']\n",
      "['occult blood testing', 'performed', 'bleeding  lesions']\n",
      "['iron it', 'predicts', 'confirmation']\n",
      "['neurological B12 deficiency', 'produce neurological', 'neurological  symptoms']\n",
      "['factor  which', 'caused', 'vitamin B12']\n",
      "['atrophic  that', 'arise', 'intrinsic  factor']\n",
      "['Hypothyroidism Alcoholism', 'causes', 'commonly  macrocytosis']\n",
      "['Other  types', 'cause', 'also liver macrocytosis']\n",
      "['Drugs', 'inhibit', 'other DNA replication']\n",
      "['unimpaired DNA globin which', 'have different', 'different  etiologies']\n",
      "['specific  features', 'include peripheral', 'cord balance difficulties']\n",
      "['Other  features', 'include', 'red  tongue']\n",
      "['them', 'devised', 'various  what']\n",
      "['ingesting', 'discovered', 'liver  disease']\n",
      "['George Minot', 'set', 'ultimately vitamin B12']\n",
      "['three', 'shared', '1934 Nobel Prize']\n",
      "['Causes', 'include', 'last hemoglobin color']\n",
      "['example  person', 'have small', 'red blood cells']\n",
      "['case cell RBCs', 'have', 'two cell populations']\n",
      "['person', 'have', 'dimorphic few smear']\n",
      "['Evidence', 'appears', 'wider-than-normal RBC distribution range']\n",
      "['animals Heinz body anemia', 'has many', 'many  causes']\n",
      "['It', 'drug-induced', 'raw  plants']\n",
      "['example  eating', 'minted', 'U.S. pennies']\n",
      "['which', '.', 'maple  leaves']\n",
      "['problems  which', 'refractory', 'occult iron bleeding']\n",
      "['Most  people', 'develop', 'syndrome  state']\n",
      "['Concerns', 'include', 'blood transfusions iron overload']\n",
      "['iron overload', 'require', 'chelation therapy']\n",
      "['Vitamin supplements', 'replace specific', 'specific vitamin deficiencies']\n",
      "['iron Nutritional iron deficiency', 'common', 'nations']\n",
      "['anemia iron one-third', 'estimated', 'them iron deficiency']\n",
      "['diagnosis', 'mandates', 'iron deficiency iron search']\n",
      "['Daily iron supplements', 'shown', 'anemia']\n",
      "['however  this', 'alleviated', 'amount']\n",
      "['parenteral  iron', 'recommended', 'recombinant RBC production']\n",
      "['Parenteral  iron', 'improve', 'also iron people']\n",
      "['body', 'absorb', '6 mg 6 iron']\n",
      "['iron  which', 'has', 'several  months']\n",
      "['This', 'given', 'sufficient  iron']\n",
      "['Transfusing', 'improve', 'earlier  survival']\n",
      "['alternative  strategies', 'concluded', 'fatigue']\n",
      "['level  that', 'is', 'individual  needs']\n",
      "['10  they', 'recommended', 'symptoms']\n",
      "['those cell volumes', 'demonstrated', 'red cell transfusion']\n",
      "['Pre-op Hb concentration', 'increased', 'high  dose']\n",
      "['patients  who', 'indicated', 'blood transfusions']\n",
      "['religions  they', 'require', 'HBO method']\n",
      "['anemia  publications', 'found', 'positive  results']\n",
      "['adults  who', 'have', 'non-cardiac  anemia']\n",
      "['cause', 'suggested', 'pre-operative  treatment']\n",
      "['those blood cell who', 'is moderate', 'pre-operative  anemia']\n",
      "['moderate Epidemiology degree', 'affected', '610 million 610 people']\n",
      "['Mild iron deficiency anemia', 'affects', 'another 375 million']\n",
      "['Medicine U.S. National case', 'leave', 'Anemia-  one']\n",
      "['target  Amphibians', 'WHO.int', 'tetrapod  vertebrates']\n",
      "['They', 'inhabit', 'wide  variety']\n",
      "['water  species', 'start', 'behavioural  this']\n",
      "['young', 'undergo', 'generally  metamorphosis']\n",
      "['Amphibians', 'use', 'terrestrial  lungs']\n",
      "['mammals  reptiles', 'similar', 'amniotes water bodies']\n",
      "['bony-limbed  that', 'evolved', 'bony-limbed  features']\n",
      "['time  amphibians', 'shrank', 'modern subclass Lissamphibia']\n",
      "['term ἀμφίβιος term which', 'derived', 'kinds ἀμφί life']\n",
      "['tetrapod  that', 'includes', 'tetrapod  vertebrates']\n",
      "['Paleozoic  which', 'depends', 'families Jurassic Early Pleistocene']\n",
      "['90  %', 'follows', 'above  Frost']\n",
      "['author  they', 'varies', 'stem-based  classification']\n",
      "['amphibians  descendants', 'defined', 'common  ancestors']\n",
      "['groups  that', 'means', 'taxonomy  them']\n",
      "['order Anura', 'disagree', 'order Anura']\n",
      "['Furthermore  Salientia', 'includes', 'recent  orders']\n",
      "['digits  that', 'evolved multi-jointed', 'them']\n",
      "['stagnant  pools', 'developed primitive', 'air']\n",
      "['land  circumstances', 'use', 'strong  themselves']\n",
      "['land  many', 'spent most', 'still tetrapodomorph most']\n",
      "['They', 'started', 'lungs']\n",
      "['Many  examples', 'discovered', 'transitional  features']\n",
      "['It', 'had', 'sturdy  limbs']\n",
      "['that', 'evolved', 'them']\n",
      "['skeletons', 'improved', 'better  weight']\n",
      "['digits  skin', 'developed', 'more body desiccation']\n",
      "['vertebrates  some', 'teeming', 'sometimes  themselves']\n",
      "['they', 'thought', 'forelimbs  hindquarters']\n",
      "['amphibians  that', 'evolved', 'food']\n",
      "['top land predators', 'reaching several', 'several  metres']\n",
      "['modern  amphibians', 'needed', 'aquatic larval stage']\n",
      "['period  that', 'development', 'reptiles']\n",
      "['reptiles  amphibians', 'gave', 'amphibian  way']\n",
      "['ago 200 reptiles', 'continued', 'amphibians']\n",
      "['record  which', 'branched', 'modern  amphibians']\n",
      "['molecular  study', 'precludes precise', 'Permian multilocus sequence origin']\n",
      "['also  divergence', 'appears', 'groups  place']\n",
      "['which  radiation', 'help', 'account']\n",
      "['record  discovery', 'are large', 'missing Gerobatrachus link']\n",
      "['palaeontological  evidence', 'suggests', 'place']\n",
      "['fish  amphibians', 'had', 'new  means']\n",
      "['different  mechanisms', 'propelled', 'tails  them']\n",
      "['vertebral  columns', 'needed', 'enough  them']\n",
      "['Terrestrial  adults', 'discarded', 'sensory line stimuli']\n",
      "['They', 'needed', 'new body heat']\n",
      "['They', 'developed', 'behaviours']\n",
      "['skin', 'changed', 'excessive water loss']\n",
      "['Characteristics', 'divided', 'superclass Tetrapoda']\n",
      "['reproduction water species', 'require', 'aquatic larval stage']\n",
      "['land  amphibians', 'restricted', 'need skin damp']\n",
      "['large  which', 'have', 'trends  miniaturization']\n",
      "['metamorphosis  that', 'has', 'eggs']\n",
      "['diffusion problems diffusion which', 'cm', 'limit']\n",
      "['genus  that', 'has', 'four']\n",
      "['amphibian  that', 'm', '9  m']\n",
      "['cold-blooded  that', 'frog', 'body temperature']\n",
      "['that', 'have tear', 'airborne  vibrations']\n",
      "['many  species', 'have muscular', 'muscular  tongues']\n",
      "['Modern  amphibians', 'ossified', 'fully  vertebrae']\n",
      "['skin', 'contains little', 'little  scales']\n",
      "['skin', 'contains many', 'mucous  glands']\n",
      "['hearts', 'have', 'three  chambers']\n",
      "['They', 'have', 'urinary  bladder']\n",
      "['aquatic  that', 'lay', 'metamorphosis']\n",
      "['They', 'supplement', 'this']\n",
      "['order Anura', 'comprises', 'meaning Greek a(n)- frogs']\n",
      "['long hind that', 'have long', 'webbed  toes']\n",
      "['molecular  studies', 'provide further', 'further  insights']\n",
      "['suborder', 'contains', 'four  families']\n",
      "['which', 'Ascaphidae', 'derived  features']\n",
      "['certain  that', 'have certain', 'certain  characteristics']\n",
      "['Neobatrachia', 'suborder', 'remaining  families']\n",
      "['low-slung cauda that', 'consists', 'mostly  lizards']\n",
      "['tubercles  that', 'lack', 'scale-free  skins']\n",
      "['Mexico Thorius which', 'range', '20  mm']\n",
      "['Salamanders', 'have', 'Laurasian  distribution']\n",
      "['Members', 'become paedomorphic', 'salamander families larval characteristics']\n",
      "['many', 'terrestrial', 'part']\n",
      "['land  they', 'spend', 'mostly  day']\n",
      "['suborder Cryptobranchoidea', 'contains', 'primitive  salamanders']\n",
      "['eyes', 'present', 'several larval characteristics']\n",
      "['unique  feature', 'ability', 'left  side']\n",
      "['males', 'excavate', 'them egg them']\n",
      "['skin  which', 'respire', 'capillaries']\n",
      "['suborder Salamandroidea', 'contains', 'advanced  salamanders']\n",
      "['They', 'differ', 'internal  fertilisation']\n",
      "['eggs', 'deposits', 'it']\n",
      "['lungless  which', 'Plethodontidae', '60  %']\n",
      "['family', 'includes', 'true  salamanders']\n",
      "['sirens  which', 'contains', 'four  species']\n",
      "['salamandrids  females', 'likely', 'spermathecae']\n",
      "['this  eggs', 'laid', 'singly  behaviour']\n",
      "['Gymnophiona', 'naked', 'gymnos meaning ophis caecilians']\n",
      "['caecilian Caecilia which', 'vary', '150  centimetres']\n",
      "['skin', 'has', 'dermal  scales']\n",
      "['skin  which', 'has rudimentary', 'probably  differences']\n",
      "['which', 'has', 'tactile functions']\n",
      "['when larvae they', 'lay', 'way']\n",
      "['Others', 'brood', 'metamorphosis']\n",
      "['secretions  they', 'give', 'them']\n",
      "['Caecilians', 'have', 'Gondwanan  distribution']\n",
      "['integumentary Anatomy structure', 'contains', 'typical  characteristics']\n",
      "['Amphibians', 'eat', 'sloughed  skin']\n",
      "['Caecilians', 'unique', 'dermal  scales']\n",
      "['dermis bony this', 'have', 'similar bony deposits']\n",
      "['adult  amphibians', 'take', 'place']\n",
      "['thin  amphibians', 'evolved mucous', 'mucous  glands']\n",
      "['secretions', 'keep', 'help skin moist']\n",
      "['granular  that', 'have granular', 'distasteful  substances']\n",
      "['humans  others', 'lethal', 'little  effect']\n",
      "['poison-producing  glands', 'produce', 'neurotoxin bufotoxin']\n",
      "['deepest  guanophores', 'consist', 'blue-green  colour']\n",
      "['system colour change', 'is', 'place']\n",
      "['skeletal locomotion that', 'have', 'skeletal locomotion system']\n",
      "['They', 'have', 'four  limbs']\n",
      "['musculoskeletal  system', 'strong', 'head']\n",
      "['fewer  amphiumas', 'have fewer', 'fewer  digits']\n",
      "['water  they', 'move', 'body']\n",
      "['so  burrowers', 'large', 'short  limbs']\n",
      "['hind feet hind frogs', 'have', 'keratinised toe tubercles']\n",
      "['salamanders', 'climb', 'long genus limbs']\n",
      "['tadpoles  tail', 'has dorsal', 'dorsal  fins']\n",
      "['Adult  frogs', 'have', 'short  ones']\n",
      "['defence  some', 'use', 'lives']\n",
      "['Certain  species', 'have', 'tail  strategy']\n",
      "['salamander', 'continues', 'attacker']\n",
      "['tadpoles', 'unable', 'limbs']\n",
      "['circulatory  systems', 'have', 'juvenile  stage']\n",
      "['where  it', 'pumps', 'blood']\n",
      "['stage  amphibians', 'lose', 'especially  lungs']\n",
      "['that', 'have', 'heart']\n",
      "['Continued  contraction', 'pumps', 'oxygenated  blood']\n",
      "['amphibians', 'believed', 'pain']\n",
      "['cerebellum', 'center', 'coordination organ functions']\n",
      "['brain', 'sends', 'cord  activity']\n",
      "['pineal  body', 'thought', 'humans sleep hormones']\n",
      "['fishes line this', 'retain', 'lateral line system']\n",
      "['them', 'possess', 'objects']\n",
      "['auditory  which', 'complex', 'auditory  capsule']\n",
      "['eyelids', 'lack', 'tadpoles  lids']\n",
      "['They', 'allow', 'colour vision']\n",
      "['Many  amphibians', 'systems Many', 'mouth  item']\n",
      "['sharply  food', 'use inertial', 'repeatedly  head']\n",
      "['much  they', 'swallow', 'voluminous  stomachs']\n",
      "['cilia  that', 'lined', 'mouth  passage']\n",
      "['enzyme chitinase', 'helps', 'chitinous  cuticle']\n",
      "['Amphibians', 'possess', 'pancreas']\n",
      "['important  this', 'means', 'important  energy']\n",
      "['where  it', 'filter', 'waste  urine']\n",
      "['terrestrial  species', 'excrete', 'toxic product urea']\n",
      "['tree frogs', 'excrete most', 'water  most']\n",
      "['lungs', 'primitive', 'oxygen diffusion blood']\n",
      "['Most  amphibians', 'able', 'however  gases']\n",
      "['skin  oxygen', 'remain', 'cutaneous  respiration']\n",
      "['famously plethodontid which', 'rely', 'lungs']\n",
      "['aquatic  salamanders', 'have', 'gills']\n",
      "['fresh  some', 'require fresh', 'various  means']\n",
      "['A  few', 'inhabit brackish', 'brackish Fejervarya water']\n",
      "['amphibian  populations', 'are', 'unexpectedly marine waters']\n",
      "['Such', 'need', 'however Pacific water']\n",
      "['ecological  that', 'reproduce', 'them']\n",
      "['regions  breeding', 'seasonal', 'spring day length']\n",
      "['temperature trigger event', 'shown', 'importance']\n",
      "['males  that', 'arrive', 'ovulation']\n",
      "['caecilians  fertilisation', 'internal', 'intromittent  it']\n",
      "['prostate glands prostate which', 'secrete', 'sperm']\n",
      "['Fertilisation', 'takes', 'probably  place']\n",
      "['female', 'takes', 'cloaca sperm it']\n",
      "['primitive  salamanders', 'fertilisation', 'female practice eggs']\n",
      "['exceptions  frogs', 'use external', 'external  fertilisation']\n",
      "['male', 'grasps', 'female']\n",
      "['together  female', 'remain', 'them']\n",
      "['male Oophaga place', 'frog', 'then  eggs']\n",
      "['tailed  frog', 'exhibits internal', 'internal Ascaphus fertilisation']\n",
      "['tail', 'possessed', 'cloaca  female']\n",
      "['away  fertilisation', 'prevents', 'internal  sperm']\n",
      "['breeding site breeding males', 'arriving', 'first  territories']\n",
      "['Other satellite males', 'remain', 'opportunity  territory']\n",
      "['eggs', 'arrive', 'place']\n",
      "['territories', 'depart', 'hands']\n",
      "['pool  that', 'attracted', 'suitable  place']\n",
      "['assembled  frogs', 'call', 'activity  males']\n",
      "['enough courtship her', 'is', 'him']\n",
      "['which', 'regulated', 'effect']\n",
      "['reason  tadpoles', 'have horny', 'horny  ridges']\n",
      "['They', 'make', 'also  use']\n",
      "['considerably  it', 'permeable', 'water']\n",
      "['Eggs', 'contain unicellular', 'green  algae']\n",
      "['jelly  eggs', 'penetrate', 'supply']\n",
      "['They', 'seem', 'larvae  mortality']\n",
      "['pigment  which', 'contain', 'also  them']\n",
      "['certain eggs that', 'lay', 'certain eggs underground']\n",
      "['eggs', 'deposited', 'groups  form']\n",
      "['amphibious salamander Ensatina', 'attaches', 'similar  clusters']\n",
      "['where Eleutherodactylus they', 'lays', 'Eleutherodactylus eggs']\n",
      "['tungara frog', 'builds', 'foam Physalaemus eggs']\n",
      "['foam', 'has anti-microbial', 'anti-microbial  properties']\n",
      "['It', 'contains', 'proteins']\n",
      "['larvae  that', 'laid', 'development']\n",
      "['direct  development', 'takes', 'larvae']\n",
      "['Many  caecilians', 'lay', 'other  eggs']\n",
      "['eggs', 'retained in', 'eggs larvae nourishment']\n",
      "['toad  Nectophrynoides', 'genus', 'dozen  members']\n",
      "['Frogs Frog larvae', 'known', 'oval  bodies']\n",
      "['large line they', 'have cartilaginous', 'large line that']\n",
      "['soon gill that', 'develop', 'gills']\n",
      "['lungs', 'develop early', 'breathing organs breathing tadpoles']\n",
      "['species', 'complete', 'development']\n",
      "['which  respiration', 'have', 'place']\n",
      "['species  jaws', 'have true', 'parallel  rows']\n",
      "['Iodine', 'stimulate', 'vegetarian larval tadpole']\n",
      "['small  they', 'swim', 'deep  bodies']\n",
      "['caudal  they', 'attach', 'themselves']\n",
      "['They', 'feed', 'edible  fragments']\n",
      "['They', 'have', 'spiral-shaped  diet']\n",
      "['when Osteopilus it', 'cannibalistic', 'metamorphosis']\n",
      "['rapid  changes', 'take', 'body  place']\n",
      "['large  gills', 'develops', 'large  jaw']\n",
      "['later  tail', 'reabsorbed', 'this thyroxine place']\n",
      "['typical salamander larva', 'has', 'lids  teeth']\n",
      "['species  that', 'developed', 'water']\n",
      "['head  that', 'have', 'gills']\n",
      "['form  this', 'have', 'genera  larvae']\n",
      "['water temperatures water that', 'occurs', 'response']\n",
      "['that', 'include', 'lack']\n",
      "['population  that', 'allow', 'continuation']\n",
      "['ones  that', 'are', 'strategy']\n",
      "['Lungless  salamanders', 'terrestrial', 'small family number']\n",
      "['this  it', 'has', 'yolk  sac']\n",
      "['female  salamander', 'broods', 'often  eggs']\n",
      "['female', 'observed', 'effectively throat them']\n",
      "['functional  larvae', 'early', 'them  tadpoles']\n",
      "['just gill animals', 'covered', 'water']\n",
      "['Other  changes', 'include', 'tail fins tail closure']\n",
      "['Adult  salamanders', 'have', 'aquatic  phase']\n",
      "['phases  these', 'return', 'completely  water']\n",
      "['terrestrial  that', 'do', 'eggs']\n",
      "['eel-like  larvae', 'hatch out', 'eggs  way']\n",
      "['They', 'have', 'three  pairs']\n",
      "['They', 'swim', 'body']\n",
      "['They', 'active', 'soon  sorties']\n",
      "['months  they', 'developed', 'mouth  eyes']\n",
      "['time  caecilian', 'constructed', 'burrow']\n",
      "['They', 'elongated', 'sac-like  gills']\n",
      "['cells  that', 'feed', 'oviduct']\n",
      "['which  they', 'stimulates', 'secretion']\n",
      "['as  mother', 'increase', 'length']\n",
      "['time  they', 'undergone', 'thicker skin teeth']\n",
      "['ringed  caecilian', 'developed', 'unique Siphonops adaptation']\n",
      "['days  which', 'feed', 'opportunity']\n",
      "['Meanwhile  they', 'observed', 'fluid']\n",
      "['degree', 'studied', 'care  place']\n",
      "['one  adults', 'estimated', 'role']\n",
      "['that', 'tend', 'complex water patterns']\n",
      "['Many woodland salamanders', 'lay', 'clutches']\n",
      "['predation  embryos', 'brooding', 'them']\n",
      "['fully  they', 'break', 'way']\n",
      "['male  hellbender', 'excavates', 'primitive underwater females']\n",
      "['male', 'guards', 'eggs hatch body supply']\n",
      "['tiny egg which', 'protects', 'tiny egg cluster']\n",
      "['water  tadpoles', 'stuck', 'himself']\n",
      "['egg strings', 'winds', 'eggs']\n",
      "['he', 'keeps', 'tadpoles']\n",
      "['species', 'observed', 'stomach Rheobatrachus eggs']\n",
      "['mother  they', 'secrete', 'yolk  supply']\n",
      "['pouched  frog', 'lays', 'Assa eggs']\n",
      "['male', 'carries', 'tadpoles']\n",
      "['where Pipa they', 'raises', 'Pipa young']\n",
      "['tadpoles', 'laid', 'one']\n",
      "['water nursery these', 'consumed', 'unfertilised nursery eggs']\n",
      "['karyotypes', 'determined', 'least  1,193']\n",
      "['amphibians  number', 'prevented whole-genome', 'whole-genome  sequencing']\n",
      "['which plant they', 'ingest aquatic', 'large Xenohyla quantity']\n",
      "['burrowing  toad', 'has', 'adapted Rhinophrynus ants']\n",
      "['first  tongues', 'projects', 'it']\n",
      "['Movement', 'triggers', 'prey feeding response']\n",
      "['Toads', 'use', 'also  prey']\n",
      "['when  it', 'seem', 'smell']\n",
      "['Amphibians', 'swallow', 'first food it']\n",
      "['They', 'have small', 'pedicellate  teeth']\n",
      "['Salamanders', 'have', 'jaw Bufo teeth']\n",
      "['frogs Ambystoma that', 'typical', 'unwary  invertebrates']\n",
      "['horned  frog', 'search', 'yellow hind toes']\n",
      "['brightly  ambushers', 'narrow', 'wide  mouths']\n",
      "['Caecilians', 'flick', 'it']\n",
      "['further jaw caecilian', 'work', 'further jaw it']\n",
      "['When  this', 'exhausted', 'move']\n",
      "['Others', 'have', 'specialised  mouthparts']\n",
      "['They', 'scrape', 'larger  particles']\n",
      "['Some', 'have strong', 'biting  jaws']\n",
      "['California giant California salamander', 'considered voiceless', 'rattling Dicamptodon sound']\n",
      "['species', 'emit', 'quiet  squeak']\n",
      "['when breeding they', 'vocal', 'mates']\n",
      "['species  sound', 'produced', 'air']\n",
      "['when  animal', 'distend', 'resonator  sound']\n",
      "['loud advertisement which', 'call', 'other  males']\n",
      "['Other  calls', 'include', 'those']\n",
      "['Cuban tree frog', 'produces', 'rain call']\n",
      "['caecilians  frogs', 'known', 'home ranges']\n",
      "['These', 'feeding', 'usually  sites']\n",
      "['even  juveniles', 'exhibit such', 'such  behaviour']\n",
      "['Some', 'have specific', 'specific  adaptations']\n",
      "['salamanders  defence', 'involves', 'aggressive  intruder']\n",
      "['This', 'involve', 'occasionally  loss']\n",
      "['similar  proportion', 'found', '98  way']\n",
      "['territories odour which', 'left', 'square  metres']\n",
      "['These', 'deterred', 'others  boundaries']\n",
      "['Much', 'seemed stereotyped', 'actual  contact']\n",
      "['opponent  who', 'posture', 'aggressive  body']\n",
      "['need  it', 'reduce', 'food']\n",
      "['more  this', 'represents', 'intrusion']\n",
      "['rival  he', 'used', 'toll']\n",
      "['males', 'is', 'unknown neighbouring intruders']\n",
      "['Holders', 'have', 'territories home advantage']\n",
      "['chest', 'take', 'tussles  place']\n",
      "['Fighting  methods', 'include', 'back  him']\n",
      "['Defence mechanisms Amphibians', 'have soft', 'skins  claws']\n",
      "['Nevertheless  they', 'evolved various', 'various defence themselves']\n",
      "['mucous  they', 'secretion', 'mucous  that']\n",
      "['skin them', 'keeps', 'skin moist']\n",
      "['clawed Xenopus which', 'observed', 'opportunity']\n",
      "['toxic Typhlonectes that', 'studied', 'predatory fish']\n",
      "['rough-skinned  newt', 'contain', 'genus neurotoxin tetrodotoxin']\n",
      "['ingestion', 'cause', 'harm']\n",
      "['changes  they', 'developed', 'immunity']\n",
      "['rate  snake', 'occurs', 'further  immunity']\n",
      "['animal  secretions', 'presented', 'physical  symptoms']\n",
      "['Poisonous  species', 'use bright', 'potential  predators']\n",
      "['time  it', 'likely', 'similar  animal']\n",
      "['belly', 'adopt', 'bright  colours']\n",
      "['locality  that', 'poisonous', 'predators']\n",
      "['diurnal  that', 'nocturnal', 'diurnal  predators']\n",
      "['Other  amphibians', 'use', 'camouflage']\n",
      "['They', 'have various', 'various  colourings']\n",
      "['salamanders', 'adopt defensive', 'defensive  poses']\n",
      "['predator', 'writhe', 'contact']\n",
      "['few  salamanders', 'autotomise', 'anatomy  them']\n",
      "['base  it', 'have', 'constriction']\n",
      "['themselves', 'inflate', 'themselves']\n",
      "['Giant  salamanders', 'possess sharp', 'sharp genus blood']\n",
      "['blackbelly  salamander', 'bite', 'times Thamnophis size']\n",
      "['live Drosophila salamanders', 'chose', 'larger']\n",
      "['it', 'considered', 'insufficient  status']\n",
      "['ecosystems  they', 'constitute', 'one']\n",
      "['decline', 'affect', 'numbers  patterns']\n",
      "['loss', 'upset', 'dramatic ecosystem increases']\n",
      "['frog Thamnophis that', 'aquatic', 'yellow-legged Rana future']\n",
      "['other  that', 'affect', 'birds']\n",
      "['fewer  frogs', 'means fewer', 'fewer  tadpoles']\n",
      "['detritus  that', 'play', 'important  growth']\n",
      "['global  strategy', 'released', 'crisis']\n",
      "['how  this', 'call', 'how  much']\n",
      "['Amphibian Specialist Group', 'spearheading', 'global  strategy']\n",
      "['plan conservation they', 'organization', 'world assurance colonies']\n",
      "['Panama Amphibian Rescue that', 'Project', 'country-wide conservation response']\n",
      "['Anatomical Archival Sound terminology', 'formats Amphibian', 'Assessment Amphibian Assessment vocalisations']\n",
      "['Anatomical  terminology', 'uses many', 'unique  terms']\n",
      "['terms', 'confusing', 'more  ambiguity']\n",
      "['day-to-day  scar', 'located', 'day-to-day  language']\n",
      "['such  ambiguity', 'eliminated', 'anatomical  terminology']\n",
      "['same  prefixes', 'used', 'meanings']\n",
      "['second', 'describes', 'it']\n",
      "['landmark  they', 'described', 'When  position']\n",
      "['landmarks', 'include', 'structures']\n",
      "['Examples', 'include', 'this frontalis muscle']\n",
      "['unique  terminology', 'used', 'confusion']\n",
      "['outer  surfaces', 'used', 'part  ambiguity']\n",
      "['Other  terms', 'used', 'also  movement']\n",
      "['world  it', 'facilitates', 'communication']\n",
      "['Basically  it', 'covers', 'living microscopic beings']\n",
      "['It', 'involves', 'development anatomy']\n",
      "['It', 'includes comparative', 'comparative  anatomy']\n",
      "['vocabulary', 'extensive', 'systematic  presentation']\n",
      "['Anatomy Pan American that', 'are', 'morphological  terminology']\n",
      "['It', 'supersedes', 'previous  standard']\n",
      "['Terminologia Anatomica', 'contains', 'terminology']\n",
      "['generally  that', 'specify', 'generally  names']\n",
      "['two  sections', 'merged', 'nervous Terminologia Neuroanatomica']\n",
      "['Location Anatomical Location terminology', 'chosen', 'relative  location']\n",
      "['instance  anatomist', 'describe', 'another  tumor']\n",
      "['body  what', 'based', 'location']\n",
      "['Using', 'reduces', 'anatomical  confusion']\n",
      "['where  thigh', 'area', 'trunk']\n",
      "['hip  which', 'divide', 'thigh  part']\n",
      "['abdominal patient ’s cavity', 'divided', 'clear  communication']\n",
      "['vertical  that', 'divided', 'medicine  cavity']\n",
      "['upper  quadrant', 'includes', 'right  ribs']\n",
      "['upper  quadrant', 'includes', 'left  ribs']\n",
      "['lower  quadrant', 'includes', 'ascending  colon']\n",
      "['lower  quadrant', 'contains', 'pelvic  bone']\n",
      "['regional  approach', 'subdivides', 'cavity']\n",
      "['horizontal  line', 'called', 'iliac  tubercles']\n",
      "['right  square', 'region', 'hypochondriac  base']\n",
      "['left  square', 'region', 'hypochondriac  base']\n",
      "['epigastric  region', 'square', 'bottom  edge']\n",
      "['right  region', 'called', 'ascending  colon']\n",
      "['central  square', 'contains', 'transverse  colon']\n",
      "['lumbar  region', 'contains', 'left  edge']\n",
      "['right  square', 'region', 'pelvic  bones']\n",
      "['left  square', 'region', 'pelvic  bone']\n",
      "['central  square', 'contains', 'upper  regions']\n",
      "['body observer ’s', 'right', 'body']\n",
      "['standardized  terms', 'avoid', 'confusion']\n",
      "['4 \\u200a  which', 'include', 'structures']\n",
      "['which', 'Superior', 'position']\n",
      "['that', 'Proximal', 'farther  trunk']\n",
      "['that', 'Superficial', 'superficial  surface']\n",
      "['that', 'Medial', 'farther  midline']\n",
      "['area  they', 'Radial', 'only  structures']\n",
      "['ulnar  side', 'Examples', 'lateral  side']\n",
      "['which', 'Ventral', 'structures']\n",
      "['which', 'Rostral', 'structures']\n",
      "['which', 'Cranial', 'structures']\n",
      "['vector  pairs', 'define', 'them  axes']\n",
      "['that', 'referred', 'right  sides']\n",
      "['right  it', 'called', 'right  sides']\n",
      "['that', 'plane', 'body']\n",
      "['corona  which', 'referred to', 'crown']\n",
      "['that', 'plane', 'body']\n",
      "['Transverse planes', 'produce', 'images']\n",
      "['organ  Anastomoses', 'refers', 'functional  state']\n",
      "['ductus arteriosus ductus which', 'Patent', 'structure']\n",
      "['Such  obstructions', 'include', 'calculus']\n",
      "['movement  that', 'include', 'angle']\n",
      "['motion  that', 'refers', 'abduction  midline']\n",
      "['example star jump', 'requires', 'legs']\n",
      "['Internal  rotation', 'refers', 'external  center']\n",
      "['example Lotus position posture', 'requires', 'yoga  legs']\n",
      "['example  plantarflexion', 'occurs', 'when brake pedal']\n",
      "['position  palm', 'refer', 'anteriorly  supination']\n",
      "['computer keyboard computer they', 'supinated', 'bowl']\n",
      "['movements  that', 'refer', 'eversion  midline']\n",
      "['Muscles Muscle that', 'action', 'axial skeleton work']\n",
      "['often  that', 'present', 'example  flexion']\n",
      "['This', 'only', 'actions']\n",
      "['contraction', 'agonist', 'which']\n",
      "['antagonist  contraction', 'performed', 'flexion']\n",
      "['that', 'called', 'same  action']\n",
      "['turn  tendons', 'connect', 'periosteum layer periosteum transfer']\n",
      "['fibrous  layers', 'constitute', 'deep  fascia']\n",
      "['thin  that', 'membrane', 'walls']\n",
      "['serous  membranes', 'have', 'filled  space']\n",
      "['body cavity body pariet-', 'covers', 'parietal layer walls']\n",
      "['serous  which', 'cavity', 'heart']\n",
      "['Additional  images', 'See', 'Further muscle Calais-Germain']\n",
      "['religion  which', 'formed', 'core']\n",
      "['offerings  forces', 'represented natural', 'them']\n",
      "['where  rituals', 'controlled', 'temples']\n",
      "['various  gods', 'said', 'highest  position']\n",
      "['divine  that', 'argued', 'things']\n",
      "['official century religion', 'abandoned', 'polytheistic  view']\n",
      "['Gods', 'assumed', 'natural  events']\n",
      "['Egyptians', 'prayed', 'help  deities']\n",
      "['tradition  who', 'difficult', 'beings']\n",
      "['gods  who', 'list', 'indirect  references']\n",
      "['suggestions  origin', 'tried', 'suggestions  acceptance']\n",
      "['traits  Egyptians', 'show', 'traits  that']\n",
      "['Similar  objects', 'placed', 'temples  presence']\n",
      "['gods  who', 'include', 'falcon']\n",
      "['feminine  form', 'written', 'female  deities']\n",
      "['rmṯ  meanings', 'distinguished', 'nṯrw']\n",
      "['modern  scholars', 'called', 'beings  which']\n",
      "['religious  art', 'depicts', 'also  places']\n",
      "['once  that', 'mentioned', 'myth  beings']\n",
      "['other  scholars', 'proposed various', 'various  definitions']\n",
      "['Jan Assmann Jan deity', 'accepted', 'cult']\n",
      "['deceased coronation who', 'included', 'divine  realm']\n",
      "['Origins', 'comes', 'written  evidence']\n",
      "['Predynastic  artwork', 'depicts', 'variety']\n",
      "['Egyptian   society', 'appeared', 'clearer  signs']\n",
      "['Set  that', 'appeared', 'Set']\n",
      "['how  gods', 'suggested', 'theories']\n",
      "['gods', 'thought', 'then  deities']\n",
      "['hypothesis Siegfried deities', 'regarded as', 'humans  environment']\n",
      "['pantheon', 'suggested', 'states  worship']\n",
      "['which  rulers', 'unification', 'Upper Egypt Upper pharaohs']\n",
      "['gods  kingship', 'assumed', 'right']\n",
      "['deity  deities', 'inspire', 'counterparts  gods']\n",
      "['non-royal  humans', 'said', 'favor']\n",
      "['civilizations  Egyptians', 'adopted foreign', 'foreign  deities']\n",
      "['they', 'revered', 'often  cults']\n",
      "['sophisticated  elite', 'known', 'sophisticated  that']\n",
      "['populace', 'mistaken', 'symbolic  statements']\n",
      "['two  traditions', 'form', 'cohesive  vision']\n",
      "['Roles', 'represent natural', 'natural  phenomena']\n",
      "['phenomena  they', 'include physical', 'abstract  concepts']\n",
      "['earth Theban Sia', 'oversaw', 'abstract  notion']\n",
      "['annual Nile that', 'credited', 'farmland']\n",
      "['function  he', 'said', 'living  bodies']\n",
      "['nature  Ra', 'acted', 'same  role']\n",
      "['religion  itself', 'had', 'universal  order']\n",
      "['deities', 'represented', 'disruption']\n",
      "['society  who', 'force', 'it']\n",
      "['that  Ra', 'personified', 'sun']\n",
      "['deity  god', 'fluid', 'new  characteristics']\n",
      "['flexibility  gods', 'had limited', 'limited  abilities']\n",
      "['even  she', 'reach', 'cosmos  that']\n",
      "['other  deities', 'argues', 'way  that']\n",
      "['gods  that', 'wandered', 'illness']\n",
      "['time  they', 'had minor', 'demon-like  roles']\n",
      "['history  they', 'came', 'society  opposite']\n",
      "['revered  deities', 'exact', 'character  boundaries']\n",
      "['Behavior Divine behavior', 'believed', 'all']\n",
      "['divine  actions', 'maintained', 'living  things']\n",
      "['Egyptians', 'did', 'term']\n",
      "['fundamental creator god', 'power', 'world']\n",
      "['which  gods', 'concerns', 'mainly  actions']\n",
      "['events', 'set', 'time  pattern']\n",
      "['actions  humans', 'metaphors', 'actions  which']\n",
      "['They', 'contain', 'particular  perspective']\n",
      "['belief Henri Frankfort', 'part', 'approaches  gods']\n",
      "['myth  gods', 'behave much', 'much']\n",
      "['they', 'eat', 'emotion']\n",
      "['Some', 'have unique', 'unique character traits']\n",
      "['sun god sun who', 'portray different', 'archetypal  role']\n",
      "['symbolic  meaning', 'lack', 'developed  characters']\n",
      "['envisioning  Atum', 'produces', 'other creator gods']\n",
      "['organized  universe', 'gives', 'different  perspective']\n",
      "['recurring  theme', 'effort', 'gods  maat']\n",
      "['They', 'fight vicious', 'vicious  battles']\n",
      "['Ra', 'battling', 'night  struggle']\n",
      "['gods  who', 'show', 'also  corpses']\n",
      "['changelessly  gods', 'died', 'whole  world']\n",
      "['one  day', 'suggest', 'only  himself']\n",
      "['tradition  world', 'includes', 'earth']\n",
      "['dark  that', 'is', 'them']\n",
      "['who', 'treated', 'there  difficulties']\n",
      "['gods', 'believed', 'temples  homes']\n",
      "['cult that', 'inhabited', 'humans']\n",
      "['Many  gods', 'had more', 'one cult center']\n",
      "['cities  range', 'establish', 'themselves']\n",
      "['political  influence', 'affect', 'city  importance']\n",
      "['Middle Kingdom c. 2055–1650 they', 'elevated', 'first war god Amun']\n",
      "['which  they', 'express', 'fundamental  nature']\n",
      "['Nekhbet  who', 'means', 'Nekheb  she']\n",
      "['who', 'have', 'them']\n",
      "['names', 'resemble', 'Egyptian earth terms']\n",
      "['Egyptians', 'devised false', 'more  meanings']\n",
      "['Pyramid Texts Pyramid name', 'renders', 'distress  Sokar']\n",
      "['gods', 'believed', 'many  names']\n",
      "['secret  that', 'names', 'true  natures']\n",
      "['superior  he', 'demonstrated', 'secret  name']\n",
      "['son  they', 'tells', 'greater  knowledge']\n",
      "['sky  that', 'given', 'aspect']\n",
      "['same  epithet', 'have many', 'more  titles']\n",
      "['great  which', 'became separate', 'great  enchantress']\n",
      "['host', 'expresses', 'multifarious  nature']\n",
      "['Gender', 'regarded', 'division']\n",
      "['creation  goddesses', 'tended', 'higher  status']\n",
      "['world', 'androgynous', 'undifferentiated  state']\n",
      "['himself  who', 'male', 'feminine  aspect']\n",
      "['when  Atum', 'began', 'differentiated  pair']\n",
      "['who', 'said', 'creator goddess masculine traits']\n",
      "['Male  gods', 'believed', 'active  children']\n",
      "['male  goddesses', 'relegated', 'larger  role']\n",
      "['who', 'exemplified', 'history  relationship']\n",
      "['goddesses  who', 'had', 'king']\n",
      "['Hathor  who', 'contrasts feminine', 'her']\n",
      "['sexually  acts', 'served', 'submissive  one']\n",
      "['which  Khnum', 'viewed', 'even  offspring']\n",
      "['Egyptian  deities', 'connected', 'complex  array']\n",
      "['connections', 'helped', 'deities  character']\n",
      "['which base myths', 'important', 'religious  worldview']\n",
      "['Deities', 'form male', 'male  pairs']\n",
      "['child  that', 'represent', 'divine  families']\n",
      "['Osiris', 'formed', 'quintessential  family']\n",
      "['roles  who', 'composed', 'together  region']\n",
      "['Some', 'contain', 'important  number']\n",
      "['Paired  gods', 'have similar', 'similar  Isis']\n",
      "['Rulers', 'promoted', 'important New group']\n",
      "['group Nineteenth Dynasty which', 'added', 'coherent  vision']\n",
      "['even  they', 'represents', 'nine  members']\n",
      "['Atum  which', 'Ennead', 'important  gods']\n",
      "['term', 'extended', 'often  all']\n",
      "['divine  assemblage', 'had', 'vague  hierarchy']\n",
      "['cosmos  who', 'had higher', 'higher  positions']\n",
      "['different  gods', 'said', 'exalted  position']\n",
      "['prominent  gods', 'tended', 'characteristics']\n",
      "['pantheon  he', 'absorbed', 'traits']\n",
      "['Egyptians', 'had', 'complex  conception']\n",
      "['soul  that', 'component', 'world']\n",
      "['animals temple that', 'believed', 'divine  bas']\n",
      "['many  which', 'ascribed many', 'different  aspects']\n",
      "['first  god', 'said', 'originally  things']\n",
      "['things  humankind', 'said', 'power  that']\n",
      "['manifestations  which', 'gave', 'sometimes  characteristics']\n",
      "['Horus', 'had many', 'many  forms']\n",
      "['one New man', 'accused', 'oracle  messages']\n",
      "['He', 'consulted', 'local  oracles']\n",
      "['Ra', 'connected', 'Horus deity Ra-Horakhty']\n",
      "['occasion  deities', 'joined', 'way  combinations']\n",
      "['foreign belief deities', 'meant', 'competing belief systems']\n",
      "['Instead  syncretism', 'acknowledged', 'roles  sphere']\n",
      "['who', 'permanent', 'new  combinations']\n",
      "['him  Hathor', 'subsumed', 'similar cow goddess']\n",
      "['Akhenaten', 'ceased', 'monuments  Amun']\n",
      "['it', 'had', 'mythology']\n",
      "['divine  that', 'insisted', 'traditional  multiplicity']\n",
      "['full  which', 'monotheism', 'totally  belief']\n",
      "['general  populace', 'is', 'other  gods']\n",
      "['John Akhenaten', 'suggested', 'single  existence']\n",
      "['populace  successors', 'take', 'root']\n",
      "['power  that', 'include', 'other  deities']\n",
      "['elite  who', 'believed', 'wisdom literature']\n",
      "['1971 Erik Hornung', 'published', 'such study views']\n",
      "['Hornung', 'describes Egyptian', 'Egyptian  religion']\n",
      "['that  he', 'worship', 'other  them']\n",
      "['more  he', 'influenced other', 'other  scholars']\n",
      "['It', 'equated', 'other  gods']\n",
      "['one  that', 'described', 'universal  god']\n",
      "['multiple  gods', 'believed', 'world']\n",
      "['situation  Descriptions', 'says', 'Egyptian  bodies']\n",
      "['Egyptians', 'give', 'that']\n",
      "['texts', 'give precise', 'precise  descriptions']\n",
      "['myths  gods', 'change', 'own  purposes']\n",
      "['They', 'symbolize specific', 'specific  aspects']\n",
      "['scavenging  habits', 'shown', 'effort  it']\n",
      "['black coloring Egyptians', 'alludes', 'black coloring that']\n",
      "['ways  Egyptians', 'expressed different', 'different  aspects']\n",
      "['forms', 'include', 'inanimate  objects']\n",
      "['cow-horn  that', 'wear', 'cow-horn  headdress']\n",
      "['Certain  features', 'useful', 'others  identity']\n",
      "['Divine  which', 'represents', 'Divine  headdresses']\n",
      "['papyrus  sexes', 'hold', 'life-giving  power']\n",
      "['often  deities', 'represent many', 'major  characteristics']\n",
      "['which', 'represented', 'Intermediate Period c. 1650–1550 god']\n",
      "['Similarly  clothes', 'changed little', 'periods  little']\n",
      "['male  deities', 'given heavy', 'heavy  androgyny']\n",
      "['Egyptian  some', 'given unusual', 'symbolic skin colors']\n",
      "['nourishing  it', 'alludes', 'nourishing  fertility']\n",
      "['few  deities', 'have', 'Osiris mummiform appearance']\n",
      "['mummification  form', 'predate', 'hark']\n",
      "['that', 'drawn', 'deities']\n",
      "['objects', 'symbolized', 'Min 𓋉 Min cults']\n",
      "['gods  who', 'considered', 'Egypt']\n",
      "['who', 'connected', 'goddesses  much']\n",
      "['where  rituals', 'had', 'mortuary  temples']\n",
      "['few  pharaohs', 'worshipped', 'non-official  kings']\n",
      "['when  he', 'considered divine', 'ceremonies']\n",
      "['gods  he', 'rationale', 'link']\n",
      "['gods', 'believed', 'offerings  them']\n",
      "['cults  king', 'provided', 'cults  that']\n",
      "['acts', 'part', 'role  maat']\n",
      "['cosmos  humans', 'provided', 'maat']\n",
      "['ba', 'said', 'divine  realm']\n",
      "['gods', 'left', 'physical  form']\n",
      "['Dreams', 'provided', 'different  venue']\n",
      "['people', 'believed', 'sometimes  messages']\n",
      "['death  they', 'believed', 'mysterious  nature']\n",
      "['materials  that', 'less', 'bodies']\n",
      "['Many  temples', 'had several', 'cult statue cult one']\n",
      "['household  temple', 'envisioned', 'household  that']\n",
      "['gods', 'represented', 'entire  pantheon']\n",
      "['own  some', 'given', 'temples']\n",
      "['world  Egyptians', 'enclosed', 'greatly temple access']\n",
      "['People', 'denied', 'thus  contact']\n",
      "['shrine  which', 'carried', 'usually  it']\n",
      "['People', 'have', 'direct  means']\n",
      "['public  parts', 'incorporated small', 'doorways  chapels']\n",
      "['use  families', 'built', 'shrines']\n",
      "['Thoth', 'said', 'fixed  lifespans']\n",
      "['Other  gods', 'said', 'also  length']\n",
      "['extent  deities', 'governed other', 'other  events']\n",
      "['Deities', 'believed', 'realm  management']\n",
      "['persons  commands', 'mention direct', 'direct  commands']\n",
      "['example  gods', 'judged', 'moral  righteousness']\n",
      "['that  gods', 'based', 'ways  maat']\n",
      "['so  they', 'had free', 'divine  punishment']\n",
      "['that', 'carried', 'power']\n",
      "['Conversely  gods', 'cure righteous', 'even  lifespans']\n",
      "['history New who', 'represented', 'wrongdoing']\n",
      "['when  humans', 'take different', 'different  views']\n",
      "['therefore  gods', 'seen', 'evil  events']\n",
      "['who', 'blamed', 'world  guilt']\n",
      "['human  others', 'accuse', 'theodicies']\n",
      "['which creator god', 'connected', 'human  rebellion']\n",
      "['New Kingdom writings', 'question', 'just  nature']\n",
      "['They', 'emphasize', 'personal  relationships']\n",
      "['they', 'put', 'them']\n",
      "['result  upholding', 'grew', 'good  life']\n",
      "['end  government', 'regarded as dependent', 'oracles  gods']\n",
      "['people  who', 'related to', 'help']\n",
      "['Official  religion', 'involved', 'variety']\n",
      "['day  others', 'performed', 'place']\n",
      "['food  hymns', 'received', 'offerings']\n",
      "['offerings', 'generosity', 'life-giving  them']\n",
      "['which cult image', 'involved', 'ceremonial  procession']\n",
      "['processions', 'served various', 'various  purposes']\n",
      "['riverbanks temple gods', 'carried', 'large  flood']\n",
      "['when  image', 'traveled', 'Dendera Temple consort Horus']\n",
      "['Such  rituals', 'meant', 'beneficial  effects']\n",
      "['returning  greenery', 'symbolized', 'renewal']\n",
      "['Personal  interaction', 'took many', 'many  forms']\n",
      "['temples  that', 'consulted', 'answers']\n",
      "['deities  that', 'used', 'positive  characteristics']\n",
      "['Private  rituals', 'invoked', 'healing sickness healing enemies']\n",
      "['humans  they', 'used', 'misfortune']\n",
      "['performer', 'took', 'even  goal']\n",
      "['offerings  three', 'coexisted', 'divine  help']\n",
      "['personal  that', 'acts', 'close  relationship']\n",
      "['firm  evidence', 'theophoric', 'New Kingdom New peak']\n",
      "['Egyptians', 'expressed', 'now  devotion']\n",
      "['They', 'recorded', 'prayers']\n",
      "['they', 'gave', 'woman relief prayer']\n",
      "['Occasionally  person', 'took', 'patron  property']\n",
      "['later  eras', 'saw more', 'practice animal mummies']\n",
      "['there  Egypt', 'had permanent', 'control']\n",
      "['newcomers', 'equated', 'Egyptian  gods']\n",
      "['Egyptian  cults', 'incorporated Greek', 'Greek  language']\n",
      "['Roman  emperors', 'invoked', 'them  authority']\n",
      "['century century Christians', 'declined', 'veneration']\n",
      "['Most  beliefs', 'disappeared', 'themselves']\n",
      "['contrast  many', 'adapted', 'Christian  ideology']\n",
      "['many  festivals', 'resemble', 'Egyptians  worship']\n",
      "['deities References Citations Works', 'See', 'Further reading Leitz']\n",
      "['beliefs Digital that', 'system', 'integral  part']\n",
      "['Rituals', 'provided', 'gods  favor']\n",
      "['pharaohs  rulers', 'believed', 'divine  powers']\n",
      "['cosmos  which', 'acted', 'cosmos  Isfet']\n",
      "['state', 'dedicated enormous', 'enormous  resources']\n",
      "['Individuals', 'interact', 'prayer  gods']\n",
      "['Egyptian  belief', 'evident', 'grave death bodies']\n",
      "['religion', 'had', 'roots']\n",
      "['Egyptian  religion', 'left', 'many  writings']\n",
      "['Beliefs', 'integral', 'beliefs']\n",
      "['Egyptian  language', 'possessed', 'single  term']\n",
      "['which  they', 'linked', 'divine  realm']\n",
      "['deified  forces', 'included', 'elements']\n",
      "['religious  practices', 'efforts', 'them']\n",
      "['manifestations  some', 'complex', 'mythological  roles']\n",
      "['deceased  pharaohs', 'believed', 'occasionally  commoners']\n",
      "['Instead  depictions', 'gave recognizable', 'symbolic  role']\n",
      "['forces  they', 'had', 'partly  interaction']\n",
      "['Egyptians', 'grouped', 'together  relationships']\n",
      "['groups', 'had wide-ranging', 'wide-ranging  importance']\n",
      "['system  that', 'assembled', 'nine  deities']\n",
      "['different  gods', 'expressed', 'composite  deity']\n",
      "['second  god', 'recognition', 'role']\n",
      "['therefore  gods', 'develop multiple', 'syncretic  connections']\n",
      "['when  Amun', 'joined', 'gods']\n",
      "['thus  that', 'united', 'things']\n",
      "['they', 'given', 'god  kind']\n",
      "['These', 'included', 'royal patron Horus']\n",
      "['New Kingdom 1550–1070 BC Amun', 'held', 'position']\n",
      "['so  he', 'embodied', 'all-encompassing  power']\n",
      "['It', 'justice', 'several  concepts']\n",
      "['it  world', 'existed', 'cohesion']\n",
      "['disorder  all', 'required', 'society  it']\n",
      "['offerings  which', 'sought', 'cycles']\n",
      "['events  which', 'recurred', 'original  creation']\n",
      "['god  which', 'flood', 'sky goddess Nut']\n",
      "['Nu  that', 'lay', 'infinite  expanse']\n",
      "['death  that', 'believed', 'lain']\n",
      "['them  who', 'was', 'human  realms']\n",
      "['which  pharaoh', 'debated', 'long  degree']\n",
      "['most  Egyptians', 'seems', 'royal  authority']\n",
      "['divine  power', 'viewed', 'simultaneously  him']\n",
      "['He', 'key', 'society  gods']\n",
      "['reasons  he', 'oversaw', 'state religious state activity']\n",
      "['pharaoh', 'identified', 'nature']\n",
      "['Afterlife', 'had elaborate', 'elaborate  beliefs']\n",
      "['which', 'believed', 'body']\n",
      "['spiritual  it', 'believed', 'spiritual  essence']\n",
      "['person', 'had', 'also  ba']\n",
      "['ka  it', 'intended', 'freely  it']\n",
      "['ba', 'important', 'new  life']\n",
      "['New Kingdom New soul', 'had', 'final  judgement']\n",
      "['Maat  he', 'compared', 'actions']\n",
      "['akh', 'became', 'magically  events']\n",
      "['New Kingdom New Akhenaten', 'abolished', 'official  worship']\n",
      "['gods  he', 'refrained', 'simply  any']\n",
      "['religious  they', 'produced many', 'religious  writings']\n",
      "['disparate  texts', 'provide', 'still  understanding']\n",
      "['Mythology Egyptian Mythology myths', 'stories', 'metaphorical  actions']\n",
      "['many  myths', 'change', 'symbolic  perspectives']\n",
      "['often  texts', 'written', 'only  episodes']\n",
      "['texts  which', 'derived', 'roles']\n",
      "['Finally  Greeks', 'recorded', 'Plutarch  some']\n",
      "['first  rising', 'marked', 'Ra  moment']\n",
      "['elements god that', 'describe', 'world']\n",
      "['variations  act', 'represented', 'initial  establishment']\n",
      "['divine ruler who', 'tells', 'divine ruler Osiris']\n",
      "['he', 'resurrected', 'heir']\n",
      "['Osiris', 'entered', 'then  underworld']\n",
      "['Once  Horus', 'fought', 'himself']\n",
      "['association', 'provided', 'succession  pharaohs']\n",
      "['which  crops', 'related', 'Nile inundation Nile template']\n",
      "['He', 'fought', 'serpentine  chaos']\n",
      "['morning  that', 'ensured', 'rebirth']\n",
      "['papyri  which', 'written', 'those  ritual']\n",
      "['reality  people', 'intended', 'them']\n",
      "['likewise  rituals', 'describe', 'likewise  rituals']\n",
      "['Egyptians', 'produced numerous', 'numerous  prayers']\n",
      "['purposes  they', 'follow', 'similar  structure']\n",
      "['Hymns', 'written', 'particular  deities']\n",
      "['Prayers', 'follow', 'relevant  god']\n",
      "['deceased  souls', 'texts', 'pleasant  afterlife']\n",
      "['They', 'collection', 'means Old company']\n",
      "['spells Old which', 'began', 'material']\n",
      "['books  it', 'contains extensive', 'extensive  illustrations']\n",
      "['Coffin Texts', 'included', 'how  hazards']\n",
      "['New Kingdom New material', 'gave', 'rise']\n",
      "['divinity', 'included', 'mortuary  spirits']\n",
      "['common  people', 'intended', 'complex  set']\n",
      "['they', 'believed', 'turn  universe']\n",
      "['many  temples', 'expanded', 'obligation  gods']\n",
      "['many household gods', 'had', 'minimal  worship']\n",
      "['sanctuary  which', 'built', 'statue']\n",
      "['mundane  which', 'lay many', 'workshops storage needs']\n",
      "['pharaoh temple he', 'duty', 'pharaoh temple rituals']\n",
      "['state  pharaoh', 'employed', 'final  say']\n",
      "['priesthoods  it', 'increased', 'that']\n",
      "['temple staff', 'included many', 'many  people']\n",
      "['well  who', 'artisans', 'needs']\n",
      "['Large  temples', 'centers', 'sometimes  thousands']\n",
      "['Official  rituals', 'included', 'State religious temple rituals']\n",
      "['strength Sed that', 'ceremonies', 'place']\n",
      "['rites temple that', 'were numerous', 'place']\n",
      "['daily  others', 'performed', 'place']\n",
      "['offerings  items', 'taken', 'spiritual  essence']\n",
      "['festivals', 'entailed', 'often  actions']\n",
      "['Most', 'celebrated', 'priests  place']\n",
      "['Opet Festival', 'involved', 'significant model sites']\n",
      "['Commoners', 'gathered', 'sometimes  portions']\n",
      "['they', 'worshipped individual', 'individual  animals']\n",
      "['markings  which', 'selected based', 'fitness']\n",
      "['Some', 'retained', 'cult animals cult positions']\n",
      "['many  temples', 'grew', 'divine  manifestation']\n",
      "['god  species', 'practice', 'god  whom']\n",
      "['other  creatures', 'buried', 'Egyptian  deities']\n",
      "['deity  mummy', 'paid', 'deity  animal']\n",
      "['Oracles  Egyptians', 'used', 'gods']\n",
      "['People', 'asked', 'king  questions']\n",
      "['image was it', 'means', 'procession  answer']\n",
      "['which consulting priest', 'included', 'cult animals cult lots']\n",
      "['priests  who', 'gave great', 'message']\n",
      "['religious  that', 'had', 'religious  practices']\n",
      "['it', 'left less', 'practices']\n",
      "['religious  practice', 'included', 'important  transitions']\n",
      "['process  name', 'included', 'birth']\n",
      "['surrounding  they', 'death', 'survival']\n",
      "['religious  practices', 'sought', 'knowledge']\n",
      "['dreams  which', 'included', 'interpretation']\n",
      "['People', 'sought', 'also  behavior']\n",
      "['Individual  Egyptians', 'prayed', 'private  offerings']\n",
      "['gods', 'became', 'lives  pious']\n",
      "['Egyptians', 'donated', 'frequently  goods']\n",
      "['temples  populace', 'used separate', 'local  chapels']\n",
      "['Households', 'had', 'small  shrines']\n",
      "['Many', 'had', 'goddess Taweret household temples']\n",
      "['Often  they', 'favored', 'deities']\n",
      "['craftsmen cult he', 'important', 'nationwide  veneration']\n",
      "['gods', 'used', 'will']\n",
      "['magical  practices', 'use', 'also  it']\n",
      "['Individuals', 'employed magical', 'magical  techniques']\n",
      "['way  humans', 'seen', 'negative  events']\n",
      "['lector priests lector who', 'ascribed', 'texts']\n",
      "['priests', 'worked', 'magical  services']\n",
      "['magical  knowledge', 'is', 'simple  magic']\n",
      "['degree  Thoth', 'linked', 'degree  that']\n",
      "['written  these', 'involved', 'written  incantations']\n",
      "['Often  rituals', 'invoked', 'heka  deity']\n",
      "['person  it', 'entailed', 'thus  god']\n",
      "['Rituals', 'employed sympathetic', 'significant  resemblance']\n",
      "['arid  conditions', 'buried', 'body']\n",
      "['protection  body', 'began', 'tombs']\n",
      "['which  corpse', 'developed', 'embalming  practices']\n",
      "['who', 'varied', 'it']\n",
      "['procession  that', 'carried', 'relatives']\n",
      "['burial  priests', 'performed several', 'dead mouth offerings']\n",
      "['Afterwards  relatives', 'gave', 'hired food offerings']\n",
      "['mortuary  cults', 'neglected', 'one  generations']\n",
      "['living  gods', 'wrote', 'world']\n",
      "['Each', 'contained', 'subterranean burial chamber']\n",
      "['pyramid  which', 'developed', 'primeval  mound']\n",
      "['popularity', 'continued', 'pyramids']\n",
      "['case  it', 'contain', 'great  variety']\n",
      "['life  burials', 'believed', 'humans  work']\n",
      "['Human  sacrifices', 'meant', 'probably  pharaoh']\n",
      "['tombs', 'contain', 'magical  protection']\n",
      "['mortuary  offerings', 'bore', 'magically  sustenance']\n",
      "['ritually  which', 'buried', 'development']\n",
      "['god', 'had', 'other']\n",
      "['locally  others', 'resulted', 'universal  significance']\n",
      "['Egyptian  deities', 'transformed Egyptian', 'Egyptian  religion']\n",
      "['early  rulers', 'Abydos', 'funerary  complexes']\n",
      "['Heliopolis cult which', 'attempted', 'important  deities']\n",
      "['Meanwhile  pyramids', 'replaced', 'temple complexes temple mastabas']\n",
      "['official  religion', 'remained', 'period  cult']\n",
      "['funerary  rituals', 'influenced', 'elaborate  gods']\n",
      "['Ancient Egyptians', 'regarded', 'sun']\n",
      "['pantheon Sun Cult', 'was', 'power']\n",
      "['kingship  he', 'god', 'kingship  that']\n",
      "['afterlife  they', 'reflect', 'also  remnants']\n",
      "['texts', 'source', 'Egyptian  theology']\n",
      "['Symbols', 'took', 'new  features']\n",
      "['winged  disc', 'had protective', 'protective  significance']\n",
      "['Eventually  rulers', 'reunified', 'Egyptian  nation']\n",
      "['Middle Kingdom Middle he', 'promoted', 'initially patron god Montu']\n",
      "['writing  that', 'grew', 'writing  trend']\n",
      "['theological  discussion', 'produced detailed', 'detailed  descriptions']\n",
      "['subjugated  Nubians', 'absorbed Egyptian', 'particular  Amun']\n",
      "['when  Akhenaten', 'disrupted', 'Amun']\n",
      "['Eventually  he', 'eliminated', 'gods  capital']\n",
      "['populace', 'worship', 'worship']\n",
      "['new  order', 'lacked well-developed', 'well-developed  mythology']\n",
      "['Thus  many', 'continued', 'traditional  gods']\n",
      "['eventually  they', 'restored', 'Atenist  monuments']\n",
      "['traditional  religion', 'reversed', 'trend']\n",
      "['importance', 'did', 'grew  wealth']\n",
      "['trends', 'undermined', 'traditional  structure']\n",
      "['periods  foreigners', 'weaker', 'position']\n",
      "['dynasty 305–30 which', 'became', 'many  temples']\n",
      "['Greek ruling class', 'identified', 'Egyptian  deities']\n",
      "['deities  who', 'emerged', 'Osiris']\n",
      "['Egypt', 'changed', 'little']\n",
      "['centuries  edicts', 'spread', 'traditional  beliefs']\n",
      "['enduring  it', 'produced', 'other  cultures']\n",
      "['Greeks belief who', 'influenced', 'Egypt']\n",
      "['1798  their', 'remained', 'monuments']\n",
      "['religious  motifs', 'began', 'Egyptian  beliefs']\n",
      "['Egyptian   religion', 'had', 'significant  influence']\n",
      "['mythology articles References Bibliography', 'See', 'Further  Willy']\n",
      "['Problématique', 'prémisses', 'problèmes majeurs']\n",
      "['21 Andrea Alpago', 'retrieved', 'Italian  physician']\n",
      "['1487 Andrea Alpago', 'moved', 'work']\n",
      "['strongly Ibn al-Makkī', 'influenced', 'him']\n",
      "['textual  that', 'completed', 'better  topic']\n",
      "['same translating ability', 'gave', 'new  opportunities']\n",
      "['new  it', 'sent', 'new  cultures']\n",
      "['He', 'send', 'consulate  subjects']\n",
      "['he', 'left', 'him']\n",
      "['Venice  he', 'ventured', 'better  languages']\n",
      "['death  they', 'published', 'ay']\n",
      "['library', 'included several', 'several  books']\n",
      "['Canon', 'explains', 'vital  parts']\n",
      "['effort  translation', 'done', 'more  sense']\n",
      "['regardless  he', 'change', 'same  view']\n",
      "['he', 'clarify', 'simply  translations']\n",
      "['Alpago', 'explained major', 'occasionally  it']\n",
      "['it', 'found', 'corrections']\n",
      "['manuscripts  it', 'found', 'life  person']\n",
      "['Ancient  Greek', 'includes', 'forms']\n",
      "['It', 'contributed many', 'many  words']\n",
      "['article', 'contains', 'primarily  information']\n",
      "['Homeric  Greek', 'had significant', 'significant  differences']\n",
      "['Hellenic dialect groups', 'exist', 'what']\n",
      "['They', 'have', 'general  outline']\n",
      "['invaders', 'Dorian', 'cultural  relationship']\n",
      "['regions  who', 'known', 'themselves']\n",
      "['Northwest Doric Northwest which', 'suggest', 'isoglosses']\n",
      "['Most', 'had further', 'further dialect subdivisions']\n",
      "['Doric', 'had several', 'intermediate  divisions']\n",
      "['well Greece colonies', 'represented', 'Greek  dialects']\n",
      "['language  which', 'replaced most', 'slowly  most']\n",
      "['Doric', 'passed', 'aorist  terminations']\n",
      "['descendants  Greek', 'see', 'Indo-Iranian  Graeco-Aryan']\n",
      "['Ancient  Greek', 'diphthongs', 'double  stops']\n",
      "['Many', 'took', 'changes  place']\n",
      "['writing system', 'reflect', 'however pronunciation changes']\n",
      "['examples', 'represent Attic', '5th century BC']\n",
      "['sounds  letters', 'reconstructed', 'sounds  that']\n",
      "['Verbs', 'have', 'three  persons']\n",
      "['Most  tenses', 'display', 'four  moods']\n",
      "['Augment', 'called', 'indicative']\n",
      "['then  tenses', 'word', 'aspectual  meaning']\n",
      "['common  variation', 'added', 'vowels  vowel']\n",
      "['when  it', 'explained', 'augment']\n",
      "['word  αὐτο(-)μολῶ', 'goes', 'augment']\n",
      "['Most  verbs', 'reduplication', 'equivalent  law']\n",
      "['Attic  verbs', 'reduplication', 'following  vowel']\n",
      "['This', 'involved', 'originally  cluster']\n",
      "['perfect stem it', 'has', 'perfect stem eilēpha']\n",
      "['stems', 'add', 'syllable']\n",
      "['δ οὕτω πιθανῶς ἔλεγον', 'see', 'δ ὀλίγου ἐμαυτοῦ ἐπελαθόμην']\n",
      "['‖', 'éɡɔː dûːŋ', 'autōn olígou emautoû epelathómēn']\n",
      "['Modern  use', 'occupied', 'important  place']\n",
      "['280,000 Federal Statistical pupils', 'studied ancient', 'it']\n",
      "['primary language schools', 'offered', 'drive education standards']\n",
      "['Ancient  Greek', 'taught', 'international Ancient Greek Language']\n",
      "['It', 'appears', '2010  recognition']\n",
      "['language Harry Potter', 'write', 'poetry']\n",
      "['Septuagint Robert Hanhart', 'included', 'Rahlfs – Hanhart edition']\n",
      "['Akropolis World News', 'reports', 'weekly  summary']\n",
      "['mainly  who', 'used', 'respect']\n",
      "['modern  Greeks', 'shows', 'Greek  affinity']\n",
      "['Ancient  Greek', 'see English', 'English  words']\n",
      "['Allan', 'Mnemosyne', 'Topic Rutger Position']\n",
      "['600 c. that', 'unified', 'loose  collection']\n",
      "['urban Bronze Age poleis', 'began', '8th century BC']\n",
      "['conquests', 'spread Hellenistic', 'Hellenistic  civilization']\n",
      "['Rome  which', 'had', 'version']\n",
      "['modern  West', 'considered', 'many']\n",
      "['Chronology Classical Chronology antiquity', 'considered', '6th century AD']\n",
      "['century BC century which', 'Period', 'early  developments']\n",
      "['Late  Antiquity', 'refers', '6th centuries 6th AD']\n",
      "['450s 420s work', 'reaches', 'century historical Darius I']\n",
      "['scope', 'limited', 'economic  history']\n",
      "['Dark Ages Dark which', 'began', 'collapse']\n",
      "['Greeks', 'lost', 'Phoenician Greek alphabet']\n",
      "['war  Chalcis', 'seem', 'decline']\n",
      "['aristocratic  regimes', 'seems', 'tension']\n",
      "['BC onwards BC aristocracies', 'had', 'themselves']\n",
      "['growing  population', 'seem', 'internal  strife']\n",
      "['soldiers  that', 'obliged', 'social  conflict']\n",
      "['Athens', 'suffered', 'agrarian land crisis']\n",
      "['hence law these', 'made severe', 'conflict']\n",
      "['moderate  reforms', 'gave', 'power  stability']\n",
      "['control  Athens', 'brought', 'rural  areas']\n",
      "['centuries  BC', 'resulted', 'Greeks  colonies']\n",
      "['6th Greek world', 'ceased', '6th century time']\n",
      "['cities  they', 'controlled', 'religious  links']\n",
      "['when Roman Republic', 'lasted', 'new  tyrant']\n",
      "['period  Greece', 'enjoyed huge', 'economic  development']\n",
      "['Greek  household', 'estimate', 'large  increase']\n",
      "['Athenians', 'helped', 'tyranny']\n",
      "['I', 'turned', 'Isagoras']\n",
      "['political  citizens', 'proposed', 'status  Athens']\n",
      "['democratic  enthusiasm', 'swept', 'Spartan-led  him']\n",
      "['advent', 'cured many', 'democracy  many']\n",
      "['Athens  they', 'advanced', 'Sardis  city']\n",
      "['490  he', 'forget', 'armada']\n",
      "['Persian  fleet', 'supported', 'tail']\n",
      "['resistance  coalition', 'submitted', 'Persian city invaders']\n",
      "['small  rearguard', 'fought', 'Carthaginian three invasion']\n",
      "['naval Greek power', 'transformed', 'other league states']\n",
      "['empire  conflict', 'ended', 'campaigns']\n",
      "['Delian League Delian Sparta', 'offered', 'aid']\n",
      "['helot aid', 'exacerbated', 'helot revolt']\n",
      "['450s  Athens', 'took', 'Boeotia  victories']\n",
      "['However  Athens', 'failed', '447  Boeotia']\n",
      "['Athens', 'signed', '446/5 Thirty conflict']\n",
      "['plague  which', 'saw', 'Athenian statesman Pericles']\n",
      "['peace  Athenians', 'turned', 'proposal']\n",
      "['Athenian  failure', 'improved', '424  position']\n",
      "['ships', 'ended', 'naval  Sicily']\n",
      "['league  Persia', 'began', 'again  itself']\n",
      "['hunger  Athens', 'defeated', 'peace Spartan-led Peloponnesian League']\n",
      "['start  this', 'entered', '4th century BC']\n",
      "['Sparta', 'meant', 'Athens Spartan dominance']\n",
      "['Thebans  Spartans', 'lasted', 'when  will']\n",
      "['other Theban city-states', 'led', 'then Theban troops']\n",
      "['Thebans', 'able', 'Messenia helot population']\n",
      "['even  they', 'short-lived', 'key  leader']\n",
      "['Mantinea  none', 'losses', 'aftermath']\n",
      "['years  Philip', 'unified', 'then  Thessaly']\n",
      "['338  he', 'became', 'allied  army']\n",
      "['He', 'compelled', 'him Hellenic peace']\n",
      "['Alexander', 'continued', 'Philip  war']\n",
      "['campaigns  Alexander', 'defeated', 'Macedon Achaemenid Great']\n",
      "['Hellenistic Greece', 'lasted', 'BC  end']\n",
      "['Christianity  it', 'mark', 'end']\n",
      "['period  poleis', 'able', 'Greece  some']\n",
      "['conquests', 'had numerous', 'numerous  consequences']\n",
      "['It', 'widened', 'greatly  horizons']\n",
      "['city-states', 'formed', 'Greece  themselves']\n",
      "['fashion  it', 'continued', 'fashion  Macedon']\n",
      "['Aetolian  it', 'defeated', 'Greek  independence']\n",
      "['Greek  poleis', 'became', 'partial  taxation']\n",
      "['further  Augustus', 'devastated', 'peninsula']\n",
      "['Greek  intellectuals', 'served', 'Galen  most']\n",
      "['ancient  Greece', 'mountainous', 'regions  each']\n",
      "['Cities', 'tended', 'certain  area']\n",
      "['Mainland Greece', 'known', 'east Central Boeotia']\n",
      "['Epirus', 'lay', 'Thessaly']\n",
      "['Argead Alexander kings', 'started', 'Eordaia Axius regions']\n",
      "['whom  Macedonians', 'lay various', 'north  Thracians']\n",
      "['BC  Greeks', 'began', 'expansion  colonies']\n",
      "['Modern Syracuse', 'had', 'Greek colonies Syracusae']\n",
      "['colonies', 'played', 'Greek city-states Greek economy']\n",
      "['one  they', 'had', 'same  religion']\n",
      "['origins  Herodotus', 'aware', 'extensively  city-states']\n",
      "['they', 'seem', 'major  role']\n",
      "['defeat  allies', 'remained neutral', 'city-states  Greece']\n",
      "['fragmentary  this', 'nature', 'tribal  origin']\n",
      "['they', 'evidenced', 'certain Greek polis']\n",
      "['leagues  membership', 'grouped', 'themselves']\n",
      "['Greece  he', 'attempt', 'own Corinthian League']\n",
      "['Greek Government city-states', 'was', 'ceremonial city functions']\n",
      "['Inevitably  domination', 'apt', 'social  unrest']\n",
      "['populist point seize agenda', 'help', 'them']\n",
      "['Athenians', 'founded', 'solution  power']\n",
      "['poorest  citizens', 'permitted', 'assembly']\n",
      "['government jure citizens', 'had equal', 'equal  privileges']\n",
      "['However  non-citizens', 'had', 'political  rights']\n",
      "['other  city-states', 'founded', 'democracies']\n",
      "['However  many', 'retained', 'traditional  forms']\n",
      "['social  prominence', 'allow special', 'special  rights']\n",
      "['religious  this', 'controlled public', 'extra  power']\n",
      "['they', 'change', 'more  money']\n",
      "['male  citizens', 'called', 'peers']\n",
      "['Slavery Slaves', 'had', 'power']\n",
      "['goodwill  they', 'had', 'political  rights']\n",
      "['century  slaves', 'made', 'one-third']\n",
      "['poor household families', 'owned', 'few  slaves']\n",
      "['Owners', 'allowed', 'slaves']\n",
      "['Owners', 'promised', 'future  slaves']\n",
      "['other  who', 'mixed', 'people']\n",
      "['public  slaves', 'had', 'specialized  tasks']\n",
      "['Sparta', 'had', 'special  type']\n",
      "['strong  men', 'raised', 'time']\n",
      "['BC  they', 'treated', 'freedom']\n",
      "['period  city-states', 'established public', 'public  schools']\n",
      "['wealthy  families', 'afford', 'teacher']\n",
      "['Boys', 'learned', 'how  literature']\n",
      "['They', 'learned', 'musical  instrument']\n",
      "['They', 'studied', 'job']\n",
      "['simple  they', 'learned', 'household']\n",
      "['They', 'received', 'never  education']\n",
      "['task household who', 'taken', 'boy']\n",
      "['Classes', 'held', 'houses  lyre']\n",
      "['years  schooling', 'started', 'wrestling  discus']\n",
      "['older  youths', 'attended', 'academy']\n",
      "['small  number', 'continued', 'boys  education']\n",
      "['elder  which', 'mentorship', 'places  pederasty']\n",
      "['agora  him', 'learned', 'gymnasium  symposia']\n",
      "['richest  students', 'continued', 'education']\n",
      "['Some', 'included', 'schools  Lyceum']\n",
      "['free  citizenry', 'represented', 'economic Classical historians']\n",
      "['Greek farm incomes', 'reached', '3.75  kg']\n",
      "['widely  institution', 'served', 'overall  level']\n",
      "['Warfare', 'increased', 'conversely Archaic scale']\n",
      "['professional  city-states', 'relied', 'professional  armies']\n",
      "['campaigns  citizens', 'reduced', 'potential  duration']\n",
      "['they', 'set', 'usually  piece']\n",
      "['prominent  who', 'slight compared', 'prominent  citizens']\n",
      "['eventual  triumph', 'achieved', 'time  pooling']\n",
      "['Peloponnesian War Peloponnesian which', 'led', 'further  development']\n",
      "['financial manpower resources', 'increased', 'diversification']\n",
      "['changes', 'increased', 'greatly  number']\n",
      "['Athens', 'owned', 'one']\n",
      "['oarsmen  who', 'had', '200  triremes']\n",
      "['silver mines silver that', 'had', 'lot']\n",
      "['Josiah Ober Greek city-states', 'faced', 'one-in-three  chance']\n",
      "['ways  it', 'had', 'modern  science']\n",
      "['Defining', 'topic', 'difference']\n",
      "['Greece  who', 'pre-Socratics', 'non-mythical  descriptions']\n",
      "['They', 'followed', 'own  basis']\n",
      "['concrete disciple who', 'influential', 'radical  difference']\n",
      "['first  poet', 'developed', 'certainly  work']\n",
      "['Tragedy', 'developed', 'period  elements']\n",
      "['ancient City comedy', 'began', 'earliest  date']\n",
      "['Greek  prose', 'had', 'origins']\n",
      "['philosophers Anaximander philosophers Thales', 'emerged', 'apparently  nothing']\n",
      "['major Greek prose genres', 'reached', 'genre  maturity']\n",
      "['Athens Greek it', 'saw', 'literary  centre']\n",
      "['Hellenistic  kings', 'patrons', 'scholarship  Pella']\n",
      "['Library', 'had', 'previously-unenvisaged  copies']\n",
      "['Hellenistic  poetry', 'poetry', 'linear  narratives']\n",
      "['period  it', 'saw', 'also  shift']\n",
      "['Greek  art', 'depicts musical', 'musical  instruments']\n",
      "['geometry  idea', 'contributed many', 'integral number calculus']\n",
      "['they', 'developed', 'which']\n",
      "['geometrical  models', 'developed', 'apparent  motion']\n",
      "['century BC century Aristarchus', 'first', 'heliocentric  system']\n",
      "['Earth', 'revives', 'hypothesis']\n",
      "['Eratosthenes', 'estimated', 'regions  circumference']\n",
      "['which star he', 'made', 'modern  system']\n",
      "['Antikythera mechanism', 'dates', 'movements']\n",
      "['ancient  Greeks', 'made important', 'important  discoveries']\n",
      "['thus  medicine', 'revolutionized', 'Greece  it']\n",
      "['Art', 'exercised', 'enormous  influence']\n",
      "['East Alexander conquests', 'initiated several', 'Greek art Greek generations']\n",
      "['classical  tradition', 'dominated', 'Greece  art']\n",
      "['gods', 'uniform', 'similar  gods']\n",
      "['Greeks', 'polytheistic', 'many  gods']\n",
      "['It', 'became', 'Italic  traditions']\n",
      "['2.1.156f Captive Greece', 'took captive', 'uncivilised  arts']\n",
      "['intermediation  preservation', 'inherited Classical', 'strong  influence']\n",
      "['modern  revival', 'took', 'learning  place']\n",
      "['Empires', 'phase', 'Ancient Greece Ancient period']\n",
      "['It', 'represents', 'distinctively  civilization']\n",
      "['power  that', 'included', 'Pylos']\n",
      "['Thera  they', 'that', 'Thera  which']\n",
      "['commander', 'took', 'Libyan  Battos']\n",
      "['Athens Delian purpose', 'association', 'Persian Empire']\n",
      "['mixed  population', 'state', 'Greek  language']\n",
      "['century  it', 'controlled', 'whole']\n",
      "['peak  territory', 'included', 'Locris']\n",
      "['certain Greek city-states', 'joined', 'Aetolian League']\n",
      "['He', 'founded', 'probably  Cyropolis']\n",
      "['cities brick he', 'built', 'garrison']\n",
      "['region', 'wrested', 'then  independence']\n",
      "['territories Near that', 'expanded', 'territories Near dynasty']\n",
      "['now  Kuwait', 'spanned', 'Anatolia']\n",
      "['origin Hellenistic-era which', 'kingdom', 'Darius  Great']\n",
      "['Mithridates VI Mithridates who', 'reached', 'Colchis']\n",
      "['dynasty Dynasteía ton that', 'romanized', 'city']\n",
      "['One', 'took', 'lieutenants  control']\n",
      "['later  Attalids', 'descended', 'father  city']\n",
      "['Peloponnese  which', 'named', 'original  core']\n",
      "['Rome Antigonid league', 'played', 'major  role']\n",
      "['federalism Greek which', 'represents', 'need']\n",
      "['statesman Polybius statesman structure', 'had', 'influence']\n",
      "['Greco-Bactrian  Kingdom', 'part', 'world easternmost Bactria']\n",
      "['BC Indo-Greek which', 'established', 'BC Indo-Greek Kingdom']\n",
      "['northwestern Indo-Greek which', 'kingdom', 'modern-day Indo-Greek Afghanistan']\n",
      "['External  links', 'database', 'ancient Ancient Theatre Archive']\n",
      "['It', 'practice', 'time  names']\n",
      "['great  grandfather', 'received', 'Pavia Jan van medicine']\n",
      "['successor Charles V. Anders', 'Physician', 'prior family medicine']\n",
      "['where  he', 'decided', 'instead  career']\n",
      "['There  he', 'studied', 'theories']\n",
      "['anatomy  he', 'was', 'excavated  bones']\n",
      "['Vesalius', 'forced', 'Paris']\n",
      "['He', 'completed', 'studies']\n",
      "['graduation  he', 'offered', 'immediately  chair']\n",
      "['Padua  Vesalius', 'traveled', 'Loyola Pope Paul those']\n",
      "['1542  he', 'met', 'illustrator']\n",
      "['Vesalius', 'Sex', 'anatomical  text']\n",
      "['surgeon barber work', 'taught', 'classical  texts']\n",
      "['which', 'made', 'claims']\n",
      "['Vesalius', 'performed', 'actual teaching themselves']\n",
      "['He', 'considered hands-on', 'direct  observation']\n",
      "['Vesalius', 'created detailed', 'detailed  illustrations']\n",
      "['widely  he', 'published', '1538 Tabulae anatomicae sex']\n",
      "['He', 'followed', 'this']\n",
      "['1539  he', 'published', 'also Venesection Epistle']\n",
      "['This', 'treatment', 'where  blood']\n",
      "['Greek  procedure', 'collect', 'Galen  blood']\n",
      "['Muslim  practice', 'However', 'smaller  amount']\n",
      "['qualifications  that', 'supported', 'infiltration']\n",
      "['instead  he', 'dissected Barbary', 'instead  which']\n",
      "['so  findings', 'based', 'findings']\n",
      "['Vesalius', 'contributed', 'anatomical Giunta text']\n",
      "['anatomy  it', 'gone unnoticed', 'human  anatomy']\n",
      "['However  people', 'chose', 'still  attention']\n",
      "['heart  veins', 'assumed', 'blood']\n",
      "['opening  Galen', 'needed', 'them']\n",
      "['he', 'paramount', 'them']\n",
      "['so  it', 'venture', 'other  solution']\n",
      "['brain blood that', 'discoveries', 'rete  mirabile']\n",
      "['1543  Vesalius', 'conducted', 'public  dissection']\n",
      "['He', 'assembled', 'finally  skeleton']\n",
      "['preparation', 'preparation', 'anatomical Basel preparation']\n",
      "['single  artist', 'took', '273  illustrations']\n",
      "['time  he', 'published', 'librorum de humani it']\n",
      "['this  it', 'marks', 'establishment']\n",
      "['dissections  it', 'made', 'it']\n",
      "['Pisa I de he', 'invited', 'Pisa I de which']\n",
      "['physicians  who', 'took', 'him']\n",
      "['emperor  Vesalius', 'married', 'Anne van Hamme']\n",
      "['one  who', 'had', 'medical  questions']\n",
      "['plant China he', 'wrote', 'plant China efficacy']\n",
      "['him', 'elicited', 'new  round']\n",
      "['1551 Charles V', 'commissioned', 'religious  implications']\n",
      "['Galen', 'published', 'it']\n",
      "['life  him', 'continued', 'him']\n",
      "['1555  he', 'published', 'revised  edition']\n",
      "['Holy Land Holy some', 'said', 'living  body']\n",
      "['Ionian Sea Ionian he', 'received', 'again Paduan professorship']\n",
      "['Spain  heart', 'appears', 'Inquisition  him']\n",
      "['claim Philip II', 'went', 'sentence']\n",
      "['decision', 'likely', 'Spanish  court']\n",
      "['he', 'please', 'research']\n",
      "['resignation  he', 'managed', 'asking']\n",
      "['many  believe', 'asked', 'Johannes book']\n",
      "['time  he', 'published', 'easily Fabrica Librorum findings']\n",
      "['He', 'dedicated', 'it']\n",
      "['dissection  what', 'emphasized', 'internal  functioning']\n",
      "['book', 'contains', 'drawings']\n",
      "['This', 'allows', 'diagrams  them']\n",
      "['previously  which', 'contrast', 'well Galenic/Aristotelean elements']\n",
      "['bone  he', 'showed', 'accurately sternum vestibule']\n",
      "['also vena which', 'verified', 'also vena canal']\n",
      "['He', 'described', 'good  account']\n",
      "['inferior  account', 'understand', 'inferior  recesses']\n",
      "['work  Vesalius', 'becomes', 'mechanical  ventilation']\n",
      "['neck  some', 'take', 'noose']\n",
      "['which  blood', 'wrote', 'revived  venesection']\n",
      "['He', 'sought', 'precise  site']\n",
      "['real   significance', 'attempt', 'book  arguments']\n",
      "['anatomical  dissection', 'posed', 'speculation']\n",
      "['Fabrica  he', 'wrote', 'radicis Chynae decocti']\n",
      "['1561  Vesalius', 'given', 'copy']\n",
      "['dissection  he', 'recognizes', 'true  equal']\n",
      "['Scientific  findings', 'believed', 'skeletal system system']\n",
      "['theories  he', 'chapter', 'theories  which']\n",
      "['He', 'described', 'accurately  vestibule']\n",
      "['parts  he', 'discovered', 'parts  which']\n",
      "['women fibula bones', 'disproved', 'common  belief']\n",
      "['De fabrica De which', 'illustrations', 'text']\n",
      "['He', 'describes', 'body  information']\n",
      "['Vesalius Michael it', 'described', 'Vesalius Michael public']\n",
      "['septum', 'published', 'mitral blood flow']\n",
      "['also azygos which', 'verified', 'also azygos canal']\n",
      "['thus  ligaments', 'defined', 'thus  claims']\n",
      "['conclusion  nerves', 'came', 'optic  nerve']\n",
      "['right  kidney', 'corrected', 'earlier  claim']\n",
      "['well  excretions', 'claimed', 'blood']\n",
      "['He', 'described', 'correct  views']\n",
      "['He', 'observed', 'good  account']\n",
      "['uterus', 'find', 'distinct  sections']\n",
      "['He', 'identified', 'two  chambers']\n",
      "['He', 'addressed', 'controversial  issue']\n",
      "['He', 'wished', 'conclusions']\n",
      "['men', 'disproved', 'more  teeth']\n",
      "['Vesalius', 'introduced', 'notion']\n",
      "['own  they', 'encouraged', 'better  structure']\n",
      "['efforts  he', 'addition', 'conclusions  syphilis']\n",
      "['medicine', 'claimed', \"hands'—mainly  surgery\"]\n",
      "['animal  cadaver', 'supporter', 'Galenic  errors']\n",
      "['da Cortona Pietro da who', 'apparent', 'anatomical  plates']\n",
      "['Jacob Lawrence', 'created', 'Vesalius Suite']\n",
      "['External Andreae Vesalii Bruxellensis', 'includes', 'virtual Humanis Corporis copy']\n",
      "['Epitome', 'coloured', 'digital Bibliothèque interuniversitaire library']\n",
      "['arteries  that', 'due', 'blood']\n",
      "['Other  causes', 'include', 'anemia']\n",
      "['medical  outlook', 'improved', 'medical  therapies']\n",
      "['years  who', 'have', '15 survival minutes']\n",
      "['heart they', 'require urgent', 'medical  attention']\n",
      "['when  activity', 'abate several', 'several  minutes']\n",
      "['recognized  precipitants', 'include cold', 'cold  weather']\n",
      "['rest  which', 'occurs', '10  minutes']\n",
      "['symptoms  pathophysiology', 'is', 'stable  angina']\n",
      "['ischemia  which', 'starts', 'thrombosis']\n",
      "['angina blood clots', 'rupture', 'further  area']\n",
      "['recent  data', 'considered', 'attitude']\n",
      "['microvascular Ischemia Syndrome angina', 'suggest', 'higher heart rates']\n",
      "['pain Angina discomfort', 'painful', 'pressure  sensation']\n",
      "['that', 'explained', 'ability  two']\n",
      "['It', 'exacerbated', 'full  stomach']\n",
      "['Chest  pain', 'angina', 'few  seconds']\n",
      "['when  myocardium', 'comes', 'increased oxygen demand']\n",
      "['Major risk factors', 'include', 'angina cigarette smoking']\n",
      "['It', 'occurs', 'more']\n",
      "['factors Routine risk factors counseling', 'found', 'significantly  behavior']\n",
      "['One  smokers', 'found', 'increased artery level']\n",
      "['those  that', 'found', 'those  smoking']\n",
      "['heart blood that', 'result', 'heart diseaseMyocardial heart ischemia']\n",
      "['This', 'decreases', 'hemoglobin  oxygen']\n",
      "['patients heart vasospasm', 'cause', 'factors blood composition']\n",
      "['heavy  that', 'suspected', 'heavy  discomfort']\n",
      "['Antacids', 'relieve', 'usually  pain']\n",
      "['chest  electrocardiogram', 'normal', 'chest  pain']\n",
      "['depression  test', 'performed', 'changes']\n",
      "['whom treadmill ECG', 'include', 'exercise test thallium scintigram']\n",
      "['lesion  this', 'performed', 'coronary artery bypass treatment']\n",
      "['syndromes  those', 'undergo coronary', 'coronary ECG angiography']\n",
      "['heart oxygen it', 'is', 'inaqedate oxygen supply']\n",
      "['main  goals', 'relief', 'symptoms  progression']\n",
      "['short-acting nitroglycerin medications', 'have', 'large  body']\n",
      "['which  they', 'provide', 'brief  overview']\n",
      "['Nevibolol  which', 'agents such', 'cAMP']\n",
      "['muscle cells heart muscle which', 'increase', 'usually Ca+2 levels']\n",
      "['heart muscle heart it', 'decreases', 'less oxygen demand']\n",
      "['doses  it', 'means', 'selectivity hypertension']\n",
      "['vasodilatory  organonitrates', 'complement', 'when  use']\n",
      "['lesser beta blocker', 'do', 'instrinsic sympathetic instrinsic activity']\n",
      "['beta-adrenergic  antagonists', 'yield', 'same  action']\n",
      "['Specifically  cAMP', 'responsible', 'Myosin Light Myosin Kinase']\n",
      "['cAMP  which', 'result', 'muscle cells muscle enzyme']\n",
      "['that', 'desirable', 'patients  medication']\n",
      "['Calcium channel blockers', 'act', 'oxygen calcium channels']\n",
      "['muscle cell heart muscle it', 'form', 'therefore  need']\n",
      "['medication  that', 'nitrates', 'angina']\n",
      "['Organic  nitrates', 'used', 'extensively  angina']\n",
      "['heart muscle heart which', 'improve coronary', 'heart perfusion delivery']\n",
      "['drugs', 'reduce systemic', 'vascular  resistance']\n",
      "['myocardial oxygen which', 'decreases', 'myocardial oxygen demand']\n",
      "['potent  that', 'vasodilator', 'myocardial oxygen workload']\n",
      "['certain  inhibitors', 'given', 'serious  drop']\n",
      "['which balloon balloon', 'angioplasty', 'arterial  lumen']\n",
      "['Stents', 'used', 'arterial  widening']\n",
      "['Coronary bypass surgery', 'involves', 'constricted  arteries']\n",
      "['recently  Ivabradine', 'provides', 'anti-ischemic heart rate efficacy']\n",
      "['used lipid/cholesterol which', 'modifiers', 'atheromatous  plaque']\n",
      "['Low-dose  aspirin', 'decreases', 'risk']\n",
      "['longer  risk', 'offsets', 'gastrointestinal  benefits']\n",
      "['Exercise', 'treatment', 'coronary artery collateralisation']\n",
      "['patients  evidence', 'support', 'use']\n",
      "['Identifying', 'priority', 'risk factors']\n",
      "['This', 'means', 'high smoking cessation']\n",
      "['channel blocker nifedipine', 'prolongs cardiovascular', 'event-  survival']\n",
      "['Microvascular  angina', 'have', 'often women no']\n",
      "['many  women', 'found', 'cardiac  ischemia']\n",
      "['ischemic  that', 'constrict', 'ischemic  pain']\n",
      "['adipokines platelet activation', 'complex', 'factors']\n",
      "['diagnosis', 'require', 'MVA  catheterization']\n",
      "['New  techniques', 'include', 'positron emission scanning']\n",
      "['example  women', 'challenging', 'nitrates  those']\n",
      "['Women', 'have traditional', 'traditional risk factors']\n",
      "['Aggressive  interventions', 'component', 'modifiable risk factors']\n",
      "['combination', 'effective', 'Ranolazine reductase promise']\n",
      "['Other  approaches', 'include spinal', 'spinal cord stimulators']\n",
      "['exertion  that', 'recommended', 'unstable  angina']\n",
      "['1.5%).In 10.2 million', 'affects', 'angina']\n",
      "['Men', 'found', 'increased  risk']\n",
      "['References External links Treatment', 'technique', 'medical imaging inside']\n",
      "['This', 'done', 'based blood techniques']\n",
      "['synonymously term venogram', 'used', 'usage  angiogram']\n",
      "['History  technique', 'developed', 'several X-ray kinds']\n",
      "['1927 Reynaldo dos Santos', 'performed', 'first  aortogram']\n",
      "['first  cavogram', 'performed', 'pulmonary  angiogram']\n",
      "['where Eduardo Pereira', 'traced', 'coronary  angiogram']\n",
      "['blood  it', 'added', 'X-rays']\n",
      "['heart  images', 'taken', 'usually  technique']\n",
      "['second  which', 'taken', 'interventional  flow']\n",
      "['technique', 'subtracts', 'bones']\n",
      "['heart images', 'taken', 'second subtraction technique']\n",
      "['it', 'used', 'patient']\n",
      "['vessel  which', 'enable', 'blood  pain']\n",
      "['site', 'compressed', 'access-site  complications']\n",
      "['Uses', 'is', 'angiograms  blood']\n",
      "['desired X-ray contrast area', 'used', 'X-ray contrast agent']\n",
      "['X-ray images', 'allows', 'arteries radiocontrast visualization']\n",
      "['Coronary  angiography', 'visualize coronary', 'coronary artery stenosis']\n",
      "['degree', 'determined', 'stenosis  width']\n",
      "['coronary CT scan', 'satisfactory', 'coronary artery disease']\n",
      "['Moreover  CT', 'requires shorter', 'breath-hold  time']\n",
      "['eye blood they', 'highlights', 'blood vessels']\n",
      "['test', 'used', 'often eye disorders']\n",
      "['angiography Optical coherence tomography', 'technology', 'particular  micro-structure']\n",
      "['ocular OCT angiography', 'method', 'vascular OCT health']\n",
      "['Microangiography Microangiography', 'used', 'tiny blood vessels']\n",
      "['angiographic  procedure', 'angiography', 'arterial subtraction supply']\n",
      "['stenosis blood which', 'performed', 'high blood pressure']\n",
      "['cases CT Post', 'method', 'CT angiography']\n",
      "['watery waste solutions', 'seem', 'special waste water']\n",
      "['oily CT tissue solutions', 'documented', 'also CT tissue differentiation']\n",
      "['watery  solutions', 'seem', 'post mortem CT angiography']\n",
      "['usually  they', 'cause', 'little  pain']\n",
      "['angiography Major angiography complications', 'rare', 'also contrast stroke']\n",
      "['contrast that', 'produces', 'few  seconds']\n",
      "['considerably  catheter', 'reduced', 'thus blood chances']\n",
      "['clean  that', 'given', 'clean  procedures']\n",
      "['Prophylaxis', 'given', 'also  infection']\n",
      "['arteries  that', 'due', 'blood']\n",
      "['Other  causes', 'include', 'anemia']\n",
      "['medical  outlook', 'improved', 'medical  therapies']\n",
      "['years  who', 'have', '15 survival minutes']\n",
      "['heart they', 'require urgent', 'medical  attention']\n",
      "['when  activity', 'abate several', 'several  minutes']\n",
      "['recognized  precipitants', 'include cold', 'cold  weather']\n",
      "['rest  which', 'occurs', '10  minutes']\n",
      "['symptoms  pathophysiology', 'is', 'stable  angina']\n",
      "['ischemia  which', 'starts', 'thrombosis']\n",
      "['angina blood clots', 'rupture', 'further  area']\n",
      "['recent  data', 'considered', 'attitude']\n",
      "['microvascular Ischemia Syndrome angina', 'suggest', 'higher heart rates']\n",
      "['pain Angina discomfort', 'painful', 'pressure  sensation']\n",
      "['that', 'explained', 'ability  two']\n",
      "['It', 'exacerbated', 'full  stomach']\n",
      "['Chest  pain', 'angina', 'few  seconds']\n",
      "['when  myocardium', 'comes', 'increased oxygen demand']\n",
      "['Major risk factors', 'include', 'angina cigarette smoking']\n",
      "['It', 'occurs', 'more']\n",
      "['factors Routine risk factors counseling', 'found', 'significantly  behavior']\n",
      "['One  smokers', 'found', 'increased artery level']\n",
      "['those  that', 'found', 'those  smoking']\n",
      "['heart blood that', 'result', 'heart diseaseMyocardial heart ischemia']\n",
      "['This', 'decreases', 'hemoglobin  oxygen']\n",
      "['patients heart vasospasm', 'cause', 'factors blood composition']\n",
      "['heavy  that', 'suspected', 'heavy  discomfort']\n",
      "['Antacids', 'relieve', 'usually  pain']\n",
      "['chest  electrocardiogram', 'normal', 'chest  pain']\n",
      "['depression  test', 'performed', 'changes']\n",
      "['whom treadmill ECG', 'include', 'exercise test thallium scintigram']\n",
      "['lesion  this', 'performed', 'coronary artery bypass treatment']\n",
      "['syndromes  those', 'undergo coronary', 'coronary ECG angiography']\n",
      "['heart oxygen it', 'is', 'inaqedate oxygen supply']\n",
      "['main  goals', 'relief', 'symptoms  progression']\n",
      "['short-acting nitroglycerin medications', 'have', 'large  body']\n",
      "['which  they', 'provide', 'brief  overview']\n",
      "['Nevibolol  which', 'agents such', 'cAMP']\n",
      "['muscle cells heart muscle which', 'increase', 'usually Ca+2 levels']\n",
      "['heart muscle heart it', 'decreases', 'less oxygen demand']\n",
      "['doses  it', 'means', 'selectivity hypertension']\n",
      "['vasodilatory  organonitrates', 'complement', 'when  use']\n",
      "['lesser beta blocker', 'do', 'instrinsic sympathetic instrinsic activity']\n",
      "['beta-adrenergic  antagonists', 'yield', 'same  action']\n",
      "['Specifically  cAMP', 'responsible', 'Myosin Light Myosin Kinase']\n",
      "['cAMP  which', 'result', 'muscle cells muscle enzyme']\n",
      "['that', 'desirable', 'patients  medication']\n",
      "['Calcium channel blockers', 'act', 'oxygen calcium channels']\n",
      "['muscle cell heart muscle it', 'form', 'therefore  need']\n",
      "['medication  that', 'nitrates', 'angina']\n",
      "['Organic  nitrates', 'used', 'extensively  angina']\n",
      "['heart muscle heart which', 'improve coronary', 'heart perfusion delivery']\n",
      "['drugs', 'reduce systemic', 'vascular  resistance']\n",
      "['myocardial oxygen which', 'decreases', 'myocardial oxygen demand']\n",
      "['potent  that', 'vasodilator', 'myocardial oxygen workload']\n",
      "['certain  inhibitors', 'given', 'serious  drop']\n",
      "['which balloon balloon', 'angioplasty', 'arterial  lumen']\n",
      "['Stents', 'used', 'arterial  widening']\n",
      "['Coronary bypass surgery', 'involves', 'constricted  arteries']\n",
      "['recently  Ivabradine', 'provides', 'anti-ischemic heart rate efficacy']\n",
      "['used lipid/cholesterol which', 'modifiers', 'atheromatous  plaque']\n",
      "['Low-dose  aspirin', 'decreases', 'risk']\n",
      "['longer  risk', 'offsets', 'gastrointestinal  benefits']\n",
      "['Exercise', 'treatment', 'coronary artery collateralisation']\n",
      "['patients  evidence', 'support', 'use']\n",
      "['Identifying', 'priority', 'risk factors']\n",
      "['This', 'means', 'high smoking cessation']\n",
      "['channel blocker nifedipine', 'prolongs cardiovascular', 'event-  survival']\n",
      "['Microvascular  angina', 'have', 'often women no']\n",
      "['many  women', 'found', 'cardiac  ischemia']\n",
      "['ischemic  that', 'constrict', 'ischemic  pain']\n",
      "['adipokines platelet activation', 'complex', 'factors']\n",
      "['diagnosis', 'require', 'MVA  catheterization']\n",
      "['New  techniques', 'include', 'positron emission scanning']\n",
      "['example  women', 'challenging', 'nitrates  those']\n",
      "['Women', 'have traditional', 'traditional risk factors']\n",
      "['Aggressive  interventions', 'component', 'modifiable risk factors']\n",
      "['combination', 'effective', 'Ranolazine reductase promise']\n",
      "['Other  approaches', 'include spinal', 'spinal cord stimulators']\n",
      "['exertion  that', 'recommended', 'unstable  angina']\n",
      "['1.5%).In 10.2 million', 'affects', 'angina']\n",
      "['Men', 'found', 'increased  risk']\n",
      "['medical  that', 'Treatment', 'review articles']\n",
      "['2021 Journal Citation Reports', 'gives', 'category impact Medicine']\n",
      "['which publication someone', 'indicate', 'Dates publication years']\n",
      "['even  it', 'credited', 'volume  that']\n",
      "['links Official links Animals', 'abstracted', 'links Official links website']\n",
      "['which  body', 'consume organic', 'breathe  oxygen']\n",
      "['They', 'have complex', 'intricate food webs']\n",
      "['members', 'Bilateria', 'symmetric body plan']\n",
      "['Bilateria', 'include', 'nematodes  latter']\n",
      "['Historically  Aristotle', 'divided', 'animals']\n",
      "['Systema Naturae Jean-Baptiste Lamarck', 'created', 'Systema Naturae Systema which']\n",
      "['1874 Ernst Haeckel', 'divided', 'animal kingdom']\n",
      "['phylogenetics  which', 'relies', 'evolutionary  relationships']\n",
      "['Humans', 'make', 'pets  animals']\n",
      "['terrestrial  animals', 'used', 'hunting  birds']\n",
      "['word animal', 'comes', 'Latin animalis Latin soul']\n",
      "['biological  definition', 'includes', 'members']\n",
      "['several  that', 'have several', 'them']\n",
      "['plants  which', 'heterotrophic', 'material nutrients it']\n",
      "['life cycle life animals', 'motile', 'spontaneously  bodies']\n",
      "['which matrix cells', 'making', 'formation']\n",
      "['This', 'calcified', 'structures']\n",
      "['Animal cells', 'possess', 'uniquely cell junctions']\n",
      "['nerve which', 'include', 'body']\n",
      "['Reproduction', 'make', 'Nearly  use']\n",
      "['non-motile  gametes', 'produce haploid', 'haploid  gametes']\n",
      "['which', 'called', 'zygotes']\n",
      "['blastula', 'undergoes', 'complicated  rearrangement']\n",
      "['It', 'invaginates', 'first  gastrula']\n",
      "['germ layers', 'differentiate', 'then  tissues']\n",
      "['Animals', 'evolved numerous', 'close  inbreeding']\n",
      "['fertile  eggs', 'take', 'place']\n",
      "['how  they', 'categorised', 'organic  material']\n",
      "['Interactions', 'form complex', 'complex food webs']\n",
      "['process  adults', 'use multiple', 'primarily  nectar']\n",
      "['hawksbill sea turtles', 'have', 'primarily  sponges']\n",
      "['directly plant carnivores', 'eat', 'other  animals']\n",
      "['animal', 'oxidize', 'biological  processes']\n",
      "['Animals', 'consume organic', 'organic sea matter']\n",
      "['Lineages', 'colonised', 'arthropods  land']\n",
      "['Animals', 'occupy', 'virtually  all']\n",
      "['few  species', 'inhabit', 'cold  deserts']\n",
      "['Argentinosaurus  which', 'animals', '73  tonnes']\n",
      "['Numbers', 'estimated', 'fresh animal ways']\n",
      "['published  estimates', 'described', 'species  10,000–20,000']\n",
      "['total  number', 'calculated', 'patterns']\n",
      "['first  that', 'origin', 'animals']\n",
      "['discovery', 'doubted', 'Dickinsonia lipid nature']\n",
      "['Extant  phyla', 'include', 'rocks  molluscs']\n",
      "['Trace fossils', 'indicate', 'period  presence']\n",
      "['Tonian trace fossils', 'produced', 'early animal evolution']\n",
      "['which  they', 'sister', 'Choanozoa']\n",
      "['body that', 'have', 'bilateral  symmetry']\n",
      "['animals  both', 'disputed', 'which hox genes']\n",
      "['dimensions  7', 'components', 'pattern']\n",
      "['ago  lineages', 'indicates', 'many  millions']\n",
      "['animal  phyla', 'lack bilateral', 'bilateral  symmetry']\n",
      "['these  sponges', 'diverged', 'animal  phylum']\n",
      "['animal phyla animal cells', 'lack', 'complex  organization']\n",
      "['opening sea which', 'symmetric', 'digestive sea chambers']\n",
      "['distinct  these', 'have distinct', 'distinct  tissues']\n",
      "['They', 'diploblastic', 'main germ layers']\n",
      "['they', 'similar', 'digestive  chamber']\n",
      "['Bilateria', 'form', 'million  clade']\n",
      "['germ layers germ tissues', 'triploblastic', 'distinct  organs']\n",
      "['digestive  chamber', 'has', 'two  openings']\n",
      "['therefore tail they', 'have', 'left  side']\n",
      "['front end part', 'Having', 'food  development']\n",
      "['these', 'have', 'soft-bodied  animals']\n",
      "['also  that', 'have', 'also  gut']\n",
      "['primary  which', 'have primary', 'sensory  cells']\n",
      "['parasitic  worms', 'are', 'extremely body structures']\n",
      "['Genetic  studies', 'have', 'changed  understanding']\n",
      "['many cell protostomes', 'undergo radial', 'spiral  cleavage']\n",
      "['first  opening', 'possess', 'digestive  tract']\n",
      "['where  cells', 'have schizocoelous', 'gastrula  mesoderm']\n",
      "['Echinodermata Echinoderms', 'marine', 'exclusively  starfish']\n",
      "['deuterostomes', 'include', 'Hemichordata acorn Hemichordata worms']\n",
      "['animal  which', 'include', 'insects']\n",
      "['All', 'have', 'these  segments']\n",
      "['smaller  phyla', 'relatives', 'arthropods  traits']\n",
      "['ecdysozoans', 'include', 'animal  phylum']\n",
      "['groups', 'have', 'reduced  coelom']\n",
      "['Rouphozoa superphylum which', 'disputed', 'gastrotrichs']\n",
      "['sister which', 'grouped', 'rotifers']\n",
      "['Lophotrochozoa', 'includes', 'molluscs']\n",
      "['species animal annelids', 'includes', 'species animal snails']\n",
      "['close  they', 'considered close', 'trochophore larvae']\n",
      "['era  Aristotle', 'divided', 'roughly  vertebrates']\n",
      "['they', 'knew', 'rocks']\n",
      "['1758 Carl Linnaeus', 'created', 'hierarchical  classification']\n",
      "['Vermes', 'subsumed', 'crustaceans']\n",
      "['phyla une espèce which', 'begun', 'corals']\n",
      "['where  he', 'created', '4  phyla']\n",
      "['1817 Animal Georges Cuvier', 'used comparative', 'comparative  animals']\n",
      "['1874 Ernst Haeckel', 'divided', 'phyla animal coelenterates']\n",
      "['protozoa', 'moved', 'only kingdom Metazoa']\n",
      "['much  insects', 'make', '90  %']\n",
      "['lashings  leather', 'used', 'widely  shoes']\n",
      "['Animals', 'hunted', 'fur  items']\n",
      "['Animals', 'fly', 'major Drosophila role']\n",
      "['Animals', 'used', 'vaccines']\n",
      "['tethered hunting cormorants', 'used', 'fish']\n",
      "['Poison dart frogs', 'used', 'tips']\n",
      "['tarantulas  insects', 'finding', 'canaries  place']\n",
      "['Major animal paintings', 'include', 'c. 1762 horse portrait roles']\n",
      "['species Anopheles gambiae complex', 'See', '– multimedia database']\n",
      "['complex', 'recognised', 'important  vectors']\n",
      "['Lymphatic  symptom', 'transmits', 'Lymphatic  filariasis']\n",
      "['other coluzzii Anopheles it', 'consists', 'individual coluzzii Anopheles species']\n",
      "['species', 'exhibit different', 'behavioural  traits']\n",
      "['animals gambiae sensu stricto', 'quadriannulatus', 'generally blood meal']\n",
      "['Identification', 'have important', 'important Scott et implications']\n",
      "['mosquitoes catalase catalase', 'reduces reproductive', 'central  oocytes']\n",
      "['1930  which', 'invaded northeastern', 'northeastern  Brazil']\n",
      "['Brazilian  government', 'eradicated', 'Fred Soper Fred mosquitoes']\n",
      "['marginal  vein', 'comprise', 'blood']\n",
      "['heart  other', 'one', 'ventricles']\n",
      "['heart  other', 'incorporates', 'ventricles']\n",
      "['inexpensive meat that', 'incorporates', 'inexpensive meat dishes']\n",
      "['traditional  that', 'was', 'traditional  llama']\n",
      "['enslaved  which', 'brought enslaved', 'enslaved  blacks']\n",
      "['They', 'adopted', 'dish']\n",
      "['desire  that', 'using non-offal', 'desire  dish']\n",
      "['used  recipe', 'uses', 'specifically beef heart']\n",
      "['Tradiciones Peruanos', 'published', '1833  sale']\n",
      "['lemon  which', 'sauce', 'garlic  cilantro']\n",
      "['Peru Anticuchos', 'include smaller', 'smaller  sticks']\n",
      "['which', 'See', 'action']\n",
      "['diuretic  that', 'uses', 'diuretic  drugs']\n",
      "['sodium which', 'decrease', 'sodium reabsorption']\n",
      "['heart blood which', 'lower', 'blood fluid']\n",
      "['side  effects', 'include', 'medications  nausea']\n",
      "['significant  hyperkalemia', 'possible', 'serum potassium monitoring']\n",
      "['antimineralocorticoid  medications', 'is', 'potassium excretion']\n",
      "['glands  it', 'binds', 'tubule cell tubule complex']\n",
      "['complex', 'enhances', 'protein transporters Na+/K+ ATPase pump']\n",
      "['protein transporters', 'increase', 'sodium reabsorption']\n",
      "['body', 'helps', 'normal blood pressure']\n",
      "['Mineralocorticoid receptor antagonists', 'decrease', 'mineralocorticoid receptor mineralocorticoid aldosterone']\n",
      "['two  drugs', 'is clear', 'pharmacokinetic Mineralocorticoid receptor properties']\n",
      "['shorter  t1/2', 'has shorter', '4 6 4 hours']\n",
      "['Eplerenone', 'goes', '4 6 4 hours']\n",
      "['metabolites  which', 'metabolized', 'prolonged  activity']\n",
      "['Spironolactone', 'has', '47  %']\n",
      "['Patients', 'require close', 'when kidney drug']\n",
      "['information', 'plays', 'appropriate  doses']\n",
      "['kidneys  it', 'important', 'high  concentration']\n",
      "['Structure-activity  relationship', 'block', 'mineralocorticoid receptor mineralocorticoid reabsorption']\n",
      "['C-7 position', 'important', 'sterically  interaction']\n",
      "['C-7 y-lactone eplerenone', 'has', '9α,11α-epoxy  group']\n",
      "['why  eplerenone', 'believed', 'lower 20 affinity']\n",
      "['steroidal core component', 'equal', 'different  lipophilicity']\n",
      "['aldosterone antagonists aldosterone which', 'was', '1950s  inhibitors']\n",
      "['rats aldosterone use', 'studied', 'aldosterone antagonists aldosterone them']\n",
      "['later aldosterone antagonists', 'became clear', 'specific receptor protein']\n",
      "['protein', 'has high', 'high  affinity']\n",
      "['first mineralocorticoid receptor wave', 'been', 'place']\n",
      "['second  wave', 'discovering', 'steroidal  anti-mineralocorticoids']\n",
      "['pharmaceutical Selye ’s companies', 'began', 'drug discovery programs']\n",
      "['goal', 'discover novel', 'non-steroidal mineralocorticoid receptor antagonists']\n",
      "['goal', 'use', 'candidates']\n",
      "['Widespread  use', 'include', 'antimineralocorticoid potassium effects']\n",
      "['Examples', 'include', 'progesterone']\n",
      "['pharmaceuticals platelet aggregation that', 'member', 'thrombus formation']\n",
      "['where  anticoagulants', 'effective', 'little  effect']\n",
      "['Antiplatelet therapy', 'decreases', 'drugs  ability']\n",
      "['Antiplatelet  drugs', 'inhibit', 'irreversibly  process']\n",
      "['low-dose  aspirin', 'increases', 'risk']\n",
      "['Often antiplatelet combination', 'result', 'greater ADP/P2Y effectiveness']\n",
      "['whereby thrombosis risk', 'include', 'class']\n",
      "['who', 'stroke', 'use']\n",
      "['Treatment', 'includes', 'thrombosis  use']\n",
      "['Antiplatelet  drugs', 'alter', 'platelet activation']\n",
      "['powerful platelet that', 'inhibits', 'cyclic platelet release reaction']\n",
      "['Dipyridamole', 'inhibits', 'receptor antagonists receptor receptor']\n",
      "['that', 'non-peptides', 'platelet aggregation']\n",
      "['however stopping therapy', 'increase', 'risk']\n",
      "['surgery  medication', 'consider', 'clot']\n",
      "['major  that', 'found low-certainity', 'surgery']\n",
      "['continuing  therapy', 'found', 'bleeds blood transfusion']\n",
      "['postponing', 'stopped', 'surgery']\n",
      "['Examples', 'include', 'surgeries cancer surgery']\n",
      "['12  months', 'continued', 'elective  surgery']\n",
      "['Bare metal stents', 'proceed', 'one  month']\n",
      "['dental  that', 'proceed', 'dental  treatments']\n",
      "['dentists', 'important', 'how  them']\n",
      "['Assess bleeding Assess risk', 'Identify', 'bleeding  complications']\n",
      "['increase', 'increase', 'effect  risk']\n",
      "['decrease', 'reduce', 'thromboembolic  risk']\n",
      "['disease Erythromycin Fluconazole NSAIDS', 'discouraged', 'antiplatelet  effect']\n",
      "['dentist', 'aware', 'risk treatment length']\n",
      "['Medical  that', 'conditions Medical', 'antiplatelet drugs effect']\n",
      "['that', 'name', '= drug Nitrophorin References']\n",
      "['Archeologists', 'identified', 'sacred  animal']\n",
      "['genetic  analysis', 'called', 'taxonomy']\n",
      "['result  Anubis', 'referred to', 'often jackal head']\n",
      "['deities  Anubis', 'assumed different', 'different  roles']\n",
      "['roles  who', 'god', 'souls']\n",
      "['soul', 'attended', 'realm']\n",
      "['pantheon  Anubis', 'played', 'almost  role']\n",
      "['black  that', 'depicted', 'regeneration']\n",
      "['which', 'associated', 'human  flesh']\n",
      "['cultivation.\"\"In Old Anubis', 'chosen', 'dead']\n",
      "['him', 'depict', 'persons  them']\n",
      "['tradition', 'depicted', 'him']\n",
      "['he', 'stated', 'him']\n",
      "['Nubia 30–380 Anubis', 'sees', 'independent deity Anubis']\n",
      "['they', 'considered similar', 'souls']\n",
      "['Apuleius Golden worship', 'is', 'city']\n",
      "['Greeks  Anubis', 'called', 'animal-headed  gods']\n",
      "['often  Socrates', 'has', 'dog ton god']\n",
      "['land  which', 'took other', 'him']\n",
      "['where  Anubis', 'recounts', 'body']\n",
      "['Set', 'attempted', 'Osiris  himself']\n",
      "['however  he', 'stopped', 'skin']\n",
      "['evil-doers  who', 'flayed', 'tombs']\n",
      "['who', 'wore leopard', 'order  victory']\n",
      "['how  leopard', 'used', 'spots']\n",
      "['ancient  tombs', 'had', 'prayers']\n",
      "['where  embalming', 'called ḫnty', 'either']\n",
      "['Osiris myth Osiris Anubis', 'helped', 'Osiris']\n",
      "['connection  Anubis', 'became', 'upright patron mummy']\n",
      "['664–332  Anubis', 'depicted', 'often  individuals']\n",
      "['Hathor  Anubis', 'chosen', 'commonly  function']\n",
      "['god  who', 'designated', 'also  role']\n",
      "['Osiris  who', 'represents', 'period  men']\n",
      "['person', 'shows', 'dead  underworld']\n",
      "['feather  Anubis', 'dictated', 'fate']\n",
      "['god', 'treating', 'typically  sovereign']\n",
      "['ears gold heart', 'standing', 'ears gold scale']\n",
      "['rather  it', 'had several', 'symbolic  meanings']\n",
      "['It', 'represented', 'discolouration']\n",
      "['Anubis', 'depicted', 'nḫ3ḫ3  flail']\n",
      "['contexts  Anubis', 'shown', 'tomb  it']\n",
      "['bows  that', 'depict', 'domination']\n",
      "['god  who', 'linked', 'dead']\n",
      "['beliefs  he', 'worshipped', 'hope']\n",
      "['male  who', 'had male', 'when wood rituals']\n",
      "['where video artists', 'gained', 'evil  powers']\n",
      "['Abatur-Mandaean  who', 'See', 'dead  fate']\n",
      "['Claude The', 'Tell Amarna', 'Amarna Tablets']\n",
      "['aorta', 'distributes oxygenated', 'oxygenated  blood']\n",
      "['where thoracic aorta', 'way', 'One  part']\n",
      "['system', 'divides', 'course  direction']\n",
      "['system  aorta', 'starts', 'then hairpin turn']\n",
      "['arch  aorta', 'travels', 'then  inferiorly']\n",
      "['descending  aorta', 'has', 'two  parts']\n",
      "['aorta  which', 'has', 'small  pockets']\n",
      "['aortic  sinus', 'contains', 'likewise  rise']\n",
      "['two  arteries', 'supply', 'heart']\n",
      "['aortic  sinus', 'give', 'rise']\n",
      "['laryngeal  which', 'gives', 'major  branch']\n",
      "['distal  they', 'has', 'common carotid artery']\n",
      "['latter arm two', 'supplies', 'left  side']\n",
      "['thoracic descending thoracic aorta', 'ends', 'rise']\n",
      "['which', 'begins', 'diaphragm']\n",
      "['It', 'gives', 'rise']\n",
      "['It', 'ends', 'iliac  arteries']\n",
      "['arches  which', 'springs', 'great  arteries']\n",
      "['left  4th', 'start', 'base  part']\n",
      "['aorticopulmonary  that', 'derived', 'aorta  artery']\n",
      "['which', 'derived', 'smooth  muscle']\n",
      "['failure', 'results', 'great  vessels']\n",
      "['vasa blood which', 'requires', 'media outer media layers']\n",
      "['that', 'contains', 'information']\n",
      "['information', 'processed', 'homeostatic  responses']\n",
      "['smooth muscle component', 'alter', 'rather  stiffness']\n",
      "['elastic  matrix', 'dominates', 'biomechanical  properties']\n",
      "['which  arteries', 'occur', 'aorta']\n",
      "['fetal ductus arteriosis', 'fails', 'pulmonary  artery']\n",
      "['entire  body', 'Function', 'lung  blood']\n",
      "['supply aorta branches', 'speaking', 'aorta supply aorta abdomen']\n",
      "['pelvis', 'get', 'blood']\n",
      "['waves', 'creates', 'rebound']\n",
      "['reflected pressure waves', 'create', 'dicrotic  notch']\n",
      "['which', 'propagated', 'blood pressure']\n",
      "['Measuring', 'is', 'arterial pulse wave stiffness']\n",
      "['aorta  aorta', 'expands', 'blood']\n",
      "['time aorta contracts', 'gives', 'blood pressure']\n",
      "['Windkessel effect', 'has important', 'biomechanical  implications']\n",
      "['elastic  recoil', 'helps', 'pulsatile pumping nature']\n",
      "['such  flow', 'highest', 'less  pressure']\n",
      "['Other Marfan syndrome amniotes', 'thoracic', 'similar  arrangement']\n",
      "['tetrapods  remainder', 'carries', 'pulmonary  artery']\n",
      "['dorsal  aorta', 'carries oxygenated', 'oxygenated  blood']\n",
      "['connecting  aorta', 'retain', 'parallel  arches']\n",
      "['how  it', 'stems', 'when  aorta']\n",
      "['where  perforation', 'documented', 'vessels  heart']\n",
      "['aortic Wikimedia bodies', 'References External', 'dictionary   definition']\n",
      "['aortic pH. Structure bodies', 'important', 'partial  pressures']\n",
      "['other  sources', 'equate', 'aortic  bodies']\n",
      "['chromaffin  which', 'chemoreceptors', 'catecholamines']\n",
      "['Function', 'measure', 'aortic  changes']\n",
      "['aortic  bodies', 'give', 'feedback']\n",
      "['medulla oblongata', 'regulates', 'turn breathing pressure']\n",
      "['chemodectoma  that', 'tumor', 'aortic  body']\n",
      "['aortic blood pressure', 'See', 'blood pressure']\n",
      "['Studies', 'shown', 'pressure  efficacy']\n",
      "['traditional  method', 'shown', 'amlodipine blood efficacy']\n",
      "['different  medications', 'demonstrated', 'branchial blood pressure readings']\n",
      "['radial artery tonometry', 'reading', 'aortic blood pressure']\n",
      "['Central   et pressure', 'relates', 'brachial  pressure']\n",
      "['arterial blood you', 'pressure', 'arterial blood what']\n",
      "['aortic  sinus', 'gives', 'rise']\n",
      "['aortic  sinus', 'gives', 'rise']\n",
      "['aortic  sinus', 'gives', 'usually  rise']\n",
      "['sinuses  this', 'put', 'ventricles']\n",
      "['aortic Downstate Medical valve', 'See', 'Medical Center Downstate Medical Heart']\n",
      "['population  it', 'has', 'two  leaflets']\n",
      "['heart  blood', 'structure', 'flow']\n",
      "['aortic Structure valve', 'has', 'three  cusps']\n",
      "['Anatomists', 'named', 'traditionally  them']\n",
      "['when  valve', 'contain', 'sinus']\n",
      "['two  that', 'sinuses', 'origin']\n",
      "['still  origins', 'reversed', 'pulmonary  valve']\n",
      "['blood', 'opens', 'left  ventricle']\n",
      "['ventricular  systole', 'ends', 'rapidly  drops']\n",
      "['When  pressure', 'decreases', 'ventricle  momentum']\n",
      "['closure', 'contributes', 'valve A2 component']\n",
      "['Insufficiency Closure', 'permits', 'left blood ventricle']\n",
      "['endocardium perfuses', 'reduce', 'aortic  perfusion']\n",
      "['insufficiency  which', 'results', 'heart']\n",
      "['functioning significance valve', 'permits normal', 'normal  physiology']\n",
      "['Common  causes', 'include', 'valve  syndrome']\n",
      "['two  options', 'repair', 'valve']\n",
      "['Aortic  valve', 'repair Aortic', 'aortic valve reconstruction']\n",
      "['Aortic valve replacement Replacement', 'done', 'native  valve']\n",
      "['surgical  procedure', 'delivers', 'prosthetic valve valve']\n",
      "['Mechanical  valves', 'made', 'time  ball']\n",
      "['valves blood that', 'require lifelong', 'forming blood clots']\n",
      "['shape', 'mimic normal', 'normal heart valves']\n",
      "['tissue', 'pretreated', 'calcification']\n",
      "['valves  that', 'tend', 'cusps']\n",
      "['Ross procedure', 'involves', 'aortic  it']\n",
      "['pulmonary  homograft', 'used', 'pulmonary  valve']\n",
      "['aortic valve surgery', 'took', 'place']\n",
      "['aortic  it', 'spot', 'aortic  valve']\n",
      "['test splitting Transthoracic it', 'contributes', 'inspiration splitting Transthoracic echocardiography']\n",
      "['degree', 'quantified', 'stenosis valve dysfunction']\n",
      "['MRI', 'used', 'valve']\n",
      "['Quantification', 'parameters', 'aortic sinotubular valve']\n",
      "['Aortic valve area calculation', 'method', 'indirect  area']\n",
      "['aortic valve orifice area', 'one', 'measures  severity']\n",
      "['used   methods', 'involve', 'measurements']\n",
      "['technician  who', 'difficult', 'manually  perimeter']\n",
      "['flow', 'states', 'area  flow']\n",
      "['integral velocity which', 'calculated', 'velocity time']\n",
      "['0.78540 LVOT which', 'calculated', 'pulsed-wave Doppler Doppler']\n",
      "['these  it', 'easy', 'continuous-wave Doppler Doppler']\n",
      "['LVOT area LVOT it', '=', 'LVOT dimension']\n",
      "['sonographer', 'crucial', 'great LVOT diameter']\n",
      "['measurement', 'inaccurate', 'echocardiogram']\n",
      "['viewpoint', 'distort', 'true  diameter']\n",
      "['so Gorlin patient', 'obtained', 'validation Gorlin formula']\n",
      "['flow', 'calculated', 'beat ejection flow']\n",
      "['44.3\\\\cdot Gorlin equation', '=', '\\\\displaystyle \\\\text{Valve Area']\n",
      "['measurement', 'accomplished', 'cardiac  output']\n",
      "['Hakki equation', 'simplification', 'numerical systolic ejection period']\n",
      "['It', 'derived', 'genetic Jander algorithm']\n",
      "['such  problems', '=', 'Aortic \\\\sqrt Gradient stenosis']\n",
      "['Signs', 'include', 'heart failure heart shortness']\n",
      "['aortic  valve', 'affects', 'two  percent']\n",
      "['Risk factors', 'similar', 'artery disease artery smoking']\n",
      "['aortic  valve', 'has', 'three  leaflets']\n",
      "['Aortic  stenosis', 'followed', 'repeated ultrasound scans']\n",
      "['some valve who', 'involves', 'primarily valve replacement surgery']\n",
      "['Valves', 'mechanical', 'risks']\n",
      "['invasive  procedure', 'result', 'aortic  valvuloplasty']\n",
      "['people  who', 'affects', '2  %']\n",
      "['those  who', '%', 'chance']\n",
      "['Most  people', 'have', 'stenosis  symptoms']\n",
      "['Angina Angina', 'increases', 'also heart risk']\n",
      "['hypertrophy  that', 'occurs due', 'pressure pressure gradient']\n",
      "['so  muscle', 'get', 'enough oxygen requirement']\n",
      "['when heart muscle', 'evident', 'increased blood supply']\n",
      "['however heart muscle', 'require more', 'more blood supply']\n",
      "['heart failure heart it', 'increases', 'risk']\n",
      "['aortic  stenosis', 'unclear', 'syncope']\n",
      "['severe  AS', 'is', 'cardiac  output']\n",
      "['more  them', 'dilate', 'more  work']\n",
      "['person', 'falls', 'cardiac  output']\n",
      "['peripheral  that', 'is', 'decreased blood flow']\n",
      "['heart', 'impossible', 'peripheral  vasodilation']\n",
      "['abnormal heart rhythms', 'develop', 'myocardium  Angina']\n",
      "['syncope', 'block', 'symptom']\n",
      "['failure Congestive heart failure', 'carries', 'grave  prognosis']\n",
      "['aortic mortality valve', 'have', '2-year mortality rate']\n",
      "['stenosis', 'shown', 'form']\n",
      "['foregoing American Heart Association', 'changed', 'recently  recommendations']\n",
      "['diseases  that', 'use', 'any']\n",
      "['Examples', 'include', 'nitroglycerin']\n",
      "['stenosis  heart', 'able', 'thereby  effect']\n",
      "['Those', 'need', 'typically  intervention']\n",
      "['typically 30 presenting', 'cause', '30 40 30 %']\n",
      "['Rare  causes', 'include', 'stenosis Fabry disease']\n",
      "['aortic Pathophysiology valve', 'consists', 'cusps  opening']\n",
      "['it', 'forces', 'blood']\n",
      "['aortic  valve', 'closes', 'blood']\n",
      "['associated risk factors', 'thought', 'significant LDL damage']\n",
      "['left  ventricle', 'generate', 'effectively  blood']\n",
      "['Initially  LV', 'generates', 'muscular  walls']\n",
      "['systolic  function', 'dilates', 'ability  blood']\n",
      "['valve ejection which', 'vary', 'it']\n",
      "['heard ejection murmur', 'systolic', 'loudest']\n",
      "['maneuver  which', 'increases', 'it']\n",
      "['This', 'result', 'loud  sound']\n",
      "['physical  exam', 'reveal', 'diastolic decrescendo murmur']\n",
      "['that', 'bisferiens', 'presence']\n",
      "['electrocardiogram  it', 'leads', 'narrowed pulse pressure Electrocardiogram']\n",
      "['that', 'common', 'high-pressure  load']\n",
      "['Evidence', 'include', 'rarely ECG patterns']\n",
      "['catheterization Cardiac chamber catheterization', 'provides', 'severe  stenosis']\n",
      "['It', 'measure', 'directly  pressure']\n",
      "['which  discrepancy', 'reserved', 'aortic  valve']\n",
      "['Echocardiogram Echocardiogram', 'way', 'aortic valve anatomy']\n",
      "['aortic valve area', 'calculated', 'echocardiographic flow velocities']\n",
      "['modified continuity Gradient', 'calculated', 'aortic 4(velocity)² gradient']\n",
      "['increased pressure parameters', 'causes', 'aortic  stenosis']\n",
      "['pressure gradient', 'low', 'aortic blood valve']\n",
      "['chest Chest X-ray X-ray', 'assist', 'disease  degree']\n",
      "['related  symptoms', 'make', 'immediately  revisit']\n",
      "['processes  targeting', 'indicated', 'processes']\n",
      "['latest  trials', 'show', 'AS  decrease']\n",
      "['medical  therapy', 'has', 'aortic  stenosis']\n",
      "['stenosis  angina', 'useful', 'coexisting  conditions']\n",
      "['Nitrates', 'contraindicated due', 'profound  hypotension']\n",
      "['observational  studies', 'failed', '2005  effect']\n",
      "['2007  study', 'find', 'slowing']\n",
      "['Aortic  valve', 'repair Aortic', 'aortic valve reconstruction']\n",
      "['aortic  stenosis', 'requires aortic', 'aortic valve replacement']\n",
      "['aortic valve replacement approaches', 'include open', 'open heart surgery']\n",
      "['aortic valve replacement', 'well-studied', 'longer-term  prognosis']\n",
      "['aortic  valve', 'replaced', 'surgical  procedure']\n",
      "['250,000  people', 'received', 'transcatheter aortic valve replacement']\n",
      "['where balloon balloon', 'effective', 'greater  flow']\n",
      "['surgeon', 'make', 'leg  balloon']\n",
      "['aortic  stenosis', 'carries', 'poor  prognosis']\n",
      "['75 4 % percent', 'have aortic', 'aortic valve stenosis']\n",
      "['Risk factors', 'include', 'AS lifestyle habits']\n",
      "['stenosis  some', 'found', 'less  progression']\n",
      "['Subsequent  research', 'failed', 'positive  result']\n",
      "['term  which', 'classified', 'birds']\n",
      "['Extinct  archosaurs', 'include non-avian', 'non-avian  dinosaurs']\n",
      "['crown group crown that', 'define', 'common  ancestor']\n",
      "['extinct  which', 'splits', 'birds']\n",
      "['extinct  reptiles', 'possessed', 'proterosuchids  features']\n",
      "['morphological  definition', 'corresponds', 'crown-group  archosaurs']\n",
      "['Birds', 'archosaurs', 'only K-Pg extinction']\n",
      "['obvious  features', 'include', 'teeth']\n",
      "['early  paleontologists', 'responsible', 'which']\n",
      "['non-muscular  cheek', 'appear', 'non-muscular lip lips']\n",
      "['skull  which', 'reduced', 'weight']\n",
      "['Mandibular  fenestrae', 'reduced', 'also  weight']\n",
      "['fourth  trochanter', 'provides', 'large  site']\n",
      "['Stronger  muscles', 'allowed', 'Permian-Triassic extinction event']\n",
      "['archosauriforms  themselves', 'subgroup', 'archosauriforms  which']\n",
      "['These', 'include', 'well  Xilousuchus']\n",
      "['known  fossils', 'stage', 'Tanzania 247 Asilisaurus']\n",
      "['Triassic Synapsids Triassic that', 'clade', 'mammals']\n",
      "['large  synapsids', 'survived', 'widespread  distribution']\n",
      "['synapsids  this', 'are', 'greater  constraint']\n",
      "['they', 'is', 'sprawling  limbs']\n",
      "['Archosaurs', 'have', 'unidirectional air flow']\n",
      "['uric  which', 'excrete uric', 'uric  acid']\n",
      "['archosaurs', 'reasonable', 'therefore  water']\n",
      "['aglandular glandless skins', 'helped', 'also  water']\n",
      "['which', 'excrete', 'urinary  urine']\n",
      "['many  which', 'contain many', 'also  water']\n",
      "['Palaeos  they', 'Assuming', 'similar  features']\n",
      "['archosaurs  cynodonts', 'points', 'synapsid  coincides']\n",
      "['study', 'favors', 'competition']\n",
      "['1970s  scientists', 'classified', 'archosaurs']\n",
      "['mesotarsal  astragalus', 'had', 'mesotarsal  ankles']\n",
      "['later  crurotarsans', 'crurotarsans', 'erect  limbs']\n",
      "['Euparkeria', 'had', 'crurotarsal  ankles']\n",
      "['Most  Ornithodirans', 'had', 'mesotarsal  ankles']\n",
      "['form', 'incorporated', 'large  astragalus']\n",
      "['when  animals', 'provided more', 'more  stability']\n",
      "['earliest  avemetatarsalians', 'retained', 'mesotarsal  ankles']\n",
      "['many  ornithodirans', 'built', 'S-shaped  curve']\n",
      "['it', 'made', 'more  leverage']\n",
      "['Triassic  ornithodirans', 'diversified', 'dinosaurs']\n",
      "['it', 'defined', 'only  descendants']\n",
      "['larger clade which', 'Archosauriformes', 'close  relatives']\n",
      "['relatives', 'referred to', 'crown group crown Archosauria']\n",
      "['clade  some', 'continue', 'biological  rank']\n",
      "['21st century researchers', 'treated', 'it']\n",
      "['which', 'coined', 'Cope  rhynchosaurs']\n",
      "['1986  Archosauria', 'was', 'crown-clade  use']\n",
      "['1859 Triassic it', 'considered', '1859 Triassic archosaurs']\n",
      "['They', 'possess', 'features']\n",
      "['used  thecodonts', 'considered', 'valid  grouping']\n",
      "['Thecodontia  it', 'paraphyletic', 'descendants']\n",
      "['many  cladists', 'provided', 'artificial  grouping']\n",
      "['crurotarsan  ankle', 'identified', 'basal  split']\n",
      "['advanced ankle members', 'thought', 'semi-erect']\n",
      "['analyses  archosaurs', 'shown', 'true  clade']\n",
      "['1988 paleontologists Michael Benton', 'produced', 'new J.M. tree']\n",
      "['tree', 'revealed', 'basal  split']\n",
      "['Ornithodira', 'first', 'clade']\n",
      "['Crurotarsi', 'replaced', 'Pseudosuchia']\n",
      "['analyses ankle which', 'incorporated archosaur', 'archosaur  features']\n",
      "['they', 'meaning', 'common  ancestor']\n",
      "['Crurotarsi', 'includes', 'common  ancestor']\n",
      "['Benton', 'proposed', 'bird-line  archosaurs']\n",
      "['archosaurs Triassic archosaur Ornithodira', 'placed', 'archosaur Scleromochlus Triassic archosaur it']\n",
      "['phylogenetic Sterling analysis', 'found strong', 'strong  support']\n",
      "['subsequent  studies', 'supported', 'phylogeny']\n",
      "['Archosauria  Crurotarsi', 'means', 'all']\n",
      "['Nesbitt', 'reinstated', 'archosaurs clade it']\n",
      "['other 200 archosaurs', 'survived', 'Extinction Jurassic extinction event']\n",
      "['Both', 'descendants', 'therefore  themselves']\n",
      "['which', 'flourish', 'modern  crocodiles']\n",
      "['generally  birds', 'agreed', 'most  species']\n",
      "['knobs', 'had', 'sideways']\n",
      "['hip that', 'developed', 'hip joints']\n",
      "['i.e.  they', 'gave', 'constraint']\n",
      "['femur  which', 'were', 'sideways']\n",
      "['more  it', 'pointed', 'higher  metabolism']\n",
      "['some', 'herbivores', 'extensive  armor']\n",
      "['Many land phytosaurs', 'portrayed', 'even  seas']\n",
      "['Two  clades', 'dominated', 'ornithodirans  air']\n",
      "['metabolism  they', 'have', 'oxygen supply']\n",
      "['4-chambered  which', 'have 4-chambered', 'completely  flows']\n",
      "['less  they', 'have 3-chambered', 'de-oxygenated flows blood']\n",
      "['them', 'have', 'water  oxygen']\n",
      "['mammals  researchers', 'different', 'mammals  what']\n",
      "['ambush predators ambush that', 'been', 'vast  majority']\n",
      "['feather-like  filaments', 'likely', 'thermal  insulation']\n",
      "['when  it', 'support', 'aquatic predator niche']\n",
      "['Crocodilian  embryos', 'develop', '4-chambered  hearts']\n",
      "['aortic  which', 'form', 'ventricle  foramen']\n",
      "['shunt', 'used', 'heart heart crocodilian']\n",
      "['therefore living they', 'concluded', '4-chambered living hearts']\n",
      "['authors', 'provide other', 'other  evidence']\n",
      "['pulmonary bypass they', 'reasonable', 'pulmonary bypass shunt']\n",
      "['active  which', 'help', 'fast  metabolism']\n",
      "['erect  those', 'appear', 'erect  limbs']\n",
      "['animals  they', 'advantageous', 'energy costs']\n",
      "['time  it', 'had', 'synapsids  same']\n",
      "['non-avian  which', 'seen', 'air sacs']\n",
      "['parabronchi air which', 'achieve unidirectional', 'unidirectional air flow']\n",
      "['alveoli  which', 'given', 'lungs']\n",
      "['extinct  dinosaurs', 'lay hard-shelled', 'hard-shelled  eggs']\n",
      "['hard  shells', 'have soft-shelled', 'soft-shelled  eggs']\n",
      "['species  animals', 'bury', 'eggs']\n",
      "['sex determination sex that', 'Neornithes', 'survival advantage']\n",
      "['UCMP Paleos', 'reviews', 'excellent family image']\n",
      "['animals  which', 'Archosauria', 'blood']\n",
      "['pumped  blood', 'carries', 'metabolic  waste']\n",
      "['two  reptiles', 'have', 'three  chambers']\n",
      "['heart valves heart which', 'flows', 'backflow']\n",
      "['sac  which', 'enclosed', 'small  amount']\n",
      "['heart', 'pumps', 'blood']\n",
      "['that', 'generate', 'contraction']\n",
      "['circulation  which', 'receives', 'right  atrium']\n",
      "['where  it', 'pumped', 'carbon dioxide']\n",
      "['Exercise', 'increases', 'resting heart rate']\n",
      "['Cardiovascular  diseases', 'have', 'chest  pain']\n",
      "['Structure Location', 'situated', 'human  heart']\n",
      "['double-membraned  sac', 'surrounds', 'heart']\n",
      "['left  lung', 'smaller', 'border  heart']\n",
      "['adult  heart', 'has', 'mass']\n",
      "['Well-trained  athletes', 'have', 'larger  hearts']\n",
      "['Chambers', 'has', 'four  chambers']\n",
      "['tissue  this', 'made', 'structure']\n",
      "['fibrous  which', 'forms', 'atria']\n",
      "['conduction system conduction collagen', 'provides', 'electricity']\n",
      "['interventricular  septum', 'separates', 'ventricles']\n",
      "['when  they', 'thicker', 'greater  pressure']\n",
      "['four  which', 'has', 'chambers']\n",
      "['three  which', 'has', 'three  cusps']\n",
      "['mitral  valve', 'lies', 'atrium  ventricle']\n",
      "['bicuspid valve bicuspid its', 'known', 'two  cusps']\n",
      "['when  they', 'prevent', 'valves']\n",
      "['This', 'creates', 'place chordae them']\n",
      "['three  which', 'has', 'three  cusps']\n",
      "['cusps  which', 'flows', 'valve']\n",
      "['three  which', 'has', 'three  cusps']\n",
      "['right  atrium', 'receives', 'blood']\n",
      "['muscles  which', 'smooth', 'prominent  ridges']\n",
      "['endocardium moderator band', 'addition', 'crucial  role']\n",
      "['It', 'arises', 'interior  space']\n",
      "['which  it', 'tapers', 'blood']\n",
      "['arteries trunk that', 'branches', 'blood']\n",
      "['left  heart', 'has', 'left  atrium']\n",
      "['left  atrium', 'receives', 'oxygenated  blood']\n",
      "['left  atrium', 'has', 'outpouching']\n",
      "['left  ventricle', 'thicker', 'force  blood']\n",
      "['ventricle  left', 'has', 'trabeculae  carneae']\n",
      "['left  ventricle', 'pumps', 'blood']\n",
      "['coronary heart artery', 'carry', 'valve  blood']\n",
      "['It', 'made', 'epithelium heart chambers']\n",
      "['endocardium', 'play', 'also  contraction']\n",
      "['muscle cells', 'elegant', 'inner figure figure']\n",
      "['swirling  pattern', 'allows', 'blood']\n",
      "['muscle muscle which', 'are', 'ability']\n",
      "['muscle cells', 'make', 'bulk']\n",
      "['discs  which', 'connected', 'rapid  response']\n",
      "['syncytium  that', 'allow', 'blood']\n",
      "['pacemaker cells', 'make', 'cells conduction system']\n",
      "['few  which', 'smaller', 'limited  contractibility']\n",
      "['Cardiac muscle tissue', 'has', 'cell rate contraction']\n",
      "['They', 'include', 'MYH6']\n",
      "['that', 'sac', 'heart']\n",
      "['serous  that', 'lined', 'pericardial  surface']\n",
      "['pericardium', 'present', 'chest  heart']\n",
      "['Coronary circulation Heart tissue', 'needs', 'metabolic  wastes']\n",
      "['circulation  which', 'achieved', 'arteries']\n",
      "['arteries  which', 'receives', 'blood']\n",
      "['coronary  artery', 'splits', 'shortly  aorta']\n",
      "['It', 'does', 'this']\n",
      "['coronary  artery', 'supplies', 'posterior  sections']\n",
      "['coronary  artery', 'supplies', 'also  blood']\n",
      "['large  that', 'vein', 'atrium  most']\n",
      "['It', 'receives', 'cardiac  bottom']\n",
      "['cardiac  veins', 'drain', 'front']\n",
      "['smaller  they', 'collect', 'smaller  vessels']\n",
      "['third  which', 'travel', 'section']\n",
      "['left  vessel', 'joins', 'artery  atrium']\n",
      "['Nerve supply heart', 'receives', 'nerve signals']\n",
      "['nerves', 'act', 'heart rate']\n",
      "['Sympathetic  nerves', 'influence', 'also  force']\n",
      "['vagus  nerve', 'acts', 'trunk act heart rate']\n",
      "['nerves  that', 'form', 'network']\n",
      "['wandering  that', 'nerve', 'parasympathetic  stimulation']\n",
      "['Sympathetic  stimulation', 'causes', 'release']\n",
      "['depolarization repolarization which', 'shortens', 'thus repolarization rate']\n",
      "['It', 'opens', 'chemical ion influx']\n",
      "['Development heart', 'organ', 'functional  blood']\n",
      "['plate  which', 'derives', 'cardiogenic  region']\n",
      "['here  that', 'form', 'primitive heart tube']\n",
      "['week heart tube', 'lengthens', 'S-shape']\n",
      "['Further  development', 'include', 'formation']\n",
      "['atrium  blood', 'allowed', 'lungs']\n",
      "['septum primum septum that', 'closes', 'cardiac circulation pattern']\n",
      "['embryonic heart rate', 'accelerates', 'peak  rate']\n",
      "['Physiology Blood flow', 'functions', 'continuous heart flow']\n",
      "['systemic  circulation', 'transports', 'deoxygenated carbon blood']\n",
      "['right  heart', 'collects deoxygenated', 'deoxygenated  blood']\n",
      "['Blood', 'collects', 'right  atrium']\n",
      "['inferior vena cava', 'drains', 'blood']\n",
      "['lungs  it', 'divides', 'capillaries']\n",
      "['which  ventricles', 'period', 'blood']\n",
      "['atria', 'relaxed', 'blood']\n",
      "['When  ventricles', 'contract', 'diastole atria blood']\n",
      "['ventricles', 'completed most', 'ventricles atria pump']\n",
      "['aortic aorta valves', 'open', 'further  pressure']\n",
      "['Blood', 'ejected', 'heart  pressure']\n",
      "['This', 'calculated', 'stroke volume']\n",
      "['So  CO', '=', 'SV HR']\n",
      "['cardiac  output', 'L/min', 'average stroke volume']\n",
      "['stroke volume', 'measured', 'normally  echocardiogram']\n",
      "['less  preload', 'is', 'ventricles']\n",
      "['much  heart', 'influenced', 'blood']\n",
      "['strength', 'controls', 'muscle contractions stroke volume']\n",
      "['adrenaline  inotropes', 'decrease', 'contraction calcium channel blockers']\n",
      "['that', 'created', 'heart heart muscle']\n",
      "['which', 'part', 'signal']\n",
      "['signal', 'travels', 'right bundle branches']\n",
      "['tissue Purkinje which', 'carried', 'electric  charge']\n",
      "['Cells', 'do', 'node action potential']\n",
      "['they', 'have', 'negative  charge']\n",
      "['rapid  influx', 'causes', 'sodium ions sodium charge']\n",
      "['potassium', 'close', 'it']\n",
      "['only  it', 'has', 'high  charge']\n",
      "['potassium', 'close', 'cell']\n",
      "['This', 'causes', 'resting  charge']\n",
      "['process', 'close', '−60  mV']\n",
      "['Calcium', 'plays', 'critical  role']\n",
      "['when plateau they', 'means', 'positive  charge']\n",
      "['Calcium ions', 'combine', 'protein troponin relaxation']\n",
      "['Influences', 'influenced', 'resting heart rate']\n",
      "['cardiovascular  centres', 'control', 'sympathetic  influences']\n",
      "['reflexes carbon help', 'receive', 'blood flow']\n",
      "['cardiac baroreceptor firing centers', 'decrease sympathetic', 'parasympathetic  stimulation']\n",
      "['pressure  rate', 'increase sympathetic', 'parasympathetic baroreceptor firing stimulation']\n",
      "['specialized  baroreceptors', 'stretches', 'walls']\n",
      "['cardiac blood center', 'responds', 'parasympathetic heart rate']\n",
      "['Low  oxygen', 'stimulate', 'high carbon firing']\n",
      "['Exercise levels', 'affect', 'all heart rate']\n",
      "['High  levels', 'increase', 'hormones heart rate']\n",
      "['low blood oxygen', 'increase', 'low blood it']\n",
      "['which', 'cause', 'diseases']\n",
      "['medical  professionals', 'involved', 'diseases']\n",
      "['coronary  severe', 'narrow', 'blood flow']\n",
      "['then  patient', 'experience', 'symptoms']\n",
      "['Severe  narrowings', 'cause chest', 'chest  pain']\n",
      "['thin  covering', 'rupture', 'fatty  centre']\n",
      "['case  clot', 'form', 'myocardial heart infarction']\n",
      "['case  this', 'cause cardiac', 'cardiac  arrest']\n",
      "['Obesity', 'increase', 'all blood atherosclerosis']\n",
      "['which  heart', 'defined', 'enough  demands']\n",
      "['Patients', 'experience', 'heart failure heart breathlessness']\n",
      "['Heart failure', 'result', 'diseases end heart']\n",
      "['common  causes', 'include various', 'various  cardiomyopathies']\n",
      "['condition', 'affect', 'right  ventricle']\n",
      "['Patients', 'risk', 'dangerous heart rhythm disturbances']\n",
      "['Cardiomyopathies Cardiomyopathies', 'diseases', 'muscle']\n",
      "['heart', 'cause', 'dilated  cardiomyopathy']\n",
      "['blood', 'allow', 'direction  it']\n",
      "['Diseased heart valves', 'have', 'valve  blood']\n",
      "['Valvular heart disease', 'cause', 'abnormal  heart']\n",
      "['Abnormal heart rhythms', 'asymptomatic', 'palpitations']\n",
      "['types', 'increase', 'long term risk']\n",
      "['re-entrant AV others', 'take many', 'heart  arise']\n",
      "['which', 'become inflamed', 'heart']\n",
      "['chest  that', 'causes chest', 'chest  pain']\n",
      "['Pericardial  effusions', 'occur secondary', 'frequently kidney symptoms']\n",
      "['which', 'compress', 'tamponade  breathlessness']\n",
      "['Fluid', 'removed', 'diagnosis  syringe']\n",
      "['heart that', 'include', 'heart  hole']\n",
      "['main blood that', 'include', 'e.g.  coarctation']\n",
      "['that', 'seen', 'one  part']\n",
      "['oxygen  that', 'allow', 'blood']\n",
      "['transposition', 'picked', 'arteries  breathlessness']\n",
      "['minor  forms', 'remain undetected', 'only heart themselves']\n",
      "['invasive  procedures', 'play', 'also  role']\n",
      "['cardiac Examination examination', 'includes', 'chest']\n",
      "['signs  that', 'involves', 'assessment']\n",
      "['blood pressure', 'taken', 'invasive  measurement']\n",
      "['healthy  hearts', 'sounds', 'audible heart sounds']\n",
      "['two  valves', 'consists', 'slight  difference']\n",
      "['also  these', 'present', 'rise']\n",
      "['S3', 'indicates', 'usually  increase']\n",
      "['combined  presence', 'give', 'quadruple  gallop']\n",
      "['tests Blood tests', 'play', 'important  role']\n",
      "['It', 'released', '4–6 hours']\n",
      "['significant  rise', 'taken', 'often  one']\n",
      "['frequently blood it', 'provides', 'creatine kinase creatine information']\n",
      "['general health that', 'taken', 'general health factors']\n",
      "['metabolic blood that', 'include', 'disturbances']\n",
      "['Fasting  lipids', 'ordered', 'often cholesterol status']\n",
      "['body surface it', 'possible', 'electrical  activity']\n",
      "['ECG', 'test', 'bedside placement']\n",
      "['ground).There', 'produces', '12  lead']\n",
      "['that', 'create', 'current']\n",
      "['negative  lead', 'depends', 'positive  deflection']\n",
      "['ECG', 'tool', 'insufficient blood supply']\n",
      "['suspected rhythm abnormality', 'worn', 'abnormality']\n",
      "['Several imaging methods', 'used', 'anatomy']\n",
      "['echocardiogram', 'ultrasound', 'heart  function']\n",
      "['much  blood', 'include', 'valves  stenosis']\n",
      "['Ejection fraction', 'obtained', 'then  volume']\n",
      "['where  this', 'involves', 'injection']\n",
      "['CT scans', 'help', 'imaging  size']\n",
      "['major blood which', 'useful', 'heart']\n",
      "['Treatment Diseases', 'treated', 'heart']\n",
      "['when heart muscle artery', 'treated', 'myocardial  infarction']\n",
      "['preventative calcium channel treatments', 'include', 'aspirin lifestyle smoking']\n",
      "['narrowed heart arteries', 'treated', 'blood  obstruction']\n",
      "['which  narrowings', 'performed', 'stent artery open']\n",
      "['whereby blood vessel', 'performed', 'mammary  blood']\n",
      "['that', 'require', 'abnormally  surgery']\n",
      "['This', 'performed', 'damaged heart valve']\n",
      "['circumstances tricuspid valves', 'repaired', 'surgically  need']\n",
      "['percutaneously  that', 'treated', 'many  similarities']\n",
      "['Transcatheter aortic valve replacement', 'used', 'high  risk']\n",
      "['Cardiac  arrhythmias', 'treated', 'antiarrhythmic heart drugs']\n",
      "['These', 'work', 'nervous sodium channel effect']\n",
      "['stroke  risk', 'reduced', 'anticoagulants']\n",
      "['treatment option', 'ablation', 'arrhythmia']\n",
      "['tissue  that', 'passed', 'arrhythmia']\n",
      "['abnormal  tissue', 'damaged', 'further heart rhythm disturbances']\n",
      "['invasive catheter arrhythmias', 'treated', 'open  surgery']\n",
      "['electric  shock', 'used', 'heart']\n",
      "['Cardiac  devices', 'required', 'also  arrhythmias']\n",
      "['skin  that', 'leads', 'slow heart rhythms']\n",
      "['Implantable  defibrillators', 'used', 'rapid heart rhythms']\n",
      "['dangerous heart racing', 'monitor', 'automatically  heart']\n",
      "['Heart failure', 'medication', 'underlying  cause']\n",
      "['that', 'include', 'resynchronisation therapy pumping efficiency']\n",
      "['which', 'implanted', 'own pumping ability']\n",
      "['blood  Hippocrates', 'considered', 'blood']\n",
      "['they', 'noted', 'pump  dilation']\n",
      "['He', 'discovered', 'also heart valves']\n",
      "['Greek physician Galen', 'knew', 'brighter blood blood']\n",
      "['body  it', 'concluded', 'heat']\n",
      "['diastole  blood', 'pump', 'blood']\n",
      "['academic  doctrines', 'continued', 'academic  community']\n",
      "['authorities  he', 'questioned', 'some']\n",
      "['Christianismi Restitutio Christianismi blood', 'wrote', 'Christianismi Restitutio Christianismi that']\n",
      "['William Harvey physician William book', 'came', 'systemic  circulation']\n",
      "['English  who', 'physiologist', 'also  heart']\n",
      "['heart Sunao Tawara', 'recognized', 'Reizleitungssystem des Säugetierherzens']\n",
      "['discovery', 'prompted', 'node Arthur Keith']\n",
      "['electrocardiogram  inventor', 'form', 'Nobel Prize']\n",
      "['This', 'marked', 'surgery  attention']\n",
      "['American surgeon Norman Shumway', 'credited', 'efforts transplantation techniques']\n",
      "['United States United it', 'surpassed infectious', 'infectious  disease']\n",
      "['ongoing Framingham Heart Study', 'shed', 'light']\n",
      "['heart failure heart disease', 'continues', 'year 30 diagnosis']\n",
      "['heart', 'symbol', 'religions  temple']\n",
      "['expressions  which', 'evidenced', 'ib']\n",
      "['where nether it', 'conceived', 'evidence']\n",
      "['Maat  which', 'weighed more', 'ideal  standard']\n",
      "['it', 'devoured', 'just  afterlife']\n",
      "['Chinese  character', 'derives', 'heart heart chambers']\n",
      "['Chinese  word', 'takes', 'metaphorical  meanings']\n",
      "['heart', 'associated', 'six  organs']\n",
      "['Sanskrit  it', 'mean', 'anatomical  seat']\n",
      "['classical  philosophers', 'considered', 'often  brain']\n",
      "['physician Galen physician who', 'due', 'also  seat']\n",
      "['heart', 'played', 'also  role']\n",
      "['Jesus Christ Jesus which', 'consider', 'prominence']\n",
      "['tradition', 'influenced', 'development']\n",
      "['that', 'ancient', 'explicit']\n",
      "['little Renaissance that', 'theme', 'little heart symbols']\n",
      "['Many  recipes', 'combined', 'them']\n",
      "['Australian  recipe', 'braised', 'stuffed beef heart']\n",
      "['Other  animals', 'Vertebrates', 'size']\n",
      "['which', 'continuous', 'beat']\n",
      "['systems Adult systems amphibians', 'have', 'circulatory  system']\n",
      "['lungs  which', 'allows', 'oxygenated  blood']\n",
      "['fact  snakes', 'different', 'elongated  body']\n",
      "['that', 'tend', 'higher blood pressure']\n",
      "['rule  which', 'crocodiles', 'four-chambered  heart']\n",
      "['spongy  nature', 'seem', 'ventricle  more']\n",
      "['valve  that', 'replaced', 'two  bloodstreams']\n",
      "['four-chambered  heart', 'thought', 'complete  separation']\n",
      "['what', 'have', 'one  it']\n",
      "['sometimes  what', 'has', 'entry compartments']\n",
      "['primitive  heart', 'considered', 'four-chambered  heart']\n",
      "['sinus which', 'venosus', 'deoxygenated  blood']\n",
      "['main pumping action', 'flows', 'place']\n",
      "['conus  which', 'arteriosus', 'several  blood']\n",
      "['two  chambers', 'delivers', 'instead  S-shape']\n",
      "['Invertebrates Arthropods', 'have', 'circulatory  system']\n",
      "['blood', 'permeates', 'slowly  heart']\n",
      "['heart', 'pumps', 'then  blood']\n",
      "['muscular  that', 'tube', 'length']\n",
      "['which', 'haemolymph', 'pigment copper-based pigment haemocyanin']\n",
      "['circulatory  system', 'used', 'much  veins']\n",
      "['animals  that', 'travels', 'two gill hearts']\n",
      "['systemic  heart', 'have', 'two  atria']\n",
      "['central  which', 'have', 'aorta  blood']\n",
      "['This', 'suggests', 'presence']\n",
      "['article', 'Notes', 'text']\n",
      "['– NIH Atlas', 'discussion', 'human development Animal Heart']\n",
      "['Arterioles', 'have muscular', 'muscular  walls']\n",
      "['endothelium  which', 'promoted', 'biochemical  reaction']\n",
      "['pressure Blood pressure', 'result', 'cardiac  output']\n",
      "['decreased  velocity', 'increases', 'capillaries blood pressure']\n",
      "['This', 'induces', 'gas']\n",
      "['when  blood', 'occurs', 'venules']\n",
      "['Arterioles', 'receive autonomic', 'order system diameter']\n",
      "['Retinal  vessels', 'lack', 'sympathetic  innervation']\n",
      "['number', 'influence', 'arteriole  tone']\n",
      "['which', 'increase total', 'peripheral blood resistance']\n",
      "['example blood which', 'targeted', 'arterioles calcium relaxation']\n",
      "['This', 'decreases', 'systemic  pressure']\n",
      "['which', 'arteriole', 'capillary  circulation']\n",
      "['muscle cells heart muscle which', 'caused', 'cells']\n",
      "['proteins  many', 'composed', 'harmful  mutations']\n",
      "['right  cases', 'type', 'right  ventricle']\n",
      "['associated  arrhythmias', 'characterized', 'free  wall']\n",
      "['currently  ACM', 'thought', 'dysplasia']\n",
      "['513 \\u200a ACM', 'found', 'also  integrity']\n",
      "['30–50  %', 'seen', 'familial  distribution']\n",
      "['Signs', 'have', 'significant  abnormalities']\n",
      "['abnormal heart which', 'rhythms', 'cardiomyopathy  form']\n",
      "['50  %', 'test positive', 'ACM  positive']\n",
      "['mutations', 'showed', 'intercalated point disc']\n",
      "['mutations', 'shown', 'DES gene desmin DES ACM']\n",
      "['Different DES mutations', 'cause', 'abnormal  aggregation']\n",
      "['Apoptosis', 'appears', 'large cell role']\n",
      "['recent  cohorts', 'thought', 'many  cases']\n",
      "['disease process', 'starts', 'region  way']\n",
      "['it', 'late', 'poor  prognosis']\n",
      "['This', 'involves', 'partial  substitution']\n",
      "['Fibro-fatty  infiltration', 'involves', 'fibro-fatty  replacement']\n",
      "['regions', 'include', 'RV inflow tract']\n",
      "['Recently  studies', 'identified strenuous', 'strenuous  exercise']\n",
      "['conclusively  subpopulations', 'demonstrated', 'earlier  onset']\n"
     ]
    }
   ],
   "source": [
    "for enitity_relations in ner_core:\n",
    "    print(enitity_relations)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# for enitity_relations in ner:\n",
    "#     print(enitity_relations)\n",
    "\n",
    "\n",
    "#Add method to remove special characters"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "jnlpba-labels ['CELL_LINE', 'CELL_TYPE', 'DNA', 'PROTEIN', 'RNA']\n",
      "craft-labels ['CHEBI', 'CL', 'GGP', 'GO', 'SO', 'TAXON']\n",
      "bionlp-labels ['AMINO_ACID', 'ANATOMICAL_SYSTEM', 'CANCER', 'CELL', 'CELLULAR_COMPONENT', 'DEVELOPING_ANATOMICAL_STRUCTURE', 'GENE_OR_GENE_PRODUCT', 'IMMATERIAL_ANATOMICAL_ENTITY', 'MULTI_TISSUE_STRUCTURE', 'ORGAN', 'ORGANISM', 'ORGANISM_SUBDIVISION', 'ORGANISM_SUBSTANCE', 'PATHOLOGICAL_FORMATION', 'SIMPLE_CHEMICAL', 'TISSUE']\n",
      "Bc5cdr-labels ['CHEMICAL', 'DISEASE']\n"
     ]
    }
   ],
   "source": [
    "#Ner Models\n",
    "print(\"jnlpba-labels\",nlp_jnlpba.pipe_labels['ner'])\n",
    "print(\"craft-labels\",nlp_craft.pipe_labels['ner'])\n",
    "print(\"bionlp-labels\",nlp_bionlp.pipe_labels['ner'])\n",
    "print(\"Bc5cdr-labels\",nlp_bc5cdr.pipe_labels['ner'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Bc5cdr-labels ['CHEMICAL', 'DISEASE']\n"
     ]
    }
   ],
   "source": [
    "print(\"Bc5cdr-labels\",nlp_bc5cdr.pipe_labels['ner'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Entity-Ruler\n",
    "ruler = nlp_bc5cdr.add_pipe(\"entity_ruler\",after=\"ner\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Bc5cdr-labels ['CHEMICAL', 'DISEASE']\n"
     ]
    }
   ],
   "source": [
    "print(\"Bc5cdr-labels\",nlp_bc5cdr.pipe_labels['ner'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Custom Entities and Labels\n",
    "pattern = [\n",
    "    #CVD\n",
    "    {\"label\":\"CVD\",\"pattern\":\"cardiomyopathies\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"angina\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"arrhythmia\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"dilated cardiomyopathy\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"hypertrophic cardiomyopathy\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"mitral regurgitation\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"mitral valve prolapse\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"pulmonary stenosis\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"aortic stenosis\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"atrial fibrillation\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"peripheral artery disease\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"aneurysm\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"atherosclerosis\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"raynaud’s disease\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"peripheral venous disease\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"ischemic stroke\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"venous blood clots\"},\n",
    "    {\"label\":\"CVD\",\"pattern\":\"buerger’s disease\"},\n",
    "    \n",
    "    #Drug\n",
    "    {\"label\":\"Drug\",\"pattern\":\"statins\"},\n",
    "    {\"label\":\"Drug\",\"pattern\":\"aspirin\"},\n",
    "    {\"label\":\"Drug\",\"pattern\":\"clopidogrel\"},\n",
    "    {\"label\":\"Drug\",\"pattern\":\"warfarin\"},\n",
    "    {\"label\":\"Drug\",\"pattern\":\"beta-blockers\"},\n",
    "    {\"label\":\"Drug\",\"pattern\":\"ace inhibitors\"},\n",
    "    {\"label\":\"Drug\",\"pattern\":\"apixaban\"},\n",
    "    {\"label\":\"Drug\",\"pattern\":\"dabigatran\"},\n",
    "    {\"label\":\"Drug\",\"pattern\":\"edoxaban\"},\n",
    "    {\"label\":\"Drug\",\"pattern\":\"heparin\"},\n",
    "    {\"label\":\"Drug\",\"pattern\":\"rivaroxaban\"},\n",
    "    {\"label\":\"Drug\",\"pattern\":\"dipyridamole\"},\n",
    "    {\"label\":\"Drug\",\"pattern\":\"prasugrel\"},\n",
    "    {\"label\":\"Drug\",\"pattern\":\"ticagrelor\"},\n",
    "    \n",
    "    #Symptoms\n",
    "    {\"label\":\"Symptoms\",\"pattern\":\"chest pain\"},\n",
    "    {\"label\":\"Symptoms\",\"pattern\":\"chest tightness\"},\n",
    "    {\"label\":\"Symptoms\",\"pattern\":\"chest pressure\"},\n",
    "    {\"label\":\"Symptoms\",\"pattern\":\"chest discomfort\"},\n",
    "    {\"label\":\"Symptoms\",\"pattern\":\"shortness of breath\"},\n",
    "    {\"label\":\"Symptoms\",\"pattern\":\"numbness\"},\n",
    "    {\"label\":\"Symptoms\",\"pattern\":\"coldness\"},\n",
    "    {\"label\":\"Symptoms\",\"pattern\":\"neck pain\"},\n",
    "    {\"label\":\"Symptoms\",\"pattern\":\"jaw pain\"},\n",
    "    {\"label\":\"Symptoms\",\"pattern\":\"throat pain\"},\n",
    "    {\"label\":\"Symptoms\",\"pattern\":\"upper abdomen pain\"},\n",
    "    {\"label\":\"Symptoms\",\"pattern\":\"back pain\"},\n",
    "    \n",
    "    #Parts of the human heart\n",
    "    {\"label\":\"Parts of the human heart\",\"pattern\":\"superior vena cava\"},\n",
    "    {\"label\":\"Parts of the human heart\",\"pattern\":\"inferior vena cava\"},\n",
    "    {\"label\":\"Parts of the human heart\",\"pattern\":\"pulmonary vein\"},\n",
    "    {\"label\":\"Parts of the human heart\",\"pattern\":\"right atrium\"},\n",
    "    {\"label\":\"Parts of the human heart\",\"pattern\":\"pulmonary valve\"},\n",
    "    {\"label\":\"Parts of the human heart\",\"pattern\":\"tricuspid valve\"},\n",
    "    {\"label\":\"Parts of the human heart\",\"pattern\":\"right ventricle\"},\n",
    "    {\"label\":\"Parts of the human heart\",\"pattern\":\"aorta\"},\n",
    "    {\"label\":\"Parts of the human heart\",\"pattern\":\"pulmonary artery\"},\n",
    "    {\"label\":\"Parts of the human heart\",\"pattern\":\"left atrium\"},\n",
    "    {\"label\":\"Parts of the human heart\",\"pattern\":\"mitral valve\"},\n",
    "    {\"label\":\"Parts of the human heart\",\"pattern\":\"aortic valve\"},\n",
    "    {\"label\":\"Parts of the human heart\",\"pattern\":\"left ventricle\"},\n",
    "    \n",
    "    #Causes\n",
    "    {\"label\":\"Causes\",\"pattern\":\"family history\"},\n",
    "    {\"label\":\"Causes\",\"pattern\":\"smoking\"},\n",
    "    {\"label\":\"Causes\",\"pattern\":\"poor diet\"},\n",
    "    {\"label\":\"Causes\",\"pattern\":\"high blood pressure\"},\n",
    "    {\"label\":\"Causes\",\"pattern\":\"high blood cholesterol levels\"},\n",
    "    {\"label\":\"Causes\",\"pattern\":\"age\"},\n",
    "    {\"label\":\"Causes\",\"pattern\":\"sex\"},\n",
    "    {\"label\":\"Causes\",\"pattern\":\"stress\"},\n",
    "    {\"label\":\"Causes\",\"pattern\":\"obesity\"},\n",
    "    {\"label\":\"Causes\",\"pattern\":\"physical inactivity\"},\n",
    "    {\"label\":\"Causes\",\"pattern\":\"stress\"},\n",
    "    {\"label\":\"Causes\",\"pattern\":\"poor dental health\"},\n",
    "    \n",
    "    #Complications\n",
    "    {\"label\":\"Complications\",\"pattern\":\"heart failure\"},\n",
    "    {\"label\":\"Complications\",\"pattern\":\"heart attack\"},\n",
    "    {\"label\":\"Complications\",\"pattern\":\"stroke\"},\n",
    "    {\"label\":\"Complications\",\"pattern\":\"aneurysm\"},\n",
    "    {\"label\":\"Complications\",\"pattern\":\"peripheral artery disease\"},\n",
    "    {\"label\":\"Complications\",\"pattern\":\"sudden cardiac arrest\"},\n",
    "\n",
    "    #Prevention\n",
    "    {\"label\":\"Prevention\",\"pattern\":\"healthy weight\"},\n",
    "    {\"label\":\"Prevention\",\"pattern\":\"manage stress\"},\n",
    "    {\"label\":\"Prevention\",\"pattern\":\"hygiene\"},\n",
    "    {\"label\":\"Prevention\",\"pattern\":\"exercise\"},\n",
    "    {\"label\":\"Prevention\",\"pattern\":\"diet\"},\n",
    "    ]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "for i in range(len(pattern)):\n",
    "    s = pattern[i]['pattern']\n",
    "    s_cap = s.upper()\n",
    "    s_fcap = s.capitalize()\n",
    "    pattern.append({\"label\":pattern[i]['label'],\"pattern\":s_cap})\n",
    "    pattern.append({\"label\":pattern[i]['label'],\"pattern\":s_fcap})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "ruler.add_patterns(pattern)\n",
    "\n",
    "doc_ner1 = nlp_bc5cdr(text)\n",
    "doc_ner2 = nlp_jnlpba(text)\n",
    "doc_ner3 = nlp_craft(text)\n",
    "doc_ner4 = nlp_bionlp(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "oxygen\n",
      "carbon dioxide\n",
      "right atrium\n",
      "oxygen\n",
      "right atrium\n",
      "inferior venae cavae\n",
      "right ventricle\n",
      "oxygen\n",
      "carbon dioxide\n",
      "left atrium\n",
      "left ventricle\n",
      "aorta\n",
      "circulation−where\n",
      "oxygen\n",
      "carbon dioxide\n",
      "heart beats\n",
      "Exercise\n",
      "Cardiovascular diseases\n",
      "death\n",
      "deaths\n",
      "coronary artery disease\n",
      "stroke\n",
      "smoking\n",
      "exercise\n",
      "cholesterol\n",
      "high blood pressure\n",
      "diabetes\n",
      "Cardiovascular diseases\n",
      "chest pain\n",
      "shortness of breath\n",
      "heart disease\n",
      "diseases of the heart\n",
      "aorta\n",
      "pulmonary trunk\n",
      "cardiac notch\n",
      "exercise\n",
      "heart muscle\n",
      "right atrium\n",
      "left atrium\n",
      "right atrium\n",
      "right ventricle\n",
      "left atrium\n",
      "left ventricle\n",
      "right atrium\n",
      "right ventricle\n",
      "tricuspid valve\n",
      "tricuspid valve\n",
      "mitral valve\n",
      "left atrium\n",
      "left ventricle\n",
      "pulmonary valve\n",
      "pulmonary artery\n",
      "aortic valve\n",
      "aorta\n",
      "aorta\n",
      "right atrium\n",
      "right ventricle\n",
      "tricuspid valve\n",
      "right atrium\n",
      "veins\n",
      "right atrium\n",
      "inferior vena cava\n",
      "right atrium\n",
      "depression\n",
      "right atrium\n",
      "depression\n",
      "right atrium\n",
      "right ventricle\n",
      "tricuspid valve\n",
      "right ventricle\n",
      "cardiac muscle\n",
      "cardiac muscle\n",
      "right ventricle\n",
      "right ventricle\n",
      "inferior papillary muscle\n",
      "right ventricle\n",
      "pulmonary trunk\n",
      "pulmonary valve\n",
      "pulmonary trunk\n",
      "left atrium\n",
      "left ventricle\n",
      "mitral valve\n",
      "left atrium\n",
      "left atrium\n",
      "right atrium\n",
      "left atrium\n",
      "left atrium\n",
      "left ventricle\n",
      "mitral valve\n",
      "left ventricle\n",
      "right ventricle\n",
      "left ventricle\n",
      "aortic valve\n",
      "aorta\n",
      "aortic valve\n",
      "heart muscle\n",
      "endothelins\n",
      "cardiac muscle—a\n",
      "involuntary striated muscle\n",
      "cardiac muscle\n",
      "cardiac muscle\n",
      "Cardiac muscle\n",
      "muscle contraction\n",
      "myosin\n",
      "tropomyosin\n",
      "LDB3\n",
      "lubricate\n",
      "lubricate\n",
      "infection\n",
      "oxygen\n",
      "heart muscle's relaxation\n",
      "aortic valve\n",
      "aorta\n",
      "left ventricle\n",
      "left ventricle\n",
      "right atrium\n",
      "right ventricle\n",
      "left ventricle\n",
      "right atrium\n",
      "cardiac vein\n",
      "left atrium\n",
      "left ventricle\n",
      "small cardiac veins\n",
      "right ventricle\n",
      "right atrium\n",
      "left ventricle\n",
      "pulmonary artery\n",
      "left atrium\n",
      "right atrium\n",
      "right ventricle\n",
      "aorta\n",
      "norepinephrine\n",
      "noradrenaline\n",
      "sodium\n",
      "calcium\n",
      "Norepinephrine\n",
      "right atrium\n",
      "left atrium\n",
      "depression\n",
      "right atrium\n",
      "165–185\n",
      "carbon dioxide\n",
      "oxygen\n",
      "oxygen\n",
      "carbon dioxide\n",
      "veins\n",
      "left atrium\n",
      "superior vena cava\n",
      "right atrium\n",
      "inferior vena cava drains the blood\n",
      "superior vena cava\n",
      "inferior vena cava\n",
      "right atrium\n",
      "right atrium\n",
      "right atrium\n",
      "tricuspid valve\n",
      "right ventricle\n",
      "right ventricle\n",
      "tricuspid valve\n",
      "pulmonary valve\n",
      "pulmonary trunk\n",
      "carbon dioxide\n",
      "oxygen\n",
      "left atrium\n",
      "left ventricle\n",
      "mitral valve\n",
      "aorta\n",
      "aortic valve\n",
      "aorta\n",
      "oxygen\n",
      "carbon dioxide\n",
      "aorta\n",
      "pulmonary artery\n",
      "mitral and tricuspid valves\n",
      "mitral and tricuspid valves\n",
      "aorta\n",
      "right atrium\n",
      "left atrium\n",
      "aorta\n",
      "mitral and tricuspid valves\n",
      "stroke\n",
      "stroke\n",
      "stroke\n",
      "4.0–8.0\n",
      "stroke\n",
      "sex\n",
      "stenosis\n",
      "heart muscle\n",
      "stroke\n",
      "adrenaline\n",
      "noradrenaline\n",
      "dopamine\n",
      "calcium\n",
      "right atrium\n",
      "superior vena cava\n",
      "right atrium\n",
      "left atrium\n",
      "right atrium\n",
      "right atrium\n",
      "left ventricle\n",
      "heart muscle\n",
      "right atrium\n",
      "sodium\n",
      "sodium\n",
      "calcium\n",
      "potassium\n",
      "potassium\n",
      "calcium\n",
      "calcium\n",
      "potassium\n",
      "potassium\n",
      "potassium\n",
      "sodium\n",
      "potassium\n",
      "Calcium\n",
      "Calcium\n",
      "cardiac muscle\n",
      "exercise\n",
      "oxygen\n",
      "carbon dioxide\n",
      "aorta\n",
      "carbon dioxide\n",
      "oxygen\n",
      "carbon dioxide\n",
      "Exercise\n",
      "age\n",
      "epinephrine\n",
      "norepinephrine\n",
      "calcium\n",
      "potassium\n",
      "sodium\n",
      "oxygen\n",
      "dehydration\n",
      "Diseases Cardiovascular diseases\n",
      "diseases of the heart\n",
      "death\n",
      "cardiovascular disease\n",
      "Heart disease\n",
      "death\n",
      "deaths\n",
      "diseases of the heart\n",
      "Ischaemic heart disease Coronary artery disease\n",
      "ischaemic heart disease\n",
      "atherosclerosis\n",
      "fatty deposits\n",
      "atherosclerotic\n",
      "stenosis\n",
      "narrowings\n",
      "chest pain\n",
      "angina\n",
      "breathlessness\n",
      "exercise\n",
      "atherosclerotic\n",
      "thrombus\n",
      "heart muscle\n",
      "myocardial infarction\n",
      "heart attack\n",
      "unstable angina\n",
      "cardiac arrest\n",
      "Obesity\n",
      "high blood pressure\n",
      "diabetes\n",
      "smoking\n",
      "cholesterol\n",
      "atherosclerosis\n",
      "coronary artery disease\n",
      "Heart failure Heart failure\n",
      "heart failure\n",
      "breathlessness\n",
      "ankle swelling\n",
      "peripheral oedema\n",
      "Heart failure\n",
      "diseases affecting the heart\n",
      "ischaemic heart disease\n",
      "valvular heart disease\n",
      "high blood pressure\n",
      "cardiomyopathies\n",
      "Heart failure\n",
      "weakness of the heart muscle\n",
      "systolic heart failure\n",
      "heart muscle\n",
      "heart failure\n",
      "left ventricle\n",
      "predominantly breathlessness\n",
      "right ventricle\n",
      "heart failure\n",
      "arrhythmias\n",
      "Cardiomyopathies Cardiomyopathies\n",
      "abnormal thickening of the heart muscle\n",
      "hypertrophic cardiomyopathy\n",
      "dilated cardiomyopathy\n",
      "heart muscle\n",
      "cardiomyopathy\n",
      "arrhythmogenic cardiomyopathy\n",
      "dilated cardiomyopathy\n",
      "alcohol\n",
      "cardiomyopathies\n",
      "hypertrophic cardiomopathy\n",
      "cardiac death\n",
      "cardiomyopathies\n",
      "heart failure\n",
      "Valvular heart disease\n",
      "Diseased\n",
      "valvular regurgitation\n",
      "Valvular heart disease\n",
      "breathlessness\n",
      "chest pain\n",
      "valvular heart disease\n",
      "age\n",
      "infection of the heart valves\n",
      "endocarditis\n",
      "heart disease\n",
      "valvular heart disease\n",
      "stenosis\n",
      "throat infection\n",
      "Cardiac arrhythmias\n",
      "arrhythmias\n",
      "palpitations\n",
      "breathlessness\n",
      "arrhythmia\n",
      "atrial fibrillation\n",
      "stroke\n",
      "arrhythmias\n",
      "bradycardia\n",
      "bradyarrhythmia\n",
      "arrhythmias\n",
      "tachycardia\n",
      "tachyarrhythmia\n",
      "arrhythmias\n",
      "atrial flutter\n",
      "re-entrant tachycardia\n",
      "ventricular tachycardia\n",
      "tachyarrhythmias\n",
      "ventricular tachycardia\n",
      "atrial tachycardia\n",
      "Wolff-Parkinson-White syndrome\n",
      "ventricular fibrillation\n",
      "Pericardial disease\n",
      "pericarditis\n",
      "chest pain\n",
      "viral infection\n",
      "glandular fever\n",
      "pericardial effusion\n",
      "Pericardial effusions\n",
      "pericarditis\n",
      "kidney failure\n",
      "tumours\n",
      "cardiac tamponade\n",
      "breathlessness\n",
      "tamponade\n",
      "pericardiocentesis\n",
      "Congenital heart disease\n",
      "congenital heart defects\n",
      "patent foramen ovale\n",
      "life-threatening abnormalities\n",
      "hypoplastic left heart syndrome\n",
      "ventricular septal defect\n",
      "congenital aortic stenosis\n",
      "coarctation of the aorta\n",
      "congenital heart defects\n",
      "oxygen\n",
      "cyanotic congenital heart defects\n",
      "congenital heart defects\n",
      "breathlessness\n",
      "congenital heart disease\n",
      "atrial septal defect\n",
      "Heart disease\n",
      "valvular or cardiac problems\n",
      "quadruple\n",
      "Heart murmurs\n",
      "congenital heart disease\n",
      "ventricular septal defects\n",
      "pericarditis\n",
      "rub\n",
      "Troponin\n",
      "troponin\n",
      "heart failure\n",
      "left ventricle\n",
      "cardiac disease\n",
      "creatine\n",
      "heart disease\n",
      "anaemia\n",
      "cholesterol\n",
      "diabetes\n",
      "ground).There\n",
      "rhythm disturbances\n",
      "rhythm abnormality\n",
      "valve disease\n",
      "stenosis\n",
      "blood (regurgitation\n",
      "stroke\n",
      "stress\n",
      "exercise\n",
      "dobutamine\n",
      "pulmonary oedema\n",
      "aorta\n",
      "Diseases affecting the heart\n",
      "Ischaemic heart disease Narrowings of the coronary arteries (ischaemic heart disease\n",
      "chest pain\n",
      "artery (angina pectoris\n",
      "heart muscle damage\n",
      "myocardial infarction\n",
      "myocardial infarction\n",
      "angina\n",
      "nitroglycerin\n",
      "calcium\n",
      "antiplatelets\n",
      "aspirin\n",
      "statins\n",
      "smoking\n",
      "weight loss\n",
      "high blood pressure\n",
      "diabetes\n",
      "narrowings\n",
      "narrowings\n",
      "narrowings\n",
      "aorta\n",
      "Valvular heart disease Diseased heart valves\n",
      "aortic valve\n",
      "Cardiac arrhythmias\n",
      "arrhythmias\n",
      "calcium\n",
      "sodium\n",
      "amiodarone\n",
      "digoxin\n",
      "atropine\n",
      "arrhythmias\n",
      "atrial fibrillation\n",
      "stroke\n",
      "warfarin\n",
      "arrhythmia\n",
      "arrhythmia\n",
      "arrhythmias\n",
      "arrhythmias\n",
      "atrial fibrillation\n",
      "shock\n",
      "arrhythmias\n",
      "shock\n",
      "heart failure\n",
      "cardiomyopathies\n",
      "arrhythmia\n",
      "Heart failure\n",
      "heart failure\n",
      "ischaemic heart disease\n",
      "hypertension\n",
      "heart failure\n",
      "ACE inhibitors and mineralocorticoid receptor antagonists).In\n",
      "heart failure\n",
      "heart failure\n",
      "Galen\n",
      "Galen believed the arterial blood\n",
      "left ventricle\n",
      "pulmonary artery\n",
      "left ventricle\n",
      "Galen\n",
      "Galen\n",
      "Galen's beliefs of the heart\n",
      "De humani corporis\n",
      "magnum\n",
      "attacks\n",
      "Otto\n",
      "1865–1944\n",
      "Tawara's discovery of the atrioventricular\n",
      "heart disease\n",
      "infectious disease\n",
      "death\n",
      "deaths\n",
      "diet\n",
      "exercise\n",
      "aspirin\n",
      "ACE inhibitors\n",
      "chronic heart failure\n",
      "death\n",
      "xīn\n",
      "神\n",
      "Hrd\n",
      "Galen\n",
      "heart-soul (tona-tiuh):\n",
      "pulsating\"\".In\n",
      "beef, pork,\n",
      "grilled or braised\n",
      "anticuchos de corazón, barbecued beef\n",
      "spice\n",
      "braised stuffed beef heart\n",
      "heart is stewed,\n",
      "braised\n",
      "right atrium\n",
      "pulmonary artery\n",
      "aorta\n",
      "conus arteriosus\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "conus arteriosus\n",
      "right atrium\n",
      "oxygen\n",
      "oxygen\n",
      "Oxygen\n",
      "small muscular\n",
      "aorta\n",
      "Nicki R. Colledge\n",
      "129–134\n",
      "cardiac muscle alpha\n",
      "muscle contraction\n",
      "alpha-actinin\n",
      "amino acids (Asp4Glu, Glu5Asp\n",
      "Leu301Met\n",
      "amino\n",
      "Myosin\n",
      "myosin\n",
      "amino acid\n",
      "Dilated Cardiomyopathy\n",
      "E101K\n",
      "Hypertrophic Cardiomyopathy\n",
      "Left Ventricular Noncompaction\n",
      "atrial septal defects\n",
      "COPaKB\n",
      "Hypertrophic Cardiomyopathy\n",
      "\\displaystyle {\\dot {u}}=0}    (\n",
      "de-inactivate\n",
      "potassium\n",
      "potassium\n",
      "K+\n",
      "potassium\n",
      "potassium\n",
      "tachycardia\n",
      "cardiac arrhythmias\n",
      "atrial fibrillation\n",
      "sodium\n",
      "sodium ions\n",
      "sodium\n",
      "potassium\n",
      "sodium\n",
      "potassium\n",
      "potassium\n",
      "potassium\n",
      "sodium\n",
      "potassium\n",
      "sodium\n",
      "sodium\n",
      "sodium\n",
      "potassium\n",
      "sodium\n",
      "potassium\n",
      "heart beats\n",
      "acetylcholine\n",
      "noradrenaline\n",
      "AV-nodal reentrant tachycardia\n",
      "AVNRT\n",
      "abnormal fast heart rhythm\n",
      "supraventricular tachycardia\n",
      "AV nodal reentrant tachycardia\n",
      "supraventricular tachycardia\n",
      "palpitations\n",
      "AVNRT\n",
      "right atrium\n",
      "Wolff-Parkinson-White syndrome\n",
      "WPW syndrome\n",
      "atrioventricular reciprocating tachycardia\n",
      "AVRT\n",
      "AVNRT\n",
      "right atrium\n",
      "WPW syndrome\n",
      "AVRT\n",
      "AVNRT\n",
      "palpitations\n",
      "palpitations\n",
      "tricuspid valve\n",
      "anxiety\n",
      "panic attacks\n",
      "dizziness\n",
      "coronary artery disease\n",
      "atherosclerosis\n",
      "chest pain\n",
      "angina\n",
      "pain\n",
      "pressure-like\n",
      "palpitations\n",
      "palpitations\n",
      "arrhythmia\n",
      "AVNRT\n",
      "140\n",
      "right atrium\n",
      "tricuspid valve\n",
      "AVNRT\n",
      "AVNRT\n",
      "AVNRT\n",
      "AVNRT\n",
      "AVNRT\n",
      "AVNRT\n",
      "atypical AVNRT\n",
      "heart block\n",
      "palpitations\n",
      "palpitations\n",
      "AVNRT\n",
      "abnormal fast heart rhythms\n",
      "atrial fibrillation\n",
      "atrial flutter\n",
      "sinus tachycardia\n",
      "ventricular tachycardia\n",
      "tachyarrhythmias\n",
      "Wolff-Parkinson-White syndrome\n",
      "palpitations\n",
      "AVNRT\n",
      "potassium\n",
      "calcium\n",
      "magnesium\n",
      "AVNRT\n",
      "myocardial infarction\n",
      "heart attack\n",
      "AVNRT\n",
      "chest pain\n",
      "AVNRT\n",
      "tachycardia\n",
      "Arrhythmia\n",
      "supraventricular tachycardia\n",
      "AVNRT\n",
      "AVNRT\n",
      "AVNRT\n",
      "adenosine\n",
      "non-dihydropyridine calcium\n",
      "verapamil\n",
      "diltiazem\n",
      "adenosine\n",
      "flecainide\n",
      "amiodarone\n",
      "heart failure\n",
      "coma\n",
      "AVNRT\n",
      "shock\n",
      "Arrhythmia\n",
      "AVNRT\n",
      "arrhythmia\n",
      "calcium\n",
      "flecainide\n",
      "amiodarone\n",
      "digoxin\n",
      "EP\n",
      "AVNRT\n",
      "AVNRT\n",
      "ACE inhibitors\n",
      "high blood pressure\n",
      "heart failure\n",
      "decrease in blood volume\n",
      "oxygen\n",
      "angiotensin\n",
      "angiotensin I to\n",
      "angiotensin II\n",
      "bradykinin\n",
      "ACE inhibitors decrease the formation\n",
      "angiotensin II\n",
      "bradykinin\n",
      "bradykinin\n",
      "bradykinin\n",
      "angioedema\n",
      "cough\n",
      "Bradykinin\n",
      "prostaglandin\n",
      "benazepril\n",
      "zofenopril\n",
      "perindopril\n",
      "trandolapril\n",
      "captopril\n",
      "enalapril\n",
      "lisinopril\n",
      "ramipril\n",
      "hypertension\n",
      "cardiovascular and kidney diseases\n",
      "myocardial infarction\n",
      "heart attack\n",
      "Heart failure\n",
      "diabetes mellitus\n",
      "diabetic nephropathy\n",
      "high blood pressure\n",
      "ACE inhibitors\n",
      "diabetes\n",
      "age\n",
      "ACE inhibitor\n",
      "thiazide\n",
      "ACE inhibitors\n",
      "chronic kidney failure\n",
      "systemic sclerosis\n",
      "renal crisis\n",
      "coronary artery disease\n",
      "heart failure\n",
      "ACE inhibitors\n",
      "pneumonia\n",
      "Angiotensin II\n",
      "stroke\n",
      "heart failure\n",
      "pneumonia\n",
      "ACE inhibitors\n",
      "schizophrenia\n",
      "psychogenic polydipsia\n",
      "enalapril\n",
      "ACE inhibitors\n",
      "ACEi\n",
      "erythrocytosis\n",
      "ACEi\n",
      "cough\n",
      "hyperkalemia\n",
      "headache\n",
      "dizziness\n",
      "fatigue\n",
      "nausea\n",
      "kidney impairment\n",
      "ACE inhibitors\n",
      "reduction in glomerular filtration\n",
      "renal artery stenosis\n",
      "heart failure\n",
      "polycystic kidney disease\n",
      "ACE inhibitor\n",
      "reduction in renal function\n",
      "creatinine\n",
      "renal failure\n",
      "potassium\n",
      "aldosterone\n",
      "angiotensin II\n",
      "aldosterone\n",
      "aldosterone\n",
      "potassium\n",
      "ACE inhibitors\n",
      "potassium\n",
      "potassium\n",
      "Hyperkalemia\n",
      "cardiac dysfunction\n",
      "muscle weakness\n",
      "paresthesia\n",
      "nausea\n",
      "diarrhea\n",
      "potassium\n",
      "ACE inhibitors\n",
      "hyperkalemia\n",
      "ACE inhibitors\n",
      "RAAS\n",
      "bradykinin\n",
      "dry cough\n",
      "bradykinin\n",
      "ACE inhibitors\n",
      "bradykinin\n",
      "cough\n",
      "ACE inhibitors\n",
      "cough\n",
      "angiotensin II\n",
      "angioedema\n",
      "bradykinin\n",
      "allergic reaction\n",
      "abdominal pain\n",
      "neutropenia\n",
      "agranulocytosis\n",
      "blood dyscrasias\n",
      "ACE inhibitors\n",
      "ACE inhibitors\n",
      "congenital malformations\n",
      "stillbirths\n",
      "deaths\n",
      "hypotension\n",
      "renal dysplasia\n",
      "anuria/oliguria\n",
      "oligohydramnios\n",
      "intrauterine growth retardation\n",
      "pulmonary hypoplasia\n",
      "patent ductus arteriosus\n",
      "ACE inhibitors\n",
      "birth defects\n",
      "ACE inhibitors\n",
      "ACE inhibitors\n",
      "birth defects\n",
      "congenital malformations\n",
      "Overdose\n",
      "ACE inhibitor overdose\n",
      "hypotension\n",
      "hyperkalemia\n",
      "hyponatremia\n",
      "renal impairment\n",
      "metabolic acidosis\n",
      "hypotension\n",
      "charcoal\n",
      "Captopril\n",
      "enalapril\n",
      "lisinopril\n",
      "perindopril\n",
      "ACE inhibitors\n",
      "angioedema\n",
      "ACE inhibitor therapy Bilateral\n",
      "renal artery stenosis Hypersensitivity\n",
      "ACE inhibitorsACE inhibitors\n",
      "Impaired renal function Aortic valve stenosis\n",
      "cardiac outflow obstruction Hypovolemia\n",
      "dehydration\n",
      "acute renal failure\n",
      "hypotension\n",
      "hyperkalemia\n",
      "RAAS\n",
      "potassium-sparing\n",
      "cyclosporine\n",
      "potassium\n",
      "Potassium\n",
      "hyperkalemic\n",
      "ACE inhibitors\n",
      "hypotensive\n",
      "ACE inhibitors\n",
      "angiotensin\n",
      "aldosterone\n",
      "hypertension\n",
      "diabetes mellitus\n",
      "insulin-resistance syndrome\n",
      "renal disease\n",
      "angiotensin\n",
      "aldosterone\n",
      "angiotensin\n",
      "aldosterone\n",
      "hypotension\n",
      "low distal tubule\n",
      "sodium\n",
      "amino acid\n",
      "angiotensin I. ACE\n",
      "angiotensin\n",
      "angiotensin\n",
      "angiotensin II\n",
      "salt\n",
      "angiotensin\n",
      "ACE inhibitors block\n",
      "angiotensin I (ATI)\n",
      "angiotensin II\n",
      "stroke\n",
      "sodium\n",
      "aldosterone\n",
      "Bradykinin\n",
      "angiotensin II\n",
      "muscle hypertrophy\n",
      "hypertension\n",
      "ventricular remodeling\n",
      "ventricular hypertrophy\n",
      "fibrogenesis\n",
      "programmed cell death\n",
      "aldosterone\n",
      "sodium\n",
      "chloride ions\n",
      "potassium\n",
      "Sodium\n",
      "vasopressin\n",
      "heart failure\n",
      "hyponatremia\n",
      "death\n",
      "heart failure\n",
      "aldosterone\n",
      "sodium ions\n",
      "potassium\n",
      "ACE inhibitors\n",
      "diabetic nephropathy\n",
      "ACE inhibitors\n",
      "diabetic renal failure\n",
      "ACE inhibitors\n",
      "hypertension\n",
      "ACE inhibitors\n",
      "diabetic nephropathy\n",
      "congestive heart failure\n",
      "cardiovascular events\n",
      "ACE inhibitors\n",
      "dizziness\n",
      "fainting\n",
      "ACE inhibitors\n",
      "parasympathetic nervous\n",
      "heart failure\n",
      "malignant cardiac arrhythmias\n",
      "norepinephrine\n",
      "heart failure\n",
      "angiotensin\n",
      "congestive heart failure\n",
      "ACE inhibitor enalapril\n",
      "cardiac cachexia\n",
      "chronic heart failure\n",
      "Cachexia\n",
      "chronic heart failure\n",
      "ACE inhibitors\n",
      "muscle wasting\n",
      "sarcopenia\n",
      "heart failure\n",
      "ACE inhibitors\n",
      "-pril\n",
      "ACE inhibitors\n",
      "sulfhydryl\n",
      "Alacepril Captopril\n",
      "Capoten\n",
      "Dicarboxylate-containing agents\n",
      "Enalapril\n",
      "Ramipril\n",
      "Altace/Prilace/Ramace/Ramiwin/Triatec/Tritace/Ramitac\n",
      "Quinapril\n",
      "Accupril\n",
      "Perindopril\n",
      "Coversyl/Aceon/Perindo\n",
      "Lisinopril\n",
      "Listril/Lopril/Novatec/Prinivil/Zestril\n",
      "Benazepril\n",
      "Lotensin\n",
      "Imidapril\n",
      "Trandolapril\n",
      "Cilazapril\n",
      "Inhibace\n",
      "Fosinopril\n",
      "Fositen/Monopril\n",
      "Arfalasin\n",
      "HOE 409\n",
      "angiotensin\n",
      "Casokinins\n",
      "lactokinins\n",
      "lactotripeptides\n",
      "Lactobacillus helveticus\n",
      "L. helveticus PR4\n",
      "ACE inhibitors\n",
      "captopril\n",
      "Captopril\n",
      "ramipril\n",
      "Altace\n",
      "myocardial infarction\n",
      "heart failure\n",
      "ramipril\n",
      "hypertension\n",
      "ramipril\n",
      "ramipril\n",
      "ACE inhibitors\n",
      "hypertension\n",
      "158,998\n",
      "hypertensive\n",
      "ACE inhibitors\n",
      "angiotensin receptor blocker\n",
      "ARB\n",
      "ACE inhibitors\n",
      "ARB\n",
      "ACE inhibitors\n",
      "perindopril-based\n",
      "hypertensive\n",
      "ACE inhibitors\n",
      "perindopril\n",
      "hypertension\n",
      "ACE inhibitors\n",
      "Angiotensin II\n",
      "ACE inhibitors\n",
      "angiotensin II\n",
      "ACE inhibitors\n",
      "ACE inhibitors\n",
      "angiotensin II\n",
      "angiotensin II\n",
      "angiotensin II\n",
      "angiotensin II\n",
      "ACE inhibitors\n",
      "bradykinin\n",
      "angiotensin II\n",
      "angiotensin II\n",
      "hypertension\n",
      "chronic heart failure\n",
      "nephropathy\n",
      "hypertension\n",
      "ACE inhibitors\n",
      "heart failure\n",
      "ventricular remodeling\n",
      "nephropathy\n",
      "proteinuria\n",
      "diabetic nephropathy\n",
      "IgA nephropathy\n",
      "Sérgio\n",
      "Bothrops jararaca\n",
      "angiotensin\n",
      "angiotensin II\n",
      "K. F. Ng\n",
      "angiotensin I\n",
      "angiotensin II\n",
      "Bradykinin\n",
      "Angiotensin I also disappears in the pulmonary circulation because of its\n",
      "angiotensin II\n",
      "angiotensin II\n",
      "bradykinin\n",
      "angiotensin I\n",
      "angiotensin II\n",
      "Ng\n",
      "bradykinin\n",
      "BPF\n",
      "hypotensive\n",
      "Teprotide\n",
      "captopril\n",
      "ACE inhibitor\n",
      "1975.Captopril\n",
      "ACE inhibitor\n",
      "enalapril\n",
      "ACE inhibitors\n",
      "ACE inhibitor\n",
      "milk\n",
      "tripeptide isoleucine-proline-proline\n",
      "Valine-proline-proline\n",
      "VPP\n",
      "lactotripeptides\n",
      "VPP\n",
      "VPP\n",
      "lactotripeptides\n",
      "Angiotensin II receptor blocker\n",
      "angiotensin\n",
      "Loop diuretic\n",
      "CHF\n",
      "K\n",
      "Gautam A\n",
      "doi:10.1093/nar/gku1141\n",
      "three-year-old\n",
      "mitral valve\n",
      "oxygen\n",
      "coronary artery disease\n",
      "stress\n",
      "liver disease\n",
      "stroke\n",
      "brain death\n",
      "shock\n",
      "cardiac death\n",
      "brain death\n",
      "PG\n",
      "°\n",
      "tricuspid atresia\n",
      "Ebstein's anomaly\n",
      "hypothermia\n",
      "°\n",
      "shock\n",
      "Faltine\n",
      "Faltine\n",
      "Faltine\n",
      "Faltine\n",
      "aorta\n",
      "helium\n",
      "heart attack\n",
      "heart attack\n",
      "shock\n",
      "death\n",
      "heart failure\n",
      "death\n",
      "age\n",
      "heart failure\n",
      "Adrenaline\n",
      "epinephrine\n",
      "Adrenaline\n",
      "adrenaline\n",
      "anaphylaxis\n",
      "cardiac arrest\n",
      "bleeding\n",
      "adrenaline\n",
      "croup\n",
      "shakiness\n",
      "anxiety\n",
      "high blood pressure\n",
      "adrenaline\n",
      "adrenaline\n",
      "catecholamines\n",
      "L-DOPA\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "α1\n",
      "adrenaline\n",
      "noradrenaline\n",
      "adrenaline\n",
      "Adrenaline\n",
      "hypoglycemia\n",
      "exercise\n",
      "Exercise\n",
      "adrenaline\n",
      "exercise\n",
      "catecholamines\n",
      "catecholamine\n",
      "adrenaline\n",
      "enzyme-isotope\n",
      "adrenaline\n",
      "adrenaline\n",
      "catecholamines\n",
      "exercise\n",
      "exercise\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "exercise\n",
      "adrenaline\n",
      "adrenaline\n",
      "airway hyper-reactivity\n",
      "histamine\n",
      "adrenaline\n",
      "asthma\n",
      "airway hyper-reactivity\n",
      "Exercise\n",
      "beta blockade\n",
      "exercise\n",
      "propranolol\n",
      "exercise\n",
      "exercise\n",
      "exercise\n",
      "adrenaline\n",
      "stress\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "stress\n",
      "Adrenaline\n",
      "post-traumatic stress disorder\n",
      "epinephrine\n",
      "adrenaline\n",
      "Adrenaline\n",
      "sotalol\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "pheochromocytoma\n",
      "hypoglycemia\n",
      "myocardial infarction\n",
      "tremor\n",
      "idiopathic tremor\n",
      "adrenaline\n",
      "hypoxia\n",
      "hypoglycaemia\n",
      "adrenaline\n",
      "noradrenaline\n",
      "Myocardial infarction\n",
      "adrenaline\n",
      "noradrenaline\n",
      "cardiogenic shock\n",
      "β2-stimulation\n",
      "tremor\n",
      "adrenaline\n",
      "noradrenaline\n",
      "adrenaline\n",
      "autonomic neuropathy\n",
      "Addison's disease\n",
      "adrenaline\n",
      "cortisol\n",
      "adrenaline\n",
      "epinephrine\n",
      "epinephrine\n",
      "adrenaline\n",
      "INN\n",
      "adrenaline\n",
      "adrenaline\n",
      "epinephrine\n",
      "adrenaline\n",
      "adrenaline\n",
      "Adrenaline\n",
      "α1\n",
      "Adrenaline\n",
      "glycolysis\n",
      "glycogenesis\n",
      "glucagon\n",
      "glucose\n",
      "fatty acids\n",
      "Adrenaline\n",
      "glucose\n",
      "Adrenaline\n",
      "GTP\n",
      "Gs alpha and Gs beta/gamma subunits.\n",
      "adenosine\n",
      "adenosine\n",
      "AMP\n",
      "AMP\n",
      "Adrenaline\n",
      "α1\n",
      "inositol trisphosphate\n",
      "calcium\n",
      "Calcium\n",
      "glucose\n",
      "Adrenaline\n",
      "oxygen\n",
      "adrenaline\n",
      "CO2\n",
      "ETCO2\n",
      "adrenaline\n",
      "Adrenaline\n",
      "poisoning\n",
      "adrenaline\n",
      "exercise\n",
      "stress\n",
      "Pheochromocytoma\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "monoamines\n",
      "catecholamines\n",
      "Adrenaline\n",
      "amino acids phenylalanine\n",
      "tyrosine\n",
      "adrenaline\n",
      "Tyrosine\n",
      "L-DOPA\n",
      "tyrosine\n",
      "dopamine\n",
      "DOPA\n",
      "aromatic L-amino acid\n",
      "Dopamine\n",
      "noradrenaline\n",
      "dopamine\n",
      "ascorbic acid\n",
      "vitamin C\n",
      "adrenaline\n",
      "amine\n",
      "noradrenaline\n",
      "S-adenosyl methionine\n",
      "SAMe\n",
      "adrenaline\n",
      "adrenaline\n",
      "tyrosine\n",
      "dopamine\n",
      "catecholamine\n",
      "cortisol\n",
      "adrenaline\n",
      "stress\n",
      "adrenaline\n",
      "Acetylcholine\n",
      "acetylcholine\n",
      "calcium\n",
      "calcium\n",
      "Calcium\n",
      "adrenaline\n",
      "noradrenaline\n",
      "noradrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "catecholamines\n",
      "adrenaline\n",
      "adrenaline\n",
      "pheochromocytoma\n",
      "tumors\n",
      "nadnerczyna\n",
      "adrenaline\n",
      "catecholamines\n",
      "adrenaline\n",
      "epinephrine\n",
      "cardiac arrests\n",
      "allergic reactions\n",
      "adrenaline\n",
      "Adrenaline\n",
      "adrenaline\n",
      "epinephrine\n",
      "epinephrine\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "epinephrine\n",
      "adrenaline\n",
      "adrenaline\n",
      "Adrenaline\n",
      "adrenaline\n",
      "sensation-seeking behavior\n",
      "substance abuse\n",
      "sex\n",
      "adrenaline\n",
      "stress\n",
      "adrenaline\n",
      "stress\n",
      "adrenaline\n",
      "adrenaline\n",
      "adrenaline\n",
      "Adrenaline\n",
      "Epinephrine\n",
      "sodium ions\n",
      "sodium\n",
      "sodium\n",
      "sodium ions\n",
      "Potassium\n",
      "potassium\n",
      "sodium\n",
      "calcium\n",
      "calcium-based\n",
      "calcium\n",
      "sodium\n",
      "sodium\n",
      "calcium\n",
      "ions\n",
      "sodium\n",
      "calcium\n",
      "sodium\n",
      "sodium\n",
      "sodium ions\n",
      "sodium\n",
      "sodium\n",
      "potassium\n",
      "potassium\n",
      "sodium\n",
      "sodium\n",
      "potassium\n",
      "potassium\n",
      "potassium\n",
      "sodium\n",
      "sodium\n",
      "sodium\n",
      "sodium\n",
      "ions\n",
      "sodium\n",
      "potassium\n",
      "sodium ions\n",
      "potassium\n",
      "sodium\n",
      "potassium\n",
      "Calcium\n",
      "depression\n",
      "calcium\n",
      "sodium\n",
      "calcium\n",
      "sodium\n",
      "calcium\n",
      "sodium\n",
      "potassium\n",
      "sodium\n",
      "potassium\n",
      "sodium\n",
      "potassium\n",
      "sodium\n",
      "sodium\n",
      "peripheral nervous system)\n",
      "sodium\n",
      "sodium\n",
      "sodium\n",
      "cations\n",
      "sodium\n",
      "chloride ions\n",
      "potassium\n",
      "K+\n",
      "K+\n",
      "ions\n",
      "potassium\n",
      "potassium\n",
      "EK ≈ –75\n",
      "sodium\n",
      "potassium\n",
      "potassium\n",
      "sodium\n",
      "sodium\n",
      "potassium\n",
      "sodium\n",
      "sodium\n",
      "sodium\n",
      "sodium\n",
      "sodium\n",
      "sodium\n",
      "−30\n",
      "sodium\n",
      "sodium\n",
      "sodium\n",
      "sodium\n",
      "sodium\n",
      "sodium\n",
      "potassium\n",
      "potassium\n",
      "potassium\n",
      "sodium\n",
      "potassium\n",
      "potassium\n",
      "potassium\n",
      "calcium\n",
      "potassium\n",
      "potassium\n",
      "potassium\n",
      "sodium\n",
      "potassium\n",
      "sodium\n",
      "sodium\n",
      "potassium\n",
      "potassium\n",
      "sodium\n",
      "potassium\n",
      "potassium\n",
      "sodium\n",
      "sodium\n",
      "peripheral nervous system\n",
      "human nervous system\n",
      "diseases degrade myelin and impair saltatory conduction\n",
      "multiple sclerosis\n",
      "\\displaystyle \\tau {\\frac {\\partial V}{\\partial t}}=\\lambda ^{2}{\\frac {\\partial ^{2}V}{\\partial x^{2}}}-V}   where V(x, t\n",
      "calcium\n",
      "calcium\n",
      "tetanus\n",
      "botulism\n",
      "acetylcholine\n",
      "acetylcholine\n",
      "acetylcholine\n",
      "sarin\n",
      "tabun\n",
      "diazinon\n",
      "potassium\n",
      "calcium\n",
      "sodium\n",
      "anomalies\n",
      "congenital mutation or injury—\n",
      "arrhythmias\n",
      "quinidine\n",
      "lidocaine\n",
      "verapamil\n",
      "sodium\n",
      "potassium\n",
      "calcium\n",
      "tropomyosin\n",
      "sodium\n",
      "calcium\n",
      "calcium\n",
      "chloride ions\n",
      "potassium\n",
      "calcium\n",
      "chloride ions\n",
      "diet\n",
      "Calcium\n",
      "calcium\n",
      "Calcium\n",
      "potassium\n",
      "salt\n",
      "KCl\n",
      "sodium\n",
      "potassium\n",
      "after-hyperpolarization\n",
      "calcium\n",
      "potassium\n",
      "potassium\n",
      "ATP\n",
      "hydrogen\n",
      "cross-purposed\n",
      "biofilm\n",
      "fine\n",
      "Ca2\n",
      "Sakmann\n",
      "Tetrodotoxin\n",
      "saxitoxin\n",
      "sodium\n",
      "dendrotoxin\n",
      "potassium\n",
      "permethrin\n",
      "sodium\n",
      "ions\n",
      "sodium\n",
      "sodium\n",
      "potassium\n",
      "Sakmann\n",
      "David E. Goldman to the eponymous\n",
      "sodium\n",
      "potassium\n",
      "X-ray crystallography\n",
      "neuronal and cardiac action potentials at SourceForge.net\n",
      "muscle contraction\n",
      "actins\n",
      "tropomyosin\n",
      "cancer\n",
      "nucleotide\n",
      "illnesses and diseases\n",
      "infection\n",
      "muscular diseases\n",
      "deafness\n",
      "myosin\n",
      "myosin\n",
      "ATP\n",
      "myosin\n",
      "myosin\n",
      "myosin\n",
      "ATP\n",
      "nucleotide\n",
      "ADP\n",
      "phosphate\n",
      "amino acid\n",
      "G-actin\n",
      "ADP\n",
      "G-actin\n",
      "rhodamine\n",
      "amino acid\n",
      "amino acid\n",
      "ATP\n",
      "ATP\n",
      "Myosin\n",
      "calcium\n",
      "stress\n",
      "MreB\n",
      "Ta0583\n",
      "G-actin\n",
      "adenosine\n",
      "ATP\n",
      "adenosine\n",
      "ADP\n",
      "Mg2\n",
      "ATP-G-Actin\n",
      "G-actin\n",
      "X-ray crystallography\n",
      "ATP\n",
      "Mg2\n",
      "ADP\n",
      "phosphate\n",
      "triphosphate\n",
      "G-actin\n",
      "ADP\n",
      "ATP\n",
      "ATP\n",
      "41,785 Da\n",
      "structureElzinga\n",
      "amino acid\n",
      "aspartate\n",
      "amino\n",
      "phenylalanine\n",
      "cysteine\n",
      "Nτ-methylhistidine\n",
      "structuresThe\n",
      "β-α-β\n",
      "adenosine\n",
      "adenosine\n",
      "Mg2\n",
      "nucleotide\n",
      "calcium\n",
      "amino acids Asp11\n",
      "nucleotide\n",
      "divalent\n",
      "D-loop\n",
      "nucleotide\n",
      "°\n",
      "Å\n",
      "Å\n",
      "Å\n",
      "Å\n",
      "hydrophobic\n",
      "MreB.The\n",
      "ATP\n",
      "myosin\n",
      "tannic acid\n",
      "myosin\n",
      "myosin\n",
      "myosin\n",
      "myosin II\n",
      "G-actin\n",
      "ATP\n",
      "ATP\n",
      "tropomyosin\n",
      "tropomyosin\n",
      "actin-myosin\n",
      "muscular contraction\n",
      "tropomyosin\n",
      "troponins\n",
      "troponin\n",
      "chaperonins\n",
      "GroEL\n",
      "tubulin\n",
      "tubulin\n",
      "tubulin\n",
      "PFD4\n",
      "170–198\n",
      "chaperonin\n",
      "ATP\n",
      "AMP-PNP\n",
      "chaperonin\n",
      "CAP\n",
      "ATP\n",
      "Pi\n",
      "ADP\n",
      "ATP\n",
      "glutamic acid\n",
      "ATP\n",
      "γ-phosphate\n",
      "nucleotide\n",
      "slowness\n",
      "amino acid\n",
      "MreB\n",
      "Arp2/3\n",
      "G-actin\n",
      "Arp2/3\n",
      "ATP\n",
      "ATP\n",
      "thymosin\n",
      "Thymosin\n",
      "ADP\n",
      "ATP\n",
      "anomaly\n",
      "agitation\n",
      "divalent\n",
      "ATP\n",
      "Cc\n",
      "ATP\n",
      "ATP\n",
      "ATP\n",
      "ADP\n",
      "ATP\n",
      "F-actin-ADP\n",
      "ADP\n",
      "ATP\n",
      "ATP\n",
      "G-actin\n",
      "ATP\n",
      "Pi\n",
      "ADP\n",
      "ATP\n",
      "ADP+Pi\n",
      "ADP\n",
      "ADP+Pi\n",
      "ATP\n",
      "ATP\n",
      "Cc\n",
      "nucleotides\n",
      "Thymosin\n",
      "G-actin-ATP\n",
      "thymosin β-4\n",
      "G-actin\n",
      "G-actin-ATP\n",
      "ADP\n",
      "ATP\n",
      "proline\n",
      "Arp2/3\n",
      "G-actin\n",
      "latrunculin\n",
      "cytochalasin D\n",
      "phalloidin): Latrunculin\n",
      "Cytochalasin\n",
      "Cytochalasin\n",
      "Phalloidin\n",
      "death\n",
      "myosin\n",
      "muscle contraction\n",
      "myosin V and VI\n",
      "ATP\n",
      "Myosin\n",
      "myosin\n",
      "myosin\n",
      "myosin VI\n",
      "inositol phosphate\n",
      "myosin\n",
      "cytochalasins\n",
      "myosin\n",
      "sodium\n",
      "Srv2/CAP\n",
      "α-tubulins\n",
      "β-tubulins\n",
      "profilins\n",
      "myosin\n",
      "gelsolin/severin\n",
      "calcium\n",
      "formins\n",
      "myosin\n",
      "KAM1/MUR3\n",
      "stress\n",
      "ATP\n",
      "ADP\n",
      "ATP\n",
      "phalloidin\n",
      "human melanoma\n",
      "alpha skeletal muscle\n",
      "myosin\n",
      "Pol II\n",
      "myosin\n",
      "muscle contraction\n",
      "myosin\n",
      "ATP\n",
      "ATP\n",
      "myosin\n",
      "stroke\n",
      "alpha-actinin\n",
      "myosin\n",
      "myosin\n",
      "muscle contraction\n",
      "tropomyosin\n",
      "40-nanometre\n",
      "tropomyosin\n",
      "actin-myosin\n",
      "muscular contraction\n",
      "tropomyosin\n",
      "troponins\n",
      "troponin\n",
      "Tropomyosin\n",
      "troponin\n",
      "Ca2\n",
      "myosin\n",
      "myosin\n",
      "tropomyosin\n",
      "myosin\n",
      "ATP\n",
      "ATP\n",
      "myosin\n",
      "tropomyosin\n",
      "actin-myosin\n",
      "myosin\n",
      "Arp2/3\n",
      "formins\n",
      "programmed cell death\n",
      "stress\n",
      "cytocalasin\n",
      "Candida albicans\n",
      "spermatogenesis\n",
      "myosin\n",
      "myosin\n",
      "cardiac muscle\n",
      "infectious agents\n",
      "myopathy\n",
      "ACTA1 ACTA1\n",
      "heart muscle\n",
      "amino acids\n",
      "myopathy\n",
      "myopathy\n",
      "congenital myopathy\n",
      "CM\n",
      "congenital myopathy\n",
      "myopathies\n",
      "myopathy\n",
      "myopathy\n",
      "actinic nemaline myopathy\n",
      "myopathic facies\n",
      "muscular weakness\n",
      "respiratory difficulties\n",
      "age\n",
      "myopathy\n",
      "myopathy\n",
      "myopathy\n",
      "nucleotide\n",
      "Nemaline\n",
      "myopathy\n",
      "CFTDM\n",
      "muscular weakness\n",
      "type II muscular\n",
      "cisplatin\n",
      "MYH11\n",
      "hereditary thoracic aortic aneurisms\n",
      "stenosis\n",
      "aorta\n",
      "afflictions\n",
      "Moyamoya disease\n",
      "thoracic aortic aneurysm\n",
      "ischaemic heart disease\n",
      "liver cirrhosis\n",
      "heart muscle\n",
      "heart muscle\n",
      "structural disorders\n",
      "Type 1R dilated cardiomyopathy\n",
      "hypertrophic cardiomyopathy\n",
      "dilated cardiomyopathy\n",
      "amino acids belonging to the protein\n",
      "hypertrophic cardiomyopathies\n",
      "actin-myosin\n",
      "abnormal mechanical behaviour\n",
      "hypertrophy\n",
      "cardiac muscle\n",
      "stress\n",
      "idiopathic restrictive cardiomyopathy\n",
      "carcinomas\n",
      "juvenile dystonia\n",
      "infection\n",
      "nervous system malformations\n",
      "tumour\n",
      "tumours\n",
      "Hemangiopericytoma\n",
      "dystonia\n",
      "degenerative disease\n",
      "sensory hearing loss\n",
      "dystonia\n",
      "amino acid tryptophan\n",
      "arginine\n",
      "infections\n",
      "amyloidosis\n",
      "retinitis pigmentosa\n",
      "infection\n",
      "kidney diseases\n",
      "congenital hearing loss\n",
      "autosomal-dominant\n",
      "hearing loss\n",
      "sensorineural hearing loss\n",
      "DFNA\n",
      "hearing loss\n",
      "myopathies\n",
      "Listeria\n",
      "Rickettsia\n",
      "S.\n",
      "Listeria\n",
      "Arp2/3\n",
      "infection\n",
      "Arp2/3\n",
      "Pseudomonas aeruginosa\n",
      "biofilm\n",
      "biofilm\n",
      "cancer\n",
      "nucleotide\n",
      "nucleotide\n",
      "tubulin\n",
      "nucleotides\n",
      "crystalline\n",
      "G-actin\n",
      "tubulin\n",
      "AlfA\n",
      "amino acid\n",
      "MreB\n",
      "myosin\n",
      "Actin-myosin\n",
      "neoplasia\n",
      "vasculitis\n",
      "atrophy\n",
      "3-methylhistidine\n",
      "F-myosin\n",
      "histidine\n",
      "Bank(EMDB\n",
      "ventricular contraction\n",
      "stroke\n",
      "stroke\n",
      "dilated left ventricle\n",
      "hypertrophy\n",
      "left ventricle\n",
      "oxygen\n",
      "left ventricle\n",
      "pulmonary artery\n",
      "right ventricle\n",
      "stress\n",
      "left ventricle\n",
      "{\\textstyle \\left({\\frac {EDP\\cdot EDR}{2h}}\\right)}    where EDP\n",
      "left ventricle\n",
      "pulmonary artery\n",
      "left ventricle\n",
      "left ventricle\n",
      "left ventricle\n",
      "afterload Disease\n",
      "valve disease\n",
      "hypertension\n",
      "HTN\n",
      "aorta\n",
      "aortic valve\n",
      "left ventricle\n",
      "aorta\n",
      "Pulmonary hypertension\n",
      "stenosis\n",
      "left ventricle\n",
      "aortic valve\n",
      "aorta\n",
      "valve stenosis\n",
      "left ventricle\n",
      "aortic valve\n",
      "aorta\n",
      "aorta\n",
      "stenosis\n",
      "hypertrophy\n",
      "left ventricle\n",
      "aortic valve\n",
      "aorta\n",
      "Mitral regurgitation\n",
      "mitral valve\n",
      "aortic valve\n",
      "mitral valve\n",
      "left ventricle\n",
      "Cardiovascular Diseases\n",
      "doi:10.1016/0033-0620(76)90021-9\n",
      "stress\n",
      "pulmonary embolism\n",
      "P.\n",
      "P.\n",
      "doi:10.1161/CIRCULATIONAHA.106.668681\n",
      "P.\n",
      "K\n",
      "J. J.\n",
      "A. P.\n",
      "Nitroglycerin\n",
      "cognitive and social functions\n",
      "\"\"—\n",
      "substance abuse\n",
      "Vols\n",
      "1898–1941\n",
      "10th-53rd\n",
      "Death\n",
      "Duat\n",
      "Amiodarone\n",
      "cardiac dysrhythmias\n",
      "ventricular tachycardia\n",
      "ventricular fibrillation\n",
      "VF\n",
      "tachycardia\n",
      "atrial fibrillation\n",
      "supraventricular tachycardia\n",
      "cardiac arrest\n",
      "tremor\n",
      "nausea\n",
      "constipation\n",
      "amiodarone\n",
      "ventricular arrhythmias\n",
      "lung toxicity\n",
      "interstitial pneumonitis\n",
      "liver problems\n",
      "heart arrhythmias\n",
      "thyroid problems\n",
      "death\n",
      "Amiodarone\n",
      "chest pain\n",
      "arrhythmias\n",
      "Amiodarone\n",
      "arrhythmias\n",
      "arrhythmias\n",
      "supraventricular arrhythmias\n",
      "ventricular arrhythmias\n",
      "Cardiac arrest\n",
      "ventricular fibrillation\n",
      "pulseless\n",
      "ventricular tachycardia\n",
      "cardiac arrest\n",
      "amiodarone\n",
      "Amiodarone\n",
      "cardiac arrest\n",
      "Ventricular tachycardia Amiodarone\n",
      "ventricular tachycardia\n",
      "ventricular tachycardia\n",
      "amiodarone\n",
      "Amiodarone\n",
      "ventricular tachycardia\n",
      "amiodarone\n",
      "ventricular tachycardia\n",
      "monomorphic ventricular tachycardia\n",
      "ventricular tachycardia\n",
      "Atrial fibrillation\n",
      "atrial fibrillation\n",
      "amiodarone\n",
      "atrial fibrillation\n",
      "pulmonary toxicities\n",
      "amiodarone\n",
      "FDA\n",
      "atrial fibrillation\n",
      "amiodarone\n",
      "amiodarone\n",
      "atrial fibrillation\n",
      "amiodarone\n",
      "amiodarone\n",
      "breast milk\n",
      "amiodarone\n",
      "bradycardia\n",
      "atrioventricular block\n",
      "heart block\n",
      "depressed lung function\n",
      "amiodarone\n",
      "amiodarone\n",
      "benzyl alcohol\n",
      "benzyl alcohol\n",
      "syndrome\"\".Amiodarone\n",
      "cardiac arrhythmia\n",
      "digitalis toxicity\n",
      "Amiodarone\n",
      "amiodarone\n",
      "amiodarone\n",
      "amiodarone\n",
      "interstitial lung disease\n",
      "age\n",
      "pulmonary disease\n",
      "pulmonary fibrosis\n",
      "decreased lung function\n",
      "pulmonary toxicity\n",
      "amiodarone\n",
      "Thyroid Induced abnormalities in thyroid function\n",
      "Amiodarone\n",
      "thyroxine\n",
      "iodine\n",
      "amiodarone\n",
      "Amiodarone\n",
      "iodine\n",
      "cardiac hypothyroidism\n",
      "bradycardia\n",
      "arrhythmia\n",
      "Hypothyroidism\n",
      "amiodarone\n",
      "atrial fibrillation\n",
      "hypothyroidism\n",
      "amiodarone-treated\n",
      "sotalol\n",
      "Overt hypothyroidism\n",
      "amiodarone\n",
      "Hyperthyroidism\n",
      "Jod-Basedow\n",
      "hyperthyroidism\n",
      "Low thyroid\n",
      "hyperthyroidism\n",
      "amiodarone\n",
      "amiodarone\n",
      "iodine\n",
      "iodine\n",
      "amiodarone-induced hyperthyroidism\n",
      "keratopathy\n",
      "amiodarone\n",
      "Optic neuropathy\n",
      "nonarteritic\n",
      "ischemic optic neuropathy\n",
      "N-AION\n",
      "optic disc swelling\n",
      "visual field defects\n",
      "Loss of eyelashes\n",
      "amiodarone\n",
      "Liver Abnormal liver enzyme\n",
      "amiodarone\n",
      "jaundice\n",
      "hepatomegaly\n",
      "liver enlargement\n",
      "hepatitis\n",
      "amiodarone\n",
      "pseudo-alcoholic cirrhosis\n",
      "amiodarone\n",
      "blue-grey discoloration\n",
      "ultraviolet-A\n",
      "discoloration\n",
      "heart problems\n",
      "neurological problems\n",
      "amiodarone\n",
      "peripheral neuropathies\n",
      "Amiodarone\n",
      "epididymitis\n",
      "Amiodarone\n",
      "inflammation\n",
      "amiodarone\n",
      "gynecomastia\n",
      "amiodarone\n",
      "amiodarone\n",
      "cancer\n",
      "heart disease\n",
      "amiodarone\n",
      "digoxin\n",
      "amiodarone\n",
      "Amiodarone\n",
      "sotalol\n",
      "Amiodarone\n",
      "warfarin\n",
      "warfarin\n",
      "warfarin\n",
      "amiodarone\n",
      "warfarin\n",
      "amiodarone\n",
      "amiodarone\n",
      "amiodarone\n",
      "amiodarone\n",
      "amiodarone\n",
      "warfarin\n",
      "Amiodarone\n",
      "Ciclosporin\n",
      "Quinidine\n",
      "Simvastatin Theophylline\n",
      "ledipasvir/sofosbuvir\n",
      "sofosbuvir\n",
      "amiodarone\n",
      "cardiac arrest\n",
      "Amiodarone\n",
      "digoxin\n",
      "warfarin\n",
      "phenytoin\n",
      "amiodarone\n",
      "desethylamiodarone\n",
      "DEA\n",
      "amiodarone\n",
      "amiodarone\n",
      "rhabdomyolysis\n",
      "kidney failure\n",
      "death\n",
      "simvastatin\n",
      "amiodarone\n",
      "simvastatin\n",
      "simvastatin\n",
      "amiodarone\n",
      "desethylamiodarone\n",
      "DEA\n",
      "amiodarone\n",
      "DEA\n",
      "breast milk\n",
      "amiodarone\n",
      "DEA\n",
      "amiodarone\n",
      "Amiodarone\n",
      "calcium\n",
      "potassium\n",
      "Amiodarone\n",
      "potassium\n",
      "calcium\n",
      "(CACNA2D2).Amiodarone\n",
      "Amiodarone\n",
      "calcium\n",
      "sodium-\n",
      "amiodarone\n",
      "Long QT-3 syndrome\n",
      "∆KPQ\n",
      "sodium\n",
      "sodium\n",
      "Amiodarone\n",
      "thyroxine\n",
      "amiodarone\n",
      "khellin\n",
      "Cairo\n",
      "Ammi visnaga\n",
      "khellin\n",
      "non-cardiac ailments\n",
      "Amiodarone\n",
      "khellin\n",
      "angina pectoris\n",
      "amiodarone\n",
      "sotalol\n",
      "amiodarone\n",
      "sotalol\n",
      "K+\n",
      "amiodarone\n",
      "supraventricular\n",
      "ventricular arrhythmias\n",
      "amiodarone\n",
      "arrhythmias\n",
      "amiodarone\n",
      "arrhythmias\n",
      "amiodarone\n",
      "amiodarone\n",
      "amiodarone\n",
      "amiodarone\n",
      "amiodarone\n",
      "arrhythmias\n",
      "amiodarone\n",
      "Amiodarone\n",
      "(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone\n",
      "dronedarone\n",
      "benzofuran\n",
      "amiodarone\n",
      "arylmethanone\n",
      "Amiodarone\n",
      "Pacerone\n",
      "Cordarone\n",
      "amiodarone\n",
      "amiodarone\n",
      "dysrhythmia\n",
      "amiodarone\n",
      "Amiodarone\n",
      "Amiodarone\n",
      "LA\n",
      "Amiodarone\n",
      "Amiodarone\n",
      "Casineria\n",
      "depressions\n",
      "gas\n",
      "carbon dioxide\n",
      "herbivores\n",
      "pectoral girdle\n",
      "Hesperornithes\n",
      "Pareiasauromorpha\n",
      "Pareiasauridae\n",
      "Weigeltisauridae\n",
      "†\n",
      "Unnamed infrasubclass\n",
      "†\n",
      "†\n",
      "Nothosauria †\n",
      "Protorosauria †\n",
      "Archosauria\n",
      "Stagonolepididae\n",
      "cladogram\n",
      "cladogram\n",
      "Anemia\n",
      "anaemia\n",
      "erythrocytopenia\n",
      "oxygen\n",
      "anemia\n",
      "weakness\n",
      "shortness of breath\n",
      "exercise\n",
      "anemia\n",
      "confusion\n",
      "loss of consciousness\n",
      "thirst\n",
      "Anemia\n",
      "anemia\n",
      "Anemia\n",
      "bleeding\n",
      "bleeding\n",
      "trauma\n",
      "gastrointestinal bleeding\n",
      "iron\n",
      "vitamin B12\n",
      "thalassemia\n",
      "neoplasms\n",
      "sickle cell anemia\n",
      "infections\n",
      "malaria\n",
      "autoimmune diseases\n",
      "Anemia\n",
      "microcytic anemia\n",
      "macrocytic anemia\n",
      "anemia\n",
      "anemia\n",
      "iron\n",
      "acute bleeding\n",
      "anemia\n",
      "Anemia\n",
      "blood disorder\n",
      "Iron-deficiency anemia\n",
      "anemia\n",
      "iron\n",
      "deaths\n",
      "Anemia\n",
      "ἀν- an-\n",
      "blood\"\".Anemia\n",
      "anemia\n",
      "Anemia\n",
      "anemia\n",
      "anemia\n",
      "fatigue\n",
      "shortness of breath\n",
      "anemia\n",
      "anemia\n",
      "anemia\n",
      "tiredness\n",
      "dizziness headaches\n",
      "tiredness\n",
      "shortness of breath\n",
      "heartbeat) breathlessness\n",
      "chest pain\n",
      "nausea\n",
      "bruising\n",
      "bleeding\n",
      "anemia\n",
      "palpitations\n",
      "angina\n",
      "heart disease\n",
      "intermittent claudication of the legs\n",
      "heart failure\n",
      "iron-deficiency anemia\n",
      "anemia\n",
      "koilonychia\n",
      "iron\n",
      "jaundice\n",
      "anemia\n",
      "hemolytic anemia\n",
      "nerve cell damage\n",
      "vitamin B12\n",
      "bone deformities\n",
      "thalassemia\n",
      "sickle-cell disease\n",
      "anemia\n",
      "tachycardia\n",
      "cardiac ventricular hypertrophy\n",
      "heart failure\n",
      "iron\n",
      "anemia\n",
      "behavioral disturbances\n",
      "impaired neurological development\n",
      "age\n",
      "Restless legs syndrome\n",
      "iron-deficiency anemia\n",
      "anemia\n",
      "impaired red blood cell (RBC\n",
      "RBC destruction\n",
      "hemolytic anemias\n",
      "blood loss\n",
      "hypervolemia\n",
      "anemia\n",
      "anemia\n",
      "blood loss\n",
      "iron\n",
      "Impaired production Disturbance of proliferation\n",
      "Fanconi anemia\n",
      "hereditary disorder\n",
      "aplastic anemia\n",
      "Anemia\n",
      "kidney failure\n",
      "Anemia\n",
      "endocrine disease\n",
      "Pernicious anemia\n",
      "megaloblastic anemia\n",
      "vitamin B12\n",
      "vitamin B12\n",
      "non-pernicious megaloblastic anemia\n",
      "Anemia\n",
      "folate\n",
      "vitamin B12\n",
      "megaloblastic anemia Anemia\n",
      "prematurity\n",
      "blood loss\n",
      "age\n",
      "Iron\n",
      "anemia\n",
      "Thalassemias\n",
      "Congenital dyserythropoietic anemias\n",
      "Anemia of kidney failure\n",
      "stem cell dysfunction\n",
      "anemia\n",
      "myelophthisis\n",
      "anemia\n",
      "malignant tumors\n",
      "fibrosis\n",
      "granulomas\n",
      "Myelodysplastic syndrome anemia\n",
      "chronic inflammation\n",
      "anemia\n",
      "Anemias\n",
      "hemolytic anemias\n",
      "jaundice\n",
      "lactate\n",
      "premature destruction\n",
      "nocturnal hemoglobinuria\n",
      "Hereditary spherocytosis\n",
      "Hereditary elliptocytosis\n",
      "Abetalipoproteinemia\n",
      "Pyruvate\n",
      "glutathione\n",
      "stress Hemoglobinopathies Sickle cell anemia\n",
      "nocturnal hemoglobinuria\n",
      "autoimmune hemolytic anemia\n",
      "autoimmune hemolytic diseases\n",
      "idiopathic\n",
      "systemic lupus erythematosus\n",
      "malignancy\n",
      "chronic lymphocytic leukemia\n",
      "Cold agglutinin hemolytic anemia\n",
      "idiopathic\n",
      "Rh disease\n",
      "hemolytic disease\n",
      "trauma\n",
      "Microangiopathic hemolytic anemias\n",
      "thrombotic thrombocytopenic purpura\n",
      "intravascular coagulation Infections\n",
      "malaria\n",
      "Blood loss Anemia\n",
      "prematurity\n",
      "Trauma\n",
      "acute blood loss Gastrointestinal tract\n",
      "acute bleeds\n",
      "variceal lesions\n",
      "ulcers\n",
      "chronic blood loss\n",
      "angiodysplasia\n",
      "chronic blood loss\n",
      "fibroids\n",
      "cancers\n",
      "colorectal cancer\n",
      "cancer of the urinary bladder\n",
      "blood loss\n",
      "Infection\n",
      "intestinal nematodes\n",
      "whipworm Trichuris trichiura  \n",
      "anemia\n",
      "blood loss\n",
      "anemia\n",
      "ischemia\n",
      "anemia\n",
      "ischemia\n",
      "anemia\n",
      "blood loss\n",
      "ischemia\n",
      "ischemia\n",
      "Fluid overload Fluid overload\n",
      "hypervolemia\n",
      "anemia\n",
      "hypervolemia\n",
      "sodium\n",
      "sodium\n",
      "Intestinal inflammation\n",
      "gastrointestinal disorders\n",
      "anemia\n",
      "intestinal inflammation\n",
      "iron\n",
      "pylori infection\n",
      "Gluten-related disorders\n",
      "celiac disease\n",
      "non-celiac gluten\n",
      "Anemia\n",
      "celiac disease\n",
      "Inflammatory bowel disease\n",
      "anemia\n",
      "oxygen\n",
      "bleeding\n",
      "anemia\n",
      "anemia\n",
      "Anemia\n",
      "anemia\n",
      "anemia\n",
      "anemia\n",
      "iron\n",
      "iron\n",
      "vitamin B12\n",
      "anemia\n",
      "vitamin B12\n",
      "oxygen\n",
      "bone marrow sample\n",
      "anemia\n",
      "anemia\n",
      "anemia\n",
      "blood loss\n",
      "iron\n",
      "folate\n",
      "creatinine\n",
      "anemia\n",
      "anemia\n",
      "microcytic\n",
      "anemia\n",
      "macrocytic\n",
      "anemia\n",
      "microcytic anemia\n",
      "iron\n",
      "iron\n",
      "vitamin B12\n",
      "macrocytosis\n",
      "anemia\n",
      "anemia\n",
      "loss or destruction\n",
      "hemolysis\n",
      "bleeding\n",
      "frank bleeding\n",
      "sickle cell anemia\n",
      "iron\n",
      "chronic gastric bleeding\n",
      "B12\n",
      "folate\n",
      "anemia\n",
      "hemolysis\n",
      "bone marrow failure\n",
      "anemia\n",
      "chronic disease\n",
      "hemolysis\n",
      "blood loss\n",
      "anemia\n",
      "Microcytic Microcytic anemia\n",
      "failure/insufficiency\n",
      "Iron\n",
      "anemia\n",
      "anemia\n",
      "Iron\n",
      "anemia\n",
      "iron\n",
      "iron\n",
      "Iron\n",
      "iron\n",
      "age\n",
      "iron\n",
      "iron\n",
      "anemia\n",
      "Iron\n",
      "abnormal fissuring\n",
      "iron\n",
      "bleeding\n",
      "blood loss\n",
      "gastrointestinal tract\n",
      "Fecal occult blood testing\n",
      "bleeding\n",
      "bleeding\n",
      "gastrointestinal tract\n",
      "colon polyps\n",
      "colorectal cancer\n",
      "iron\n",
      "anemia\n",
      "amebiasis\n",
      "schistosomiasis\n",
      "whipworms).The\n",
      "microcytic anemia\n",
      "iron\n",
      "thalassemia\n",
      "Macrocytic Megaloblastic anemia\n",
      "macrocytic anemia\n",
      "vitamin B12\n",
      "folic acid\n",
      "folate\n",
      "vitamin B12\n",
      "Folate\n",
      "neurological symptoms\n",
      "B12 deficiency\n",
      "Pernicious anemia\n",
      "vitamin B12\n",
      "atrophic gastritis\n",
      "vitamin B12\n",
      "Macrocytic anemia\n",
      "vitamin B12/folate\n",
      "anemia\n",
      "Hypothyroidism Alcoholism\n",
      "macrocytosis\n",
      "anemia\n",
      "liver disease\n",
      "macrocytosis\n",
      "methotrexate\n",
      "zidovudine\n",
      "anemia\n",
      "megaloblastic anemia\n",
      "megaloblastic anemia\n",
      "megaloblastic anemias\n",
      "hypersegmentation\n",
      "nonmegaloblastic macrocytic anemias\n",
      "etiologies\n",
      "alcoholism\n",
      "anemia\n",
      "vitamin B12\n",
      "peripheral neuropathy\n",
      "glossitis\n",
      "vitamin B12-deficient anemia\n",
      "vitamin B12\n",
      "Normocytic Normocytic anemia\n",
      "iron\n",
      "iron\n",
      "folate\n",
      "vitamin B12\n",
      "sideroblastic anemia\n",
      "alcoholism\n",
      "nutritional deficiencies\n",
      "congenital diseases\n",
      "sideroblastic anemia\n",
      "nutritional anemia\n",
      "anemia\n",
      "anemia\n",
      "drug-induced\n",
      "acetaminophen\n",
      "paracetamol\n",
      "zinc\n",
      "Hyperanemia\n",
      "anemia\n",
      "anemia\n",
      "anemia\n",
      "anemia\n",
      "myelodysplastic syndromes\n",
      "Iron\n",
      "anemia\n",
      "gastrointestinal problems\n",
      "iron\n",
      "occult bleeding\n",
      "anemia\n",
      "anemia\n",
      "myelodysplastic syndrome\n",
      "Beta thalassemia\n",
      "iron\n",
      "iron\n",
      "anemia\n",
      "Vitamin\n",
      "folic acid\n",
      "vitamin B12\n",
      "vitamin B12\n",
      "iron\n",
      "iron\n",
      "age\n",
      "iron\n",
      "anemia\n",
      "iron\n",
      "anemia\n",
      "Iron\n",
      "iron\n",
      "iron\n",
      "blood loss\n",
      "gastrointestinal bleeding\n",
      "ulcers\n",
      "colon cancer\n",
      "iron-deficiency anemia\n",
      "iron\n",
      "ferrous sulfate\n",
      "ferrous fumarate\n",
      "ferrous gluconate\n",
      "iron\n",
      "anemia\n",
      "age\n",
      "iron\n",
      "iron\n",
      "iron\n",
      "Vitamin C\n",
      "iron\n",
      "iron\n",
      "anemia\n",
      "chronic kidney disease\n",
      "epoetin\n",
      "iron\n",
      "inflammation\n",
      "iron\n",
      "iron\n",
      "iron\n",
      "inflammation\n",
      "iron\n",
      "iron\n",
      "iron\n",
      "haemorrhage\n",
      "inflammatory bowel disease\n",
      "chronic heart failure\n",
      "iron\n",
      "gastrointestinal tract\n",
      "deficit of over\n",
      "iron\n",
      "iron\n",
      "coronary artery disease\n",
      "bleeding\n",
      "cardiovascular instability\n",
      "anaemia\n",
      "cancer\n",
      "fatigue\n",
      "breathlessness\n",
      "cancer\n",
      "haemorrhage\n",
      "anemia\n",
      "chronic kidney disease\n",
      "anemia\n",
      "iron\n",
      "iron\n",
      "iron\n",
      "oxygen\n",
      "blood loss\n",
      "anemia\n",
      "oxygen\n",
      "HBO\n",
      "HBO\n",
      "oxygen\n",
      "HBO\n",
      "HBO\n",
      "HBO\n",
      "anemia\n",
      "anemia\n",
      "anemia\n",
      "anemia\n",
      "iron\n",
      "anemia\n",
      "iron-deficiency anemia\n",
      "iron\n",
      "anemia\n",
      "anaemia\n",
      "infections\n",
      "malaria\n",
      "bacterial infections\n",
      "anemia\n",
      "Anemia\n",
      "Anemia-\n",
      "decline in amphibian populations\n",
      "sligoi\n",
      "ἀμφί\n",
      "Labyrinthodontia\n",
      "oxygen\n",
      "hearing on dry\n",
      "horsetails\n",
      "aquatic larval stage with gills like their\n",
      "stereospondyls\n",
      "aquatic larval stage\n",
      "paedomorphosis\n",
      "tear ducts\n",
      "urinary bladder\n",
      "urea\n",
      "throat\n",
      "gas\n",
      "Mesobatrachia\n",
      "low-slung\n",
      "terrestrial or aquatic and\n",
      "Sirenoidea\n",
      "external fertilisation\n",
      "Gas\n",
      "parotoids\n",
      "pectoral girdle\n",
      "pelvic girdle\n",
      "muscle contractions\n",
      "twitch\n",
      "juvenile stage\n",
      "pulmonary artery\n",
      "Nervous and sensory systems\n",
      "pain\n",
      "optic lobe\n",
      "cornea\n",
      "Digestive and excretory systems\n",
      "pancreas, liver and gall bladder\n",
      "ammonia\n",
      "urea\n",
      "uric acid\n",
      "oxygen\n",
      "oxygen\n",
      "oxygen\n",
      "oxygen\n",
      "gas\n",
      "fertilisation\n",
      "external fertilisation\n",
      "thyroxine\n",
      "thyroxine\n",
      "teeth, whisker-like skin\n",
      "death\n",
      "mucoproteins\n",
      "oxygen\n",
      "°\n",
      "°\n",
      "Nannophrys ceylonensis\n",
      "teeth\n",
      "programmed cell death\n",
      "diet\n",
      "eating insects\n",
      "loss of the lateral line system\n",
      "thyroxine\n",
      "thyroxine\n",
      "Proteus\n",
      "Ensatinas\n",
      "thyroxine\n",
      "age\n",
      "teeth\n",
      "mucoproteins\n",
      "skin and mouth tentacles\n",
      "teeth\n",
      "oxygen\n",
      "GB\n",
      "Gb\n",
      "diet\n",
      "diet\n",
      "diet\n",
      "dentine\n",
      "yelp\n",
      "throat\n",
      "snapping\n",
      "biting lunge\n",
      "chest to chest tussles\n",
      "Defence\n",
      "tetrodotoxin\n",
      "TTX\n",
      "immunity\n",
      "toxicity\n",
      "zaparo\n",
      "poisonous\n",
      "autotomise\n",
      "Ceratophrine\n",
      "teeth\n",
      "declines in amphibian populations\n",
      "crashes\n",
      "ozone\n",
      "diseases like chytridiomycosis\n",
      "loss of carnivorous species\n",
      "increases in opportunistic species\n",
      "eating frog legs\n",
      "oxygen\n",
      "declines and extinctions\n",
      "Ark\n",
      "W.\n",
      "W.\n",
      "Darrel R.\n",
      "Julián\n",
      "Lynch\n",
      "P. L.\n",
      "Andrés\n",
      "S2CID\n",
      "Neil A.\n",
      "S. L.\n",
      "Debra L.\n",
      "W.\n",
      "declines and extinctions\n",
      "306.1783S\n",
      "S2CID\n",
      "P.\n",
      "B. E.\n",
      "bucca (cheek)\n",
      "confusion\n",
      "FICAT\n",
      "peripheral nervous system\n",
      "tumor\n",
      "confusion\n",
      "groin\n",
      "ankle\n",
      "pes\n",
      "abdominal pain\n",
      "QuadrantsThe\n",
      "transverse colon\n",
      "transverse colon\n",
      "inferior horizontal\n",
      "transverse colon\n",
      "transverse colon\n",
      "confusion\n",
      "patent ductus arteriosus\n",
      "obstructions\n",
      "calculus\n",
      "kidney stone\n",
      "gallstone\n",
      "unspecified obstruction\n",
      "bowel obstruction\n",
      "congenital anomalies\n",
      "Movement Joints\n",
      "synovial joints\n",
      "decreases (flexion) or increases (extension) the\n",
      "Abduction\n",
      "depression\n",
      "inferior (depression\n",
      "Pronation\n",
      "muscle contraction\n",
      "muscle coactivation\n",
      "synovial joints\n",
      "synovial joints\n",
      "serous\n",
      "serous\n",
      "Addison\n",
      "temples\n",
      "deceased souls\n",
      "cattle\n",
      "temples\n",
      "deaths\n",
      "non-royal\n",
      "Hapu\n",
      "Dedun\n",
      "Anat\n",
      "AD\n",
      "cohesive vision\n",
      "Khnum\n",
      "Elephantine\n",
      "Nile\n",
      "Nile\n",
      "Duat\n",
      "aggressive and impulsive\n",
      "Deities' mythic behavior\n",
      "birth to the sun god\n",
      "death\n",
      "changelessly\n",
      "temples\n",
      "myths\n",
      "Sex\n",
      "feminine aggression\n",
      "disapproval\n",
      "homosexual behavior\n",
      "Khnum\n",
      "Egyptian deities\n",
      "healer\n",
      "bas\n",
      "Nekhen\n",
      "Buhen\n",
      "Amun-Ra\n",
      "Ra-Horakhty\n",
      "foreign deities\n",
      "Khenti-Amentiu\n",
      "1353–1336\n",
      "Atenism\n",
      "Amun-Ra\n",
      "Atenism\n",
      "silver\n",
      "Egyptians' visual representations\n",
      "anthropomorphic deities\n",
      "breasts\n",
      "emblems of deities\n",
      "deaths\n",
      "ḏsr—\"\"sacred\"\"—\n",
      "human souls\n",
      "death\n",
      "death\n",
      "Meskhenet\n",
      "Renenutet\n",
      "death\n",
      "\"\"—\n",
      "death\n",
      "human ailments\n",
      "cosmic disorder\n",
      "isfet\n",
      "guilt\n",
      "festivals\n",
      "Nile\n",
      "flood\n",
      "temples\n",
      "death\n",
      "temples\n",
      "theophoric\n",
      "Egyptian deities\n",
      "Oasis\n",
      "interpretatio\n",
      "Egyptian deities—\n",
      "Trismegistus\n",
      "Trismegistus\n",
      "Egyptian deities\n",
      "festivals\n",
      "Egyptian deities\n",
      "Lexikon der ägyptischen Götter\n",
      "VI\n",
      "temples\n",
      "death\n",
      "multiple deities\n",
      "Ra\n",
      "Amun-Ra\n",
      "Nu\n",
      "death\n",
      "human weakness\n",
      "temples\n",
      "death\n",
      "death\n",
      "death\n",
      "death\n",
      "death\n",
      "death\n",
      "akh\n",
      "heir\n",
      "death\n",
      "Nile\n",
      "human souls\n",
      "death\n",
      "serpentine\n",
      "Apep\n",
      "deceased souls\n",
      "non-royal\n",
      "spells\n",
      "temples\n",
      "festivals\n",
      "particular deities\n",
      "Egyptian deities\n",
      "barque's movements\n",
      "death\n",
      "temples\n",
      "temples\n",
      "mastabas\n",
      "mastabas\n",
      "Nekhen\n",
      "mastabas\n",
      "Ra\n",
      "Hermeticism\n",
      "Campaign\n",
      "Geraldine\n",
      "Bilolo\n",
      "Les cosmo-théologies philosophiques\n",
      "Essai de thématisation\n",
      "———\n",
      "Les cosmo-théologies philosophiques\n",
      "l'Égypte\n",
      "———\n",
      "———\n",
      "Création dans la pensée memphite\n",
      "Geraldine\n",
      "Alpago\n",
      "death\n",
      "Cremonensis\n",
      "castigationibus\n",
      "complurium codicum arabicorum (Ibn Sina's Canon of\n",
      "Koine\n",
      "Classical-era\n",
      "Age\n",
      "Hatzopoulos\n",
      "γάλακτος\n",
      "PIE phonemes\n",
      "sex\n",
      "γένους\n",
      "PIE\n",
      "quis\n",
      "stress\n",
      "/oː/\n",
      "aorist\n",
      "PIE\n",
      "aorist\n",
      "aorist\n",
      "ī → ī o, ō → ō u, ū → ū ai → ēi ei → ēi or\n",
      "→ h₃leh₃l →\n",
      "eilēpha\n",
      "lelēpha\n",
      "slambanō\n",
      "eilēpha\n",
      "Reduplication\n",
      "πεπόνθατε ὑπὸ τῶν ἐμῶν κατηγόρων\n",
      "οἶδα· ἐγὼ δ' οὖν καὶ\n",
      "ἐμαυτοῦ\n",
      "ἔπος εἰπεῖν οὐδὲν εἰρήκασιν\n",
      "IPA\n",
      "| ɔ̂ː ándres atʰɛːnaî̯i̯oi | pepóntʰate | hypo tɔ̂ːn emɔ̂ːŋ katɛːɡórɔːn | oːk oî̯da ‖ éɡɔː dûːŋ kai̯ au̯tos | hyp au̯tɔ̂ːn olíɡoː emau̯tûː | epelatʰómɛːn | hǔːtɔː pitʰanɔ̂ːs éleɡon ‖ kaí̯toi̯ alɛːtʰéz ɡe | hɔːs épos eːpêːn | oːden eːrɛ̌ːkaːsin\n",
      "Athēnaîoi\n",
      "pepónthate\n",
      "epelathómēn\n",
      "age\n",
      "Potter and the Philosopher's Stone\n",
      "Ὀνόματα Kεχιασμένα (Onomata Kechiasmena\n",
      "Hebdomada\n",
      "Hanhart\n",
      "Athenaze\n",
      "S. P.\n",
      "Chantraine\n",
      "Pierre\n",
      "Taillardat\n",
      "Anastasios-Phoibos\n",
      "W.\n",
      "8–19\n",
      "A. W.\n",
      "Pierre\n",
      "Alfons\n",
      "P.\n",
      "Ἑλλάς\n",
      "c. AD 600\n",
      "Age\n",
      "age\n",
      "death\n",
      "death\n",
      "AD\n",
      "Lelantine\n",
      "poleis\n",
      "Chalcis\n",
      "Lelantine\n",
      "Chalcis\n",
      "Messenia\n",
      "helots\n",
      "labored\n",
      "Mamertines\n",
      "Peisistratos\n",
      "Cleomenes\n",
      "Isagoras\n",
      "Age\n",
      "Marathon\n",
      "Darius' son Xerxes\n",
      "defeat\n",
      "death\n",
      "Boeotia\n",
      "Boeotia\n",
      "Sphakteria\n",
      "Boeotia\n",
      "Delium\n",
      "Sphakteria\n",
      "deaths\n",
      "Aegospotami\n",
      "Mantinea\n",
      "Chaeronea\n",
      "poleis\n",
      "death\n",
      "Alexandria\n",
      "Alexandria\n",
      "poleis\n",
      "Galen\n",
      "Messenia\n",
      "Boeotia\n",
      "Chaonia\n",
      "Elimeia\n",
      "Lyncestae\n",
      "Orestae\n",
      "Mygdonia\n",
      "Almopia\n",
      "7½-10\n",
      "Illyria\n",
      "Neapolis\n",
      "poleis\n",
      "poleis\n",
      "poleis\n",
      "poleis\n",
      "poleis\n",
      "poleis\n",
      "poleis\n",
      "hereditary\n",
      "poleis\n",
      "Eurysthenes\n",
      "Aristodemus\n",
      "Helots\n",
      "age\n",
      "paidagogos\n",
      "age\n",
      "labor\n",
      "silver\n",
      "age\n",
      "Plato's disciple Aristotle\n",
      "Antisthenes\n",
      "Citium\n",
      "Acharnians\n",
      "Alexandria\n",
      "Alexandria\n",
      "Actium\n",
      "calculus\n",
      "theurgy\n",
      "Horace\n",
      "artis\n",
      "Epistulae\n",
      "Age\n",
      "Age\n",
      "1600–1100\n",
      "Midea\n",
      "Paeonia\n",
      "death\n",
      "Kyrenaika\n",
      "famine\n",
      "Bosporan\n",
      "Bosporan\n",
      "Βασίλειον\n",
      "Kimmerikou\n",
      "Phocis\n",
      "Kydonia\n",
      "Ἤπειρος\n",
      "329–160\n",
      "fortified\n",
      "Leninabad\n",
      "Transoxiana\n",
      "Basileía tōn\n",
      "Babylonia\n",
      "/ænˈtɪɡoʊnɪd/\n",
      "Monophthalmus\n",
      "Πτολεμαϊκὴ βασιλεία, romanized\n",
      "death\n",
      "Basileía toû Póntou\n",
      "Hellenistic-era\n",
      "Bithynia\n",
      "death\n",
      "Lysimachus' lieutenants\n",
      "Sogdiana\n",
      "Age\n",
      "Age\n",
      "Hurwit\n",
      "1100–480\n",
      "Latinize\n",
      "Pedagogium\n",
      "Dubois (Jacobus Sylvius) and Jean Fernel\n",
      "affectuum singularum corporis partium curatione\n",
      "leprosy\n",
      "Sex\n",
      "Galen\n",
      "sex\n",
      "Galen\n",
      "Galen's view\n",
      "Galen\n",
      "Galen\n",
      "Galen\n",
      "Galen\n",
      "Galen\n",
      "left ventricle\n",
      "right ventricle\n",
      "Galen\n",
      "Galen's assertions\n",
      "Galen\n",
      "felon\n",
      "corporis\n",
      "suorum\n",
      "corporis\n",
      "death\n",
      "1588.Over\n",
      "Galen\n",
      "De humani corporis\n",
      "death\n",
      "death\n",
      "age\n",
      "death\n",
      "Galen\n",
      "vena azygos\n",
      "noose\n",
      "laterali secandam\n",
      "pain\n",
      "gout\n",
      "syphilis\n",
      "death\n",
      "Galen's theories\n",
      "Galen\n",
      "mitral valve\n",
      "azygos vein\n",
      "Catholic\n",
      "right atrium\n",
      "left atrium\n",
      "pulmonary vein\n",
      "Galen's theory\n",
      "teeth\n",
      "empyema\n",
      "syphilis\n",
      "chinaroot\n",
      "diet\n",
      "hands'—mainly\n",
      "UP\n",
      "CM\n",
      "W. F. Richardson and J. B.\n",
      "Bruxellensis\n",
      "Dе humani corporis\n",
      "Jacqueline\n",
      "De humani corporis\n",
      "Angina\n",
      "angina pectoris\n",
      "chest pain\n",
      "heart muscle\n",
      "Angina\n",
      "obstruction\n",
      "spasm\n",
      "heart muscle\n",
      "anemia\n",
      "abnormal heart rhythms\n",
      "heart failure\n",
      "coronary artery obstruction\n",
      "atherosclerosis\n",
      "coronary artery disease\n",
      "pectus\n",
      "pain\n",
      "oxygen\n",
      "heart muscle\n",
      "pain\n",
      "myocardial infarction\n",
      "heart attack\n",
      "heart attack\n",
      "pain\n",
      "angina\n",
      "death\n",
      "age\n",
      "angina\n",
      "92%.Worsening angina\n",
      "angina\n",
      "angina\n",
      "unstable angina\n",
      "heart attack\n",
      "myocardial infarction\n",
      "angina\n",
      "angina\n",
      "angina\n",
      "myocardial ischemia\n",
      "angina\n",
      "chest discomfort\n",
      "nitroglycerin\n",
      "angina\n",
      "intermittent claudication\n",
      "angina\n",
      "stress\n",
      "Unstable angina Unstable angina\n",
      "UA\n",
      "crescendo angina\n",
      "acute coronary syndrome\n",
      "angina pectoris\n",
      "crescendo\n",
      "heart attack\n",
      "angina\n",
      "unstable angina\n",
      "atherosclerosis\n",
      "unstable angina\n",
      "platelet aggregation\n",
      "coronary artery spasms\n",
      "thrombosis\n",
      "atherosclerosis\n",
      "inflammation\n",
      "thrombosis\n",
      "acute myocardial ischemia\n",
      "necrosis\n",
      "infarction\n",
      "anginas\n",
      "angina\n",
      "atheroma\n",
      "unstable angina\n",
      "unstable angina\n",
      "Cardiac syndrome X\n",
      "Cardiac syndrome\n",
      "microvascular angina\n",
      "chest pain\n",
      "cardiac syndrome\n",
      "exercise\n",
      "stress\n",
      "cardiac syndrome\n",
      "spasm\n",
      "microvascular angina\n",
      "arterial blockages\n",
      "Microvascular angina\n",
      "Ischemia\n",
      "microvascular angina\n",
      "ischemic heart disease\n",
      "angina\n",
      "ischemia\n",
      "acute coronary syndromes\n",
      "obstructive coronary artery disease\n",
      "Angina pectoris\n",
      "angina\n",
      "chest discomfort\n",
      "pain\n",
      "heaviness\n",
      "tightness\n",
      "choking\n",
      "chest discomfort\n",
      "pains\n",
      "pain\n",
      "pain\n",
      "Angina\n",
      "stress\n",
      "Pain\n",
      "breathlessness\n",
      "nausea\n",
      "Chest pain\n",
      "angina\n",
      "Myocardial ischemia\n",
      "oxygen\n",
      "oxygen\n",
      "oxygen\n",
      "nausea\n",
      "vomiting\n",
      "pallor\n",
      "angina\n",
      "smoking\n",
      "diabetes\n",
      "cholesterol\n",
      "high blood pressure\n",
      "family history\n",
      "premature heart disease\n",
      "angina—Prinzmetal's angina—\n",
      "atherosclerosis\n",
      "spasms\n",
      "Coital angina\n",
      "angina d'amour\n",
      "angina\n",
      "coronary artery disease\n",
      "diet\n",
      "angina\n",
      "coronary artery disease\n",
      "nicotine\n",
      "angina\n",
      "Coronary heart disease\n",
      "stroke\n",
      "PVD\n",
      "Peripheral vascular disease\n",
      "smoking\n",
      "angina\n",
      "smoking\n",
      "smoking\n",
      "smoking\n",
      "Esophageal disorders Gastroesophageal reflux disease\n",
      "GERD\n",
      "Hyperthyroidism\n",
      "anemia\n",
      "hypertension\n",
      "Bradyarrhythmia\n",
      "Hypertrophic cardiomyopathy\n",
      "Valvular heart diseaseMyocardial ischemia\n",
      "reduction of blood flow\n",
      "stenosis\n",
      "spasm\n",
      "acute occlusion\n",
      "embolus\n",
      "oxygen\n",
      "oxygen\n",
      "Atherosclerosis\n",
      "stenosis\n",
      "angina pectoris\n",
      "chest pain\n",
      "vasospasm\n",
      "pain\n",
      "'s angina\n",
      "Myocardial ischemia\n",
      "anemia\n",
      "smoking\n",
      "Angina\n",
      "oxygen\n",
      "exercise\n",
      "obstruction\n",
      "atherosclerosis\n",
      "angina\n",
      "Non-obstructive coronary disease\n",
      "Angina\n",
      "chest discomfort\n",
      "stress\n",
      "breathlessness\n",
      "nausea\n",
      "diabetes\n",
      "Anginal pain\n",
      "Antacids\n",
      "pain\n",
      "chest discomfort\n",
      "glyceryl trinitrate\n",
      "angina\n",
      "angina\n",
      "chest pain\n",
      "pain\n",
      "depression\n",
      "exercise\n",
      "fatigue\n",
      "breathlessness\n",
      "pain\n",
      "depression\n",
      "angina\n",
      "angina\n",
      "exercise\n",
      "myocardial ischemia\n",
      "dysrhythmia\n",
      "exercise\n",
      "thallium\n",
      "sestamibi\n",
      "exercise\n",
      "arthritis\n",
      "stress\n",
      "unstable angina\n",
      "acute coronary syndromes\n",
      "troponin\n",
      "Angina pectoris\n",
      "oxygen\n",
      "angina\n",
      "oxygen\n",
      "oxygen\n",
      "angina pectoris\n",
      "heart attacks\n",
      "death\n",
      "carvedilol\n",
      "metoprolol\n",
      "propranolol\n",
      "nitroglycerin\n",
      "angina\n",
      "angina\n",
      "angina\n",
      "angina\n",
      "cardioselective\n",
      "Nevibolol\n",
      "Atenolol\n",
      "Metoprolol\n",
      "Bisoprolol\n",
      "cAMP\n",
      "cAMP\n",
      "ryanodine\n",
      "Ca+2\n",
      "heart muscle\n",
      "oxygen\n",
      "cardioselective\n",
      "cardioselective\n",
      "hypertension\n",
      "angina\n",
      "angina\n",
      "cardioselective\n",
      "cardioselective\n",
      "beta-blocker\n",
      "ISA\n",
      "angina\n",
      "Acebutolol\n",
      "Propranolol\n",
      "Nadolol\n",
      "cAMP\n",
      "Myosin\n",
      "Actin-Myosin\n",
      "cAMP\n",
      "Myosin\n",
      "Actin-Myosin\n",
      "hypertension\n",
      "Calcium\n",
      "oxygen\n",
      "calcium\n",
      "calcium\n",
      "heart muscle cell\n",
      "oxygen\n",
      "angina\n",
      "angina\n",
      "heart muscle\n",
      "vasospasm\n",
      "oxygen\n",
      "pain\n",
      "angina\n",
      "veins\n",
      "oxygen\n",
      "oxygen\n",
      "Nitroglycerin\n",
      "decreases myocardial oxygen\n",
      "Nitroglycerin\n",
      "sildenafil\n",
      "tadalafil\n",
      "vardenafil\n",
      "angina\n",
      "Calcium\n",
      "nifedipine\n",
      "Adalat\n",
      "amlodipine\n",
      "isosorbide mononitrate\n",
      "nicorandil\n",
      "angina\n",
      "Ivabradine\n",
      "anti-ischemic\n",
      "ACE inhibitors\n",
      "Statins\n",
      "lipid/cholesterol\n",
      "atheromatous\n",
      "aspirin\n",
      "heart attack\n",
      "chronic stable angina\n",
      "cardiovascular disease\n",
      "hemorrhagic stroke\n",
      "gastrointestinal bleeding\n",
      "myocardial infarction\n",
      "Exercise\n",
      "angina\n",
      "exercise\n",
      "coronary artery collateralisation\n",
      "angina\n",
      "coronary heart disease\n",
      "angina\n",
      "cholesterol\n",
      "diabetes\n",
      "hypertension\n",
      "high blood pressure\n",
      "smoking\n",
      "calcium\n",
      "nifedipine\n",
      "coronary artery disease\n",
      "Microvascular angina\n",
      "myocardial ischemia\n",
      "palpitations\n",
      "anxiety\n",
      "weakness\n",
      "fatigue\n",
      "angina\n",
      "cardiac ischemia\n",
      "obstructive coronary artery disease\n",
      "myocardial ischemia\n",
      "coronary microvascular disease\n",
      "microvascular angina\n",
      "ischemic pain\n",
      "coronary artery disease\n",
      "CAD\n",
      "endothelial dysfunction\n",
      "inflammation\n",
      "adenosine\n",
      "acetylcholine\n",
      "coronary microvascular dilation\n",
      "nitrates\n",
      "CAD\n",
      "obesity\n",
      "dyslipidemia\n",
      "diabetes\n",
      "hypertension\n",
      "smoking\n",
      "exercise\n",
      "diabetes\n",
      "non-nitrate\n",
      "calcium\n",
      "statins\n",
      "Ranolazine\n",
      "Ivabradine\n",
      "adenosine\n",
      "psychiatric\n",
      "angina\n",
      "unstable angina\n",
      "pain\n",
      "pain\n",
      "angina\n",
      "angina\n",
      "chest pain\n",
      "coronary heart disease\n",
      "angina\n",
      "ischemic heart disease\n",
      "angina\n",
      "Angina\n",
      "coronary artery disease\n",
      "angina\n",
      "age\n",
      "age\n",
      "angina\n",
      "coronary heart disease\n",
      "angina\n",
      "acute myocardial infarction\n",
      "coronary heart disease\n",
      "death\n",
      "coronary heart disease\n",
      "angina pectoris\n",
      "angina\n",
      "Angina\n",
      "Angina\n",
      "angina pectoris\n",
      "Angina\n",
      "graphein\n",
      "CO2\n",
      "isotope\n",
      "isotope\n",
      "nervous diseases\n",
      "tumors\n",
      "artery disease\n",
      "arteriovenous malformations\n",
      "stenosis\n",
      "narrowings\n",
      "pain\n",
      "atherosclerosis\n",
      "atheroma\n",
      "coronary artery stenosis\n",
      "stenosis\n",
      "coronary artery disease\n",
      "Fluorescein\n",
      "Fluorescein\n",
      "aneurysms\n",
      "leg claudication\n",
      "cramps\n",
      "renal stenosis\n",
      "high blood pressure\n",
      "stroke\n",
      "watery\n",
      "watery\n",
      "Watery\n",
      "watery\n",
      "shock\n",
      "pain\n",
      "heart attacks\n",
      "strokes\n",
      "stroke\n",
      "allergic reaction\n",
      "pseudoaneurysm\n",
      "thrombosis\n",
      "embolism\n",
      "Bleeding\n",
      "bruising\n",
      "bleeding\n",
      "allergic\n",
      "Infection\n",
      "necrotic\n",
      "infection\n",
      "Org C-Arms\n",
      "Angina\n",
      "angina pectoris\n",
      "chest pain\n",
      "heart muscle\n",
      "Angina\n",
      "obstruction\n",
      "spasm\n",
      "heart muscle\n",
      "anemia\n",
      "abnormal heart rhythms\n",
      "heart failure\n",
      "coronary artery obstruction\n",
      "atherosclerosis\n",
      "coronary artery disease\n",
      "pectus\n",
      "pain\n",
      "oxygen\n",
      "heart muscle\n",
      "pain\n",
      "myocardial infarction\n",
      "heart attack\n",
      "heart attack\n",
      "pain\n",
      "angina\n",
      "death\n",
      "age\n",
      "angina\n",
      "92%.Worsening angina\n",
      "angina\n",
      "angina\n",
      "unstable angina\n",
      "heart attack\n",
      "myocardial infarction\n",
      "angina\n",
      "angina\n",
      "angina\n",
      "myocardial ischemia\n",
      "angina\n",
      "chest discomfort\n",
      "nitroglycerin\n",
      "angina\n",
      "intermittent claudication\n",
      "angina\n",
      "stress\n",
      "Unstable angina Unstable angina\n",
      "UA\n",
      "crescendo angina\n",
      "acute coronary syndrome\n",
      "angina pectoris\n",
      "crescendo\n",
      "heart attack\n",
      "angina\n",
      "unstable angina\n",
      "atherosclerosis\n",
      "unstable angina\n",
      "platelet aggregation\n",
      "coronary artery spasms\n",
      "thrombosis\n",
      "atherosclerosis\n",
      "inflammation\n",
      "thrombosis\n",
      "acute myocardial ischemia\n",
      "necrosis\n",
      "infarction\n",
      "anginas\n",
      "angina\n",
      "atheroma\n",
      "unstable angina\n",
      "unstable angina\n",
      "Cardiac syndrome X\n",
      "Cardiac syndrome\n",
      "microvascular angina\n",
      "chest pain\n",
      "cardiac syndrome\n",
      "exercise\n",
      "stress\n",
      "cardiac syndrome\n",
      "spasm\n",
      "microvascular angina\n",
      "arterial blockages\n",
      "Microvascular angina\n",
      "Ischemia\n",
      "microvascular angina\n",
      "ischemic heart disease\n",
      "angina\n",
      "ischemia\n",
      "acute coronary syndromes\n",
      "obstructive coronary artery disease\n",
      "Angina pectoris\n",
      "angina\n",
      "chest discomfort\n",
      "pain\n",
      "heaviness\n",
      "tightness\n",
      "choking\n",
      "chest discomfort\n",
      "pains\n",
      "pain\n",
      "pain\n",
      "Angina\n",
      "stress\n",
      "Pain\n",
      "breathlessness\n",
      "nausea\n",
      "Chest pain\n",
      "angina\n",
      "Myocardial ischemia\n",
      "oxygen\n",
      "oxygen\n",
      "oxygen\n",
      "nausea\n",
      "vomiting\n",
      "pallor\n",
      "angina\n",
      "smoking\n",
      "diabetes\n",
      "cholesterol\n",
      "high blood pressure\n",
      "family history\n",
      "premature heart disease\n",
      "angina—Prinzmetal's angina—\n",
      "atherosclerosis\n",
      "spasms\n",
      "Coital angina\n",
      "angina d'amour\n",
      "angina\n",
      "coronary artery disease\n",
      "diet\n",
      "angina\n",
      "coronary artery disease\n",
      "nicotine\n",
      "angina\n",
      "Coronary heart disease\n",
      "stroke\n",
      "PVD\n",
      "Peripheral vascular disease\n",
      "smoking\n",
      "angina\n",
      "smoking\n",
      "smoking\n",
      "smoking\n",
      "Esophageal disorders Gastroesophageal reflux disease\n",
      "GERD\n",
      "Hyperthyroidism\n",
      "anemia\n",
      "hypertension\n",
      "Bradyarrhythmia\n",
      "Hypertrophic cardiomyopathy\n",
      "Valvular heart diseaseMyocardial ischemia\n",
      "reduction of blood flow\n",
      "stenosis\n",
      "spasm\n",
      "acute occlusion\n",
      "embolus\n",
      "oxygen\n",
      "oxygen\n",
      "Atherosclerosis\n",
      "stenosis\n",
      "angina pectoris\n",
      "chest pain\n",
      "vasospasm\n",
      "pain\n",
      "'s angina\n",
      "Myocardial ischemia\n",
      "anemia\n",
      "smoking\n",
      "Angina\n",
      "oxygen\n",
      "exercise\n",
      "obstruction\n",
      "atherosclerosis\n",
      "angina\n",
      "Non-obstructive coronary disease\n",
      "Angina\n",
      "chest discomfort\n",
      "stress\n",
      "breathlessness\n",
      "nausea\n",
      "diabetes\n",
      "Anginal pain\n",
      "Antacids\n",
      "pain\n",
      "chest discomfort\n",
      "glyceryl trinitrate\n",
      "angina\n",
      "angina\n",
      "chest pain\n",
      "pain\n",
      "depression\n",
      "exercise\n",
      "fatigue\n",
      "breathlessness\n",
      "pain\n",
      "depression\n",
      "angina\n",
      "angina\n",
      "exercise\n",
      "myocardial ischemia\n",
      "dysrhythmia\n",
      "exercise\n",
      "thallium\n",
      "sestamibi\n",
      "exercise\n",
      "arthritis\n",
      "stress\n",
      "unstable angina\n",
      "acute coronary syndromes\n",
      "troponin\n",
      "Angina pectoris\n",
      "oxygen\n",
      "angina\n",
      "oxygen\n",
      "oxygen\n",
      "angina pectoris\n",
      "heart attacks\n",
      "death\n",
      "carvedilol\n",
      "metoprolol\n",
      "propranolol\n",
      "nitroglycerin\n",
      "angina\n",
      "angina\n",
      "angina\n",
      "angina\n",
      "cardioselective\n",
      "Nevibolol\n",
      "Atenolol\n",
      "Metoprolol\n",
      "Bisoprolol\n",
      "cAMP\n",
      "cAMP\n",
      "ryanodine\n",
      "Ca+2\n",
      "heart muscle\n",
      "oxygen\n",
      "cardioselective\n",
      "cardioselective\n",
      "hypertension\n",
      "angina\n",
      "angina\n",
      "cardioselective\n",
      "cardioselective\n",
      "beta-blocker\n",
      "ISA\n",
      "angina\n",
      "Acebutolol\n",
      "Propranolol\n",
      "Nadolol\n",
      "cAMP\n",
      "Myosin\n",
      "Actin-Myosin\n",
      "cAMP\n",
      "Myosin\n",
      "Actin-Myosin\n",
      "hypertension\n",
      "Calcium\n",
      "oxygen\n",
      "calcium\n",
      "calcium\n",
      "heart muscle cell\n",
      "oxygen\n",
      "angina\n",
      "angina\n",
      "heart muscle\n",
      "vasospasm\n",
      "oxygen\n",
      "pain\n",
      "angina\n",
      "veins\n",
      "oxygen\n",
      "oxygen\n",
      "Nitroglycerin\n",
      "decreases myocardial oxygen\n",
      "Nitroglycerin\n",
      "sildenafil\n",
      "tadalafil\n",
      "vardenafil\n",
      "angina\n",
      "Calcium\n",
      "nifedipine\n",
      "Adalat\n",
      "amlodipine\n",
      "isosorbide mononitrate\n",
      "nicorandil\n",
      "angina\n",
      "Ivabradine\n",
      "anti-ischemic\n",
      "ACE inhibitors\n",
      "Statins\n",
      "lipid/cholesterol\n",
      "atheromatous\n",
      "aspirin\n",
      "heart attack\n",
      "chronic stable angina\n",
      "cardiovascular disease\n",
      "hemorrhagic stroke\n",
      "gastrointestinal bleeding\n",
      "myocardial infarction\n",
      "Exercise\n",
      "angina\n",
      "exercise\n",
      "coronary artery collateralisation\n",
      "angina\n",
      "coronary heart disease\n",
      "angina\n",
      "cholesterol\n",
      "diabetes\n",
      "hypertension\n",
      "high blood pressure\n",
      "smoking\n",
      "calcium\n",
      "nifedipine\n",
      "coronary artery disease\n",
      "Microvascular angina\n",
      "myocardial ischemia\n",
      "palpitations\n",
      "anxiety\n",
      "weakness\n",
      "fatigue\n",
      "angina\n",
      "cardiac ischemia\n",
      "obstructive coronary artery disease\n",
      "myocardial ischemia\n",
      "coronary microvascular disease\n",
      "microvascular angina\n",
      "ischemic pain\n",
      "coronary artery disease\n",
      "CAD\n",
      "endothelial dysfunction\n",
      "inflammation\n",
      "adenosine\n",
      "acetylcholine\n",
      "coronary microvascular dilation\n",
      "nitrates\n",
      "CAD\n",
      "obesity\n",
      "dyslipidemia\n",
      "diabetes\n",
      "hypertension\n",
      "smoking\n",
      "exercise\n",
      "diabetes\n",
      "non-nitrate\n",
      "calcium\n",
      "statins\n",
      "Ranolazine\n",
      "Ivabradine\n",
      "adenosine\n",
      "psychiatric\n",
      "angina\n",
      "unstable angina\n",
      "pain\n",
      "pain\n",
      "angina\n",
      "angina\n",
      "chest pain\n",
      "coronary heart disease\n",
      "angina\n",
      "ischemic heart disease\n",
      "angina\n",
      "Angina\n",
      "coronary artery disease\n",
      "angina\n",
      "age\n",
      "age\n",
      "angina\n",
      "coronary heart disease\n",
      "angina\n",
      "acute myocardial infarction\n",
      "coronary heart disease\n",
      "death\n",
      "coronary heart disease\n",
      "angina pectoris\n",
      "angina\n",
      "Angina\n",
      "Angina\n",
      "angina pectoris\n",
      "Angina\n",
      "P.\n",
      "Creger (1974–1993)\n",
      "C. Thomas Caskey (2001–2019\n",
      "140\n",
      "death\n",
      "oxygen\n",
      "depression\n",
      "recessive traits\n",
      "oxygen\n",
      "hydrogen\n",
      "°\n",
      "°\n",
      "cholesterol\n",
      "oxygen\n",
      "comb jellies\n",
      "anus\n",
      "anus\n",
      "head end (anterior)\n",
      "cephalisation\n",
      "peristalsis\n",
      "anus\n",
      "digestive tract\n",
      "anus\n",
      "anus\n",
      "invagination of the endoderm\n",
      "blood, 2 legs\n",
      "blood, 4 legs\n",
      "1860.In\n",
      "cattle\n",
      "textiles\n",
      "carmine\n",
      "shellac\n",
      "kermes\n",
      "cattle\n",
      "Yondelis\n",
      "terrestrial and aquatic animals\n",
      "cattle\n",
      "zodiacs\n",
      "malaria\n",
      "malaria\n",
      "Plasmodium falciparum\n",
      "malaria\n",
      "Wuchereria bancrofti\n",
      "Lymphatic filariasis\n",
      "elephantiasis\n",
      "Anopheles arabiensis Anopheles bwambae Anopheles melas Anopheles merus Anopheles quadriannulatus Anopheles gambiae sensu stricto Anopheles coluzzii Anopheles\n",
      "behavioural traits\n",
      "A. melas\n",
      "stricto\n",
      "oxygen\n",
      "malaria\n",
      "right ventricle\n",
      "right ventricle\n",
      "right atrium\n",
      "right atrium\n",
      "right atrium\n",
      "cardiac vein\n",
      "cardiac vein\n",
      "Kuchu\n",
      "Kuchu\n",
      "Anti-style cuts', 'Eastern-style cuts')\n",
      "Tawantinsuyu\n",
      "anticucheras\n",
      "Señor\n",
      "Anticuchos\n",
      "Ciudad de los\n",
      "Tradiciones\n",
      "salt\n",
      "grilled meats\n",
      "choripanes\n",
      "Fiestas\n",
      "fondas\n",
      "Şiş\n",
      "MCRA\n",
      "aldosterone\n",
      "aldosterone\n",
      "chronic heart failure\n",
      "Spironolactone\n",
      "hyperaldosteronism\n",
      "Conn's syndrome\n",
      "hirsutism\n",
      "antiandrogen\n",
      "spironolactone\n",
      "spirolactones\n",
      "Finerenone\n",
      "sodium\n",
      "diseases like primary aldosteronism\n",
      "hypertension\n",
      "heart failure\n",
      "chronic kidney disease\n",
      "ACE inhibitors or beta blockers.\n",
      "nausea\n",
      "vomiting\n",
      "stomach cramps\n",
      "diarrhoea\n",
      "hyperkalemia\n",
      "potassium\n",
      "hyperkalemia\n",
      "potassium\n",
      "K\n",
      "Aldosterone\n",
      "aldosterone\n",
      "sodium\n",
      "potassium\n",
      "aldosterone\n",
      "aldosterone\n",
      "potassium\n",
      "sodium\n",
      "spironolactone\n",
      "eplerenone\n",
      "Spironolactone\n",
      "eplerenone\n",
      "Eplerenone\n",
      "spironolactone\n",
      "Spironolactone\n",
      "chronic kidney disease\n",
      "Spironolactone\n",
      "eplerenone\n",
      "renal and/or hepatic dysfunction\n",
      "renal dysfunction\n",
      "potassium\n",
      "Spironolactone\n",
      "Eplerenone\n",
      "aldosterone\n",
      "sodium\n",
      "chloride ions\n",
      "C-7-unsubstituted\n",
      "aldosterone\n",
      "Eplerenone\n",
      "spironolactone\n",
      "eplerenone\n",
      "eplerenone\n",
      "spironolactone\n",
      "finerenone\n",
      "spironolactone\n",
      "eplerenone\n",
      "aldosterone\n",
      "aldosterone\n",
      "aldosterone\n",
      "sodium\n",
      "potassium\n",
      "aldosterone\n",
      "aldosterone\n",
      "spironolactone\n",
      "cardiac necrosis\n",
      "spironolactone\n",
      "potassium-sparing\n",
      "aldosterone\n",
      "aldosterone\n",
      "cortisol\n",
      "corticosterone\n",
      "aldosterone\n",
      "aldosterone\n",
      "steroid-based spironolactone\n",
      "anti-mineralocorticoid\n",
      "Spironolactone\n",
      "Eplerenone\n",
      "spironolactone\n",
      "Canrenone\n",
      "potassium canrenoate\n",
      "eplerenone\n",
      "spironolactoneSome\n",
      "progesterone\n",
      "drospirenone\n",
      "gestodene\n",
      "benidipine\n",
      "Potassium-sparing diuretic Mineralocorticoid Corticosteroid Antiglucocorticoid References External links Aldosterone+Antagonists at the US National Library of Medicine\n",
      "platelet aggregation\n",
      "platelet aggregation\n",
      "thrombus\n",
      "thrombotic cerebrovascular or cardiovascular disease\n",
      "aspirin\n",
      "bleeding\n",
      "bleeding\n",
      "aspirin\n",
      "low-dose aspirin\n",
      "bleeding\n",
      "aspirin\n",
      "clopidogrel\n",
      "prasugrel\n",
      "ticagrelor\n",
      "DAPT\n",
      "Aspirin\n",
      "Disgren\n",
      "Adenosine\n",
      "ADP\n",
      "Clopidogrel\n",
      "Plavix\n",
      "Prasugrel\n",
      "Ticagrelor\n",
      "Brilinta\n",
      "Ticlopidine\n",
      "Ticlid\n",
      "Cilostazol\n",
      "Vorapaxar\n",
      "Abciximab\n",
      "ReoPro\n",
      "Eptifibatide\n",
      "Integrilin\n",
      "Tirofiban\n",
      "Aggrastat\n",
      "Adenosine\n",
      "Dipyridamole\n",
      "Persantine\n",
      "Thromboxane\n",
      "Thromboxane\n",
      "Thromboxane\n",
      "thrombosis\n",
      "thrombosis\n",
      "thrombosis\n",
      "thromboembolism\n",
      "heart attack\n",
      "pulmonary embolism\n",
      "stroke\n",
      "stroke\n",
      "atrial fibrillation\n",
      "Coronary Heart Disease\n",
      "angina\n",
      "unstable angina\n",
      "heart attack\n",
      "thrombus\n",
      "thrombosis\n",
      "vascular damage\n",
      "thrombosis\n",
      "Aspirin\n",
      "Triflusal\n",
      "TXA2\n",
      "thromboxane\n",
      "AMP\n",
      "Dipyridamole\n",
      "AMP\n",
      "PGI2\n",
      "Clopidogrel\n",
      "abciximab\n",
      "eptifibatide\n",
      "tirofiban\n",
      "Epoprostenol\n",
      "prostacyclin\n",
      "platelet aggregation\n",
      "heparin\n",
      "primary pulmonary hypertension\n",
      "thrombotic\n",
      "myocardial infarction\n",
      "bleeding\n",
      "DAPT\n",
      "cancer\n",
      "non-urgent/emergent fracture\n",
      "DAPT\n",
      "DAPT\n",
      "DAPT\n",
      "bleeding\n",
      "bleeding\n",
      "bleeding\n",
      "bleeding\n",
      "bleeding\n",
      "toxicity\n",
      "bleeding\n",
      "bleeding\n",
      "bleeding\n",
      "thromboembolic\n",
      "toxicity\n",
      "Gastrointestinal bleeding\n",
      "Aspirin\n",
      "Ibuprofen\n",
      "Diclofenac\n",
      "Naproxen\n",
      "bone marrow suppression\n",
      "Leflunamide\n",
      "Hydroxychloroquine\n",
      "Adalimumab\n",
      "Infliximab\n",
      "Etanercept\n",
      "Sulfasalazine\n",
      "Penicillamine\n",
      "Methotrexate\n",
      "Azathioprine\n",
      "Mycophenolate\n",
      "serotonin\n",
      "Carbamazepine\n",
      "Fluconazole\n",
      "vascular disease\n",
      "Paracetamol\n",
      "Co-codamol\n",
      "bleeding\n",
      "Chronic kidney failure\n",
      "liver disease\n",
      "haematological malignancy\n",
      "heart failure\n",
      "bleeding disorders\n",
      "haemophilia\n",
      "Willebrand's disease\n",
      "idiopathic thrombocytopenic purpura\n",
      "Ginkgo biloba\n",
      "Nitrophorin\n",
      "(;\n",
      "death\n",
      "mummification\n",
      "Egyptian deities\n",
      "Nile\n",
      "Wepwawet\n",
      "Kebechet\n",
      "Anubis' name jnpw\n",
      "rˁ-nfr\n",
      "myths\n",
      "Khenty-Amentiu\n",
      "Nile\n",
      "tpy-ḏw.f\n",
      "iron\n",
      "Imiut\n",
      "Imiut\n",
      "king's corpse\n",
      "Nile\n",
      "imiut\n",
      "myths\n",
      "death\n",
      "Turner\n",
      "Down\n",
      "W.\n",
      "}} Lapp\n",
      "Günther\n",
      "Die Opferformel des\n",
      "S2CID\n",
      "Christina\n",
      "Zandee, Jan (1960)\n",
      "Death\n",
      "GGKEY\n",
      "Deities\n",
      "alexandrin\n",
      "E. J. Brill\n",
      "aorta\n",
      "left ventricle\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aortic valve\n",
      "left ventricle\n",
      "pulmonary trunk\n",
      "aorta\n",
      "pulmonary trunk\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aortic valve\n",
      "aorta\n",
      "pulmonary artery\n",
      "pulmonary trunk\n",
      "brachiocephalic trunk\n",
      "brachiocephalic trunk\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "celiac trunk\n",
      "aorta\n",
      "aorta\n",
      "pulmonary trunk\n",
      "aorta\n",
      "muscle of the great arteries\n",
      "aorta\n",
      "pulmonary artery\n",
      "aorta\n",
      "muscle of mesodermal\n",
      "truncus arteriosus\n",
      "aorta\n",
      "aorta\n",
      "muscle, nerves\n",
      "aorta\n",
      "aorta\n",
      "carbon dioxide\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "dextrocardia\n",
      "situs inversus\n",
      "aorta\n",
      "patent ductus arteriosus\n",
      "congenital disorder\n",
      "pulmonary artery\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "age\n",
      "aorta stiffens\n",
      "aorta\n",
      "diseases and pathologies\n",
      "hypertension\n",
      "aorta\n",
      "aorta\n",
      "veins\n",
      "left ventricle\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aneurysm\n",
      "mycotic\n",
      "syphilis\n",
      "valvular heart disease\n",
      "coarctation – pre-ductal\n",
      "stenosis\n",
      "aneurysm Aortitis\n",
      "inflammation\n",
      "aorta\n",
      "trauma\n",
      "infections\n",
      "autoimmune disease Atherosclerosis\n",
      "Ehlers–Danlos syndrome Marfan syndrome Trauma\n",
      "traumatic\n",
      "aorta\n",
      "aorta\n",
      "pulmonary artery\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "perforation\n",
      "death\n",
      "aorta\n",
      "Aorta\n",
      "oxygen\n",
      "carbon dioxide\n",
      "pulmonary artery\n",
      "catecholamines\n",
      "oxygen\n",
      "carbon dioxide\n",
      "carbon dioxide\n",
      "oxygen\n",
      "oxygen\n",
      "paraganglioma\n",
      "chemodectoma\n",
      "tumor\n",
      "aorta\n",
      "amlodipine\n",
      "atenolol\n",
      "CAP\n",
      "cardiovascular and kidney outcomes\n",
      "Hypertension\n",
      "doi:10.1038/sj.jhh.1001126\n",
      "Williams B\n",
      "PS\n",
      "doi:10.1161/CIRCULATIONAHA.105.595496\n",
      "vascular disease\n",
      "Hypertension\n",
      "66–70\n",
      "sinus of Valsalva\n",
      "aorta\n",
      "aortic valve\n",
      "aorta\n",
      "aortic valve\n",
      "ischaemia\n",
      "heart attack\n",
      "age\n",
      "exercise\n",
      "Morgagni\n",
      "Otto\n",
      "Aneurysm\n",
      "sinus of Valsalva References External links Anatomy\n",
      "photo:20:29\n",
      "aortic valve\n",
      "left ventricle\n",
      "aorta\n",
      "pulmonary valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "aorta\n",
      "aorta\n",
      "aortic valve\n",
      "pulmonary valve\n",
      "pulmonary valve\n",
      "congenital disease\n",
      "aortic valve\n",
      "pulmonary valve\n",
      "left ventricle\n",
      "left ventricle\n",
      "left ventricle\n",
      "aorta\n",
      "aortic valve\n",
      "left ventricle\n",
      "aorta\n",
      "left ventricle\n",
      "left ventricle\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "left ventricle\n",
      "left ventricle\n",
      "Abrupt loss of function\n",
      "aortic valve\n",
      "acute aortic insufficiency\n",
      "acute aortic insufficiency\n",
      "heart failure\n",
      "pulmonary edema\n",
      "chronic insufficiency\n",
      "hypertrophy\n",
      "left ventricle\n",
      "aortic valve\n",
      "calcification\n",
      "stenosis\n",
      "hypertrophy\n",
      "left ventricle\n",
      "ventricular hypertrophy\n",
      "heart failure\n",
      "Dysfunctional aortic valves often\n",
      "heart failure\n",
      "fatigue\n",
      "shortness of breath\n",
      "aorta\n",
      "rheumatic fever\n",
      "infection\n",
      "infective endocarditis\n",
      "degeneration of the aortic valve\n",
      "Marfan's syndrome\n",
      "Aortic stenosis\n",
      "rheumatic fever\n",
      "degenerative calcification\n",
      "congenital heart defect\n",
      "aortic valve\n",
      "Turner syndrome\n",
      "Aortic valve\n",
      "Aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic regurgitation\n",
      "aneurysm\n",
      "congenital aortic stenosis\n",
      "Aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "valve dysfunction\n",
      "aortic valve\n",
      "aorta\n",
      "embolism\n",
      "stroke\n",
      "calcification\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "pulmonary valve\n",
      "pulmonary valve\n",
      "valvular prothesis\n",
      "pulmonary valve\n",
      "aortic valve\n",
      "Endocarditis Endocarditis\n",
      "infection of the heart\n",
      "aortic valve\n",
      "aortic valve\n",
      "stenosis\n",
      "insufficiency\n",
      "valve dysfunction\n",
      "stenosis\n",
      "insufficiency\n",
      "aortic valve\n",
      "calcification\n",
      "bicuspid, unicuspid)\n",
      "aortic valve\n",
      "aortic valve\n",
      "left ventricle\n",
      "aorta\n",
      "20:07\n",
      "Aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "stenosis\n",
      "aortic stenosis\n",
      "stenosis\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "LV stroke\n",
      "aortic valve\n",
      "LV stroke\n",
      "Stroke\n",
      "Diameter2\n",
      "\\displaystyle {\\text{Aortic\n",
      "subvalvular stenosis\n",
      "Gorlin\n",
      "Gorlin\n",
      "Gorlin\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "\\displaystyle {\\text{Valve\n",
      "cm}}^{2}{\\text{)}}={\\frac {{\\text{Cardiac Output }}({\\frac {\\text{ml}}{\\text{min}}})}{{\\text{Heart rate }}({\\frac {\\text{beats}}{\\text{min}}})\\cdot {\\text{Systolic ejection\n",
      "Gorlin\n",
      "dobutamine\n",
      "Gorlin\n",
      "(bpm)}}\\cdot {\\text{systolic ejection\n",
      "\\displaystyle {\\text{Aortic\n",
      "Gorlin\n",
      "\\displaystyle {\\text{Valve Area\n",
      "cm}}^{2}{\\text{)}}={\\text{(0.83}}^{2}+{\\frac {\\frac {{\\text{Q (}}{\\frac {ml}{min}})}{\\text{60}}}{{\\text{0.35 }}\\cdot {\\sqrt {\\text{mean Gradient (dynes/cm2)}}}}}{\\text{)}}^{\\text{0.5}}-{\\text{0.87}}}     == References\n",
      "Aortic stenosis\n",
      "left ventricle\n",
      "aorta\n",
      "aortic valve\n",
      "exercise\n",
      "heart failure\n",
      "loss of consciousness\n",
      "chest pain\n",
      "Loss of consciousness\n",
      "heart failure\n",
      "shortness of breath\n",
      "exercise\n",
      "aortic sclerosis\n",
      "bicuspid aortic valve\n",
      "rheumatic fever\n",
      "aortic valve\n",
      "rheumatic heart disease\n",
      "coronary artery disease\n",
      "smoking\n",
      "high blood pressure\n",
      "cholesterol\n",
      "diabetes\n",
      "aortic valve\n",
      "left ventricle\n",
      "aorta\n",
      "stenosis\n",
      "aortic valve\n",
      "heart failure\n",
      "ACE inhibitors\n",
      "nitroglycerin\n",
      "Nitroprusside\n",
      "phenylephrine\n",
      "heart failure\n",
      "stenosis\n",
      "valvular heart disease\n",
      "age\n",
      "death\n",
      "stenosis\n",
      "Rivière\n",
      "stenosis\n",
      "stenosis\n",
      "stenosis\n",
      "aortic stenosis\n",
      "stenosis\n",
      "stenosis\n",
      "loss of consciousness\n",
      "chest pain\n",
      "shortness of breath\n",
      "heart failure\n",
      "shortness of breath\n",
      "shortness of breath\n",
      "Angina\n",
      "Angina\n",
      "heart failure\n",
      "death\n",
      "angina\n",
      "aortic valve\n",
      "Angina\n",
      "ventricular hypertrophy\n",
      "left ventricle\n",
      "oxygen\n",
      "ischemia\n",
      "exercise\n",
      "heart muscle\n",
      "anginal chest pain\n",
      "stress\n",
      "ischemia\n",
      "depression\n",
      "subendocardial ischemia\n",
      "subendocardium\n",
      "ischemia\n",
      "Syncope Syncope\n",
      "fainting\n",
      "valve stenosis\n",
      "exertional\n",
      "heart failure\n",
      "death\n",
      "syncope\n",
      "aortic valve\n",
      "aortic stenosis\n",
      "syncope\n",
      "aortic stenosis\n",
      "exercise\n",
      "left ventricle\n",
      "loss of consciousness\n",
      "stenosis\n",
      "hypertrophy\n",
      "left ventricle\n",
      "stenosis\n",
      "Angina\n",
      "abnormal heart rhythms\n",
      "syncope\n",
      "calcific aortic stenosis\n",
      "calcification\n",
      "aortic valve\n",
      "heart block\n",
      "syncope\n",
      "Congestive heart failure Congestive heart failure\n",
      "CHF\n",
      "CHF\n",
      "aortic valve\n",
      "CHF\n",
      "ventricular hypertrophy\n",
      "fibrosis\n",
      "systolic dysfunction\n",
      "diastolic dysfunction\n",
      "Heyde's syndrome\n",
      "stenosis\n",
      "gastrointestinal bleeding\n",
      "angiodysplasia\n",
      "stenosis\n",
      "Willebrand disease\n",
      "endocarditis\n",
      "endocarditis\n",
      "congenital heart disease\n",
      "aortic valve\n",
      "stenosis\n",
      "syncope\n",
      "cardiovascular diseases\n",
      "aortic stenosis\n",
      "nitroglycerin\n",
      "nitrates\n",
      "ACE inhibitors\n",
      "terazosin\n",
      "Hytrin\n",
      "hydralazine\n",
      "stenosis\n",
      "stenosis\n",
      "obstruction of blood flow\n",
      "aortic valve\n",
      "syncope\n",
      "stenosis\n",
      "calcification\n",
      "age\n",
      "stenosis\n",
      "calcification of a\n",
      "congenital bicuspid aortic valve\n",
      "congenital unicuspid aortic valve\n",
      "unicuspid aortic valves typically\n",
      "congenital bicuspid aortic valve\n",
      "rheumatic fever\n",
      "stenosis\n",
      "Fabry disease\n",
      "systemic lupus erythematosus\n",
      "Paget disease\n",
      "high blood uric acid\n",
      "infection\n",
      "aortic valve\n",
      "left ventricle\n",
      "aorta\n",
      "left ventricle\n",
      "aortic valve\n",
      "aorta\n",
      "left ventricle\n",
      "stenosis\n",
      "aortic valve\n",
      "calcification\n",
      "bicuspid aortic stenosis\n",
      "stress\n",
      "Inflammation\n",
      "cholesterol\n",
      "lipoprotein(a\n",
      "aortic valve\n",
      "stenosis\n",
      "stenosis\n",
      "left ventricle\n",
      "aorta\n",
      "myocardial hypertrophy\n",
      "hypertrophy\n",
      "concentric hypertrophy\n",
      "left ventricle\n",
      "valve diseases\n",
      "inflammation\n",
      "stenosis\n",
      "pulsus parvus\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "stenotic pulmonary valve\n",
      "isometric muscular contraction\n",
      "hypertrophic obstructive cardiomyopathy\n",
      "HOCM\n",
      "stenosis\n",
      "aortic stenosis\n",
      "calcification of the valve\n",
      "aortic valve\n",
      "hypertrophy\n",
      "stenosis\n",
      "aortic regurgitation\n",
      "stenosis\n",
      "valve abnormalities\n",
      "aortic stenosis\n",
      "insufficiency\n",
      "stenosis\n",
      "3.1–50).Other\n",
      "systolic dysfunction\n",
      "left ventricle\n",
      "stenosis\n",
      "electrocardiographic abnormalities\n",
      "ventricular hypertrophy\n",
      "stenosis\n",
      "stenosis\n",
      "high-pressure\n",
      "left ventricle\n",
      "left ventricle\n",
      "stenosis\n",
      "aortic valve\n",
      "heart block\n",
      "bundle branch block\n",
      "stenosis\n",
      "aortic valve\n",
      "stenosis\n",
      "aortic valve\n",
      "stroke\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic stenosis\n",
      "mitral stenosis\n",
      "heart failure\n",
      "ischaemic heart disease\n",
      "oxygen\n",
      "ischemia).Echocardiogram\n",
      "left ventricular hypertrophy\n",
      "aortic valve\n",
      "X-ray A chest\n",
      "calcification of the valve\n",
      "left ventricle\n",
      "stress\n",
      "valve stenosis\n",
      "statins\n",
      "decrease in ischemic cardiovascular\n",
      "stenosis\n",
      "aortic stenosis\n",
      "angina\n",
      "beta-blockers\n",
      "calcium\n",
      "Nitrates\n",
      "hypotension\n",
      "aortic stenosis\n",
      "hypertension\n",
      "beta-blockers\n",
      "heart failure\n",
      "digoxin\n",
      "ACE inhibitors\n",
      "cholesterol\n",
      "statins\n",
      "calcific aortic stenosis\n",
      "aortic stenosis\n",
      "statin\n",
      "Aortic valve\n",
      "Aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic regurgitation\n",
      "aneurysm\n",
      "congenital aortic stenosis\n",
      "Aortic valve\n",
      "aortic stenosis\n",
      "aortic valve\n",
      "stenosis\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "aortic valve\n",
      "Heart failure Acute decompensated heart failure\n",
      "high blood pressure\n",
      "nitroprusside\n",
      "Phenylephrine\n",
      "stenosis\n",
      "aortic valve\n",
      "age\n",
      "age\n",
      "age\n",
      "valve stenosis\n",
      "coronary artery disease\n",
      "hypertension\n",
      "age\n",
      "hyperlipidemia\n",
      "diabetes mellitus\n",
      "smoking\n",
      "metabolic syndrome\n",
      "end-stage kidney disease\n",
      "stenosis\n",
      "Rivière\n",
      "bisphosphonates\n",
      "stenosis\n",
      "stenosis\n",
      "ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS\n",
      "doi:10.1016/j.jacc.2017.09.018\n",
      "Archosauria\n",
      "Archosauria\n",
      "Archosauria\n",
      "Archosauria\n",
      "proterosuchids\n",
      "Archosauria\n",
      "Archosauria\n",
      "crocodilian-line\n",
      "Teleocrater\n",
      "oxygen\n",
      "uric acid\n",
      "uric acid\n",
      "aglandular (glandless)\n",
      "urea\n",
      "Pseudosuchia\n",
      "suture\n",
      "age\n",
      "Teleocrater\n",
      "Archosauria\n",
      "Archosauria\n",
      "proterochampsids\n",
      "Archosauria\n",
      "proterosuchids\n",
      "Archosauria\n",
      "Archosauria\n",
      "Archosauria\n",
      "Archosauria\n",
      "Archosauria\n",
      "Ornithosuchids\n",
      "Archosauria\n",
      "Ornithosuchia\n",
      "Ornithosuchia\n",
      "proterosuchids\n",
      "Archosauria\n",
      "Archosauria\n",
      "Ornithosuchia\n",
      "Ornithosuchia\n",
      "Archosauria\n",
      "Ornithosuchia\n",
      "cladogram\n",
      "branch-based\n",
      "cladogram\n",
      "Archosauria\n",
      "Archosauria\n",
      "Archosauria\n",
      "cladogram\n",
      "Hip joints\n",
      "hip joints\n",
      "Diet\n",
      "teleosaurs\n",
      "fluke\n",
      "oxygen\n",
      "oxygen\n",
      "palate\n",
      "right ventricle\n",
      "pulmonary artery\n",
      "terrestrial predators\n",
      "gas\n",
      "Archosauria\n",
      "gas\n",
      "oxygen\n",
      "sex\n",
      "sex\n",
      "R. L. (1988)\n",
      "W.\n",
      "Archosauria\n",
      "oxygen\n",
      "carbon dioxide\n",
      "right atrium\n",
      "oxygen\n",
      "right atrium\n",
      "inferior venae cavae\n",
      "right ventricle\n",
      "oxygen\n",
      "carbon dioxide\n",
      "left atrium\n",
      "left ventricle\n",
      "aorta\n",
      "circulation−where\n",
      "oxygen\n",
      "carbon dioxide\n",
      "heart beats\n",
      "Exercise\n",
      "Cardiovascular diseases\n",
      "death\n",
      "deaths\n",
      "coronary artery disease\n",
      "stroke\n",
      "smoking\n",
      "exercise\n",
      "cholesterol\n",
      "high blood pressure\n",
      "diabetes\n",
      "Cardiovascular diseases\n",
      "chest pain\n",
      "shortness of breath\n",
      "heart disease\n",
      "diseases of the heart\n",
      "aorta\n",
      "pulmonary trunk\n",
      "cardiac notch\n",
      "exercise\n",
      "heart muscle\n",
      "right atrium\n",
      "left atrium\n",
      "right atrium\n",
      "right ventricle\n",
      "left atrium\n",
      "left ventricle\n",
      "right atrium\n",
      "right ventricle\n",
      "tricuspid valve\n",
      "tricuspid valve\n",
      "mitral valve\n",
      "left atrium\n",
      "left ventricle\n",
      "pulmonary valve\n",
      "pulmonary artery\n",
      "aortic valve\n",
      "aorta\n",
      "aorta\n",
      "right atrium\n",
      "right ventricle\n",
      "tricuspid valve\n",
      "right atrium\n",
      "veins\n",
      "right atrium\n",
      "inferior vena cava\n",
      "right atrium\n",
      "depression\n",
      "right atrium\n",
      "depression\n",
      "right atrium\n",
      "right ventricle\n",
      "tricuspid valve\n",
      "right ventricle\n",
      "cardiac muscle\n",
      "cardiac muscle\n",
      "right ventricle\n",
      "right ventricle\n",
      "inferior papillary muscle\n",
      "right ventricle\n",
      "pulmonary trunk\n",
      "pulmonary valve\n",
      "pulmonary trunk\n",
      "left atrium\n",
      "left ventricle\n",
      "mitral valve\n",
      "left atrium\n",
      "left atrium\n",
      "right atrium\n",
      "left atrium\n",
      "left atrium\n",
      "left ventricle\n",
      "mitral valve\n",
      "left ventricle\n",
      "right ventricle\n",
      "left ventricle\n",
      "aortic valve\n",
      "aorta\n",
      "aortic valve\n",
      "heart muscle\n",
      "endothelins\n",
      "cardiac muscle—a\n",
      "involuntary striated muscle\n",
      "cardiac muscle\n",
      "cardiac muscle\n",
      "Cardiac muscle\n",
      "muscle contraction\n",
      "myosin\n",
      "tropomyosin\n",
      "LDB3\n",
      "lubricate\n",
      "lubricate\n",
      "infection\n",
      "oxygen\n",
      "heart muscle's relaxation\n",
      "aortic valve\n",
      "aorta\n",
      "left ventricle\n",
      "left ventricle\n",
      "right atrium\n",
      "right ventricle\n",
      "left ventricle\n",
      "right atrium\n",
      "cardiac vein\n",
      "left atrium\n",
      "left ventricle\n",
      "small cardiac veins\n",
      "right ventricle\n",
      "right atrium\n",
      "left ventricle\n",
      "pulmonary artery\n",
      "left atrium\n",
      "right atrium\n",
      "right ventricle\n",
      "aorta\n",
      "norepinephrine\n",
      "noradrenaline\n",
      "sodium\n",
      "calcium\n",
      "Norepinephrine\n",
      "right atrium\n",
      "left atrium\n",
      "depression\n",
      "right atrium\n",
      "165–185\n",
      "carbon dioxide\n",
      "oxygen\n",
      "oxygen\n",
      "carbon dioxide\n",
      "veins\n",
      "left atrium\n",
      "superior vena cava\n",
      "right atrium\n",
      "inferior vena cava drains the blood\n",
      "superior vena cava\n",
      "inferior vena cava\n",
      "right atrium\n",
      "right atrium\n",
      "right atrium\n",
      "tricuspid valve\n",
      "right ventricle\n",
      "right ventricle\n",
      "tricuspid valve\n",
      "pulmonary valve\n",
      "pulmonary trunk\n",
      "carbon dioxide\n",
      "oxygen\n",
      "left atrium\n",
      "left ventricle\n",
      "mitral valve\n",
      "aorta\n",
      "aortic valve\n",
      "aorta\n",
      "oxygen\n",
      "carbon dioxide\n",
      "aorta\n",
      "pulmonary artery\n",
      "mitral and tricuspid valves\n",
      "mitral and tricuspid valves\n",
      "aorta\n",
      "right atrium\n",
      "left atrium\n",
      "aorta\n",
      "mitral and tricuspid valves\n",
      "stroke\n",
      "stroke\n",
      "stroke\n",
      "4.0–8.0\n",
      "stroke\n",
      "sex\n",
      "stenosis\n",
      "heart muscle\n",
      "stroke\n",
      "adrenaline\n",
      "noradrenaline\n",
      "dopamine\n",
      "calcium\n",
      "right atrium\n",
      "superior vena cava\n",
      "right atrium\n",
      "left atrium\n",
      "right atrium\n",
      "right atrium\n",
      "left ventricle\n",
      "heart muscle\n",
      "right atrium\n",
      "sodium\n",
      "sodium\n",
      "calcium\n",
      "potassium\n",
      "potassium\n",
      "calcium\n",
      "calcium\n",
      "potassium\n",
      "potassium\n",
      "potassium\n",
      "sodium\n",
      "potassium\n",
      "Calcium\n",
      "Calcium\n",
      "cardiac muscle\n",
      "exercise\n",
      "oxygen\n",
      "carbon dioxide\n",
      "aorta\n",
      "carbon dioxide\n",
      "oxygen\n",
      "carbon dioxide\n",
      "Exercise\n",
      "age\n",
      "epinephrine\n",
      "norepinephrine\n",
      "calcium\n",
      "potassium\n",
      "sodium\n",
      "oxygen\n",
      "dehydration\n",
      "Diseases Cardiovascular diseases\n",
      "diseases of the heart\n",
      "death\n",
      "cardiovascular disease\n",
      "Heart disease\n",
      "death\n",
      "deaths\n",
      "diseases of the heart\n",
      "Ischaemic heart disease Coronary artery disease\n",
      "ischaemic heart disease\n",
      "atherosclerosis\n",
      "fatty deposits\n",
      "atherosclerotic\n",
      "stenosis\n",
      "narrowings\n",
      "chest pain\n",
      "angina\n",
      "breathlessness\n",
      "exercise\n",
      "atherosclerotic\n",
      "thrombus\n",
      "heart muscle\n",
      "myocardial infarction\n",
      "heart attack\n",
      "unstable angina\n",
      "cardiac arrest\n",
      "Obesity\n",
      "high blood pressure\n",
      "diabetes\n",
      "smoking\n",
      "cholesterol\n",
      "atherosclerosis\n",
      "coronary artery disease\n",
      "Heart failure Heart failure\n",
      "heart failure\n",
      "breathlessness\n",
      "ankle swelling\n",
      "peripheral oedema\n",
      "Heart failure\n",
      "diseases affecting the heart\n",
      "ischaemic heart disease\n",
      "valvular heart disease\n",
      "high blood pressure\n",
      "cardiomyopathies\n",
      "Heart failure\n",
      "weakness of the heart muscle\n",
      "systolic heart failure\n",
      "heart muscle\n",
      "heart failure\n",
      "left ventricle\n",
      "predominantly breathlessness\n",
      "right ventricle\n",
      "heart failure\n",
      "arrhythmias\n",
      "Cardiomyopathies Cardiomyopathies\n",
      "abnormal thickening of the heart muscle\n",
      "hypertrophic cardiomyopathy\n",
      "dilated cardiomyopathy\n",
      "heart muscle\n",
      "cardiomyopathy\n",
      "arrhythmogenic cardiomyopathy\n",
      "dilated cardiomyopathy\n",
      "alcohol\n",
      "cardiomyopathies\n",
      "hypertrophic cardiomopathy\n",
      "cardiac death\n",
      "cardiomyopathies\n",
      "heart failure\n",
      "Valvular heart disease\n",
      "Diseased\n",
      "valvular regurgitation\n",
      "Valvular heart disease\n",
      "breathlessness\n",
      "chest pain\n",
      "valvular heart disease\n",
      "age\n",
      "infection of the heart valves\n",
      "endocarditis\n",
      "heart disease\n",
      "valvular heart disease\n",
      "stenosis\n",
      "throat infection\n",
      "Cardiac arrhythmias\n",
      "arrhythmias\n",
      "palpitations\n",
      "breathlessness\n",
      "arrhythmia\n",
      "atrial fibrillation\n",
      "stroke\n",
      "arrhythmias\n",
      "bradycardia\n",
      "bradyarrhythmia\n",
      "arrhythmias\n",
      "tachycardia\n",
      "tachyarrhythmia\n",
      "arrhythmias\n",
      "atrial flutter\n",
      "re-entrant tachycardia\n",
      "ventricular tachycardia\n",
      "tachyarrhythmias\n",
      "ventricular tachycardia\n",
      "atrial tachycardia\n",
      "Wolff-Parkinson-White syndrome\n",
      "ventricular fibrillation\n",
      "Pericardial disease\n",
      "pericarditis\n",
      "chest pain\n",
      "viral infection\n",
      "glandular fever\n",
      "pericardial effusion\n",
      "Pericardial effusions\n",
      "pericarditis\n",
      "kidney failure\n",
      "tumours\n",
      "cardiac tamponade\n",
      "breathlessness\n",
      "tamponade\n",
      "pericardiocentesis\n",
      "Congenital heart disease\n",
      "congenital heart defects\n",
      "patent foramen ovale\n",
      "life-threatening abnormalities\n",
      "hypoplastic left heart syndrome\n",
      "ventricular septal defect\n",
      "congenital aortic stenosis\n",
      "coarctation of the aorta\n",
      "congenital heart defects\n",
      "oxygen\n",
      "cyanotic congenital heart defects\n",
      "congenital heart defects\n",
      "breathlessness\n",
      "congenital heart disease\n",
      "atrial septal defect\n",
      "Heart disease\n",
      "valvular or cardiac problems\n",
      "quadruple\n",
      "Heart murmurs\n",
      "congenital heart disease\n",
      "ventricular septal defects\n",
      "pericarditis\n",
      "rub\n",
      "Troponin\n",
      "troponin\n",
      "heart failure\n",
      "left ventricle\n",
      "cardiac disease\n",
      "creatine\n",
      "heart disease\n",
      "anaemia\n",
      "cholesterol\n",
      "diabetes\n",
      "ground).There\n",
      "rhythm disturbances\n",
      "rhythm abnormality\n",
      "valve disease\n",
      "stenosis\n",
      "blood (regurgitation\n",
      "stroke\n",
      "stress\n",
      "exercise\n",
      "dobutamine\n",
      "pulmonary oedema\n",
      "aorta\n",
      "Diseases affecting the heart\n",
      "Ischaemic heart disease Narrowings of the coronary arteries (ischaemic heart disease\n",
      "chest pain\n",
      "artery (angina pectoris\n",
      "heart muscle damage\n",
      "myocardial infarction\n",
      "myocardial infarction\n",
      "angina\n",
      "nitroglycerin\n",
      "calcium\n",
      "antiplatelets\n",
      "aspirin\n",
      "statins\n",
      "smoking\n",
      "weight loss\n",
      "high blood pressure\n",
      "diabetes\n",
      "narrowings\n",
      "narrowings\n",
      "narrowings\n",
      "aorta\n",
      "Valvular heart disease Diseased heart valves\n",
      "aortic valve\n",
      "Cardiac arrhythmias\n",
      "arrhythmias\n",
      "calcium\n",
      "sodium\n",
      "amiodarone\n",
      "digoxin\n",
      "atropine\n",
      "arrhythmias\n",
      "atrial fibrillation\n",
      "stroke\n",
      "warfarin\n",
      "arrhythmia\n",
      "arrhythmia\n",
      "arrhythmias\n",
      "arrhythmias\n",
      "atrial fibrillation\n",
      "shock\n",
      "arrhythmias\n",
      "shock\n",
      "heart failure\n",
      "cardiomyopathies\n",
      "arrhythmia\n",
      "Heart failure\n",
      "heart failure\n",
      "ischaemic heart disease\n",
      "hypertension\n",
      "heart failure\n",
      "ACE inhibitors and mineralocorticoid receptor antagonists).In\n",
      "heart failure\n",
      "heart failure\n",
      "Galen\n",
      "Galen believed the arterial blood\n",
      "left ventricle\n",
      "pulmonary artery\n",
      "left ventricle\n",
      "Galen\n",
      "Galen\n",
      "Galen's beliefs of the heart\n",
      "De humani corporis\n",
      "magnum\n",
      "attacks\n",
      "Otto\n",
      "1865–1944\n",
      "Tawara's discovery of the atrioventricular\n",
      "heart disease\n",
      "infectious disease\n",
      "death\n",
      "deaths\n",
      "diet\n",
      "exercise\n",
      "aspirin\n",
      "ACE inhibitors\n",
      "chronic heart failure\n",
      "death\n",
      "xīn\n",
      "神\n",
      "Hrd\n",
      "Galen\n",
      "heart-soul (tona-tiuh):\n",
      "pulsating\"\".In\n",
      "beef, pork,\n",
      "grilled or braised\n",
      "anticuchos de corazón, barbecued beef\n",
      "spice\n",
      "braised stuffed beef heart\n",
      "heart is stewed,\n",
      "braised\n",
      "right atrium\n",
      "pulmonary artery\n",
      "aorta\n",
      "conus arteriosus\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "aorta\n",
      "conus arteriosus\n",
      "right atrium\n",
      "oxygen\n",
      "oxygen\n",
      "Oxygen\n",
      "small muscular\n",
      "aorta\n",
      "Nicki R. Colledge\n",
      "129–134\n",
      "nitric oxide\n",
      "polyphenols\n",
      "nitric oxide\n",
      "L-arginine\n",
      "luminal\n",
      "hypertensive\n",
      "arteriolosclerosis\n",
      "luminal\n",
      "stroke\n",
      "gas\n",
      "carbon dioxide\n",
      "oxygen\n",
      "norepinephrine\n",
      "epinephrine\n",
      "cardiac muscle\n",
      "oxygen\n",
      "carbon dioxide\n",
      "oxygen\n",
      "angiotensin II\n",
      "bradykinin\n",
      "prostacyclin\n",
      "age\n",
      "stenosis\n",
      "hypertension\n",
      "Arteriosclerosis\n",
      "hypertension\n",
      "atherosclerosis\n",
      "Arteritis\n",
      "muscular contraction\n",
      "dihydropyridines\n",
      "nifedipine\n",
      "nicardipine\n",
      "calcium\n",
      "Arrhythmogenic cardiomyopathy\n",
      "ACM\n",
      "arrhythmogenic right ventricular dysplasia\n",
      "ARVD\n",
      "arrhythmogenic right ventricular cardiomyopathy\n",
      "ARVC\n",
      "heart disease\n",
      "ACM\n",
      "heart muscle\n",
      "right ventricle\n",
      "left ventricular disease\n",
      "arrhythmias\n",
      "right ventricle\n",
      "ARVD\n",
      "ACM\n",
      "dysplasia of the ventricular wall\n",
      "ACM\n",
      "left ventricle\n",
      "name ARVC\n",
      "ACM\n",
      "keratoderma\n",
      "Naxos disease\n",
      "stress\n",
      "ventricular arrhythmias\n",
      "arrhythmogenic cardiomyopathy\n",
      "arrhythmias\n",
      "arrhythmogenic cardiomyopathy\n",
      "palpitations\n",
      "Sudden death\n",
      "ACM\n",
      "ACM\n",
      "right ventricle\n",
      "fatigue\n",
      "ankle swelling\n",
      "shortness of breath\n",
      "ACM\n",
      "ACM\n",
      "ACM\n",
      "ACM\n",
      "DES\n",
      "ACM\n",
      "DES\n",
      "abnormal aggregation\n",
      "ACM\n",
      "ACM\n",
      "programmed cell death\n",
      "right ventricle\n",
      "ventricular disease\n",
      "biventricular disease\n",
      "aneurysmal dilatation\n",
      "Aneurysmal dilatation\n",
      "dysplasia\n",
      "left ventricle\n",
      "left ventricle\n",
      "ACM\n",
      "Fatty infiltration\n",
      "fibro-fatty infiltration\n",
      "Fatty infiltration\n",
      "fatty infiltration\n",
      "right ventricle\n",
      "fatty\n",
      "left ventricle\n",
      "fatty infiltration\n",
      "death\n",
      "fatty infiltration\n",
      "Fibro-fatty infiltration\n",
      "fibro-fatty infiltration\n",
      "myocarditis\n",
      "Myocardial atrophy\n",
      "aneurysm\n",
      "Exercise\n",
      "exercise\n",
      "Ventricular arrhythmias Ventricular arrhythmias\n",
      "ACM\n",
      "right ventricle\n",
      "arrhythmia\n",
      "premature ventricular complexes (PVCs\n",
      "ventricular tachycardia\n",
      "ventricular fibrillation\n",
      "VF\n",
      "ventricular arrhythmias\n",
      "Ventricular arrhythmias\n"
     ]
    }
   ],
   "source": [
    "for ents in doc_ner1.ents:\n",
    "    print(ents)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">&quot;The heart is a muscular organ in most animals, which pumps blood through the blood vessels of the circulatory system. The pumped blood carries \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and nutrients to the body, while carrying metabolic waste such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to the lungs. In humans, the heart is approximately the size of a closed fist and is located between the lungs, in the middle compartment of the chest.In humans, other mammals, and birds, the heart is divided into four chambers: upper left and right atria and lower left and right ventricles. Commonly the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and ventricle are referred together as the right heart and their left counterparts as the left heart. Fish, in contrast, have two chambers, an atrium and a ventricle, while reptiles have three chambers. In a healthy heart blood flows one way through the heart due to heart valves, which prevent backflow. The heart is enclosed in a protective sac, the pericardium, which also contains a small amount of fluid. The wall of the heart is made up of three layers: epicardium, myocardium, and endocardium.The heart pumps blood with a rhythm determined by a group of pacemaker cells in the sinoatrial node. These generate a current that causes contraction of the heart, traveling through the atrioventricular node and along the conduction system of the heart. The heart receives blood low in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " from the systemic circulation, which enters the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " from the superior and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inferior venae cavae\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and passes to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". From here it is pumped into the pulmonary circulation, through the lungs where it receives \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and gives off \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Oxygenated blood then returns to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", passes through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and is pumped out through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to the systemic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    circulation−where\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is used and metabolized to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart beats\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " at a resting rate close to 72 beats per minute. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " temporarily increases the rate, but lowers resting heart rate in the long term, and is good for heart health.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiovascular diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (CVD) are the most common cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " globally as of 2008, accounting for 30% of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deaths\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Of these more than three-quarters are a result of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Risk factors include: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", being overweight, little \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ", high \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", and poorly controlled \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", among others. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiovascular diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " frequently do not have symptoms or may cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shortness of breath\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Diagnosis of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is often done by the taking of a medical history, listening to the heart-sounds with a stethoscope, ECG, echocardiogram, and ultrasound. Specialists who focus on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diseases of the heart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are called cardiologists, although many specialties of medicine may be involved in treatment. Structure Location and shape The human heart is situated in the mediastinum, at the level of thoracic vertebrae T5-T8. A double-membraned sac called the pericardium surrounds the heart and attaches to the mediastinum. The back surface of the heart lies near the vertebral column, and the front surface sits behind the sternum and rib cartilages. The upper part of the heart is the attachment point for several large blood vessels—the venae cavae, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary trunk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The upper part of the heart is located at the level of the third costal cartilage. The lower tip of the heart, the apex, lies to the left of the sternum (8 to 9 cm from the midsternal line) between the junction of the fourth and fifth ribs near their articulation with the costal cartilages.The largest part of the heart is usually slightly offset to the left side of the chest (though occasionally it may be offset to the right) and is felt to be on the left because the left heart is stronger and larger, since it pumps to all body parts. Because the heart is between the lungs, the left lung is smaller than the right lung and has a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac notch\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in its border to accommodate the heart. The heart is cone-shaped, with its base positioned upwards and tapering down to the apex. An adult heart has a mass of 250–350 grams (9–12 oz). The heart is often described as the size of a fist: 12 cm (5 in) in length, 8 cm (3.5 in) wide, and 6 cm (2.5 in) in thickness, although this description is disputed, as the heart is likely to be slightly larger. Well-trained athletes can have much larger hearts due to the effects of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " on the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", similar to the response of skeletal muscle. Chambers The heart has four chambers, two upper atria, the receiving chambers, and two lower ventricles, the discharging chambers. The atria open into the ventricles via the atrioventricular valves, present in the atrioventricular septum. This distinction is visible also on the surface of the heart as the coronary sulcus. There is an ear-shaped structure in the upper \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " called the right atrial appendage, or auricle, and another in the upper \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", the left atrial appendage. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " together are sometimes referred to as the right heart. Similarly, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " together are sometimes referred to as the left heart. The ventricles are separated from each other by the interventricular septum, visible on the surface of the heart as the anterior longitudinal sulcus and the posterior interventricular sulcus.The cardiac skeleton is made of dense connective tissue and this gives structure to the heart. It forms the atrioventricular septum, which separates the atria from the ventricles, and the fibrous rings, which serve as bases for the four heart valves. The cardiac skeleton also provides an important boundary in the heart's electrical conduction system since collagen cannot conduct electricity. The interatrial septum separates the atria, and the interventricular septum separates the ventricles. The interventricular septum is much thicker than the interatrial septum since the ventricles need to generate greater pressure when they contract. Valves The heart has four valves, which separate its chambers. One valve lies between each atrium and ventricle, and one valve rests at the exit of each ventricle.The valves between the atria and ventricles are called the atrioventricular valves. Between the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tricuspid valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tricuspid valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " has three cusps, which connect to chordae tendinae and three papillary muscles named the anterior, posterior, and septal muscles, after their relative positions. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " lies between the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". It is also known as the bicuspid valve due to its having two cusps, an anterior and a posterior cusp. These cusps are also attached via chordae tendinae to two papillary muscles projecting from the ventricular wall.The papillary muscles extend from the walls of the heart to valves by cartilaginous connections called chordae tendinae. These muscles prevent the valves from falling too far back when they close. During the relaxation phase of the cardiac cycle, the papillary muscles are also relaxed and the tension on the chordae tendineae is slight. As the heart chambers contract, so do the papillary muscles. This creates tension on the chordae tendineae, helping to hold the cusps of the atrioventricular valves in place and preventing them from being blown back into the atria. Two additional semilunar valves sit at the exit of each of the ventricles. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is located at the base of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". This has three cusps which are not attached to any papillary muscles. When the ventricle relaxes blood flows back into the ventricle from the artery and this flow of blood fills the pocket-like valve, pressing against the cusps which close to seal the valve. The semilunar \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is at the base of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and also is not attached to papillary muscles. This too has three cusps which close with the pressure of the blood flowing back from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Right heart The right heart consists of two chambers, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", separated by a valve, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tricuspid valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " receives blood almost continuously from the body's two major \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    veins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the superior and inferior venae cavae. A small amount of blood from the coronary circulation also drains into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " via the coronary sinus, which is immediately above and to the middle of the opening of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inferior vena cava\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In the wall of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is an oval-shaped \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " known as the fossa ovalis, which is a remnant of an opening in the fetal heart known as the foramen ovale. Most of the internal surface of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is smooth, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the fossa ovalis is medial, and the anterior surface has prominent ridges of pectinate muscles, which are also present in the right atrial appendage.The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is connected to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " by the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tricuspid valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The walls of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " are lined with trabeculae carneae, ridges of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " covered by endocardium. In addition to these muscular ridges, a band of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", also covered by endocardium, known as the moderator band reinforces the thin walls of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and plays a crucial role in cardiac conduction. It arises from the lower part of the interventricular septum and crosses the interior space of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to connect with the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inferior papillary muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " tapers into the pulmonary trunk, into which it ejects blood when contracting. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary trunk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " branches into the left and right pulmonary arteries that carry the blood to each lung. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " lies between the right heart and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary trunk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Left heart The left heart has two chambers: the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", separated by the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " receives oxygenated blood back from the lungs via one of the four pulmonary veins. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " has an outpouching called the left atrial appendage. Like the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is lined by pectinate muscles. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is connected to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " by the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is much thicker as compared with the right, due to the greater force needed to pump blood to the entire body. Like the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", the left also has trabeculae carneae, but there is no moderator band. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " pumps blood to the body through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Two small openings above the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " carry blood to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; the left coronary artery is above the left cusp of the valve,  and the right coronary artery is above the right cusp. Wall The heart wall is made up of three layers: the inner endocardium, middle myocardium and outer epicardium. These are surrounded by a double-membraned sac called the pericardium. The innermost layer of the heart is called the endocardium. It is made up of a lining of simple squamous epithelium and covers heart chambers and valves. It is continuous with the endothelium of the veins and arteries of the heart, and is joined to the myocardium with a thin layer of connective tissue. The endocardium, by secreting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    endothelins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", may also play a role in regulating the contraction of the myocardium. The middle layer of the heart wall is the myocardium, which is the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle—a\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " layer of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    involuntary striated muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " tissue surrounded by a framework of collagen. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " pattern is elegant and complex, as the muscle cells swirl and spiral around the chambers of the heart, with the outer muscles forming a figure 8 pattern around the atria and around the bases of the great vessels and the inner muscles, forming a figure 8 around the two ventricles and proceeding toward the apex. This complex swirling pattern allows the heart to pump blood more effectively.There are two types of cells in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ": muscle cells which have the ability to contract easily, and pacemaker cells of the conducting system. The muscle cells make up the bulk (99%) of cells in the atria and ventricles. These contractile cells are connected by intercalated discs which allow a rapid response to impulses of action potential from the pacemaker cells. The intercalated discs allow the cells to act as a syncytium and enable the contractions that pump blood through the heart and into the major arteries. The pacemaker cells make up 1% of cells and form the conduction system of the heart. They are generally much smaller than the contractile cells and have few myofibrils which gives them limited contractibility. Their function is similar in many respects to neurons. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiac muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " tissue has autorhythmicity, the unique ability to initiate a cardiac action potential at a fixed rate—spreading the impulse rapidly from cell to cell to trigger the contraction of the entire heart.There are specific proteins expressed in cardiac muscle cells. These are mostly associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle contraction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and bind with actin, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tropomyosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and troponin. They include MYH6, ACTC1, TNNI3, CDH2 and PKP2. Other proteins expressed are MYH7 and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LDB3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " that are also expressed in skeletal muscle. Pericardium The pericardium is the sac that surrounds the heart. The tough outer surface of the pericardium is called the fibrous membrane. This is lined by a double inner membrane called the serous membrane that produces pericardial fluid to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lubricate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " the surface of the heart. The part of the serous membrane attached to the fibrous membrane is called the parietal pericardium, while the part of the serous membrane attached to the heart is known as the visceral pericardium. The pericardium is present in order to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lubricate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " its movement against other structures within the chest, to keep the heart's position stabilised within the chest, and to protect the heart from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Coronary circulation Heart tissue, like all cells in the body, needs to be supplied with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", nutrients and a way of removing metabolic wastes. This is achieved by the coronary circulation, which includes arteries, veins, and lymphatic vessels. Blood flow through the coronary vessels occurs in peaks and troughs relating to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle's relaxation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or contraction.Heart tissue receives blood from two arteries which arise just above the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". These are the left main coronary artery and the right coronary artery. The left main coronary artery splits shortly after leaving the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " into two vessels, the left anterior descending and the left circumflex artery. The left anterior descending artery supplies heart tissue and the front, outer side, and septum of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". It does this by branching into smaller arteries—diagonal and septal branches. The left circumflex supplies the back and underneath of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The right coronary artery supplies the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", and lower posterior sections of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The right coronary artery also supplies blood to the atrioventricular node (in about 90% of people) and the sinoatrial node (in about 60% of people). The right coronary artery runs in a groove at the back of the heart and the left anterior descending artery runs in a groove at the front. There is significant variation between people in the anatomy of the arteries that supply the heart  The arteries divide at their furthest reaches into smaller branches that join together at the edges of each arterial distribution.The coronary sinus is a large vein that drains into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", and receives most of the venous drainage of the heart. It receives blood from the great \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac vein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (receiving the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and both ventricles), the posterior cardiac vein (draining the back of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       "), the middle cardiac vein (draining the bottom of the left and right ventricles), and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    small cardiac veins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The anterior cardiac veins drain the front of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and drain directly into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".Small lymphatic networks called plexuses exist beneath each of the three layers of the heart. These networks collect into a main left and a main right trunk, which travel up the groove between the ventricles that exists on the heart's surface, receiving smaller vessels as they travel up. These vessels then travel into the atrioventricular groove, and receive a third vessel which drains the section of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " sitting on the diaphragm. The left vessel joins with this third vessel, and travels along the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", ending in the inferior tracheobronchial node. The right vessel travels along the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the part of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " sitting on the diaphragm. It usually then travels in front of the ascending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and then ends in a brachiocephalic node. Nerve supply The heart receives nerve signals from the vagus nerve and from nerves arising from the sympathetic trunk. These nerves act to influence, but not control, the heart rate. Sympathetic nerves also influence the force of heart contraction. Signals that travel along these nerves arise from two paired cardiovascular centres in the medulla oblongata. The vagus nerve of the parasympathetic nervous system acts to decrease the heart rate, and nerves from the sympathetic trunk act to increase the heart rate. These nerves form a network of nerves that lies over the heart called the cardiac plexus.The vagus nerve is a long, wandering nerve that emerges from the brainstem and provides parasympathetic stimulation to a large number of organs in the thorax and abdomen, including the heart. The nerves from the sympathetic trunk emerge through the T1-T4 thoracic ganglia and travel to both the sinoatrial and atrioventricular nodes, as well as to the atria and ventricles. The ventricles are more richly innervated by sympathetic fibers than parasympathetic fibers. Sympathetic stimulation causes the release of the neurotransmitter \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    norepinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (also known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    noradrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") at the neuromuscular junction of the cardiac nerves. This shortens the repolarization period, thus speeding the rate of depolarization and contraction, which results in an increased heart rate. It opens chemical or ligand-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ion channels, allowing an influx of positively charged ions. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Norepinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " binds to the beta–1 receptor. Development The heart is the first functional organ to develop and starts to beat and pump blood at about three weeks into embryogenesis. This early start is crucial for subsequent embryonic and prenatal development. The heart derives from splanchnopleuric mesenchyme in the neural plate which forms the cardiogenic region. Two endocardial tubes form here that fuse to form a primitive heart tube known as the tubular heart. Between the third and fourth week, the heart tube lengthens, and begins to fold to form an S-shape within the pericardium. This places the chambers and major vessels into the correct alignment for the developed heart. Further development will include the formation of the septa and the valves and the remodeling of the heart chambers. By the end of the fifth week, the septa are complete, and by the ninth week, the heart valves are complete.Before the fifth week, there is an opening in the fetal heart known as the foramen ovale. The foramen ovale allowed blood in the fetal heart to pass directly from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", allowing some blood to bypass the lungs. Within seconds after birth, a flap of tissue known as the septum primum that previously acted as a valve closes the foramen ovale and establishes the typical cardiac circulation pattern. A \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the surface of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " remains where the foramen ovale was, called the fossa ovalis. The embryonic heart begins beating at around 22 days after conception (5 weeks after the last normal menstrual period, LMP). It starts to beat at a rate near to the mother's which is about 75–80 beats per minute (bpm). The embryonic heart rate then accelerates and reaches a peak rate of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    165–185\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " bpm early in the early 7th week (early 9th week after the LMP). After 9 weeks (start of the fetal stage) it starts to decelerate, slowing to around 145 (±25) bpm at birth. There is no difference in female and male heart rates before birth. Physiology Blood flow The heart functions as a pump in the circulatory system to provide a continuous flow of blood throughout the body. This circulation consists of the systemic circulation to and from the body and the pulmonary circulation to and from the lungs. Blood in the pulmonary circulation exchanges \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the lungs through the process of respiration. The systemic circulation then transports \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to the body and returns \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and relatively deoxygenated blood to the heart for transfer to the lungs.The right heart collects deoxygenated blood from two large \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    veins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the superior and inferior venae cavae. Blood collects in the right and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " continuously. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    superior vena cava\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " drains blood from above the diaphragm and empties into the upper back part of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inferior vena cava drains the blood\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from below the diaphragm and empties into the back part of the atrium below the opening for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    superior vena cava\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Immediately above and to the middle of the opening of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inferior vena cava\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the opening of the thin-walled coronary sinus. Additionally, the coronary sinus returns deoxygenated blood from the myocardium to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The blood collects in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". When the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " contracts, the blood is pumped through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tricuspid valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". As the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " contracts, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tricuspid valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " closes and the blood is pumped into the pulmonary trunk through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary trunk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " divides into pulmonary arteries and progressively smaller arteries throughout the lungs, until it reaches capillaries. As these pass by alveoli \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is exchanged for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". This happens through the passive process of diffusion. In the left heart, oxygenated blood is returned to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " via the pulmonary veins. It is then pumped into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " for systemic circulation. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is a large artery that branches into many smaller arteries, arterioles, and ultimately capillaries. In the capillaries, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and nutrients from blood are supplied to body cells for metabolism, and exchanged for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and waste products. Capillary blood, now deoxygenated, travels into venules and veins that ultimately collect in the superior and inferior vena cavae, and into the right heart. Cardiac cycle The cardiac cycle refers to the sequence of events in which the heart contracts and relaxes with every heartbeat. The period of time during which the ventricles contract, forcing blood out into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and main \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", is known as systole, while the period during which the ventricles relax and refill with blood is known as diastole. The atria and ventricles work in concert, so in systole when the ventricles are contracting, the atria are relaxed and collecting blood. When the ventricles are relaxed in diastole, the atria contract to pump blood to the ventricles. This coordination ensures blood is pumped efficiently to the body.At the beginning of the cardiac cycle, the ventricles are relaxing. As they do so, they are filled by blood passing through the open \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral and tricuspid valves\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". After the ventricles have completed most of their filling, the atria contract, forcing further blood into the ventricles and priming the pump. Next, the ventricles start to contract. As the pressure rises within the cavities of the ventricles, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral and tricuspid valves\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are forced shut. As the pressure within the ventricles rises further, exceeding the pressure with the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and pulmonary arteries, the aortic and pulmonary valves open. Blood is ejected from the heart, causing the pressure within the ventricles to fall. Simultaneously, the atria refill as blood flows into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " through the superior and inferior vena cavae, and into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " through the pulmonary veins. Finally, when the pressure within the ventricles falls below the pressure within the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and pulmonary arteries, the aortic and pulmonary valves close. The ventricles start to relax, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral and tricuspid valves\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " open, and the cycle begins again. Cardiac output Cardiac output (CO) is a measurement of the amount of blood pumped by each ventricle (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume) in one minute. This is calculated by multiplying the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume (SV) by the beats per minute of the heart rate (HR). So that: CO = SV x HR. The cardiac output is normalized to body size through body surface area and is called the cardiac index. The average cardiac output, using an average \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume of about 70mL, is 5.25 L/min, with a normal range of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    4.0–8.0\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " L/min. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume is normally measured using an echocardiogram and can be influenced by the size of the heart, physical and mental condition of the individual, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sex\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", contractility, duration of contraction, preload and afterload.Preload refers to the filling pressure of the atria at the end of diastole, when the ventricles are at their fullest. A main factor is how long it takes the ventricles to fill: if the ventricles contract more frequently, then there is less time to fill and the preload will be less. Preload can also be affected by a person's blood volume. The force of each contraction of the heart muscle is proportional to the preload, described as the Frank-Starling mechanism. This states that the force of contraction is directly proportional to the initial length of muscle fiber, meaning a ventricle will contract more forcefully, the more it is stretched.Afterload, or how much pressure the heart must generate to eject blood at systole, is influenced by vascular resistance. It can be influenced by narrowing of the heart valves (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") or contraction or relaxation of the peripheral blood vessels.The strength of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " contractions controls the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume. This can be influenced positively or negatively by agents termed inotropes. These agents can be a result of changes within the body, or be given as drugs as part of treatment for a medical disorder, or as a form of life support, particularly in intensive care units. Inotropes that increase the force of contraction are &quot;&quot;positive&quot;&quot; inotropes, and include sympathetic agents such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    noradrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dopamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". &quot;&quot;Negative&quot;&quot; inotropes decrease the force of contraction and include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blockers. Electrical conduction The normal rhythmical heart beat, called sinus rhythm, is established by the heart's own pacemaker, the sinoatrial node (also known as the sinus node or the SA node). Here an electrical signal is created that travels through the heart, causing the heart muscle to contract. The sinoatrial node is found in the upper part of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " near to the junction with the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    superior vena cava\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The electrical signal generated by the sinoatrial node travels through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " in a radial way that is not completely understood. It travels to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " via Bachmann's bundle, such that the muscles of the left and right atria contract together. The signal then travels to the atrioventricular node. This is found at the bottom of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " in the atrioventricular septum—the boundary between the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The septum is part of the cardiac skeleton, tissue within the heart that the electrical signal cannot pass through, which forces the signal to pass through the atrioventricular node only. The signal then travels along the bundle of His to left and right bundle branches through to the ventricles of the heart. In the ventricles the signal is carried by specialized tissue called the Purkinje fibers which then transmit the electric charge to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Heart rate The normal resting heart rate is called the sinus rhythm, created and sustained by the sinoatrial node, a group of pacemaking cells found in the wall of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Cells in the sinoatrial node do this by creating an action potential. The cardiac action potential is created by the movement of specific electrolytes into and out of the pacemaker cells. The action potential then spreads to nearby cells.When the sinoatrial cells are resting, they have a negative charge on their membranes. However a rapid influx of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions causes the membrane's charge to become positive. This is called depolarisation and occurs spontaneously. Once the cell has a sufficiently high charge, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels close and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions then begin to enter the cell, shortly after which \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " begins to leave it. All the ions travel through ion channels in the membrane of the sinoatrial cells. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " start to move out of and into the cell only once it has a sufficiently high charge, and so are called voltage-gated. Shortly after this, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels close and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels open, allowing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to leave the cell. This causes the cell to have a negative resting charge and is called repolarization. When the membrane potential reaches approximately −60 mV, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels close and the process may begin again.The ions move from areas where they are concentrated to where they are not. For this reason \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " moves into the cell from outside, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " moves from within the cell to outside the cell. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " also plays a critical role. Their influx through slow channels means that the sinoatrial cells have a prolonged &quot;&quot;plateau&quot;&quot; phase when they have a positive charge. A part of this is called the absolute refractory period. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions also combine with the regulatory protein troponin C in the troponin complex to enable contraction of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and separate from the protein to allow relaxation.The adult resting heart rate ranges from 60 to 100 bpm. The resting heart rate of a newborn can be 129 beats per minute (bpm) and this gradually decreases until maturity. An athlete's heart rate can be lower than 60 bpm. During \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " the rate can be 150 bpm with maximum rates reaching from 200 to 220 bpm. Influences The normal sinus rhythm of the heart, giving the resting heart rate, is influenced by a number of factors. The cardiovascular centres in the brainstem control the sympathetic and parasympathetic influences to the heart through the vagus nerve and sympathetic trunk. These cardiovascular centres receive input from a series of receptors including baroreceptors, sensing stretch the stretching of blood vessels and chemoreceptors, sensing the amount of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the blood and its pH. Through a series of reflexes these help regulate and sustain blood flow.Baroreceptors are stretch receptors located in the aortic sinus, carotid bodies, the venae cavae, and other locations, including pulmonary vessels and the right side of the heart itself. Baroreceptors fire at a rate determined by how much they are stretched, which is influenced by blood pressure, level of physical activity, and the relative distribution of blood. With increased pressure and stretch, the rate of baroreceptor firing increases, and the cardiac centers decrease sympathetic stimulation and increase parasympathetic stimulation. As pressure and stretch decrease, the rate of baroreceptor firing decreases, and the cardiac centers increase sympathetic stimulation and decrease parasympathetic stimulation. There is a similar reflex, called the atrial reflex or Bainbridge reflex, associated with varying rates of blood flow to the atria. Increased venous return stretches the walls of the atria where specialized baroreceptors are located. However, as the atrial baroreceptors increase their rate of firing and as they stretch due to the increased blood pressure, the cardiac center responds by increasing sympathetic stimulation and inhibiting parasympathetic stimulation to increase heart rate. The opposite is also true. Chemoreceptors present in the carotid body or adjacent to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " in an aortic body respond to the blood's oxygen, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels. Low \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or high \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " will stimulate firing of the receptors.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " and fitness levels, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", body temperature, basal metabolic rate, and even a person's emotional state can all affect the heart rate. High levels of the hormones \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    norepinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and thyroid hormones can increase the heart rate. The levels of electrolytes including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can also influence the speed and regularity of the heart rate; low blood \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", low blood pressure and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dehydration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may increase it. Clinical significance \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diseases Cardiovascular diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diseases of the heart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", are the leading cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " worldwide. The majority of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiovascular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is noncommunicable and related to lifestyle and other factors, becoming more prevalent with ageing. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a major cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", accounting for an average of 30% of all \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deaths\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in 2008, globally. This rate varies from a lower 28% to a high 40% in high-income countries. Doctors that specialise in the heart are called cardiologists. Many other medical professionals are involved in treating \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diseases of the heart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", including doctors, cardiothoracic surgeons, intensivists, and allied health practitioners including physiotherapists and dieticians. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ischaemic heart disease Coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", also known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischaemic heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", is caused by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "—a build-up of fatty material along the inner walls of the arteries. These \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatty deposits\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerotic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " plaques narrow the coronary arteries, and if severe may reduce blood flow to the heart. If a narrowing (or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") is relatively minor then the patient may not experience any symptoms. Severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    narrowings\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " during \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " or even at rest. The thin covering of an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerotic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " plaque can rupture, exposing the fatty centre to the circulating blood. In this case a clot or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can form, blocking the artery, and restricting blood flow to an area of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " causing a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       ") or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In the worst case this may cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac arrest\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a sudden and utter loss of output from the heart. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Obesity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", uncontrolled \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and high \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can all increase the risk of developing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart failure Heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is defined as a condition in which the heart is unable to pump enough blood to meet the demands of the body. Patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may experience \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " especially when lying flat, as well as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ankle swelling\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    peripheral oedema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the end result of many \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diseases affecting the heart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", but is most commonly associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischaemic heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valvular heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". Less common causes include various \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiomyopathies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is frequently associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    weakness of the heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the ventricles (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    systolic heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), but can also be seen in patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that is strong but stiff (diastolic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       "). The condition may affect the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " (causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    predominantly breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " (causing predominantly swelling of the legs and an elevated jugular venous pressure), or both ventricles. Patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are at higher risk of developing dangerous heart rhythm disturbances or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiomyopathies Cardiomyopathies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are diseases affecting the muscle of the heart. Some cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abnormal thickening of the heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertrophic cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), some cause the heart to abnormally expand and weaken (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dilated cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), some cause the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to become stiff and unable to fully relax between contractions (restrictive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") and some make the heart prone to abnormal heart rhythms (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmogenic cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). These conditions are often genetic and can be inherited, but some such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dilated cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be caused by damage from toxins such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    alcohol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiomyopathies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertrophic cardiomopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are linked to a higher risk of sudden \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", particularly in athletes. Many \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiomyopathies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can lead to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the later stages of the disease. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Valvular heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Healthy heart valves allow blood to flow easily in one direction, but prevent it from flowing in the other direction. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diseased\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " heart valves may have a narrow opening and therefore restrict the flow of blood in the forward direction (referred to as a stenotic valve), or may allow blood to leak in the reverse direction (referred to as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valvular regurgitation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Valvular heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", blackouts, or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", but may be asymptomatic and only detected on a routine examination by hearing abnormal heart sounds or a heart murmur. In the developed world, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valvular heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is most commonly caused by degeneration secondary to old \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", but may also be caused by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection of the heart valves\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    endocarditis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). In some parts of the world rheumatic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a major cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valvular heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", typically leading to mitral or aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and caused by the body's immune system reacting to a streptococcal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    throat infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiac arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " While in the healthy heart, waves of electrical impulses originate in the sinus node before spreading to the rest of the atria, the atrioventricular node, and finally the ventricles (referred to as a normal sinus rhythm), this normal rhythm can be disrupted. Abnormal heart rhythms or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be asymptomatic or may cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", blackouts, or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Some types of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " increase the long term risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " cause the heart to beat abnormally slowly, referred to as a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradyarrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". This may be caused by an abnormally slow sinus node or damage within the cardiac conduction system (heart block). In other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " the heart may beat abnormally rapidly, referred to as a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachyarrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". These \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can take many forms and can originate from different structures within the heart—some arise from the atria (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial flutter\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), some from the atrioventricular node (e.g. AV nodal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    re-entrant tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") whilst others arise from the ventricles (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). Some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachyarrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are caused by scarring within the heart (e.g. some forms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), others by an irritable focus (e.g. focal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), while others are caused by additional abnormal conduction tissue that has been present since birth (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Wolff-Parkinson-White syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). The most dangerous form of heart racing is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", in which the ventricles quiver rather than contract, and which if untreated is rapidly fatal. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pericardial disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " The sac which surrounds the heart, called the pericardium, can become inflamed in a condition known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pericarditis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". This condition typically causes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that may spread to the back, and is often caused by a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    viral infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glandular fever\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", cytomegalovirus, or coxsackievirus). Fluid can build up within the pericardial sac, referred to as a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pericardial effusion\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pericardial effusions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " often occur secondary to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pericarditis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    kidney failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tumours\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and frequently do not cause any symptoms. However, large effusions or effusions which accumulate rapidly can compress the heart in a condition known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac tamponade\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and potentially fatal low blood pressure. Fluid can be removed from the pericardial space for diagnosis or to relieve \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tamponade\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " using a syringe in a procedure called \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pericardiocentesis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Congenital heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Some people are born with hearts that are abnormal and these abnormalities are known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital heart defects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". They may range from the relatively minor (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    patent foramen ovale\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", arguably a variant of normal) to serious \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    life-threatening abnormalities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypoplastic left heart syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). Common abnormalities include those that affect the heart muscle that separates the two side of the heart (a &quot;&quot;hole in the heart&quot;&quot; - e.g., \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular septal defect\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). Other defects include those affecting the heart valves (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), or the main blood vessels that lead from the heart (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coarctation of the aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). More complex syndromes are seen that affect more than one part of the heart (e.g. Tetralogy of Fallot). Some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital heart defects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " allow blood that is low in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " that would normally be returned to the lungs to instead be pumped back to the rest of the body. These are known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cyanotic congenital heart defects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and are often more serious. Major \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital heart defects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are often picked up in childhood, shortly after birth, or even before a child is born (e.g. transposition of the great arteries), causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and a lower rate of growth. More minor forms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may remain undetected for many years and only reveal themselves in adult life (e.g., \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial septal defect\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). Diagnosis \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is diagnosed by the taking of a medical history, a cardiac examination, and further investigations, including blood tests, echocardiograms, ECGs and imaging. Other invasive procedures such as cardiac catheterisation can also play a role. Examination The cardiac examination includes inspection, feeling the chest with the hands (palpation) and listening with a stethoscope (auscultation). It involves assessment of signs that may be visible on a person's hands (such as splinter haemorrhages), joints and other areas. A person's pulse is taken, usually at the radial artery near the wrist, in order to assess for the rhythm and strength of the pulse. The blood pressure is taken, using either a manual or automatic sphygmomanometer or using a more invasive measurement from within the artery. Any elevation of the jugular venous pulse is noted. A person's chest is felt for any transmitted vibrations from the heart, and then listened to with a stethoscope. Heart sounds Typically, healthy hearts have only two audible heart sounds, called S1 and S2. The first heart sound S1, is the sound created by the closing of the atrioventricular valves during ventricular contraction and is normally described as &quot;&quot;lub&quot;&quot;. The second heart sound, S2, is the sound of the semilunar valves closing during ventricular diastole and is described as &quot;&quot;dub&quot;&quot;. Each sound consists of two components, reflecting the slight difference in time as the two valves close. S2 may split into two distinct sounds, either as a result of inspiration or different \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valvular or cardiac problems\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Additional heart sounds may also be present and these give rise to gallop rhythms. A third heart sound, S3 usually indicates an increase in ventricular blood volume. A fourth heart sound S4 is referred to as an atrial gallop and is produced by the sound of blood being forced into a stiff ventricle. The combined presence of S3 and S4 give a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    quadruple\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " gallop.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart murmurs\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are abnormal heart sounds which can be either related to disease or benign, and there are several kinds. There are normally two heart sounds, and abnormal heart sounds can either be extra sounds, or &quot;&quot;murmurs&quot;&quot; related to the flow of blood between the sounds. Murmurs are graded by volume, from 1 (the quietest), to 6 (the loudest), and evaluated by their relationship to the heart sounds, position in the cardiac cycle, and additional features such as their radiation to other sites, changes with a person's position, the frequency of the sound as determined by the side of the stethoscope by which they are heard, and site at which they are heard loudest. Murmurs may be caused by damaged heart valves or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular septal defects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or may be heard in normal hearts. A different type of sound, a pericardial friction rub can be heard in cases of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pericarditis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " where the inflamed membranes can \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rub\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " together. Blood tests Blood tests play an important role in the diagnosis and treatment of many cardiovascular conditions. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Troponin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is a sensitive biomarker for a heart with insufficient blood supply. It is released 4–6 hours after injury, and usually peaks at about 12–24 hours. Two tests of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    troponin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are often taken—one at the time of initial presentation, and another within 3–6 hours, with either a high level or a significant rise being diagnostic. A test for brain natriuretic peptide (BNP) can be used to evaluate for the presence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and rises when there is increased demand on the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". These tests are considered biomarkers because they are highly specific for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Testing for the MB form of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    creatine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " kinase provides information about the heart's blood supply, but is used less frequently because it is less specific and sensitive.Other blood tests are often taken to help understand a person's general health and risk factors that may contribute to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". These often include a full blood count investigating for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and basic metabolic panel that may reveal any disturbances in electrolytes. A coagulation screen is often required to ensure that the right level of anticoagulation is given. Fasting lipids and fasting blood glucose (or an HbA1c level) are often ordered to evaluate a person's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " status, respectively. Electrocardiogram Using surface electrodes on the body, it is possible to record the electrical activity of the heart. This tracing of the electrical signal is the electrocardiogram (ECG) or (EKG). An ECG is a bedside test and involves the placement of ten leads on the body. This produces a &quot;&quot;12 lead&quot;&quot; ECG (three extra leads are calculated mathematically, and one lead is a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ground).There\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are five prominent features on the ECG: the P wave (atrial depolarisation), the QRS complex (ventricular depolarisation) and the T wave (ventricular repolarisation). As the heart cells contract, they create a current that travels through the heart. A downward deflection on the ECG implies cells are becoming more positive in charge (&quot;&quot;depolarising&quot;&quot;) in the direction of that lead, whereas an upward inflection implies cells are becoming more negative (&quot;&quot;repolarising&quot;&quot;) in the direction of the lead. This depends on the position of the lead, so if a wave of depolarising moved from left to right, a lead on the left would show a negative deflection, and a lead on the right would show a positive deflection. The ECG is a useful tool in detecting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rhythm disturbances\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and in detecting insufficient blood supply to the heart. Sometimes abnormalities are suspected, but not immediately visible on the ECG. Testing when exercising can be used to provoke an abnormality, or an ECG can be worn for a longer period such as a 24-hour Holter monitor if a suspected \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rhythm abnormality\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is not present at the time of assessment. Imaging Several imaging methods can be used to assess the anatomy and function of the heart, including ultrasound (echocardiography), angiography, CT scans, MRI and PET. An echocardiogram is an ultrasound of the heart used to measure the heart's function, assess for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valve disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and look for any abnormalities. Echocardiography can be conducted by a probe on the chest (&quot;&quot;transthoracic&quot;&quot;) or by a probe in the esophagus (&quot;&quot;transoesophageal&quot;&quot;). A typical echocardiography report will include information about the width of the valves noting any \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", whether there is any backflow of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood (regurgitation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") and information about the blood volumes at the end of systole and diastole, including an ejection fraction, which describes how much blood is ejected from the left and right ventricles after systole. Ejection fraction can then be obtained by dividing the volume ejected by the heart (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume) by the volume of the filled heart (end-diastolic volume). Echocardiograms can also be conducted under circumstances when the body is more stressed, in order to examine for signs of lack of blood supply. This cardiac \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " test involves either direct \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ", or where this is not possible, injection of a drug such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dobutamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".CT scans, chest X-rays and other forms of imaging can help evaluate the heart's size, evaluate for signs of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary oedema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and indicate whether there is fluid around the heart. They are also useful for evaluating the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", the major blood vessel which leaves the heart. Treatment \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diseases affecting the heart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be treated by a variety of methods including lifestyle modification, drug treatment, and surgery. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ischaemic heart disease Narrowings of the coronary arteries (ischaemic heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") are treated to relieve symptoms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " caused by a partially narrowed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    artery (angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), to minimise \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle damage\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " when an artery is completely occluded (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), or to prevent a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from occurring. Medications to improve \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " symptoms include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nitroglycerin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", beta blockers, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blockers, while preventative treatments include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    antiplatelets\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aspirin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    statins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", lifestyle measures such as stopping \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    weight loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and treatment of risk factors such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".In addition to using medications, narrowed heart arteries can be treated by expanding the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    narrowings\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or redirecting the flow of blood to bypass an obstruction. This may be performed using a percutaneous coronary intervention, during which \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    narrowings\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be expanded by passing small balloon-tipped wires into the coronary arteries, inflating the balloon to expand the narrowing, and sometimes leaving behind a metal scaffold known as a stent to keep the artery open.If the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    narrowings\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in coronary arteries are unsuitable for treatment with a percutaneous coronary intervention, open surgery may be required. A coronary artery bypass graft can be performed, whereby a blood vessel from another part of the body (the saphenous vein, radial artery, or internal mammary artery) is used to redirect blood from a point before the narrowing (typically the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ") to a point beyond the obstruction. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Valvular heart disease Diseased heart valves\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that have become abnormally narrow or abnormally leaky may require surgery. This is traditionally performed as an open surgical procedure to replace the damaged heart valve with a tissue or metallic prosthetic valve. In some circumstances, the tricuspid or mitral valves can be repaired surgically, avoiding the need for a valve replacement. Heart valves can also be treated percutaneously, using techniques that share many similarities with percutaneous coronary intervention. Transcatheter \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " replacement is increasingly used for patients consider very high risk for open valve replacement. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiac arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Abnormal heart rhythms (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") can be treated using antiarrhythmic drugs. These may work by manipulating the flow of electrolytes across the cell membrane (such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blockers, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blockers, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    digoxin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), or modify the autonomic nervous system's effect on the heart (beta blockers and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atropine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "). In some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " which increase the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", this risk can be reduced using anticoagulants such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    warfarin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or novel oral anticoagulants.If medications fail to control an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", another treatment option may be catheter ablation. In these procedures, wires are passed from a vein or artery in the leg to the heart to find the abnormal area of tissue that is causing the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The abnormal tissue can be intentionally damaged, or ablated, by heating or freezing to prevent further heart rhythm disturbances. Whilst the majority of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be treated using minimally invasive catheter techniques, some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (particularly \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") can also be treated using open or thoracoscopic surgery, either at the time of other cardiac surgery or as a standalone procedure. A cardioversion, whereby an electric \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shock\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is used to stun the heart out of an abnormal rhythm, may also be used. Cardiac devices in the form of pacemakers or implantable defibrillators may also be required to treat \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Pacemakers, comprising a small battery powered generator implanted under the skin and one or more leads that extend to the heart, are most commonly used to treat abnormally slow heart rhythms. Implantable defibrillators are used to treat serious life-threatening rapid heart rhythms. These devices monitor the heart, and if dangerous heart racing is detected can automatically deliver a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shock\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to restore the heart to a normal rhythm. Implantable defibrillators are most commonly used in patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiomyopathies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or inherited \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " syndromes. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " As well as addressing the underlying cause for a patient's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (most commonly \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischaemic heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), the mainstay of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " treatment is with medication. These include drugs to prevent fluid from accumulating in the lungs by increasing the amount of urine a patient produces (diuretics), and drugs that attempt to preserve the pumping function of the heart (beta blockers, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors and mineralocorticoid receptor antagonists).In\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " some patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a specialised pacemaker known as cardiac resynchronisation therapy can be used to improve the heart's pumping efficiency. These devices are frequently combined with a defibrillator. In very severe cases of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a small pump called a ventricular assist device may be implanted which supplements the heart's own pumping ability. In the most severe cases, a cardiac transplant may be considered. History Ancient Humans have known about the heart since ancient times, although its precise function and anatomy were not clearly understood. From the primarily religious views of earlier societies towards the heart, ancient Greeks are considered to have been the primary seat of scientific understanding of the heart in the ancient world. Aristotle considered the heart to be the organ responsible for creating blood; Plato considered the heart as the source of circulating blood and Hippocrates noted blood circulating cyclically from the body through the heart to the lungs. Erasistratos (304–250 BCE) noted the heart as a pump, causing dilation of blood vessels, and noted that arteries and veins both radiate from the heart, becoming progressively smaller with distance, although he believed they were filled with air and not blood. He also discovered the heart valves.The Greek physician Galen (2nd century CE) knew blood vessels carried blood and identified venous (dark red) and arterial (brighter and thinner) blood, each with distinct and separate functions. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", noting the heart as the hottest organ in the body, concluded that it provided heat to the body. The heart did not pump blood around, the heart's motion sucked blood in during diastole and the blood moved by the pulsation of the arteries themselves. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen believed the arterial blood\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was created by venous blood passing from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to the right through 'pores' between the ventricles. Air from the lungs passed from the lungs via the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to the left side of the heart and created arterial blood.These ideas went unchallenged for almost a thousand years. Pre-modern The earliest descriptions of the coronary and pulmonary circulation systems can be found in the Commentary on Anatomy in Avicenna's Canon, published in 1242 by Ibn al-Nafis. In his manuscript, al-Nafis wrote that blood passes through the pulmonary circulation instead of moving from the right to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " as previously believed by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". His work was later translated into Latin by Andrea Alpago.In Europe, the teachings of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " continued to dominate the academic community and his doctrines were adopted as the official canon of the Church. Andreas Vesalius questioned some of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen's beliefs of the heart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    De humani corporis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " fabrica (1543), but his \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    magnum\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " opus was interpreted as a challenge to the authorities and he was subjected to a number of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    attacks\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Michael Servetus wrote in Christianismi Restitutio (1553) that blood flows from one side of the heart to the other via the lungs. Modern A breakthrough in understanding the flow of blood through the heart and body came with the publication of De Motu Cordis (1628) by the English physician William Harvey. Harvey's book completely describes the systemic circulation and the mechanical force of the heart, leading to an overhaul of the Galenic doctrines. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Otto\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Frank (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    1865–1944\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") was a German physiologist; among his many published works are detailed studies of this important heart relationship. Ernest Starling (1866–1927) was an important English physiologist who also studied the heart. Although they worked largely independently, their combined efforts and similar conclusions have been recognized in the name &quot;&quot;Frank–Starling mechanism&quot;&quot;.Although Purkinje fibers and the bundle of His were discovered as early as the 19th century, their specific role in the electrical conduction system of the heart remained unknown until Sunao Tawara published his monograph, titled Das Reizleitungssystem des Säugetierherzens, in 1906. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Tawara's discovery of the atrioventricular\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " node prompted Arthur Keith and Martin Flack to look for similar structures in the heart, leading to their discovery of the sinoatrial node several months later. These structures form the anatomical basis of the electrocardiogram, whose inventor, Willem Einthoven, was awarded the Nobel Prize in Medicine or Physiology in 1924.The first successful heart transplantation was performed in 1967 by the South African surgeon Christiaan Barnard at Groote Schuur Hospital in Cape Town. This marked an important milestone in cardiac surgery, capturing the attention of both the medical profession and the world at large. However, long-term survival rates of patients were initially very low. Louis Washkansky, the first recipient of a donated heart, died 18 days after the operation while other patients did not survive for more than a few weeks. The American surgeon Norman Shumway has been credited for his efforts to improve transplantation techniques, along with pioneers Richard Lower, Vladimir Demikhov and Adrian Kantrowitz. As of March 2000, more than 55,000 heart transplantations have been performed worldwide.By the middle of the 20th century, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " had surpassed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infectious disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as the leading cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the United States, and it is currently the leading cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deaths\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " worldwide. Since 1948, the ongoing Framingham Heart Study has shed light on the effects of various influences on the heart, including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ", and common medications such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aspirin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Although the introduction of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and beta blockers has improved the management of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the disease continues to be an enormous medical and societal burden, with 30 to 40% of patients dying within a year of receiving the diagnosis. Society and culture Symbolism As one of the vital organs, the heart was long identified as the center of the entire body, the seat of life, or emotion, or reason, will, intellect, purpose or the mind. The heart is an emblematic symbol in many religions, signifying &quot;&quot;truth, conscience or moral courage in many religions—the temple or throne of God in Islamic and Judeo-Christian thought; the divine centre, or atman, and the third eye of transcendent wisdom in Hinduism; the diamond of purity and essence of the Buddha; the Taoist centre of understanding.&quot;&quot;In the Hebrew Bible, the word for heart, lev, is used in these meanings, as the seat of emotion, the mind, and referring to the anatomical organ. It is also connected in function and symbolism to the stomach.An important part of the concept of the soul in Ancient Egyptian religion was thought to be the heart, or ib. The ib or metaphysical heart was believed to be formed from one drop of blood from the child's mother's heart, taken at conception. To ancient Egyptians, the heart was the seat of emotion, thought, will, and intention. This is evidenced by Egyptian expressions which incorporate the word ib, such as Awi-ib for &quot;&quot;happy&quot;&quot; (literally, &quot;&quot;long of heart&quot;&quot;), Xak-ib for &quot;&quot;estranged&quot;&quot; (literally, &quot;&quot;truncated of heart&quot;&quot;). In Egyptian religion, the heart was the key to the afterlife. It was conceived as surviving \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the nether world, where it gave evidence for, or against, its possessor. It was thought that the heart was examined by Anubis and a variety of deities during the Weighing of the Heart ceremony. If the heart weighed more than the feather of Maat, which symbolized the ideal standard of behavior. If the scales balanced, it meant the heart's possessor had lived a just life and could enter the afterlife; if the heart was heavier, it would be devoured by the monster Ammit.The Chinese character for &quot;&quot;heart&quot;&quot;, 心, derives from a comparatively realistic depiction of a heart (indicating the heart chambers) in seal script. The Chinese word \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    xīn\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " also takes the metaphorical meanings of &quot;&quot;mind&quot;&quot;, &quot;&quot;intention&quot;&quot;, or &quot;&quot;core&quot;&quot;. In Chinese medicine, the heart is seen as the center of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    神\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " shén &quot;&quot;spirit, consciousness&quot;&quot;. The heart is associated with the small intestine, tongue, governs the six organs and five viscera, and belongs to fire in the five elements.The Sanskrit word for heart is hṛd or hṛdaya, found in the oldest surviving Sanskrit text, the Rigveda. In Sanskrit, it may mean both the anatomical object and &quot;&quot;mind&quot;&quot; or &quot;&quot;soul&quot;&quot;, representing the seat of emotion. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hrd\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may be a cognate of the word for heart in Greek, Latin, and English.Many classical philosophers and scientists, including Aristotle, considered the heart the seat of thought, reason, or emotion, often disregarding the brain as contributing to those functions. The identification of the heart as the seat of emotions in particular is due to the Roman physician \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", who also located the seat of the passions in the liver, and the seat of reason in the brain.The heart also played a role in the Aztec system of belief. The most common form of human sacrifice practiced by the Aztecs was heart-extraction. The Aztec believed that the heart (tona) was both the seat of the individual and a fragment of the Sun's heat (istli). To this day, the Nahua consider the Sun to be a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart-soul (tona-tiuh):\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " &quot;&quot;round, hot, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulsating&quot;&quot;.In\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Catholicism, there has been a long tradition of veneration of the heart, stemming from worship of the wounds of Jesus Christ which gained prominence from the mid sixteenth century. This tradition influenced the development of the medieval Christian devotion to the Sacred Heart of Jesus and the parallel veneration of the Immaculate Heart of Mary, made popular by John Eudes.The expression of a broken heart is a cross-cultural reference to grief for a lost one or to unfulfilled romantic love. The notion of &quot;&quot;Cupid's arrows&quot;&quot; is ancient, due to Ovid, but while Ovid describes Cupid as wounding his victims with his arrows, it is not made explicit that it is the heart that is wounded. The familiar iconography of Cupid shooting little heart symbols is a Renaissance theme that became tied to Valentine's day. Food Animal hearts are widely consumed as food. As they are almost entirely muscle, they are high in protein. They are often included in dishes with other offal, for example in the pan-Ottoman kokoretsi. Chicken hearts are considered to be giblets, and are often grilled on skewers; examples of this are Japanese hāto yakitori, Brazilian churrasco de coração, and Indonesian chicken heart satay. They can also be pan-fried, as in Jerusalem mixed grill. In Egyptian cuisine, they can be used, finely chopped, as part of stuffing for chicken. Many recipes combined them with other giblets, such as the Mexican pollo en menudencias and the Russian ragu iz kurinyikh potrokhov.The hearts of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    beef, pork,\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and mutton can generally be interchanged in recipes. As heart is a hard-working muscle, it makes for &quot;&quot;firm and rather dry&quot;&quot; meat, so is generally slow-cooked. Another way of dealing with toughness is to julienne the meat, as in Chinese stir-fried heart.Beef heart may be \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    grilled or braised\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In the Peruvian \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anticuchos de corazón, barbecued beef\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " hearts are grilled after being tenderized through long marination in a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spice\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and vinegar mixture. An Australian recipe for &quot;&quot;mock goose&quot;&quot; is actually \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    braised stuffed beef heart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Pig \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart is stewed,\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " poached, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    braised\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or made into sausage. The Balinese oret is a sort of blood sausage made with pig heart and blood. A French recipe for cœur de porc à l'orange is made of braised heart with an orange sauce. Other animals Vertebrates The size of the heart varies among the different animal groups, with hearts in vertebrates ranging from those of the smallest mice (12 mg) to the blue whale (600 kg). In vertebrates, the heart lies in the middle of the ventral part of the body, surrounded by a pericardium. which in some fish may be connected to the peritoneum.The SA node is found in all amniotes but not in more primitive vertebrates. In these animals, the muscles of the heart are relatively continuous, and the sinus venosus coordinates the beat, which passes in a wave through the remaining chambers. Indeed, since the sinus venosus is incorporated into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " in amniotes, it is likely homologous with the SA node. In teleosts, with their vestigial sinus venosus, the main centre of coordination is, instead, in the atrium. The rate of heartbeat varies enormously between different species, ranging from around 20 beats per minute in codfish to around 600 in hummingbirds and up to 1200 bpm in the ruby-throated hummingbird. Double circulatory systems Adult amphibians and most reptiles have a double circulatory system, meaning a circulatory system divided into arterial and venous parts. However, the heart itself is not completely separated into two sides. Instead, it is separated into three chambers—two atria and one ventricle. Blood returning from both the systemic circulation and the lungs is returned, and blood is pumped simultaneously into the systemic circulation and the lungs. The double system allows blood to circulate to and from the lungs which deliver oxygenated blood directly to the heart.In reptiles, the heart is usually situated around the middle of the thorax, and in snakes, usually between the junction of the upper first and second third. There is a heart with three chambers: two atria and one ventricle. The form and function of these hearts are different than mammalian hearts due to the fact that snakes have an elongated body, and thus are affected by different environmental factors. In particular, the snake's heart relative to the position in their body has been influenced greatly by gravity. Therefore, snakes that are larger in size tend to have a higher blood pressure due to gravitational change. This results in the heart being located in different regions of the body that is relative to the snake's body length. The ventricle is incompletely separated into two-halves by a wall (septum), with a considerable gap near the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and aortic openings. In most reptilian species, there appears to be little, if any, mixing between the bloodstreams, so the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " receives, essentially, only oxygenated blood. The exception to this rule is crocodiles, which have a four-chambered heart.In the heart of lungfish, the septum extends partway into the ventricle. This allows for some degree of separation between the de-oxygenated bloodstream destined for the lungs and the oxygenated stream that is delivered to the rest of the body. The absence of such a division in living amphibian species may be partly due to the amount of respiration that occurs through the skin; thus, the blood returned to the heart through the venae cavae is already partially oxygenated. As a result, there may be less need for a finer division between the two bloodstreams than in lungfish or other tetrapods. Nonetheless, in at least some species of amphibian, the spongy nature of the ventricle does seem to maintain more of a separation between the bloodstreams. Also, the original valves of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    conus arteriosus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " have been replaced by a spiral valve that divides it into two parallel parts, thereby helping to keep the two bloodstreams separate. Full division Archosaurs (crocodilians and birds) and mammals show complete separation of the heart into two pumps for a total of four heart chambers; it is thought that the four-chambered heart of archosaurs evolved independently from that of mammals. In crocodilians, there is a small opening, the foramen of Panizza, at the base of the arterial trunks and there is some degree of mixing between the blood in each side of the heart, during a dive underwater; thus, only in birds and mammals are the two streams of blood—those to the pulmonary and systemic circulations—permanently kept entirely separate by a physical barrier. Fish Fish have what is often described as a two-chambered heart, consisting of one atrium to receive blood and one ventricle to pump it. However, the fish heart has entry and exit compartments that may be called chambers, so it is also sometimes described as three-chambered or four-chambered, depending on what is counted as a chamber. The atrium and ventricle are sometimes considered &quot;&quot;true chambers&quot;&quot;, while the others are considered &quot;&quot;accessory chambers&quot;&quot;.Primitive fish have a four-chambered heart, but the chambers are arranged sequentially so that this primitive heart is quite unlike the four-chambered hearts of mammals and birds. The first chamber is the sinus venosus, which collects deoxygenated blood from the body through the hepatic and cardinal veins. From here, blood flows into the atrium and then to the powerful muscular ventricle where the main pumping action will take place. The fourth and final chamber is the conus arteriosus, which contains several valves and sends blood to the ventral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The ventral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " delivers blood to the gills where it is oxygenated and flows, through the dorsal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", into the rest of the body. (In tetrapods, the ventral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " has divided in two; one half forms the ascending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", while the other forms the pulmonary artery).In the adult fish, the four chambers are not arranged in a straight row but instead form an S-shape, with the latter two chambers lying above the former two. This relatively simple pattern is found in cartilaginous fish and in the ray-finned fish. In teleosts, the conus arteriosus is very small and can more accurately be described as part of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " rather than of the heart proper. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    conus arteriosus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is not present in any amniotes, presumably having been absorbed into the ventricles over the course of evolution. Similarly, while the sinus venosus is present as a vestigial structure in some reptiles and birds, it is otherwise absorbed into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and is no longer distinguishable. Invertebrates Arthropods and most mollusks have an open circulatory system. In this system, deoxygenated blood collects around the heart in cavities (sinuses). This blood slowly permeates the heart through many small one-way channels. The heart then pumps the blood into the hemocoel, a cavity between the organs. The heart in arthropods is typically a muscular tube that runs the length of the body, under the back and from the base of the head. Instead of blood the circulatory fluid is haemolymph which carries the most commonly used respiratory pigment, copper-based haemocyanin as the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " transporter. Haemoglobin is only used by a few arthropods.In some other invertebrates such as earthworms, the circulatory system is not used to transport \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and so is much reduced, having no veins or arteries and consisting of two connected tubes. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " travels by diffusion and there are five \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    small muscular\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " vessels that connect these vessels that contract at the front of the animals that can be thought of as &quot;&quot;hearts&quot;&quot;.Squids and other cephalopods have two &quot;&quot;gill hearts&quot;&quot; also known as branchial hearts, and one &quot;&quot;systemic heart&quot;&quot;. The branchial hearts have two atria and one ventricle each, and pump to the gills, whereas the systemic heart pumps to the body. Only the chordates (including vertebrates) and the hemichordates have a central &quot;&quot;heart&quot;&quot;, which is a vesicle formed from the thickening of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and contracts to pump blood. This suggests a presence of it in the last common ancestor of these groups (may have been lost in the echinoderms). Additional images Notes References This article incorporates text from the CC-BY book: OpenStax College,  Anatomy &amp; Physiology. OpenStax CNX. 30 Jul 2014. Bibliography Hall, John (2011). Guyton and Hall textbook of medical physiology (12th ed.). Philadelphia: Saunders/Elsevier. ISBN 978-1-4160-4574-8. Longo, Dan; Fauci, Anthony; Kasper, Dennis; Hauser, Stephen; Jameson, J.; Loscalzo, Joseph (2011). Harrison's Principles of Internal Medicine (18 ed.). McGraw-Hill Professional. ISBN 978-0-07-174889-6. Susan Standring; Neil R. Borley;  et al., eds. (2008). Gray's anatomy : the anatomical basis of clinical practice (40th ed.). London: Churchill Livingstone. ISBN 978-0-8089-2371-8. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nicki R. Colledge\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; Brian R. Walker; Stuart H. Ralston, eds. (2010). Davidson's principles and practice of medicine (21st ed.). Edinburgh: Churchill Livingstone/Elsevier. ISBN 978-0-7020-3085-7. External links What Is the Heart? – NIH Atlas of Human Cardiac Anatomy Dissection review of the anatomy of the Human Heart including vessels, internal and external features Prenatal human heart development Animal hearts: fish, squid The Heart, BBC Radio 4 interdisciplinary discussion with David Wootton, Fay Bound Alberti &amp; Jonathan Sawday (In Our Time, 1 June 2006) &quot;&quot;Heart&quot;&quot; . Encyclopædia Britannica. 13 (11th ed.). 1911. pp. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    129–134\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".&quot; &quot;ACTC1 encodes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle alpha\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " actin. This isoform differs from the alpha actin that is expressed in skeletal muscle, ACTA1. Alpha cardiac actin is the major protein of the thin filament in cardiac sarcomeres, which are responsible for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle contraction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and generation of force to support the pump function of the heart. Structure Cardiac alpha actin is a 42.0 kDa protein composed of 377 amino acids. Cardiac alpha actin is a filamentous protein extending from a complex mesh with cardiac \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    alpha-actinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (ACTN2) at Z-lines towards the center of the sarcomere. Polymerization of globular actin (G-actin) leads to a structural filament (F-actin) in the form of a two-stranded helix. Each actin can bind to four others. The atomic structure of monomeric actin was solved by Kabsch et al., and closely thereafter this same group published the structure of the actin filament. Actins are highly conserved proteins; the alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. Cardiac (ACTC1) and skeletal (ACTA1) alpha actins differ by only four \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acids (Asp4Glu, Glu5Asp\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Leu301Met\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Ser360Thr; cardiac/skeletal). The actin monomer has two asymmetric domains; the larger inner domain comprised by sub-domains 3 and 4, and the smaller outer domain by sub-domains 1 and 2. Both the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and carboxy-termini lie in sub-domain 1 of the outer domain. Function Actin is a dynamic structure that can adapt two states of flexibility, with the greatest difference between the states occurring as a result of movement within sub-domain 2. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " binding increases the flexibility of actin, and cross-linking studies have shown that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " subfragment-1 binds to actin \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " residues 48-67 within actin sub-domain 2, which may account for this effect.It has been suggested that the ACTC1 gene has a role during development. Experiments in chick embryos found an association between ACTC1 knockdown and a reduction in the atrial septa. Clinical significance Polymorphisms in ACTC1 have been linked to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Dilated Cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in a small number of Japanese patients. Further studies in patients from South Africa found no association. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    E101K\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " missense mutation has been associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hypertrophic Cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Left Ventricular Noncompaction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Another mutation has in the ACTC1 gene has been associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial septal defects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". References Further reading External links Mass spectrometry characterization of human ACTC1 at \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    COPaKB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " GeneReviews/NIH/NCBI/UW entry on Familial \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hypertrophic Cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Overview Human ACTC1 genome location and ACTC1 gene details page  in the UCSC Genome Browser.&quot; &quot;Refractoriness is the fundamental property of any object of autowave nature (especially excitable medium) not to respond on stimuli, if the object stays in the specific refractory state. In common sense, refractory period is the characteristic recovery time, a period that is associated with the motion of the image point on the left branch of the isocline                                                                u               ˙                                          =         0                 {\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    \\displaystyle {\\dot {u}}=0}    (\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "for more details, see also Reaction–diffusion and Parabolic partial differential equation). In physiology, a refractory period is a period of time during which an organ or cell is incapable of repeating a particular action, or (more precisely) the amount of time it takes for an excitable membrane to be ready for a second  stimulus once it returns to its resting state following an excitation. It most commonly refers to electrically excitable muscle cells or neurons. Absolute refractory period corresponds to depolarization and repolarization, whereas relative refractory period corresponds to hyperpolarization. Electrochemical usage After initiation of an action potential, the refractory period is defined two ways: The absolute refractory period coincides with nearly the entire duration of the action potential. In neurons, it is caused by the inactivation of the Na+ channels that originally opened to depolarize the membrane. These channels remain inactivated until the membrane hyperpolarizes. The channels then close, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    de-inactivate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and regain their ability to open in response to stimulus. The relative refractory period immediately follows the absolute. As voltage-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels open to terminate the action potential by repolarizing the membrane, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " conductance of the membrane increases dramatically. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    K+\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions moving out of the cell bring the membrane potential closer to the equilibrium potential for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". This causes brief hyperpolarization of the membrane, that is, the membrane potential becomes transiently more negative than the normal resting potential. Until the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " conductance returns to the resting value, a greater stimulus will be required to reach the initiation threshold for a second depolarization. The return to the equilibrium resting potential marks the end of the relative refractory period. Cardiac refractory period The refractory period in cardiac physiology is related to the ion currents that, in cardiac cells as in nerve cells, flow into and out of the cell freely.  The flow of ions translates into a change in the voltage of the inside of the cell relative to the extracellular space.  As in nerve cells, this characteristic change in voltage is referred to as an action potential.  Unlike that in nerve cells, the cardiac action potential duration is closer to 100 ms (with variations depending on cell type, autonomic tone, etc.).  After an action potential initiates, the cardiac cell is unable to initiate another action potential for some duration of time (which is slightly shorter than the &quot;&quot;true&quot;&quot; action potential duration).  This period of time is referred to as the refractory period, which is 250ms in duration and helps to protect the heart. In the classical sense, the cardiac refractory period is separated into an absolute refractory period and a relative refractory period.  During the absolute refractory period, a new action potential cannot be elicited.  During the relative refractory period, a new action potential can be elicited under the correct circumstances. The cardiac refractory period can result in different forms of re-entry, which are a cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Vortices of excitation in the myocardium (autowave vortices) are a form of re-entry. Such vortices can be a mechanism of life-threatening \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In particular, the autowave reverberator, more commonly referred to as spiral waves or rotors, can be found within the atria and may be a cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Neuronal refractory period The refractory period in a neuron occurs after an action potential and generally lasts one millisecond. An action potential consists of three phases. Phase one is depolarization.  During depolarization, voltage-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ion channels open, increasing the neuron's membrane conductance for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium ions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and depolarizing the cell's membrane potential (from typically -70 mV toward a positive potential).  In other words, the membrane is made less negative. After the potential reaches the activation threshold (-55 mV), the depolarization is actively driven by the neuron and overshoots the equilibrium  potential of an activated membrane (+30 mV). Phase two is repolarization. During repolarization, voltage-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ion channels inactivate (different from the closed state) due to the now-depolarized membrane, and voltage-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels activate (open). Both the inactivation of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ion channels and the opening of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ion channels act to repolarize the cell's membrane potential back to its resting membrane potential. When the cell's membrane voltage overshoots its resting membrane potential (near -60mV), the cell enters a phase of hyperpolarization. This is due to a larger-than-resting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " conductance across the cell membrane. This \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " conductance eventually drops and the cell returns to its resting membrane potential. The refractory periods are due to the inactivation property of voltage-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels and the lag of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels in closing. Voltage-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels have two gating mechanisms, the activation mechanism that opens the channel with depolarization and the inactivation mechanism that closes the channel with repolarization.  While the channel is in the inactive state, it will not open in response to depolarization.  The period when the majority of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels remain in the inactive state is the absolute refractory period.  After this period, there are enough voltage-activated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels in the closed (active) state to respond to depolarization.  However, voltage-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels that opened in response to repolarization do not close as quickly as voltage-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels; to return to the active closed state.  During this time, the extra \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " conductance means that the membrane is at a higher threshold and will require a greater stimulus to cause action potentials to fire. In other words, because the membrane potential inside the axon becomes increasingly negative relative to the outside of the membrane, a stronger stimulus will be required to reach the threshold voltage, and thus, initiate another action potential. This period is the relative refractory period. Skeletal muscle refractory period The muscle action potential lasts roughly 2–4 ms and the absolute refractory period is roughly 1–3 ms, shorter than other cells. See also References Books Papers&quot; &quot;The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart beats\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " according to a rhythm set up by the sinus node or pacemaker. It is acted on by the nervous system, as well as hormones in the blood, and venous return: the amount of blood being returned to the heart. The two nerves acting on the heart are the vagus nerve, which slows heart rate down by emitting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acetylcholine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and the accelerans nerve which speeds it up by emitting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    noradrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". This results in an increased bloodflow, preparing the body for a sudden increase in activity. These nerve fibres are part of the autonomic nervous system, part of the 'fight or flight' system.  == References ==&quot; &quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AV-nodal reentrant tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") is a type of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abnormal fast heart rhythm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It is a type of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    supraventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (SVT), meaning that it originates from a location within the heart above the bundle of His. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AV nodal reentrant tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the most common regular \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    supraventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It is more common in women than men (approximately 75% of cases occur in females). The main symptom is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Treatment may be with specific physical maneuvers, medications, or, rarely, synchronized cardioversion. Frequent attacks may require radiofrequency ablation, in which the abnormally conducting tissue in the heart is destroyed. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " occurs when a reentrant circuit forms within or just next to the atrioventricular node. The circuit usually involves two anatomical pathways: the fast pathway and the slow pathway, which are both in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The slow pathway (which is usually targeted for ablation) is located inferior and slightly posterior to the AV node, often following the anterior margin of the coronary sinus. The fast pathway is usually located just superior and posterior to the AV node. These pathways are formed from tissue that behaves very much like the AV node, and some authors regard them as part of the AV node. The fast and slow pathways should not be confused with the accessory pathways that give rise to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Wolff-Parkinson-White syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    WPW syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrioventricular reciprocating tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). In \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the fast and slow pathways are located within the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " close to or within the AV node and exhibit electrophysiologic properties similar to AV nodal tissue. Accessory pathways that give rise to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    WPW syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are located in the atrioventricular valvular rings. They provide a direct connection between the atria and ventricles, and have electrophysiologic properties similar to muscular heart tissue of the heart's ventricles. Signs and symptoms The main symptom of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the sudden development of rapid regular \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". These \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be associated with a fluttering sensation in the neck, caused by near-simultaneous contraction of the atria and ventricles against a closed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tricuspid valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " leading to the pressure or atrial contraction being transmitted backwards into the venous system.  The rapid heart rate may lead to feelings of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anxiety\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and may therefore be mistaken for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    panic attacks\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In some cases, the onset of the fast heart is associated with a brief drop in blood pressure. When this happens, someone may experience \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dizziness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or rarely lose consciousness (faint). Someone with underlying \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (narrowing of the arteries of the heart by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") who has a very rapid heart rate may experience \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " similar to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; this \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is band- or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pressure-like\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " around the chest and often radiates to the left arm and angle of the left jaw.Symptoms often occur without any specific trigger, although some find that their \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " often occur after lifting heavy items or bending forwards. The onset of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is sudden, with the acceleration of the heart rate occurring within a single beat, and may be preceded by a feeling of the heart skipping a beat.  The heart may continue to race for minutes or hours, but the eventual termination of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is as rapid as its onset.During \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " the heart rate is typically between \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    140\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and 280 beats per minute. Close inspection of the neck may reveal pulsation of the jugular vein in the form of &quot;&quot;cannon A-waves&quot;&quot; as the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " contracts against a closed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tricuspid valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Mechanisms The fundamental mechanism of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a re-entrant circuit within the atrioventricular node. This can take several forms. &quot;&quot;Typical&quot;&quot;, &quot;&quot;common&quot;&quot;, or &quot;&quot;slow-fast&quot;&quot; AVNRT uses the slow AV nodal pathway to conduct towards the ventricle (the anterograde limb of the circuit) and the fast AV nodal pathway to conduct to the atria (the retrograde limb).  The re-entrant circuit can be reversed such that the fast AV nodal pathway is the anterograde limb and the slow AV nodal pathway is the retrograde limb, referred to as &quot;&quot;atypical&quot;&quot;, &quot;&quot;uncommon&quot;&quot;, or &quot;&quot;fast-slow&quot;&quot; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Atypical AVNRT may also use the slow AV nodal pathway as the anterograde limb and left atrial fibres that approach the AV node from the left side of the inter-atrial septum as the retrograde limb, and is sometimes referred to as &quot;&quot;slow-slow&quot;&quot; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Typical \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " In typical \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the anterograde conduction is via the slow pathway and the retrograde conduction is via the fast pathway (&quot;&quot;slow-fast&quot;&quot; AVNRT).Because the retrograde conduction is via the fast pathway, stimulation of the atria (which produces the inverted P wave) occurs very soon after stimulation of the ventricles (which causes the QRS complex).  As a result, the time from the QRS complex to the P wave (the RP interval) is short, less than 50% of the time between consecutive QRS complexes.  The RP interval is often so short that the inverted P waves may not be seen on the surface electrocardiogram (ECG) as they are buried within or immediately after the QRS complexes, appearing as a &quot;&quot;pseudo R prime&quot;&quot; wave in lead V1 or a &quot;&quot;pseudo S&quot;&quot; wave in the inferior leads. Atypical \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " In \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atypical AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the anterograde conduction is via the fast pathway and the retrograde conduction is via the slow pathway (&quot;&quot;fast-slow&quot;&quot; AVNRT).Multiple slow pathways can exist so that both anterograde and retrograde conduction are over slow pathways. (&quot;&quot;slow-slow&quot;&quot; AVNRT).Because the retrograde conduction is via the slow pathway, stimulation of the atria will be delayed by the slow conduction tissue and will typically produce an inverted P wave that falls after the QRS complex on the surface  ECG. Diagnosis If the symptoms are present while the person is receiving medical care (e.g., in an emergency department), an ECG  may show typical changes that confirm the diagnosis ie, QRS duration &lt;120  ms,  unless a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart block\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is suspected. If the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are recurrent, a doctor may request a Holter monitor (portable, wearable ECG recorder). Again, this will show the diagnosis if the recorder is attached at the time of the symptoms. In rare cases, disabling but infrequent episodes of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may require the insertion of a small device under the skin that continuously record heart activity (an implantable loop recorder). All these ECG-based technologies also enable the distinction between \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abnormal fast heart rhythms\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial flutter\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sinus tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachyarrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " related to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Wolff-Parkinson-White syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", all of which may have symptoms that are similar to AVNRT.Blood tests commonly performed in people with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are: thyroid function tests (TFTs) – an overactive thyroid increases the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " electrolytes – disturbances in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    magnesium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may predispose to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " cardiac markers – if there is a concern that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       ") has occurred either as a cause or as a result of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; this is usually only the case if the patient has experienced \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Treatment Treatments for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " aim to terminate episodes of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and to prevent further episodes from occurring in the future. These treatments include physical manoeuvres, medication, and invasive procedures such as ablation. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Arrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CVD</span>\n",
       "</mark>\n",
       " termination An episode of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    supraventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be terminated by any action that transiently blocks the AV node. Some of those with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be able to stop their attack by using physical manoeuvres that increase the activity of the vagus nerve on the heart, specifically on the atrioventricular node. These manoeuvres include carotid sinus massage (pressure on the carotid sinus in the neck) and the Valsalva manoeuvre (increasing the pressure in the chest by attempting to exhale against a closed airway by bearing down or holding one's breath).Medications that slow or briefly halt electrical conduction through the AV node can terminate \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adenosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", beta blockers, or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    non-dihydropyridine calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blockers (such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    verapamil\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diltiazem\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ").  Both \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adenosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and beta blockers may cause tightening of the airways, and are therefore used with caution in people who are known to have asthma. Less commonly used drugs for this purpose include antiarrhythmic drugs such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    flecainide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".If the fast heart rate is poorly tolerated (e.g. the development of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " symptoms, low blood pressure or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") then \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be terminated electrically using a cardioversion.  In this procedure, after administering a strong sedative or general anaesthetic, an electric \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shock\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is applied to the heart to restore a normal rhythm. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Arrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CVD</span>\n",
       "</mark>\n",
       " prevention While preventative treatment may be very helpful at stopping the unpleasant symptoms associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", as this \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a benign condition, preventative treatment is not essential. Some of those who choose not to have further treatment will eventually become asymptomatic. Those who wish to have further treatment can choose to take long term antiarrhythmic medication.  The first line drugs are \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel antagonists and beta blockers, with second line agents including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    flecainide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and occasionally \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    digoxin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". These drugs are moderately effective at preventing further episodes but need to be taken long term.Alternatively, an invasive procedure called an electrophysiology (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    EP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") study and catheter ablation can be used to confirm the diagnosis and potentially offer a cure. This procedure involves introducing wires or catheters into the heart through a vein in the leg.  The tip of one of these catheters can be used to heat or freeze the slow pathway of the AV node, destroying its ability to conduct electrical impulses, and preventing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The risks and benefits are weighed up before this is performed. Catheter ablation of the slow pathway, if successfully carried out, can potentially cure \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AVNRT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with success rates of &gt;95%, balanced against a small risk of complications including damaging the AV node and subsequently requiring a pacemaker. References  == External links ==&quot; &quot;Angiotensin-converting-enzyme inhibitors (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") are a class of medication used primarily for the treatment of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". They work by causing relaxation of blood vessels as well as a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    decrease in blood volume\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which leads to lower blood pressure and decreased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " demand from the heart.  ACE inhibitors inhibit the activity of angiotensin-converting enzyme, an important component of the renin–\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " system which converts \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin I to\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and hydrolyses \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradykinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Therefore, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors decrease the formation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", a vasoconstrictor, and increase the level of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradykinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ",  a peptide vasodilator. This combination is synergistic in lowering blood pressure. As a result of inhibiting the ACE enzyme in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradykinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " system, the ACE inhibitor drugs allow for increased levels of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradykinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " which would normally be degraded. This mechanism can explain the two most common side effects seen with ACE Inhibitors: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angioedema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cough\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bradykinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " produces \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    prostaglandin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".   Frequently prescribed ACE inhibitors include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    benazepril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    zofenopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    perindopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    trandolapril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    captopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    enalapril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lisinopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ramipril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Medical use ACE inhibitors were initially approved for the treatment of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and can be used alone or in combination with other anti-hypertensive medications.  Later, they were found useful for other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiovascular and kidney diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " including: Acute \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       ") \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (left ventricular systolic dysfunction) Kidney complications of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes mellitus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetic nephropathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") by means of decreasing the blood pressure and increasing perfusion in glomerular arterioles.In treating \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are often the first drug choice, particularly when \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is present, but \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " can lead to different choices and it is common to need more than one drug to obtain the desired improvement. There are fixed-dose combination drugs, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thiazide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " combinations. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " have also been used in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic kidney failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and kidney involvement in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    systemic sclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (hardening of tissues, as scleroderma \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    renal crisis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). In those with stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", but no \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", benefits are similar to other usual treatments.In 2012, there was a meta-analysis published in the BMJ that described the protective role of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in reducing the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pneumonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " when compared to ARBs (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Receptor Blockers). The authors found a decreased risk in patients with previous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (54% risk reduction), with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (37%  risk reduction), and of Asian descent (43% risk reduction vs 54% risk reduction in non-Asian population). However, no reduced \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pneumonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " related mortality was observed. Other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may also be used to help decrease excessive water consumption in people with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    schizophrenia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " resulting in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    psychogenic polydipsia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". A double-blind, placebo-controlled trial showed that when used for this purpose, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    enalapril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " led to decreased consumption (determined by urine output and osmolality) in 60% of people; the same effect has been demonstrated in other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".Additionally \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACEi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are commonly used after renal transplant to manage post-transplant \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    erythrocytosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a condition characterised by a persistently high hematocrit greater than 51% which often develops 8-24 months after successful transplantation, as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACEi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " have been shown to decrease erythropoietin production. Adverse effects Common side effects include: low blood pressure, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cough\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperkalemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    headache\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dizziness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatigue\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    kidney impairment\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".The main adverse effects of ACE inhibition can be understood from their pharmacological action. The other reported adverse effects are liver problems and effects on the fetus. Kidney problems may occur with all \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " that directly follows from their mechanism of action. Patients starting on an ACE inhibitor usually have a modest \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    reduction in glomerular filtration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " rate (GFR). However, the decrease may be significant in conditions of pre-existing decreased renal perfusions, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    renal artery stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    polycystic kidney disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or volume depletion. In these patients, the maintenance of GFR depends on angiotensin-II-dependent efferent vasomotor tone. Therefore, renal function should be closely monitored over the first few days after initiation of treatment with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in patients with decreased renal perfusion. A moderate \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    reduction in renal function\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", no greater than 30% rise in serum \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    creatinine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", that is stabilized after a week of treatment is deemed acceptable as part of the therapeutic effect, providing the residual renal function is sufficient.  Reduced GFR is especially a problem if the patient is concomitantly taking an NSAID and a diuretic. When the three drugs are taken together,  the risk of developing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    renal failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is significantly increased.High blood \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is another possible complication of treatment with an ACE inhibitor due to its effect on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Suppression of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " leads to a decrease in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels. Since \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is responsible for increasing the excretion of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can cause retention of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Some people, however, can continue to lose \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " while on an ACE inhibitor. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hyperkalemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may decrease the velocity of impulse conduction in the nerves and muscles, including cardiac tissues. This leads to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac dysfunction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and neuromuscular consequences, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle weakness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    paresthesia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diarrhea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and others. Close monitoring of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels is required in patients receiving treatment with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " who are at risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperkalemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Another possible adverse effect specific for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", but not for other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RAAS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " blockers, is an increase in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradykinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " level.A persistent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dry cough\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a relatively common adverse effect believed to be associated with the increases in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradykinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels produced by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", although the role of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradykinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in producing these symptoms has been disputed. Many cases of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cough\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in people on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may not be from the medication itself, however. People who experience this \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cough\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are often switched to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " receptor antagonists. Some (0.7%) develop \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angioedema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " due to increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradykinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels. A genetic predisposition may exist.A severe rare \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    allergic reaction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can affect the bowel wall and secondarily cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abdominal pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Blood Hematologic effects, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    neutropenia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    agranulocytosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood dyscrasias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", have occurred during therapy with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", especially in people with additional risk factors. Pregnancy In pregnant women, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " taken during all the trimesters have been reported to cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital malformations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stillbirths\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and neonatal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deaths\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Commonly reported fetal abnormalities include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    renal dysplasia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anuria/oliguria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oligohydramnios\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    intrauterine growth retardation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary hypoplasia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    patent ductus arteriosus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and incomplete ossification of the skull. Overall, about half of newborns exposed to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are adversely affected, leading to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    birth defects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are ADEC pregnancy category D and should be avoided in women who are likely to become pregnant. In the U.S., \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " must be labeled with a boxed warning concerning the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    birth defects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " when taken during the second and third trimester. Their use in the first trimester is also associated with a risk of major \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital malformations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", particularly affecting the cardiovascular and central nervous systems. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Overdose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Symptoms and Treatment: There are few reports of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitor overdose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the literature. The most likely manifestations are \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which may be severe, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperkalemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyponatremia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    renal impairment\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    metabolic acidosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Treatment should be mainly symptomatic and supportive, with volume expansion using normal saline to correct \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and improve renal function, and gastric lavage followed by activated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    charcoal\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and a cathartic to prevent further absorption of the drug. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Captopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    enalapril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lisinopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    perindopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are known to be removable by hemodialysis. Contraindications and precautions The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are contraindicated in people with: Pregnancy or breastfeeding Previous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angioedema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitor therapy Bilateral\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    renal artery stenosis Hypersensitivity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitorsACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " should be used with caution in people with: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Impaired renal function Aortic valve stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac outflow obstruction Hypovolemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dehydration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Hemodialysis with high-flux polyacrylonitrile membranesA combination of ACE inhibitor with other drugs may increase effects of these drugs, but also the risk of adverse effects. The commonly reported adverse effects of drug combination with ACE are \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute renal failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperkalemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The drugs interacting with ACE inhibitor should be prescribed with caution. Special attention should be given to combinations of ACE inhibitor with other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RAAS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " blockers, diuretics (especially \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium-sparing\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " diuretics), NSAIDs, anticoagulants, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cyclosporine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", DPP-4 inhibitors, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " supplements. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " supplementation should be used with caution and under medical supervision owing to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperkalemic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " effect of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".Concomitant use with cyclooxygenase inhibitors tends to decrease ACE inhibitor's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotensive\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " effect. Mechanism of action \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " reduce the activity of the renin–\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "–\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " system (RAAS) as the primary etiologic (causal) event in the development of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in people with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes mellitus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", as part of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insulin-resistance syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or as a manifestation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    renal disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Renin–\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "–\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " system The renin–\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "–\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " system is a major blood pressure regulating mechanism. Markers of electrolyte and water imbalance in the body such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    low distal tubule\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " concentration, decreased blood volume and high sympathetic tone trigger the release of the enzyme renin from the cells of juxtaglomerular apparatus in the kidney.  Renin activates a circulating liver derived prohormone angiotensinogen by proteolytic cleavage of all but its first ten \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " residues known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin I. ACE\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " converting enzyme) then removes a further two residues, converting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " I into \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". ACE is found in the pulmonary circulation and in the endothelium of many blood vessels. The system increases blood pressure by increasing the amount of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    salt\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and water the body retains, although \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is also very good at causing the blood vessels to tighten (a potent vasoconstrictor). Effects \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors block\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " the conversion of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin I (ATI)\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (ATII). They thereby lower arteriolar resistance and increase venous capacity; decrease cardiac output, cardiac index, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " work, and volume; lower resistance in blood vessels in the kidneys; and lead to increased natriuresis (excretion of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the urine). Renin increases in concentration in the blood as a result of negative feedback of conversion of ATI to ATII. ATI increases for the same reason; ATII and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " decrease. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bradykinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " increases because of less inactivation by ACE. Under normal conditions, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has these effects: Vasoconstriction (narrowing of blood vessels) and vascular smooth \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (enlargement) induced by ATII may lead to increased blood pressure and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Further, constriction of the efferent arterioles of the kidney leads to increased perfusion pressure in the glomeruli. It contributes to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular remodeling\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the heart through stimulation of the proto-oncogenes c-fos, c-jun, c-myc, transforming growth factor beta (TGF-B), through \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fibrogenesis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and apoptosis (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    programmed cell death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). Stimulation by ATII of the adrenal cortex to release \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", a hormone that acts on kidney tubules, causes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chloride ions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " retention and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " excretion. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is a &quot;&quot;water-holding&quot;&quot; ion, so water is also retained, which leads to increased blood volume, hence an increase in blood pressure. Stimulation of the posterior pituitary to release \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vasopressin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (antidiuretic hormone, ADH) also acts on the kidneys to increase water retention. If ADH production is excessive in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", Na+ level in the plasma may fall (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyponatremia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), and this is a sign of increased risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " patients. A decrease renal protein kinase CDuring the course of ACE inhibitor use, the production of ATII is decreased, which prevents \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " release from the adrenal cortex. This allows the kidney to excrete \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium ions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " along with obligate water, and retain \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions. This decreases blood volume, leading to decreased blood pressure.Epidemiological and clinical studies have shown \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " reduce the progress of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetic nephropathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " independently from their blood pressure-lowering effect. This action of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is used in the prevention of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetic renal failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " have been shown to be effective for indications other than \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " even in patients with normal blood pressure. The use of a maximum dose of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in such patients (including for prevention of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetic nephropathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congestive heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and prophylaxis of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiovascular events\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") is justified, because it improves clinical outcomes independently of the blood pressure-lowering effect of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Such therapy, of course, requires careful and gradual titration of the dose to prevent the effects of rapidly decreasing blood pressure (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dizziness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fainting\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", etc.). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " have also been shown to cause a central enhancement of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    parasympathetic nervous\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " system activity in healthy volunteers and patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". This action may reduce the prevalence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    malignant cardiac arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and the reduction in sudden death reported in large clinical trials. ACE Inhibitors also reduce plasma \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    norepinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels, and its resulting vasoconstriction effects, in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " patients, thus breaking the vicious circles of sympathetic and renin \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " system activation, which sustains the downward spiral in cardiac function in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congestive heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitor enalapril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has also been shown to reduce \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac cachexia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cachexia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a poor prognostic sign in patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are under early investigation for the treatment of frailty and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle wasting\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sarcopenia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") in elderly patients without \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Examples \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are easily identifiable by their common suffix, '\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    -pril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "'. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can be divided into three groups based on their molecular structure of the enzyme binding sites (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sulfhydryl\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", phosphinyl, carboxyl) to the active center of ACE: Sulfhydryl-containing agents \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Alacepril Captopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (trade name \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Capoten\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), the first ACE inhibitor. ZofenoprilThese agents appear to show antioxidative properties but may be involved in adverse events such as skin eruptions. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Dicarboxylate-containing agents\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " This is the largest group, including: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Enalapril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (Vasotec/Renitec/Berlipril/Enap/Enalapril Profarma) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ramipril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Altace/Prilace/Ramace/Ramiwin/Triatec/Tritace/Ramitac\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Quinapril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Accupril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Perindopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Coversyl/Aceon/Perindo\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lisinopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Listril/Lopril/Novatec/Prinivil/Zestril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Lisidigal) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Benazepril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lotensin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Imidapril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (Tanatril) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Trandolapril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (Mavik/Odrik/Gopten) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cilazapril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Inhibace\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") Phosphonate-containing agents \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Fosinopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Fositen/Monopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") is the only member of this group Naturally occurring A comprehensive resource on anti-hypertensive peptides is available in form of a database. It contains around 1700 unique antihypertensive peptides \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Arfalasin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HOE 409\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " antagonist. Dairy products \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Casokinins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lactokinins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", breakdown products of casein and whey, occur naturally after ingestion of milk products, especially cultured milk. Their role in blood pressure control is uncertain. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lactotripeptides\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Val-Pro-Pro and Ile-Pro-Pro produced by the probiotic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lactobacillus helveticus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or derived from casein have been shown to have ACE-inhibiting and antihypertensive functions. In one study, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    L. helveticus PR4\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was isolated from Italian cheeses. Comparative information All \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " have similar antihypertensive efficacy when equivalent doses are administered. The main differences lie with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    captopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the first ACE inhibitor. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Captopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has a shorter duration of action and an increased incidence of adverse effects. It is also the only ACE inhibitor capable of passing through the blood–brain barrier, although the significance of this characteristic has not been shown to have any positive clinical effects. In a large clinical study, one of the agents in the ACE inhibitor class, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ramipril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Altace\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), demonstrated an ability to reduce the mortality rates of patients suffering from a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and to slow the subsequent development of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". This finding was made after it was discovered that regular use of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ramipril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " reduced mortality rates even in test subjects not having suffered from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Some believe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ramipril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "'s additional benefits may be shared by some or all drugs in the ACE-inhibitor class. However, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ramipril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " currently remains the only ACE inhibitor for which such effects are actually evidence-based.A meta-analysis confirmed that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are effective and certainly the first-line choice in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " treatment. This meta-analysis was based on 20 trials and a cohort of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    158,998\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " patients, of whom 91% were \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertensive\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " were used as the active treatment in seven trials (n=76,615) and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin receptor blocker\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ARB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") in 13 trials (n=82,383). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " were associated with a statistically significant 10% mortality reduction: (HR 0.90; 95% CI, 0.84–0.97; P=0.004). In contrast, no significant mortality reduction was observed with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ARB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " treatment (HR 0.99; 95% CI, 0.94–1.04; P=0.683). Analysis of mortality reduction by different \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " showed that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    perindopril-based\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " regimens are associated with a statistically significant 13% all-cause mortality reduction. Taking into account the broad spectrum of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertensive\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " population, one might expect that an effective treatment with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", in particular with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    perindopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", would result in an important gain of lives saved. Equivalent doses in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " have different strengths with different starting dosages. Dosage should be adjusted according to the clinical response. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " receptor antagonists \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " possess many common characteristics with another class of cardiovascular drugs, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " receptor antagonists, which are often used when patients are intolerant of the adverse effects produced by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " do not completely prevent the formation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", as blockage is dose-dependent, so \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " receptor antagonists may be useful because they act to prevent the action of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " at the AT1 receptor, leaving AT2 receptor unblocked; the latter may have consequences needing further study. Use in combination The combination therapy of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " receptor antagonists with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may be superior to either agent alone. This combination may increase levels of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradykinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " while blocking the generation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and its activity at the AT1 receptor. This 'dual blockade' may be more effective than using an ACE inhibitor alone, because \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can be generated via non-ACE-dependent pathways. Preliminary studies suggest this combination of pharmacologic agents may be advantageous in the treatment of essential \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nephropathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". However, the more recent ONTARGET study showed no benefit of combining the agents and more adverse events. While statistically significant results have been obtained for its role in treating \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", clinical significance may be lacking. There are warnings about the combination of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " with ARBs.Patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may benefit from the combination in terms of reducing morbidity and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular remodeling\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".The most compelling evidence for the treatment of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nephropathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " has been found: This combination therapy partially reversed the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    proteinuria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and also exhibited a renoprotective effect in patients afflicted with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetic nephropathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and pediatric \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    IgA nephropathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". History Leonard T. Skeggs and his colleagues (including Norman Shumway) discovered ACE in plasma in 1956. It was also noted that those who worked in banana plantations in South-western Brazil collapsed after being bitten by a pit viper, leading to a search for a blood pressure lowering component in its venom. Brazilian scientist \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sérgio\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Henrique Ferreira reported a bradykinin-potentiating factor (BPF) present in the venom of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bothrops jararaca\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a South American pit viper, in 1965. Ferreira then went to John Vane's laboratory as a postdoctoral fellow with his already-isolated BPF. The conversion of the inactive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " I to the potent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was thought to take place in the plasma. However, in 1967, Kevin \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    K. F. Ng\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and John R. Vane showed plasma ACE is too slow to account for the conversion of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin I\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in vivo. Subsequent investigation showed rapid conversion occurs during its passage through the pulmonary circulation.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bradykinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is rapidly inactivated in the circulating blood, and it disappears completely in a single pass through the pulmonary circulation. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angiotensin I also disappears in the pulmonary circulation because of its\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " conversion to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Furthermore, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " passes through the lungs without any loss. The inactivation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradykinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and the conversion of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin I\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the lungs was thought to be caused by the same enzyme. In 1970, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ng\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and Vane, using BPF provided by Ferreira, showed the conversion is inhibited during its passage through the pulmonary circulation.BPFs are members of a family of peptides whose potentiating action is linked to inhibition of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradykinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " by ACE. Molecular analysis of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    BPF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " yielded a nonapeptide BPF teprotide (SQ 20,881), which showed the greatest ACE inhibition potency and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotensive\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " effect in vivo. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Teprotide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " had limited clinical value as a result of its peptide nature and lack of activity when given orally. In the early 1970s, knowledge of the structure-activity relationship required for inhibition of ACE was growing. David Cushman, Miguel Ondetti and colleagues used peptide analogues to study the structure of ACE, using carboxypeptidase A as a model. Their discoveries led to the development of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    captopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the first orally-active \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    1975.Captopril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was approved by the United States Food and Drug Administration in 1981. The first nonsulfhydryl-containing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    enalapril\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", was marketed two years later. At least 12 other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " have since been marketed.In 1991, Japanese scientists created the first milk-based \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", in the form of a fermented \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    milk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " drink, using specific cultures to liberate the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tripeptide isoleucine-proline-proline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (IPP) from the dairy protein. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Valine-proline-proline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    VPP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") is also liberated in this process—another milk tripeptide with a very similar chemical structure to IPP. Together, these peptides are now often referred to as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lactotripeptides\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". In 1996, the first human study confirmed the blood pressure-lowering effect of IPP in fermented milk. Although twice the amount of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    VPP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is needed to achieve the same ACE-inhibiting activity as the originally discovered IPP, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    VPP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " also is assumed to add to the total blood pressure lowering effect. Since the first \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lactotripeptides\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " discovery, more than 20 human clinical trials have been conducted in many different countries. Note See also \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angiotensin II receptor blocker\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Discovery and development of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " receptor blockers \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Loop diuretic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", also used to treat \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CHF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Renin inhibitor References External links Kumar R, Chaudhary \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    K\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Sharma M, Nagpal G, Chauhan JS, Singh S, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gautam A\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", Raghava GP (2014). &quot;&quot;AHTPDB: a comprehensive platform for analysis and presentation of antihypertensive peptides&quot;&quot;. Nucleic Acids Res. 43 (Database issue): D956–D962. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    doi:10.1093/nar/gku1141\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". PMC 4383949. PMID 25392419.CS1 maint: multiple names: authors list (link) ACE Inhibitors: Summary of Recommendations – Consumer Reports Best Buy Drugs – free public education project&quot; &quot;Acta Physiologica is a monthly peer-reviewed scientific journal that is published by Wiley-Blackwell on behalf of the Scandinavian Physiological Society. According to the Journal Citation Reports, it has a 2017 impact factor of  5.97. It is the official journal of the Federation of European Physiological Societies. The journal was established in 1889 as the Skandinavisches Archiv für Physiologie and renamed to Acta Physiologica Scandinavica in 1940, before obtaining its current name in 2006. References External links Official website&quot; &quot;Adrian Kantrowitz (October 4, 1918 – November 14, 2008) was an American cardiac surgeon whose team performed the world's second heart transplant attempt (after Christiaan Barnard) at Maimonides Medical Center in Brooklyn, New York on December 6, 1967.  The infant lived for only six hours.  At a press conference afterwards, Kantrowitz emphasized that he considered the operation to have been a failure.Kantrowitz also invented the intra-aortic balloon pump (IABP), a left ventricular assist device (L-VAD), and an early version of the implantable pacemaker.In 1981, Kantrowitz became a founding member of the World Cultural Council. Early life and education Kantrowitz was born in New York City on October 4, 1918. His mother was a costume designer and his father ran a clinic in the Bronx, and his grandparents were from Vermont. Adrian told his mother as a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    three-year-old\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that he wanted to be a doctor, and as a child built an electrocardiograph from old radio parts, together with his brother Arthur. Even though his surname is of Polish origin, he has no Polish ancestry. He graduated from New York University in 1940, having majored in mathematics. He attended the Long Island College of Medicine (now SUNY Downstate Medical Center) and was awarded his medical degree in 1943 as part of an effort to accelerate the availability of physicians during World War II. During an internship at the Jewish Hospital of Brooklyn, he developed an interest in neurosurgery, and had a paper published in 1944, &quot;&quot;A Method of Holding Galea Hemostats in Craniotomies&quot;&quot;, in which he proposed a new type of clamp to be used while performing a craniotomy during brain surgery. Early career He served for two years as a battalion surgeon in the United States Army Medical Corps and was discharged from the Army in 1946 with the rank of major.After his military service, he switched to specialize in cardiac surgery due to the paucity of positions in neurosurgery. In 1947, he was an assistant resident in surgery at Mount Sinai Hospital in Manhattan. Montefiore Hospital He was on the surgical staff of Montefiore Hospital in the Bronx from 1948 until 1955. He started at Montefiore as assistant resident in surgery and pathology, and progressed to cardiovascular research fellow before becoming chief resident in surgery. At the New York Academy of Medicine, on October 16, 1951, he screened the world's first movies taken inside a living heart, showing the sequential opening and closing of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " inside a beating heart. Using dogs and other animals as experimental subjects, Kantrowitz developed an artificial left heart, an early version of an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " generator for use as a component in a heart-lung machine and a treatment for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in which blood vessels would be rearranged during surgery. He also developed a device that allowed individuals who were paralyzed to have their bladders empty through a signal sent from a radio-controlled device. Maimonides Medical Center and early work on left ventricular assist device (LVAD) From 1955 to 1970, he held surgical posts at Maimonides Medical Center in Brooklyn. In February 1958, a heart-lung machine Kantrowitz had developed was used during open heart surgery on a six-year-old boy while the surgeons repaired a one-inch hole between the chambers of the boy's heart that was present since birth. In an October 1959 lecture at the American College of Surgeons, Kantrowitz and colleague Dr. William M. P. McKinnon reported on a procedure in which a portion of muscle from the diaphragm was used to create a &quot;&quot;booster&quot;&quot; heart to help pump blood in a dog, taking over as much as 25% of the pumping burden of the natural heart. The booster heart functions by receiving a signal sent by a radio transmitter triggered by the pulse of the natural heart. Kantrowitz noted that the procedure was not ready to be performed on humans. Ruff, a &quot;&quot;friendly dog of unknown ancestry&quot;&quot; was honored by the New York Academy of Sciences as &quot;&quot;research dog of the year&quot;&quot; for his unwitting participation in the implantation of a booster heart 18 months earlier in a procedure performed by Kantrowitz.In the early 1960s, Kantrowitz developed an implantable artificial pacemaker together with General Electric. The first of these pacemakers was implanted in May 1961. The device included an external control unit that could adjust the pacing rate from 64 to 120 beats per minute to allow the patient to deal with physical or emotional \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ".Throughout the 1960s, he collaborated with a team that included his brother, engineer Arthur Kantrowitz, on the development of a left ventricular assist device. Building on his experiments with dogs, he performed the world's second permanent partial mechanical heart implantation in a human on February 4, 1966, which was successful, though the patient died 24 hours after surgery as a result of preexisting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    liver disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". His second implant of a partial mechanical heart on a 63-year-old woman, on May 18, 1966, lasted 13 days, until the patient died of a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". During these almost two weeks after the surgery, the patient was improving, and was able to sit up and eat well. This surgery used a valveless device developed with his brother Arthur in which the natural electrical impulses of the patient's heart controlled the action of the pump.As part of Kantrowitz's research for this project, he conceived of ABO-incompatible heart transplantation, though it would be three decades before it would be put into practice. Worldwide context of heart transplantation Dr. James Hardy had performed the world's first heart transplant attempt and first heart xenograft at the University of Mississippi Medical Center on January 24, 1964.  Since there was no standard of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    brain death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", Hardy had acquired four chimpanzees as potential back-up donors.  A comatose Boyd Rush with a faint pulse had been brought to the hospital several days earlier and when he went into \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shock\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and was taken into surgery, Hardy polled the fellow doctors on his team, with three voting yes and one abstaining.  Hardy and his team then proceeded with the transplant using a chimpanzee heart which beat in Rush's chest approximately 60 to 90 minutes (sources vary), and Rush died without regaining consciousness.  The hospital's public relations department put out a guarded statement, with many of the early newspaper articles making the assumption that the donor was a human.  In addition, when Hardy attended the Sixth International Transplantation Conference several weeks later, he was treated with &quot;&quot;icy disdain.&quot;&quot;  Hardy withdrew from active pursuit of a successful heart transplant.In what turned out to be a four-way race between South African cardiac surgeon Dr. Christiaan Barnard and Americans Norman Shumway and Richard Lower, Kantrowitz prepared for a potential human heart transplant by transplanting hearts in 411 dogs over a five-year period together with members of his surgical team. On June 29, 1966, by which time Kantrowitz had completed the necessary technical research, one of his patients was an 18-day-old infant who very much needed a new heart.  He and his team had located an anencephalic baby whose parents agreed to let her be the donor.  Due to disagreements with senior staffers Howard Joos and Harry Weiss, Kantrowitz was forced to wait until \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (instead of the more modern use of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    brain death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") to retrieve the donor heart, which was found to be useless.  According to the Every Second Counts: The Race to Transplant the First Human Heart (2006), Kantrowitz did not know at the time that the donor parents in Oregon both expected and wanted their baby's heart to be taken before it stopped beating (anencephalic babies typically live 24 to 48 hours). Barnard performed the first human-to-human heart transplant with an adult donor and recipient on December 3, 1967, at Groote Schuur Hospital in Cape Town, South Africa.Worldwide, especially following Barnard's December 1967 transplant, there were more than 100 transplants were performed by various doctors during 1968.  However, only a third of these patients lived longer than three months. Kantrowitz's 1967 pediatric heart transplant attempt at Maimonides On December 6, 1967, at Maimonides Medical Center, Kantrowitz's team, including Bjørnstad \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PG\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Lindberg HL, Smevik B, Rian R, Sørland SJ, Tjønneland S, performed the world's first pediatric heart transplant attempt as well as the first human-to-human heart transplant in the United States.  The donor infant was David McIntire Bashaw who was anencephalic baby with a brain which was &quot;&quot;grossly malformed&quot;&quot; and who had a poor Moro reflex (infant's startle response).  However, this infant could move its extremities and had a feeble cry.  According to Every Second Counts, both this infant and the recipient infant had their body temperatures cooled from 98.6 to 59 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    °\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "F, at which time surgeons then waited for the donor baby's heart to stop beating.The recipient infant was 19-day-old Jamie Scudero who had the heart conditions of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tricuspid atresia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ebstein's anomaly\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". At 3:45 a.m., the cooling procedure began.  At 4:25 a.m., the Bashaw baby flat-lined, and Jordan Haller removed his heart.  He and Kantrowitz sutured the heart into Scudero's chest.  This took 40 minutes.  Kantrowitz was relying on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypothermia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " alone for Scudero which meant the entire operation needed to be completed in less than an hour. The team then warmed Scudero to 79 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    °\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "F, at which point they administered an electrical \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shock\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to the heart and it began to beat.  Scudero lived for a little more than six hours, and then his new heart stopped beating and could not be restarted. At a press conference, Kantrowitz emphasized that he did not view the operation as a success.Alex \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Faltine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was the head technician and was responsible for re-warming Scudero.  During the procedure, a connector between two hot water pipes came loose.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Faltine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " simply held it in place with his thinly-gloved hands and didn't say anything to slow down the operation.  Afterwards, Haller was astonished to see his blistered hands and asked \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Faltine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " how long he had had to hold the pipes together.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Faltine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", a man in his fifties who occasionally showed off by doing one-armed push-ups in the hallway, simply shrugged it off. Pump to assist heart The intra-aortic balloon pump was invented by Kantrowitz, working in conjunction with his brother, Arthur Kantrowitz. Inserted through the patient's thigh, it was directed into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", and alternately expanded and contracted in order to reduce strain on the heart. Based on Kantrowitz's theory of &quot;&quot;counterpulsation&quot;&quot;, the device inflated the balloon with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    helium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " gas when the heart relaxed and deflated it when the heart pumped blood. The pump did not require surgery and could be inserted using local anesthetic in an emergency room or at a patient's bedside. The device was first used in August 1967 to save the life of a 45-year-old woman who was having a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       ". The device could be used in the 15% of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       " patients who went into severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shock\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", 80% of whom could not be helped by the protocols that existed before the balloon pump. Since the device went into widespread use in the 1980s, it had been used in some three million patients by the time of his \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Sinai Hospital He and his entire team of surgeons, researchers, biomedical engineers, and nurses relocated to Sinai Hospital (now Sinai-Grace Hospital) in Detroit in 1970, where he assumed the position of attending surgeon and chairman of the Department of Surgery.At Sinai Hospital, Kantrowitz experimented further with heart transplants and continued development of the balloon pump, and partial mechanical hearts. In August 1971, he implanted an artificial heart booster in a 63-year-old man whose weakened heart could not pump sufficient oxygenated blood to his body. The patient became the first partial mechanical heart patient to be sent home, and died three months after the surgery. Personal life, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Kantrowitz married Jean Rosensaft on November 25, 1948. His wife was an administrator on the surgical research laboratories at Maimonides Medical Center while he was there. In 1983, they co-founded L.VAD Technology, Inc., a company specializing in research and development of cardiovascular devices, with Kantrowitz as president and his wife as vice president.Kantrowitz died at \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " 90 in Ann Arbor, Michigan, on November 14, 2008 of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Awards and honors Golden Plate Award of the American Academy of Achievement (1966) References External links First U.S. Human-to-Human Heart Transplant at Wayne State University Library contains high-definition images from this procedure, performed by Dr. Adrian Kantrowitz. AP Obituary Adrian Kantrowitz Papers (1944-2004) - National Library of Medicine finding aid The Adrian Kantrowitz Papers - Profiles in Science, National Library of Medicine&quot; &quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", also known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", is a hormone and medication which is involved in regulating visceral functions (e.g., respiration). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is normally produced both by the adrenal glands and by a small number of neurons in the medulla oblongata. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart by acting on the SA node, pupil dilation response and blood sugar level. It does this by binding to alpha and beta receptors. It is found in many animals and some single-celled organisms. Polish physiologist Napoleon Cybulski first isolated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in 1895. Medical uses As a medication, it is used to treat a number of conditions including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anaphylaxis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac arrest\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and superficial \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Inhaled \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may be used to improve the symptoms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    croup\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It may also be used for asthma when other treatments are not effective. It is given intravenously, by injection into a muscle, by inhalation, or by injection just under the skin. Common side effects include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shakiness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anxiety\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and sweating. A fast heart rate and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " may occur. Occasionally it may result in an abnormal heart rhythm. While the safety of its use during pregnancy and breastfeeding is unclear, the benefits to the mother must be taken into account.A case has been made for the use of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " infusion in place of the widely accepted treatment of inotropes for preterm infants with clinical cardiovascular compromise. Although there is sufficient data which strongly recommends \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " infusions as a viable treatment, more trials are needed in order to conclusively determine that these infusions will successfully reduce morbidity and mortality rates among preterm, cardiovascularly compromised infants. Physiological effects The adrenal medulla is a minor contributor to total circulating \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    catecholamines\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    L-DOPA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is at a higher concentration in the plasma), though it contributes over 90% of circulating \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Little \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is found in other tissues, mostly in scattered chromaffin cells, and in a small number of neurons which use \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " as a neurotransmitter. Following adrenalectomy, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " disappears below the detection limit in the blood stream.Pharmacological doses of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " stimulate \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    α1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", α2, β1, β2, and β3 adrenoceptors of the sympathetic nervous system. Sympathetic nerve receptors are classified as adrenergic, based on their responsiveness to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The term &quot;&quot;adrenergic&quot;&quot; is often misinterpreted in that the main sympathetic neurotransmitter is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    noradrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", rather than \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", as discovered by Ulf von Euler in 1946. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " does have a β2 adrenoceptor-mediated effect on metabolism and the airway, there being no direct neural connection from the sympathetic ganglia to the airway.The concept of the adrenal medulla and the sympathetic nervous system being involved in the flight, fight and fright response was originally proposed by Walter Bradford Cannon. But the adrenal medulla, in contrast to the adrenal cortex, is not required for survival. In adrenalectomized patients hemodynamic and metabolic responses to stimuli such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypoglycemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " remain normal. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " One physiological stimulus to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " secretion is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ". This was first demonstrated by measuring the dilation of a (denervated) pupil of a cat on a treadmill, later confirmed using a biological assay on urine samples. Biochemical methods for measuring \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    catecholamines\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in plasma were published from 1950 onwards. Although much valuable work has been published using fluorimetric assays to measure total \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    catecholamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " concentrations, the method is too non-specific and insensitive to accurately determine the very small quantities of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in plasma. The development of extraction methods and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    enzyme-isotope\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " derivate radio-enzymatic assays (REA) transformed the analysis down to a sensitivity of 1 pg for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Early REA plasma assays indicated that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and total \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    catecholamines\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " rise late in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ", mostly when anaerobic metabolism commences.During \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ", the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " blood concentration rises partially from the increased secretion of the adrenal medulla and partly from the decreased metabolism of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " due to reduced blood flow to the liver. Infusion of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to reproduce \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " circulating concentrations of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in subjects at rest has little haemodynamic effect, other than a small β2-mediated fall in diastolic blood pressure. Infusion of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " well within the physiological range suppresses human \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    airway hyper-reactivity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " sufficiently to antagonize the constrictor effects of inhaled \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    histamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".A link between the sympathetic nervous system and the lungs was shown in 1887 when Grossman showed that stimulation of cardiac accelerator nerves reversed muscarine-induced airway constriction. In experiments in the dog, where the sympathetic chain was cut at the level of the diaphragm, Jackson showed that there was no direct sympathetic innervation to the lung, but that bronchoconstriction was reversed by release of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " from the adrenal medulla. An increased incidence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    asthma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " has not been reported for adrenalectomized patients; those with a predisposition to asthma will have some protection from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    airway hyper-reactivity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from their corticosteroid replacement therapy. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " induces progressive airway dilation in normal subjects that correlates with work load and is not prevented by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    beta blockade\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The progressive dilation of the airway with increasing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " is mediated by a progressive reduction in resting vagal tone. Beta blockade with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    propranolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " causes a rebound in airway resistance after \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " in normal subjects over the same time course as the bronchoconstriction seen with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " induced asthma. The reduction in airway resistance during \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " reduces the work of breathing. Emotional response Every emotional response has a behavioral component, an autonomic component, and a hormonal component. The hormonal component includes the release of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", an adrenomedullary response that occurs in response to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " and that is controlled by the sympathetic nervous system. The major emotion studied in relation to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is fear. In an experiment, subjects who were injected with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " expressed more negative and fewer positive facial expressions to fear films compared to a control group. These subjects also reported a more intense fear from the films and greater mean intensity of negative memories than control subjects. The findings from this study demonstrate that there are learned associations between negative feelings and levels of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Overall, the greater amount of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is positively correlated with an aroused state of negative feelings. These findings can be an effect in part that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " elicits physiological sympathetic responses including an increased heart rate and knee shaking, which can be attributed to the feeling of fear regardless of the actual level of fear elicited from the video. Although studies have found a definite relation between \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and fear, other emotions have not had such results. In the same study, subjects did not express a greater amusement to an amusement film nor greater anger to an anger film. Similar findings were also supported in a study that involved rodent subjects that either were able or unable to produce \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Findings support the idea that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " does have a role in facilitating the encoding of emotionally arousing events, contributing to higher levels of arousal due to fear. Memory It has been found that adrenergic hormones, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", can produce retrograde enhancement of long-term memory in humans. The release of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " due to emotionally stressful events, which is endogenous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", can modulate memory consolidation of the events, ensuring memory strength that is proportional to memory importance. Post-learning \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " activity also interacts with the degree of arousal associated with the initial coding. There is evidence that suggests \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " does have a role in long-term \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " adaptation and emotional memory encoding specifically. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may also play a role in elevating arousal and fear memory under particular pathological conditions including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    post-traumatic stress disorder\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Overall, &quot;&quot;Extensive evidence indicates that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (EPI) modulates memory consolidation for emotionally arousing tasks in animals and human subjects.” Studies have also found that recognition memory involving \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " depends on a mechanism that depends on β adrenoceptors. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " does not readily cross the blood–brain barrier, so its effects on memory consolidation are at least partly initiated by β adrenoceptors in the periphery. Studies have found that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sotalol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", a β adrenoceptor antagonist that also does not readily enter the brain, blocks the enhancing effects of peripherally administered \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " on memory. These findings suggest that β adrenoceptors are necessary for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to have an effect on memory consolidation. Pathology Increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " secretion is observed in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pheochromocytoma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypoglycemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and to a lesser degree in essential \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tremor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (also known as benign, familial or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    idiopathic tremor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). A general increase in sympathetic neural activity is usually accompanied by increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " secretion, but there is selectivity during \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypoxia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypoglycaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", when the ratio of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    noradrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is considerably increased. Therefore, there must be some autonomy of the adrenal medulla from the rest of the sympathetic system. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is associated with high levels of circulating \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    noradrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", particularly in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiogenic shock\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Benign familial tremor (BFT) is responsive to peripheral β adrenergic blockers and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    β2-stimulation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is known to cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tremor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Patients with BFT were found to have increased plasma \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", but not \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    noradrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".Low, or absent, concentrations of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can be seen in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    autonomic neuropathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or following adrenalectomy. Failure of the adrenal cortex, as with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Addison's disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", can suppress \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " secretion as the activity of the synthesing enzyme, phenylethanolamine-N-methyltransferase, depends on the high concentration of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cortisol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " that drains from the cortex to the medulla. Terminology In 1901, Jōkichi Takamine patented a purified extract from the adrenal glands which was trademarked by Parke, Davis &amp; Co in the US.  The British Approved Name and European Pharmacopoeia term for this drug is hence \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".However, the pharmacologist John Abel had already prepared an extract from adrenal glands as early as 1897, and coined the name \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "  to describe it (from the Greek epi and nephros, &quot;&quot;on top of the kidneys&quot;&quot;). In the belief that Abel's extract was the same as Takamine's (a belief since disputed), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " became the generic name in the US, and remains the pharmaceutical's United States Adopted Name and International Nonproprietary Name (though the name \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is frequently used). The terminology is now one of the few differences between the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    INN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and BAN systems of names.  Although European health professionals and scientists preferentially use the term \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the converse is true among American health professionals and scientists.  Nevertheless, even among the latter, receptors for this substance are called adrenergic receptors or adrenoceptors, and pharmaceuticals that mimic its effects are often called adrenergics.  The history of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is reviewed by Rao. Mechanism of action As a hormone, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " acts on nearly all body tissues by binding to adrenergic receptors. Its effects on various tissues depend of the type of tissue and expression of specific forms of adrenergic receptors. For example, high levels of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " causes smooth muscle relaxation in the airways but causes contraction of the smooth muscle that lines most arterioles. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is a nonselective agonist of all adrenergic receptors, including the major subtypes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    α1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", α2, β1, β2, and β3. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "'s binding to these receptors triggers a number of metabolic changes. Binding to α-adrenergic receptors inhibits insulin secretion by the pancreas, stimulates glycogenolysis in the liver and muscle, and stimulates \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glycolysis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and inhibits insulin-mediated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glycogenesis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in muscle. β adrenergic receptor binding triggers \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucagon\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " secretion in the pancreas, increased adrenocorticotropic hormone (ACTH) secretion by the pituitary gland, and increased lipolysis by adipose tissue. Together, these effects lead to increased blood \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatty acids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", providing substrates for energy production within cells throughout the body.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " causes liver cells to release \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " into the blood, acting through both alpha and beta adrenergic receptors to stimulate glycogenolysis. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " binds to β2 receptors on liver cells, which changes conformation and helps Gs, a heterotrimeric G protein, exchange GDP to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GTP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". This trimeric G protein dissociates to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gs alpha and Gs beta/gamma subunits.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Gs alpha stimulates adenylyl cyclase, thus converting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adenosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " triphosphate into cyclic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adenosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " monophosphate (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AMP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "). Cyclic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AMP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " activates protein kinase A. Protein kinase A phosphorylates and partially activates phosphorylase kinase. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " also binds to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    α1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " adrenergic receptors, causing an increase in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inositol trisphosphate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", inducing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions to enter the cytoplasm. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions bind to calmodulin, which leads to further activation of phosphorylase kinase. Phosphorylase kinase phosphorylates glycogen phosphorylase, which then breaks down glycogen leading to the production of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glucose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " also has significant effects on the cardiovascular system. It increases peripheral resistance via α1 receptor-dependent vasoconstriction and increases cardiac output by binding to β1 receptors. The goal of reducing peripheral circulation is to increase coronary and cerebral perfusion pressures and therefore increase \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " exchange at the cellular level. While \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " does increase aortic, cerebral, and carotid circulation pressure, it lowers carotid blood flow and end-tidal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CO2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ETCO2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels. It appears that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may be improving macrocirculation at the expense of the capillary beds where actual perfusion is taking place. Measurement in biological fluids \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may be quantified in blood, plasma or serum as a diagnostic aid, to monitor therapeutic administration, or to identify the causative agent in a potential \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    poisoning\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " victim. Endogenous plasma \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " concentrations in resting adults are normally less than 10 ng/L, but may increase by 10-fold during \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " and by 50-fold or more during times of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pheochromocytoma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " patients often have plasma \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels of 1000–10,000 ng/L. Parenteral administration of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to acute-care cardiac patients can produce plasma concentrations of 10,000 to 100,000 ng/L. Biosynthesis and regulation In chemical terms, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is one of a group of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    monoamines\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " called the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    catecholamines\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is synthesized in the chromaffin cells of the adrenal medulla of the adrenal gland and a small number of neurons in the medulla oblongata in the brain through a metabolic pathway that converts the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acids phenylalanine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tyrosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " into a series of metabolic intermediates and, ultimately, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Tyrosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is first oxidized to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    L-DOPA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tyrosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " hydroxylase, this is the rate-limiting step. Then it is subsequently decarboxylated to give \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dopamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DOPA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " decarboxylase (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aromatic L-amino acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " decarboxylase). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Dopamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is then converted to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    noradrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dopamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " beta-hydroxylase which utilizes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ascorbic acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin C\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") and copper. The final step in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " biosynthesis is the methylation of the primary \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    noradrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". This reaction is catalyzed by the enzyme phenylethanolamine N-methyltransferase (PNMT) which utilizes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    S-adenosyl methionine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    SAMe\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") as the methyl donor. While PNMT is found primarily in the cytosol of the endocrine cells of the adrenal medulla (also known as chromaffin cells), it has been detected at low levels in both the heart and brain. Regulation The major physiologic triggers of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " release center upon stresses, such as physical threat, excitement, noise, bright lights, and high or low ambient temperature. All of these stimuli are processed in the central nervous system.Adrenocorticotropic hormone (ACTH) and the sympathetic nervous system stimulate the synthesis of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " precursors by enhancing the activity of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tyrosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " hydroxylase and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dopamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " β-hydroxylase, two key enzymes involved in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    catecholamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " synthesis. ACTH also stimulates the adrenal cortex to release \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cortisol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which increases the expression of PNMT in chromaffin cells, enhancing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " synthesis. This is most often done in response to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". The sympathetic nervous system, acting via splanchnic nerves to the adrenal medulla, stimulates the release of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Acetylcholine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " released by preganglionic sympathetic fibers of these nerves acts on nicotinic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acetylcholine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " receptors, causing cell depolarization and an influx of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " through voltage-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " triggers the exocytosis of chromaffin granules and, thus, the release of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    noradrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") into the bloodstream. For \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    noradrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to be acted upon by PNMT in the cytosol, it must first be shipped out of granules of the chromaffin cells. This may occur via the catecholamine-H+ exchanger VMAT1. VMAT1 is also responsible for transporting newly synthesized \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " from the cytosol back into chromaffin granules in preparation for release.Unlike many other hormones \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (as with other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    catecholamines\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") does not exert negative feedback to down-regulate its own synthesis. Abnormally elevated levels of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can occur in a variety of conditions, such as surreptitious \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " administration, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pheochromocytoma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tumors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the sympathetic ganglia. Its action is terminated with reuptake into nerve terminal endings, some minute dilution, and metabolism by monoamine oxidase and catechol-O-methyl transferase. History Extracts of the adrenal gland were first obtained by Polish physiologist Napoleon Cybulski in 1895. These extracts, which he called \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nadnerczyna\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (&quot;&quot;adrenalin&quot;&quot;), contained \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    catecholamines\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". American ophthalmologist William H. Bates discovered \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "'s usage for eye surgeries prior to 20 April 1896. In 1897, John Jacob Abel (1857-1938), the father of modern pharmacology, finds a natural substance produced by the adrenal glands that he names \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The first hormone to be identified, it remains a crucial, firstline treatment for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac arrests\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    allergic reactions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and other conditions. Japanese chemist Jōkichi Takamine and his assistant Keizo Uenaka independently discovered \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in 1900. In 1901, Takamine successfully isolated and purified the hormone from the adrenal glands of sheep and oxen. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was first synthesized in the laboratory by Friedrich Stolz and Henry Drysdale Dakin, independently, in 1904.Even though secretin is mentioned as the first hormone, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is the actual first hormone since the discovery of activity of adrenal extract on blood pressure was observed in 1895 before that of secretin in 1902. In 1895, George Oliver (1841-1915), a general practitioner in North Yorkshire and Edward Albert Schäfer (1850-1935), a physiologist at University College of London published a paper about the active component of adrenal gland extract causing the increase in blood pressure and heart rate was from medulla, but not the cortex of the adrenal gland. In 1897, John Jacob Abel (1857-1938) of Johns Hopkins University, the first chairman of the first U.S department of pharmacology, found a compound called \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " with the molecular formula of C17H15NO4.  Abel claimed his principle from adrenal gland extract was active. In 1900, Jōkichi Takamine (1854-1922), a Japanese chemist worked with his assistant, Keizo Uenaka (1876-1960) to purified a 2000 times more active principle than \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " from adrenal gland, named \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " with the molecular formula C10H15NO3.  In addition, in 1900 Thomas Aldrich of Parke-Davis Scientific Laboratory also purified \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " independently. Takamine and Parke-Davis later in 1901 both got the patent for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The fight for terminology between \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was not ended until the first \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " structural discovery of Hermann Pauly (1870-1950) in 1903, and the first \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " synthesis of Friedrich Stolz (1860-1936), a German chemist in 1904. They both believed that Takamine's compound was the active principle while Abel's compound was the inactive one. Society and culture \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " junkie An \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " junkie is somebody who engages in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sensation-seeking behavior\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " through &quot;&quot;the pursuit of novel and intense experiences without regard for physical, social, legal or financial risk&quot;&quot;. Such activities include extreme and risky sports, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    substance abuse\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", unsafe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sex\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", and crime. The term relates to the increase in circulating levels of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " during physiological \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". Such an increase in the circulating concentration of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is secondary to activation of the sympathetic nerves innervating the adrenal medulla, as it is rapid and not present in animals where the adrenal gland has been removed. Although such \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " triggers \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " release, it also activates many other responses within the central nervous system reward system which drives behavioral responses, so while the circulating \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " concentration is present, it may not drive behavior. Nevertheless, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " infusion alone does increase alertness and has roles in the brain including the augmentation of memory consolidation. Strength \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has been implicated in feats of great strength, often occurring in times of crisis. For example, there are stories of a parent lifting part of a car when their child is trapped underneath. References External links U.S. National Library of Medicine: Drug Information Portal – \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Epinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "&quot; &quot;In physiology, an action potential (AP) occurs when the membrane potential of a specific cell location rapidly rises and falls: this depolarization then causes adjacent locations to similarly depolarize. Action potentials occur in several types of animal cells, called excitable cells, which include neurons, muscle cells, endocrine cells and in some plant cells. In neurons, action potentials play a central role in cell-to-cell communication by providing for—or with regard to saltatory conduction, assisting—the propagation of signals along the neuron's axon toward synaptic boutons situated at the ends of an axon; these signals can then connect with other neurons at synapses, or to motor cells or glands. In other types of cells, their main function is to activate intracellular processes. In muscle cells, for example, an action potential is the first step in the chain of events leading to contraction. In beta cells of the pancreas, they provoke release of insulin. Action potentials in neurons are also known as &quot;&quot;nerve impulses&quot;&quot; or &quot;&quot;spikes&quot;&quot;, and the temporal sequence of action potentials generated by a neuron is called its &quot;&quot;spike train&quot;&quot;. A neuron that emits an action potential, or nerve impulse, is often said to &quot;&quot;fire&quot;&quot;. Action potentials are generated by special types of voltage-gated ion channels embedded in a cell's plasma membrane. These channels are shut when the membrane potential is near the (negative) resting potential of the cell, but they rapidly begin to open if the membrane potential increases to a precisely defined threshold voltage, depolarising the transmembrane potential. When the channels open, they allow an inward flow of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium ions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which changes the electrochemical gradient, which in turn produces a further rise in the membrane potential towards zero. This then causes more channels to open, producing a greater electric current across the cell membrane and so on. The process proceeds explosively until all of the available ion channels are open, resulting in a large upswing in the membrane potential. The rapid influx of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions causes the polarity of the plasma membrane to reverse, and the ion channels then rapidly inactivate. As the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels close, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium ions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can no longer enter the neuron, and they are then actively transported back out of the plasma membrane. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels are then activated, and there is an outward current of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions, returning the electrochemical gradient to the resting state. After an action potential has occurred, there is a transient negative shift, called the afterhyperpolarization. In animal cells, there are two primary types of action potentials. One type is generated by voltage-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels, the other by voltage-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels. Sodium-based action potentials usually last for under one millisecond, but \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium-based\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " action potentials may last for 100 milliseconds or longer. In some types of neurons, slow \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " spikes provide the driving force for a long burst of rapidly emitted \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " spikes. In cardiac muscle cells, on the other hand, an initial fast \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " spike provides a &quot;&quot;primer&quot;&quot; to provoke the rapid onset of a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " spike, which then produces muscle contraction. Overview Nearly all cell membranes in animals, plants and fungi maintain a voltage difference between the exterior and interior of the cell, called the membrane potential. A typical voltage across an animal cell membrane is −70 mV. This means that the interior of the cell has a negative voltage relative to the exterior. In most types of cells, the membrane potential usually stays fairly constant. Some types of cells, however, are electrically active in the sense that their voltages fluctuate over time. In some types of electrically active cells, including neurons and muscle cells, the voltage fluctuations frequently take the form of a rapid upward spike followed by a rapid fall. These up-and-down cycles are known as action potentials. In some types of neurons, the entire up-and-down cycle takes place in a few thousandths of a second. In muscle cells, a typical action potential lasts about a fifth of a second. In some other types of cells and plants, an action potential may last three seconds or more.The electrical properties of a cell are determined by the structure of the membrane that surrounds it. A cell membrane consists of a lipid bilayer of molecules in which larger protein molecules are embedded. The lipid bilayer is highly resistant to movement of electrically charged ions, so it functions as an insulator. The large membrane-embedded proteins, in contrast, provide channels through which \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can pass across the membrane. Action potentials are driven by channel proteins whose configuration switches between closed and open states as a function of the voltage difference between the interior and exterior of the cell. These voltage-sensitive proteins are known as voltage-gated ion channels. Process in a typical neuron All cells in animal body tissues are electrically polarized – in other words, they maintain a voltage difference across the cell's plasma membrane, known as the membrane potential. This electrical polarization results from a complex interplay between protein structures embedded in the membrane called ion pumps and ion channels. In neurons, the types of ion channels in the membrane usually vary across different parts of the cell, giving the dendrites, axon, and cell body different electrical properties. As a result, some parts of the membrane of a neuron may be excitable (capable of generating action potentials), whereas others are not. Recent studies have shown that the most excitable part of a neuron is the part after the axon hillock (the point where the axon leaves the cell body), which is called the axonal initial segment, but the axon and cell body are also excitable in most cases.Each excitable patch of membrane has two important levels of membrane potential: the resting potential, which is the value the membrane potential maintains as long as nothing perturbs the cell, and a higher value called the threshold potential. At the axon hillock of a typical neuron, the resting potential is around –70 millivolts (mV) and the threshold potential is around –55 mV. Synaptic inputs to a neuron cause the membrane to depolarize or hyperpolarize; that is, they cause the membrane potential to rise or fall. Action potentials are triggered when enough depolarization accumulates to bring the membrane potential up to threshold. When an action potential is triggered, the membrane potential abruptly shoots upward and then equally abruptly shoots back downward, often ending below the resting level, where it remains for some period of time. The shape of the action potential is stereotyped; this means that the rise and fall usually have approximately the same amplitude and time course for all action potentials in a given cell. (Exceptions are discussed later in the article). In most neurons, the entire process takes place in about a thousandth of a second. Many types of neurons emit action potentials constantly at rates of up to 10–100 per second. However, some types are much quieter, and may go for minutes or longer without emitting any action potentials. Biophysical basis Action potentials result from the presence in a cell's membrane of special types of voltage-gated ion channels. A voltage-gated ion channel is a transmembrane protein that has three key properties: It is capable of assuming more than one conformation. At least one of the conformations creates a channel through the membrane that is permeable to specific types of ions. The transition between conformations is influenced by the membrane potential.Thus, a voltage-gated ion channel tends to be open for some values of the membrane potential, and closed for others. In most cases, however, the relationship between membrane potential and channel state is probabilistic and involves a time delay. Ion channels switch between conformations at unpredictable times: The membrane potential determines the rate of transitions and the probability per unit time of each type of transition. Voltage-gated ion channels are capable of producing action potentials because they can give rise to positive feedback loops: The membrane potential controls the state of the ion channels, but the state of the ion channels controls the membrane potential. Thus, in some situations, a rise in the membrane potential can cause ion channels to open, thereby causing a further rise in the membrane potential. An action potential occurs when this positive feedback cycle (Hodgkin cycle) proceeds explosively. The time and amplitude trajectory of the action potential are determined by the biophysical properties of the voltage-gated ion channels that produce it. Several types of channels capable of producing the positive feedback necessary to generate an action potential do exist. Voltage-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels are responsible for the fast action potentials involved in nerve conduction. Slower action potentials in muscle cells and some types of neurons are generated by voltage-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels. Each of these types comes in multiple variants, with different voltage sensitivity and different temporal dynamics. The most intensively studied type of voltage-dependent ion channels comprises the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels involved in fast nerve conduction. These are sometimes known as Hodgkin-Huxley \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels because they were first characterized by Alan Hodgkin and Andrew Huxley in their Nobel Prize-winning studies of the biophysics of the action potential, but can more conveniently be referred to as NaV channels. (The &quot;&quot;V&quot;&quot; stands for &quot;&quot;voltage&quot;&quot;.) An NaV channel has three possible states, known as deactivated, activated, and inactivated. The channel is permeable only to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium ions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " when it is in the activated state. When the membrane potential is low, the channel spends most of its time in the deactivated (closed) state. If the membrane potential is raised above a certain level, the channel shows increased probability of transitioning to the activated (open) state. The higher the membrane potential the greater the probability of activation. Once a channel has activated, it will eventually transition to the inactivated (closed) state. It tends then to stay inactivated for some time, but, if the membrane potential becomes low again, the channel will eventually transition back to the deactivated state. During an action potential, most channels of this type go through a cycle deactivated→activated→inactivated→deactivated. This is only the population average behavior, however – an individual channel can in principle make any transition at any time. However, the likelihood of a channel's transitioning from the inactivated state directly to the activated state is very low: A channel in the inactivated state is refractory until it has transitioned back to the deactivated state. The outcome of all this is that the kinetics of the NaV channels are governed by a transition matrix whose rates are voltage-dependent in a complicated way. Since these channels themselves play a major role in determining the voltage, the global dynamics of the system can be quite difficult to work out. Hodgkin and Huxley approached the problem by developing a set of differential equations for the parameters that govern the ion channel states, known as the Hodgkin-Huxley equations. These equations have been extensively modified by later research, but form the starting point for most theoretical studies of action potential biophysics. As the membrane potential is increased, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ion channels open, allowing the entry of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions into the cell. This is followed by the opening of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ion channels that permit the exit of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions from the cell. The inward flow of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions increases the concentration of positively charged cations in the cell and causes depolarization, where the potential of the cell is higher than the cell's resting potential. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels close at the peak of the action potential, while \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " continues to leave the cell. The efflux of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions decreases the membrane potential or hyperpolarizes the cell. For small voltage increases from rest, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " current exceeds the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " current and the voltage returns to its normal resting value, typically −70 mV. However, if the voltage increases past a critical threshold, typically 15 mV higher than the resting value, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " current dominates. This results in a runaway condition whereby the positive feedback from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " current activates even more \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels. Thus, the cell fires, producing an action potential. The frequency at which a neuron elicits action potentials is often referred to as a firing rate or neural firing rate. Currents produced by the opening of voltage-gated channels in the course of an action potential are typically significantly larger than the initial stimulating current. Thus, the amplitude, duration, and shape of the action potential are determined largely by the properties of the excitable membrane and not the amplitude or duration of the stimulus. This all-or-nothing property of the action potential sets it apart from graded potentials such as receptor potentials, electrotonic potentials, subthreshold membrane potential oscillations, and synaptic potentials, which scale with the magnitude of the stimulus. A variety of action potential types exist in many cell types and cell compartments as determined by the types of voltage-gated channels, leak channels, channel distributions, ionic concentrations, membrane capacitance, temperature, and other factors. The principal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " involved in an action potential are \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " cations; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium ions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " enter the cell, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions leave, restoring equilibrium. Relatively few ions need to cross the membrane for the membrane voltage to change drastically. The ions exchanged during an action potential, therefore, make a negligible change in the interior and exterior ionic concentrations. The few ions that do cross are pumped out again by the continuous action of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "–\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " pump, which, with other ion transporters, maintains the normal ratio of ion concentrations across the membrane. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " cations and chloride anions are involved in a few types of action potentials, such as the cardiac action potential and the action potential in the single-cell alga Acetabularia, respectively. Although action potentials are generated locally on patches of excitable membrane, the resulting currents can trigger action potentials on neighboring stretches of membrane, precipitating a domino-like propagation. In contrast to passive spread of electric potentials (electrotonic potential), action potentials are generated anew along excitable stretches of membrane and propagate without decay. Myelinated sections of axons are not excitable and do not produce action potentials and the signal is propagated passively as electrotonic potential. Regularly spaced unmyelinated patches, called the nodes of Ranvier, generate action potentials to boost the signal. Known as saltatory conduction, this type of signal propagation provides a favorable tradeoff of signal velocity and axon diameter. Depolarization of axon terminals, in general, triggers the release of neurotransmitter into the synaptic cleft. In addition, backpropagating action potentials have been recorded in the dendrites of pyramidal neurons, which are ubiquitous in the neocortex. These are thought to have a role in spike-timing-dependent plasticity. In the Hodgkin–Huxley membrane capacitance model, the speed of transmission of an action potential was undefined and it was assumed that adjacent areas became depolarized due to released ion interference with neighbouring channels. Measurements of ion diffusion and radii have since shown this not to be possible. Moreover, contradictory measurements of entropy changes and timing disputed the capacitance model as acting alone. Alternatively, Gilbert Ling's adsorption hypothesis, posits that the membrane potential and action potential of a living cell is due to the adsorption of mobile ions onto adsorption sites of cells. Maturation of the electrical properties of the action potential A neuron's ability to generate and propagate an action potential changes during development. How much the membrane potential of a neuron changes as the result of a current impulse is a function of the membrane input resistance. As a cell grows, more channels are added to the membrane, causing a decrease in input resistance. A mature neuron also undergoes shorter changes in membrane potential in response to synaptic currents. Neurons from a ferret lateral geniculate nucleus have a longer time constant and larger voltage deflection at P0 than they do at P30. One consequence of the decreasing action potential duration is that the fidelity of the signal can be preserved in response to high frequency stimulation. Immature neurons are more prone to synaptic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " than potentiation after high frequency stimulation.In the early development of many organisms, the action potential is actually initially carried by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " current rather than \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " current. The opening and closing kinetics of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels during development are slower than those of the voltage-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels that will carry the action potential in the mature neurons. The longer opening times for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels can lead to action potentials that are considerably slower than those of mature neurons. Xenopus neurons initially have action potentials that take 60–90 ms. During development, this time decreases to 1 ms. There are two reasons for this drastic decrease. First, the inward current becomes primarily carried by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels. Second, the delayed rectifier, a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel current, increases to 3.5 times its initial strength.In order for the transition from a calcium-dependent action potential to a sodium-dependent action potential to proceed new channels must be added to the membrane. If Xenopus neurons are grown in an environment with RNA synthesis or protein synthesis inhibitors that transition is prevented. Even the electrical activity of the cell itself may play a role in channel expression. If action potentials in Xenopus myocytes are blocked, the typical increase in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " current density is prevented or delayed.This maturation of electrical properties is seen across species. Xenopus \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " currents increase drastically after a neuron goes through its final phase of mitosis. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " current density of rat cortical neurons increases by 600% within the first two postnatal weeks. Neurotransmission Anatomy of a neuron Several types of cells support an action potential, such as plant cells, muscle cells, and the specialized cells of the heart (in which occurs the cardiac action potential). However, the main excitable cell is the neuron, which also has the simplest mechanism for the action potential. Neurons are electrically excitable cells composed, in general, of one or more dendrites, a single soma, a single axon and one or more axon terminals. Dendrites are cellular projections whose primary function is to receive synaptic signals. Their protrusions, known as dendritic spines, are designed to capture the neurotransmitters released by the presynaptic neuron. They have a high concentration of ligand-gated ion channels. These spines have a thin neck connecting a bulbous protrusion to the dendrite. This ensures that changes occurring inside the spine are less likely to affect the neighboring spines. The dendritic spine can, with rare exception (see LTP), act as an independent unit. The dendrites extend from the soma, which houses the nucleus, and many of the &quot;&quot;normal&quot;&quot; eukaryotic organelles. Unlike the spines, the surface of the soma is populated by voltage activated ion channels. These channels help transmit the signals generated by the dendrites. Emerging out from the soma is the axon hillock. This region is characterized by having a very high concentration of voltage-activated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels. In general, it is considered to be the spike initiation zone for action potentials, i.e. the trigger zone. Multiple signals generated at the spines, and transmitted by the soma all converge here. Immediately after the axon hillock is the axon. This is a thin tubular protrusion traveling away from the soma. The axon is insulated by a myelin sheath. Myelin is composed of either Schwann cells (in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    peripheral nervous system)\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or oligodendrocytes (in the central nervous system), both of which are types of glial cells. Although glial cells are not involved with the transmission of electrical signals, they communicate and provide important biochemical support to neurons. To be specific, myelin wraps multiple times around the axonal segment, forming a thick fatty layer that prevents ions from entering or escaping the axon. This insulation prevents significant signal decay as well as ensuring faster signal speed. This insulation, however, has the restriction that no channels can be present on the surface of the axon. There are, therefore, regularly spaced patches of membrane, which have no insulation. These nodes of Ranvier can be considered to be &quot;&quot;mini axon hillocks&quot;&quot;, as their purpose is to boost the signal in order to prevent significant signal decay. At the furthest end, the axon loses its insulation and begins to branch into several axon terminals. These presynaptic terminals, or synaptic boutons, are a specialized area within the axon of the presynaptic cell that contains neurotransmitters enclosed in small membrane-bound spheres called synaptic vesicles. Initiation Before considering the propagation of action potentials along axons and their termination at the synaptic knobs, it is helpful to consider the methods by which action potentials can be initiated at the axon hillock. The basic requirement is that the membrane voltage at the hillock be raised above the threshold for firing. There are several ways in which this depolarization can occur. Dynamics Action potentials are most commonly initiated by excitatory postsynaptic potentials from a presynaptic neuron. Typically, neurotransmitter molecules are released by the presynaptic neuron. These neurotransmitters then bind to receptors on the postsynaptic cell. This binding opens various types of ion channels. This opening has the further effect of changing the local permeability of the cell membrane and, thus, the membrane potential. If the binding increases the voltage (depolarizes the membrane), the synapse is excitatory. If, however, the binding decreases the voltage (hyperpolarizes the membrane), it is inhibitory. Whether the voltage is increased or decreased, the change propagates passively to nearby regions of the membrane (as described by the cable equation and its refinements). Typically, the voltage stimulus decays exponentially with the distance from the synapse and with time from the binding of the neurotransmitter. Some fraction of an excitatory voltage may reach the axon hillock and may (in rare cases) depolarize the membrane enough to provoke a new action potential. More typically, the excitatory potentials from several synapses must work together at nearly the same time to provoke a new action potential. Their joint efforts can be thwarted, however, by the counteracting inhibitory postsynaptic potentials. Neurotransmission can also occur through electrical synapses. Due to the direct connection between excitable cells in the form of gap junctions, an action potential can be transmitted directly from one cell to the next in either direction. The free flow of ions between cells enables rapid non-chemical-mediated transmission. Rectifying channels ensure that action potentials move only in one direction through an electrical synapse. Electrical synapses are found in all nervous systems, including the human brain, although they are a distinct minority. &quot;&quot;All-or-none&quot;&quot; principle The amplitude of an action potential is independent of the amount of current that produced it. In other words, larger currents do not create larger action potentials. Therefore, action potentials are said to be all-or-none signals, since either they occur fully or they do not occur at all. This is in contrast to receptor potentials, whose amplitudes are dependent on the intensity of a stimulus. In both cases, the frequency of action potentials is correlated with the intensity of a stimulus. Sensory neurons In sensory neurons, an external signal such as pressure, temperature, light, or sound is coupled with the opening and closing of ion channels, which in turn alter the ionic permeabilities of the membrane and its voltage. These voltage changes can again be excitatory (depolarizing) or inhibitory (hyperpolarizing) and, in some sensory neurons, their combined effects can depolarize the axon hillock enough to provoke action potentials. Some examples in humans include the olfactory receptor neuron and Meissner's corpuscle, which are critical for the sense of smell and touch, respectively. However, not all sensory neurons convert their external signals into action potentials; some do not even have an axon. Instead, they may convert the signal into the release of a neurotransmitter, or into continuous graded potentials, either of which may stimulate subsequent neuron(s) into firing an action potential. For illustration, in the human ear, hair cells convert the incoming sound into the opening and closing of mechanically gated ion channels, which may cause neurotransmitter molecules to be released. In similar manner, in the human retina, the initial photoreceptor cells and the next layer of cells (comprising bipolar cells and horizontal cells) do not produce action potentials; only some amacrine cells and the third layer, the ganglion cells, produce action potentials, which then travel up the optic nerve. Pacemaker potentials In sensory neurons, action potentials result from an external stimulus. However, some excitable cells require no such stimulus to fire: They spontaneously depolarize their axon hillock and fire action potentials at a regular rate, like an internal clock. The voltage traces of such cells are known as pacemaker potentials. The cardiac pacemaker cells of the sinoatrial node in the heart provide a good example. Although such pacemaker potentials have a natural rhythm, it can be adjusted by external stimuli; for instance, heart rate can be altered by pharmaceuticals as well as signals from the sympathetic and parasympathetic nerves. The external stimuli do not cause the cell's repetitive firing, but merely alter its timing. In some cases, the regulation of frequency can be more complex, leading to patterns of action potentials, such as bursting. Phases The course of the action potential can be divided into five parts: the rising phase, the peak phase, the falling phase, the undershoot phase, and the refractory period. During the rising phase the membrane potential depolarizes (becomes more positive). The point at which depolarization stops is called the peak phase. At this stage, the membrane potential reaches a maximum. Subsequent to this, there is a falling phase. During this stage the membrane potential becomes more negative, returning towards resting potential. The undershoot, or afterhyperpolarization, phase is the period during which the membrane potential temporarily becomes more negatively charged than when at rest (hyperpolarized). Finally, the time during which a subsequent action potential is impossible or difficult to fire is called the refractory period, which may overlap with the other phases.The course of the action potential is determined by two coupled effects. First, voltage-sensitive ion channels open and close in response to changes in the membrane voltage Vm. This changes the membrane's permeability to those ions. Second, according to the Goldman equation, this change in permeability changes the equilibrium potential Em, and, thus, the membrane voltage Vm. Thus, the membrane potential affects the permeability, which then further affects the membrane potential. This sets up the possibility for positive feedback, which is a key part of the rising phase of the action potential. A complicating factor is that a single ion channel may have multiple internal &quot;&quot;gates&quot;&quot; that respond to changes in Vm in opposite ways, or at different rates. For example, although raising Vm opens most gates in the voltage-sensitive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel, it also closes the channel's &quot;&quot;inactivation gate&quot;&quot;, albeit more slowly. Hence, when Vm is raised suddenly, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels open initially, but then close due to the slower inactivation. The voltages and currents of the action potential in all of its phases were modeled accurately by Alan Lloyd Hodgkin and Andrew Huxley in 1952, for which they were awarded the Nobel Prize in Physiology or Medicine in 1963. However, their model considers only two types of voltage-sensitive ion channels, and makes several assumptions about them, e.g., that their internal gates open and close independently of one another. In reality, there are many types of ion channels, and they do not always open and close independently. Stimulation and rising phase A typical action potential begins at the axon hillock with a sufficiently strong depolarization, e.g., a stimulus that increases Vm. This depolarization is often caused by the injection of extra \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " cations into the cell; these \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can come from a wide variety of sources, such as chemical synapses, sensory neurons or pacemaker potentials. For a neuron at rest, there is a high concentration of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chloride ions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the extracellular fluid compared to the intracellular fluid, while there is a high concentration of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions in the intracellular fluid compared to the extracellular fluid. The difference in concentrations, which causes ions to move from a high to a low concentration, and electrostatic effects (attraction of opposite charges) are responsible for the movement of ions in and out of the neuron. The inside of a neuron has a negative charge, relative to the cell exterior, from the movement of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    K+\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " out of the cell. The neuron membrane is more permeable to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    K+\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " than to other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", allowing this ion to selectively move out of the cell, down its concentration gradient. This concentration gradient along with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " leak channels present on the membrane of the neuron causes an efflux of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions making the resting potential close to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    EK ≈ –75\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " mV. Since Na+ ions are in higher concentrations outside of the cell, the concentration and voltage differences both drive them into the cell when Na+ channels open. Depolarization opens both the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels in the membrane, allowing the ions to flow into and out of the axon, respectively. If the depolarization is small (say, increasing Vm from −70 mV to −60 mV), the outward \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " current overwhelms the inward \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " current and the membrane repolarizes back to its normal resting potential around −70 mV. However, if the depolarization is large enough, the inward \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " current increases more than the outward \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " current and a runaway condition (positive feedback) results: the more inward current there is, the more Vm increases, which in turn further increases the inward current. A sufficiently strong depolarization (increase in Vm) causes the voltage-sensitive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels to open; the increasing permeability to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " drives Vm closer to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " equilibrium voltage ENa≈ +55 mV. The increasing voltage in turn causes even more \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels to open, which pushes Vm still further towards ENa. This positive feedback continues until the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels are fully open and Vm is close to ENa. The sharp rise in Vm and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " permeability correspond to the rising phase of the action potential.The critical threshold voltage for this runaway condition is usually around −45 mV, but it depends on the recent activity of the axon. A cell that has just fired an action potential cannot fire another one immediately, since the Na+ channels have not recovered from the inactivated state. The period during which no new action potential can be fired is called the absolute refractory period. At longer times, after some but not all of the ion channels have recovered, the axon can be stimulated to produce another action potential, but with a higher threshold, requiring a much stronger depolarization, e.g., to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    −30\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " mV. The period during which action potentials are unusually difficult to evoke is called the relative refractory period. Peak phase The positive feedback of the rising phase slows and comes to a halt as the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ion channels become maximally open. At the peak of the action potential, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " permeability is maximized and the membrane voltage Vm is nearly equal to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " equilibrium voltage ENa. However, the same raised voltage that opened the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels initially also slowly shuts them off, by closing their pores; the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels become inactivated. This lowers the membrane's permeability to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " relative to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", driving the membrane voltage back towards the resting value. At the same time, the raised voltage opens voltage-sensitive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels; the increase in the membrane's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " permeability drives Vm towards EK. Combined, these changes in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " permeability cause Vm to drop quickly, repolarizing the membrane and producing the &quot;&quot;falling phase&quot;&quot; of the action potential. Afterhyperpolarization The depolarized voltage opens additional voltage-dependent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels, and some of these do not close right away when the membrane returns to its normal resting voltage. In addition, further \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels open in response to the influx of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions during the action potential. The intracellular concentration of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions is transiently unusually low, making the membrane voltage Vm even closer to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " equilibrium voltage EK. The membrane potential goes below the resting membrane potential. Hence, there is an undershoot or hyperpolarization, termed an afterhyperpolarization, that persists until the membrane \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " permeability returns to its usual value, restoring the membrane potential to the resting state. Refractory period Each action potential is followed by a refractory period, which can be divided into an absolute refractory period, during which it is impossible to evoke another action potential, and then a relative refractory period, during which a stronger-than-usual stimulus is required. These two refractory periods are caused by changes in the state of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel molecules. When closing after an action potential, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels enter an &quot;&quot;inactivated&quot;&quot; state, in which they cannot be made to open regardless of the membrane potential—this gives rise to the absolute refractory period. Even after a sufficient number of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels have transitioned back to their resting state, it frequently happens that a fraction of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels remains open, making it difficult for the membrane potential to depolarize, and thereby giving rise to the relative refractory period. Because the density and subtypes of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels may differ greatly between different types of neurons, the duration of the relative refractory period is highly variable. The absolute refractory period is largely responsible for the unidirectional propagation of action potentials along axons. At any given moment, the patch of axon behind the actively spiking part is refractory, but the patch in front, not having been activated recently, is capable of being stimulated by the depolarization from the action potential. Propagation The action potential generated at the axon hillock propagates as a wave along the axon. The currents flowing inwards at a point on the axon during an action potential spread out along the axon, and depolarize the adjacent sections of its membrane. If sufficiently strong, this depolarization provokes a similar action potential at the neighboring membrane patches. This basic mechanism was demonstrated by Alan Lloyd Hodgkin in 1937. After crushing or cooling nerve segments and thus blocking the action potentials, he showed that an action potential arriving on one side of the block could provoke another action potential on the other, provided that the blocked segment was sufficiently short.Once an action potential has occurred at a patch of membrane, the membrane patch needs time to recover before it can fire again. At the molecular level, this absolute refractory period corresponds to the time required for the voltage-activated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels to recover from inactivation, i.e., to return to their closed state. There are many types of voltage-activated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels in neurons. Some of them inactivate fast (A-type currents) and some of them inactivate slowly or not inactivate at all; this variability guarantees that there will be always an available source of current for repolarization, even if some of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels are inactivated because of preceding depolarization. On the other hand, all neuronal voltage-activated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels inactivate within several milliseconds during strong depolarization, thus making following depolarization impossible until a substantial fraction of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels have returned to their closed state. Although it limits the frequency of firing, the absolute refractory period ensures that the action potential moves in only one direction along an axon. The currents flowing in due to an action potential spread out in both directions along the axon. However, only the unfired part of the axon can respond with an action potential; the part that has just fired is unresponsive until the action potential is safely out of range and cannot restimulate that part. In the usual orthodromic conduction, the action potential propagates from the axon hillock towards the synaptic knobs (the axonal termini); propagation in the opposite direction—known as antidromic conduction—is very rare. However, if a laboratory axon is stimulated in its middle, both halves of the axon are &quot;&quot;fresh&quot;&quot;, i.e., unfired; then two action potentials will be generated, one traveling towards the axon hillock and the other traveling towards the synaptic knobs. Myelin and saltatory conduction In order to enable fast and efficient transduction of electrical signals in the nervous system, certain neuronal axons are covered with myelin sheaths. Myelin is a multilamellar membrane that enwraps the axon in segments separated by intervals known as nodes of Ranvier. It is produced by specialized cells: Schwann cells exclusively in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    peripheral nervous system\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and oligodendrocytes exclusively in the central nervous system. Myelin sheath reduces membrane capacitance and increases membrane resistance in the inter-node intervals, thus allowing a fast, saltatory movement of action potentials from node to node. Myelination is found mainly in vertebrates, but an analogous system has been discovered in a few invertebrates, such as some species of shrimp. Not all neurons in vertebrates are myelinated; for example, axons of the neurons comprising the autonomous nervous system are not, in general, myelinated. Myelin prevents ions from entering or leaving the axon along myelinated segments. As a general rule, myelination increases the conduction velocity of action potentials and makes them more energy-efficient. Whether saltatory or not, the mean conduction velocity of an action potential ranges from 1 meter per second (m/s) to over 100 m/s, and, in general, increases with axonal diameter.Action potentials cannot propagate through the membrane in myelinated segments of the axon. However, the current is carried by the cytoplasm, which is sufficient to depolarize the first or second subsequent node of Ranvier. Instead, the ionic current from an action potential at one node of Ranvier provokes another action potential at the next node; this apparent &quot;&quot;hopping&quot;&quot; of the action potential from node to node is known as saltatory conduction. Although the mechanism of saltatory conduction was suggested in 1925 by Ralph Lillie, the first experimental evidence for saltatory conduction came from Ichiji Tasaki and Taiji Takeuchi and from Andrew Huxley and Robert Stämpfli. By contrast, in unmyelinated axons, the action potential provokes another in the membrane immediately adjacent, and moves continuously down the axon like a wave. Myelin has two important advantages: fast conduction speed and energy efficiency. For axons larger than a minimum diameter (roughly 1 micrometre), myelination increases the conduction velocity of an action potential, typically tenfold. Conversely, for a given conduction velocity, myelinated fibers are smaller than their unmyelinated counterparts. For example, action potentials move at roughly the same speed (25 m/s) in a myelinated frog axon and an unmyelinated squid giant axon, but the frog axon has a roughly 30-fold smaller diameter and 1000-fold smaller cross-sectional area. Also, since the ionic currents are confined to the nodes of Ranvier, far fewer ions &quot;&quot;leak&quot;&quot; across the membrane, saving metabolic energy. This saving is a significant selective advantage, since the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human nervous system\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " uses approximately 20% of the body's metabolic energy.The length of axons' myelinated segments is important to the success of saltatory conduction. They should be as long as possible to maximize the speed of conduction, but not so long that the arriving signal is too weak to provoke an action potential at the next node of Ranvier. In nature, myelinated segments are generally long enough for the passively propagated signal to travel for at least two nodes while retaining enough amplitude to fire an action potential at the second or third node. Thus, the safety factor of saltatory conduction is high, allowing transmission to bypass nodes in case of injury. However, action potentials may end prematurely in certain places where the safety factor is low, even in unmyelinated neurons; a common example is the branch point of an axon, where it divides into two axons.Some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diseases degrade myelin and impair saltatory conduction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", reducing the conduction velocity of action potentials. The most well-known of these is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    multiple sclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", in which the breakdown of myelin impairs coordinated movement. Cable theory The flow of currents within an axon can be described quantitatively by cable theory and its elaborations, such as the compartmental model. Cable theory was developed in 1855 by Lord Kelvin to model the transatlantic telegraph cable and was shown to be relevant to neurons by Hodgkin and Rushton in 1946. In simple cable theory, the neuron is treated as an electrically passive, perfectly cylindrical transmission cable, which can be described by a partial differential equation                        τ                                                ∂               V                                         ∂               t                                          =                    λ                        2                                                                                     ∂                                    2                                               V                                         ∂                                x                                    2                                                                          −         V                 {\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    \\displaystyle \\tau {\\frac {\\partial V}{\\partial t}}=\\lambda ^{2}{\\frac {\\partial ^{2}V}{\\partial x^{2}}}-V}   where V(x, t\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") is the voltage across the membrane at a time t and a position x along the length of the neuron, and where λ and τ are the characteristic length and time scales on which those voltages decay in response to a stimulus. Referring to the circuit diagram on the right, these scales can be determined from the resistances and capacitances per unit length.                        τ         =                              r                        m                                        c                        m                                              {\\displaystyle \\tau =\\ r_{m}c_{m}\\,}                           λ         =                                                                 r                                    m                                                                r                                    ℓ                                                                                  {\\displaystyle \\lambda ={\\sqrt {\\frac {r_{m}}{r_{\\ell }}}}}   These time and length-scales can be used to understand the dependence of the conduction velocity on the diameter of the neuron in unmyelinated fibers. For example, the time-scale τ increases with both the membrane resistance rm and capacitance cm. As the capacitance increases, more charge must be transferred to produce a given transmembrane voltage (by the equation Q = CV); as the resistance increases, less charge is transferred per unit time, making the equilibration slower. In a similar manner, if the internal resistance per unit length ri is lower in one axon than in another (e.g., because the radius of the former is larger), the spatial decay length λ becomes longer and the conduction velocity of an action potential should increase. If the transmembrane resistance rm is increased, that lowers the average &quot;&quot;leakage&quot;&quot; current across the membrane, likewise causing λ to become longer, increasing the conduction velocity. Termination Chemical synapses In general, action potentials that reach the synaptic knobs cause a neurotransmitter to be released into the synaptic cleft. Neurotransmitters are small molecules that may open ion channels in the postsynaptic cell; most axons have the same neurotransmitter at all of their termini. The arrival of the action potential opens voltage-sensitive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels in the presynaptic membrane; the influx of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " causes vesicles filled with neurotransmitter to migrate to the cell's surface and release their contents into the synaptic cleft. This complex process is inhibited by the neurotoxins tetanospasmin and botulinum toxin, which are responsible for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tetanus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    botulism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", respectively. Electrical synapses Some synapses dispense with the &quot;&quot;middleman&quot;&quot; of the neurotransmitter, and connect the presynaptic and postsynaptic cells together. When an action potential reaches such a synapse, the ionic currents flowing into the presynaptic cell can cross the barrier of the two cell membranes and enter the postsynaptic cell through pores known as connexons. Thus, the ionic currents of the presynaptic action potential can directly stimulate the postsynaptic cell. Electrical synapses allow for faster transmission because they do not require the slow diffusion of neurotransmitters across the synaptic cleft. Hence, electrical synapses are used whenever fast response and coordination of timing are crucial, as in escape reflexes, the retina of vertebrates, and the heart. Neuromuscular junctions A special case of a chemical synapse is the neuromuscular junction, in which the axon of a motor neuron terminates on a muscle fiber. In such cases, the released neurotransmitter is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acetylcholine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which binds to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acetylcholine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " receptor, an integral membrane protein in the membrane (the sarcolemma) of the muscle fiber. However, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acetylcholine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " does not remain bound; rather, it dissociates and is hydrolyzed by the enzyme, acetylcholinesterase, located in the synapse. This enzyme quickly reduces the stimulus to the muscle, which allows the degree and timing of muscular contraction to be regulated delicately. Some poisons inactivate acetylcholinesterase to prevent this control, such as the nerve agents \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sarin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tabun\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and the insecticides \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diazinon\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and malathion. Other cell types Cardiac action potentials The cardiac action potential differs from the neuronal action potential by having an extended plateau, in which the membrane is held at a high voltage for a few hundred milliseconds prior to being repolarized by the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " current as usual. This plateau is due to the action of slower \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels opening and holding the membrane voltage near their equilibrium potential even after the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels have inactivated. The cardiac action potential plays an important role in coordinating the contraction of the heart. The cardiac cells of the sinoatrial node provide the pacemaker potential that synchronizes the heart. The action potentials of those cells propagate to and through the atrioventricular node (AV node), which is normally the only conduction pathway between the atria and the ventricles. Action potentials from the AV node travel through the bundle of His and thence to the Purkinje fibers. Conversely, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anomalies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the cardiac action potential—whether due to a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital mutation or injury—\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "can lead to human pathologies, especially \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Several anti-arrhythmia drugs act on the cardiac action potential, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    quinidine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lidocaine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", beta blockers, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    verapamil\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Muscular action potentials The action potential in a normal skeletal muscle cell is similar to the action potential in neurons. Action potentials result from the depolarization of the cell membrane (the sarcolemma), which opens voltage-sensitive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels; these become inactivated and the membrane is repolarized through the outward current of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions. The resting potential prior to the action potential is typically −90mV, somewhat more negative than typical neurons. The muscle action potential lasts roughly 2–4 ms, the absolute refractory period is roughly 1–3 ms, and the conduction velocity along the muscle is roughly 5 m/s. The action potential releases \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions that free up the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tropomyosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and allow the muscle to contract. Muscle action potentials are provoked by the arrival of a pre-synaptic neuronal action potential at the neuromuscular junction, which is a common target for neurotoxins. Plant action potentials Plant and fungal cells are also electrically excitable. The fundamental difference from animal action potentials is that the depolarization in plant cells is not accomplished by an uptake of positive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions, but by release of negative chloride ions.  In 1906, J. C. Bose published the first measurements of action potentials in plants, which had previously been discovered by Burdon-Sanderson and Darwin.  An increase in cytoplasmic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions may be the cause of anion release into the cell. This makes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " a precursor to ion movements, such as the influx of negative \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chloride ions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and efflux of positive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions, as seen in barley leaves.The initial influx of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions also poses a small cellular depolarization, causing the voltage-gated ion channels to open and allowing full depolarization to be propagated by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chloride ions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Some plants (e.g. Dionaea muscipula) use sodium-gated channels to operate movements and essentially &quot;&quot;count&quot;&quot;. Dionaea muscipula, also known as the Venus flytrap, is found in subtropical wetlands in North and South Carolina. When there are poor soil nutrients, the flytrap relies on a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " of insects and animals. Despite research on the plant, there lacks an understanding behind the molecular basis to the Venus flytraps, and carnivore plants in general.However, plenty of research has been done on action potentials and how they affect movement and clockwork within the Venus flytrap. To start, the resting membrane potential of the Venus flytrap (-120mV) is lower than animal cells (usually -90mV to -40mV). The lower resting potential makes it easier to activate an action potential. Thus, when an insect lands on the trap of the plant, it triggers a hair-like mechanoreceptor. This receptor then activates an action potential which lasts around 1.5 ms. Ultimately, this causes an increase of positive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions into the cell, slightly depolarizing it. However, the flytrap doesn't close after one trigger. Instead, it requires the activation of 2 or more hairs. If only one hair is triggered, it throws the activation as a false positive. Further, the second hair must be activated within a certain time interval (0.75 s - 40 s) for it to register with the first activation. Thus, a buildup of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " starts and slowly falls from the first trigger. When the second action potential is fired within the time interval, it reaches the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " threshold to depolarize the cell, closing the trap on the prey within a fraction of a second.Together with the subsequent release of positive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions the action potential in plants involves an osmotic loss of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    salt\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    KCl\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "). Whereas, the animal action potential is osmotically neutral because equal amounts of entering \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and leaving \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " cancel each other osmotically. The interaction of electrical and osmotic relations in plant cells appears to have arisen from an osmotic function of electrical excitability in a common unicellular ancestors of plants and animals under changing salinity conditions. Further, the present function of rapid signal transmission is seen as a newer accomplishment of metazoan cells in a more stable osmotic environment. It is likely that the familiar signaling function of action potentials in some vascular plants (e.g. Mimosa pudica) arose independently from that in metazoan excitable cells. Unlike the rising phase and peak, the falling phase and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    after-hyperpolarization\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " seem to depend primarily on cations that are not \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". To initiate repolarization, the cell requires movement of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " out of the cell through passive transportation on the membrane. This differs from neurons because the movement of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " does not dominate the decrease in membrane potential; In fact, to fully repolarize, a plant cell requires energy in the form of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to assist in the release of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hydrogen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " from the cell – utilizing a transporter commonly known as H+-ATPase. Taxonomic distribution and evolutionary advantages Action potentials are found throughout multicellular organisms, including plants, invertebrates such as insects, and vertebrates such as reptiles and mammals. Sponges seem to be the main phylum of multicellular eukaryotes that does not transmit action potentials, although some studies have suggested that these organisms have a form of electrical signaling, too. The resting potential, as well as the size and duration of the action potential, have not varied much with evolution, although the conduction velocity does vary dramatically with axonal diameter and myelination. Given its conservation throughout evolution, the action potential seems to confer evolutionary advantages. One function of action potentials is rapid, long-range signaling within the organism; the conduction velocity can exceed 110 m/s, which is one-third the speed of sound. For comparison, a hormone molecule carried in the bloodstream moves at roughly 8 m/s in large arteries. Part of this function is the tight coordination of mechanical events, such as the contraction of the heart. A second function is the computation associated with its generation. Being an all-or-none signal that does not decay with transmission distance, the action potential has similar advantages to digital electronics. The integration of various dendritic signals at the axon hillock and its thresholding to form a complex train of action potentials is another form of computation, one that has been exploited biologically to form central pattern generators and mimicked in artificial neural networks. The common prokaryotic/eukaryotic ancestor, which lived perhaps four billion years ago, is believed to have had voltage-gated channels. This functionality was likely, at some later point, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cross-purposed\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to provide a communication mechanism. Even modern single-celled bacteria can utilize action potentials to communicate with other bacteria in the same \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    biofilm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Experimental methods The study of action potentials has required the development of new experimental methods. The initial work, prior to 1955, was carried out primarily by Alan Lloyd Hodgkin and Andrew Fielding Huxley, who were, along John Carew Eccles, awarded the 1963 Nobel Prize in Physiology or Medicine for their contribution to the description of the ionic basis of nerve conduction. It focused on three goals: isolating signals from single neurons or axons, developing fast, sensitive electronics, and shrinking electrodes enough that the voltage inside a single cell could be recorded. The first problem was solved by studying the giant axons found in the neurons of the squid (Loligo forbesii and Doryteuthis pealeii, at the time classified as Loligo pealeii). These axons are so large in diameter (roughly 1 mm, or 100-fold larger than a typical neuron) that they can be seen with the naked eye, making them easy to extract and manipulate. However, they are not representative of all excitable cells, and numerous other systems with action potentials have been studied. The second problem was addressed with the crucial development of the voltage clamp, which permitted experimenters to study the ionic currents underlying an action potential in isolation, and eliminated a key source of electronic noise, the current IC associated with the capacitance C of the membrane. Since the current equals C times the rate of change of the transmembrane voltage Vm, the solution was to design a circuit that kept Vm fixed (zero rate of change) regardless of the currents flowing across the membrane. Thus, the current required to keep Vm at a fixed value is a direct reflection of the current flowing through the membrane. Other electronic advances included the use of Faraday cages and electronics with high input impedance, so that the measurement itself did not affect the voltage being measured.The third problem, that of obtaining electrodes small enough to record voltages within a single axon without perturbing it, was solved in 1949 with the invention of the glass micropipette electrode, which was quickly adopted by other researchers. Refinements of this method are able to produce electrode tips that are as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " as 100 Å (10 nm), which also confers high input impedance. Action potentials may also be recorded with small metal electrodes placed just next to a neuron, with neurochips containing EOSFETs, or optically with dyes that are sensitive to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ca2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "+ or to voltage. While glass micropipette electrodes measure the sum of the currents passing through many ion channels, studying the electrical properties of a single ion channel became possible in the 1970s with the development of the patch clamp by Erwin Neher and Bert \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sakmann\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". For this discovery, they were awarded the Nobel Prize in Physiology or Medicine in 1991. Patch-clamping verified that ionic channels have discrete states of conductance, such as open, closed and inactivated. Optical imaging technologies have been developed in recent years to measure action potentials, either via simultaneous multisite recordings or with ultra-spatial resolution. Using voltage-sensitive dyes, action potentials have been optically recorded from a tiny patch of cardiomyocyte membrane. Neurotoxins Several neurotoxins, both natural and synthetic, are designed to block the action potential. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Tetrodotoxin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " from the pufferfish and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    saxitoxin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " from the Gonyaulax (the dinoflagellate genus responsible for &quot;&quot;red tides&quot;&quot;) block action potentials by inhibiting the voltage-sensitive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel; similarly, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dendrotoxin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " from the black mamba snake inhibits the voltage-sensitive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel. Such inhibitors of ion channels serve an important research purpose, by allowing scientists to &quot;&quot;turn off&quot;&quot; specific channels at will, thus isolating the other channels' contributions; they can also be useful in purifying ion channels by affinity chromatography or in assaying their concentration. However, such inhibitors also make effective neurotoxins, and have been considered for use as chemical weapons. Neurotoxins aimed at the ion channels of insects have been effective insecticides; one example is the synthetic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    permethrin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which prolongs the activation of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels involved in action potentials. The ion channels of insects are sufficiently different from their human counterparts that there are few side effects in humans. History The role of electricity in the nervous systems of animals was first observed in dissected frogs by Luigi Galvani, who studied it from 1791 to 1797. Galvani's results stimulated Alessandro Volta to develop the Voltaic pile—the earliest-known electric battery—with which he studied animal electricity (such as electric eels) and the physiological responses to applied direct-current voltages.Scientists of the 19th century studied the propagation of electrical signals in whole nerves (i.e., bundles of neurons) and demonstrated that nervous tissue was made up of cells, instead of an interconnected network of tubes (a reticulum). Carlo Matteucci followed up Galvani's studies and demonstrated that cell membranes had a voltage across them and could produce direct current. Matteucci's work inspired the German physiologist, Emil du Bois-Reymond, who discovered the action potential in 1843. The conduction velocity of action potentials was first measured in 1850 by du Bois-Reymond's friend, Hermann von Helmholtz. To establish that nervous tissue is made up of discrete cells, the Spanish physician Santiago Ramón y Cajal and his students used a stain developed by Camillo Golgi to reveal the myriad shapes of neurons, which they rendered painstakingly. For their discoveries, Golgi and Ramón y Cajal were awarded the 1906 Nobel Prize in Physiology. Their work resolved a long-standing controversy in the neuroanatomy of the 19th century; Golgi himself had argued for the network model of the nervous system. The 20th century was a significant era for electrophysiology. In 1902 and again in 1912, Julius Bernstein advanced the hypothesis that the action potential resulted from a change in the permeability of the axonal membrane to ions. Bernstein's hypothesis was confirmed by Ken Cole and Howard Curtis, who showed that membrane conductance increases during an action potential. In 1907, Louis Lapicque suggested that the action potential was generated as a threshold was crossed, what would be later shown as a product of the dynamical systems of ionic conductances. In 1949, Alan Hodgkin and Bernard Katz refined Bernstein's hypothesis by considering that the axonal membrane might have different permeabilities to different \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "; in particular, they demonstrated the crucial role of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " permeability for the action potential. They made the first actual recording of the electrical changes across the neuronal membrane that mediate the action potential. This line of research culminated in the five 1952 papers of Hodgkin, Katz and Andrew Huxley, in which they applied the voltage clamp technique to determine the dependence of the axonal membrane's permeabilities to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions on voltage and time, from which they were able to reconstruct the action potential quantitatively. Hodgkin and Huxley correlated the properties of their mathematical model with discrete ion channels that could exist in several different states, including &quot;&quot;open&quot;&quot;, &quot;&quot;closed&quot;&quot;, and &quot;&quot;inactivated&quot;&quot;. Their hypotheses were confirmed in the mid-1970s and 1980s by Erwin Neher and Bert \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sakmann\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", who developed the technique of patch clamping to examine the conductance states of individual ion channels. In the 21st century, researchers are beginning to understand the structural basis for these conductance states and for the selectivity of channels for their species of ion, through the atomic-resolution crystal structures, fluorescence distance measurements and cryo-electron microscopy studies.Julius Bernstein was also the first to introduce the Nernst equation for resting potential across the membrane; this was generalized by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    David E. Goldman to the eponymous\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Goldman equation in 1943. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "–\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " pump was identified in 1957 and its properties gradually elucidated, culminating in the determination of its atomic-resolution structure by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    X-ray crystallography\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The crystal structures of related ionic pumps have also been solved, giving a broader view of how these molecular machines work. Quantitative models Mathematical and computational models are essential for understanding the action potential, and offer predictions that may be tested against experimental data, providing a stringent test of a theory. The most important and accurate of the early neural models is the Hodgkin–Huxley model, which describes the action potential by a coupled set of four ordinary differential equations (ODEs). Although the Hodgkin–Huxley model may be a simplification with few limitations compared to the realistic nervous membrane as it exists in nature, its complexity has inspired several even-more-simplified models, such as the Morris–Lecar model and the FitzHugh–Nagumo model, both of which have only two coupled ODEs. The properties of the Hodgkin–Huxley and FitzHugh–Nagumo models and their relatives, such as the Bonhoeffer–Van der Pol model, have been well-studied within mathematics, computation and electronics. However the simple models of generator potential and action potential fail to accurately reproduce the near threshold neural spike rate and spike shape, specifically for the mechanoreceptors like the Pacinian corpuscle. More modern research has focused on larger and more integrated systems; by joining action-potential models with models of other parts of the nervous system (such as dendrites and synapses), researchers can study neural computation and simple reflexes, such as escape reflexes and others controlled by central pattern generators. See also Notes References Footnotes Journal articles Books Web pages Further reading External links Ionic flow in action potentials at Blackwell Publishing Action potential propagation in myelinated and unmyelinated axons at Blackwell Publishing Generation of AP in cardiac cells and generation of AP in neuron cells Resting membrane potential from Life: The Science of Biology, by WK Purves, D Sadava, GH Orians, and HC Heller, 8th edition, New York: WH Freeman, ISBN 978-0-7167-7671-0. Ionic motion and the Goldman voltage for arbitrary ionic concentrations at The University of Arizona A cartoon illustrating the action potential Action potential propagation Production of the action potential: voltage and current clamping simulations Open-source software to simulate \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    neuronal and cardiac action potentials at SourceForge.net\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Introduction to the Action Potential, Neuroscience Online (electronic neuroscience textbook by UT Houston Medical School) Khan Academy: Electrotonic and action potential&quot; &quot;Actin is a family of globular multi-functional proteins that form microfilaments in the cytoskeleton, and the thin filaments in muscle fibrils. It is found in essentially all eukaryotic cells, where it may be present at a concentration of over 100 μM; its mass is roughly 42 kDa, with a diameter of 4 to 7 nm. An actin protein is the monomeric subunit of two types of filaments in cells: microfilaments, one of the three major components of the cytoskeleton, and thin filaments, part of the contractile apparatus in muscle cells. It can be present as either a free monomer called G-actin (globular) or as part of a linear polymer microfilament called F-actin (filamentous), both of which are essential for such important cellular functions as the mobility and contraction of cells during cell division. Actin participates in many important cellular processes, including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle contraction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", cell motility, cell division and cytokinesis, vesicle and organelle movement, cell signaling, and the establishment and maintenance of cell junctions and cell shape. Many of these processes are mediated by extensive and intimate interactions of actin with cellular membranes. In vertebrates, three main groups of actin isoforms, alpha, beta, and gamma have been identified. The alpha \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    actins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", found in muscle tissues, are a major constituent of the contractile apparatus. The beta and gamma actins coexist in most cell types as components of the cytoskeleton, and as mediators of internal cell motility. It is believed that the diverse range of structures formed by actin enabling it to fulfill such a large range of functions is regulated through the binding of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tropomyosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " along the filaments.A cell's ability to dynamically form microfilaments provides the scaffolding that allows it to rapidly remodel itself in response to its environment or to the organism's internal signals, for example, to increase cell membrane absorption or increase cell adhesion in order to form cell tissue. Other enzymes or organelles such as cilia can be anchored to this scaffolding in order to control the deformation of the external cell membrane, which allows endocytosis and cytokinesis. It can also produce movement either by itself or with the help of molecular motors. Actin therefore contributes to processes such as the intracellular transport of vesicles and organelles as well as muscular contraction and cellular migration. It therefore plays an important role in embryogenesis, the healing of wounds, and the invasivity of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " cells. The evolutionary origin of actin can be traced to prokaryotic cells, which have equivalent proteins. Actin homologs from prokaryotes and archaea polymerize into different helical or linear filaments consisting of one or multiple strands. However the in-strand contacts and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nucleotide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " binding sites are preserved in prokaryotes and in archaea. Lastly, actin plays an important role in the control of gene expression. A large number of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    illnesses and diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are caused by mutations in alleles of the genes that regulate the production of actin or of its associated proteins. The production of actin is also key to the process of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " by some pathogenic microorganisms. Mutations in the different genes that regulate actin production in humans can cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscular diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", variations in the size and function of the heart as well as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deafness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The make-up of the cytoskeleton is also related to the pathogenicity of intracellular bacteria and viruses, particularly in the processes related to evading the actions of the immune system. Discovery and early investigation Actin was first observed experimentally in 1887 by W.D. Halliburton, who extracted a protein from muscle that 'coagulated' preparations of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " that he called &quot;&quot;myosin-ferment&quot;&quot;. However, Halliburton was unable to further refine his findings, and the discovery of actin is credited instead to Brunó Ferenc Straub, a young biochemist working in Albert Szent-Györgyi's laboratory at the Institute of Medical Chemistry at the University of Szeged, Hungary. Following up on the discovery of Ilona Banga &amp; Szent-Györgyi in 1941 that the coagulation only occurs in some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " extractions and was reversed upon the addition of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Straub identified and purified actin from those \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " preparations that did coagulate. Building on Banga's original extraction method, he developed a novel technique for extracting muscle protein that allowed him to isolate substantial amounts of relatively pure actin, published in 1942. Straub's method is essentially the same as that used in laboratories today. Since Straub's protein was necessary to activate the coagulation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", it was dubbed actin. Realizing that Banga's coagulating \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " preparations contained actin as well, Szent-Györgyi called the mixture of both proteins actomyosin.The hostilities of World War II meant Szent-Gyorgyi was unable to publish his lab's work in Western scientific journals. Actin therefore only became well known in the West in 1945, when their paper was published as a supplement to the Acta Physiologica Scandinavica. Straub continued to work on actin, and in 1950 reported that actin contains bound \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and that, during polymerization of the protein into microfilaments, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nucleotide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is hydrolyzed to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and inorganic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    phosphate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (which remain bound to the microfilament). Straub suggested that the transformation of ATP-bound actin to ADP-bound actin played a role in muscular contraction. In fact, this is true only in smooth muscle, and was not supported through experimentation until 2001.The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " sequencing of actin was completed by M. Elzinga and co-workers in 1973. The crystal structure of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    G-actin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was solved in 1990 by Kabsch and colleagues. In the same year, a model for F-actin was proposed by Holmes and colleagues following experiments using co-crystallization with different proteins. The procedure of co-crystallization with different proteins was used repeatedly during the following years, until in 2001 the isolated protein was crystallized along with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". However, there is still no high-resolution X-ray structure of F-actin. The crystallization of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    G-actin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was possible due to the use of a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rhodamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " conjugate that impedes polymerization by blocking the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " cys-374. Christine Oriol-Audit died in the same year that actin was first crystallized but she was the researcher that in 1977 first crystallized actin in the absence of Actin Binding Proteins (ABPs). However, the resulting crystals were too small for the available technology of the time.Although no high-resolution model of actin's filamentous form currently exists, in 2008 Sawaya's team were able to produce a more exact model of its structure based on multiple crystals of actin dimers that bind in different places. This model has subsequently been further refined by Sawaya and Lorenz. Other approaches such as the use of cryo-electron microscopy and synchrotron radiation have recently allowed increasing resolution and better understanding of the nature of the interactions and conformational changes implicated in the formation of actin filaments. Structure Actin's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " sequence is one of the most highly conserved of the proteins as it has changed little over the course of evolution, differing by no more than 20% in species as diverse as algae and humans. It is therefore considered to have an optimised structure. It has two distinguishing features: it is an enzyme that slowly hydrolizes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the &quot;&quot;universal energy currency&quot;&quot; of biological processes. However, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is required in order to maintain its structural integrity. Its efficient structure is formed by an almost unique folding process. In addition, it is able to carry out more interactions than any other protein, which allows it to perform a wider variety of functions than other proteins at almost every level of cellular life. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is an example of a protein that bonds with actin. Another example is villin, which can weave actin into bundles or cut the filaments depending on the concentration of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " cations in the surrounding medium.Actin is one of the most abundant proteins in eukaryotes, where it is found throughout the cytoplasm. In fact, in muscle fibres it comprises 20% of total cellular protein by weight and between 1% and 5% in other cells. However, there is not only one type of actin; the genes that code for actin are defined as a gene family (a family that in plants contains more than 60 elements, including genes and pseudogenes and in humans more than 30 elements). This means that the genetic information of each individual contains instructions that generate actin variants (called isoforms) that possess slightly different functions. This, in turn, means that eukaryotic organisms express different genes that give rise to: α-actin, which is found in contractile structures; β-actin, found at the expanding edge of cells that use the projection of their cellular structures as their means of mobility; and γ-actin, which is found in the filaments of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " fibres. In addition to the similarities that exist between an organism's isoforms there is also an evolutionary conservation in the structure and function even between organisms contained in different eukaryotic domains. In bacteria the actin homologue \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MreB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has been identified, which is a protein that is capable of polymerizing into microfilaments; and in archaea the homologue \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ta0583\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is even more similar to the eukaryotic actins.Cellular actin has two forms: monomeric globules called \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    G-actin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and polymeric filaments called F-actin (that is, as filaments made up of many G-actin monomers). F-actin can also be described as a microfilament. Two parallel F-actin strands must rotate 166 degrees to lie correctly on top of each other. This creates the double helix structure of the microfilaments found in the cytoskeleton. Microfilaments measure approximately 7 nm in diameter with the helix repeating every 37 nm. Each molecule of actin is bound to a molecule of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adenosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " triphosphate (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adenosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " diphosphate (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") that is associated with a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Mg2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "+ cation. The most commonly found forms of actin, compared to all the possible combinations, are \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP-G-Actin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and ADP-F-actin. G-actin Scanning electron microscope images indicate that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    G-actin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has a globular structure; however, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    X-ray crystallography\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " shows that each of these globules consists of two lobes separated by a cleft. This structure represents the “ATPase fold”, which is a centre of enzymatic catalysis that binds \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Mg2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "+ and hydrolyzes the former to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " plus \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    phosphate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". This fold is a conserved structural motif that is also found in other proteins that interact with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    triphosphate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " nucleotides such as hexokinase (an enzyme used in energy metabolism) or in Hsp70 proteins (a protein family that play an important part in protein folding). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    G-actin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is only functional when it contains either \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in its cleft but the form that is bound to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " predominates in cells when actin is present in its free state. The X-ray crystallography model of actin that was produced by Kabsch from the striated muscle tissue of rabbits is the most commonly used in structural studies as it was the first to be purified. The G-actin crystallized by Kabsch is approximately 67 x 40 x 37 Å in size, has a molecular mass of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    41,785 Da\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and an estimated isoelectric point of 4.8. Its net charge at pH = 7 is -7. Primary \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    structureElzinga\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and co-workers first determined the complete peptide sequence for this type of actin in 1973, with later work by the same author adding further detail to the model. It contains 374 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " residues. Its N-terminus is highly acidic and starts with an acetyled \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aspartate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in its \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " group. While its C-terminus is alkaline and is formed by a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    phenylalanine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " preceded by a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cysteine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which has a degree of functional importance. Both extremes are in close proximity within the I-subdomain. An anomalous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nτ-methylhistidine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is located at position 73. Tertiary structure — domainsThe tertiary structure is formed by two domains known as the large and the small, which are separated by a cleft centred around the location of the bond with ATP-ADP+Pi. Below this there is a deeper notch called a “groove”. In the native state, despite their names, both have a comparable depth.The normal convention in topological studies means that a protein is shown with the biggest domain on the left-hand side and the smallest domain on the right-hand side. In this position the smaller domain is in turn divided into two: subdomain I (lower position, residues 1–32, 70–144, and 338–374) and subdomain II (upper position, residues 33–69). The larger domain is also divided in two: subdomain III (lower, residues 145–180 and 270–337) and subdomain IV (higher, residues 181–269). The exposed areas of subdomains I and III are referred to as the “barbed” ends, while the exposed areas of domains II and IV are termed the “pointed&quot;&quot; ends. This nomenclature refers to the fact that, due to the small mass of subdomain II actin is polar; the importance of this will be discussed below in the discussion on assembly dynamics. Some authors call the subdomains Ia, Ib, IIa, and IIb, respectively. Other important \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    structuresThe\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " most notable supersecondary structure is a five chain beta sheet that is composed of a β-meander and a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    β-α-β\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " clockwise unit. It is present in both domains suggesting that the protein arose from gene duplication. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adenosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " nucleotide binding site is located between two beta hairpin-shaped structures pertaining to the I and III domains. The residues that are involved are Asp11-Lys18 and Asp154-His161 respectively. The divalent cation binding site is located just below that for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adenosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " nucleotide. In vivo it is most often formed by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Mg2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "+ or Ca2+ while in vitro it is formed by a chelating structure made up of Lys18 and two oxygens from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nucleotide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "'s α-and β-phosphates. This \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is coordinated with six water molecules that are retained by the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acids Asp11\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Asp154, and Gln137. They form a complex with the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nucleotide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " that restricts the movements of the so-called &quot;&quot;hinge&quot;&quot; region, located between residues 137 and 144. This maintains the native form of the protein until its withdrawal denatures the actin monomer. This region is also important because it determines whether the protein's cleft is in the &quot;&quot;open&quot;&quot; or &quot;&quot;closed&quot;&quot; conformation. It is highly likely that there are at least three other centres with a lesser affinity (intermediate) and still others with a low affinity for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    divalent\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " cations. It has been suggested that these centres may play a role in the polymerization of actin by acting during the activation stage. There is a structure in subdomain 2 that is called the “\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    D-loop\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "” because it binds with DNase I, it is located between the His40 and Gly48 residues. It has the appearance of a disorderly element in the majority of crystals, but it looks like a β-sheet when it is complexed with DNase I. It has been proposed that the key event in polymerization is probably the propagation of a conformational change from the centre of the bond with the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nucleotide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to this domain, which changes from a loop to a spiral. However, this hypothesis has been refuted by other studies. F-actin The classical description of F-actin states that it has a filamentous structure that can be considered to be a single stranded levorotatory helix with a rotation of 166\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    °\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " around the helical axis and an axial translation of 27.5 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Å\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", or a single stranded dextrorotatory helix with a cross over spacing of 350–380 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Å\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", with each actin surrounded by four more. The symmetry of the actin polymer at 2.17 subunits per turn of a helix is incompatible with the formation of crystals, which is only possible with a symmetry of exactly 2, 3, 4 or 6 subunits per turn. Therefore, models have to be constructed that explain these anomalies using data from electron microscopy, cryo-electron microscopy, crystallization of dimers in different positions and diffraction of X-rays. It should be pointed out that it is not correct to talk of a “structure” for a molecule as dynamic as the actin filament. In reality we talk of distinct structural states, in these the measurement of axial translation remains constant at 27.5 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Å\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " while the subunit rotation data shows considerable variability, with displacements of up to 10% from its optimum position commonly seen. Some proteins, such as cofilin appear to increase the angle of turn, but again this could be interpreted as the establishment of different structural states. These could be important in the polymerization process.There is less agreement regarding measurements of the turn radius and filament thickness: while the first models assigned a length of 25 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Å\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", current X-ray diffraction data, backed up by cryo-electron microscopy suggests a length of 23.7 Å. These studies have shown the precise contact points between monomers. Some are formed with units of the same chain, between the &quot;&quot;barbed&quot;&quot; end on one monomer and the &quot;&quot;pointed&quot;&quot; end of the next one. While the monomers in adjacent chains make lateral contact through projections from subdomain IV, with the most important projections being those formed by the C-terminus and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hydrophobic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " link formed by three bodies involving residues 39–42, 201–203, and 286. This model suggests that a filament is formed by monomers in a &quot;&quot;sheet&quot;&quot; formation, in which the subdomains turn about themselves, this form is also found in the bacterial actin homologue \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MreB.The\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " F-actin polymer is considered to have structural polarity due to the fact that all the microfilament's subunits point towards the same end. This gives rise to a naming convention: the end that possesses an actin subunit that has its \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " binding site exposed is called the &quot;&quot;(-) end&quot;&quot;, while the opposite end where the cleft is directed at a different adjacent monomer is called the &quot;&quot;(+) end&quot;&quot;. The terms &quot;&quot;pointed&quot;&quot; and &quot;&quot;barbed&quot;&quot; referring to the two ends of the microfilaments derive from their appearance under transmission electron microscopy when samples are examined following a preparation technique called &quot;&quot;decoration&quot;&quot;. This method consists of the addition of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " S1 fragments to tissue that has been fixed with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tannic acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". This \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " forms polar bonds with actin monomers, giving rise to a configuration that looks like arrows with feather fletchings along its shaft, where the shaft is the actin and the fletchings are the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Following this logic, the end of the microfilament that does not have any protruding \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is called the point of the arrow (- end) and the other end is called the barbed end (+ end). A S1 fragment is composed of the head and neck domains of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Under physiological conditions, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    G-actin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (the monomer form) is transformed to F-actin (the polymer form) by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", where the role of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is essential.The helical F-actin filament found in muscles also contains a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tropomyosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " molecule, which is a 40 nanometre long protein that is wrapped around the F-actin helix. During the resting phase the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tropomyosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " covers the actin's active sites so that the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    actin-myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " interaction cannot take place and produce \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscular contraction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". There are other protein molecules bound to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tropomyosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " thread, these are the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    troponins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " that have three polymers: troponin I, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    troponin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " T, and troponin C. Folding Actin can spontaneously acquire a large part of its tertiary structure. However, the way it acquires its fully functional form from its newly synthesized native form is special and almost unique in protein chemistry. The reason for this special route could be the need to avoid the presence of incorrectly folded actin monomers, which could be toxic as they can act as inefficient polymerization terminators. Nevertheless, it is key to establishing the stability of the cytoskeleton, and additionally, it is an essential process for coordinating the cell cycle.CCT is required in order to ensure that folding takes place correctly. CCT is a group II chaperonin, a large protein complex that assists in the folding of other proteins. CCT is formed of a double ring of eight different subunits (hetero-octameric) and it differs from group I \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chaperonins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " like \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GroEL\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which is found in Eubacteria and in eukaryotic organelles, as it does not require a co-chaperone to act as a lid over the central catalytic cavity. Substrates bind to CCT through specific domains. It was initially thought that it only bound with actin and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tubulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", although recent immunoprecipitation studies have shown that it interacts with a large number of polypeptides, which possibly function as substrates. It acts through ATP-dependent conformational changes that on occasion require several rounds of liberation and catalysis in order to complete a reaction.In order to successfully complete their folding, both actin and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tubulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " need to interact with another protein called prefoldin, which is a heterohexameric complex (formed by six distinct subunits), in an interaction that is so specific that the molecules have coevolved. Actin complexes with prefoldin while it is still being formed, when it is approximately 145 amino acids long, specifically those at the N-terminal.Different recognition sub-units are used for actin or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tubulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " although there is some overlap. In actin the subunits that bind with prefoldin are probably PFD3 and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PFD4\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which bind in two places one between residues 60–79 and the other between residues \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    170–198\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The actin is recognized, loaded, and delivered to the cytosolic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chaperonin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (CCT) in an open conformation by the inner end of prefoldin's &quot;&quot;tentacles” (see the image and note). The contact when actin is delivered is so brief that a tertiary complex is not formed, immediately freeing the prefoldin. The CCT then causes actin's sequential folding by forming bonds with its subunits rather than simply enclosing it in its cavity. This is why it possesses specific recognition areas in its apical β-domain. The first stage in the folding consists of the recognition of residues 245–249. Next, other determinants establish contact. Both actin and tubulin bind to CCT in open conformations in the absence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". In actin's case, two subunits are bound during each conformational change, whereas for tubulin binding takes place with four subunits. Actin has specific binding sequences, which interact with the δ and β-CCT subunits or with δ-CCT and ε-CCT. After \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AMP-PNP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is bound to CCT the substrates move within the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chaperonin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "'s cavity. It also seems that in the case of actin, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CAP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " protein is required as a possible cofactor in actin's final folding states.The exact manner by which this process is regulated is still not fully understood, but it is known that the protein PhLP3 (a protein similar to phosducin) inhibits its activity through the formation of a tertiary complex. ATPase’s catalytic mechanism Actin is an ATPase, which means that it is an enzyme that hydrolyzes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". This group of enzymes is characterised by their slow reaction rates. It is known that this ATPase is “active”, that is, its speed increases by some 40,000 times when the actin forms part of a filament. A reference value for this rate of hydrolysis under ideal conditions is around 0.3 s−1. Then, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " remains bound to the actin next to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " for a long time, until it is cooperatively liberated from the interior of the filament.The exact molecular details of the catalytic mechanism are still not fully understood. Although there is much debate on this issue, it seems certain that a &quot;&quot;closed&quot;&quot; conformation is required for the hydrolysis of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and it is thought that the residues that are involved in the process move to the appropriate distance. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glutamic acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Glu137 is one of the key residues, which is located in subdomain 1. Its function is to bind the water molecule that produces a nucleophilic attack on the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "'s \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    γ-phosphate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " bond, while the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nucleotide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is strongly bound to subdomains 3 and 4. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    slowness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the catalytic process is due to the large distance and skewed position of the water molecule in relation to the reactant. It is highly likely that the conformational change produced by the rotation of the domains between actin's G and F forms moves the Glu137 closer allowing its hydrolysis. This model suggests that the polymerization and ATPase's function would be decoupled straight away. The &quot;&quot;open&quot;&quot; to &quot;&quot;closed&quot;&quot; transformation between G and F forms and its implications on the relative motion of several key residues and the formation of water wires have been characterized in molecular dynamics and QM/MM simulations. Genetics Actin has been one of the most highly conserved proteins throughout evolution because it interacts with a large number of other proteins. It has 80.2% sequence conservation at the gene level between Homo sapiens and Saccharomyces cerevisiae (a species of yeast), and 95% conservation of the primary structure of the protein product.Although most yeasts have only a single actin gene, higher eukaryotes, in general, express several isoforms of actin encoded by a family of related genes. Mammals have at least six actin isoforms coded by separate genes, which are divided into three classes (alpha, beta, and gamma) according to their isoelectric points. In general, alpha actins are found in muscle (α-skeletal, α-aortic smooth, α-cardiac), whereas beta and gamma isoforms are prominent in non-muscle cells (β-cytoplasmic, γ1-cytoplasmic, γ2-enteric smooth). Although the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " sequences and in vitro properties of the isoforms are highly similar, these isoforms cannot completely substitute for one another in vivo.The typical actin gene has an approximately 100-nucleotide 5' UTR, a 1200-nucleotide translated region, and a 200-nucleotide 3' UTR. The majority of actin genes are interrupted by introns, with up to six introns in any of 19 well-characterised locations. The high conservation of the family makes actin the favoured model for studies comparing the introns-early and introns-late models of intron evolution. All non-spherical prokaryotes appear to possess genes such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MreB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which encode homologues of actin; these genes are required for the cell's shape to be maintained. The plasmid-derived gene ParM encodes an actin-like protein whose polymerized form is dynamically unstable, and appears to partition the plasmid DNA into its daughter cells during cell division by a mechanism analogous to that employed by microtubules in eukaryotic mitosis. Actin is found in both smooth and rough endoplasmic reticulums. Assembly dynamics Nucleation and polymerization Nucleating factors are necessary to stimulate actin polymerization. One such nucleating factor is the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Arp2/3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " complex, which mimics a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    G-actin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " dimer in order to stimulate the nucleation (or formation of the first trimer) of monomeric G-actin. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Arp2/3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " complex binds to actin filaments at 70 degrees to form new actin branches off existing actin filaments. Arp2/3-mediated nucleation is necessary for directed cell migration. Also, actin filaments themselves bind \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and hydrolysis of this \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " stimulates destabilization of the polymer. The growth of actin filaments can be regulated by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thymosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and profilin. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Thymosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " binds to G-actin to buffer the polymerizing process, while profilin binds to G-actin to exchange \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", promoting the monomeric addition to the barbed, plus end of F-actin filaments. F-actin is both strong and dynamic. Unlike other polymers, such as DNA, whose constituent elements are bound together with covalent bonds, the monomers of actin filaments are assembled by weaker bonds. The lateral bonds with neighbouring monomers resolve this \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anomaly\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which in theory should weaken the structure as they can be broken by thermal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    agitation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In addition, the weak bonds give the advantage that the filament ends can easily release or incorporate monomers. This means that the filaments can be rapidly remodelled and can change cellular structure in response to an environmental stimulus. Which, along with the biochemical mechanism by which it is brought about is known as the &quot;&quot;assembly dynamic&quot;&quot;. In vitro studiesStudies focusing on the accumulation and loss of subunits by microfilaments are carried out in vitro (that is, in the laboratory and not on cellular systems) as the polymerization of the resulting actin gives rise to the same F-actin as produced in vivo. The in vivo process is controlled by a multitude of proteins in order to make it responsive to cellular demands, this makes it difficult to observe its basic conditions.In vitro production takes place in a sequential manner: first, there is the &quot;&quot;activation phase&quot;&quot;, when the bonding and exchange of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    divalent\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " cations occurs in specific places on the G-actin, which is bound to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". This produces a conformational change, sometimes called G*-actin or F-actin monomer as it is very similar to the units that are located on the filament. This prepares it for the &quot;&quot;nucleation phase&quot;&quot;, in which the G-actin gives rise to small unstable fragments of F-actin that are able to polymerize. Unstable dimers and trimers are initially formed. The &quot;&quot;elongation phase&quot;&quot; begins when there are a sufficiently large number of these short polymers. In this phase the filament forms and rapidly grows through the reversible addition of new monomers at both extremes. Finally, a stationary equilibrium is achieved where the G-actin monomers are exchanged at both ends of the microfilament without any change to its total length. In this last phase the &quot;&quot;critical concentration Cc&quot;&quot; is defined as the ratio between the assembly constant and the dissociation constant for G-actin, where the dynamic for the addition and elimination of dimers and trimers does not produce a change in the microfilament's length. Under in vitro conditions \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cc\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is 0.1 μM, which means that at higher values polymerization occurs and at lower values depolymerization occurs. Role of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " hydrolysisAs indicated above, although actin hydrolyzes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", everything points to the fact that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is not required for actin to be assembled, given that, on one hand, the hydrolysis mainly takes place inside the filament, and on the other hand the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " could also instigate polymerization. This poses the question of understanding which thermodynamically unfavourable process requires such a prodigious expenditure of energy. The actin cycle, which couples \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " hydrolysis to actin polymerization, consists of the preferential addition of G-actin-ATP monomers to a filament's barbed end, and the simultaneous disassembly of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    F-actin-ADP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " monomers at the pointed end where the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is subsequently changed into \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", thereby closing the cycle. This aspect of actin filament formation is known as “treadmilling”. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is hydrolysed relatively rapidly just after the addition of a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    G-actin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " monomer to the filament. There are two hypotheses regarding how this occurs; the stochastic, which suggests that hydrolysis randomly occurs in a manner that is in some way influenced by the neighbouring molecules; and the vectorial, which suggests that hydrolysis only occurs adjacent to other molecules whose \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has already been hydrolysed. In either case, the resulting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is not released; it remains for some time noncovalently bound to actin's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". In this way there are three species of actin in a filament: ATP-Actin, ADP+Pi-Actin and ADP-Actin. The amount of each one of these species present in a filament depends on its length and state: as elongation commences the filament has an approximately equal amount of actin monomers bound with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP+Pi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and a small amount of ADP-Actin at the (-) end. As the stationary state is reached the situation reverses, with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " present along the majority of the filament and only the area nearest the (+) end containing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP+Pi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " only present at the tip.If we compare the filaments that only contain ADP-Actin with those that include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", in the former the critical constants are similar at both ends, while \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cc\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " for the other two \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nucleotides\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is different: At the (+) end Cc+=0.1 μM, while at the (-) end Cc−=0.8 μM, which gives rise to the following situations: For G-actin-ATP concentrations less than Cc+ no elongation of the filament occurs. For G-actin-ATP concentrations less than Cc− but greater than Cc+ elongation occurs at the (+) end. For G-actin-ATP concentrations greater than Cc− the microfilament grows at both ends.It is therefore possible to deduce that the energy produced by hydrolysis is used to create a true “stationary state”, that is a flux, instead of a simple equilibrium, one that is dynamic, polar, and attached to the filament. This justifies the expenditure of energy as it promotes essential biological functions. In addition, the configuration of the different monomer types is detected by actin binding proteins, which also control this dynamism, as will be described in the following section. Microfilament formation by treadmilling has been found to be atypical in stereocilia. In this case the control of the structure's size is totally apical and it is controlled in some way by gene expression, that is, by the total quantity of protein monomer synthesized in any given moment. Associated proteins The actin cytoskeleton in vivo is not exclusively composed of actin, other proteins are required for its formation, continuance, and function. These proteins are called actin-binding proteins (ABP) and they are involved in actin's polymerization, depolymerization, stability, organisation in bundles or networks, fragmentation, and destruction. The diversity of these proteins is such that actin is thought to be the protein that takes part in the greatest number of protein-protein interactions. For example, G-actin sequestering elements exist that impede its incorporation into microfilaments. There are also proteins that stimulate its polymerization or that give complexity to the synthesizing networks. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Thymosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " β-4 is a 5 kDa protein that can bind with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    G-actin-ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in a 1:1 stoichiometry; which means that one unit of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thymosin β-4\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " binds to one unit of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    G-actin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Its role is to impede the incorporation of the monomers into the growing polymer. Profilin, is a cytosolic protein with a molecular weight of 15 kDa, which also binds with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    G-actin-ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or -ADP with a stoichiometry of 1:1, but it has a different function as it facilitates the replacement of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " nucleotides by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". It is also implicated in other cellular functions, such as the binding of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    proline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " repetitions in other proteins or of lipids that act as secondary messengers. Other proteins that bind to actin regulate the length of the microfilaments by cutting them, which gives rise to new active ends for polymerization. For example, if a microfilament with two ends is cut twice, there will be three new microfilaments with six ends. This new situation favors the dynamics of assembly and disassembly. The most notable of these proteins are gelsolin and cofilin. These proteins first achieve a cut by binding to an actin monomer located in the polymer they then change the actin monomer's conformation while remaining bound to the newly generated (+) end. This has the effect of impeding the addition or exchange of new G-actin subunits. Depolymerization is encouraged as the (-) ends are not linked to any other molecule.Other proteins that bind with actin cover the ends of F-actin in order to stabilize them, but they are unable to break them. Examples of this type of protein are CapZ, which binds the (+) ends depending on a cell's levels of Ca2+/calmodulin. These levels depend on the cell's internal and external signals and are involved in the regulation of its biological functions). Another example is tropomodulin (that binds to the (-) end). Tropomodulin basically acts to stabilize the F-actin present in the myofibrils present in muscle sarcomeres, which are structures characterized by their great stability. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Arp2/3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " complex is widely found in all eukaryotic organisms. It is composed of seven subunits, some of which possess a topology that is clearly related to their biological function: two of the subunits, ARP2 and ARP3, have a structure similar to that of actin monomers. This homology allows both units to act as nucleation agents in the polymerization of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    G-actin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and F-actin. This complex is also required in more complicated processes such as in establishing dendritic structures and also in anastomosis (the reconnection of two branching structures that had previously been joined, such as in blood vessels). Chemical inhibitors There are a number of toxins that interfere with actin's dynamics, either by preventing it from polymerizing (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    latrunculin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cytochalasin D\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") or by stabilizing it (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    phalloidin): Latrunculin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is a toxin produced by sponges. It binds to G-actin preventing it from binding with microfilaments. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cytochalasin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " D, is an alkaloid produced by fungi, that binds to the (+) end of F-actin preventing the addition of new monomers. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cytochalasin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " D has been found to disrupt actin's dynamics, activating protein p53 in animals. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Phalloidin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", is a toxin that has been isolated from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " cap mushroom Amanita phalloides. It binds to the interface between adjacent actin monomers in the F-actin polymer, preventing its depolymerization. Functions and location Actin forms filaments ('F-actin' or microfilaments) are essential elements of the eukaryotic cytoskeleton, able to undergo very fast polymerization and depolymerization dynamics. In most cells actin filaments form larger-scale networks which are essential for many key functions in cells: Various types of actin networks (made of actin filaments) give mechanical support to cells, and provide trafficking routes through the cytoplasm to aid signal transduction. Rapid assembly and disassembly of actin network enables cells to migrate (Cell migration). In metazoan muscle cells, to be the scaffold on which \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " proteins generate force to support \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle contraction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In non-muscle cells, to be a track for cargo transport myosins (nonconventional myosins) such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin V and VI\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Nonconventional myosins use \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " hydrolysis to transport cargo, such as vesicles and organelles, in a directed fashion much faster than diffusion. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " V walks towards the barbed end of actin filaments, while \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " VI walks toward the pointed end. Most actin filaments are arranged with the barbed end toward the cellular membrane and the pointed end toward the cellular interior. This arrangement allows \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " V to be an effective motor for the export of cargos, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin VI\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to be an effective motor for import.The actin protein is found in both the cytoplasm and the cell nucleus. Its location is regulated by cell membrane signal transduction pathways that integrate the stimuli that a cell receives stimulating the restructuring of the actin networks in response. In Dictyostelium, phospholipase D has been found to intervene in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inositol phosphate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " pathways. Actin filaments are particularly stable and abundant in muscle fibres. Within the sarcomere (the basic morphological and physiological unit of muscle fibres) actin is present in both the I and A bands; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is also present in the latter. Cytoskeleton Microfilaments are involved in the movement of all mobile cells, including non-muscular types, and drugs that disrupt F-actin organization (such as the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cytochalasins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") affect the activity of these cells. Actin comprises 2% of the total amount of proteins in hepatocytes, 10% in fibroblasts, 15% in amoebas and up to 50–80% in activated platelets. There are a number of different types of actin with slightly different structures and functions. This means that α-actin is found exclusively in muscle fibres, while types β and γ are found in other cells. In addition, as the latter types have a high turnover rate the majority of them are found outside permanent structures. This means that the microfilaments found in cells other than muscle cells are present in three forms: Microfilament networks - Animal cells commonly have a cell cortex under the cell membrane that contains a large number of microfilaments, which precludes the presence of organelles. This network is connected with numerous receptor cells that relay signals to the outside of a cell. Microfilament bundles - These extremely long microfilaments are located in networks and, in association with contractile proteins such as non-muscular \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", they are involved in the movement of substances at an intracellular level. Periodic actin rings - A periodic structure constructed of evenly spaced actin rings is recently found to specifically exist in axons (not dendrites). In this structure, the actin rings, together with spectrin tetramers that link the neighboring actin rings, form a cohesive cytoskeleton that supports the axon membrane. The structure periodicity may also regulate the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ion channels in axons. Yeasts Actin's cytoskeleton is key to the processes of endocytosis, cytokinesis, determination of cell polarity and morphogenesis in yeasts. In addition to relying on actin these processes involve 20 or 30 associated proteins, which all have a high degree of evolutionary conservation, along with many signalling molecules. Together these elements allow a spatially and temporally modulated assembly that defines a cell's response to both internal and external stimuli.Yeasts contain three main elements that are associated with actin: patches, cables, and rings that, despite not being present for long, are subject to a dynamic equilibrium due to continual polymerization and depolymerization. They possess a number of accessory proteins including ADF/cofilin, which has a molecular weight of 16kDa and is coded for by a single gene, called COF1; Aip1, a cofilin cofactor that promotes the disassembly of microfilaments; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Srv2/CAP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", a process regulator related to adenylate cyclase proteins; a profilin with a molecular weight of approximately 14 kDa that is related/associated with actin monomers; and twinfilin, a 40 kDa protein involved in the organization of patches. Plants Plant genome studies have revealed the existence of protein isovariants within the actin family of genes. Within Arabidopsis thaliana, a dicotyledon used as a model organism, there are ten types of actin, nine types of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    α-tubulins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", six \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    β-tubulins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", six \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    profilins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and dozens of myosins. This diversity is explained by the evolutionary necessity of possessing variants that slightly differ in their temporal and spatial expression. The majority of these proteins were jointly expressed in the tissue analysed. Actin networks are distributed throughout the cytoplasm of cells that have been cultivated in vitro. There is a concentration of the network around the nucleus that is connected via spokes to the cellular cortex, this network is highly dynamic, with a continuous polymerization and depolymerization. Even though the majority of plant cells have a cell wall that defines their morphology and impedes their movement, their microfilaments can generate sufficient force to achieve a number of cellular activities, such as, the cytoplasmic currents generated by the microfilaments and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Actin is also involved in the movement of organelles and in cellular morphogenesis, which involve cell division as well as the elongation and differentiation of the cell.The most notable proteins associated with the actin cytoskeleton in plants include: villin, which belongs to the same family as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gelsolin/severin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and is able to cut microfilaments and bind actin monomers in the presence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " cations; fimbrin, which is able to recognize and unite actin monomers and which is involved in the formation of networks (by a different regulation process from that of animals and yeasts); \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    formins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which are able to act as an F-actin polymerization nucleating agent; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", a typical molecular motor that is specific to eukaryotes and which in Arabidopsis thaliana is coded for by 17 genes in two distinct classes; CHUP1, which can bind actin and is implicated in the spatial distribution of chloroplasts in the cell; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    KAM1/MUR3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " that define the morphology of the Golgi apparatus as well as the composition of xyloglucans in the cell wall; NtWLIM1, which facilitates the emergence of actin cell structures; and ERD10, which is involved in the association of organelles within membranes and microfilaments and which seems to play a role that is involved in an organism's reaction to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". Nuclear actin Nuclear actin was first noticed and described in 1977 by Clark and Merriam. Authors describe a protein present in the nuclear fraction, obtained from Xenopus laevis oocytes, which shows the same features as skeletal muscle actin. Since that time there have been many scientific reports about the structure and functions of actin in the nucleus (for review see: Hofmann 2009.) The controlled level of actin in the nucleus, its interaction with actin-binding proteins (ABP) and the presence of different isoforms allows actin to play an important role in many important nuclear processes. Transport of actin through the nuclear membrane The actin sequence does not contain a nuclear localization signal. The small size of actin (about 43 kDa) allows it to enter the nucleus by passive diffusion. Actin however shuttles between cytoplasm and nucleus quite quickly, which indicates the existence of active transport. The import of actin into the nucleus (probably in a complex with cofilin) is facilitated by the import protein importin 9.Low level of actin in the nucleus seems to be very important, because actin has two nuclear export signals (NES) into its sequence. Microinjected actin is quickly removed from the nucleus to the cytoplasm. Actin is exported at least in two ways, through exportin 1 (EXP1) and exportin 6 (Exp6).Specific modifications, such as SUMOylation, allows for nuclear actin retention. It was demonstrated that a mutation preventing SUMOylation causes rapid export of beta actin from the nucleus.Based on the experimental results a general mechanism of nuclear actin transport can be proposed: In the cytoplasm cofilin bind ADP-actin monomers. This complex is actively imported into the nucleus. Higher concentration of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the nucleus (compared to the cytoplasm) promote \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " exchange in the actin-cofilin complex. This weakens the strength of binding of these two proteins. Cofilin-actin complex finally dissociate after cofilin phosphorylation by nuclear LIM kinase. Actin is SUMOylated and in this form is retained inside the nucleus. Actin can form complexes with profilin and leave the nucleus via exportin 6. The organization of nuclear actin Nuclear actin exists mainly as a monomer, but can also form dynamic oligomers and short polymers. Nuclear actin organization varies in different cell types. For example, in Xenopus oocytes (with higher nuclear actin level in comparison to somatic cells) actin forms filaments, which stabilize nucleus architecture. These filaments can be observed under the microscope thanks to fluorophore-conjugated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    phalloidin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " staining.In somatic cell nuclei, however, actin filaments cannot be observed using this technique. The DNase I inhibition assay, so far the only test which allows the quantification of the polymerized actin directly in biological samples, has revealed that endogenous nuclear actin indeed occurs mainly in a monomeric form.Precisely controlled level of actin in the cell nucleus, lower than in the cytoplasm, prevents the formation of filaments. The polymerization is also reduced by the limited access to actin monomers, which are bound in complexes with ABPs, mainly cofilin. Actin isoforms in the cell nucleus Little attention is paid to actin isoforms; however, it has been shown that different isoforms of actin are present in the cell nucleus. Actin isoforms, despite their high sequence similarity, have different biochemical properties such as polymerization and depolymerization kinetic. They also show different localization and functions. The level of actin isoforms, both in the cytoplasm and the nucleus, may change for example in response to stimulation of cell growth or arrest of proliferation and transcriptional activity.Research concerns on nuclear actin are usually focused on isoform beta. However the use of antibodies directed against different actin isoforms allows identifying not only the cytoplasmic beta in the cell nucleus, but also: gamma actin in the cell nuclei of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human melanoma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    alpha skeletal muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " actin in the nuclei of mouse myoblasts, cytoplasmic gamma actin and also alpha smooth muscle actin in the nucleus of the foetal mouse fibroblastThe presence of different isoforms of actin may have a significant effect on its function in nuclear processes, especially because the level of individual isoforms can be controlled independently. Nuclear actin functions Functions of actin in the nucleus are associated with its ability to polymerize and interaction with variety of ABPs and with structural elements of the nucleus. Nuclear actin is involved in: Architecture of the nucleus - Interaction of actin with alpha II-spectrin and other proteins are important for maintaining proper shape of the nucleus. Transcription – Actin is involved in chromatin reorganization, transcription initiation and interaction with the transcription complex. Actin takes part in the regulation of chromatin structure, interacting with RNA polymerase I, II and III. In Pol I transcription, actin and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (MYO1C, which binds DNA) act as a molecular motor. For \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pol II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " transcription, β-actin is needed for the formation of the preinitiation complex. Pol III contains β-actin as a subunit. Actin can also be a component of chromatin remodelling complexes as well as pre-mRNP particles (that is, precursor messenger RNA bundled in proteins), and is involved in nuclear export of RNAs and proteins. Regulation of gene activity – Actin binds to the regulatory regions of different kinds of genes. Actin's ability to regulate gene activity is used in the molecular reprogramming method, which allows differentiated cells return to their embryonic state. Translocation of the activated chromosome fragment from under membrane region to euchromatin where transcription starts. This movement requires the interaction of actin and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Integration of different cellular compartments. Actin is a molecule that integrates cytoplasmic and nuclear signal transduction pathways. An example is the activation of transcription in response to serum stimulation of cells in vitro. Immune response - Nuclear actin polymerizes upon T-cell receptor stimulation and is required for cytokine expression and antibody production in vivo.Due to its ability to undergo conformational changes and interaction with many proteins, actin acts as a regulator of formation and activity of protein complexes such as transcriptional complex. Muscle contraction Outline of a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle contraction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " In muscle cells, actomyosin myofibrils make up much of the cytoplasmic material. These myofibrils are made of thin filaments of actin (typically around 7 nm in diameter), and thick filaments of the motor-protein \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (typically around 15 nm in diameter). These myofibrils use energy derived from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to create movements of cells, such as muscle contraction. Using the hydrolysis of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " for energy, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " heads undergo a cycle during which they attach to thin filaments, exert a tension, and then, depending on the load, perform a power \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that causes the thin filaments to slide past, shortening the muscle. In contractile bundles, the actin-bundling protein \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    alpha-actinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " separates each thin filament by ≈35 nm. This increase in distance allows thick filaments to fit in between and interact, enabling deformation or contraction. In deformation, one end of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is bound to the plasma membrane, while the other end &quot;&quot;walks&quot;&quot; toward the plus end of the actin filament. This pulls the membrane into a different shape relative to the cell cortex. For contraction, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " molecule is usually bound to two separate filaments and both ends simultaneously &quot;&quot;walk&quot;&quot; toward their filament's plus end, sliding the actin filaments closer to each other. This results in the shortening, or contraction, of the actin bundle (but not the filament). This mechanism is responsible for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle contraction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and cytokinesis, the division of one cell into two. Actin’s role in muscle contraction The helical F-actin filament found in muscles also contains a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tropomyosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " molecule, a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    40-nanometre\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " protein that is wrapped around the F-actin helix. During the resting phase the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tropomyosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " covers the actin's active sites so that the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    actin-myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " interaction cannot take place and produce \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscular contraction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (the interaction gives rise to a movement between the two proteins that, because it is repeated many times, produces a contraction). There are other protein molecules bound to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tropomyosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " thread, these include the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    troponins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " that have three polymers: troponin I, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    troponin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " T, and troponin C. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Tropomyosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "'s regulatory function depends on its interaction with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    troponin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the presence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ca2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "+ ions.Both actin and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are involved in muscle contraction and relaxation and they make up 90% of muscle protein. The overall process is initiated by an external signal, typically through an action potential stimulating the muscle, which contains specialized cells whose interiors are rich in actin and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " filaments. The contraction-relaxation cycle comprises the following steps: Depolarization of the sarcolemma and transmission of an action potential through the T-tubules. Opening of the sarcoplasmic reticulum’s Ca2+ channels. Increase in cytosolic Ca2+ concentrations and the interaction of these cations with troponin causing a conformational change in its structure. This in turn alters the structure of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tropomyosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which covers actin's active site, allowing the formation of myosin-actin cross-links (the latter being present as thin filaments). Movement of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " heads over the thin filaments, this can either involve \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or be independent of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ATP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The former mechanism, mediated by ATPase activity in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " heads, causes the movement of the actin filaments towards the Z-disc. Ca2+ capture by the sarcoplasmic reticulum, causing a new conformational change in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tropomyosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " that inhibits the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    actin-myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " interaction. Other biological processes The traditional image of actin's function relates it to the maintenance of the cytoskeleton and, therefore, the organization and movement of organelles, as well as the determination of a cell's shape. However, actin has a wider role in eukaryotic cell physiology, in addition to similar functions in prokaryotes. Cytokinesis. Cell division in animal cells and yeasts normally involves the separation of the parent cell into two daughter cells through the constriction of the central circumference. This process involves a constricting ring composed of actin, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", anillin, and α-actinin. In the fission yeast Schizosaccharomyces pombe, actin is actively formed in the constricting ring with the participation of Arp3, the formin Cdc12, profilin, and WASp, along with preformed microfilaments. Once the ring has been constructed the structure is maintained by a continual assembly and disassembly that, aided by the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Arp2/3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " complex and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    formins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", is key to one of the central processes of cytokinesis. The totality of the contractile ring, the spindle apparatus, microtubules, and the dense peripheral material is called the &quot;&quot;Fleming body&quot;&quot; or &quot;&quot;intermediate body&quot;&quot;. Apoptosis. During \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    programmed cell death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " the ICE/ced-3 family of proteases (one of the interleukin-1β-converter proteases) degrade actin into two fragments in vivo; one of the fragments is 15 kDa and the other 31 kDa. This represents one of the mechanisms involved in destroying cell viability that form the basis of apoptosis. The protease calpain has also been shown to be involved in this type of cell destruction; just as the use of calpain inhibitors has been shown to decrease actin proteolysis and the degradation of DNA (another of the characteristic elements of apoptosis). On the other hand, the stress-induced triggering of apoptosis causes the reorganization of the actin cytoskeleton (which also involves its polymerization), giving rise to structures called \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " fibers; this is activated by the MAP kinase pathway. Cellular adhesion and development. The adhesion between cells is a characteristic of multicellular organisms that enables tissue specialization and therefore increases cell complexity. Adhesion of cell epithelia involves the actin cytoskeleton in each of the joined cells as well as cadherins acting as extracellular elements with the connection between the two mediated by catenins. Interfering in actin dynamics has repercussions for an organism's development, in fact actin is such a crucial element that systems of redundant genes are available. For example, if the α-actinin or gelation factor gene has been removed in Dictyostelium individuals do not show an anomalous phenotype possibly due to the fact that each of the proteins can perform the function of the other. However, the development of double mutations that lack both gene types is affected. Gene expression modulation. Actin's state of polymerization affects the pattern of gene expression. In 1997, it was discovered that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cytocalasin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " D-mediated depolymerization in Schwann cells causes a specific pattern of expression for the genes involved in the myelinization of this type of nerve cell. F-actin has been shown to modify the transcriptome in some of the life stages of unicellular organisms, such as the fungus \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Candida albicans\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In addition, proteins that are similar to actin play a regulatory role during \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spermatogenesis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in mice and, in yeasts, actin-like proteins are thought to play a role in the regulation of gene expression. In fact, actin is capable of acting as a transcription initiator when it reacts with a type of nuclear \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " that interacts with RNA polymerases and other enzymes involved in the transcription process. Stereocilia dynamics. Some cells develop fine filliform outgrowths on their surface that have a mechanosensory function. For example, this type of organelle is present in the Organ of Corti, which is located in the ear. The main characteristic of these structures is that their length can be modified. The molecular architecture of the stereocilia includes a paracrystalline actin core in dynamic equilibrium with the monomers present in the adjacent cytosol. Type VI and VIIa myosins are present throughout this core, while \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " XVa is present in its extremities in quantities that are proportional to the length of the stereocilia. Intrinsic chirality. Actomyosin networks have been implicated in generating an intrinsic chirality in individual cells. Cells grown out on chiral surfaces can show a directional left/right bias that is actomyosin dependent. Molecular pathology The majority of mammals possess six different actin genes. Of these, two code for the cytoskeleton (ACTB and ACTG1) while the other four are involved in skeletal striated muscle (ACTA1), smooth muscle tissue (ACTA2), intestinal muscles (ACTG2) and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (ACTC1). The actin in the cytoskeleton is involved in the pathogenic mechanisms of many \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infectious agents\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", including HIV. The vast majority of the mutations that affect actin are point mutations that have a dominant effect, with the exception of six mutations involved in nemaline \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". This is because in many cases the mutant of the actin monomer acts as a “cap” by preventing the elongation of F-actin. Pathology associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACTA1 ACTA1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the gene that codes for the α-isoform of actin that is predominant in human skeletal striated muscles, although it is also expressed in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and in the thyroid gland. Its DNA sequence consists of seven exons that produce five known transcripts. The majority of these consist of point mutations causing substitution of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The mutations are in many cases associated with a phenotype that determines the severity and the course of the affliction. The mutation alters the structure and function of skeletal muscles producing one of three forms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ": type 3 nemaline \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital myopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with an excess of thin myofilaments (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital myopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with fibre type disproportion (CMFTD). Mutations have also been found that produce core \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myopathies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Although their phenotypes are similar, in addition to typical nemaline \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " some specialists distinguish another type of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " called \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    actinic nemaline myopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In the former, clumps of actin form instead of the typical rods. It is important to state that a patient can show more than one of these phenotypes in a biopsy. The most common symptoms consist of a typical facial morphology (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myopathic facies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscular weakness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a delay in motor development and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    respiratory difficulties\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The course of the illness, its gravity, and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " at which it appears are all variable and overlapping forms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are also found. A symptom of nemaline \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is that &quot;&quot;nemaline rods&quot;&quot; appear in differing places in type 1 muscle fibres. These rods are non-pathognomonic structures that have a similar composition to the Z disks found in the sarcomere.The pathogenesis of this \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is very varied. Many mutations occur in the region of actin's indentation near to its \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nucleotide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " binding sites, while others occur in Domain 2, or in the areas where interaction occurs with associated proteins. This goes some way to explain the great variety of clumps that form in these cases, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nemaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or Intranuclear Bodies or Zebra Bodies. Changes in actin's folding occur in nemaline \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as well as changes in its aggregation and there are also changes in the expression of other associated proteins. In some variants where intranuclear bodies are found the changes in the folding masks the nucleus's protein exportation signal so that the accumulation of actin's mutated form occurs in the cell nucleus. On the other hand, it appears that mutations to ACTA1 that give rise to a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CFTDM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " have a greater effect on sarcomeric function than on its structure. Recent investigations have tried to understand this apparent paradox, which suggests there is no clear correlation between the number of rods and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscular weakness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It appears that some mutations are able to induce a greater apoptosis rate in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    type II muscular\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " fibres. In smooth muscle There are two isoforms that code for actins in the smooth muscle tissue: ACTG2 codes for the largest actin isoform, which has nine exons, one of which, the one located at the 5' end, is not translated. It is a γ-actin that is expressed in the enteric smooth muscle. No mutations to this gene have been found that correspond to pathologies, although microarrays have shown that this protein is more often expressed in cases that are resistant to chemotherapy using \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cisplatin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".ACTA2 codes for an α-actin located in the smooth muscle, and also in vascular smooth muscle. It has been noted that the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MYH11\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " mutation could be responsible for at least 14% of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hereditary thoracic aortic aneurisms\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " particularly Type 6. This is because the mutated variant produces an incorrect filamentary assembly and a reduced capacity for vascular smooth muscle contraction. Degradation of the aortic media has been recorded in these individuals, with areas of disorganization and hyperplasia as well as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       "'s vasa vasorum. The number of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    afflictions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that the gene is implicated in is increasing. It has been related to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Moyamoya disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and it seems likely that certain mutations in heterozygosis could confer a predisposition to many vascular pathologies, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thoracic aortic aneurysm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischaemic heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The α-actin found in smooth muscles is also an interesting marker for evaluating the progress of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    liver cirrhosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " The ACTC1 gene codes for the α-actin isoform present in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It was first sequenced by Hamada and co-workers in 1982, when it was found that it is interrupted by five introns. It was the first of the six genes where alleles were found that were implicated in pathological processes. A number of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    structural disorders\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " associated with point mutations of this gene have been described that cause malfunctioning of the heart, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Type 1R dilated cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and Type 11 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertrophic cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Certain defects of the atrial septum have been described recently that could also be related to these mutations.Two cases of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dilated cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " have been studied involving a substitution of highly conserved \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acids belonging to the protein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " domains that bind and intersperse with the Z discs. This has led to the theory that the dilation is produced by a defect in the transmission of contractile force in the myocytes.The mutations in ACTC1 are responsible for at least 5% of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertrophic cardiomyopathies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The existence of a number of point mutations have also been found: Mutation E101K: changes of net charge and formation of a weak electrostatic link in the actomyosin-binding site. P166A: interaction zone between actin monomers. A333P: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    actin-myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " interaction zone.Pathogenesis appears to involve a compensatory mechanism: the mutated proteins act like toxins with a dominant effect, decreasing the heart's ability to contract causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abnormal mechanical behaviour\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such that the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", that is usually delayed, is a consequence of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "'s normal response to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ".Recent studies have discovered ACTC1 mutations that are implicated in two other pathological processes: Infantile \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    idiopathic restrictive cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and noncompaction of the left ventricular myocardium. In cytoplasmatic actins ACTB is a highly complex locus. A number of pseudogenes exist that are distributed throughout the genome, and its sequence contains six exons that can give rise to up to 21 different transcriptions by alternative splicing, which are known as the β-actins. Consistent with this complexity, its products are also found in a number of locations and they form part of a wide variety of processes (cytoskeleton, NuA4 histone-acyltransferase complex, cell nucleus) and in addition they are associated with the mechanisms of a great number of pathological processes (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carcinomas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    juvenile dystonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " mechanisms, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nervous system malformations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tumour\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " invasion, among others). A new form of actin has been discovered, kappa actin, which appears to substitute for β-actin in processes relating to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tumours\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Three pathological processes have so far been discovered that are caused by a direct alteration in gene sequence: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hemangiopericytoma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with t(7;12)(p22;q13)-translocations is a rare affliction, in which a translocational mutation causes the fusion of the ACTB gene over GLI1 in Chromosome 12. Juvenile onset \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dystonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a rare \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    degenerative disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that affects the central nervous system; in particular, it affects areas of the neocortex and thalamus, where rod-like eosinophilic inclusions are formed. The affected individuals represent a phenotype with deformities on the median line, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sensory hearing loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dystonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It is caused by a point mutation in which the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acid tryptophan\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " replaces \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arginine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in position 183. This alters actin's interaction with the ADF/cofilin system, which regulates the dynamics of nerve cell cytoskeleton formation. A dominant point mutation has also been discovered that causes neutrophil granulocyte dysfunction and recurring \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infections\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It appears that the mutation modifies the domain responsible for binding between profilin and other regulatory proteins. Actin's affinity for profilin is greatly reduced in this allele.The ACTG1 locus codes for the cytosolic γ-actin protein that is responsible for the formation of cytoskeletal microfilaments. It contains six exons, giving rise to 22 different mRNAs, which produce four complete isoforms whose form of expression is probably dependent on the type of tissue they are found in. It also has two different DNA promoters. It has been noted that the sequences translated from this locus and from that of β-actin are very similar to the predicted ones, suggesting a common ancestral sequence that suffered duplication and genetic conversion.In terms of pathology, it has been associated with processes such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amyloidosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    retinitis pigmentosa\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " mechanisms, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    kidney diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and various types of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital hearing loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Six \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    autosomal-dominant\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " point mutations in the sequence have been found to cause various types of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hearing loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", particularly \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sensorineural hearing loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " linked to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DFNA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " 20/26 locus. It seems that they affect the stereocilia of the ciliated cells present in the inner ear's Organ of Corti. β-actin is the most abundant protein found in human tissue, but it is not very abundant in ciliated cells, which explains the location of the pathology. On the other hand, it appears that the majority of these mutations affect the areas involved in linking with other proteins, particularly actomyosin. Some experiments have suggested that the pathological mechanism for this type of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hearing loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " relates to the F-actin in the mutations being more sensitive to cofilin than normal.However, although there is no record of any case, it is known that γ-actin is also expressed in skeletal muscles, and although it is present in small quantities, model organisms have shown that its absence can give rise to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myopathies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Other pathological mechanisms Some infectious agents use actin, especially cytoplasmic actin, in their life cycle. Two basic forms are present in bacteria: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Listeria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " monocytogenes, some species of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Rickettsia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", Shigella flexneri and other intracellular germs escape from phagocytic vacuoles by coating themselves with a capsule of actin filaments. L. monocytogenes and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    S.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " flexneri both generate a tail in the form of a &quot;&quot;comet tail&quot;&quot; that gives them mobility. Each species exhibits small differences in the molecular polymerization mechanism of their &quot;&quot;comet tails&quot;&quot;. Different displacement velocities have been observed, for example, with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Listeria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and Shigella found to be the fastest. Many experiments have demonstrated this mechanism in vitro. This indicates that the bacteria are not using a myosin-like protein motor, and it appears that their propulsion is acquired from the pressure exerted by the polymerization that takes place near to the microorganism's cell wall. The bacteria have previously been surrounded by ABPs from the host, and as a minimum the covering contains \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Arp2/3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " complex, Ena/VASP proteins, cofilin, a buffering protein and nucleation promoters, such as vinculin complex. Through these movements they form protrusions that reach the neighbouring cells, infecting them as well so that the immune system can only fight the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " through cell immunity. The movement could be caused by the modification of the curve and debranching of the filaments. Other species, such as Mycobacterium marinum and Burkholderia pseudomallei, are also capable of localized polymerization of cellular actin to aid their movement through a mechanism that is centered on the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Arp2/3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " complex. In addition the vaccine virus Vaccinia also uses elements of the actin cytoskeleton for its dissemination. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pseudomonas aeruginosa\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is able to form a protective \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    biofilm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in order to escape a host organism’s defences, especially white blood cells and antibiotics. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    biofilm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is constructed using DNA and actin filaments from the host organism.In addition to the previously cited example, actin polymerization is stimulated in the initial steps of the internalization of some viruses, notably HIV, by, for example, inactivating the cofilin complex.The role that actin plays in the invasion process of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " cells has still not been determined. Evolution The eukaryotic cytoskeleton of organisms among all taxonomic groups have similar components to actin and tubulin. For example, the protein that is coded by the ACTG2 gene in humans is completely equivalent to the homologues present in rats and mice, even though at a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nucleotide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " level the similarity decreases to 92%. However, there are major differences with the equivalents in prokaryotes (FtsZ and MreB), where the similarity between \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nucleotide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " sequences is between 40 and 50 % among different bacteria and archaea species. Some authors suggest that the ancestral protein that gave rise to the model eukaryotic actin resembles the proteins present in modern bacterial cytoskeletons. Some authors point out that the behaviour of actin, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tubulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and histone, a protein involved in the stabilization and regulation of DNA, are similar in their ability to bind \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nucleotides\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and in their ability of take advantage of Brownian motion. It has also been suggested that they all have a common ancestor. Therefore, evolutionary processes resulted in the diversification of ancestral proteins into the varieties present today, conserving, among others, actins as efficient molecules that were able to tackle essential ancestral biological processes, such as endocytosis. Equivalents in bacteria The bacterial cytoskeleton may not be as complex as that found in eukaryotes; however, it contains proteins that are highly similar to actin monomers and polymers. The bacterial protein MreB polymerizes into thin non-helical filaments and occasionally into helical structures similar to F-actin. Furthermore, its \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    crystalline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " structure is very similar to that of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    G-actin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (in terms of its three-dimensional conformation), there are even similarities between the MreB protofilaments and F-actin. The bacterial cytoskeleton also contains the FtsZ proteins, which are similar to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tubulin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".Bacteria therefore possess a cytoskeleton with homologous elements to actin (for example, MreB, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AlfA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", ParM, FtsA, and MamK), even though the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amino acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " sequence of these proteins diverges from that present in animal cells. However, such proteins have a high degree of structural similarity to eukaryotic actin. The highly dynamic microfilaments formed by the aggregation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MreB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and ParM are essential to cell viability and they are involved in cell morphogenesis, chromosome segregation, and cell polarity. ParM is an actin homologue that is coded in a plasmid and it is involved in the regulation of plasmid DNA. ParMs from different bacterial plasmids can form astonishingly diverse helical structures comprising two or four strands to maintain faithful plasmid inheritance. Applications Actin is used in scientific and technological laboratories as a track for molecular motors such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (either in muscle tissue or outside it) and as a necessary component for cellular functioning. It can also be used as a diagnostic tool, as several of its anomalous variants are related to the appearance of specific pathologies. Nanotechnology. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Actin-myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " systems act as molecular motors that permit the transport of vesicles and organelles throughout the cytoplasm. It is possible that actin could be applied to nanotechnology as its dynamic ability has been harnessed in a number of experiments including those carried out in acellular systems. The underlying idea is to use the microfilaments as tracks to guide molecular motors that can transport a given load. That is actin could be used to define a circuit along which a load can be transported in a more or less controlled and directed manner. In terms of general applications, it could be used for the directed transport of molecules for deposit in determined locations, which would permit the controlled assembly of nanostructures. These attributes could be applied to laboratory processes such as on lab-on-a-chip, in nanocomponent mechanics and in nanotransformers that convert mechanical energy into electrical energy. Actin is used as an internal control in western blots to ascertain that equal amounts of protein have been loaded on each lane of the gel. In the blot example shown on the left side, 75 µg of total protein was loaded in each well. The blot was reacted with anti-β-actin antibody (for other details of the blot see the reference )The use of actin as an internal control is based on the assumption that its expression is practically constant and independent of experimental conditions. By comparing the expression of the gene of interest to that of the actin, it is possible to obtain a relative quantity that can be compared between different experiments, whenever the expression of the latter is constant. It is worth pointing out that actin does not always have the desired stability in its gene expression. Health. Some alleles of actin cause diseases; for this reason techniques for their detection have been developed. In addition, actin can be used as an indirect marker in surgical pathology: it is possible to use variations in the pattern of its distribution in tissue as a marker of invasion in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    neoplasia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vasculitis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and other conditions. Further, due to actin's close association with the apparatus of muscular contraction its levels in skeletal muscle diminishes when these tissues \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", it can therefore be used as a marker of this physiological process. Food technology. It is possible to determine the quality of certain processed foods, such as sausages, by quantifying the amount of actin present in the constituent meat. Traditionally, a method has been used that is based on the detection of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    3-methylhistidine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in hydrolyzed samples of these products, as this compound is present in actin and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    F-myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "'s heavy chain (both are major components of muscle). The generation of this compound in flesh derives from the methylation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    histidine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " residues present in both proteins. Genes Human genes encoding actin proteins include: See also References External links Actin Staining Techniques (Live and Fixed Cell Staining) Eukaryotic Linear Motif resource motif class LIG_Actin_RPEL_3 Eukaryotic Linear Motif resource motif class LIG_Actin_WH2_1 Eukaryotic Linear Motif resource motif class LIG_Actin_WH2_2 3D macromolecular structures of actin filaments from the EM Data \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bank(EMDB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ")&quot; &quot;Afterload is the pressure that the heart must work against to eject blood during systole (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular contraction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). Afterload is proportional to the average arterial pressure. As aortic and pulmonary pressures increase, the afterload increases on the left and right ventricles respectively.  Afterload changes to adapt to the continually changing demands on an animal's cardiovascular system. Afterload is proportional to mean systolic blood pressure and is measured in millimeters of mercury (mm Hg). Hemodynamics Afterload is a determinant of cardiac output.  Cardiac output is the product of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume and heart rate.  Afterload is a determinant of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume (in addition to preload, and strength of myocardial contraction).Following Laplace's law, the tension upon the muscle fibers in the heart wall is the pressure within the ventricle multiplied by the volume within the ventricle divided by the wall thickness (this ratio is the other factor in setting the afterload). Therefore, when comparing a normal heart to a heart with a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dilated left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", if the aortic pressure is the same in both hearts, the dilated heart must create a greater tension to overcome the same aortic pressure to eject blood because it has a larger internal radius and volume. Thus, the dilated heart has a greater total load (tension) on the myocytes, i.e., has a higher afterload. This is also true in the eccentric \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " consequent to high-intensity aerobic training. Conversely, a concentrically hypertrophied \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " may have a lower afterload for a given aortic pressure. When contractility becomes impaired and the ventricle dilates, the afterload rises and limits output. This may start a vicious circle, in which cardiac output is reduced as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " requirements are increased.Afterload can also be described as the pressure that the chambers of the heart must generate to eject blood from the heart, and this is a consequence of aortic pressure (for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ") and pulmonic pressure or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " pressure (for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       "). The pressure in the ventricles must be greater than the systemic and pulmonary pressure to open the aortic and pulmonic valves, respectively. As afterload increases, cardiac output decreases. Cardiac imaging is a somewhat limited modality in defining afterload because it depends on the interpretation of volumetric data. Calculating afterload Quantitatively, afterload can be calculated by determining the wall \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", using the Young–Laplace equation:                                   (                                                        E                 D                 P                 ⋅                 E                 D                 R                                               2                 h                                                  )                          \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    {\\textstyle \\left({\\frac {EDP\\cdot EDR}{2h}}\\right)}    where EDP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is end diastolic pressure in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", which is typically approximated by taking \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " wedge pressure, EDR is end-diastolic radius at the midpoint of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", and h is the mean thickness of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " wall. Both radius and mean thickness of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " may be measured by echocardiography. Factors affecting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    afterload Disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " processes pathology that include indicators such as an increasing left ventricular afterload include elevated blood pressure and aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valve disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Systolic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HTN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") (elevated blood pressure) increases the left ventricular (LV) afterload because the LV must work harder to eject blood into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".  This is because the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " won't open until the pressure generated in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is higher than the elevated blood pressure in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pulmonary hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (PH) is increased blood pressure within the right heart leading to the lungs. PH indicates a regionally applied increase in afterload dedicated to the right side of the heart, divided and isolated from the left heart by the interventricular septum.In the natural aging process, aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " often increases afterload because the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " must overcome the pressure gradient caused by the calcified and stenotic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", in addition to the blood pressure required to eject blood into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". For instance, if the blood pressure is 120/80, and the aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valve stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " creates a trans-valvular gradient of 30 mmHg, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " has to generate a pressure of 110 mmHg to open the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and eject blood into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".Due to the increased afterload, the ventricle has to work harder to accomplish its goal of ejecting blood into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Thus, in the long-term, increased afterload (due to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") results in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to account for the increased work required.Aortic insufficiency (Aortic Regurgitation) increases afterload, because a percentage of the blood that ejects forward regurgitates back through the diseased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".  This leads to elevated systolic blood pressure. The diastolic blood pressure in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " falls, due to regurgitation. This increases pulse pressure.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Mitral regurgitation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (MR) decreases afterload. In ventricular systole under MR, regurgitant blood flows backwards/retrograde back and forth through a diseased and leaking \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".  The remaining blood loaded into the LV is then optimally ejected out through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".  With an extra pathway for blood flow through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " does not have to work as hard to eject its blood, i.e. there is a decreased afterload.  Afterload is largely dependent upon aortic pressure. See also Cardiac output Hemodynamics Preload References Further reading Ross, John (1976). &quot;&quot;Afterload mismatch and preload reserve: A conceptual framework for the analysis of ventricular function&quot;&quot;. Progress in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiovascular Diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". 18 (4): 255–64. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    doi:10.1016/0033-0620(76)90021-9\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". PMID 128034. Kasper, W.; Konstantinides, S.; Geibel, A.; Tiede, N.; Krause, T.; Just, H. (1997). &quot;&quot;Prognostic significance of right ventricular afterload \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " detected by echocardiography in patients with clinically suspected \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary embolism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "&quot;&quot;. Heart. 77 (4): 346–9. doi:10.1136/hrt.77.4.346. PMC 484729. PMID 9155614. Mahler, Felix; Ross, John; O'Rourke, Robert A.; Covell, James W. (1975). &quot;&quot;Effects of changes in preload, afterload and inotropic state on ejection and isovolumic phase measures of contractility in the conscious dog&quot;&quot;. The American Journal of Cardiology. 35 (5): 626–34. doi:10.1016/0002-9149(75)90048-X. PMID 1124716. Hachicha, Z.; Dumesnil, J. G.; Bogaty, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    P.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; Pibarot, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    P.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (2007). &quot;&quot;Paradoxical Low-Flow, Low-Gradient Severe Aortic Stenosis Despite Preserved Ejection Fraction is Associated with Higher Afterload and Reduced Survival&quot;&quot;. Circulation. 115 (22): 2856–64. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    doi:10.1161/CIRCULATIONAHA.106.668681\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". PMID 17533183. Kelly, R. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    P.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; Gibbs, H. H.; O'Rourke, M. F.; Daley, J. E.; Mang, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    K\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "; Morgan, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    J. J.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; Avolio, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    A. P.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (1990). &quot;&quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nitroglycerin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery&quot;&quot;. European Heart Journal. 11 (2): 138–44. doi:10.1093/oxfordjournals.eurheartj.a059669. PMID 2107077. External links Overview at cvphysiology.com&quot; &quot;Allied health professions  are health care professions distinct from optometry, dentistry, nursing, medicine, and pharmacy. They provide a range of diagnostic, technical, therapeutic, and support services in connection with health care. Definition In 2012, the International Chief Health Professions Officers defined the allied health professions: Allied Health Professions are a distinct group of health professionals who apply their expertise to prevent disease transmission, diagnose, treat and rehabilitate people of all ages and all specialties. Together with a range of technical and support staff they may deliver direct patient care, rehabilitation, treatment, diagnostics and health improvement interventions to restore and maintain optimal physical, sensory, psychological, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cognitive and social functions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Professions Depending on the country and local health care system, a limited subset of the following professions (professional areas) may be represented, and may be regulated: The precise titles, roles and requisites of allied health professionals may vary considerably from country to country. A generic definition for the United States is in the Public Health Service Act. Excluded professions The Association of Schools of Allied Health Professions uses wording from the Public Health Service Act to list those who are and are not allied health professionals in the United States. Those professionals who are excluded are those who possess degrees, or an equivalent degree, in the following: Training and education Some allied health professions are more specialized, and so must adhere to national training and education standards and their professional scope of practice. Often they must prove their skills through degrees, diplomas, certified credentials, and continuing education. Other allied health professions require no special training or credentials and are trained for their work by their employer through on-the-job training (which would then exclude them from consideration as an allied health profession in a country like Australia). Many allied health jobs are considered career ladder jobs because of the opportunities for advancement within specific fields.Allied health professions can include the use of many skills. Depending on the profession, these may include basic life support; medical terminology, acronyms and spelling; basics of medical law and ethics; understanding of human relations; interpersonal communication skills; counseling skills; computer literacy; ability to document healthcare information; interviewing skills; and proficiency in word processing; database management and electronic dictation. History The explosion of scientific knowledge that followed World War II brought increasingly sophisticated and complex medical diagnostic and treatment procedures. Increasing public demand for medical services combined with higher health care costs provoked a trend toward expansion of service delivery from treating patients in hospitals to widespread provision of care in physician's private and group practices, ambulatory medical and emergency clinics, and mobile clinics and community-based care. In the developing world, international development assistance led to numerous initiatives for strengthening health workforce capacity to deliver essential health care services. What followed has been an increase in the need for skilled health care delivery personnel worldwide. Changes in the health industry and emphasis on cost-efficient solutions to health care delivery will continue to encourage expansion of the allied health workforce. The World Health Organization estimates there is currently a worldwide shortage of about 2 million allied health professionals (considering all health workers aside from medical and nursing personnel) needed in order to meet global health goals.In recognition of the growth of the number and diversity of allied health professionals in recent years, the 2008 version of the International Standard Classification of Occupations increased the number of groups dedicated to allied health professions. Depending on the presumed skill level, they may either be identified as &quot;&quot;health professionals&quot;&quot; or &quot;&quot;health associate professionals&quot;&quot;. For example, new categories have been created for delineating &quot;&quot;paramedical practitioners\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    &quot;&quot;—\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "grouping professions such as clinical officers, clinical associates, physician assistants, Feldshers, and assistant medical officers—as well as for community health workers; dietitians and nutritionists; audiologists and speech therapists; and others. Employment projections Projections in the United States and many other countries have shown an expected long-term shortage of qualified workers to fill many allied health positions. This is primarily due to expansion of the health industry due to demographic changes (a growing and aging population), large numbers of health workers nearing retirement, the industry's need to be cost efficient, and a lack of sufficient investment in training programs to keep pace with these trends.Studies have also pointed to the need for increased diversity in the allied health workforce to realize a culturally competent health system in the United States and elsewhere. Workforce and health care experts anticipate that health services will increasingly be delivered via ambulatory and nursing care settings rather than in hospitals. According to the North American Industry Classification System (NAICS), the health care industry consists of four main sub-sectors, divided by the types of services provided at each facility: Hospitals: primarily provides inpatient health services and may provide some outpatient services as a secondary activity. Ambulatory health care settings: primarily provides outpatient services at facilities such as doctors' offices, outpatient clinics and clinical laboratories. Nursing and residential care facilities: provides residential care, such as community care for the elderly or mental health and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    substance abuse\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " facilities. Social Assistance: provides services for the elderly and/or disabled, services for the homeless and poor, vocational rehabilitation, or child day care services.In the US, a larger proportion of the allied health care workforce is already employed in ambulatory settings. In California, nearly half (49.4 percent) of the allied health workforce is employed in ambulatory health care settings, compared with 28.7 percent and 21.9 percent employed in hospital and nursing care, respectively. One source reported allied health professionals making up 60 percent of the total US health workforce.In the United Kingdom there are 12 distinct professions who are considered allied health professionals; in combination they account for about 6% of the NHS workforce. In 2013 the annual expenditure on services provided by allied health professionals amounted to around £2 billion, although there is a lack of evidence around the extent to which these services improve the quality of care.Advancements in medical technology also allow for more services that formerly required expensive hospital stays to be delivered via ambulatory care. For example, in California, research has predicted the total consumption of hospital days per person will decline from 4 days in 2010 to 3.2 days in 2020 to 2.5 days in 2030. In contrast, the number of ambulatory visits per person will increase from 3.2 visits per person in 2010 to 3.6 visits per person in 2020 to 4.2 visits in 2030.In developing countries, many national human resources for health strategic plans and international development initiatives are focusing on scaling up training of allied health professions, such as HIV/AIDS counsellors, clinical officers and community health workers, in providing essential preventive and treatment services in ambulatory and community-based care settings.With this growing demand for ambulatory health care, researchers expect to witness a heavier demand for professions that are employed within the ambulatory sector and other non-hospital settings—in other words, allied health. See also Health care providers Human resources for health Paramedicine Unlicensed assistive personnel References External links AMA Allied health professionals Association of Schools of Allied Health Professions (ASAHP) Allied Health Professionals on NHS Careers (UK)&quot; &quot;The American Journal of Physiology is a peer-reviewed scientific journal on physiology published by the American Physiological Society.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Vols\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    1898–1941\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and 1948-56 include the Society's proceedings, including abstracts of papers presented at the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    10th-53rd\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " annual meetings, and the 1948-56 fall meetings. Subjournals The American Journal of Physiology has seven subjournals; according to the 2019 Journal Citation Reports their impact factors vary from 2.992 to 4.406: AJP-Cell Physiology AJP-Endocrinology and Metabolism AJP-Gastrointestinal and Liver Physiology AJP-Heart and Circulatory Physiology AJP-Lung Cellular and Molecular Physiology AJP-Regulatory, Integrative and Comparative Physiology AJP-Renal Physiology References External links Official website&quot; &quot;Ammit (; Ancient Egyptian: ꜥm-mwt, &quot;&quot;devourer of the dead&quot;&quot;; also rendered Ammut or Ahemait) was a demoness and goddess in ancient Egyptian religion with the forequarters of a lion, the hindquarters of a hippopotamus, and the head of a crocodile—the three largest &quot;&quot;man-eating&quot;&quot; animals known to ancient Egyptians. A funerary deity, her titles included &quot;&quot;Devourer of the Dead&quot;&quot;, &quot;&quot;Eater of Hearts&quot;&quot;, and &quot;&quot;Great of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "&quot;&quot;. Ammit lived near the scales of justice in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Duat\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the Egyptian underworld. In the Hall of Two Truths, Anubis weighed the heart of a person against the feather of Ma'at, the goddess of truth, which was depicted as an ostrich feather (the feather was often pictured in Ma'at's headdress). If the heart was judged to be not pure, Ammit would devour it, and the person undergoing judgment was not allowed to continue their voyage towards Osiris and immortality. Once Ammit swallowed the heart, the soul was believed to become restless forever; this was called &quot;&quot;to die a second time&quot;&quot;. Ammit was also sometimes said to stand by a lake of fire. In some traditions, the unworthy hearts were cast into the fiery lake to be destroyed. Some scholars believe Ammit and the lake represent the same concept of destruction. Ammit was not worshipped; instead, she embodied all that the Egyptians feared, threatening to bind them to eternal restlessness if they did not follow the principle of Ma'at. See also Book of the Dead Chalkydri References External links  Media related to Ammit at Wikimedia Commons&quot; &quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is an antiarrhythmic medication used to treat and prevent a number of types of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac dysrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". This includes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (VT), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    VF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), and wide complex \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", as well as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and paroxysmal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    supraventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Evidence in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac arrest\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", however, is poor. It can be given by mouth, intravenously, or intraosseously. When used by mouth, it can take a few weeks for effects to begin.Common side effects include feeling tired, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tremor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    constipation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". As \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can have serious side effects, it is mainly recommended only for significant \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Serious side effects include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lung toxicity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    interstitial pneumonitis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    liver problems\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", vision problems, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thyroid problems\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". If taken during pregnancy or breastfeeding it can cause problems in the fetus. It is a class III antiarrhythmic medication. It works partly by increasing the time before a heart cell can contract again.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was first made in 1961 and came into medical use in 1962 for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " believed to be related to the heart. It was pulled from the market in 1967 due to side effects. In 1974 it was found to be useful for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and reintroduced. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. In 2018, it was the 189th most commonly prescribed medication in the United States, with more than 3 million prescriptions. Medical uses \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has been used both in the treatment of acute life-threatening \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as well as the long term suppression of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It is used both in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    supraventricular arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiac arrest\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Defibrillation is the treatment of choice for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulseless\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " resulting in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac arrest\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". While \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has been used in shock-refractory cases, evidence of benefit is poor. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " does not appear to improve survival or positive outcomes in those who had a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac arrest\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ventricular tachycardia Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be used in the treatment of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in certain instances.  Individuals with hemodynamically unstable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " should not initially receive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  These individuals should be cardioverted. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can be used in individuals with hemodynamically stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  In these cases, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can be used regardless of the individual's underlying heart function and the type of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; it can be used in individuals with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    monomorphic ventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", but is contraindicated in individuals with polymorphic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as it is associated with a prolonged QT interval which will be made worse with anti-arrhythmic drugs. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Individuals who have undergone open heart surgery are at an increased risk of developing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (or AF) in the first few days post-procedure.  In the ARCH trial, intravenous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (2 g administered over 2 d) has been shown to reduce the incidence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " after open heart surgery when compared to placebo.  However, clinical studies have failed to demonstrate long-term efficacy and have shown potentially fatal side effects such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary toxicities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  While \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is not approved for AF by the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    FDA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", it is a commonly prescribed off-label treatment due to the lack of equally effective treatment alternatives. So-called 'acute onset \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "', defined by the North American Society of Pacing and Electrophysiology (NASPE) in 2003, responds well to short duration treatment with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". This has been demonstrated in seventeen randomized controlled trials, of which five included a placebo arm. The incidence of severe side effects in this group is low. The benefit of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the treatment of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the critical care population has yet to be determined but it may prove to be the agent of choice where the patient is hemodynamically unstable and unsuitable for DC cardioversion. It is recommended in such a role by the UK government's National Institute for Health and Clinical Excellence (NICE). Contraindications Women who are pregnant or may become pregnant are strongly advised to not take \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  Since \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can be expressed in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breast milk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", women taking \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are advised to stop nursing. It is contraindicated in individuals with sinus nodal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrioventricular block\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and second or third degree \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart block\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " who do not have an artificial pacemaker. Individuals with baseline \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depressed lung function\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " should be monitored closely if \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " therapy is to be initiated. Formulations of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " that contain \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    benzyl alcohol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " should not be given to neonates, because the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    benzyl alcohol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may cause the potentially fatal &quot;&quot;gasping \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    syndrome&quot;&quot;.Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can worsen the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac arrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " brought on by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    digitalis toxicity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Side effects \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has numerous side effects. Most individuals administered \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " on a chronic basis will experience at least one side effect. Lung Side effects of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " include various pulmonary effects.  The most serious reaction that is due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    interstitial lung disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Risk factors include high cumulative dose, more than 400 milligrams per day, duration over two months, increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", and preexisting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  Some individuals were noted to develop \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary fibrosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " after a week of treatment, while others did not develop it after years of continuous use.  Common practice is to avoid the agent if possible in individuals with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    decreased lung function\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The most specific test of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary toxicity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is a dramatically decreased DLCO noted on pulmonary function testing. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Thyroid Induced abnormalities in thyroid function\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are common. Both under- and overactivity of the thyroid may occur. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is structurally similar to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thyroxine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and  also contains \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iodine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Both of these contribute to the effects of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " on thyroid function. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " also causes an anti-thyroid action, via Wolff–Chaikoff effect, due its large amount of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iodine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in its molecule, which causes a particular &quot;&quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac hypothyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "&quot;&quot; with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Thyroid function should be checked at least every six months. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hypothyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (slowing of the thyroid) occurs frequently; in the SAFE trial, which compared \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " with other medications for the treatment of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", biochemical \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypothyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (as defined by a TSH level of 4.5-10 mU/l) occurred in 25.8% of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone-treated\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " group as opposed to 6.6% of the control group (taking placebo or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sotalol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Overt hypothyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (defined as TSH &gt;10 mU/l) occurred at 5.0% compared to 0.3%; most of these (&gt;90%) were detected within the first six months of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " treatment. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hyperthyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (an overactive thyroid, due to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Jod-Basedow\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " effect) can also occur. However, in the SAFE trial, the increased rate of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperthyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (5.3% compared to 2.4%) was not significant. Most hyperthyroid patients (defined as TSH &lt;0.35 mU/l) were asymptomatic. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Low thyroid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is based on both a high TSH and a low free T4.Thyroid uptake measurements (I-123 or I-131), which are used to differentiate causes of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperthyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", are generally unreliable in patients who have been taking \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Because of the high iodine content of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the thyroid gland is effectively saturated, thus preventing further uptake of isotopes of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iodine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  However, the radioactive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iodine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " uptake (nuclear thyroid uptake test) may still be helpful in the diagnosis and management of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone-induced hyperthyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Eye Corneal micro-deposits (cornea verticillata, also called vortex or whorl \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    keratopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") are almost universally present (over 90%) in individuals taking \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " longer than 6 months, especially doses greater than 400 mg/day.  These deposits typically do not cause any symptoms.  About 1 in 10 individuals may complain of a bluish halo.  Anterior subcapsular lens deposits are relatively common (50%) in higher doses (greater than 600 mg/day) after 6 months of treatment.   \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Optic neuropathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nonarteritic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " anterior \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemic optic neuropathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    N-AION\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), occurs in 1-2% of people and is not dosage dependent. Bilateral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    optic disc swelling\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and mild and reversible \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    visual field defects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can also occur.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Loss of eyelashes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " has been linked to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " use. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Liver Abnormal liver enzyme\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " results are common in patients on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Much rarer are \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    jaundice\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hepatomegaly\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    liver enlargement\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hepatitis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (inflammation of the liver).Low-dose \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has been reported to cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pseudo-alcoholic cirrhosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Skin Long-term administration of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (usually more than eighteen months) is associated with a light-sensitive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blue-grey discoloration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the skin, sometimes called ceruloderma; such patients should avoid exposure to the sun and use sunscreen that protects against \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ultraviolet-A\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "  and -B. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    discoloration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " will slowly improve upon cessation of the medication, however, the skin color may not return completely. Pregnancy and breastfeeding Use during pregnancy may result in a number of problems in the infant including thyroid problems, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart problems\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    neurological problems\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and preterm birth. Use during breastfeeding is generally not recommended though one dose may be okay. Other Long-term use of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has been associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    peripheral neuropathies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is sometimes responsible for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epididymitis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " accumulates in the head of the organ and can cause unilateral or bilateral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inflammation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It tends to resolve if \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is stopped.Some cases of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gynecomastia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " have been reported with men on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".A study published in 2013 showed a possible association between \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and an increased risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", especially in males, with a dose-dependent effect. Interactions The pharmacokinetics of numerous drugs, including many that are commonly administered to individuals with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", are affected by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  Particularly, doses of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    digoxin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " should be halved in individuals taking \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may also interact with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sotalol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " potentiates the action of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    warfarin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " by inhibiting the clearance of both (S) and (R) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    warfarin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  Individuals taking both of these medications should have their \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    warfarin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " doses adjusted based on their dosing of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and have their anticoagulation status (measured as prothrombin time (PT) and international normalized ratio (INR)) measured more frequently. Dose reduction of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    warfarin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is as follows: 40% reduction if \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " dose is 400 mg daily, 35% reduction if \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " dose is 300 mg daily, 30% reduction if \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " dose is 200 mg daily, and 25% reduction if \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " dose is 100 mg daily. The effect of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " on the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    warfarin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " concentrations can be as early as a few days after initiation of treatment; however, the interaction may not peak for up to seven weeks. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " inhibits the action of the cytochrome P450 isozyme family. This reduces the clearance of many drugs, including the following: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ciclosporin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Digoxin Flecainide Procainamide \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Quinidine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Sildenafil \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Simvastatin Theophylline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " WarfarinIn 2015, Gilead Sciences warned health care providers about people that began taking the hepatitis C drugs \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ledipasvir/sofosbuvir\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sofosbuvir\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " along with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", who developed abnormally slow heartbeats or died of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac arrest\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Metabolism \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is extensively metabolized in the liver by cytochrome P450 3A4 and can affect the metabolism of numerous other drugs. It interacts with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    digoxin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    warfarin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    phenytoin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and others. The major metabolite of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    desethylamiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DEA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), which also has antiarrhythmic properties.  The metabolism of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is inhibited by grapefruit juice, leading to elevated serum levels of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". On 8 August 2008, the FDA issued a warning of the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rhabdomyolysis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which can lead to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    kidney failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", when \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    simvastatin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is used with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". This interaction is dose-dependent with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    simvastatin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " doses exceeding 20 mg. This drug combination especially with higher doses of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    simvastatin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " should be avoided. Excretion Excretion is primarily via the liver and the bile duct with almost no elimination via the kidney and it is not dialyzable. Elimination half-life average of 58 days (ranging from 25–100 days [Remington: The Science and Practice of Pharmacy 21st edition]) for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and 36 days for the active metabolite, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    desethylamiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DEA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "). There is 10-50% transfer of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DEA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the placenta as well as a presence in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breast milk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Accumulation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DEA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " occurs in adipose tissue and highly perfused organs (i.e. liver, lungs), therefore, if an individual was taking \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " on a chronic basis, if it is stopped it will remain in the system for weeks to months. Pharmacology \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is categorized as a class III antiarrhythmic agent, and prolongs phase 3 of the cardiac action potential, the repolarization phase where there is normally decreased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " permeability and increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " permeability.  It has numerous other effects, however, including actions that are similar to those of antiarrhythmic classes Ia, II, and IV. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is a blocker of voltage gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (KCNH2) and voltage gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    (CACNA2D2).Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " slows conduction rate and prolongs the refractory period of the SA and AV nodes. It also prolongs the refractory periods of the ventricles, bundles of His, and the Purkinje fibres without exhibiting any effects on the conduction rate. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has been shown to prolong the myocardial cell action potential duration and refractory period and is a non-competitive β-adrenergic inhibitor.It also shows  beta blocker-like and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blocker-like actions on the SA and AV nodes, increases the refractory period via \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium-\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and potassium-channel effects, and slows intra-cardiac conduction of the cardiac action potential, via sodium-channel effects. It is suggested that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may also exacerbate the phenotype associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Long QT-3 syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " causing mutations such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ∆KPQ\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". This effect is due to a combination of blocking the peak \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " current, but also contributing to an increased persistent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " current.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " chemically resembles \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thyroxine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (thyroid hormone), and its binding to the nuclear thyroid receptor might contribute to some of its pharmacologic and toxic actions. History The original observation that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "'s progenitor molecule, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    khellin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", had cardioactive properties, was made by the Russian physiologist Gleb von Anrep while working in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cairo\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in 1946. Khellin is obtained from a plant extract of Khella or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ammi visnaga\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", a common plant in north Africa. Anrep noticed that one of his technicians had been cured of anginal symptoms after taking \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    khellin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", then used for various, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    non-cardiac ailments\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  This led to efforts by European pharmaceutical industries to isolate an active compound. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was initially developed in 1961 at the Labaz company, Belgium, by chemists Tondeur and Binon, who were working on preparations derived from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    khellin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". It became popular in Europe as a treatment for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".As a doctoral candidate at Oxford University, Bramah Singh determined that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sotalol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " had antiarrhythmic properties and belonged to a new class of antiarrhythmic agents (what would become the class III antiarrhythmic agents). Today the mechanisms of action of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sotalol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " have been investigated in more detail. Both drugs have been demonstrated to prolong the duration of the action potential, prolonging the refractory period, by interacting among other cellular function with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    K+\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels. Based on Singh's work, the Argentinian physician Mauricio Rosenbaum began using \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to treat his patients who suffered from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    supraventricular\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", with impressive results.  Based on papers written by Rosenbaum developing Singh's theories, physicians in the United States began prescribing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to their patients with potentially life-threatening \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the late 1970s.  By 1980, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was commonly prescribed throughout Europe for the treatment of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", but in the U.S. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " remained unapproved by the Food and Drug Administration, and physicians were forced to directly obtain \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " from pharmaceutical companies in Canada and Europe.The FDA was reluctant to officially approve the use of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " since initial reports had shown increased incidence of serious pulmonary side-effects of the drug.  In the mid-1980s, the European pharmaceutical companies began putting pressure on the FDA to approve \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " by threatening to cut the supply to American physicians if it was not approved.  In December 1985, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was approved by the FDA for the treatment of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". This makes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " one of the few drugs approved by the FDA without rigorous randomized clinical trials. Name \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may be an acronym for its IUPAC name \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    (2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", where ar is a placeholder for phenyl. This is partially supported by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dronedarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " which is noniodinated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    benzofuran\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " derivative of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", where the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arylmethanone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is conserved. Dosing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is available in oral and intravenous formulations. Orally, it is available under the brand names \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pacerone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (produced by Upsher-Smith Laboratories, Inc.) and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cordarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (produced by Wyeth-Ayerst Laboratories). It is also available under the brand name Aratac (produced by Alphapharm Pty Ltd) in Australia and New Zealand, and further in Australia under the brands Cardinorm and Rithmik as well as a number of generic brands.  Also Arycor in South Africa (Produced by Winthrop Pharmaceuticals.). In South America, it is known as Atlansil and is produced by Roemmers. In India, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is marketed (produced by Cipla Pharmaceutical) under the brand name Tachyra. It is also available in intravenous ampules and vials. The dose of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " administered is tailored to the individual and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dysrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that is being treated.  When administered orally, the bioavailability of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is quite variable.  Absorption ranges from 22 to 95%, with better absorption when it is given with food. Administration \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " IV should be administered via a central venous catheter.  It has a pH of 4.08.  If administered outside of the standard concentration of 900 mg/500mL it should be administered using a 0.22 micron filter to prevent precipitate from reaching the patient.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " IV is a known vesicant. For infusions of longer than 1 hour, concentrations of 2 mg/mL should not be exceeded unless a central venous catheter is used. References Further reading Siddoway \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (December 2003). &quot;&quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ": guidelines for use and monitoring&quot;&quot;. Am Fam Physician. 68 (11): 2189–96. PMID 14677664. External links &quot;&quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "&quot;&quot;. Drug Information Portal. U.S. National Library of Medicine.&quot; &quot;Amniotes are a clade of tetrapod vertebrates that comprise sauropsids (including reptiles and birds) and synapsids (including mammals). They are distinguished by a membrane (amnion) protecting the embryo and a lack of a larval stage. Thanks to this, amniotes lay eggs on land or retain them within the mother, unlike anamniotes (fishes and amphibians), which typically lay eggs in water. Older sources, particularly before the 20th century, may refer to amniotes as &quot;&quot;higher vertebrates&quot;&quot; and anamniotes as &quot;&quot;lower vertebrates&quot;&quot;, based on the antiquated idea of the evolutionary great chain of being. The term amniote comes from the Greek ἀμνίον amnion, &quot;&quot;membrane surrounding the fetus&quot;&quot;, and earlier &quot;&quot;bowl in which the blood of sacrificed animals was caught&quot;&quot;, from  ἀμνός amnos, &quot;&quot;lamb&quot;&quot;.The amnion comprises several extensive membranes. In eutherian mammals (such as humans), these include the amniotic sac that surrounds the fetus. The amnion is a critical divergence within vertebrates that allows the embryos to survive out of the water. This enabled amniotes to reproduce on land and so move into drier environments—free of the need to return to water for reproduction as amphibians. The eggs could also &quot;&quot;breathe&quot;&quot; and cope with wastes, allowing the eggs and individuals to evolve into larger forms.  The first amniotes, referred to as &quot;&quot;basal amniotes&quot;&quot;, resembled small lizards and evolved from the amphibian reptiliomorphs about 312 million years ago, in the Carboniferous geologic period. Amniotes spread around Earth's land and became the dominant land vertebrates. They soon diverged into synapsids and sauropsids, which persist today. The oldest known fossil synapsid is Protoclepsydrops from about 312 million years ago, while the oldest known sauropsid is probably Paleothyris, in the order Captorhinida, from the Middle Pennsylvanian epoch (c. 306–312 million years ago). Description Zoologists characterize amniotes in part by embryonic development that includes the formation of several extensive membranes, the amnion, chorion, and allantois. Amniotes develop directly into a (typically) terrestrial form with limbs and a thick stratified epithelium (rather than first entering a feeding larval tadpole stage followed by metamorphosis, as amphibians do). In amniotes, the transition from a two-layered periderm to a cornified epithelium is triggered by thyroid hormone during embryonic development, rather than by metamorphosis. The unique embryonic features of amniotes may reflect specializations for eggs to survive drier environments; or the increase in size and yolk content of eggs may have permitted, and coevolved with, direct development of the embryo to a large size. Adaptation for terrestrial living Features of amniotes evolved for survival on land include a sturdy but porous leathery or hard eggshell and an allantois that facilitates respiration while providing a reservoir for disposal of wastes. Their kidneys and large intestines are also well-suited to water retention. Most mammals do not lay eggs, but corresponding structures develop inside the placenta. The ancestors of true amniotes, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Casineria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " kiddi, which lived about 340 million years ago, evolved from amphibian reptiliomorphs and resembled small lizards. At the late Devonian mass extinction (360 million years ago), all known tetrapods were essentially aquatic and fish-like. Because the reptiliomorphs were already established 20 million years later when all their fishlike relatives were extinct, it appears they separated from the other tetrapods somewhere during Romer's gap, when the adult tetrapods became fully terrestrial (some forms would later become secondarily aquatic). The modest-sized ancestors of the amniotes laid their eggs in moist places, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depressions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " under fallen logs or other suitable places in the Carboniferous swamps and forests; and dry conditions probably do not account for the emergence of the soft shell. Indeed, many modern-day amniotes require moisture to keep their eggs from desiccating. Although some modern amphibians lay eggs on land, all amphibians lack advanced traits like an amnion. The amniotic egg formed through a series of evolutionary steps. After internal fertilization and the habit of laying eggs in terrestrial environments became a reproduction strategy amongst the amniote ancestors, the next major breakthrough appears to have involved a gradual replacement of the gelatinous coating covering the amphibian egg with a fibrous shell membrane. This allowed the egg to increase both its size and in the rate of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " exchange, permitting a larger, metabolically more active embryo to reach full development before hatching. Further developments, like extraembryonic membranes (amnion, chorion, and allantois) and a calcified shell, were not essential and probably evolved later. It has been suggested that shelled terrestrial eggs without extraembryonic membranes could still not have been more than about 1 cm (0.4 inch) in diameter because of diffusion problems, like the inability to get rid of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " if the egg was larger. The combination of small eggs and the absence of a larval stage, where posthatching growth occurs in anamniotic tetrapods before turning into juveniles, would limit the size of the adults. This is supported by the fact that extant squamate species that lay eggs less than 1 cm in diameter have adults whose snout-vent length is less than 10 cm. The only way for the eggs to increase in size would be to develop new internal structures specialized for respiration and for waste products. As this happened, it would also affect how much the juveniles could grow before they reached adulthood. The egg membranes Fish and amphibian eggs have only one inner membrane, the embryonic membrane. Evolution of the amniote egg required increased exchange of gases and wastes between the embryo and the atmosphere. Structures to permit these traits allowed further adaption that increased the feasible size of amniote eggs and enabled breeding in progressively drier habitats. The increased size of eggs permitted increase in size of offspring and consequently of adults. Further growth for the latter, however, was limited by their position in the terrestrial food-chain, which was restricted to level three and below, with only invertebrates occupying level two. Amniotes would eventually experience adaptive radiations when some species evolved the ability to digest plants and new ecological niches opened up, permitting larger body-size for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    herbivores\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", omnivores and predators. Amniote traits While the early amniotes resembled their amphibian ancestors in many respects, a key difference was the lack of an otic notch at the back margin of the skull roof. In their ancestors, this notch held a spiracle, an unnecessary structure in an animal without an aquatic larval stage. There are three main lines of amniotes, which may be distinguished by the structure of the skull and in particular the number of temporal fenestrae (openings) behind each eye. In anapsids, the ancestral condition, there are none, in synapsids (mammals and their extinct relatives) there is one, and most diapsids (including birds, crocodilians, squamates, and tuataras), have two. Turtles were traditionally classified as anapsids because they lack fenestrae, but molecular testing firmly places them in the diapsid line of descent - they therefore secondarily lost their fenestrae. Post-cranial remains of amniotes can be identified from their Labyrinthodont ancestors by their having at least two pairs of sacral ribs, a sternum in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pectoral girdle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (some amniotes have lost it) and an astragalus bone in the ankle. Definition and classification Amniota was first formally described by the embryologist Ernst Haeckel in 1866 on the presence of the amnion, hence the name. A problem with this definition is that the trait (apomorphy) in question does not fossilize, and the status of fossil forms has to be inferred from other traits. Traditional classification Classifications of the amniotes have traditionally recognised three classes based on major traits and physiology: Class Reptilia (reptiles) Subclass Anapsida (&quot;&quot;proto-reptiles&quot;&quot;, possibly including turtles) Subclass Diapsida (majority of reptiles, progenitors of birds) Subclass Euryapsida (plesiosaurs, placodonts, and ichthyosaurs) Subclass Synapsida (mammal-like reptiles, progenitors of mammals) Class Aves (birds) Subclass Archaeornithes (reptile-like birds, progenitors of all other birds) Subclass Enantiornithes (early birds with an alternative shoulder joint) Subclass \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hesperornithes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (toothed aquatic flightless birds) Subclass Ichthyornithes (toothed, but otherwise modern birds) Subclass Neornithes (all living birds) Class Mammalia (mammals) Subclass Prototheria (Monotremata, egg-laying mammals) Subclass Theria (metatheria (such as marsupials) and eutheria (such as placental mammals))This rather orderly scheme is the one most commonly found in popular and basic scientific works. It has come under critique from cladistics, as the class Reptilia is paraphyletic—it has given rise to two other classes not included in Reptilia. Classification into monophyletic taxa A different approach is adopted by writers who reject paraphyletic groupings. One such classification, by Michael Benton, is presented in simplified form below. Series Amniota Class Synapsida A series of unassigned families, corresponding to Pelycosauria Order Therapsida Class Mammalia – mammals Class Reptilia Subclass Parareptilia Family Mesosauridae † Family Millerettidae † Family Bolosauridae † Family Procolophonidae † Order \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pareiasauromorpha\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Family Nycteroleteridae † Family \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pareiasauridae\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " † Subclass Eureptilia Family Captorhinidae † Infraclass Diapsida Family Araeoscelididae † Family \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Weigeltisauridae\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " † Order Younginiformes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    †\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Infraclass Neodiapsida Order Testudinata Suborder Testudines – turtles Infraclass Lepidosauromorpha \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Unnamed infrasubclass\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Infraclass Ichthyosauria \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    †\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Order Thalattosauria † Superorder Lepidosauriformes Order Sphenodontida – tuatara Order Squamata – lizards &amp; snakes Infrasubclass Sauropterygia † Order Placodontia † Order Eosauropterygia \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    †\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Suborder Pachypleurosauria † Suborder \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nothosauria †\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Order Plesiosauria † Infraclass Archosauromorpha Family Trilophosauridae † Order Rhynchosauria † Order \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Protorosauria †\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Division Archosauriformes Subdivision \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Infradivision Crurotarsi Order Phytosauria† Family Ornithosuchidae † Family \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Stagonolepididae\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " † Family Rauisuchidae † Superfamily Poposauroidea † Superorder Crocodylomorpha Order Crocodylia – crocodilians Infradivision Avemetatarsalia Infrasubdivision Ornithodira Order Pterosauria † Family Lagerpetidae † Family Silesauridae † Superorder Dinosauria – dinosaurs Order Ornithischia † Order Saurischia Suborder Theropoda - theropods Class Aves – birds Phylogenetic classification With the advent of cladistics, other researchers have attempted to establish new classes, based on phylogeny, but disregarding the physiological and anatomical unity of the groups. Unlike Benton, for example, Jacques Gauthier and colleagues forwarded a definition of Amniota in 1988 as &quot;&quot;the most recent common ancestor of extant mammals and reptiles, and all its descendants&quot;&quot;. As Gauthier makes use of a crown group definition, Amniota has a slightly different content than the biological amniotes as defined by an apomorphy. Cladogram The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cladogram\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " presented here illustrates the phylogeny (family tree) of amniotes, and follows a simplified version of the relationships found by Laurin &amp; Reisz (1995), with the exception of turtles, which more recent morphological and molecular phylogenetic studies placed firmly within diapsids. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cladogram\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " covers the group as defined under Gauthier's definition.  == References ==&quot; &quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", also spelled \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and sometimes called \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    erythrocytopenia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", is a decrease in the total amount of red blood cells (RBCs) or hemoglobin in the blood or a lowered ability of the blood to carry \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". When \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " comes on slowly, the symptoms are often vague and may include feeling tired, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    weakness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shortness of breath\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and a poor ability to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ". When the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " comes on quickly, symptoms may include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    confusion\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", feeling like passing out, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    loss of consciousness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thirst\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " must be significant before a person becomes noticeably pale. Additional symptoms may occur depending on the underlying cause. For people who require surgery, pre-operative \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can increase the risk of requiring a blood transfusion following surgery.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be caused by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", decreased red blood cell production, and increased red blood cell breakdown. Causes of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    trauma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Causes of decreased production include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thalassemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and a number of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    neoplasms\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the bone marrow. Causes of increased breakdown include genetic conditions such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sickle cell anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infections\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    malaria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and certain \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    autoimmune diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can also be classified based on the size of the red blood cells and amount of hemoglobin in each cell. If the cells are small, it is called \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    microcytic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; if they are large, it is called \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    macrocytic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; and if they are normal sized, it is called normocytic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The diagnosis of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in men is based on a hemoglobin of less than 130 to 140 g/L (13 to 14 g/dL); in women, it is less than 120 to 130 g/L (12 to 13 g/dL). Further testing is then required to determine the cause.Certain groups of individuals, such as pregnant women, benefit from the use of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " pills for prevention. Dietary supplementation, without determining the specific cause, is not recommended. The use of blood transfusions is typically based on a person's signs and symptoms. In those without symptoms, they are not recommended unless hemoglobin levels are less than 60 to 80 g/L (6 to 8 g/dL). These recommendations may also apply to some people with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Erythropoiesis-stimulating agents are only recommended in those with severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the most common \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood disorder\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", affecting about a third of the global population. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Iron-deficiency anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " affects nearly 1 billion people. In 2013, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency resulted in about 183,000 deaths – down from 213,000 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deaths\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in 1990. This condition is more common in women than men, during pregnancy, and in children and the elderly. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " increases costs of medical care and lowers a person's productivity through a decreased ability to work. The name is derived from Ancient Greek: ἀναιμία anaimia, meaning &quot;&quot;lack of blood&quot;&quot;, from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ἀν- an-\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", &quot;&quot;not&quot;&quot; and αἷμα haima, &quot;&quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood&quot;&quot;.Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is one of the six WHO global nutrition targets for 2025 and diet-related global NCD targets for 2025, endorsed by World Health Assembly in 2012 and 2013. Efforts to reach global targets contribute to reaching Sustainable Development Goals (SDGs), with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as one of the targets in SDG 2. Signs and symptoms \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " goes undetected in many people and symptoms can be minor. The symptoms can be related to an underlying cause or the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " itself. Most commonly, people with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " report feelings of weakness or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatigue\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and sometimes poor concentration. They may also report \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shortness of breath\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on exertion. If the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " continues slowly (chronic), the body may adapt and compensate for this change; in this case, no symptoms may appear until the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " becomes more severe. The typical symptoms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may include: feeling \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tiredness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and weakness feeling like passing out (lightheadedness), or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dizziness headaches\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " lack of physical exertion; extreme \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tiredness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on the slightest exertion (accompanied by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shortness of breath\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and rapid \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heartbeat) breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (rapid) difficulty concentrating irregular heartbeat (fluttering, or rapid heartbeat) cold hands and feet \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " constantly feeling cold soreness of the tongue pallor \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and poor appetite easy \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bruising\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " muscle weaknessIn very severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the body may compensate for the lack of oxygen-carrying capability of the blood by increasing cardiac output.  The person may have symptoms related to this, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (if pre-existing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is present), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    intermittent claudication of the legs\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and symptoms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". On examination, the signs exhibited may include pallor (pale skin, mucosa, conjunctiva and nail beds), but this is not a reliable sign. A blue coloration of the sclera may be noticed in some cases of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron-deficiency anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". There may be signs of specific causes of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    koilonychia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    jaundice\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (when \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " results from abnormal break down of red blood cells – in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hemolytic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nerve cell damage\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bone deformities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (found in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thalassemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " major) or leg ulcers (seen in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sickle-cell disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). In severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", there may be signs of a hyperdynamic circulation: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (a fast heart rate), bounding pulse, flow murmurs, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac ventricular hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (enlargement).  There may be signs of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Pica, the consumption of non-food items such as ice, but also paper, wax, or grass, and even hair or dirt, may be a symptom of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency, although it occurs often in those who have normal levels of hemoglobin. Chronic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may result in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    behavioral disturbances\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in children as a direct result of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    impaired neurological development\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in infants, and reduced academic performance in children of school \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Restless legs syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is more common in people with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron-deficiency anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " than in the general population. Causes The causes of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be classified as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    impaired red blood cell (RBC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") production, increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    RBC destruction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hemolytic anemias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and fluid overload (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypervolemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). Several of these may interplay to cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The most common cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", but this usually does not cause any lasting symptoms unless a relatively impaired RBC production develops, in turn, most commonly by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Impaired production Disturbance of proliferation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and differentiation of stem cells Pure red cell aplasia Aplastic anemia affects all kinds of blood cells. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Fanconi anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hereditary disorder\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or defect featuring \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aplastic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and various other abnormalities. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    kidney failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " due to insufficient production of the hormone erythropoietin \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    endocrine disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Disturbance of proliferation and maturation of erythroblasts \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pernicious anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a form of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    megaloblastic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency dependent on impaired absorption of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Lack of dietary B12 causes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    non-pernicious megaloblastic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    folate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency, as with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", causes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    megaloblastic anemia Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    prematurity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", by diminished erythropoietin response to declining hematocrit levels, combined with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from laboratory testing, generally occurs in premature infants at two to six weeks of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", resulting in deficient heme synthesis \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Thalassemias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", causing deficient globin synthesis \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Congenital dyserythropoietic anemias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", causing ineffective erythropoiesis \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia of kidney failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (also causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stem cell dysfunction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") Other mechanisms of impaired RBC production Myelophthisic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myelophthisis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a severe type of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " resulting from the replacement of bone marrow by other materials, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    malignant tumors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fibrosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    granulomas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Myelodysplastic syndrome anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic inflammation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Leukoerythroblastic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is caused by space-occupying lesions in the bone marrow that prevent normal production of blood cells. Increased destruction \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of increased red blood cell destruction are generally classified as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hemolytic anemias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". These are generally featuring \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    jaundice\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and elevated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lactate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " dehydrogenase levels. Intrinsic (intracorpuscular) abnormalities cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    premature destruction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". All of these, except paroxysmal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nocturnal hemoglobinuria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", are hereditary genetic disorders.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hereditary spherocytosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a hereditary defect that results in defects in the RBC cell membrane, causing the erythrocytes to be sequestered and destroyed by the spleen. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hereditary elliptocytosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is another defect in membrane skeleton proteins. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Abetalipoproteinemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", causing defects in membrane lipids Enzyme deficiencies \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pyruvate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " kinase and hexokinase deficiencies, causing defect glycolysis Glucose-6-phosphate dehydrogenase deficiency and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glutathione\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " synthetase deficiency, causing increased oxidative \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress Hemoglobinopathies Sickle cell anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Hemoglobinopathies causing unstable hemoglobins Paroxysmal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nocturnal hemoglobinuria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Extrinsic (extracorpuscular) abnormalities Antibody-mediated Warm \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    autoimmune hemolytic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is caused by autoimmune attack against red blood cells, primarily by IgG. It is the most common of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    autoimmune hemolytic diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It can be \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    idiopathic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", that is, without any known cause, drug-associated or secondary to another disease such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    systemic lupus erythematosus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    malignancy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic lymphocytic leukemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cold agglutinin hemolytic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is primarily mediated by IgM. It can be \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    idiopathic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or result from an underlying condition. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Rh disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", one of the causes of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hemolytic disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the newborn Transfusion reaction to blood transfusions Mechanical \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    trauma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to red blood cells \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Microangiopathic hemolytic anemias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombotic thrombocytopenic purpura\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and disseminated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    intravascular coagulation Infections\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    malaria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Heart surgery Haemodialysis \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Blood loss Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    prematurity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", from frequent blood sampling for laboratory testing, combined with insufficient RBC production \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Trauma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or surgery, causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute blood loss Gastrointestinal tract\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " lesions, causing either \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute bleeds\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    variceal lesions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", peptic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ulcers\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic blood loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiodysplasia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") Gynecologic disturbances, also generally causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic blood loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " From menstruation, mostly among young women or older women who have \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fibroids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Many type of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancers\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colorectal cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer of the urinary bladder\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", may cause acute or chronic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", especially at advanced stages \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    intestinal nematodes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " feeding on blood, such as hookworms and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    whipworm Trichuris trichiura  \n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "Iatrogenic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from repeated blood draws and medical procedures.The roots of the words \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " both refer to the basic idea of &quot;&quot;lack of blood&quot;&quot;, but \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are not the same thing in modern medical terminology. The word \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " used alone implies widespread effects from blood that either is too scarce (e.g., \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") or is dysfunctional in its oxygen-supplying ability (due to whatever type of hemoglobin or erythrocyte problem). In contrast, the word \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " refers solely to the lack of blood (poor perfusion). Thus \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in a body part can cause localized anemic effects within those tissues. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Fluid overload Fluid overload\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypervolemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") causes decreased hemoglobin concentration and apparent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ": General causes of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypervolemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " include excessive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or fluid intake, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or water retention and fluid shift into the intravascular space. From the 6th week of pregnancy, hormonal changes cause an increase in the mother's blood volume due to an increase in plasma. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Intestinal inflammation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Certain \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal disorders\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The mechanisms involved are multifactorial and not limited to malabsorption but mainly related to chronic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    intestinal inflammation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which causes dysregulation of hepcidin that leads to decreased access of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to the circulation. Helicobacter \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pylori infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gluten-related disorders\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ": untreated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    celiac disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    non-celiac gluten\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " sensitivity. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be the only manifestation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    celiac disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", in absence of gastrointestinal or any other symptoms. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Inflammatory bowel disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Diagnosis Definitions There are a number of definitions of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; reviews provide comparison and contrast of them. A strict but broad definition is an absolute decrease in red blood cell mass, however, a broader definition is a lowered ability of the blood to carry \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". An operational definition is a decrease in whole-blood hemoglobin concentration of more than 2 standard deviations below the mean of an age- and sex-matched reference range.It is difficult to directly measure RBC mass, so the hematocrit (amount of RBCs) or the hemoglobin (Hb) in the blood are often used instead to indirectly estimate the value. Hematocrit; however, is concentration dependent and is therefore not completely accurate. For example, during pregnancy a woman's RBC mass is normal but because of an increase in blood volume the hemoglobin and hematocrit are diluted and thus decreased. Another example would be \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " where the RBC mass would decrease but the concentrations of hemoglobin and hematocrit initially remains normal until fluids shift from other areas of the body to the intravascular space.The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is also classified by severity into mild (110 g/L to normal), moderate (80 g/L to 110 g/L), and severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (less than 80 g/L) in adult males and adult non pregnant females. Different values are used in pregnancy and children. Testing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is typically diagnosed on a complete blood count. Apart from reporting the number of red blood cells and the hemoglobin level, the automatic counters also measure the size of the red blood cells by flow cytometry, which is an important tool in distinguishing between the causes of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Examination of a stained blood smear using a microscope can also be helpful, and it is sometimes a necessity in regions of the world where automated analysis is less accessible. A blood test will provide counts of white blood cells, red blood cells and platelets. If \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " appears, further tests may determine what type it is, and whether it has a serious cause. although of that, it is possible to refer to the genetic history and physical diagnosis. These tests may include: complete blood count (CBC); a CBC is used to count the number of blood cells in a sample of the blood. For \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", it will likely to be interested in the levels of the red blood cells contained in blood (hematocrit), hemoglobin,  mean corpuscular volume. determine the size and shape of red blood cells; some of red blood cells might also be examined for unusual size, shape and color. serum ferritin; This protein helps store \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the body, a low levels of ferritin usually indicates a low levels of stored \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". serum \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "; low levels usually develop an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is needed to make red blood cells, which carry \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to all parts of human body. blood tests to detect rare causes; such as an immune attack on red blood cells, red blood cell fragility, and defects of enzymes, hemoglobin, and clotting. a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bone marrow sample\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; when the cause is unclear, a bone marrow test is performed, most often, when some blood cell defect is suspected.Reticulocyte counts, and the &quot;&quot;kinetic&quot;&quot; approach to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", have become more common than in the past in the large medical centers of the United States and some other wealthy nations, in part because some automatic counters now have the capacity to include reticulocyte counts. A reticulocyte count is a quantitative measure of the bone marrow's production of new red blood cells.  The reticulocyte production index is a calculation of the ratio between the level of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and the extent to which the reticulocyte count has risen in response. If the degree of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is significant, even a &quot;&quot;normal&quot;&quot; reticulocyte count actually may reflect an inadequate response. If an automated count is not available, a reticulocyte count can be done manually following special staining of the blood film. In manual examination, activity of the bone marrow can also be gauged qualitatively by subtle changes in the numbers and the morphology of young RBCs by examination under a microscope. Newly formed RBCs are usually slightly larger than older RBCs and show polychromasia. Even where the source of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is obvious, evaluation of erythropoiesis can help assess whether the bone marrow will be able to compensate for the loss and at what rate. When the cause is not obvious, clinicians use other tests, such as: ESR, serum \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", transferrin, RBC \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    folate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " level, hemoglobin electrophoresis, renal function tests (e.g. serum \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    creatinine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") although the tests will depend on the clinical hypothesis that is being investigated. When the diagnosis remains difficult, a bone marrow examination allows direct examination of the precursors to red cells, although is rarely used as is painful, invasive and is hence reserved for cases where severe pathology needs to be determined or excluded. Red blood cell size In the morphological approach, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is classified by the size of red blood cells; this is either done automatically or on microscopic examination of a peripheral blood smear. The size is reflected in the mean corpuscular volume (MCV). If the cells are smaller than normal (under 80 fl), the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is said to be \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    microcytic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; if they are normal size (80–100 fl), normocytic; and if they are larger than normal (over 100 fl), the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is classified as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    macrocytic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". This scheme quickly exposes some of the most common causes of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; for instance, a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    microcytic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is often the result of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency. In clinical workup, the MCV will be one of the first pieces of information available, so even among clinicians who consider the &quot;&quot;kinetic&quot;&quot; approach more useful philosophically, morphology will remain an important element of classification and diagnosis. Limitations of MCV include cases where the underlying cause is due to a combination of factors – such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency (a cause of microcytosis) and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency (a cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    macrocytosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") where the net result can be normocytic cells. Production vs. destruction or loss The &quot;&quot;kinetic&quot;&quot; approach to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " yields arguably the most clinically relevant classification of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". This classification depends on evaluation of several hematological parameters, particularly the blood reticulocyte (precursor of mature RBCs) count. This then yields the classification of defects by decreased RBC production versus increased RBC destruction or loss. Clinical signs of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    loss or destruction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " include abnormal peripheral blood smear with signs of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hemolysis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; elevated LDH suggesting cell destruction; or clinical signs of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", such as guaiac-positive stool, radiographic findings, or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    frank bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The following is a simplified schematic of this approach: * For instance, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sickle cell anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with superimposed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic gastric bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    folate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency; and other instances of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with more than one cause.** Confirm by repeating reticulocyte count: ongoing combination of low reticulocyte production index, normal MCV and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hemolysis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or loss may be seen in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bone marrow failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", with superimposed or related \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hemolysis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Here is a schematic representation of how to consider \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with MCV as the starting point: Other characteristics visible on the peripheral smear may provide valuable clues about a more specific diagnosis; for example, abnormal white blood cells may point to a cause in the bone marrow. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Microcytic Microcytic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is primarily a result of hemoglobin synthesis \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    failure/insufficiency\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which could be caused by several etiologies: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the most common type of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " overall and it has many causes. RBCs often appear hypochromic (paler than usual) and microcytic (smaller than usual) when viewed with a microscope. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is due to insufficient dietary intake or absorption of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to meet the body's needs. Infants, toddlers, and pregnant women have higher than average needs. Increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " intake is also needed to offset blood losses due to digestive tract issues, frequent blood donations, or heavy menstrual periods.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is an essential part of hemoglobin, and low \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels result in decreased incorporation of hemoglobin into red blood cells. In the United States, 12% of all women of childbearing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " have \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency, compared with only 2% of adult men. The incidence is as high as 20% among African American and Mexican American women. Studies have shown \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency without \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " causes poor school performance and lower IQ in teenage girls, although this may be due to socioeconomic factors.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency is the most prevalent deficiency state on a worldwide basis.  It is sometimes the cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abnormal fissuring\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the angular (corner) sections of the lips (angular stomatitis). In the United States, the most common cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", usually from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal tract\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Fecal occult blood testing\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", upper endoscopy and lower endoscopy should be performed to identify \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " lesions. In older men and women, the chances are higher that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal tract\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " could be due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colon polyps\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colorectal cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Worldwide, the most common cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is parasitic infestation (hookworms, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amebiasis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    schistosomiasis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    whipworms).The\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Mentzer index (mean cell volume divided by the RBC count) predicts whether \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    microcytic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thalassemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", although it requires confirmation. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Macrocytic Megaloblastic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the most common cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    macrocytic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", is due to a deficiency of either \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    folic acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", or both. Deficiency in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    folate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can be due either to inadequate intake or insufficient absorption. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Folate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency normally does not produce \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    neurological symptoms\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", while \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    B12 deficiency\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " does. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pernicious anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is caused by a lack of intrinsic factor, which is required to absorb \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " from food. A lack of intrinsic factor may arise from an autoimmune condition targeting the parietal cells (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrophic gastritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") that produce intrinsic factor or against intrinsic factor itself. These lead to poor absorption of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Macrocytic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can also be caused by the removal of the functional portion of the stomach, such as during gastric bypass surgery, leading to reduced \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12/folate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " absorption. Therefore, one must always be aware of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " following this procedure. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hypothyroidism Alcoholism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " commonly causes a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    macrocytosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", although not specifically \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Other types of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    liver disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can also cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    macrocytosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Drugs such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    methotrexate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    zidovudine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and other substances may inhibit DNA replication such as heavy metalsMacrocytic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be further divided into &quot;&quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    megaloblastic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "&quot;&quot; or &quot;&quot;nonmegaloblastic macrocytic anemia&quot;&quot;. The cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    megaloblastic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is primarily a failure of DNA synthesis with preserved RNA synthesis, which results in restricted cell division of the progenitor cells. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    megaloblastic anemias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " often present with neutrophil \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypersegmentation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (six to 10 lobes). The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nonmegaloblastic macrocytic anemias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " have different \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    etiologies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (i.e. unimpaired DNA globin synthesis,) which occur, for example, in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    alcoholism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In addition to the nonspecific symptoms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", specific features of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    peripheral neuropathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and subacute combined degeneration of the cord with resulting balance difficulties from posterior column spinal cord pathology. Other features may include a smooth, red tongue and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glossitis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The treatment for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12-deficient anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was first devised by William Murphy, who bled dogs to make them anemic, and then fed them various substances to see what (if anything) would make them healthy again. He discovered that ingesting large amounts of liver seemed to cure the disease. George Minot and George Whipple then set about to isolate the curative substance chemically and ultimately were able to isolate the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " from the liver. All three shared the 1934 Nobel Prize in Medicine. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Normocytic Normocytic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " occurs when the overall hemoglobin levels are decreased, but the red blood cell size (mean corpuscular volume) remains normal. Causes include: Dimorphic A dimorphic appearance on a peripheral blood smear occurs when there are two simultaneous populations of red blood cells, typically of different size and hemoglobin content (this last feature affecting the color of the red blood cell on a stained peripheral blood smear). For example, a person recently transfused for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency would have small, pale, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficient red blood cells (RBCs) and the donor RBCs of normal size and color. Similarly, a person transfused for severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    folate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency would have two cell populations, but, in this case, the patient's RBCs would be larger and paler than the donor's RBCs. A person with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sideroblastic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (a defect in heme synthesis, commonly caused by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    alcoholism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", but also drugs/toxins, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nutritional deficiencies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a few acquired and rare \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") can have a dimorphic smear from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sideroblastic anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " alone. Evidence for multiple causes appears with an elevated RBC distribution width (RDW), indicating a wider-than-normal range of red cell sizes, also seen in common \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nutritional anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Heinz body \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Heinz bodies form in the cytoplasm of RBCs and appear as small dark dots under the microscope. In animals, Heinz body \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " has many causes. It may be \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    drug-induced\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", for example in cats and dogs by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acetaminophen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    paracetamol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), or may be caused by eating various plants or other substances: In cats and dogs after eating either raw or cooked plants from the genus Allium, for example, onions or garlic. In dogs after ingestion of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    zinc\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", for example, after eating U.S. pennies minted after 1982. In horses which eat dry or wilted red maple leaves. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hyperanemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Hyperanemia is a severe form of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", in which the hematocrit is below 10%. Refractory \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Refractory \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " which does not respond to treatment, is often seen secondary to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myelodysplastic syndromes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may also be refractory as a manifestation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal problems\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " which disrupt \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " absorption or cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    occult bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Transfusion dependent Transfusion dependent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a form of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " where ongoing blood transfusion are required. Most people with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myelodysplastic syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " develop this state at some point in time. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Beta thalassemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may also result in transfusion dependence. Concerns from repeated blood transfusions include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " overload. This \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " overload may require chelation therapy. Treatment Treatment for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " depends on cause and severity. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Vitamin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " supplements given orally (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    folic acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") or intramuscularly (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vitamin B12\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") will replace specific deficiencies. Oral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Nutritional \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency is common in developing nations. An estimated two-thirds of children and of women of childbearing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " in most developing nations are estimated to have \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency without \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; one-third of them have \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency due to inadequate dietary \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " intake is rare in men and postmenopausal women. The diagnosis of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency mandates a search for potential sources of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ulcers\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    colon cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Mild to moderate \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron-deficiency anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is treated by oral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " supplementation with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ferrous sulfate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ferrous fumarate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ferrous gluconate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  Daily \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " supplements have been shown to be effective in reducing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in women of childbearing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ".  When taking \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " supplements, stomach upset or darkening of the feces are commonly experienced.  The stomach upset can be alleviated by taking the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " with food; however, this decreases the amount of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " absorbed.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Vitamin C\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " aids in the body's ability to absorb \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", so taking oral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " supplements with orange juice is of benefit.In the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic kidney disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", recombinant erythropoietin or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epoetin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " alfa is recommended to stimulate RBC production, and if \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inflammation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are also present, concurrent parenteral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is also recommended. Injectable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " In cases where oral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has either proven ineffective, would be too slow (for example, pre-operatively), or where absorption is impeded (for example in cases of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inflammation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), parenteral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " preparations can be used. Parenteral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can improve \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " stores rapidly and is also effective for treating people with postpartum \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    haemorrhage\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inflammatory bowel disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The body can absorb up to 6 mg \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " daily from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal tract\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In many cases, the patient has a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deficit of over\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " 1,000 mg of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " which would require several months to replace. This can be given concurrently with erythropoietin to ensure sufficient \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " for increased rates of erythropoiesis. Blood transfusions Blood transfusions in those without symptoms is not recommended until the hemoglobin is below 60 to 80 g/L (6 to 8 g/dL). In those with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " who are not actively \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " transfusions are only recommended when the hemoglobin is below 70 to 80g/L (7 to 8 g/dL). Transfusing earlier does not improve survival. Transfusions otherwise should only be undertaken in cases of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiovascular instability\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".A 2012 review concluded that when considering blood transfusions for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in people with advanced \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " who have \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatigue\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (not related to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " treatment or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    haemorrhage\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), consideration should be given to whether there are alternative strategies can be tried before a blood transfusion. Erythropoiesis-stimulating agents The objective for the administration of an erythropoiesis-stimulating agent (ESA) is to maintain hemoglobin at the lowest level that both minimizes transfusions and meets the individual person's needs. They should not be used for mild or moderate \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". They are not recommended in people with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic kidney disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " unless hemoglobin levels are less than 10 g/dL or they have symptoms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Their use should be along with parenteral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The 2020 Cochrane Anaesthesia Review Group review of Erythropoietin plus \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " versus control treatment including placebo or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " for preoperative anaemic adults undergoing non‐cardiac surgery  demonstrated that patients were much less likely to require red cell transfusion and in those transfused, the volumes were unchanged (mean difference -0.09, 95% CI -0.23 to 0.05). Pre-op Hb concentration was increased in those receiving 'high dose' EPO, but not 'low dose'. Hyperbaric \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Treatment of exceptional \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") is recognized as an indication for hyperbaric \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HBO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") by the Undersea and Hyperbaric Medical Society. The use of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HBO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is indicated when \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " delivery to tissue is not sufficient in patients who cannot be given blood transfusions for medical or religious reasons. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HBO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may be used for medical reasons when threat of blood product incompatibility or concern for transmissible disease are factors. The beliefs of some religions (ex: Jehovah's Witnesses) may require they use the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HBO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " method. A 2005 review of the use of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HBO\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " found all publications reported positive results. Pre-operative \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " An estimated 30% of adults who require non-cardiac surgery have \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In order to determine an appropriate pre-operative treatment, it is suggested that the cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " be first determined. There is moderate level medical evidence that supports a combination of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " supplementation and erythropoietin treatment to help reduce the requirement for red blood cell transfusions after surgery in those who have pre-operative \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Epidemiology A moderate degree of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron-deficiency anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " affected approximately 610 million people worldwide or 8.8% of the population. It is slightly more common in females (9.9%) than males (7.8%). Mild \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deficiency \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " affects another 375 million. Severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is prevalent globally, and especially in sub-Saharan Africa where it is associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infections\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    malaria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and invasive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bacterial infections\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". History Signs of severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in human bones from 4000 years ago have been uncovered in Thailand. Notes References External links &quot;&quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "&quot;&quot;. MedlinePlus. U.S. National Library of Medicine. &quot;&quot;The case for action on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anemia-\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " leave no one behind&quot;&quot;. devex.com. &quot;&quot;Interventions by global target&quot;&quot;. WHO.int.&quot; &quot;Amphibians are ectothermic, tetrapod vertebrates of the class Amphibia. All living amphibians belong to the group Lissamphibia. They inhabit a wide variety of habitats, with most species living within terrestrial, fossorial, arboreal or freshwater aquatic ecosystems. Thus amphibians typically start out as larvae living in water, but some species have developed behavioural adaptations to bypass this. The young generally undergo metamorphosis from larva with gills to an adult air-breathing form with lungs. Amphibians use their skin as a secondary respiratory surface and some small terrestrial salamanders and frogs lack lungs and rely entirely on their skin. They are superficially similar to lizards but, along with mammals and birds, reptiles are amniotes and do not require water bodies in which to breed. With their complex reproductive needs and permeable skins, amphibians are often ecological indicators; in recent decades there has been a dramatic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    decline in amphibian populations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " for many species around the globe. The earliest amphibians evolved in the Devonian period from sarcopterygian fish with lungs and bony-limbed fins, features that were helpful in adapting to dry land. They diversified and became dominant during the Carboniferous and Permian periods, but were later displaced by reptiles and other vertebrates. Over time, amphibians shrank in size and decreased in diversity, leaving only the modern subclass Lissamphibia. The three modern orders of amphibians are Anura (the frogs), Urodela (the salamanders), and Apoda (the caecilians). The number of known amphibian species is approximately 8,000, of which nearly 90% are frogs. The smallest amphibian (and vertebrate) in the world is a frog from New Guinea (Paedophryne amauensis) with a length of just 7.7 mm (0.30 in). The largest living amphibian is the 1.8 m (5 ft 11 in) South China giant salamander (Andrias \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sligoi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), but this is dwarfed by the extinct 9 m (30 ft) Prionosuchus from the middle Permian of Brazil. The study of amphibians is called batrachology, while the study of both reptiles and amphibians is called herpetology. Classification The word amphibian is derived from the Ancient Greek term ἀμφίβιος (amphíbios), which means 'both kinds of life', \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ἀμφί\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " meaning 'of both kinds' and βιος meaning 'life'. The term was initially used as a general adjective for animals that could live on land or in water, including seals and otters. Traditionally, the class Amphibia includes all tetrapod vertebrates that are not amniotes. Amphibia in its widest sense (sensu lato) was divided into three subclasses, two of which are extinct: Subclass Lepospondyli† (small Paleozoic group, which are more closely related to amniotes than Lissamphibia) Subclass Temnospondyli† (diverse Paleozoic and early Mesozoic grade) Subclass Lissamphibia (all modern amphibians, including frogs, toads, salamanders, newts and caecilians) Salientia (frogs, toads and relatives): Jurassic to present—7,360 current species in 53 families Caudata (salamanders, newts and relatives): Jurassic to present—764 current species in 9 families Gymnophiona (caecilians and relatives): Jurassic to present—215 current species in 10 families Allocaudata†  (Albanerpetontidae) Middle Jurassic - Early Pleistocene The actual number of species in each group depends on the taxonomic classification followed. The two most common systems are the classification adopted by the website AmphibiaWeb, University of California, Berkeley and the classification by herpetologist Darrel Frost and the American Museum of Natural History, available as the online reference database &quot;&quot;Amphibian Species of the World&quot;&quot;. The numbers of species cited above follows Frost and the total number of known amphibian species as of March 31, 2019 is exactly 8,000, of which nearly 90% are frogs.With the phylogenetic classification, the taxon \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Labyrinthodontia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has been discarded as it is a polyparaphyletic group without unique defining features apart from shared primitive characteristics. Classification varies according to the preferred phylogeny of the author and whether they use a stem-based or a node-based classification. Traditionally, amphibians as a class are defined as all tetrapods with a larval stage, while the group that includes the common ancestors of all living amphibians (frogs, salamanders and caecilians) and all their descendants is called Lissamphibia. The phylogeny of Paleozoic amphibians is uncertain, and Lissamphibia may possibly fall within extinct groups, like the Temnospondyli (traditionally placed in the subclass Labyrinthodontia) or the Lepospondyli, and in some analyses even in the amniotes. This means that advocates of phylogenetic nomenclature have removed a large number of basal Devonian and Carboniferous amphibian-type tetrapod groups that were formerly placed in Amphibia in Linnaean taxonomy, and included them elsewhere under cladistic taxonomy. If the common ancestor of amphibians and amniotes is included in Amphibia, it becomes a paraphyletic group.All modern amphibians are included in the subclass Lissamphibia, which is usually considered a clade, a group of species that have evolved from a common ancestor. The three modern orders are Anura (the frogs), Caudata (or Urodela, the salamanders), and Gymnophiona (or Apoda, the caecilians). It has been suggested that salamanders arose separately from a Temnospondyl-like ancestor, and even that caecilians are the sister group of the advanced reptiliomorph amphibians, and thus of amniotes. Although the fossils of several older proto-frogs with primitive characteristics are known, the oldest &quot;&quot;true frog&quot;&quot; is Prosalirus bitis, from the Early Jurassic Kayenta Formation of Arizona. It is anatomically very similar to modern frogs. The oldest known caecilian is another Early Jurassic species, Eocaecilia micropodia, also from Arizona. The earliest salamander is Beiyanerpeton jianpingensis from the Late Jurassic of northeastern China.Authorities disagree as to whether Salientia is a superorder that includes the order Anura, or whether Anura is a sub-order of the order Salientia. The Lissamphibia are traditionally divided into three orders, but an extinct salamander-like family, the Albanerpetontidae, is now considered part of Lissamphibia alongside the superorder Salientia. Furthermore, Salientia includes all three recent orders plus the Triassic proto-frog, Triadobatrachus. Evolutionary history The first major groups of amphibians developed in the Devonian period, around 370 million years ago, from lobe-finned fish which were similar to the modern coelacanth and lungfish. These ancient lobe-finned fish had evolved multi-jointed leg-like fins with digits that enabled them to crawl along the sea bottom. Some fish had developed primitive lungs that help them breathe air when the stagnant pools of the Devonian swamps were low in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". They could also use their strong fins to hoist themselves out of the water and onto dry land if circumstances so required. Eventually, their bony fins would evolve into limbs and they would become the ancestors to all tetrapods, including modern amphibians, reptiles, birds, and mammals. Despite being able to crawl on land, many of these prehistoric tetrapodomorph fish still spent most of their time in the water. They had started to develop lungs, but still breathed predominantly with gills.Many examples of species showing transitional features have been discovered. Ichthyostega was one of the first primitive amphibians, with nostrils and more efficient lungs. It had four sturdy limbs, a neck, a tail with fins and a skull very similar to that of the lobe-finned fish, Eusthenopteron. Amphibians evolved adaptations that allowed them to stay out of the water for longer periods. Their lungs improved and their skeletons became heavier and stronger, better able to support the weight of their bodies on land. They developed &quot;&quot;hands&quot;&quot; and &quot;&quot;feet&quot;&quot; with five or more digits; the skin became more capable of retaining body fluids and resisting desiccation. The fish's hyomandibula bone in the hyoid region behind the gills diminished in size and became the stapes of the amphibian ear, an adaptation necessary for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hearing on dry\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " land. An affinity between the amphibians and the teleost fish is the multi-folded structure of the teeth and the paired supra-occipital bones at the back of the head, neither of these features being found elsewhere in the animal kingdom. At the end of the Devonian period (360 million years ago), the seas, rivers and lakes were teeming with life while the land was the realm of early plants and devoid of vertebrates, though some, such as Ichthyostega, may have sometimes hauled themselves out of the water. It is thought they may have propelled themselves with their forelimbs, dragging their hindquarters in a similar manner to that used by the elephant seal. In the early Carboniferous (360 to 345 million years ago), the climate became wet and warm. Extensive swamps developed with mosses, ferns, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    horsetails\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and calamites. Air-breathing arthropods evolved and invaded the land where they provided food for the carnivorous amphibians that began to adapt to the terrestrial environment. There were no other tetrapods on the land and the amphibians were at the top of the food chain, occupying the ecological position currently held by the crocodile. Though equipped with limbs and the ability to breathe air, most still had a long tapering body and strong tail. They were the top land predators, sometimes reaching several metres in length, preying on the large insects of the period and the many types of fish in the water. They still needed to return to water to lay their shell-less eggs, and even most modern amphibians have a fully \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aquatic larval stage with gills like their\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " fish ancestors. It was the development of the amniotic egg, which prevents the developing embryo from drying out, that enabled the reptiles to reproduce on land and which led to their dominance in the period that followed.After the Carboniferous rainforest collapse amphibian dominance gave way to reptiles, and amphibians were further devastated by the Permian–Triassic extinction event. During the Triassic Period (250 to 200 million years ago), the reptiles continued to out-compete the amphibians, leading to a reduction in both the amphibians' size and their importance in the biosphere. According to the fossil record, Lissamphibia, which includes all modern amphibians and is the only surviving lineage, may have branched off from the extinct groups Temnospondyli and Lepospondyli at some period between the Late Carboniferous and the Early Triassic. The relative scarcity of fossil evidence precludes precise dating, but the most recent molecular study, based on multilocus sequence typing, suggests a Late Carboniferous/Early Permian origin for extant amphibians. The origins and evolutionary relationships between the three main groups of amphibians is a matter of debate. A 2005 molecular phylogeny, based on rDNA analysis, suggests that salamanders and caecilians are more closely related to each other than they are to frogs. It also appears that the divergence of the three groups took place in the Paleozoic or early Mesozoic (around 250 million years ago), before the breakup of the supercontinent Pangaea and soon after their divergence from the lobe-finned fish. The briefness of this period, and the swiftness with which radiation took place, would help account for the relative scarcity of primitive amphibian fossils. There are large gaps in the fossil record, but the discovery of a Gerobatrachus hottoni from the Early Permian in Texas in 2008 provided a missing link with many of the characteristics of modern frogs. Molecular analysis suggests that the frog–salamander divergence took place considerably earlier than the palaeontological evidence indicates. Newer research indicates that the common ancestor of all Lissamphibians lived about 315 million years ago, and that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stereospondyls\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are the closest relatives to the caecilians.As they evolved from lunged fish, amphibians had to make certain adaptations for living on land, including the need to develop new means of locomotion. In the water, the sideways thrusts of their tails had propelled them forward, but on land, quite different mechanisms were required. Their vertebral columns, limbs, limb girdles and musculature needed to be strong enough to raise them off the ground for locomotion and feeding. Terrestrial adults discarded their lateral line systems and adapted their sensory systems to receive stimuli via the medium of the air. They needed to develop new methods to regulate their body heat to cope with fluctuations in ambient temperature. They developed behaviours suitable for reproduction in a terrestrial environment. Their skins were exposed to harmful ultraviolet rays that had previously been absorbed by the water. The skin changed to become more protective and prevent excessive water loss. Characteristics The superclass Tetrapoda is divided into four classes of vertebrate animals with four limbs. Reptiles, birds and mammals are amniotes, the eggs of which are either laid or carried by the female and are surrounded by several membranes, some of which are impervious. Lacking these membranes, amphibians require water bodies for reproduction, although some species have developed various strategies for protecting or bypassing the vulnerable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aquatic larval stage\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". They are not found in the sea with the exception of one or two frogs that live in brackish water in mangrove swamps; the Anderson's salamander meanwhile occurs in brackish or salt water lakes. On land, amphibians are restricted to moist habitats because of the need to keep their skin damp.Modern amphibians have a simplified anatomy compared to their ancestors due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    paedomorphosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", caused by two evolutionary trends: miniaturization and an unusually large genome, which result in a slower growth and development rate compared to other vertebrates. Another reason for their size is associated with their rapid metamorphosis, which seems to have evolved only in the ancestors of lissamphibia; in all other known lines the development was much more gradual. Because a remodeling of the feeding apparatus means they don't eat during the metamorphosis, the metamorphosis has to go faster the smaller the individual is, so it happens at an early stage when the larvae are still small. (The largest species of salamanders don't go through a metamorphosis.) Amphibians that lay eggs on land often go through the whole metamorphosis inside the egg. An anamniotic terrestrial egg is less than 1 cm in diameter due to diffusion problems, a size which puts a limit on the amount of posthatching growth.The smallest amphibian (and vertebrate) in the world is a microhylid frog from New Guinea (Paedophryne amauensis) first discovered in 2012. It has an average length of 7.7 mm (0.30 in) and is part of a genus that contains four of the world's ten smallest frog species. The largest living amphibian is the 1.8 m (5 ft 11 in) Chinese giant salamander (Andrias davidianus) but this is a great deal smaller than the largest amphibian that ever existed—the extinct 9 m (30 ft) Prionosuchus, a crocodile-like temnospondyl dating to 270 million years ago from the middle Permian of Brazil. The largest frog is the African Goliath frog (Conraua goliath), which can reach 32 cm (13 in) and weigh 3 kg (6.6 lb).Amphibians are ectothermic (cold-blooded) vertebrates that do not maintain their body temperature through internal physiological processes. Their metabolic rate is low and as a result, their food and energy requirements are limited. In the adult state, they have \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tear ducts\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and movable eyelids, and most species have ears that can detect airborne or ground vibrations. They have muscular tongues, which in many species can be protruded. Modern amphibians have fully ossified vertebrae with articular processes. Their ribs are usually short and may be fused to the vertebrae. Their skulls are mostly broad and short, and are often incompletely ossified. Their skin contains little keratin and lacks scales, apart from a few fish-like scales in certain caecilians. The skin contains many mucous glands and in some species, poison glands (a type of granular gland). The hearts of amphibians have three chambers, two atria and one ventricle. They have a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    urinary bladder\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and nitrogenous waste products are excreted primarily as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    urea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Most amphibians lay their eggs in water and have aquatic larvae that undergo metamorphosis to become terrestrial adults. Amphibians breathe by means of a pump action in which air is first drawn into the buccopharyngeal region through the nostrils. These are then closed and the air is forced into the lungs by contraction of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    throat\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". They supplement this with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " exchange through the skin. Anura The order Anura (from the Ancient Greek a(n)- meaning &quot;&quot;without&quot;&quot; and oura meaning &quot;&quot;tail&quot;&quot;) comprises the frogs and toads. They usually have long hind limbs that fold underneath them, shorter forelimbs, webbed toes with no claws, no tails, large eyes and glandular moist skin. Members of this order with smooth skins are commonly referred to as frogs, while those with warty skins are known as toads. The difference is not a formal one taxonomically and there are numerous exceptions to this rule. Members of the family Bufonidae are known as the &quot;&quot;true toads&quot;&quot;. Frogs range in size from the 30-centimetre (12 in) Goliath frog (Conraua goliath) of West Africa to the 7.7-millimetre (0.30 in) Paedophryne amauensis, first described in Papua New Guinea in 2012, which is also the smallest known vertebrate. Although most species are associated with water and damp habitats, some are specialised to live in trees or in deserts. They are found worldwide except for polar areas.Anura is divided into three suborders that are broadly accepted by the scientific community, but the relationships between some families remain unclear. Future molecular studies should provide further insights into their evolutionary relationships. The suborder Archaeobatrachia contains four families of primitive frogs. These are Ascaphidae, Bombinatoridae, Discoglossidae and Leiopelmatidae which have few derived features and are probably paraphyletic with regard to other frog lineages. The six families in the more evolutionarily advanced suborder \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Mesobatrachia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are the fossorial Megophryidae, Pelobatidae, Pelodytidae, Scaphiopodidae and Rhinophrynidae and the obligatorily aquatic Pipidae. These have certain characteristics that are intermediate between the two other suborders. Neobatrachia is by far the largest suborder and includes the remaining families of modern frogs, including most common species. Ninety-six percent of the over 5,000 extant species of frog are neobatrachians. Caudata The order Caudata (from the Latin cauda meaning &quot;&quot;tail&quot;&quot;) consists of the salamanders—elongated, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    low-slung\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " animals that mostly resemble lizards in form. This is a symplesiomorphic trait and they are no more closely related to lizards than they are to mammals. Salamanders lack claws, have scale-free skins, either smooth or covered with tubercles, and tails that are usually flattened from side to side and often finned. They range in size from the Chinese giant salamander (Andrias davidianus), which has been reported to grow to a length of 1.8 metres (5 ft 11 in), to the diminutive Thorius pennatulus from Mexico which seldom exceeds 20 mm (0.8 in) in length. Salamanders have a mostly Laurasian distribution, being present in much of the Holarctic region of the northern hemisphere. The family Plethodontidae is also found in Central America and South America north of the Amazon basin; South America was apparently invaded from Central America by about the start of the Miocene, 23 million years ago. Urodela is a name sometimes used for all the extant species of salamanders. Members of several salamander families have become paedomorphic and either fail to complete their metamorphosis or retain some larval characteristics as adults. Most salamanders are under 15 cm (6 in) long. They may be \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    terrestrial or aquatic and\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " many spend part of the year in each habitat. When on land, they mostly spend the day hidden under stones or logs or in dense vegetation, emerging in the evening and night to forage for worms, insects and other invertebrates. The suborder Cryptobranchoidea contains the primitive salamanders. A number of fossil cryptobranchids have been found, but there are only three living species, the Chinese giant salamander (Andrias davidianus), the Japanese giant salamander (Andrias japonicus) and the hellbender (Cryptobranchus alleganiensis) from North America. These large amphibians retain several larval characteristics in their adult state; gills slits are present and the eyes are unlidded. A unique feature is their ability to feed by suction, depressing either the left side of their lower jaw or the right. The males excavate nests, persuade females to lay their egg strings inside them, and guard them. As well as breathing with lungs, they respire through the many folds in their thin skin, which has capillaries close to the surface.The suborder Salamandroidea contains the advanced salamanders. They differ from the cryptobranchids by having fused prearticular bones in the lower jaw, and by using internal fertilisation. In salamandrids, the male deposits a bundle of sperm, the spermatophore, and the female picks it up and inserts it into her cloaca where the sperm is stored until the eggs are laid. The largest family in this group is Plethodontidae, the lungless salamanders, which includes 60% of all salamander species. The family Salamandridae includes the true salamanders and the name &quot;&quot;newt&quot;&quot; is given to members of its subfamily Pleurodelinae.The third suborder, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sirenoidea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", contains the four species of sirens, which are in a single family, Sirenidae. Members of this order are eel-like aquatic salamanders with much reduced forelimbs and no hind limbs. Some of their features are primitive while others are derived. Fertilisation is likely to be external as sirenids lack the cloacal glands used by male salamandrids to produce spermatophores and the females lack spermathecae for sperm storage. Despite this, the eggs are laid singly, a behaviour not conducive for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    external fertilisation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Gymnophiona The order Gymnophiona (from the Greek gymnos meaning &quot;&quot;naked&quot;&quot; and ophis meaning &quot;&quot;serpent&quot;&quot;) or Apoda comprises the caecilians. These are long, cylindrical, limbless animals with a snake- or worm-like form. The adults vary in length from 8 to 75 centimetres (3 to 30 inches) with the exception of Thomson's caecilian (Caecilia thompsoni), which can reach 150 centimetres (4.9 feet). A caecilian's skin has a large number of transverse folds and in some species contains tiny embedded dermal scales. It has rudimentary eyes covered in skin, which are probably limited to discerning differences in light intensity. It also has a pair of short tentacles near the eye that can be extended and which have tactile and olfactory functions. Most caecilians live underground in burrows in damp soil, in rotten wood and under plant debris, but some are aquatic. Most species lay their eggs underground and when the larvae hatch, they make their way to adjacent bodies of water. Others brood their eggs and the larvae undergo metamorphosis before the eggs hatch. A few species give birth to live young, nourishing them with glandular secretions while they are in the oviduct. Caecilians have a mostly Gondwanan distribution, being found in tropical regions of Africa, Asia and Central and South America. Anatomy and physiology Skin The integumentary structure contains some typical characteristics common to terrestrial vertebrates, such as the presence of highly cornified outer layers, renewed periodically through a moulting process controlled by the pituitary and thyroid glands. Local thickenings (often called warts) are common, such as those found on toads. The outside of the skin is shed periodically mostly in one piece, in contrast to mammals and birds where it is shed in flakes. Amphibians often eat the sloughed skin. Caecilians are unique among amphibians in having mineralized dermal scales embedded in the dermis between the furrows in the skin. The similarity of these to the scales of bony fish is largely superficial. Lizards and some frogs have somewhat similar osteoderms forming bony deposits in the dermis, but this is an example of convergent evolution with similar structures having arisen independently in diverse vertebrate lineages. Amphibian skin is permeable to water. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " exchange can take place through the skin (cutaneous respiration) and this allows adult amphibians to respire without rising to the surface of water and to hibernate at the bottom of ponds. To compensate for their thin and delicate skin, amphibians have evolved mucous glands, principally on their heads, backs and tails. The secretions produced by these help keep the skin moist. In addition, most species of amphibian have granular glands that secrete distasteful or poisonous substances. Some amphibian toxins can be lethal to humans while others have little effect. The main poison-producing glands, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    parotoids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", produce the neurotoxin bufotoxin and are located behind the ears of toads, along the backs of frogs, behind the eyes of salamanders and on the upper surface of caecilians.The skin colour of amphibians is produced by three layers of pigment cells called chromatophores. These three cell layers consist of the melanophores (occupying the deepest layer), the guanophores (forming an intermediate layer and containing many granules, producing a blue-green colour) and the lipophores (yellow, the most superficial layer). The colour change displayed by many species is initiated by hormones secreted by the pituitary gland. Unlike bony fish, there is no direct control of the pigment cells by the nervous system, and this results in the colour change taking place more slowly than happens in fish. A vividly coloured skin usually indicates that the species is toxic and is a warning sign to predators. Skeletal system and locomotion Amphibians have a skeletal system that is structurally homologous to other tetrapods, though with a number of variations. They all have four limbs except for the legless caecilians and a few species of salamander with reduced or no limbs. The bones are hollow and lightweight. The musculoskeletal system is strong to enable it to support the head and body. The bones are fully ossified and the vertebrae interlock with each other by means of overlapping processes. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pectoral girdle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is supported by muscle, and the well-developed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pelvic girdle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is attached to the backbone by a pair of sacral ribs. The ilium slopes forward and the body is held closer to the ground than is the case in mammals. In most amphibians, there are four digits on the fore foot and five on the hind foot, but no claws on either. Some salamanders have fewer digits and the amphiumas are eel-like in appearance with tiny, stubby legs. The sirens are aquatic salamanders with stumpy forelimbs and no hind limbs. The caecilians are limbless. They burrow in the manner of earthworms with zones of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle contractions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " moving along the body. On the surface of the ground or in water they move by undulating their body from side to side.In frogs, the hind legs are larger than the fore legs, especially so in those species that principally move by jumping or swimming. In the walkers and runners the hind limbs are not so large, and the burrowers mostly have short limbs and broad bodies. The feet have adaptations for the way of life, with webbing between the toes for swimming, broad adhesive toe pads for climbing, and keratinised tubercles on the hind feet for digging (frogs usually dig backwards into the soil). In most salamanders, the limbs are short and more or less the same length and project at right angles from the body. Locomotion on land is by walking and the tail often swings from side to side or is used as a prop, particularly when climbing. In their normal gait, only one leg is advanced at a time in the manner adopted by their ancestors, the lobe-finned fish. Some salamanders in the genus Aneides and certain plethodontids climb trees and have long limbs, large toepads and prehensile tails. In aquatic salamanders and in frog tadpoles, the tail has dorsal and ventral fins and is moved from side to side as a means of propulsion. Adult frogs do not have tails and caecilians have only very short ones. Salamanders use their tails in defence and some are prepared to jettison them to save their lives in a process known as autotomy. Certain species in the Plethodontidae have a weak zone at the base of the tail and use this strategy readily. The tail often continues to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    twitch\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " after separation which may distract the attacker and allow the salamander to escape. Both tails and limbs can be regenerated. Adult frogs are unable to regrow limbs but tadpoles can do so. Circulatory system Amphibians have a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    juvenile stage\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and an adult stage, and the circulatory systems of the two are distinct. In the juvenile (or tadpole) stage, the circulation is similar to that of a fish; the two-chambered heart pumps the blood through the gills where it is oxygenated, and is spread around the body and back to the heart in a single loop. In the adult stage, amphibians (especially frogs) lose their gills and develop lungs. They have a heart that consists of a single ventricle and two atria. When the ventricle starts contracting, deoxygenated blood is pumped through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to the lungs. Continued contraction then pumps oxygenated blood around the rest of the body. Mixing of the two bloodstreams is minimized by the anatomy of the chambers. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nervous and sensory systems\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " The nervous system is basically the same as in other vertebrates, with a central brain, a spinal cord, and nerves throughout the body. The amphibian brain is less well developed than that of reptiles, birds and mammals but is similar in morphology and function to that of a fish. It is believed amphibians are capable of perceiving \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  The brain consists of equal parts, cerebrum, midbrain and cerebellum. Various parts of the cerebrum process sensory input, such as smell in the olfactory lobe and sight in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    optic lobe\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and it is additionally the centre of behaviour and learning. The cerebellum is the center of muscular coordination and the medulla oblongata controls some organ functions including heartbeat and respiration. The brain sends signals through the spinal cord and nerves to regulate activity in the rest of the body. The pineal body, known to regulate sleep patterns in humans, is thought to produce the hormones involved in hibernation and aestivation in amphibians.Tadpoles retain the lateral line system of their ancestral fishes, but this is lost in terrestrial adult amphibians. Some caecilians possess electroreceptors that allow them to locate objects around them when submerged in water. The ears are well developed in frogs. There is no external ear, but the large circular eardrum lies on the surface of the head just behind the eye. This vibrates and sound is transmitted through a single bone, the stapes, to the inner ear. Only high-frequency sounds like mating calls are heard in this way, but low-frequency noises can be detected through another mechanism. There is a patch of specialized haircells, called papilla amphibiorum, in the inner ear capable of detecting deeper sounds. Another feature, unique to frogs and salamanders, is the columella-operculum complex adjoining the auditory capsule which is involved in the transmission of both airborne and seismic signals. The ears of salamanders and caecilians are less highly developed than those of frogs as they do not normally communicate with each other through the medium of sound.The eyes of tadpoles lack lids, but at metamorphosis, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cornea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " becomes more dome-shaped, the lens becomes flatter, and eyelids and associated glands and ducts develop. The adult eyes are an improvement on invertebrate eyes and were a first step in the development of more advanced vertebrate eyes. They allow colour vision and depth of focus. In the retinas are green rods, which are receptive to a wide range of wavelengths. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Digestive and excretory systems\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Many amphibians catch their prey by flicking out an elongated tongue with a sticky tip and drawing it back into the mouth before seizing the item with their jaws. Some use inertial feeding to help them swallow the prey, repeatedly thrusting their head forward sharply causing the food to move backwards in their mouth by inertia. Most amphibians swallow their prey whole without much chewing so they possess voluminous stomachs. The short oesophagus is lined with cilia that help to move the food to the stomach and mucus produced by glands in the mouth and pharynx eases its passage. The enzyme chitinase produced in the stomach helps digest the chitinous cuticle of arthropod prey.Amphibians possess a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pancreas, liver and gall bladder\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The liver is usually large with two lobes. Its size is determined by its function as a glycogen and fat storage unit, and may change with the seasons as these reserves are built or used up. Adipose tissue is another important means of storing energy and this occurs in the abdomen (in internal structures called fat bodies), under the skin and, in some salamanders, in the tail.There are two kidneys located dorsally, near the roof of the body cavity. Their job is to filter the blood of metabolic waste and transport the urine via ureters to the urinary bladder where it is stored before being passed out periodically through the cloacal vent. Larvae and most aquatic adult amphibians excrete the nitrogen as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ammonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in large quantities of dilute urine, while terrestrial species, with a greater need to conserve water, excrete the less toxic product \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    urea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Some tree frogs with limited access to water excrete most of their metabolic waste as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    uric acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Respiratory system The lungs in amphibians are primitive compared to those of amniotes, possessing few internal septa and large alveoli, and consequently having a comparatively slow diffusion rate for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " entering the blood. Ventilation is accomplished by buccal pumping. Most amphibians, however, are able to exchange gases with the water or air via their skin. To enable sufficient cutaneous respiration, the surface of their highly vascularised skin must remain moist to allow the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to diffuse at a sufficiently high rate. Because \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " concentration in the water increases at both low temperatures and high flow rates, aquatic amphibians in these situations can rely primarily on cutaneous respiration, as in the Titicaca water frog and the hellbender salamander. In air, where \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is more concentrated, some small species can rely solely on cutaneous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " exchange, most famously the plethodontid salamanders, which have neither lungs nor gills. Many aquatic salamanders and all tadpoles have gills in their larval stage, with some (such as the axolotl) retaining gills as aquatic adults. Reproduction For the purpose of reproduction most amphibians require fresh water although some lay their eggs on land and have developed various means of keeping them moist. A few (e.g. Fejervarya raja) can inhabit brackish water, but there are no true marine amphibians. There are reports, however, of particular amphibian populations unexpectedly invading marine waters. Such was the case with the Black Sea invasion of the natural hybrid Pelophylax esculentus reported in 2010.Several hundred frog species in adaptive radiations (e.g., Eleutherodactylus, the Pacific Platymantis, the Australo-Papuan microhylids, and many other tropical frogs), however, do not need any water for breeding in the wild. They reproduce via direct development, an ecological and evolutionary adaptation that has allowed them to be completely independent from free-standing water. Almost all of these frogs live in wet tropical rainforests and their eggs hatch directly into miniature versions of the adult, passing through the tadpole stage within the egg. Reproductive success of many amphibians is dependent not only on the quantity of rainfall, but the seasonal timing.In the tropics, many amphibians breed continuously or at any time of year. In temperate regions, breeding is mostly seasonal, usually in the spring, and is triggered by increasing day length, rising temperatures or rainfall. Experiments have shown the importance of temperature, but the trigger event, especially in arid regions, is often a storm. In anurans, males usually arrive at the breeding sites before females and the vocal chorus they produce may stimulate ovulation in females and the endocrine activity of males that are not yet reproductively active.In caecilians, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fertilisation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is internal, the male extruding an intromittent organ, the phallodeum, and inserting it into the female cloaca. The paired Müllerian glands inside the male cloaca secrete a fluid which resembles that produced by mammalian prostate glands and which may transport and nourish the sperm. Fertilisation probably takes place in the oviduct.The majority of salamanders also engage in internal fertilisation. In most of these, the male deposits a spermatophore, a small packet of sperm on top of a gelatinous cone, on the substrate either on land or in the water. The female takes up the sperm packet by grasping it with the lips of the cloaca and pushing it into the vent. The spermatozoa move to the spermatheca in the roof of the cloaca where they remain until ovulation which may be many months later. Courtship rituals and methods of transfer of the spermatophore vary between species. In some, the spermatophore may be placed directly into the female cloaca while in others, the female may be guided to the spermatophore or restrained with an embrace called amplexus. Certain primitive salamanders in the families Sirenidae, Hynobiidae and Cryptobranchidae practice \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    external fertilisation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in a similar manner to frogs, with the female laying the eggs in water and the male releasing sperm onto the egg mass.With a few exceptions, frogs use external fertilisation. The male grasps the female tightly with his forelimbs either behind the arms or in front of the back legs, or in the case of Epipedobates tricolor, around the neck. They remain in amplexus with their cloacae positioned close together while the female lays the eggs and the male covers them with sperm. Roughened nuptial pads on the male's hands aid in retaining grip. Often the male collects and retains the egg mass, forming a sort of basket with the hind feet. An exception is the granular poison frog (Oophaga granulifera) where the male and female place their cloacae in close proximity while facing in opposite directions and then release eggs and sperm simultaneously. The tailed frog (Ascaphus truei) exhibits internal fertilisation. The &quot;&quot;tail&quot;&quot; is only possessed by the male and is an extension of the cloaca and used to inseminate the female. This frog lives in fast-flowing streams and internal fertilisation prevents the sperm from being washed away before fertilisation occurs. The sperm may be retained in storage tubes attached to the oviduct until the following spring.Most frogs can be classified as either prolonged or explosive breeders. Typically, prolonged breeders congregate at a breeding site, the males usually arriving first, calling and setting up territories. Other satellite males remain quietly nearby, waiting for their opportunity to take over a territory. The females arrive sporadically, mate selection takes place and eggs are laid. The females depart and territories may change hands. More females appear and in due course, the breeding season comes to an end. Explosive breeders on the other hand are found where temporary pools appear in dry regions after rainfall. These frogs are typically fossorial species that emerge after heavy rains and congregate at a breeding site. They are attracted there by the calling of the first male to find a suitable place, perhaps a pool that forms in the same place each rainy season. The assembled frogs may call in unison and frenzied activity ensues, the males scrambling to mate with the usually smaller number of females. There is a direct competition between males to win the attention of the females in salamanders and newts, with elaborate courtship displays to keep the female's attention long enough to get her interested in choosing him to mate with. Some species store sperm through long breeding seasons, as the extra time may allow for interactions with rival sperm. Life cycle Most amphibians go through metamorphosis, a process of significant morphological change after birth. In typical amphibian development, eggs are laid in water and larvae are adapted to an aquatic lifestyle. Frogs, toads and salamanders all hatch from the egg as larvae with external gills. Metamorphosis in amphibians is regulated by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thyroxine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " concentration in the blood, which stimulates metamorphosis, and prolactin, which counteracts \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thyroxine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "'s effect. Specific events are dependent on threshold values for different tissues. Because most embryonic development is outside the parental body, it is subject to many adaptations due to specific environmental circumstances. For this reason tadpoles can have horny ridges instead of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    teeth, whisker-like skin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " extensions or fins. They also make use of a sensory lateral line organ similar to that of fish. After metamorphosis, these organs become redundant and will be reabsorbed by controlled cell \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", called apoptosis. The variety of adaptations to specific environmental circumstances among amphibians is wide, with many discoveries still being made. Eggs The egg of an amphibian is typically surrounded by a transparent gelatinous covering secreted by the oviducts and containing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mucoproteins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and mucopolysaccharides. This capsule is permeable to water and gases, and swells considerably as it absorbs water. The ovum is at first rigidly held, but in fertilised eggs the innermost layer liquefies and allows the embryo to move freely. This also happens in salamander eggs, even when they are unfertilised. Eggs of some salamanders and frogs contain unicellular green algae. These penetrate the jelly envelope after the eggs are laid and may increase the supply of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to the embryo through photosynthesis. They seem to both speed up the development of the larvae and reduce mortality. Most eggs contain the pigment melanin which raises their temperature through the absorption of light and also protects them against ultraviolet radiation. Caecilians, some plethodontid salamanders and certain frogs lay eggs underground that are unpigmented. In the wood frog (Rana sylvatica), the interior of the globular egg cluster has been found to be up to 6 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    °\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "C (11 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    °\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "F) warmer than its surroundings, which is an advantage in its cool northern habitat.The eggs may be deposited singly or in small groups, or may take the form of spherical egg masses, rafts or long strings. In terrestrial caecilians, the eggs are laid in grape-like clusters in burrows near streams. The amphibious salamander Ensatina attaches its similar clusters by stalks to underwater stems and roots. The greenhouse frog (Eleutherodactylus planirostris) lays eggs in small groups in the soil where they develop in about two weeks directly into juvenile frogs without an intervening larval stage. The tungara frog (Physalaemus pustulosus) builds a floating nest from foam to protect its eggs. First a raft is built, then eggs are laid in the centre, and finally a foam cap is overlaid. The foam has anti-microbial properties. It contains no detergents but is created by whipping up proteins and lectins secreted by the female. Larvae The eggs of amphibians are typically laid in water and hatch into free-living larvae that complete their development in water and later transform into either aquatic or terrestrial adults. In many species of frog and in most lungless salamanders (Plethodontidae), direct development takes place, the larvae growing within the eggs and emerging as miniature adults. Many caecilians and some other amphibians lay their eggs on land, and the newly hatched larvae wriggle or are transported to water bodies. Some caecilians, the alpine salamander (Salamandra atra) and some of the African live-bearing toads (Nectophrynoides spp.) are viviparous. Their larvae feed on glandular secretions and develop within the female's oviduct, often for long periods. Other amphibians, but not caecilians, are ovoviviparous. The eggs are retained in or on the parent's body, but the larvae subsist on the yolks of their eggs and receive no nourishment from the adult. The larvae emerge at varying stages of their growth, either before or after metamorphosis, according to their species. The toad genus Nectophrynoides exhibits all of these developmental patterns among its dozen or so members. Frogs Frog larvae are known as tadpoles and typically have oval bodies and long, vertically flattened tails with fins. The free-living larvae are normally fully aquatic, but the tadpoles of some species (such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nannophrys ceylonensis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") are semi-terrestrial and live among wet rocks. Tadpoles have cartilaginous skeletons, gills for respiration (external gills at first, internal gills later), lateral line systems and large tails that they use for swimming. Newly hatched tadpoles soon develop gill pouches that cover the gills. The lungs develop early and are used as accessory breathing organs, the tadpoles rising to the water surface to gulp air. Some species complete their development inside the egg and hatch directly into small frogs. These larvae do not have gills but instead have specialised areas of skin through which respiration takes place. While tadpoles do not have true \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    teeth\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", in most species, the jaws have long, parallel rows of small keratinized structures called keradonts surrounded by a horny beak. Front legs are formed under the gill sac and hind legs become visible a few days later. Iodine and T4 (over stimulate the spectacular apoptosis [\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    programmed cell death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "] of the cells of the larval gills, tail and fins) also stimulate the evolution of nervous systems transforming the aquatic, vegetarian tadpole into the terrestrial, carnivorous frog with better neurological, visuospatial, olfactory and cognitive abilities for hunting.In fact, tadpoles developing in ponds and streams are typically herbivorous. Pond tadpoles tend to have deep bodies, large caudal fins and small mouths; they swim in the quiet waters feeding on growing or loose fragments of vegetation. Stream dwellers mostly have larger mouths, shallow bodies and caudal fins; they attach themselves to plants and stones and feed on the surface films of algae and bacteria. They also feed on diatoms, filtered from the water through the gills, and stir up the sediment at bottom of the pond, ingesting edible fragments. They have a relatively long, spiral-shaped gut to enable them to digest this \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ". Some species are carnivorous at the tadpole stage, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    eating insects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", smaller tadpoles and fish. Young of the Cuban tree frog (Osteopilus septentrionalis) can occasionally be cannibalistic, the younger tadpoles attacking a larger, more developed tadpole when it is undergoing metamorphosis. At metamorphosis, rapid changes in the body take place as the lifestyle of the frog changes completely. The spiral‐shaped mouth with horny tooth ridges is reabsorbed together with the spiral gut. The animal develops a large jaw, and its gills disappear along with its gill sac. Eyes and legs grow quickly, and a tongue is formed. There are associated changes in the neural networks such as development of stereoscopic vision and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    loss of the lateral line system\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". All this can happen in about a day. A few days later, the tail is reabsorbed, due to the higher \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thyroxine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " concentration required for this to take place. Salamanders At hatching, a typical salamander larva has eyes without lids, teeth in both upper and lower jaws, three pairs of feathery external gills, a somewhat laterally flattened body and a long tail with dorsal and ventral fins. The forelimbs may be partially developed and the hind limbs are rudimentary in pond-living species but may be rather more developed in species that reproduce in moving water. Pond-type larvae often have a pair of balancers, rod-like structures on either side of the head that may prevent the gills from becoming clogged up with sediment. Some members of the genera Ambystoma and Dicamptodon have larvae that never fully develop into the adult form, but this varies with species and with populations. The northwestern salamander (Ambystoma gracile) is one of these and, depending on environmental factors, either remains permanently in the larval state, a condition known as neoteny, or transforms into an adult. Both of these are able to breed. Neoteny occurs when the animal's growth rate is very low and is usually linked to adverse conditions such as low water temperatures that may change the response of the tissues to the hormone \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thyroxine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Other factors that may inhibit metamorphosis include lack of food, lack of trace elements and competition from conspecifics. The tiger salamander (Ambystoma tigrinum) also sometimes behaves in this way and may grow particularly large in the process. The adult tiger salamander is terrestrial, but the larva is aquatic and able to breed while still in the larval state. When conditions are particularly inhospitable on land, larval breeding may allow continuation of a population that would otherwise die out. There are fifteen species of obligate neotenic salamanders, including species of Necturus, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Proteus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and Amphiuma, and many examples of facultative ones that adopt this strategy under appropriate environmental circumstances.Lungless salamanders in the family Plethodontidae are terrestrial and lay a small number of unpigmented eggs in a cluster among damp leaf litter. Each egg has a large yolk sac and the larva feeds on this while it develops inside the egg, emerging fully formed as a juvenile salamander. The female salamander often broods the eggs. In the genus \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ensatinas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the female has been observed to coil around them and press her throat area against them, effectively massaging them with a mucous secretion.In newts and salamanders, metamorphosis is less dramatic than in frogs. This is because the larvae are already carnivorous and continue to feed as predators when they are adults so few changes are needed to their digestive systems. Their lungs are functional early, but the larvae do not make as much use of them as do tadpoles. Their gills are never covered by gill sacs and are reabsorbed just before the animals leave the water. Other changes include the reduction in size or loss of tail fins, the closure of gill slits, thickening of the skin, the development of eyelids, and certain changes in dentition and tongue structure. Salamanders are at their most vulnerable at metamorphosis as swimming speeds are reduced and transforming tails are encumbrances on land. Adult salamanders often have an aquatic phase in spring and summer, and a land phase in winter. For adaptation to a water phase, prolactin is the required hormone, and for adaptation to the land phase, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thyroxine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". External gills do not return in subsequent aquatic phases because these are completely absorbed upon leaving the water for the first time. Caecilians Most terrestrial caecilians that lay eggs do so in burrows or moist places on land near bodies of water. The development of the young of Ichthyophis glutinosus, a species from Sri Lanka, has been much studied. The eel-like larvae hatch out of the eggs and make their way to water. They have three pairs of external red feathery gills, a blunt head with two rudimentary eyes, a lateral line system and a short tail with fins. They swim by undulating their body from side to side. They are mostly active at night, soon lose their gills and make sorties onto land. Metamorphosis is gradual. By the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of about ten months they have developed a pointed head with sensory tentacles near the mouth and lost their eyes, lateral line systems and tails. The skin thickens, embedded scales develop and the body divides into segments. By this time, the caecilian has constructed a burrow and is living on land. In the majority of species of caecilians, the young are produced by viviparity. Typhlonectes compressicauda, a species from South America, is typical of these. Up to nine larvae can develop in the oviduct at any one time. They are elongated and have paired sac-like gills, small eyes and specialised scraping \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    teeth\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". At first, they feed on the yolks of the eggs, but as this source of nourishment declines they begin to rasp at the ciliated epithelial cells that line the oviduct. This stimulates the secretion of fluids rich in lipids and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mucoproteins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " on which they feed along with scrapings from the oviduct wall. They may increase their length sixfold and be two-fifths as long as their mother before being born. By this time they have undergone metamorphosis, lost their eyes and gills, developed a thicker \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    skin and mouth tentacles\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and reabsorbed their \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    teeth\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". A permanent set of teeth grow through soon after birth.The ringed caecilian (Siphonops annulatus) has developed a unique adaptation for the purposes of reproduction. The progeny feed on a skin layer that is specially developed by the adult in a phenomenon known as maternal dermatophagy. The brood feed as a batch for about seven minutes at intervals of approximately three days which gives the skin an opportunity to regenerate. Meanwhile, they have been observed to ingest fluid exuded from the maternal cloaca. Parental care The care of offspring among amphibians has been little studied but, in general, the larger the number of eggs in a batch, the less likely it is that any degree of parental care takes place. Nevertheless, it is estimated that in up to 20% of amphibian species, one or both adults play some role in the care of the young. Those species that breed in smaller water bodies or other specialised habitats tend to have complex patterns of behaviour in the care of their young.Many woodland salamanders lay clutches of eggs under dead logs or stones on land. The black mountain salamander (Desmognathus welteri) does this, the mother brooding the eggs and guarding them from predation as the embryos feed on the yolks of their eggs. When fully developed, they break their way out of the egg capsules and disperse as juvenile salamanders. The male hellbender, a primitive salamander, excavates an underwater nest and encourages females to lay there. The male then guards the site for the two or three months before the eggs hatch, using body undulations to fan the eggs and increase their supply of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The male Colostethus subpunctatus, a tiny frog, protects the egg cluster which is hidden under a stone or log. When the eggs hatch, the male transports the tadpoles on his back, stuck there by a mucous secretion, to a temporary pool where he dips himself into the water and the tadpoles drop off. The male midwife toad (Alytes obstetricans) winds egg strings round his thighs and carries the eggs around for up to eight weeks. He keeps them moist and when they are ready to hatch, he visits a pond or ditch and releases the tadpoles. The female gastric-brooding frog (Rheobatrachus spp.) reared larvae in her stomach after swallowing either the eggs or hatchlings; however, this stage was never observed before the species became extinct. The tadpoles secrete a hormone that inhibits digestion in the mother whilst they develop by consuming their very large yolk supply. The pouched frog (Assa darlingtoni) lays eggs on the ground. When they hatch, the male carries the tadpoles around in brood pouches on his hind legs. The aquatic Surinam toad (Pipa pipa) raises its young in pores on its back where they remain until metamorphosis. The granular poison frog (Oophaga granulifera) is typical of a number of tree frogs in the poison dart frog family Dendrobatidae. Its eggs are laid on the forest floor and when they hatch, the tadpoles are carried one by one on the back of an adult to a suitable water-filled crevice such as the axil of a leaf or the rosette of a bromeliad. The female visits the nursery sites regularly and deposits unfertilised eggs in the water and these are consumed by the tadpoles. Genetics and genomics Amphibians are notable among vertebrates for their diversity of chromosomes and genomes. The karyotypes (chromosomes) have been determined for at least 1,193 (14.5%) of the ~8,200 known (diploid) species, including 963 anurans, 209 salamanders, and 21 caecilians. Generally, the karyotypes of diploid amphibians are characterized by 20–26 bi-armed chromosomes. Amphibians have also very large genomes compared to other taxa of vertebrates and corresponding variation in genome size (C-value: picograms of DNA in haploid nuclei). The genome sizes range from 0.95 to 11.5 pg in frogs, from 13.89 to 120.56 pg in salamanders, and from 2.94 to 11.78 pg in caecilians.The large genome sizes have prevented whole-genome sequencing of amphibians although a number of genomes have been published recently. The 1.7\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " draft genome  of Xenopus tropicalis was the first to be reported for amphibians in 2010. Compared to some salamanders this frog genome is tiny. For instance, the genome of the Mexican axolotl turned out to be 32 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gb\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which is more than 10 times larger than the human genome (3GB). Feeding and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " With a few exceptions, adult amphibians are predators, feeding on virtually anything that moves that they can swallow. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " mostly consists of small prey that do not move too fast such as beetles, caterpillars, earthworms and spiders. The sirens (Siren spp.) often ingest aquatic plant material with the invertebrates on which they feed and a Brazilian tree frog (Xenohyla truncata) includes a large quantity of fruit in its \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ". The Mexican burrowing toad (Rhinophrynus dorsalis) has a specially adapted tongue for picking up ants and termites. It projects it with the tip foremost whereas other frogs flick out the rear part first, their tongues being hinged at the front.Food is mostly selected by sight, even in conditions of dim light. Movement of the prey triggers a feeding response. Frogs have been caught on fish hooks baited with red flannel and green frogs (Rana clamitans) have been found with stomachs full of elm seeds that they had seen floating past. Toads, salamanders and caecilians also use smell to detect prey. This response is mostly secondary because salamanders have been observed to remain stationary near odoriferous prey but only feed if it moves. Cave-dwelling amphibians normally hunt by smell. Some salamanders seem to have learned to recognize immobile prey when it has no smell, even in complete darkness.Amphibians usually swallow food whole but may chew it lightly first to subdue it. They typically have small hinged pedicellate teeth, a feature unique to amphibians. The base and crown of these are composed of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dentine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " separated by an uncalcified layer and they are replaced at intervals. Salamanders, caecilians and some frogs have one or two rows of teeth in both jaws, but some frogs (Rana spp.) lack teeth in the lower jaw, and toads (Bufo spp.) have no teeth. In many amphibians there are also vomerine teeth attached to a facial bone in the roof of the mouth. The tiger salamander (Ambystoma tigrinum) is typical of the frogs and salamanders that hide under cover ready to ambush unwary invertebrates. Others amphibians, such as the Bufo spp. toads, actively search for prey, while the Argentine horned frog (Ceratophrys ornata) lures inquisitive prey closer by raising its hind feet over its back and vibrating its yellow toes. Among leaf litter frogs in Panama, frogs that actively hunt prey have narrow mouths and are slim, often brightly coloured and toxic, while ambushers have wide mouths and are broad and well-camouflaged. Caecilians do not flick their tongues, but catch their prey by grabbing it with their slightly backward-pointing teeth. The struggles of the prey and further jaw movements work it inwards and the caecilian usually retreats into its burrow. The subdued prey is gulped down whole.When they are newly hatched, frog larvae feed on the yolk of the egg. When this is exhausted some move on to feed on bacteria, algal crusts, detritus and raspings from submerged plants. Water is drawn in through their mouths, which are usually at the bottom of their heads, and passes through branchial food traps between their mouths and their gills where fine particles are trapped in mucus and filtered out. Others have specialised mouthparts consisting of a horny beak edged by several rows of labial teeth. They scrape and bite food of many kinds as well as stirring up the bottom sediment, filtering out larger particles with the papillae around their mouths. Some, such as the spadefoot toads, have strong biting jaws and are carnivorous or even cannibalistic. Vocalization The calls made by caecilians and salamanders are limited to occasional soft squeaks, grunts or hisses and have not been much studied. A clicking sound sometimes produced by caecilians may be a means of orientation, as in bats, or a form of communication. Most salamanders are considered voiceless, but the California giant salamander (Dicamptodon ensatus) has vocal cords and can produce a rattling or barking sound. Some species of salamander emit a quiet squeak or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    yelp\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " if attacked. Frogs are much more vocal, especially during the breeding season when they use their voices to attract mates. The presence of a particular species in an area may be more easily discerned by its characteristic call than by a fleeting glimpse of the animal itself. In most species, the sound is produced by expelling air from the lungs over the vocal cords into an air sac or sacs in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    throat\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or at the corner of the mouth. This may distend like a balloon and acts as a resonator, helping to transfer the sound to the atmosphere, or the water at times when the animal is submerged. The main vocalisation is the male's loud advertisement call which seeks to both encourage a female to approach and discourage other males from intruding on its territory. This call is modified to a quieter courtship call on the approach of a female or to a more aggressive version if a male intruder draws near. Calling carries the risk of attracting predators and involves the expenditure of much energy. Other calls include those given by a female in response to the advertisement call and a release call given by a male or female during unwanted attempts at amplexus. When a frog is attacked, a distress or fright call is emitted, often resembling a scream. The usually nocturnal Cuban tree frog (Osteopilus septentrionalis) produces a rain call when there is rainfall during daylight hours. Territorial behaviour Little is known of the territorial behaviour of caecilians, but some frogs and salamanders defend home ranges. These are usually feeding, breeding or sheltering sites. Males normally exhibit such behaviour though in some species, females and even juveniles are also involved. Although in many frog species, females are larger than males, this is not the case in most species where males are actively involved in territorial defence. Some of these have specific adaptations such as enlarged teeth for biting or spines on the chest, arms or thumbs. In salamanders, defence of a territory involves adopting an aggressive posture and if necessary attacking the intruder. This may involve \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    snapping\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", chasing and sometimes biting, occasionally causing the loss of a tail. The behaviour of red back salamanders (Plethodon cinereus) has been much studied. 91% of marked individuals that were later recaptured were within a metre (yard) of their original daytime retreat under a log or rock. A similar proportion, when moved experimentally a distance of 30 metres (98 ft), found their way back to their home base. The salamanders left odour marks around their territories which averaged 0.16 to 0.33 square metres (1.7 to 3.6 sq ft) in size and were sometimes inhabited by a male and female pair. These deterred the intrusion of others and delineated the boundaries between neighbouring areas. Much of their behaviour seemed stereotyped and did not involve any actual contact between individuals. An aggressive posture involved raising the body off the ground and glaring at the opponent who often turned away submissively. If the intruder persisted, a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    biting lunge\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was usually launched at either the tail region or the naso-labial grooves. Damage to either of these areas can reduce the fitness of the rival, either because of the need to regenerate tissue or because it impairs its ability to detect food.In frogs, male territorial behaviour is often observed at breeding locations; calling is both an announcement of ownership of part of this resource and an advertisement call to potential mates. In general, a deeper voice represents a heavier and more powerful individual, and this may be sufficient to prevent intrusion by smaller males. Much energy is used in the vocalization and it takes a toll on the territory holder who may be displaced by a fitter rival if he tires. There is a tendency for males to tolerate the holders of neighbouring territories while vigorously attacking unknown intruders. Holders of territories have a &quot;&quot;home advantage&quot;&quot; and usually come off better in an encounter between two similar-sized frogs. If threats are insufficient, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest to chest tussles\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may take place. Fighting methods include pushing and shoving, deflating the opponent's vocal sac, seizing him by the head, jumping on his back, biting, chasing, splashing, and ducking him under the water. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Defence\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " mechanisms Amphibians have soft bodies with thin skins, and lack claws, defensive armour, or spines. Nevertheless, they have evolved various defence mechanisms to keep themselves alive. The first line of defence in salamanders and frogs is the mucous secretion that they produce. This keeps their skin moist and makes them slippery and difficult to grip. The secretion is often sticky and distasteful or toxic. Snakes have been observed yawning and gaping when trying to swallow African clawed frogs (Xenopus laevis), which gives the frogs an opportunity to escape. Caecilians have been little studied in this respect, but the Cayenne caecilian (Typhlonectes compressicauda) produces toxic mucus that has killed predatory fish in a feeding experiment in Brazil. In some salamanders, the skin is poisonous. The rough-skinned newt (Taricha granulosa) from North America and other members of its genus contain the neurotoxin \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tetrodotoxin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TTX\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), the most toxic non-protein substance known and almost identical to that produced by pufferfish. Handling the newts does not cause harm, but ingestion of even the most minute amounts of the skin is deadly. In feeding trials, fish, frogs, reptiles, birds and mammals were all found to be susceptible. The only predators with some tolerance to the poison are certain populations of common garter snake (Thamnophis sirtalis). In locations where both snake and salamander co-exist, the snakes have developed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    immunity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " through genetic changes and they feed on the amphibians with impunity. Coevolution occurs with the newt increasing its toxic capabilities at the same rate as the snake further develops its immunity. Some frogs and toads are toxic, the main poison glands being at the side of the neck and under the warts on the back. These regions are presented to the attacking animal and their secretions may be foul-tasting or cause various physical or neurological symptoms. Altogether, over 200 toxins have been isolated from the limited number of amphibian species that have been investigated. Poisonous species often use bright colouring to warn potential predators of their \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    toxicity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". These warning colours tend to be red or yellow combined with black, with the fire salamander (Salamandra salamandra) being an example. Once a predator has sampled one of these, it is likely to remember the colouration next time it encounters a similar animal. In some species, such as the fire-bellied toad (Bombina spp.), the warning colouration is on the belly and these animals adopt a defensive pose when attacked, exhibiting their bright colours to the predator. The frog Allobates \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    zaparo\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is not \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    poisonous\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", but mimics the appearance of other toxic species in its locality, a strategy that may deceive predators.Many amphibians are nocturnal and hide during the day, thereby avoiding diurnal predators that hunt by sight. Other amphibians use camouflage to avoid being detected. They have various colourings such as mottled browns, greys and olives to blend into the background. Some salamanders adopt defensive poses when faced by a potential predator such as the North American northern short-tailed shrew (Blarina brevicauda). Their bodies writhe and they raise and lash their tails which makes it difficult for the predator to avoid contact with their poison-producing granular glands. A few salamanders will \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    autotomise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " their tails when attacked, sacrificing this part of their anatomy to enable them to escape. The tail may have a constriction at its base to allow it to be easily detached. The tail is regenerated later, but the energy cost to the animal of replacing it is significant. Some frogs and toads inflate themselves to make themselves look large and fierce, and some spadefoot toads (Pelobates spp) scream and leap towards the attacker. Giant salamanders of the genus Andrias, as well as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ceratophrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and Pyxicephalus frogs possess sharp \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    teeth\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and are capable of drawing blood with a defensive bite. The blackbelly salamander (Desmognathus quadramaculatus) can bite an attacking common garter snake (Thamnophis sirtalis) two or three times its size on the head and often manages to escape. Cognition In amphibians, there is evidence of habituation, associative learning through both classical and instrumental learning, and discrimination abilities.In one experiment, when offered live fruit flies (Drosophila virilis), salamanders chose the larger of 1 vs 2 and 2 vs 3. Frogs can distinguish between low numbers (1 vs 2, 2 vs 3, but not 3 vs 4) and large numbers (3 vs 6, 4 vs 8, but not 4 vs 6) of prey. This is irrespective of other characteristics, i.e. surface area, volume, weight and movement, although discrimination among large numbers may be based on surface area. Conservation Dramatic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    declines in amphibian populations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", including population \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    crashes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and mass localized extinction, have been noted since the late 1980s from locations all over the world, and amphibian declines are thus perceived to be one of the most critical threats to global biodiversity. In 2004, the International Union for Conservation of Nature (IUCN) reported stating that currently birds, mammals, and amphibians extinction rates were at minimum 48 times greater than natural extinction rates—possibly 1,024 times higher. In 2006 there were believed to be 4,035 species of amphibians that depended on water at some stage during their life cycle. Of these, 1,356 (33.6%) were considered to be threatened and this figure is likely to be an underestimate because it excludes 1,427 species for which there was insufficient data to assess their status. A number of causes are believed to be involved, including habitat destruction and modification, over-exploitation, pollution, introduced species, global warming, endocrine-disrupting pollutants, destruction of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ozone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " layer (ultraviolet radiation has shown to be especially damaging to the skin, eyes, and eggs of amphibians), and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diseases like chytridiomycosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". However, many of the causes of amphibian declines are still poorly understood, and are a topic of ongoing discussion. With their complex reproductive needs and permeable skins, amphibians are often considered to be ecological indicators. In many terrestrial ecosystems, they constitute one of the largest parts of the vertebrate biomass. Any decline in amphibian numbers will affect the patterns of predation. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    loss of carnivorous species\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " near the top of the food chain will upset the delicate ecosystem balance and may cause dramatic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    increases in opportunistic species\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In the Middle East, a growing appetite for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    eating frog legs\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and the consequent gathering of them for food was linked to an increase in mosquitoes. Predators that feed on amphibians are affected by their decline. The western terrestrial garter snake (Thamnophis elegans) in California is largely aquatic and depends heavily on two species of frog that are decreasing in numbers, the Yosemite toad (Bufo canorus) and the mountain yellow-legged frog (Rana muscosa), putting the snake's future at risk. If the snake were to become scarce, this would affect birds of prey and other predators that feed on it. Meanwhile, in the ponds and lakes, fewer frogs means fewer tadpoles. These normally play an important role in controlling the growth of algae and also forage on detritus that accumulates as sediment on the bottom. A reduction in the number of tadpoles may lead to an overgrowth of algae, resulting in depletion of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the water when the algae later die and decompose. Aquatic invertebrates and fish might then die and there would be unpredictable ecological consequences.A global strategy to stem the crisis was released in 2005 in the form of the Amphibian Conservation Action Plan. Developed by over eighty leading experts in the field, this call to action details what would be required to curtail amphibian \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    declines and extinctions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " over the following five years and how much this would cost. The Amphibian Specialist Group of the IUCN is spearheading efforts to implement a comprehensive global strategy for amphibian conservation. Amphibian \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ark\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is an organization that was formed to implement the ex-situ conservation recommendations of this plan, and they have been working with zoos and aquaria around the world, encouraging them to create assurance colonies of threatened amphibians. One such project is the Panama Amphibian Rescue and Conservation Project that built on existing conservation efforts in Panama to create a country-wide response to the threat of chytridiomycosis. See also List of amphibians List of amphibian genera List of threatened reptiles and amphibians of the United States References Cited texts Dorit, R. L.; Walker, W. F.; Barnes, R. D. (1991). Zoology. Saunders College Publishing. ISBN 978-0-03-030504-7. Stebbins, Robert C.; Cohen, Nathan \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    W.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (1995). A Natural History of Amphibians. Princeton University Press. ISBN 978-0-691-03281-8. Further reading Carroll, Robert L. (1988). Vertebrate Paleontology and Evolution. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    W.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " H. Freeman. ISBN 978-0-7167-1822-2. Carroll, Robert L. (2009). The Rise of Amphibians: 365 Million Years of Evolution. Johns Hopkins University Press. ISBN 978-0-8018-9140-3. Duellman, William E.; Linda Trueb (1994). Biology of Amphibians. Johns Hopkins University Press. ISBN 978-0-8018-4780-6. Frost, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Darrel R.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; Grant, Taran; Faivovich, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Julián\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "; Bain, Raoul H.; Haas, Alexander; Haddad, Célio F.B.; De Sá, Rafael O.; Channing, Alan; Wilkinson, Mark; Donnellan, Stephen C.; Raxworthy, Christopher J.; Campbell, Jonathan A.; Blotto, Boris L.; Moler, Paul; Drewes, Robert C.; Nussbaum, Ronald A.; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lynch\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", John D.; Green, David M.; Wheeler, Ward C. (2006). &quot;&quot;The Amphibian Tree of Life&quot;&quot;. Bulletin of the American Museum of Natural History. 297: 1–291. doi:10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2. hdl:2246/5781. Pounds, J. Alan; Bustamante, Martín R.; Coloma, Luis A.; Consuegra, Jamie A.; Fogden, Michael \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    P. L.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; Foster, Pru N.; La Marca, Enrique; Masters, Karen L.; Merino-Viteri, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Andrés\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "; Puschendorf, Robert; Ron, Santiago R.; Sánchez-Azofeifa, G. Arturo; Still, Christopher J.; Young, Bruce E. (2006). &quot;&quot;Widespread amphibian extinctions from epidemic disease driven by global warming&quot;&quot;. Nature. 439 (7073): 161–167. Bibcode:2006Natur.439..161A. doi:10.1038/nature04246. PMID 16407945. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    S2CID\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 4430672. Stuart, Simon N.; Chanson, Janice S.; Cox, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Neil A.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; Young, Bruce E.; Rodrigues, Ana \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    S. L.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; Fischman, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Debra L.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; Waller, Robert \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    W.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (2004). &quot;&quot;Status and trends of amphibian \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    declines and extinctions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " worldwide&quot;&quot;. Science. 306 (5702): 1783–1786. Bibcode:2004Sci...\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    306.1783S\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". CiteSeerX 10.1.1.225.9620. doi:10.1126/science.1103538. PMID 15486254. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    S2CID\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 86238651. Stuart, S. N.; Hoffmann, M.; Chanson, J. S.; Cox, N. A.; Berridge, R. J.; Ramani, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    P.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; Young, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    B. E.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", eds. (2008). Threatened Amphibians of the World. Published by Lynx Edicions, in association with IUCN-The World Conservation Union, Conservation International and NatureServe. ISBN 978-84-96553-41-5. Archived from the original on October 30, 2014. Retrieved October 30, 2014. External links Amphibians – AnimalSpot.net ArchéoZooThèque : Amphibians skeletons drawings : available in vector, image and PDF formats Amphibian Specialist Group Amphibian Ark AmphibiaWeb Global Amphibian Assessment Amphibian vocalisations on Archival Sound Recordings&quot; &quot;Anatomical terminology is a form of scientific terminology used by anatomists, zoologists, and health professionals such as doctors. Anatomical terminology uses many unique terms, suffixes, and prefixes deriving from Ancient Greek and Latin. These terms can be confusing to those unfamiliar with them, but can be more precise, reducing ambiguity and errors. Also, since these anatomical terms are not used in everyday conversation, their meanings are less likely to change, and less likely to be misinterpreted. To illustrate how inexact day-to-day language can be: a scar &quot;&quot;above the wrist&quot;&quot; could be located on the forearm two or three inches away from the hand or at the base of the hand; and could be on the palm-side or back-side of the arm. By using precise anatomical terminology such ambiguity is eliminated.An international standard for anatomical terminology, Terminologia Anatomica has been created. Word formation Anatomical terminology has quite regular morphology: the same prefixes and suffixes are used to add meanings to different roots. The root of a term often refers to an organ or tissue. For example, the Latin names of structures such as musculus biceps brachii can be split up and refer to, musculus for muscle, biceps for &quot;&quot;two-headed&quot;&quot;, brachii as in the brachial region of the arm. The first word describes what is being spoken about, the second describes it, and the third points to location.When describing the position of anatomical structures, structures may be described according to the anatomical landmark they are near. These landmarks may include structures, such as the umbilicus or sternum, or anatomical lines, such as the midclavicular line from the centre of the clavicle. The cephalon or cephalic region refers to the head. This area is further differentiated into the cranium (skull), facies (face), frons (forehead), oculus (eye area), auris (ear), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bucca (cheek)\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", nasus (nose), oris (mouth), and mentum (chin). The neck area is called the cervix or cervical region. Examples of structures named according to this include the frontalis muscle, submental lymph nodes, buccal membrane and orbicularis oculi muscle. Sometimes, unique terminology is used to reduce \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    confusion\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in different parts of the body. For example, different terms are used when it comes to the skull in compliance with its embryonic origin and its tilted position compared to in other animals. Here, rostral refers to proximity to the front of the nose, and is particularly used when describing the skull.: 4  Similarly, different terminology is often used in the arms, in part to reduce ambiguity as to what the &quot;&quot;front&quot;&quot;, &quot;&quot;back&quot;&quot;, &quot;&quot;inner&quot;&quot; and &quot;&quot;outer&quot;&quot; surfaces are. For this reason, the terms below are used:  Radial referring to the radius bone, seen laterally in the standard anatomical position. Ulnar referring to the ulna bone, medially positioned when in the standard anatomical position.Other terms are also used to describe the movement and actions of the hands and feet, and other structures such as the eye. History International morphological terminology is used by the colleges of medicine and dentistry and other areas of the health sciences. It facilitates communication and exchanges between scientists from different countries of the world and it is used daily in the fields of research, teaching and medical care. The international morphological terminology refers to morphological sciences as a biological sciences' branch. In this field, the form and structure are examined as well as the changes or developments in the organism. It is descriptive and functional. Basically, it covers the gross anatomy and the microscopic (histology and cytology) of living beings. It involves both development anatomy (embryology) and the anatomy of the adult. It also includes comparative anatomy between different species. The vocabulary is extensive, varied and complex, and requires a systematic presentation. Within the international field, a group of experts reviews, analyzes and discusses the morphological terms of the structures of the human body, forming today's Terminology Committee (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    FICAT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") from the International Federation of Associations of Anatomists (IFAA). It deals with the anatomical, histological and embryologic terminology. In the Latin American field, there are meetings called Iberian Latin American Symposium Terminology (SILAT), where a group of experts of the Pan American Association of Anatomy (PAA) that speak Spanish and Portuguese, disseminates and studies the international morphological terminology. The current international standard for human anatomical terminology is based on the Terminologia Anatomica (TA). It was developed by the Federative Committee on Anatomical Terminology (FCAT) and the International Federation of Associations of Anatomists (IFAA) and was released in 1998. It supersedes the previous standard, Nomina Anatomica. Terminologia Anatomica contains terminology for about 7500 human gross (macroscopic) anatomical structures. For microanatomy, known as histology, a similar standard exists in Terminologia Histologica, and for embryology, the study of development, a standard exists in Terminologia Embryologica. These standards specify generally accepted names that can be used to refer to histological and embryological structures in journal articles, textbooks, and other areas. As of September 2016, two sections of the Terminologia Anatomica, including central nervous system and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    peripheral nervous system\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", were merged to form the Terminologia Neuroanatomica.Recently, the Terminologia Anatomica has been perceived with a considerable criticism regarding its content including coverage, grammar and spelling mistakes, inconsistencies, and errors. Location Anatomical terminology is often chosen to highlight the relative location of body structures. For instance, an anatomist might describe one band of tissue as &quot;&quot;inferior to&quot;&quot; another or a physician might describe a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tumor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as &quot;&quot;superficial to&quot;&quot; a deeper body structure. Anatomical position Anatomical terms used to describe location are based on a body positioned in what is called the standard anatomical position. This position is one in which a person is standing, feet apace, with palms forward and thumbs facing outwards. Just as maps are normally oriented with north at the top, the standard body &quot;&quot;map,&quot;&quot; or anatomical position, is that of the body standing upright, with the feet at shoulder width and parallel, toes forward. The upper limbs are held out to each side, and the palms of the hands face forward.Using the standard anatomical position reduces \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    confusion\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It means that regardless of the position of a body, the position of structures within it can be described without ambiguity. Regions In terms of anatomy, the body is divided into regions. In the front, the trunk is referred to as the &quot;&quot;thorax&quot;&quot; and &quot;&quot;abdomen&quot;&quot;. The back as a general area is the dorsum or dorsal area, and the lower back is the lumbus or lumbar region. The shoulder blades are the scapular area and the breastbone is the sternal region. The abdominal area is the region between the chest and the pelvis. The breast is also called the mammary region, the armpit as the axilla and axillary, and the navel as the umbilicus and umbilical. The pelvis is the lower torso, between the abdomen and the thighs. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    groin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", where the thigh joins the trunk, are the inguen and inguinal area. The entire arm is referred to as the brachium and brachial, the front of the elbow as the antecubitis and antecubital, the back of the elbow as the olecranon or olecranal, the forearm as the antebrachium and antebrachial, the wrist as the carpus and carpal area, the hand as the manus and manual, the palm as the palma and palmar, the thumb as the pollex, and the fingers as the digits, phalanges, and phalangeal. The buttocks are the gluteus or gluteal region and the pubic area is the pubis. Anatomists divide the lower limb into the thigh (the part of the limb between the hip and the knee) and the leg (which refers only to the area of the limb between the knee and the ankle). The thigh is the femur and the femoral region. The kneecap is the patella and patellar while the back of the knee is the popliteus and popliteal area. The leg (between the knee and the ankle) is the crus and crural area, the lateral aspect of the leg is the peroneal area, and the calf is the sura and sural region. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ankle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the tarsus and tarsal, and the heel is the calcaneus or calcaneal. The foot is the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and pedal region, and the sole of the foot is the planta and plantar. As with the fingers, the toes are also called the digits, phalanges, and phalangeal area. The big toe is referred to as the hallux. Abdomen To promote clear communication, for instance about the location of a patient’s \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abdominal pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or a suspicious mass, the abdominal cavity can be divided into either nine regions or four quadrants. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    QuadrantsThe\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " abdomen may be divided into four quadrants, more commonly used in medicine, subdivides the cavity with one horizontal and one vertical line that intersect at the patient’s umbilicus (navel). The right upper quadrant (RUQ) includes the lower right ribs, right side of the liver, and right side of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    transverse colon\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The left upper quadrant (LUQ) includes the lower left ribs, stomach, spleen, and upper left area of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    transverse colon\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The right lower quadrant (RLQ) includes the right half of the small intestines, ascending colon, right pelvic bone and upper right area of the bladder. The left lower quadrant (LLQ) contains the left half of the small intestine and left pelvic bone. RegionsThe more detailed regional approach subdivides the cavity into nine regions, with two vertical and two horizontal lines drawn according to landmark structures. The vertical; or midclavicular lines, are drawn as if dropped from the midpoint of each clavicle. The superior horizontal line is the subcostal line, drawn immediately inferior to the ribs. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inferior horizontal\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " line is called the intertubercular line, and is to cross the iliac tubercles, found at the superior aspect of the pelvis. The upper right square is the right hypochondriac region and contains the base of the right ribs. The upper left square is the left hypochondriac region and contains the base of the left ribs. The epigastric region is the upper central square and contains the bottom edge of the liver as well as the upper areas of the stomach. The diaphragm curves like an upside down U over these three regions. The central right region is called the right lumbar region and contains the ascending colon and the right edge of the small intestines. The central square contains the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    transverse colon\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and the upper regions of the small intestines. The left lumbar region contains the left edge of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    transverse colon\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and the left edge of the small intestine. The lower right square is the right iliac region and contains the right pelvic bones and the ascending colon. The lower left square is the left iliac region and contains the left pelvic bone and the lower left regions of the small intestine. The lower central square contains the bottom of the pubic bones, upper regions of the bladder and the lower region of the small intestine. Standard terms When anatomists refer to the right and left of the body, it is in reference to the right and left of the subject, not the right and left of the observer. When observing a body in the anatomical position, the left of the body is on the observer’s right, and vice versa. These standardized terms avoid \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    confusion\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Examples of terms include:: 4  Anterior and posterior, which describe structures at the front (anterior) and back (posterior) of the body. For example, the toes are anterior to the heel, and the popliteus is posterior to the patella. Superior and inferior, which describe a position above (superior) or below (inferior) another part of the body. For example, the orbits are superior to the oris, and the pelvis is inferior to the abdomen. Proximal and distal, which describe a position that is closer to (proximal) or farther from (distal) the trunk of the body. For example, the shoulder is proximal to the arm, and the foot is distal to the knee. Superficial and deep, which describe structures that are closer to (superficial) or farther from (deep) the surface of the body. For example, the skin is superficial to the bones, and the brain is deep to the skull. Sometimes profound is used synonymously with deep. Medial and lateral, which describe a position that is closer to (medial) or farther from (lateral) the midline of the body. For example, the shoulders are lateral to the heart, and the umbilicus is medial to the hips. The medial side of the left knee is the side toward the opposite knee. Radial and ulnar, which describe only structures at or distal to the elbow and may be used interchangeably with medial and lateral in that particular area because they are less confusing. Examples: The thumb is on the radial side of the hand (the same as saying the lateral side); the ulnar side of the wrist is the side toward the little finger  (medial side). Ventral and dorsal, which describe structures derived from the front (ventral) and back (dorsal) of the embryo, before limb rotation. Rostral and caudal, which describe structures close to (rostral) or farther from (caudal) the nose. For example, the eyes are rostral to the back of the skull, and the tailbone is caudal to the chest. Cranial and caudal, which describe structures close to the top of the skull (cranial), and towards the bottom of the body (caudal). Occasionally, sinister for left, and dexter for right are used. Paired, referring to a structure that is present on both sides of the body. For example, the hands are paired structures. Axes Each locational term above can define the direction of a vector, and pairs of them can define axes, that is, lines of orientation. For example, blood can be said to flow in a proximal or distal direction, and anteroposterior, mediolateral, and inferosuperior axes are lines along which the body extends, like the X, Y, and Z axes of a Cartesian coordinate system. An axis can be projected to a corresponding plane. Planes Anatomy is often described in planes, referring to two-dimensional sections of the body. A section is a two-dimensional surface of a three-dimensional structure that has been cut. A plane is an imaginary two-dimensional surface that passes through the body. Three planes are commonly referred to in anatomy and medicine:: 4  The sagittal plane is the plane that divides the body or an organ vertically into right and left sides. If this vertical plane runs directly down the middle of the body, it is called the midsagittal or median plane. If it divides the body into unequal right and left sides, it is called a parasagittal plane, or less commonly a longitudinal section. The frontal plane is the plane that divides the body or an organ into an anterior (front) portion and a posterior (rear) portion. The frontal plane is often referred to as a coronal plane, following Latin corona, which means &quot;&quot;crown&quot;&quot;. The transverse plane is the plane that divides the body or organ horizontally into upper and lower portions. Transverse planes produce images referred to as cross sections. Functional state Anatomical terms may be used to describe the functional state of an organ: Anastomoses refers to the connection between two structures previously branched out, such as blood vessels or leaf veins. Patent, meaning a structure such as an artery or vein that abnormally remains open, such as a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    patent ductus arteriosus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", referring to the ductus arteriosus which normally becomes ligamentum arteriosum within three weeks of birth.  Something that is patent may also refer to a channel such as a blood vessel, section of bowel, collecting system or duct that is not occluded and remains open to free flow. Such \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obstructions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may include a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calculus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (i.e. a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    kidney stone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gallstone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), plaque (like that encountered in vital arteries such as coronary arteries and cerebral arteries), or another \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unspecified obstruction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", such as a mass or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bowel obstruction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". A plexus refers to a net-like arrangement of a nerve. Anatomical variation The term anatomical variation is used to refer to a difference in anatomical structures that is not regarded as a disorder. Many structures vary slightly between people, for example muscles that attach in slightly different places. For example, the presence or absence of the palmaris longus tendon. Anatomical variation is unlike \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital anomalies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which are considered a disorder. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Movement Joints\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", especially \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    synovial joints\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " allow the body a tremendous range of movements. Each movement at a synovial joint results from the contraction or relaxation of the muscles that are attached to the bones on either side of the articulation. The type of movement that can be produced at a synovial joint is determined by its structural type. Movement types are generally paired, with one being the opposite of the other. Body movements are always described in relation to the anatomical position of the body: upright stance, with upper limbs to the side of body and palms facing forward. General motion Terms describing motion in general include: Flexion and extension, which refer to a movement that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    decreases (flexion) or increases (extension) the\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " angle between body parts. For example, when standing up, the knees are extended. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Abduction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and adduction refers to a motion that pulls a structure away from (abduction) or towards (adduction) the midline of the body or limb. For example, a star jump requires the legs to be abducted. Internal rotation (or medial rotation) and external rotation (or lateral rotation) refers to rotation towards (internal) or away from (external) the center of the body. For example, the Lotus position posture in yoga requires the legs to be externally rotated. Elevation and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " refer to movement in a superior (elevation) or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inferior (depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") direction. Primarily refers to movements involving the scapula and mandible. Special motions of the hands and feet These terms refer to movements that are regarded as unique to the hands and feet:: 590–7  Dorsiflexion and plantarflexion refers to flexion (dorsiflexion) or extension of the foot at the ankle. For example, plantarflexion occurs when pressing the brake pedal of a car. Palmarflexion and dorsiflexion refer to movement of the flexion (palmarflexion) or extension (dorsiflexion) of the hand at the wrist. For example, prayer is often conducted with the hands dorsiflexed. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pronation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and supination refer to rotation of the forearm or foot so that in the anatomical position the palm or sole is facing anteriorly (supination) or posteriorly (pronation). For example, if a person is holding a bowl of soup in one hand, the hand is &quot;&quot;supinated&quot;&quot; and the thumb will point away from the body midline and the palm will be superior; if the hands are typing on a computer keyboard, they will be &quot;&quot;pronated&quot;&quot; with the thumbs toward the body midline and the palms inferior. Eversion and inversion refer to movements that tilt the sole of the foot away from (eversion) or towards (inversion) the midline of the body. Muscles Muscle action that moves the axial skeleton work over a joint with an origin and insertion of the muscle on respective side. The insertion is on the bone deemed to move towards the origin during \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle contraction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Muscles are often present that engage in several actions of the joint; able to perform for example both flexion and extension of the forearm as in the biceps and triceps respectively. This is not only to be able to revert actions of muscles, but also brings on stability of the actions though \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle coactivation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Agonist and antagonist muscles The muscle performing an action is the agonist, while the muscle which contraction brings about an opposite action is the antagonist. For example, an extension of the lower arm is performed by the triceps as the agonist and the biceps as the antagonist (which contraction will perform flexion over the same joint). Muscles that work together to perform the same action are called synergists. In the above example synergists to the biceps can be the brachioradialis and the brachialis muscle. Skeletal and smooth muscle The gross anatomy of a muscle is the most important indicator of its role in the body. One particularly important aspect of gross anatomy of muscles is pennation or lack thereof. In most muscles, all the fibers are oriented in the same direction, running in a line from the origin to the insertion. In pennate muscles, the individual fibers are oriented at an angle relative to the line of action, attaching to the origin and insertion tendons at each end. Because the contracting fibers are pulling at an angle to the overall action of the muscle, the change in length is smaller, but this same orientation allows for more fibers (thus more force) in a muscle of a given size. Pennate muscles are usually found where their length change is less important than maximum force, such as the rectus femoris.Skeletal muscle is arranged in discrete muscles, an example of which is the biceps brachii. The tough, fibrous epimysium of skeletal muscle is both connected to and continuous with the tendons. In turn, the tendons connect to the periosteum layer surrounding the bones, permitting the transfer of force from the muscles to the skeleton. Together, these fibrous layers, along with tendons and ligaments, constitute the deep fascia of the body. Joints Movement is not limited to only \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    synovial joints\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", although they allow for most freedom. Muscles also run over symphysis, which allow for movement in for example the vertebral column by compression of the intervertebral discs. Additionally, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    synovial joints\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be divided into different types, depending on their axis of movement. Membranes A \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    serous\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " membrane (also referred to as a serosa) is a thin membrane that covers the walls of organs in the thoracic and abdominal cavities. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    serous\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " membranes have two layers; parietal and visceral, surrounding a fluid filled space. The visceral layer of the membrane covers the organ (the viscera), and the parietal layer lines the walls of the body cavity (pariet- refers to a cavity wall). Between the parietal and visceral layers is a very thin, fluid-filled serous space, or cavity. For example, the pericardium is the serous cavity which surrounds the heart. Additional images See also Glossary of medicine Anatomical terms of bone Anatomical terms of muscle References Further reading Calais-Germain, Blandine (1993). Anatomy of Movement. Eastland Press. ISBN 978-0-939616-17-6. Drake, Richard; Vogl, Wayne; Mitchell, Adam (2004). Gray's Anatomy for Students. Churchill Livingstone. ISBN 978-0-443-06612-2. Martini, Frederic; Timmons, Michael; McKinnley, Michael (2000). Human Anatomy (3rd ed.). Prentice-Hall. ISBN 978-0-13-010011-5. Marieb, Elaine (2000). Essentials of Human Anatomy and Physiology (6th ed.). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Addison\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Wesley Longman. ISBN 978-0-8053-4940-5. Muscolino, Joseph E. (2005). The Muscular System Manual: The Skeletal Muscles of the Human Body (2nd ed.). C.V. Mosby. ISBN 978-0-323-02523-2. Ngai, Steven (2006). Understanding Anatomical Latin (PDF) (3rd ed.). Archived from the original (PDF) on 2009-03-25. Retrieved 2015-11-15. Losardo, R. J.; Valverde Barbato De Prates, N. E.; Arteaga-Martinez, M.; García Peláez, M. I.; Cabral, R. H. (2017). &quot;&quot;International Morphological Terminology (anatomy, histology and embryology): beyond scientific terms&quot;&quot;. Journal of Morphological Sciences. 34 (3): 130–133. doi:10.4322/jms.109916. ISSN 2177-0298.&quot; &quot;Ancient Egyptian deities are the gods and goddesses worshipped in ancient Egypt. The beliefs and rituals surrounding these gods formed the core of ancient Egyptian religion, which emerged sometime in prehistory. Deities represented natural forces and phenomena, and the Egyptians supported and appeased them through offerings and rituals so that these forces would continue to function according to maat, or divine order. After the founding of the Egyptian state around 3100 BC, the authority to perform these tasks was controlled by the pharaoh, who claimed to be the gods' representative and managed the temples where the rituals were carried out. The gods' complex characteristics were expressed in myths and in intricate relationships between deities: family ties, loose groups and hierarchies, and combinations of separate gods into one. Deities' diverse appearances in art—as animals, humans, objects, and combinations of different forms—also alluded, through symbolism, to their essential features. In different eras, various gods were said to hold the highest position in divine society, including the solar deity Ra, the mysterious god Amun, and the mother goddess Isis. The highest deity was usually credited with the creation of the world and often connected with the life-giving power of the sun. Some scholars have argued, based in part on Egyptian writings, that the Egyptians came to recognize a single divine power that lay behind all things and was present in all the other deities. Yet they never abandoned their original polytheistic view of the world, except possibly during the era of Atenism in the 14th century BC, when official religion focused exclusively on an abstract solar deity, the Aten. Gods were assumed to be present throughout the world, capable of influencing natural events and the course of human lives. People interacted with them in temples and unofficial shrines, for personal reasons as well as for larger goals of state rites. Egyptians prayed for divine help, used rituals to compel deities to act, and called upon them for advice. Humans' relations with their gods were a fundamental part of Egyptian society. Definition The beings in ancient Egyptian tradition who might be labeled as deities are difficult to count. Egyptian texts list the names of many deities whose nature is unknown and make vague, indirect references to other gods who are not even named. The Egyptologist James P. Allen estimates that more than 1,400 deities are named in Egyptian texts, whereas his colleague Christian Leitz says there are &quot;&quot;thousands upon thousands&quot;&quot; of gods.The Egyptian language's terms for these beings were nṯr, &quot;&quot;god&quot;&quot;, and its feminine form nṯrt, &quot;&quot;goddess&quot;&quot;. Scholars have tried to discern the original nature of the gods by proposing etymologies for these words, but none of these suggestions has gained acceptance, and the terms' origin remains obscure. The hieroglyphs that were used as ideograms and determinatives in writing these words show some of the traits that the Egyptians connected with divinity. The most common of these signs is a flag flying from a pole. Similar objects were placed at the entrances of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    temples\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", representing the presence of a deity, throughout ancient Egyptian history. Other such hieroglyphs include a falcon, reminiscent of several early gods who were depicted as falcons, and a seated male or female deity. The feminine form could also be written with an egg as determinative, connecting goddesses with creation and birth, or with a cobra, reflecting the use of the cobra to depict many female deities.The Egyptians distinguished nṯrw, &quot;&quot;gods&quot;&quot;, from rmṯ, &quot;&quot;people&quot;&quot;, but the meanings of the Egyptian and the English terms do not match perfectly. The term nṯr may have applied to any being that was in some way outside the sphere of everyday life. Deceased humans were called nṯr because they were considered to be like the gods, whereas the term was rarely applied to many of Egypt's lesser supernatural beings, which modern scholars often call &quot;&quot;demons&quot;&quot;. Egyptian religious art also depicts places, objects, and concepts in human form. These personified ideas range from deities that were important in myth and ritual to obscure beings, only mentioned once or twice, that may be little more than metaphors.Confronting these blurred distinctions between gods and other beings, scholars have proposed various definitions of a &quot;&quot;deity&quot;&quot;. One widely accepted definition, suggested by Jan Assmann, says that a deity has a cult, is involved in some aspect of the universe, and is described in mythology or other forms of written tradition. According to a different definition, by Dimitri Meeks, nṯr applied to any being that was the focus of ritual. From this perspective, &quot;&quot;gods&quot;&quot; included the king, who was called a god after his coronation rites, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deceased souls\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", who entered the divine realm through funeral ceremonies. Likewise, the preeminence of the great gods was maintained by the ritual devotion that was performed for them across Egypt. Origins The first written evidence of deities in Egypt comes from the Early Dynastic Period (c. 3100–2686 BC). Deities must have emerged sometime in the preceding Predynastic Period (before 3100 BC) and grown out of prehistoric religious beliefs. Predynastic artwork depicts a variety of animal and human figures. Some of these images, such as stars and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cattle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", are reminiscent of important features of Egyptian religion in later times, but in most cases, there is not enough evidence to say whether the images are connected with deities. As  Egyptian society grew more sophisticated, clearer signs of religious activity appeared. The earliest known \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    temples\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " appeared in the last centuries of the predynastic era, along with images that resemble the iconographies of known deities: the falcon that represents Horus and several other gods, the crossed arrows that stand for Neith, and the enigmatic &quot;&quot;Set animal&quot;&quot; that represents Set. Many Egyptologists and anthropologists have suggested theories about how the gods developed in these early times. Gustave Jéquier, for instance, thought the Egyptians first revered primitive fetishes, then deities in animal form, and finally deities in human form, whereas Henri Frankfort argued that the gods must have been envisioned in human form from the beginning. Some of these theories are now regarded as too simplistic, and more current ones, such as Siegfried Morenz' hypothesis that deities emerged as humans began to distinguish themselves from and personify their environment, are difficult to prove.Predynastic Egypt originally consisted of small, independent villages. Because many deities in later times were strongly tied to particular towns and regions, many scholars have suggested that the pantheon formed as disparate communities coalesced into larger states, spreading and intermingling the worship of the old local deities. Others have argued that the most important predynastic gods were, like other elements of Egyptian culture, present all across the country despite its political divisions.The final step in the formation of Egyptian religion was the unification of Egypt, in which rulers from Upper Egypt made themselves pharaohs of the entire country. These sacred kings and their subordinates assumed the right to interact with the gods, and kingship became the unifying focus of the religion.New deities continued to emerge after this transformation. Some important deities such as Isis and Amun are not known to have appeared until the Old Kingdom (c. 2686–2181 BC). Places and concepts could inspire the creation of a deity to represent them, and deities were sometimes created to serve as opposite-sex counterparts to established gods or goddesses. Kings were said to be divine, although only a few continued to be worshipped long after their \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deaths\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    non-royal\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " humans were said to have the favor of the gods and were venerated accordingly. This veneration was usually short-lived, but the court architects Imhotep and Amenhotep son of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hapu\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " were regarded as gods centuries after their lifetimes, as were some other officials.Through contact with neighboring civilizations, the Egyptians also adopted foreign deities. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Dedun\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", who is first mentioned in the Old Kingdom, may have come from Nubia, and Baal, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anat\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and Astarte, among others, were adopted from Canaanite religion during the New Kingdom (c. 1550–1070 BC). In Greek and Roman times, from 332 BC to the early centuries \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", deities from across the Mediterranean world were revered in Egypt, but the native gods remained, and they often absorbed the cults of these newcomers into their own worship. Characteristics Modern knowledge of Egyptian beliefs about the gods is mostly drawn from religious writings produced by the nation's scribes and priests. These people were the elite of Egyptian society and were very distinct from the general populace, most of whom were illiterate. Little is known about how well this broader population knew or understood the sophisticated ideas that the elite developed. Commoners' perceptions of the divine may have differed from those of the priests. The populace may, for example, have mistaken the religion's symbolic statements about the gods and their actions for literal truth. But overall, what little is known about popular religious belief is consistent with the elite tradition. The two traditions form a largely \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cohesive vision\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the gods and their nature. Roles Most Egyptian deities represent natural or social phenomena. The gods were generally said to be immanent in these phenomena—to be present within nature. The types of phenomena they represented include physical places and objects as well as abstract concepts and forces. The god Shu was the deification of all the world's air; the goddess Meretseger oversaw a limited region of the earth, the Theban Necropolis; and the god Sia personified the abstract notion of perception. Major gods were often involved in several types of phenomena. For instance, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Khnum\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was the god of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Elephantine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Island in the midst of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nile\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the river that was essential to Egyptian civilization. He was credited with producing the annual Nile flood that fertilized the country's farmland. Perhaps as an outgrowth of this life-giving function, he was said to create all living things, fashioning their bodies on a potter's wheel. Gods could share the same role in nature; Ra, Atum, Khepri, Horus, and other deities acted as sun gods. Despite their diverse functions, most gods had an overarching role in common: maintaining maat, the universal order that was a central principle of Egyptian religion and was itself personified as a goddess. Yet some deities represented disruption to maat. Most prominently, Apep was the force of chaos, constantly threatening to annihilate the order of the universe, and Set was an ambivalent member of divine society who could both fight disorder and foment it.Not all aspects of existence were seen as deities. Although many deities were connected with the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nile\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", no god personified it in the way that Ra personified the sun. Short-lived phenomena, such as rainbows or eclipses, were not represented by gods; neither were fire, water, or many other components of the world.The roles of each deity were fluid, and each god could expand its nature to take on new characteristics. As a result, gods' roles are difficult to categorize or define. Despite this flexibility, the gods had limited abilities and spheres of influence. Not even the creator god could reach beyond the boundaries of the cosmos that he created, and even Isis, though she was said to be the cleverest of the gods, was not omniscient. Richard H. Wilkinson, however, argues that some texts from the late New Kingdom suggest that as beliefs about the god Amun evolved he was thought to approach omniscience and omnipresence, and to transcend the limits of the world in a way that other deities did not.The deities with the most limited and specialized domains are often called &quot;&quot;minor divinities&quot;&quot; or &quot;&quot;demons&quot;&quot; in modern writing, although there is no firm definition for these terms. Some demons were guardians of particular places, especially in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Duat\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the realm of the dead. Others wandered through the human world and the Duat, either as servants and messengers of the greater gods or as roving spirits that caused illness or other misfortunes among humans. Demons' position in the divine hierarchy was not fixed. The protective deities Bes and Taweret originally had minor, demon-like roles, but over time they came to be credited with great influence. The most feared beings in the Duat were regarded as both disgusting and dangerous to humans. Over the course of Egyptian history, they came to be regarded as fundamentally inferior members of divine society and to represent the opposite of the beneficial, life-giving major gods. Yet even the most revered deities could sometimes exact vengeance on humans or each other, displaying a demon-like side to their character and blurring the boundaries between demons and gods. Behavior Divine behavior was believed to govern all of nature. Except for the few deities who disrupted the divine order, the gods' actions maintained maat and created and sustained all living things. They did this work using a force the Egyptians called heka, a term usually translated as &quot;&quot;magic&quot;&quot;. Heka was a fundamental power that the creator god used to form the world and the gods themselves. The gods' actions in the present are described and praised in hymns and funerary texts. In contrast, mythology mainly concerns the gods' actions during a vaguely imagined past in which the gods were present on earth and interacted directly with humans. The events of this past time set the pattern for the events of the present. Periodic occurrences were tied to events in the mythic past; the succession of each new pharaoh, for instance, reenacted Horus's accession to the throne of his father Osiris.Myths are metaphors for the gods' actions, which humans cannot fully understand. They contain seemingly contradictory ideas, each expressing a particular perspective on divine events. The contradictions in myth are part of the Egyptians' many-faceted approach to religious belief—what Henri Frankfort called a &quot;&quot;multiplicity of approaches&quot;&quot; to understanding the gods. In myth, the gods behave much like humans. They feel emotion; they can eat, drink, fight, weep, sicken, and die. Some have unique character traits. Set is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aggressive and impulsive\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and Thoth, patron of writing and knowledge, is prone to long-winded speeches. Yet overall, the gods are more like archetypes than well drawn characters. Different versions of a myth could portray different deities playing the same archetypal role, as in the myths of the Eye of Ra, a feminine aspect of the sun god who was represented by many goddesses. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Deities' mythic behavior\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is inconsistent, and their thoughts and motivations are rarely stated. Most myths lack highly developed characters and plots, because their symbolic meaning was more important than elaborate storytelling.The first divine act is the creation of the cosmos, described in several creation myths. They focus on different gods, each of which may act as creator deities. The eight gods of the Ogdoad, who represent the chaos that precedes creation, give \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    birth to the sun god\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", who establishes order in the newly formed world; Ptah, who embodies thought and creativity, gives form to all things by envisioning and naming them; Atum produces all things as emanations of himself; and Amun, according to the theology promoted by his priesthood, preceded and created the other creator gods. These and other versions of the events of creation were not seen as contradictory. Each gives a different perspective on the complex process by which the organized universe and its many deities emerged from undifferentiated chaos. The period following creation, in which a series of gods rule as kings over the divine society, is the setting for most myths. The gods struggle against the forces of chaos and among each other before withdrawing from the human world and installing the historical kings of Egypt to rule in their place.A recurring theme in these myths is the effort of the gods to maintain maat against the forces of disorder. They fight vicious battles with the forces of chaos at the start of creation. Ra and Apep, battling each other each night, continue this struggle into the present. Another prominent theme is the gods' \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and revival. The clearest instance where a god dies is the myth of Osiris's murder, in which that god is resurrected as ruler of the Duat. The sun god is also said to grow old during his daily journey across the sky, sink into the Duat at night, and emerge as a young child at dawn. In the process, he comes into contact with the rejuvenating water of Nun, the primordial chaos. Funerary texts that depict Ra's journey through the Duat also show the corpses of gods who are enlivened along with him. Instead of being \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    changelessly\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " immortal, the gods periodically died and were reborn by repeating the events of creation, thus renewing the whole world. Nonetheless, it was always possible for this cycle to be disrupted and for chaos to return. Some poorly understood Egyptian texts even suggest that this calamity is destined to happen—that the creator god will one day dissolve the order of the world, leaving only himself and Osiris amid the primordial chaos. Locations Gods were linked to specific regions of the universe. In Egyptian tradition, the world includes the earth, the sky, and the underworld. Surrounding them is the dark formlessness that existed before creation. The gods in general were said to dwell in the sky, although gods whose roles were linked with other parts of the universe were said to live in those places instead. Most events of mythology, set in a time before the gods' withdrawal from the human realm, take place in an earthly setting. The deities there sometimes interact with those in the sky. The underworld, in contrast, is treated as a remote and inaccessible place, and the gods who dwell there have difficulties in communicating with those in the world of the living. The space outside the cosmos is also said to be very distant. It too is inhabited by deities, some hostile and some beneficial to the other gods and their orderly world.In the time after myth, most gods were said to be either in the sky or invisibly present within the world. Temples were their main means of contact with humanity. Each day, it was believed, the gods moved from the divine realm to their \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    temples\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", their homes in the human world. There they inhabited the cult images, the statues that depicted deities and allowed humans to interact with them in temple rituals. This movement between realms was sometimes described as a journey between the sky and the earth. As temples were the focal points of Egyptian cities, the god in a city's main temple was the patron deity for the city and the surrounding region. Deities' spheres of influence on earth centered on the towns and regions they presided over. Many gods had more than one cult center and their local ties changed over time. They could establish themselves in new cities, or their range of influence could contract. Therefore, a given deity's main cult center in historical times is not necessarily his or her place of origin. The political influence of a city could affect the importance of its patron deity. When kings from Thebes took control of the country at start of the Middle Kingdom (c. 2055–1650 BC), they elevated Thebes' patron gods—first the war god Montu and then Amun—to national prominence. Names and epithets In Egyptian belief, names express the fundamental nature of the things to which they refer. In keeping with this belief, the names of deities often relate to their roles or origins. The name of the predatory goddess Sekhmet means &quot;&quot;powerful one&quot;&quot;, the name of the mysterious god Amun means &quot;&quot;hidden one&quot;&quot;, and the name of Nekhbet, who was worshipped in the city of Nekheb, means &quot;&quot;she of Nekheb&quot;&quot;. Many other names have no certain meaning, even when the gods who bear them are closely tied to a single role. The names of the sky goddess Nut and the earth god Geb do not resemble the Egyptian terms for sky and earth.The Egyptians also devised false etymologies giving more meanings to divine names. A passage in the Coffin Texts renders the name of the funerary god Sokar as sk r, meaning &quot;&quot;cleaning of the mouth&quot;&quot;, to link his name with his role in the Opening of the Mouth ritual, while one in the Pyramid Texts says the name is based on words shouted by Osiris in a moment of distress, connecting Sokar with the most important funerary deity.The gods were believed to have many names. Among them were secret names that conveyed their true natures more profoundly than others. To know the true name of a deity was to have power over it. The importance of names is demonstrated by a myth in which Isis poisons the superior god Ra and refuses to cure him unless he reveals his secret name to her. Upon learning the name, she tells it to her son, Horus, and by learning it they gain greater knowledge and power.In addition to their names, gods were given epithets, like &quot;&quot;possessor of splendor&quot;&quot;, &quot;&quot;ruler of Abydos&quot;&quot;, or &quot;&quot;lord of the sky&quot;&quot;, that describe some aspect of their roles or their worship. Because of the gods' multiple and overlapping roles, deities can have many epithets—with more important gods accumulating more titles—and the same epithet can apply to many deities. Some epithets eventually became separate deities, as with Werethekau, an epithet applied to several goddesses meaning &quot;&quot;great enchantress&quot;&quot;, which came to be treated as an independent goddess. The host of divine names and titles expresses the gods' multifarious nature. Gender and sexuality The Egyptians regarded the division between male and female as fundamental to all beings, including deities. Male gods tended to have a higher status than goddesses and were more closely connected with creation and with kingship, while goddesses were more often thought of as helping and providing for humans. Some deities were androgynous, but most examples are found in the context of creation \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myths\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", in which the androgynous deity represents the undifferentiated state that existed before the world was created. Atum was primarily male but had a feminine aspect within himself, who was sometimes seen as a goddess, known as Iusaaset or Nebethetepet. Creation began when Atum produced a sexually differentiated pair of deities: Shu and his consort Tefnut. Similarly, Neith, who was sometimes regarded as a creator goddess, was said to possess masculine traits but was mainly seen as female.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sex\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " and gender were closely tied to creation and thus rebirth. Male gods were believed to have the active role in conceiving children. Female deities were often relegated to a supporting role, stimulating their male consorts' virility and nurturing their children, although goddesses were given a larger role in procreation late in Egyptian history. Goddesses acted as mythological mothers and wives of kings and thus as prototypes of human queenship. Hathor, who was the mother or consort of Horus and the most important goddess for much of Egyptian history, exemplified this relationship between divinity and the king.Female deities also had a violent aspect that could be seen either positively, as with the goddesses Wadjet and Nekhbet who protected the king, or negatively. The myth of the Eye of Ra contrasts \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    feminine aggression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with sexuality and nurturing, as the goddess rampages in the form of Sekhmet or another dangerous deity until the other gods appease her, at which point she becomes a benign goddess such as Hathor who, in some versions, then becomes the consort of a male god.The Egyptian conception of sexuality was heavily focused on heterosexual reproduction, and homosexual acts were usually viewed with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    disapproval\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Some texts nevertheless refer to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    homosexual behavior\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " between male deities. In some cases, most notably when Set sexually assaulted Horus, these acts served to assert the dominance of the active partner and humiliate the submissive one. Other couplings between male deities could be viewed positively and even produce offspring, as in one text in which \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Khnum\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is born from the union of Ra and Shu. Relationships \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Egyptian deities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are connected in a complex and shifting array of relationships. A god's connections and interactions with other deities helped define its character. Thus Isis, as the mother and protector of Horus, was a great \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    healer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as well as the patroness of kings. Such relationships were in fact more important than myths in expressing Egyptians' religious worldview, although they were also the base material from which myths were formed. Family relationships are a common type of connection between gods. Deities often form male and female pairs. Families of three deities, with a father, mother, and child, represent the creation of new life and the succession of the father by the child, a pattern that connects divine families with royal succession. Osiris, Isis, and Horus formed the quintessential family of this type. The pattern they set grew more widespread over time, so that many deities in local cult centers, like Ptah, Sekhmet, and their child Nefertum at Memphis and the Theban Triad at Thebes, were assembled into family triads. Genealogical connections like these vary according to the circumstances. Hathor could act as the mother, consort, or daughter of the sun god, and the child form of Horus acted as the third member of many local family triads.Other divine groups were composed of deities with interrelated roles, or who together represented a region of the Egyptian mythological cosmos. There were sets of gods for the hours of the day and night and for each nome (province) of Egypt. Some of these groups contain a specific, symbolically important number of deities. Paired gods sometimes have similar roles, as do Isis and her sister Nephthys in their protection and support of Osiris. Other pairs stand for opposite but interrelated concepts that are part of a greater unity. Ra, who is dynamic and light-producing, and Osiris, who is static and shrouded in darkness, merge into a single god each night. Groups of three are linked with plurality in ancient Egyptian thought, and groups of four connote completeness. Rulers in the late New Kingdom promoted a particularly important group of three gods above all others: Amun, Ra, and Ptah. These deities stood for the plurality of all gods, as well as for their own cult centers (the major cities of Thebes, Heliopolis, and Memphis) and for many threefold sets of concepts in Egyptian religious thought. Sometimes Set, the patron god of the Nineteenth Dynasty kings and the embodiment of disorder within the world, was added to this group, which emphasized a single coherent vision of the pantheon.Nine, the product of three and three, represents a multitude, so the Egyptians called several large groups &quot;&quot;Enneads&quot;&quot;, or sets of nine, even if they had more than nine members. The most prominent ennead was the Ennead of Heliopolis, an extended family of deities descended from Atum, which incorporates many important gods. The term &quot;&quot;ennead&quot;&quot; was often extended to include all of Egypt's deities.This divine assemblage had a vague and changeable hierarchy. Gods with broad influence in the cosmos or who were mythologically older than others had higher positions in divine society. At the apex of this society was the king of the gods, who was usually identified with the creator deity. In different periods of Egyptian history, different gods were most frequently said to hold this exalted position. Horus was the most important god in the Early Dynastic Period, Ra rose to preeminence in the Old Kingdom, Amun was supreme in the New, and in the Ptolemaic and Roman periods, Isis was the divine queen and creator goddess. Newly prominent gods tended to adopt characteristics from their predecessors. Isis absorbed the traits of many other goddesses during her rise, and when Amun became the ruler of the pantheon, he was conjoined with Ra to become a solar deity. Manifestations and combinations The gods were believed to manifest in many forms. The Egyptians had a complex conception of the human soul, consisting of several parts. The spirits of the gods were composed of many of these same elements. The ba was the component of the human or divine soul that affected the world around it. Any visible manifestation of a god's power could be called its ba; thus, the sun was called the ba of Ra. A depiction of a deity was considered a ka, another component of its being, which acted as a vessel for that deity's ba to inhabit. The cult images of gods that were the focus of temple rituals, as well as the sacred animals that represented certain deities, were believed to house divine bas in this way. Gods could be ascribed many \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and kas, which were sometimes given names representing different aspects of the god's nature. Everything in existence was said to be one of the kas of Atum the creator god, who originally contained all things within himself, and one deity could be called the ba of another, meaning that the first god is a manifestation of the other's power. Divine body parts could act as separate deities, like the Eye of Ra and Hand of Atum, both of which were personified as goddesses. The gods were so full of life-giving power that even their bodily fluids could transform into other living things; humankind was said to have sprung from the creator god's tears, and the other deities from his sweat.Nationally important deities gave rise to local manifestations, which sometimes absorbed the characteristics of older regional gods. Horus had many forms tied to particular places, including Horus of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nekhen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Horus of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Buhen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and Horus of Edfu. Such local manifestations could be treated almost as separate beings. During the New Kingdom, one man was accused of stealing clothes by an oracle supposed to communicate messages from Amun of Pe-Khenty. He consulted two other local oracles of Amun hoping for a different judgment. Gods' manifestations also differed according to their roles. Horus could be a powerful sky god or vulnerable child, and these forms were sometimes counted as independent deities.Gods were combined with each other as easily as they were divided. A god could be called the ba of another, or two or more deities could be joined into one god with a combined name and iconography. Local gods were linked with greater ones, and deities with similar functions were combined. Ra was connected with the local deity Sobek to form Sobek-Ra; with his fellow ruling god, Amun, to form \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amun-Ra\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "; with the solar form of Horus to form \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ra-Horakhty\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "; and with several solar deities as Horemakhet-Khepri-Ra-Atum. On rare occasion, deities of different sexes could be joined in this way, producing combinations such as Osiris-Neith. This linking of deities is called syncretism. Unlike other situations for which this term is used, the Egyptian practice was not meant to fuse competing belief systems, although \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    foreign deities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " could be syncretized with native ones. Instead, syncretism acknowledged the overlap between deities' roles and extended the sphere of influence for each of them. Syncretic combinations were not permanent; a god who was involved in one combination continued to appear separately and to form new combinations with other deities. Closely connected deities did sometimes merge. Horus absorbed several falcon gods from various regions, such as Khenti-irty and Khenti-kheti, who became little more than local manifestations of him; Hathor subsumed a similar cow goddess, Bat; and an early funerary god, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Khenti-Amentiu\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", was supplanted by Osiris and Anubis. Aten and possible monotheism In the reign of Akhenaten (c. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    1353–1336\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " BC) in the mid-New Kingdom, a single solar deity, the Aten, became the sole focus of the state religion. Akhenaten ceased to fund the temples of other deities and erased gods' names and images on monuments, targeting Amun in particular. This new religious system, sometimes called \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Atenism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", differed dramatically from the polytheistic worship of many gods in all other periods. The Aten had no mythology, and it was portrayed and described in more abstract terms than traditional deities. Whereas, in earlier times, newly important gods were integrated into existing religious beliefs, Atenism insisted on a single understanding of the divine that excluded the traditional multiplicity of perspectives. Yet Atenism may not have been full monotheism, which totally excludes belief in other deities. There is evidence suggesting that the general populace continued to worship other gods in private. The picture is further complicated by Atenism's apparent tolerance for some other deities, such as Maat, Shu, and Tefnut. For these reasons, the Egyptologists Dominic Montserrat and John Baines have suggested that Akhenaten may have been monolatrous, worshipping a single deity while acknowledging the existence of others. In any case, Atenism's aberrant theology did not take root among the Egyptian populace, and Akhenaten's successors returned to traditional beliefs. Unity of the divine in traditional religion Scholars have long debated whether traditional Egyptian religion ever asserted that the multiple gods were, on a deeper level, unified. Reasons for this debate include the practice of syncretism, which might suggest that all the separate gods could ultimately merge into one, and the tendency of Egyptian texts to credit a particular god with power that surpasses all other deities. Another point of contention is the appearance of the word &quot;&quot;god&quot;&quot; in wisdom literature, where the term does not refer to a specific deity or group of deities. In the early 20th century, for instance, E. A. Wallis Budge believed that Egyptian commoners were polytheistic, but knowledge of the true monotheistic nature of the religion was reserved for the elite, who wrote the wisdom literature. His contemporary James Henry Breasted thought Egyptian religion was instead pantheistic, with the power of the sun god present in all other gods, while Hermann Junker argued that Egyptian civilization had been originally monotheistic and became polytheistic in the course of its history.In 1971, Erik Hornung published a study rebutting such views. He points out that in any given period many deities, even minor ones, were described as superior to all others. He also argues that the unspecified &quot;&quot;god&quot;&quot; in the wisdom texts is a generic term for whichever deity is relevant to the reader in the situation at hand. Although the combinations, manifestations, and iconographies of each god were constantly shifting, they were always restricted to a finite number of forms, never becoming fully interchangeable in a monotheistic or pantheistic way. Henotheism, Hornung says, describes Egyptian religion better than other labels. An Egyptian could worship any deity at a particular time and credit it with supreme power in that moment, without denying the other gods or merging them all with the god that he or she focused on. Hornung concludes that the gods were fully unified only in myth, at the time before creation, after which the multitude of gods emerged from a uniform nonexistence.Hornung's arguments have greatly influenced other scholars of Egyptian religion, but some still believe that at times the gods were more unified than he allows. Jan Assmann maintains that the notion of a single deity developed slowly through the New Kingdom, beginning with a focus on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amun-Ra\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " as the all-important sun god. In his view, Atenism was an extreme outgrowth of this trend. It equated the single deity with the sun and dismissed all other gods. Then, in the backlash against \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Atenism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", priestly theologians described the universal god in a different way, one that coexisted with traditional polytheism. The one god was believed to transcend the world and all the other deities, while at the same time, the multiple gods were aspects of the one. According to Assmann, this one god was especially equated with Amun, the dominant god in the late New Kingdom, whereas for the rest of Egyptian history the universal deity could be identified with many other gods. James P. Allen says that coexisting notions of one god and many gods would fit well with the &quot;&quot;multiplicity of approaches&quot;&quot; in Egyptian thought, as well as with the henotheistic practice of ordinary worshippers. He says that the Egyptians may have recognized the unity of the divine by &quot;&quot;identifying their uniform notion of 'god' with a particular god, depending on the particular situation.&quot;&quot; Descriptions and depictions Egyptian writings describe the gods' bodies in detail. They are made of precious materials; their flesh is gold, their bones are \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    silver\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and their hair is lapis lazuli. They give off a scent that the Egyptians likened to the incense used in rituals. Some texts give precise descriptions of particular deities, including their height and eye color. Yet these characteristics are not fixed; in myths, gods change their appearances to suit their own purposes. Egyptian texts often refer to deities' true, underlying forms as &quot;&quot;mysterious&quot;&quot;. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Egyptians' visual representations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of their gods are therefore not literal. They symbolize specific aspects of each deity's character, functioning much like the ideograms in hieroglyphic writing. For this reason, the funerary god Anubis is commonly shown in Egyptian art as a dog or jackal, a creature whose scavenging habits threaten the preservation of buried mummies, in an effort to counter this threat and employ it for protection. His black coloring alludes to the color of mummified flesh and to the fertile black soil that Egyptians saw as a symbol of resurrection.Most deities were depicted in several ways. Hathor could be a cow, cobra, lioness, or a woman with bovine horns or ears. By depicting a given god in different ways, the Egyptians expressed different aspects of its essential nature. The gods are depicted in a finite number of these symbolic forms, so they can often be distinguished from one another by their iconographies. These forms include men and women (anthropomorphism), animals (zoomorphism), and, more rarely, inanimate objects. Combinations of forms, such as deities with human bodies and animal heads, are common. New forms and increasingly complex combinations arose in the course of history, with the most surreal forms often found among the demons of the underworld. Some gods can only be distinguished from others if they are labeled in writing, as with Isis and Hathor. Because of the close connection between these goddesses, they could both wear the cow-horn headdress that was originally Hathor's alone. Certain features of divine images are more useful than others in determining a god's identity. The head of a given divine image is particularly significant. In a hybrid image, the head represents the original form of the being depicted, so that, as the Egyptologist Henry Fischer put it, &quot;&quot;a lion-headed goddess is a lion-goddess in human form, while a royal sphinx, conversely, is a man who has assumed the form of a lion.&quot;&quot; Divine headdresses, which range from the same types of crowns used by human kings to large hieroglyphs worn on gods' heads, are another important indicator. In contrast, the objects held in gods' hands tend to be generic. Male deities hold was staffs, goddesses hold stalks of papyrus, and both sexes carry ankh signs, representing the Egyptian word for &quot;&quot;life&quot;&quot;, to symbolize their life-giving power.The forms in which the gods are shown, although diverse, are limited in many ways. Many creatures that are widespread in Egypt were never used in divine iconography. Others could represent many deities, often because these deities had major characteristics in common. Bulls and rams were associated with virility, cows and falcons with the sky, hippopotami with maternal protection, felines with the sun god, and serpents with both danger and renewal. Animals that were absent from Egypt in the early stages of its history were not used as divine images. For instance, the horse, which was only introduced in the Second Intermediate Period (c. 1650–1550 BC), never represented a god. Similarly, the clothes worn by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anthropomorphic deities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in most periods changed little from the styles used in the Old Kingdom: a kilt, false beard, and often a shirt for male gods and a long, tight-fitting dress for goddesses.The basic anthropomorphic form varies. Child gods are depicted nude, as are some adult gods when their procreative powers are emphasized. Certain male deities are given heavy bellies and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breasts\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", signifying either androgyny or prosperity and abundance. Whereas most male gods have red skin and most goddesses are yellow—the same colors used to depict Egyptian men and women—some are given unusual, symbolic skin colors. Thus, the blue skin and paunchy figure of the god Hapi alludes to the Nile flood he represents and the nourishing fertility it brought. A few deities, such as Osiris, Ptah, and Min, have a &quot;&quot;mummiform&quot;&quot; appearance, with their limbs tightly swathed in cloth. Although these gods resemble mummies, the earliest examples predate the cloth-wrapped style of mummification, and this form may instead hark back to the earliest, limbless depictions of deities.Some inanimate objects that represent deities are drawn from nature, such as trees or the disk-like emblems for the sun and the moon. Some objects associated with a specific god, like the crossed bows representing Neith (𓋋) or the emblem of Min (𓋉) symbolized the cults of those deities in Predynastic times. In many of these cases, the nature of the original object is mysterious. In the Predynastic and Early Dynastic Periods, gods were often represented by divine standards: poles topped by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    emblems of deities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", including both animal forms and inanimate objects. Interactions with humans Relationship with the pharaoh In official writings, pharaohs are said to be divine, and they are constantly depicted in the company of the deities of the pantheon. Each pharaoh and his predecessors were considered the successors of the gods who had ruled Egypt in mythic prehistory. Living kings were equated with Horus and called the &quot;&quot;son&quot;&quot; of many male deities, particularly Osiris and Ra; deceased kings were equated with these elder gods. Kings' wives and mothers were likened to many goddesses. The few women who made themselves pharaohs, such as Hatshepsut, connected themselves with these same goddesses while adopting much of the masculine imagery of kingship. Pharaohs had their own mortuary temples where rituals were performed for them during their lives and after their \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deaths\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". But few pharaohs were worshipped as gods long after their lifetimes, and non-official texts portray kings in a human light. For these reasons, scholars disagree about how genuinely most Egyptians believed the king to be a god. He may only have been considered divine when he was performing ceremonies.However much it was believed, the king's divine status was the rationale for his role as Egypt's representative to the gods, as he formed a link between the divine and human realms. The Egyptians believed the gods needed temples to dwell in, as well as the periodic performance of rituals and presentation of offerings to nourish them. These things were provided by the cults that the king oversaw, with their priests and laborers. Yet, according to royal ideology, temple-building was exclusively the pharaoh's work, as were the rituals that priests usually performed in his stead. These acts were a part of the king's fundamental role: maintaining maat. The king and the nation he represented provided the gods with maat so they could continue to perform their functions, which maintained maat in the cosmos so humans could continue to live. Presence in the human world Although the Egyptians believed their gods to be present in the world around them, contact between the human and divine realms was mostly limited to specific circumstances. In literature, gods may appear to humans in a physical form, but in real life, the Egyptians were limited to more indirect means of communication.The ba of a god was said to periodically leave the divine realm to dwell in the images of that god. By inhabiting these images, the gods left their concealed state and took on a physical form. To the Egyptians, a place or object that was \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ḏsr—&quot;&quot;sacred&quot;&quot;—\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "was isolated and ritually pure, and thus fit for a god to inhabit. Temple statues and reliefs, as well as particular sacred animals, like the Apis bull, served as divine intermediaries in this way. Dreams and trances provided a very different venue for interaction. In these states, it was believed, people could come close to the gods and sometimes receive messages from them. Finally, according to Egyptian afterlife beliefs, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human souls\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " pass into the divine realm after \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The Egyptians therefore believed that in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " they would exist on the same level as the gods and understand their mysterious nature. Temples, where the state rituals were carried out, were filled with images of the gods. The most important temple image was the cult statue in the inner sanctuary. These statues were usually less than life-size and made of the same precious materials that were said to form the gods' bodies. Many temples had several sanctuaries, each with a cult statue representing one of the gods in a group such as a family triad. The city's primary god was envisioned as its lord, employing many of the residents as servants in the divine household that the temple represented. The gods residing in the temples of Egypt collectively represented the entire pantheon. But many deities—including some important gods as well as those that were minor or hostile—were never given temples of their own, although some were represented in the temples of other gods.To insulate the sacred power in the sanctuary from the impurities of the outside world, the Egyptians enclosed temple sanctuaries and greatly restricted access to them. People other than kings and high priests were thus denied contact with cult statues. The exception was during festival processions, when the statue was carried out of the temple enclosed in a portable shrine, which usually hid it from public view. People did have less direct means of interaction. The more public parts of temples often incorporated small places for prayer, from doorways to freestanding chapels near the back of the temple building. Communities also built and managed small chapels for their own use, and some families had shrines inside their homes. Intervention in human lives Egyptian gods were involved in human lives as well as in the overarching order of nature. This divine influence applied mainly to Egypt, as foreign peoples were traditionally believed to be outside the divine order. In the New Kingdom, when other nations were under Egyptian control, foreigners were said to be under the sun god's benign rule in the same way that Egyptians were.Thoth, as the overseer of time, was said to allot fixed lifespans to both humans and gods. Other gods were also said to govern the length of human lives, including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Meskhenet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Renenutet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", both of whom presided over birth, and Shai, the personification of fate. Thus, the time and manner of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was the main meaning of the Egyptian concept of fate, although to some extent these deities governed other events in life as well. Several texts refer to gods influencing or inspiring human decisions, working through a person's &quot;&quot;heart\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    &quot;&quot;—\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "the seat of emotion and intellect in Egyptian belief. Deities were also believed to give commands, instructing the king in the governance of his realm and regulating the management of their temples. Egyptian texts rarely mention direct commands given to private persons, and these commands never evolved into a set of divinely enforced moral codes. Morality in ancient Egypt was based on the concept of maat, which, when applied to human society, meant that everyone should live in an orderly way that did not interfere with the well-being of other people. Because deities were the upholders of maat, morality was connected with them. For example, the gods judged humans' moral righteousness after \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and by the New Kingdom, a verdict of innocence in this judgement was believed to be necessary for admittance into the afterlife. In general, however, morality was based on practical ways to uphold maat in daily life, rather than on strict rules that the gods laid out. Humans had free will to ignore divine guidance and the behavior required by maat, but by doing so they could bring divine punishment upon themselves. A deity carried out this punishment using its ba, the force that manifested the god's power in the human world. Natural disasters and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human ailments\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " were seen as the work of angry divine bas. Conversely, the gods could cure righteous people of illness or even extend their lifespans. Both these types of intervention were eventually represented by deities: Shed, who emerged in the New Kingdom to represent divine rescue from harm, and Petbe, an apotropaic god from the late eras of Egyptian history who was believed to avenge wrongdoing.Egyptian texts take different views on whether the gods are responsible when humans suffer unjustly. Misfortune was often seen as a product of isfet, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cosmic disorder\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that was the opposite of maat, and therefore the gods were not guilty of causing evil events. Some deities who were closely connected with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    isfet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", such as Set, could be blamed for disorder within the world without placing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    guilt\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on the other gods. Some writings do accuse the deities of causing human misery, while others give theodicies in the gods' defense. Beginning in the Middle Kingdom, several texts connected the issue of evil in the world with a myth in which the creator god fights a human rebellion against his rule and then withdraws from the earth. Because of this human misbehavior, the creator is distant from his creation, allowing suffering to exist. New Kingdom writings do not question the just nature of the gods as strongly as those of the Middle Kingdom. They emphasize humans' direct, personal relationships with deities and the gods' power to intervene in human events. People in this era put faith in specific gods who they hoped would help and protect them through their lives. As a result, upholding the ideals of maat grew less important than gaining the gods' favor as a way to guarantee a good life. Even the pharaohs were regarded as dependent on divine aid, and after the New Kingdom came to an end, government was increasingly influenced by oracles communicating the gods' will. Worship Official religious practices, which maintained maat for the benefit of all Egypt, were related to, but distinct from, the religious practices of ordinary people, who sought the gods' help for their personal problems. Official religion involved a variety of rituals, based in temples. Some rites were performed every day, whereas others were \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    festivals\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", taking place at longer intervals and often limited to a particular temple or deity. The gods received their offerings in daily ceremonies, in which their statues were clothed, anointed, and presented with food as hymns were recited in their honor. These offerings, in addition to maintaining maat for the gods, celebrated deities' life-giving generosity and encouraged them to remain benevolent rather than vengeful. Festivals often involved a ceremonial procession in which a cult image was carried out of the temple in a barque-shaped shrine. These processions served various purposes. In Roman times, when local deities of all kinds were believed to have power over the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nile\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " inundation, processions in many communities carried temple images to the riverbanks so the gods could invoke a large and fruitful \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    flood\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Processions also traveled between \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    temples\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", as when the image of Hathor from Dendera Temple visited her consort Horus at the Temple of Edfu. Rituals for a god were often based in that deity's mythology. Such rituals were meant to be repetitions of the events of the mythic past, renewing the beneficial effects of the original events. In the Khoiak festival in honor of Osiris, his \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and resurrection were ritually reenacted at a time when crops were beginning to sprout. The returning greenery symbolized the renewal of the god's own life.Personal interaction with the gods took many forms. People who wanted information or advice consulted oracles, run by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    temples\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", that were supposed to convey gods' answers to questions. Amulets and other images of protective deities were used to ward off the demons that might threaten human well-being or to impart the god's positive characteristics to the wearer. Private rituals invoked the gods' power to accomplish personal goals, from healing sickness to cursing enemies. These practices used heka, the same force of magic that the gods used, which the creator was said to have given to humans so they could fend off misfortune. The performer of a private rite often took on the role of a god in a myth, or even threatened a deity, to involve the gods in accomplishing the goal. Such rituals coexisted with private offerings and prayers, and all three were accepted means of obtaining divine help.Prayer and private offerings are generally called &quot;&quot;personal piety&quot;&quot;: acts that reflect a close relationship between an individual and a god. Evidence of personal piety is scant before the New Kingdom. Votive offerings and personal names, many of which are \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    theophoric\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", suggest that commoners felt some connection between themselves and their gods, but firm evidence of devotion to deities became visible only in the New Kingdom, reaching a peak late in that era. Scholars disagree about the meaning of this change—whether direct interaction with the gods was a new development or an outgrowth of older traditions. Egyptians now expressed their devotion through a new variety of activities in and around temples. They recorded their prayers and their thanks for divine help on stelae. They gave offerings of figurines that represented the gods they were praying to, or that symbolized the result they desired; thus, a relief image of Hathor and a statuette of a woman could both represent a prayer for fertility. Occasionally, a person took a particular god as a patron, dedicating his or her property or labor to the god's cult. These practices continued into the latest periods of Egyptian history. These later eras saw more religious innovations, including the practice of giving animal mummies as offerings to deities depicted in animal form, such as the cat mummies given to the feline goddess Bastet. Some of the major deities from myth and official religion were rarely invoked in popular worship, but many of the great state gods were important in popular tradition.The worship of some Egyptian gods spread to neighboring lands, especially to Canaan and Nubia during the New Kingdom, when those regions were under pharaonic control. In Canaan, the exported deities, including Hathor, Amun, and Set, were often syncretized with native gods, who in turn spread to Egypt. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Egyptian deities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may not have had permanent temples in Canaan, and their importance there waned after Egypt lost control of the region. In contrast, many temples to the major Egyptian gods and deified pharaohs were built in Nubia. After the end of Egyptian rule there, the imported gods, particularly Amun and Isis, were syncretized with local deities and remained part of the religion of Nubia's independent Kingdom of Kush. These gods were incorporated into the Nubian ideology of kingship much as they were in Egypt, so that Amun was considered the divine father of the king and Isis and other goddesses were linked with the Nubian queen, the kandake. Some deities reached farther. Taweret became a goddess in Minoan Crete, and Amun's oracle at Siwa \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Oasis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was known to and consulted by people across the Mediterranean region. Under the Greek Ptolemaic Dynasty and then Roman rule, Greeks and Romans introduced their own deities to Egypt. These newcomers equated the Egyptian gods with their own, as part of the Greco-Roman tradition of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    interpretatio\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " graeca. The worship of the native gods was not swallowed up by that of foreign ones. Instead, Greek and Roman gods were adopted as manifestations of Egyptian ones. Egyptian cults sometimes incorporated Greek language, philosophy, iconography, and even temple architecture. Meanwhile, the cults of several \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Egyptian deities—\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "particularly Isis, Osiris, Anubis, the form of Horus named Harpocrates, and the fused Greco-Egyptian god Serapis—were adopted into Roman religion and spread across the Roman Empire. Roman emperors, like Ptolemaic kings before them, invoked Isis and Serapis to endorse their authority, inside and outside Egypt. In the empire's complex mix of religious traditions, Thoth was transmuted into the legendary esoteric teacher Hermes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Trismegistus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and Isis, who was venerated from Britain to Mesopotamia, became the focus of a Greek-style mystery cult. Isis and Hermes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Trismegistus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " were both prominent in the Western esoteric tradition that grew from the Roman religious world.Temples and cults in Egypt itself declined as the Roman economy deteriorated in the third century AD, and beginning in the fourth century, Christians suppressed the veneration of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Egyptian deities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The last formal cults, at Philae, died out in the fifth or sixth century. Most beliefs surrounding the gods themselves disappeared within a few hundred years, remaining in magical texts into the seventh and eighth centuries. In contrast, many of the practices involved in their worship, such as processions and oracles, were adapted to fit Christian ideology and persisted as part of the Coptic Church. Given the great changes and diverse influences in Egyptian culture since that time, scholars disagree about whether any modern Coptic practices are descended from those of pharaonic religion. But many \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    festivals\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and other traditions of modern Egyptians, both Christian and Muslim, resemble the worship of their ancestors' gods. See also List of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Egyptian deities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Notes References Citations Works cited Further reading Leitz, Christian, ed. (2002). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lexikon der ägyptischen Götter\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " und Götterbezeichnungen (in German). Peeters. Vol. I: ISBN 978-90-429-1146-8; Vol. II: ISBN 978-90-429-1147-5;  Vol. III: ISBN 978-90-429-1148-2;  Vol. IV: ISBN 978-90-429-1149-9;  Vol. V: ISBN 978-90-429-1150-5; Vol. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    VI\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ": ISBN 978-90-429-1151-2;  Vol. VII: ISBN 978-90-429-1152-9;  Vol. VIII: ISBN 978-90-429-1376-9. Watterson, Barbara (1984). Gods of Ancient Egypt. Guild Publishing. ISBN 978-0-7134-4523-7. External links Gods and goddesses in ancient Egyptian belief at Digital Egypt for Universities&quot; &quot;Ancient Egyptian religion was a complex system of polytheistic beliefs and rituals that formed an integral part of ancient Egyptian culture. It centered on the Egyptians' interactions with many deities believed to be present in, and in control of the world. Rituals such as prayer and offerings were provided to the gods to gain their favor. Formal religious practice centered on the pharaohs, the rulers of Egypt, believed to possess divine powers by virtue of their positions. They acted as intermediaries between their people and the gods, and were obligated to sustain the gods through rituals and offerings so that they could maintain Ma'at, the order of the cosmos, and repel Isfet, which was chaos. The state dedicated enormous resources to religious rituals and to the construction of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    temples\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Individuals could interact with the gods for their own purposes, appealing for help through prayer or compelling the gods to act through magic. These practices were distinct from, but closely linked with, the formal rituals and institutions. The popular religious tradition grew more prominent over the course of Egyptian history as the status of the pharaoh declined. Egyptian belief in the afterlife and the importance of funerary practices is evident in the great efforts made to ensure the survival of their souls after \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " – via the provision of tombs, grave goods and offerings to preserve the bodies and spirits of the deceased. The religion had its roots in Egypt's prehistory and lasted for 3,500 years. The details of religious belief changed over time as the importance of particular gods rose and declined, and their intricate relationships shifted.  At various times, certain gods became preeminent over the others, including the sun god Ra, the creator god Amun, and the mother goddess Isis. For a brief period, in the theology promulgated by the pharaoh Akhenaten, a single god, the Aten, replaced the traditional pantheon. Ancient Egyptian religion and mythology left behind many writings and monuments, along with significant influences on ancient and modern cultures. Beliefs The beliefs and rituals now referred to as &quot;&quot;ancient Egyptian religion&quot;&quot; were integral within every aspect of Egyptian culture. The Egyptian language possessed no single term corresponding to the modern European concept of religion. Ancient Egyptian religion consisted of a vast and varying set of beliefs and practices, linked by their common focus on the interaction between the world of humans and the world of the divine. The characteristics of the gods who populated the divine realm were inextricably linked to the Egyptians' understanding of the properties of the world in which they lived. Deities The Egyptians believed that the phenomena of nature were divine forces in and of themselves.  These deified forces included the elements, animal characteristics, or abstract forces.  The Egyptians believed in a pantheon of gods, which were involved in all aspects of nature and human society. Their religious practices were efforts to sustain and placate these phenomena and turn them to human advantage. This polytheistic system was very complex, as some deities were believed to exist in many different manifestations, and some had multiple mythological roles.  Conversely, many natural forces, such as the sun, were associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    multiple deities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  The diverse pantheon ranged from gods with vital roles in the universe to minor deities or &quot;&quot;demons&quot;&quot; with very limited or localized functions.  It could include gods adopted from foreign cultures, and sometimes humans: deceased pharaohs were believed to be divine, and occasionally, distinguished commoners such as Imhotep also became deified.The depictions of the gods in art were not meant as literal representations of how the gods might appear if they were visible, as the gods' true natures were believed to be mysterious. Instead, these depictions gave recognizable forms to the abstract deities by using symbolic imagery to indicate each god's role in nature.   This iconography was not fixed, and many of the gods could be depicted in more than one form.Many gods were associated with particular regions in Egypt where their cults were most important. However, these associations changed over time, and they did not mean that the god associated with a place had originated there. For instance, the god Montu was the original patron of the city of Thebes. Over the course of the Middle Kingdom, however, he was displaced in that role by Amun, who may have arisen elsewhere. The national popularity and importance of individual gods fluctuated in a similar way.Deities had complex interrelationships, which partly reflected the interaction of the forces they represented. The Egyptians often grouped gods together to reflect these relationships. One of the more common combinations was a family triad consisting of a father, mother, and child, who were worshipped together. Some groups had wide-ranging importance. One such group, the Ennead, assembled nine deities into a theological system that was involved in the mythological areas of creation, kingship, and the afterlife.The relationships between deities could also be expressed in the process of syncretism, in which two or more different gods were linked to form a composite deity.  This process was a recognition of the presence of one god &quot;&quot;in&quot;&quot; another when the second god took on a role belonging to the first.  These links between deities were fluid, and did not represent the permanent merging of two gods into one; therefore, some gods could develop multiple syncretic connections. Sometimes, syncretism combined deities with very similar characteristics. At other times it joined gods with very different natures, as when Amun, the god of hidden power, was linked with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ra\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the god of the sun. The resulting god, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Amun-Ra\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", thus united the power that lay behind all things with the greatest and most visible force in nature.Many deities could be given epithets that seem to indicate that they were greater than any other god, suggesting some kind of unity beyond the multitude of natural forces. This is particularly true of a few gods who, at various points, rose to supreme importance in Egyptian religion. These included the royal patron Horus, the sun god Ra, and the mother goddess Isis.  During the New Kingdom (c. 1550–1070 BC) Amun held this position. The theology of the period described in particular detail Amun's presence in and rule over all things, so that he, more than any other deity, embodied the all-encompassing power of the divine. Cosmology The Egyptian conception of the universe centered on Ma'at, a word that encompasses several concepts in English, including &quot;&quot;truth,&quot;&quot; &quot;&quot;justice,&quot;&quot; and &quot;&quot;order.&quot;&quot;  It was the fixed, eternal order of the universe, both in the cosmos and in human society, and was often personified as a goddess. It had existed since the creation of the world, and without it the world would lose its cohesion. In Egyptian belief, Ma'at was constantly under threat from the forces of disorder, so all of society was required to maintain it. On the human level this meant that all members of society should cooperate and coexist; on the cosmic level it meant that all of the forces of nature—the gods—should continue to function in balance. This latter goal was central to Egyptian religion. The Egyptians sought to maintain Ma'at in the cosmos by sustaining the gods through offerings and by performing rituals which staved off disorder and perpetuated the cycles of nature.The most important part of the Egyptian view of the cosmos was the conception of time, which was greatly concerned with the maintenance of Ma'at. Throughout the linear passage of time, a cyclical pattern recurred, in which Ma'at was renewed by periodic events which echoed the original creation. Among these events were the annual Nile flood and the succession from one king to another, but the most important was the daily journey of the sun god Ra.When thinking of the shape of the cosmos, the Egyptians saw the earth as a flat expanse of land, personified by the god Geb, over which arched the sky goddess Nut. The two were separated by Shu, the god of air. Beneath the earth lay a parallel underworld and undersky, and beyond the skies lay the infinite expanse of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nu\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the chaos that had existed before creation.  The Egyptians also believed in a place called the Duat, a mysterious region associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and rebirth, that may have lain in the underworld or in the sky.  Each day, Ra traveled over the earth across the underside of the sky, and at night he passed through the Duat to be reborn at dawn.In Egyptian belief, this cosmos was inhabited by three types of sentient beings: one was the gods; another was the spirits of deceased humans, who existed in the divine realm and possessed many of the gods' abilities; living humans were the third category, and the most important among them was the pharaoh, who bridged the human and divine realms. Kingship Egyptologists have long debated the degree to which the pharaoh was considered a god. It seems most likely that the Egyptians viewed royal authority itself as a divine force.  Therefore, although the Egyptians recognized that the pharaoh was human and subject to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human weakness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", they simultaneously viewed him as a god, because the divine power of kingship was incarnated in him. He therefore acted as intermediary between Egypt's people and the gods.  He was key to upholding Ma'at, both by maintaining justice and harmony in human society and by sustaining the gods with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    temples\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and offerings. For these reasons, he oversaw all state religious activity.  However, the pharaoh's real-life influence and prestige could differ from his portrayal in official writings and depictions, and beginning in the late New Kingdom his religious importance declined drastically.The king was also associated with many specific deities. He was identified directly with Horus, who represented kingship itself, and he was seen as the son of Ra, who ruled and regulated nature as the pharaoh ruled and regulated society.  By the New Kingdom he was also associated with Amun, the supreme force in the cosmos.  Upon his \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the king became fully deified. In this state, he was directly identified with Ra, and was also associated with Osiris, god of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and rebirth and the mythological father of Horus.  Many mortuary temples were dedicated to the worship of deceased pharaohs as gods. Afterlife The Egyptians had elaborate beliefs about \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and the afterlife. They believed that humans possessed a ka, or life-force, which left the body at the point of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In life, the ka received its sustenance from food and drink, so it was believed that, to endure after \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the ka must continue to receive offerings of food, whose spiritual essence it could still consume. Each person also had a ba, the set of spiritual characteristics unique to each individual.  Unlike the ka, the ba remained attached to the body after \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Egyptian funeral rituals were intended to release the ba from the body so that it could move freely, and to rejoin it with the ka so that it could live on as an akh. However, it was also important that the body of the deceased be preserved, as the Egyptians believed that the ba returned to its body each night to receive new life, before emerging in the morning as an akh. In early times the deceased pharaoh was believed to ascend to the sky and dwell among the stars.  Over the course of the Old Kingdom (c. 2686–2181 BC), however, he came to be more closely associated with the daily rebirth of the sun god Ra and with the underworld ruler Osiris as those deities grew more important.In the fully developed afterlife beliefs of the New Kingdom, the soul had to avoid a variety of supernatural dangers in the Duat, before undergoing a final judgement, known as the &quot;&quot;Weighing of the Heart&quot;&quot;, carried out by Osiris and by the Assessors of Maat. In this judgement, the gods compared the actions of the deceased while alive (symbolized by the heart) to the feather of Maat, to determine whether he or she had behaved in accordance with Maat. If the deceased was judged worthy, his or her ka and ba were united into an akh.  Several beliefs coexisted about the akh's destination. Often the dead were said to dwell in the realm of Osiris, a lush and pleasant land in the underworld. The solar vision of the afterlife, in which the deceased soul traveled with Ra on his daily journey, was still primarily associated with royalty, but could extend to other people as well. Over the course of the Middle and New Kingdoms, the notion that the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    akh\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " could also travel in the world of the living, and to some degree magically affect events there, became increasingly prevalent. Atenism During the New Kingdom the pharaoh Akhenaten abolished the official worship of other gods in favor of the sun-disk Aten. This is often seen as the first instance of true monotheism in history, although the details of Atenist theology are still unclear and the suggestion that it was monotheistic is disputed. The exclusion of all but one god from worship was a radical departure from Egyptian tradition and some see Akhenaten as a practitioner of monolatry rather than monotheism, as he did not actively deny the existence of other gods; he simply refrained from worshipping any but the Aten. Under Akhenaten's successors Egypt reverted to its traditional religion, and Akhenaten himself came to be reviled as a heretic. Writings While the Egyptians had no unified religious scripture, they produced many religious writings of various types. Together the disparate texts provide an extensive, but still incomplete, understanding of Egyptian religious practices and beliefs. Mythology Egyptian myths were metaphorical stories intended to illustrate and explain the gods' actions and roles in nature. The details of the events they recounted could change to convey different symbolic perspectives on the mysterious divine events they described, so many myths exist in different and conflicting versions.  Mythical narratives were rarely written in full, and more often texts only contain episodes from or allusions to a larger myth.  Knowledge of Egyptian mythology, therefore, is derived mostly from hymns that detail the roles of specific deities, from ritual and magical texts which describe actions related to mythic events, and from funerary texts which mention the roles of many deities in the afterlife. Some information is also provided by allusions in secular texts.  Finally, Greeks and Romans such as Plutarch recorded some of the extant myths late in Egyptian history.Among the significant Egyptian myths were the creation myths. According to these stories, the world emerged as a dry space in the primordial ocean of chaos.  Because the sun is essential to life on earth, the first rising of Ra marked the moment of this emergence. Different forms of the myth describe the process of creation in various ways: a transformation of the primordial god Atum into the elements that form the world, as the creative speech of the intellectual god Ptah, and as an act of the hidden power of Amun.  Regardless of these variations, the act of creation represented the initial establishment of Ma'at and the pattern for the subsequent cycles of time.The most important of all Egyptian myths was the Osiris myth.  It tells of the divine ruler Osiris, who was murdered by his jealous brother Set, a god often associated with chaos.  Osiris's sister and wife Isis resurrected him so that he could conceive an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heir\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", Horus.  Osiris then entered the underworld and became the ruler of the dead.  Once grown, Horus fought and defeated Set to become king himself.  Set's association with chaos, and the identification of Osiris and Horus as the rightful rulers, provided a rationale for pharaonic succession and portrayed the pharaohs as the upholders of order.  At the same time, Osiris's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and rebirth were related to the Egyptian agricultural cycle, in which crops grew in the wake of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nile\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " inundation, and provided a template for the resurrection of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    human souls\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " after \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Another important mythic motif was the journey of Ra through the Duat each night. In the course of this journey, Ra met with Osiris, who again acted as an agent of regeneration, so that his life was renewed. He also fought each night with Apep, a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    serpentine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " god representing chaos. The defeat of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Apep\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and the meeting with Osiris ensured the rising of the sun the next morning, an event that represented rebirth and the victory of order over chaos. Ritual and magical texts The procedures for religious rituals were frequently written on papyri, which were used as instructions for those performing the ritual.  These ritual texts were kept mainly in the temple libraries. Temples themselves are also inscribed with such texts, often accompanied by illustrations. Unlike the ritual papyri, these inscriptions were not intended as instructions, but were meant to symbolically perpetuate the rituals even if, in reality, people ceased to perform them.  Magical texts likewise describe rituals, although these rituals were part of the spells used for specific goals in everyday life. Despite their mundane purpose, many of these texts also originated in temple libraries and later became disseminated among the general populace. Hymns and prayers The Egyptians produced numerous prayers and hymns, written in the form of poetry. Hymns and prayers follow a similar structure and are distinguished mainly by the purposes they serve. Hymns were written to praise particular deities. Like ritual texts, they were written on papyri and on temple walls, and they were probably recited as part of the rituals they accompany in temple inscriptions.  Most are structured according to a set literary formula, designed to expound on the nature, aspects, and mythological functions of a given deity. They tend to speak more explicitly about fundamental theology than other Egyptian religious writings, and became particularly important in the New Kingdom, a period of particularly active theological discourse.  Prayers follow the same general pattern as hymns, but address the relevant god in a more personal way, asking for blessings, help, or forgiveness for wrongdoing. Such prayers are rare before the New Kingdom, indicating that in earlier periods such direct personal interaction with a deity was not believed possible, or at least was less likely to be expressed in writing. They are known mainly from inscriptions on statues and stelae left in sacred sites as votive offerings. Funerary texts Among the most significant and extensively preserved Egyptian writings are funerary texts designed to ensure that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deceased souls\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " reached a pleasant afterlife.  The earliest of these are the Pyramid Texts. They are a loose collection of hundreds of spells inscribed on the walls of royal pyramids during the Old Kingdom, intended to magically provide pharaohs with the means to join the company of the gods in the afterlife.  The spells appear in differing arrangements and combinations, and few of them appear in all of the pyramids.At the end of the Old Kingdom a new body of funerary spells, which included material from the Pyramid Texts, began appearing in tombs, inscribed primarily on coffins. This collection of writings is known as the Coffin Texts, and was not reserved for royalty, but appeared in the tombs of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    non-royal\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " officials.  In the New Kingdom, several new funerary texts emerged, of which the best-known is the Book of the Dead.  Unlike the earlier books, it often contains extensive illustrations, or vignettes.  The book was copied on papyrus and sold to commoners to be placed in their tombs.The Coffin Texts included sections with detailed descriptions of the underworld and instructions on how to overcome its hazards. In the New Kingdom, this material gave rise to several &quot;&quot;books of the netherworld&quot;&quot;, including the Book of Gates, the Book of Caverns, and the Amduat.  Unlike the loose collections of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spells\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", these netherworld books are structured depictions of Ra's passage through the Duat, and by analogy, the journey of the deceased person's soul through the realm of the dead. They were originally restricted to pharaonic tombs, but in the Third Intermediate Period they came to be used more widely. Practices Temples Temples existed from the beginning of Egyptian history, and at the height of the civilization they were present in most of its towns. They included both mortuary temples to serve the spirits of deceased pharaohs and temples dedicated to patron gods, although the distinction was blurred because divinity and kingship were so closely intertwined. The temples were not primarily intended as places for worship by the general populace, and the common people had a complex set of religious practices of their own. Instead, the state-run temples served as houses for the gods, in which physical images which served as their intermediaries were cared for and provided with offerings. This service was believed to be necessary to sustain the gods, so that they could in turn maintain the universe itself. Thus, temples were central to Egyptian society, and vast resources were devoted to their upkeep, including both donations from the monarchy and large estates of their own.  Pharaohs often expanded them as part of their obligation to honor the gods, so that many temples grew to enormous size.  However, not all gods had temples dedicated to them, as many gods who were important in official theology received only minimal worship, and many household gods were the focus of popular veneration rather than temple ritual.The earliest Egyptian \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    temples\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " were small, impermanent structures, but through the Old and Middle Kingdoms their designs grew more elaborate, and they were increasingly built out of stone. In the New Kingdom, a basic temple layout emerged, which had evolved from common elements in Old and Middle Kingdom temples. With variations, this plan was used for most of the temples built from then on, and most of those that survive today adhere to it. In this standard plan, the temple was built along a central processional way that led through a series of courts and halls to the sanctuary, which held a statue of the temple's god. Access to this most sacred part of the temple was restricted to the pharaoh and the highest-ranking priests. The journey from the temple entrance to the sanctuary was seen as a journey from the human world to the divine realm, a point emphasized by the complex mythological symbolism present in temple architecture.  Well beyond the temple building proper was the outermost wall. Between the two lay many subsidiary buildings, including workshops and storage areas to supply the temple's needs, and the library where the temple's sacred writings and mundane records were kept, and which also served as a center of learning on a multitude of subjects.Theoretically it was the duty of the pharaoh to carry out temple rituals, as he was Egypt's official representative to the gods. In reality, ritual duties were almost always carried out by priests. During the Old and Middle Kingdoms, there was no separate class of priests; instead, many government officials served in this capacity for several months out of the year before returning to their secular duties. Only in the New Kingdom did professional priesthood become widespread, although most lower-ranking priests were still part-time. All were still employed by the state, and the pharaoh had final say in their appointments. However, as the wealth of the temples grew, the influence of their priesthoods increased, until it rivaled that of the pharaoh. In the political fragmentation of the Third Intermediate Period (c. 1070–664 BC), the high priests of Amun at Karnak even became the effective rulers of Upper Egypt. The temple staff also included many people other than priests, such as musicians and chanters in temple ceremonies. Outside the temple were artisans and other laborers who helped supply the temple's needs, as well as farmers who worked on temple estates. All were paid with portions of the temple's income. Large temples were therefore very important centers of economic activity, sometimes employing thousands of people. Official rituals and festivals State religious practice included both temple rituals involved in the cult of a deity, and ceremonies related to divine kingship. Among the latter were coronation ceremonies and the Sed festival, a ritual renewal of the pharaoh's strength that took place periodically during his reign. There were numerous temple rituals, including rites that took place across the country and rites limited to single temples or to the temples of a single god. Some were performed daily, while others took place annually or on rare occasions. The most common temple ritual was the morning offering ceremony, performed daily in temples across Egypt. In it, a high-ranking priest, or occasionally the pharaoh, washed, anointed, and elaborately dressed the god's statue before presenting it with offerings. Afterward, when the god had consumed the spiritual essence of the offerings, the items themselves were taken to be distributed among the priests.The less frequent temple rituals, or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    festivals\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", were still numerous, with dozens occurring every year. These festivals often entailed actions beyond simple offerings to the gods, such as reenactments of particular myths or the symbolic destruction of the forces of disorder. Most of these events were probably celebrated only by the priests and took place only inside the temple. However, the most important temple festivals, like the Opet Festival celebrated at Karnak, usually involved a procession carrying the god's image out of the sanctuary in a model barque to visit other significant sites, such as the temple of a related deity. Commoners gathered to watch the procession and sometimes received portions of the unusually large offerings given to the gods on these occasions. Animal cults At many sacred sites, the Egyptians worshipped individual animals which they believed to be manifestations of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    particular deities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". These animals were selected based on specific sacred markings which were believed to indicate their fitness for the role. Some of these cult animals retained their positions for the rest of their lives, as with the Apis bull worshipped in Memphis as a manifestation of Ptah. Other animals were selected for much shorter periods. These cults grew more popular in later times, and many temples began raising stocks of such animals from which to choose a new divine manifestation. A separate practice developed in the Twenty-sixth Dynasty, when people began mummifying any member of a particular animal species as an offering to the god whom the species represented. Millions of mummified cats, birds, and other creatures were buried at temples honoring \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Egyptian deities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Worshippers paid the priests of a particular deity to obtain and mummify an animal associated with that deity, and the mummy was placed in a cemetery near the god's cult center. Oracles The Egyptians used oracles to ask the gods for knowledge or guidance. Egyptian oracles are known mainly from the New Kingdom and afterward, though they probably appeared much earlier. People of all classes, including the king, asked questions of oracles.  The most common means of consulting an oracle was to pose a question to the divine image while it was being carried in a festival procession, and interpret an answer from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    barque's movements\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Other methods included interpreting the behavior of cult animals, drawing lots, or consulting statues through which a priest apparently spoke. The means of discerning the god's will gave great influence to the priests who spoke and interpreted the god's message. Popular religion While the state cults were meant to preserve the stability of the Egyptian world, lay individuals had their own religious practices that related more directly to daily life. This popular religion left less evidence than the official cults, and because this evidence was mostly produced by the wealthiest portion of the Egyptian population, it is uncertain to what degree it reflects the practices of the populace as a whole.Popular religious practice included ceremonies marking important transitions in life. These included birth, because of the danger involved in the process, and naming, because the name was held to be a crucial part of a person's identity. The most important of these ceremonies were those surrounding \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", because they ensured the soul's survival beyond it. Other religious practices sought to discern the gods' will or seek their knowledge. These included the interpretation of dreams, which could be seen as messages from the divine realm, and the consultation of oracles. People also sought to affect the gods' behavior to their own benefit through magical rituals.Individual Egyptians also prayed to gods and gave them private offerings. Evidence of this type of personal piety is sparse before the New Kingdom. This is probably due to cultural restrictions on depiction of nonroyal religious activity, which relaxed during the Middle and New Kingdoms. Personal piety became still more prominent in the late New Kingdom, when it was believed that the gods intervened directly in individual lives, punishing wrongdoers and saving the pious from disaster. Official temples were important venues for private prayer and offering, even though their central activities were closed to laypeople. Egyptians frequently donated goods to be offered to the temple deity and objects inscribed with prayers to be placed in temple courts. Often they prayed in person before temple statues or in shrines set aside for their use. Yet in addition to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    temples\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the populace also used separate local chapels, smaller but more accessible than the formal temples. These chapels were very numerous and probably staffed by members of the community. Households, too, often had their own small shrines for offering to gods or deceased relatives.The deities invoked in these situations differed somewhat from those at the center of state cults. Many of the important popular deities, such as the fertility goddess Taweret and the household protector Bes, had no temples of their own. However, many other gods, including Amun and Osiris, were very important in both popular and official religion. Some individuals might be particularly devoted to a single god. Often they favored deities affiliated with their own region, or with their role in life. The god Ptah, for instance, was particularly important in his cult center of Memphis, but as the patron of craftsmen he received the nationwide veneration of many in that occupation. Magic The word &quot;&quot;magic&quot;&quot; is normally used to translate the Egyptian term heka, which meant, as James P. Allen puts it, &quot;&quot;the ability to make things happen by indirect means&quot;&quot;.Heka was believed to be a natural phenomenon, the force which was used to create the universe and which the gods employed to work their will. Humans could also use it, and magical practices were closely intertwined with religion. In fact, even the regular rituals performed in temples were counted as magical. Individuals also frequently employed magical techniques for personal purposes. Although these ends could be harmful to other people, no form of magic was considered inimical in itself. Instead, magic was seen primarily as a way for humans to prevent or overcome negative events.Magic was closely associated with the priesthood. Because temple libraries contained numerous magical texts, great magical knowledge was ascribed to the lector priests, who studied these texts. These priests often worked outside their \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    temples\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", hiring out their magical services to laymen. Other professions also commonly employed magic as part of their work, including doctors, scorpion-charmers, and makers of magical amulets. It is also possible that the peasantry used simple magic for their own purposes, but because this magical knowledge would have been passed down orally, there is limited evidence of it.Language was closely linked with heka, to such a degree that Thoth, the god of writing, was sometimes said to be the inventor of heka. Therefore, magic frequently involved written or spoken incantations, although these were usually accompanied by ritual actions. Often these rituals invoked an appropriate deity to perform the desired action, using the power of heka to compel the deity to act. Sometimes this entailed casting the practitioner or subject of a ritual in the role of a character in mythology, thus inducing the god to act toward that person as it had in the myth. Rituals also employed sympathetic magic, using objects believed to have a magically significant resemblance to the subject of the rite. The Egyptians also commonly used objects believed to be imbued with heka of their own, such as the magically protective amulets worn in great numbers by ordinary Egyptians. Funerary practices Because it was considered necessary for the survival of the soul, preservation of the body was a central part of Egyptian funerary practices. Originally the Egyptians buried their dead in the desert, where the arid conditions mummified the body naturally. In the Early Dynastic Period, however, they began using tombs for greater protection, and the body was insulated from the desiccating effect of the sand and was subject to natural decay. Thus, the Egyptians developed their elaborate embalming practices, in which the corpse was artificially desiccated and wrapped to be placed in its coffin.  The quality of the process varied according to cost, however, and those who could not afford it were still buried in desert graves.Once the mummification process was complete, the mummy was carried from the deceased person's house to the tomb in a funeral procession that included his or her relatives and friends, along with a variety of priests. Before the burial, these priests performed several rituals, including the Opening of the mouth ceremony intended to restore the dead person's senses and give him or her the ability to receive offerings. Then the mummy was buried and the tomb sealed.  Afterwards, relatives or hired priests gave food offerings to the deceased in a nearby mortuary chapel at regular intervals.  Over time, families inevitably neglected offerings to long-dead relatives, so most mortuary cults only lasted one or two generations.  However, while the cult lasted, the living sometimes wrote letters asking deceased relatives for help, in the belief that the dead could affect the world of the living as the gods did.The first Egyptian tombs were \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mastabas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", rectangular brick structures where kings and nobles were entombed. Each of them contained a subterranean burial chamber and a separate, above ground chapel for mortuary rituals. In the Old Kingdom the mastaba developed into the pyramid, which symbolized the primeval mound of Egyptian myth. Pyramids were reserved for royalty, and were accompanied by large mortuary temples sitting at their base. Middle Kingdom pharaohs continued to build pyramids, but the popularity of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mastabas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " waned.  Increasingly, commoners with sufficient means were buried in rock-cut tombs with separate mortuary chapels nearby, an approach which was less vulnerable to tomb robbery.  By the beginning of the New Kingdom even the pharaohs were buried in such tombs, and they continued to be used until the decline of the religion itself.Tombs could contain a great variety of other items, including statues of the deceased to serve as substitutes for the body in case it was damaged.  Because it was believed that the deceased would have to do work in the afterlife, just as in life, burials often included small models of humans to do work in place of the deceased. Human sacrifices found in early royal tombs were probably meant to serve the pharaoh in his afterlife.The tombs of wealthier individuals could also contain furniture, clothing, and other everyday objects intended for use in the afterlife, along with amulets and other items intended to provide magical protection against the hazards of the spirit world.  Further protection was provided by funerary texts included in the burial. The tomb walls also bore artwork, such as images of the deceased eating food that were believed to allow him or her to magically receive sustenance even after the mortuary offerings had ceased. History Predynastic and Early Dynastic periods The beginnings of Egyptian religion extend into prehistory, though evidence for them comes only from the sparse and ambiguous archaeological record. Careful burials during the Predynastic period imply that the people of this time believed in some form of an afterlife. At the same time, animals were ritually buried, a practice which may reflect the development of zoomorphic deities like those found in the later religion.  The evidence is less clear for gods in human form, and this type of deity may have emerged more slowly than those in animal shape. Each region of Egypt originally had its own patron deity, but it is likely that as these small communities conquered or absorbed each other, the god of the defeated area was either incorporated into the other god's mythology or entirely subsumed by it. This resulted in a complex pantheon in which some deities remained only locally important while others developed more universal significance.The Early Dynastic Period began with the unification of Egypt around 3000 BC. This event transformed Egyptian religion, as some deities rose to national importance and the cult of the divine pharaoh became the central focus of religious activity.  Horus was identified with the king, and his cult center in the Upper Egyptian city of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nekhen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was among the most important religious sites of the period. Another important center was Abydos, where the early rulers built large funerary complexes. Old and Middle Kingdoms During the Old Kingdom, the priesthoods of the major deities attempted to organize the complicated national pantheon into groups linked by their mythology and worshipped in a single cult center, such as the Ennead of Heliopolis, which linked important deities such as Atum, Ra, Osiris, and Set in a single creation myth.  Meanwhile, pyramids, accompanied by large mortuary temple complexes, replaced \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mastabas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " as the tombs of pharaohs. In contrast with the great size of the pyramid complexes, temples to gods remained comparatively small, suggesting that official religion in this period emphasized the cult of the divine king more than the direct worship of deities. The funerary rituals and architecture of this time greatly influenced the more elaborate temples and rituals used in worshipping the gods in later periods. The Ancient Egyptians regarded the sun as a powerful life force. The sun god Ra had been worshipped from the Early Dynastic period (3100 - 2686 BCE), but it wasn't until the Old Kingdom (2686 - 2181 BCE), when Ra became the dominant figure in the Egyptian pantheon, that The Sun Cult took power. Early in the Old Kingdom, Ra grew in influence, and his cult center at Heliopolis became the nation's most important religious site.  By the Fifth Dynasty, Ra was the most prominent god in Egypt and had developed the close links with kingship and the afterlife that he retained for the rest of Egyptian history.  Around the same time, Osiris became an important afterlife deity. The Pyramid Texts, first written at this time, reflect the prominence of the solar and Osirian concepts of the afterlife, although they also contain remnants of much older traditions. The texts are an extremely important source for understanding early Egyptian theology.Symbols such as the 'winged disc' took on new features. Originally, the solar disk with the wings of a hawk was originally the symbol of Horus and associated with his cult in the Delta town of Behdet. The sacred cobras were added on either side of the disc during the Old Kingdom. The winged disc had protective significance and was found on temple ceilings and ceremonial entrances.  In the 22nd century BC, the Old Kingdom collapsed into the disorder of the First Intermediate Period. Eventually, rulers from Thebes reunified the Egyptian nation in the Middle Kingdom (c. 2055–1650 BC). These Theban pharaohs initially promoted their patron god Montu to national importance, but during the Middle Kingdom, he was eclipsed by the rising popularity of Amun.  In this new Egyptian state, personal piety grew more important and was expressed more freely in writing, a trend that continued in the New Kingdom. New Kingdom The Middle Kingdom crumbled in the Second Intermediate Period (c. 1650–1550 BC), but the country was again reunited by Theban rulers, who became the first pharaohs of the New Kingdom. Under the new regime, Amun became the supreme state god. He was syncretized with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ra\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the long-established patron of kingship and his temple at Karnak in Thebes became Egypt's most important religious center.  Amun's elevation was partly due to the great importance of Thebes, but it was also due to the increasingly professional priesthood. Their sophisticated theological discussion produced detailed descriptions of Amun's universal power.Increased contact with outside peoples in this period led to the adoption of many Near Eastern deities into the pantheon. At the same time, the subjugated Nubians absorbed Egyptian religious beliefs, and in particular, adopted Amun as their own. The New Kingdom religious order was disrupted when Akhenaten acceded, and replaced Amun with the Aten as the state god. Eventually, he eliminated the official worship of most other gods and moved Egypt's capital to a new city at Amarna. This part of Egyptian history, the Amarna Period, is named after this.  In doing so, Akhenaten claimed unprecedented status: only he could worship the Aten, and the populace directed their worship toward him. The Atenist system lacked well-developed mythology and afterlife beliefs, and the Aten seemed distant and impersonal, so the new order did not appeal to ordinary Egyptians.  Thus, many probably continued to worship the traditional gods in private. Nevertheless, the withdrawal of state support for the other deities severely disrupted Egyptian society.  Akhenaten's successors restored the traditional religious system, and eventually, they dismantled all Atenist monuments.Before the Amarna Period, popular religion had trended toward more personal relationships between worshippers and their gods. Akhenaten's changes had reversed this trend, but once the traditional religion was restored, there was a backlash. The populace began to believe that the gods were much more directly involved in daily life. Amun, the supreme god, was increasingly seen as the final arbiter of human destiny, the true ruler of Egypt. The pharaoh was correspondingly more human and less divine. The importance of oracles as a means of decision-making grew, as did the wealth and influence of the oracles' interpreters, the priesthood. These trends undermined the traditional structure of society and contributed to the breakdown of the New Kingdom. Later periods In the 1st millennium BC, Egypt was significantly weaker than in earlier times, and in several periods foreigners seized the country and assumed the position of pharaoh. The importance of the pharaoh continued to decline, and the emphasis on popular piety continued to increase. Animal cults, a characteristically Egyptian form of worship, became increasingly popular in this period, possibly as a response to the uncertainty and foreign influence of the time.  Isis grew more popular as a goddess of protection, magic, and personal salvation, and became the most important goddess in Egypt.In the 4th century BC, Egypt became a Hellenistic kingdom under the Ptolemaic dynasty (305–30 BC), which assumed the pharaonic role, maintaining the traditional religion and building or rebuilding many temples. The kingdom's Greek ruling class identified the Egyptian deities with their own.  From this cross-cultural syncretism emerged Serapis, a god who combined Osiris and Apis with characteristics of Greek deities, and who became very popular among the Greek population. Nevertheless, for the most part the two belief systems remained separate, and the Egyptian deities remained Egyptian.Ptolemaic-era beliefs changed little after Egypt became a province of the Roman Empire in 30 BC, with the Ptolemaic kings replaced by distant emperors.  The cult of Isis appealed even to Greeks and Romans outside Egypt, and in Hellenized form it spread across the empire.  In Egypt itself, as the empire weakened, official temples fell into decay, and without their centralizing influence religious practice became fragmented and localized. Meanwhile, Christianity spread across Egypt, and in the third and fourth centuries AD, edicts by Christian emperors and iconoclasm by local Christians eroded traditional beliefs. While it persisted among the populace for some time, Egyptian religion slowly faded away. Legacy Egyptian religion produced the temples and tombs which are ancient Egypt's most enduring monuments, but it also influenced other cultures. In pharaonic times many of its symbols, such as the sphinx and winged solar disk, were adopted by other cultures across the Mediterranean and Near East, as were some of its deities, such as Bes.  Some of these connections are difficult to trace.  The Greek concept of Elysium may have derived from the Egyptian vision of the afterlife.  In late antiquity, the Christian conception of Hell was most likely influenced by some of the imagery of the Duat. Egyptian beliefs also influenced or gave rise to several esoteric belief systems developed by Greeks and Romans, who considered Egypt as a source of mystic wisdom. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hermeticism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", for instance, derived from the tradition of secret magical knowledge associated with Thoth. Modern times Traces of ancient beliefs remained in Egyptian folk traditions into modern times, but its influence on modern societies greatly increased with the French \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Campaign\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in Egypt and Syria in 1798 and their seeing the monuments and images. As a result of it, Westerners began to study Egyptian beliefs firsthand, and Egyptian religious motifs were adopted into Western art.  Egyptian religion has since had a significant influence in popular culture. Due to continued interest in Egyptian beliefs, in the late 20th century, several new religious groups going under the blanket term of Kemetism have formed based on different reconstructions of ancient Egyptian religion. See also Prehistoric religion Religions of the ancient Near East Outline of ancient Egypt Index of Egyptian mythology articles References Bibliography Further reading Clarysse, Willy; Schoors, Antoon; Willems, Harco; Quaegebeur, Jan (1998). Egyptian Religion: The Last Thousand Years: Studies Dedicated to the Memory of Jan Quaegebeur. Peeters. ISBN 90-429-0669-3.. Harris, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Geraldine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; Sibbick, John; O'Connor, David (1992). Gods and Pharaohs from Egyptian Mythology. Bedrick. ISBN 0-87226-907-8.. Hart, George (1997). Egyptian Myths. Legendary Past. University of Texas Press. ISBN 0-292-72076-9.. Hill, Marsha (2007). Gifts for the gods: images from Egyptian temples. New York: The Metropolitan Museum of Art. ISBN 9781588392312. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bilolo\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Mubabinge (2004) [Kinshasa-Munich 1987]. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Les cosmo-théologies philosophiques\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " d'Héliopolis et d'Hermopolis. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Essai de thématisation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " et de systématisation. Academy of African Thought (in French). 2. Munich-Paris. sec I.. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ———\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (2003) [Kinshasa-Munich, 1986]. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Les cosmo-théologies philosophiques\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " de \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    l'Égypte\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Antique. Problématique, prémisses herméneutiques et problèmes majeurs. Academy of African Thought (in French). 1. Munich-Paris. sec I.. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ———\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (2003) [Kinshasa-Munich 1995]. Métaphysique Pharaonique IIIème millénaire av. J.-C. Academy of African Thought (in French). 4. Munich-Paris: C.A. Diop-Center for Egyptological Studies-INADEP. sec I.. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ———\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (2004) [Kinshasa-Munich 1988]. Le Créateur et la \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Création dans la pensée memphite\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " et amarnienne. Approche synoptique du Document Philosophique de Memphis et du Grand Hymne Théologique d'Echnaton. Academy of African Thought (in French). 2. Munich-Paris. sec I.. Pinch, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Geraldine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (2004). Egyptian Mythology: A Guide to the Gods, Goddesses, and Traditions of ancient Egypt. Oxford University Press. ISBN 0-19-517024-5.. Schulz, R; Seidel, M (1998). Egypt: The World of the Pharaohs. Cologne: Könemann. ISBN 3-89508-913-3.. External links &quot;&quot;Ideology and Belief in Ancient Egypt&quot;&quot;, Digital Egypt, UK: UCL, archived from the original on 2014-10-22, retrieved 2018-07-21. &quot;&quot;Ancient Egypt&quot;&quot;, The Internet Sacred Text Archive. Religion in the Lives of the Ancient Egyptians, U Chicago, archived from the original on 2018-07-16, retrieved 2018-07-21.&quot; &quot;Andrea Alpago (c. 1450 – late 1521 or January 1522) was an Italian physician and arabist. In publications of his work in Latin his name is frequently given as Andreas Alpagus Bellunensis, where &quot;&quot;Bellunensis&quot;&quot; refers to his birthplace of Belluno in northeastern Italy. Not much is truly known about his childhood nor his time in medical school. However, it is commonly assumed that his school was completed in Padua. Around the year 1487, Andrea Alpago moved to go work in the city of Damascus in Syria as physician to the consulate of Republic of Venice as the successor to Girolamo Ramusio. While working for the consulate, Alpago became a friend and mentee to Ibn al-Makkī.  This friendship strongly influenced Alpago's career as Ibn al-Makkī introduced him to Avicenna's work. His translations of Avicenna's work from Arabic to Latin as possible one of his greatest and most well-known achievements from his lifetime. This work allowed for greater transmission of knowledge and Islamicate work to European and Latin speaking countries. Alpago completed these translations primarily to increase textual issues that may arise in translation in order to better explain a topic. This same translating ability also gave him new opportunities while working for the Venetian Consulate.  Alpago was occasionally sent to do non-medical work and translations, however, Alpago was already interested in learning new cultures and customs so it was no issue to him.  He would send work back to the Venetian consulate detailing subjects such as the economy and culture in letters. During this time, Alpago became very close with the Arabic physicians, it is thought he sympathized with the Safavid Dynasty due to their struggles with the Ottomans. After nearly twenty years working for the consulate in Damascus, Alpago almost left the consulate in 1507 to move back to Belluno, however, due his disagreement with the man who was supposed to replace him, he stayed until 1517.  At this time, his nephew, Paulo \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Alpago\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", traveled with him to the consulate of Nicosia in Cyprus. Alpago stayed in Cyprus until December of 1520 when he eventually traveled back to Venice. During his travel to and from Venice, he ventured through various Arabic countries to find manuscripts, learn culture, and better understand languages. Upon his return to Venice, Alpago was appointed professor of medicine in Padua in northeastern Italy in September of 1521, confirmed by the Venetian senate. Unfortunately, after only two to three months of working at the University, Andrea Alpago died after a dinner.  Alpago had not published ay of his work during his life but after his \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " they were published on the initiative of his nephew Paolo Alpago.  This library included several books as well as pamphlets.  His best known work is his commentary and editing of the Latin translation of The Canon of Medicine of Ibn Sina. This medicine book was translated from Arabic to Latin in the late 12th century by Gerard of Cremona. Andrea Alpago's edition and supplements to Gerard of Cremona's translation was widely read in European medical circles during the 16th century. It was first published in 1527 and an expanded edition was published in 1544. The Canon thoroughly explains as well as illustrates many vital parts of medicine including but not limited to anatomy and pharmacology. Although he only had about twelve corrections, they were done in an effort to make the translation make more sense when read in the other language. He did not change the meaning or purpose of any of the statements made by Gerard, regardless if he believed had the same view or not.  The corrections he made were to simply clarify his translations.  In addition to The Cannon of Medicine, Andrea Alpago's translation of Avicenna's philosophical work was historic for the time.  Alpago explained major points of Avicenna's work on philosophy and Islam while occasionally relating it back to christianity. Although Alpago did not like to change much when translating, he found it necessary to make some corrections with medical texts.  Because many of the manuscripts were very old, Alpago found it necessary to correct some of the manuscripts because it was dealing with human life and should not endanger a person. List of works (This list is incomplete) Avicennae Liber Canonis Medicinae, Gerardus \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cremonensis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ex Arabico in Latinum translatus, cum Andreae Alpagi Bellunensis clarissimi \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    castigationibus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ex \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    complurium codicum arabicorum (Ibn Sina's Canon of\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Medicine translated from Arabic to Latin by Gerard of Cremona, with clarifications and critiques by Andrea Alpago from many Arabic writings). Arabic-to-Latin translation of a Commentary on Anatomy in Avicenna's Canon  == References ==&quot; &quot;Ancient Greek includes the forms of the Greek language used in ancient Greece and the ancient world from around 1500 BC to 300 BC. It is often roughly divided into the following periods: Mycenaean Greek (c. 1400–1200 BC), Dark Ages (c. 1200–800 BC), the Archaic period (c. 800–500 BC), and the Classical period (c. 500–300 BC).Ancient Greek was the language of Homer and of fifth-century Athenian historians, playwrights, and philosophers. It has contributed many words to English vocabulary and has been a standard subject of study in educational institutions of the Western world since the Renaissance. This article primarily contains information about the Epic and Classical periods of the language. From the Hellenistic period (c. 300 BC), Ancient Greek was followed by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Koine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Greek, which is regarded as a separate historical stage, although its earliest form closely resembles Attic Greek and its latest form approaches Medieval Greek. There were several regional dialects of Ancient Greek, of which Attic Greek developed into Koine. Dialects Ancient Greek was a pluricentric language, divided into many dialects. The main dialect groups are Attic and Ionic, Aeolic, Arcadocypriot, and Doric, many of them with several subdivisions. Some dialects are found in standardized literary forms used in literature, while others are attested only in inscriptions. There are also several historical forms. Homeric Greek is a literary form of Archaic Greek (derived primarily from Ionic and Aeolic) used in the epic poems, the Iliad and the Odyssey, and in later poems by other authors. Homeric Greek had significant differences in grammar and pronunciation from Classical Attic and other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Classical-era\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " dialects. History The origins, early form and development of the Hellenic language family are not well understood because of a lack of contemporaneous evidence. Several theories exist about what Hellenic dialect groups may have existed between the divergence of early Greek-like speech from the common Proto-Indo-European language and the Classical period. They have the same general outline but differ in some of the detail. The only attested dialect from this period is Mycenaean Greek, but its relationship to the historical dialects and the historical circumstances of the times imply that the overall groups already existed in some form. Scholars assume that major ancient Greek period dialect groups developed not later than 1120 BC, at the time of the Dorian invasions—and that their first appearances as precise alphabetic writing began in the 8th century BC. The invasion would not be &quot;&quot;Dorian&quot;&quot; unless the invaders had some cultural relationship to the historical Dorians. The invasion is known to have displaced population to the later Attic-Ionic regions, who regarded themselves as descendants of the population displaced by or contending with the Dorians. The Greeks of this period believed there were three major divisions of all Greek people – Dorians, Aeolians, and Ionians (including Athenians), each with their own defining and distinctive dialects. Allowing for their oversight of Arcadian, an obscure mountain dialect, and Cypriot, far from the center of Greek scholarship, this division of people and language is quite similar to the results of modern archaeological-linguistic investigation. One standard formulation for the dialects is: West Group Northwest Greek Doric Aeolic Group Aegean/Asiatic Aeolic Thessalian Boeotian Ionic-Attic Group Attic Ionic Euboean and colonies in Italy Cycladic Asiatic Ionic Arcadocypriot Greek Arcadian CypriotWest vs. non-West Greek is the strongest-marked and earliest division, with non-West in subsets of Ionic-Attic (or Attic-Ionic) and Aeolic vs. Arcadocypriot, or Aeolic and Arcado-Cypriot vs. Ionic-Attic. Often non-West is called 'East Greek'. Arcadocypriot apparently descended more closely from the Mycenaean Greek of the Bronze \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". Boeotian had come under a strong Northwest Greek influence, and can in some respects be considered a transitional dialect. Thessalian likewise had come under Northwest Greek influence, though to a lesser degree. Pamphylian Greek, spoken in a small area on the southwestern coast of Anatolia and little preserved in inscriptions, may be either a fifth major dialect group, or it is Mycenaean Greek overlaid by Doric, with a non-Greek native influence. Regarding the speech of the ancient Macedonians diverse theories have been put forward, but the epigraphic activity and the archaeological discoveries in the Greek region of Macedonia during the last decades has brought to light documents, among which the first texts written in Macedonian, such as the Pella curse tablet, as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hatzopoulos\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and other scholars note. Based on the conclusions drawn by several studies and findings such as Pella curse tablet, Emilio Crespo and other scholars suggest that ancient Macedonian was a Northwest Doric dialect, which shares isoglosses with its neighboring Thessalian dialects spoken in northeastern Thessaly.Most of the dialect sub-groups listed above had further subdivisions, generally equivalent to a city-state and its surrounding territory, or to an island. Doric notably had several intermediate divisions as well, into Island Doric (including Cretan Doric), Southern Peloponnesus Doric (including Laconian, the dialect of Sparta), and Northern Peloponnesus Doric (including Corinthian). The Lesbian dialect was Aeolic Greek. All the groups were represented by colonies beyond Greece proper as well, and these colonies generally developed local characteristics, often under the influence of settlers or neighbors speaking different Greek dialects. The dialects outside the Ionic group are known mainly from inscriptions, notable exceptions being: fragments of the works of the poet Sappho from the island of Lesbos, in Aeolian, and the poems of the Boeotian poet Pindar and other lyric poets, usually in Doric.After the conquests of Alexander the Great in the late 4th century BC, a new international dialect known as Koine or Common Greek developed, largely based on Attic Greek, but with influence from other dialects. This dialect slowly replaced most of the older dialects, although the Doric dialect has survived in the Tsakonian language, which is spoken in the region of modern Sparta. Doric has also passed down its aorist terminations into most verbs of Demotic Greek. By about the 6th century AD, the Koine had slowly metamorphosed into Medieval Greek. Related languages Phrygian is an extinct Indo-European language of West and Central Anatolia, which is considered by some linguists to have been closely related to Greek. Among Indo-European branches with living descendants, Greek is often argued to have the closest genetic ties with Armenian (see also Graeco-Armenian) and Indo-Iranian languages (see Graeco-Aryan). Phonology Differences from Proto-Indo-European Ancient Greek differs from Proto-Indo-European (PIE) and other Indo-European languages in certain ways. In phonotactics, ancient Greek words could end only in a vowel or /n s r/; final stops were lost, as in γάλα &quot;&quot;milk&quot;&quot;, compared with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    γάλακτος\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " &quot;&quot;of milk&quot;&quot; (genitive). Ancient Greek of the classical period also differed in both the inventory and distribution of original \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PIE phonemes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " due to numerous sound changes, notably the following: PIE *s became /h/ at the beginning of a word (debuccalization): Latin \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sex\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", English six, ancient Greek ἕξ /héks/. PIE *s was elided between vowels after an intermediate step of debuccalization: Sanskrit janasas, Latin generis (where s &gt; r by rhotacism), Greek *genesos &gt; *genehos &gt; ancient Greek γένεος (/géneos/), Attic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    γένους\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (/génoːs/) &quot;&quot;of a kind&quot;&quot;. PIE *y /j/ became /h/ (debuccalization) or /(d)z/ (fortition): Sanskrit yas, ancient Greek ὅς /hós/ &quot;&quot;who&quot;&quot; (relative pronoun); Latin iugum, English yoke, ancient Greek ζυγός /zygós/. PIE *w, which occurred in Mycenaean and some non-Attic dialects, was lost: early Doric ϝέργον /wérgon/, English work, Attic Greek ἔργον /érgon/. PIE and Mycenaean labiovelars changed to plain stops (labials, dentals, and velars) in the later Greek dialects: for instance, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PIE\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " *kʷ became /p/ or /t/ in Attic: Attic Greek ποῦ /pôː/ &quot;&quot;where?&quot;&quot;, Latin quō; Attic Greek τίς /tís/, Latin \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    quis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " &quot;&quot;who?&quot;&quot;. PIE &quot;&quot;voiced aspirated&quot;&quot; stops *bʰ dʰ ǵʰ gʰ gʷʰ were devoiced and became the aspirated stops φ θ χ /pʰ tʰ kʰ/ in ancient Greek. Phonemic inventory The pronunciation of ancient Greek was very different from that of Modern Greek. Ancient Greek had long and short vowels; many diphthongs; double and single consonants; voiced, voiceless, and aspirated stops; and a pitch accent. In Modern Greek, all vowels and consonants are short. Many vowels and diphthongs once pronounced distinctly are pronounced as /i/ (iotacism). Some of the stops and glides in diphthongs have become fricatives, and the pitch accent has changed to a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " accent. Many of the changes took place in the Koine Greek period. The writing system of Modern Greek, however, does not reflect all pronunciation changes. The examples below represent Attic Greek in the 5th century BC. Ancient pronunciation cannot be reconstructed with certainty, but Greek from the period is well documented, and there is little disagreement among linguists as to the general nature of the sounds that the letters represent. Consonants [ŋ] occurred as an allophone of /n/ that was used before velars and as an allophone of /ɡ/ before nasals. /r/ was probably voiceless when word-initial (written ῥ). /s/ was assimilated to [z] before voiced consonants. Vowels \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    /oː/\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " raised to [uː], probably by the 4th century BC. Morphology Greek, like all of the older Indo-European languages, is highly inflected. It is highly archaic in its preservation of Proto-Indo-European forms. In ancient Greek, nouns (including proper nouns) have five cases (nominative, genitive, dative, accusative, and vocative), three genders (masculine, feminine, and neuter), and three numbers (singular, dual, and plural). Verbs have four moods (indicative, imperative, subjunctive, and optative) and three voices (active, middle, and passive), as well as three persons (first, second, and third) and various other forms. Verbs are conjugated through seven combinations of tenses and aspect (generally simply called &quot;&quot;tenses&quot;&quot;): the present, future, and imperfect are imperfective in aspect; the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorist\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", present perfect, pluperfect and future perfect are perfective in aspect. Most tenses display all four moods and three voices, although there is no future subjunctive or imperative. Also, there is no imperfect subjunctive, optative or imperative. The infinitives and participles correspond to the finite combinations of tense, aspect, and voice. Augment The indicative of past tenses adds (conceptually, at least) a prefix /e-/, called the augment. This was probably originally a separate word, meaning something like &quot;&quot;then&quot;&quot;, added because tenses in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PIE\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " had primarily aspectual meaning. The augment is added to the indicative of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorist\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", imperfect, and pluperfect, but not to any of the other forms of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorist\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (no other forms of the imperfect and pluperfect exist). The two kinds of augment in Greek are syllabic and quantitative. The syllabic augment is added to stems beginning with consonants, and simply prefixes e (stems beginning with r, however, add er). The quantitative augment is added to stems beginning with vowels, and involves lengthening the vowel: a, ā, e, ē → ē i, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ī → ī o, ō → ō u, ū → ū ai → ēi ei → ēi or\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ei oi → ōi au → ēu or au eu → ēu or eu ou → ouSome verbs augment irregularly; the most common variation is e → ei. The irregularity can be explained diachronically by the loss of s between vowels, or that of the letter w, which affected the augment when it was word-initial. In verbs with a preposition as a prefix, the augment is placed not at the start of the word, but between the preposition and the original verb. For example, προσ(-)βάλλω (I attack) goes to προσέβαλoν in the aorist. However compound verbs consisting of a prefix that is not a preposition retain the augment at the start of the word: αὐτο(-)μολῶ goes to ηὐτομόλησα in the aorist. Following Homer's practice, the augment is sometimes not made in poetry, especially epic poetry. The augment sometimes substitutes for reduplication; see below. Reduplication Almost all forms of the perfect, pluperfect, and future perfect reduplicate the initial syllable of the verb stem. (Note that a few irregular forms of perfect do not reduplicate, whereas a handful of irregular aorists reduplicate.) The three types of reduplication are: Syllabic reduplication: Most verbs beginning with a single consonant, or a cluster of a stop with a sonorant, add a syllable consisting of the initial consonant followed by e. An aspirated consonant, however, reduplicates in its unaspirated equivalent (see Grassmann's law). Augment: Verbs beginning with a vowel, as well as those beginning with a cluster other than those indicated previously (and occasionally for a few other verbs) reduplicate in the same fashion as the augment. This remains in all forms of the perfect, not just the indicative. Attic reduplication: Some verbs beginning with an a, e or o, followed by a sonorant (or occasionally d or g), reduplicate by adding a syllable consisting of the initial vowel and following consonant, and lengthening the following vowel. Hence er → erēr, an → anēn, ol → olōl, ed → edēd. This is not actually specific to Attic Greek, despite its name, but it was generalized in Attic. This originally involved reduplicating a cluster consisting of a laryngeal and sonorant, hence h₃l \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    → h₃leh₃l →\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " olōl with normal Greek development of laryngeals. (Forms with a stop were analogous.)Irregular duplication can be understood diachronically. For example, lambanō (root lab) has the perfect stem \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    eilēpha\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (not *\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lelēpha\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") because it was originally \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    slambanō\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", with perfect seslēpha, becoming \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    eilēpha\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " through compensatory lengthening. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Reduplication\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is also visible in the present tense stems of certain verbs. These stems add a syllable consisting of the root's initial consonant followed by i. A nasal stop appears after the reduplication in some verbs. Writing system The earliest extant examples of ancient Greek writing (circa 1450 BC) are in the syllabic script Linear B. Beginning in the 8th century BC, however, the Greek alphabet became standard, albeit with some variation among dialects. Early texts are written in boustrophedon style, but left-to-right became standard during the classic period. Modern editions of ancient Greek texts are usually written with accents and breathing marks, interword spacing, modern punctuation, and sometimes mixed case, but these were all introduced later. Sample texts The beginning of Homer's Iliad exemplifies the Archaic period of ancient Greek (see Homeric Greek for more details): The beginning of Apology by Plato exemplifies Attic Greek from the Classical period of ancient Greek: Ὅτι μὲν ὑμεῖς, ὦ ἄνδρες Ἀθηναῖοι, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    πεπόνθατε ὑπὸ τῶν ἐμῶν κατηγόρων\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", οὐκ \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    οἶδα· ἐγὼ δ' οὖν καὶ\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " αὐτὸς ὑπ' αὐτῶν ὀλίγου \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ἐμαυτοῦ\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ἐπελαθόμην, οὕτω πιθανῶς ἔλεγον. Καίτοι ἀληθές γε ὡς \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ἔπος εἰπεῖν οὐδὲν εἰρήκασιν\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".Using the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    IPA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ": [hóti men hyːmêːs \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    | ɔ̂ː ándres atʰɛːnaî̯i̯oi | pepóntʰate | hypo tɔ̂ːn emɔ̂ːŋ katɛːɡórɔːn | oːk oî̯da ‖ éɡɔː dûːŋ kai̯ au̯tos | hyp au̯tɔ̂ːn olíɡoː emau̯tûː | epelatʰómɛːn | hǔːtɔː pitʰanɔ̂ːs éleɡon ‖ kaí̯toi̯ alɛːtʰéz ɡe | hɔːs épos eːpêːn | oːden eːrɛ̌ːkaːsin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ‖]Transliterated into the Latin alphabet using a modern version of the Erasmian scheme: Hóti mèn hūmeîs, ô ándres \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Athēnaîoi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pepónthate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " hupò tôn emôn katēgórōn, ouk oîda: egṑ d' oûn kaì autòs hup' autōn olígou emautoû \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epelathómēn\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", hoútō pithanôs élegon. Kaítoi alēthés ge hōs épos eipeîn oudèn eirḗkāsin.Translated into English: How you, men of Athens, are feeling under the power of my accusers, I do not know: actually, even I myself almost forgot who I was because of them, they spoke so persuasively. And yet, loosely speaking, nothing they have said is true. Modern use In education The study of ancient Greek in European countries in addition to Latin occupied an important place in the syllabus from the Renaissance until the beginning of the 20th century. Ancient Greek is still taught as a compulsory or optional subject especially at traditional or elite schools throughout Europe, such as public schools and grammar schools in the United Kingdom. It is compulsory in the liceo classico in Italy, in the gymnasium in the Netherlands, in some classes in Austria, in klasična gimnazija (grammar school – orientation: classical languages) in Croatia, in classical studies in ASO in Belgium and it is optional in the humanities-oriented gymnasium in Germany (usually as a third language after Latin and English, from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of 14 to 18). In 2006/07, 15,000 pupils studied ancient Greek in Germany according to the Federal Statistical Office of Germany, and 280,000 pupils studied it in Italy. It is a compulsory subject alongside Latin in the humanities branch of the Spanish bachillerato. Ancient Greek is also taught at most major universities worldwide, often combined with Latin as part of the study of classics. In 2010 it was offered in three primary schools in the UK, to boost children's language skills, and was one of seven foreign languages which primary schools could teach 2014 as part of a major drive to boost education standards.Ancient Greek is also taught as a compulsory subject in all gymnasiums and lyceums in Greece. Starting in 2001, an annual international competition &quot;&quot;Exploring the Ancient Greek Language and Culture&quot;&quot; (Greek: Διαγωνισμός στην Αρχαία Ελληνική Γλώσσα και Γραμματεία) was run for upper secondary students through the Greek Ministry of National Education and Religious Affairs, with Greek language and cultural organisations as co-organisers. It appears to have ceased in 2010, having failed to gain the recognition and acceptance of teachers. Modern real-world usage Modern authors rarely write in ancient Greek, though Jan Křesadlo wrote some poetry and prose in the language, and Harry \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Potter and the Philosopher's Stone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", some volumes of Asterix, and The Adventures of Alix have been translated into ancient Greek. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ὀνόματα Kεχιασμένα (Onomata Kechiasmena\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") is the first magazine of crosswords and puzzles in ancient Greek. Its first issue appeared in April 2015 as an annex to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hebdomada\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Aenigmatum. Alfred Rahlfs included a preface, a short history of the Septuagint text, and other front matter translated into ancient Greek in his 1935 edition of the Septuagint; Robert \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hanhart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " also included the introductory remarks to the 2006 revised Rahlfs–Hanhart edition in the language as well. Akropolis World News reports weekly a summary of the most important news in ancient Greek.Ancient Greek is also used by organizations and individuals, mainly Greek, who wish to denote their respect, admiration or preference for the use of this language. This use is sometimes considered graphical, nationalistic or humorous. In any case, the fact that modern Greeks can still wholly or partly understand texts written in non-archaic forms of ancient Greek shows the affinity of the modern Greek language to its ancestral predecessor.Ancient Greek is often used in the coinage of modern technical terms in the European languages: see English words of Greek origin. Latinized forms of ancient Greek roots are used in many of the scientific names of species and in scientific terminology. See also Notes References Further reading Adams, Matthew. &quot;&quot;The Introduction of Greek into English Schools.&quot;&quot; Greece and Rome 61.1: 102–13, 2014. Allan, Rutger J. &quot;&quot;Changing the Topic: Topic Position in Ancient Greek Word Order.&quot;&quot; Mnemosyne: Bibliotheca Classica Batava 67.2: 181–213, 2014. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Athenaze\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ": An Introduction to Ancient Greek (Oxford University Press). [A series of textbooks on Ancient Greek published for school use.] Bakker, Egbert J., ed. A Companion to the Ancient Greek Language. Oxford: Wiley-Blackwell, 2010. Beekes, Robert \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    S. P.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Etymological Dictionary of Greek. Leiden, The Netherlands: Brill, 2010. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Chantraine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pierre\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Dictionnaire étymologique de la langue grecque, new and updated edn., edited by Jean \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Taillardat\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Olivier Masson, &amp; Jean-Louis Perpillou. 3 vols. Paris: Klincksieck, 2009 (1st edn. 1968–1980). Christidis, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anastasios-Phoibos\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", ed. A History of Ancient Greek: from the Beginnings to Late Antiquity. Cambridge: Cambridge University Press, 2007. Easterling, P and Handley, C. Greek Scripts: An Illustrated Introduction. London: Society for the Promotion of Hellenic Studies, 2001. ISBN 0-902984-17-9 Fortson, Benjamin \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    W.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Indo-European Language and Culture: An Introduction. 2d ed. Oxford: Wiley-Blackwell, 2010. Hansen, Hardy and Quinn, Gerald M. (1992) Greek: An Intensive Course, Fordham University Press Horrocks, Geoffrey. Greek: A History of the Language and its Speakers. 2d ed. Oxford: Wiley-Blackwell, 2010. Janko, Richard. &quot;&quot;The Origins and Evolution of the Epic Diction.&quot;&quot; In The Iliad: A Commentary. Vol. 4, Books 13–16. Edited by Richard Janko, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    8–19\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Cambridge, UK: Cambridge Univ. Press, 1992. Jeffery, Lilian Hamilton. The Local Scripts of Archaic Greece: Revised Edition with a Supplement by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    A. W.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Johnston. Oxford: Oxford Univ. Press, 1990. Morpurgo Davies, Anna, and Yves Duhoux, eds. A Companion to Linear B: Mycenaean Greek Texts and their World. Vol. 1. Louvain, Belgium: Peeters, 2008. Swiggers, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pierre\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Alfons\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Wouters. &quot;&quot;Description of the Constituent Elements of the (Greek) Language.&quot;&quot; In Brill’s Companion to Ancient Greek Scholarship. Edited by Franco Montanari and Stephanos Matthaios, 757–797. Leiden : Brill, 2015. External links Classical Greek Online by Winfred \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    P.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Lehmann and Jonathan Slocum, free online lessons at the Linguistics Research Center at the University of Texas at Austin Online Greek resources – Dictionaries, grammar, virtual libraries, fonts, etc. Alpheios – Combines LSJ, Autenrieth, Smyth's grammar and inflection tables in a browser add-on for use on any web site Ancient Greek basic lexicon at the Global Lexicostatistical Database Ancient Greek Swadesh list of basic vocabulary words (from Wiktionary's Swadesh list appendix) &quot;&quot;Greek Language&quot;&quot; . Encyclopædia Britannica (11th ed.). 1911. Slavonic – online editor for Ancient Greek glottothèque - Ancient Indo-European Grammars online, an online collection of videos on various Ancient Indo-European languages, including Ancient Greek Grammar learning A more extensive grammar of the Ancient Greek language written by J. Rietveld Recitation of classics books Perseus Greek dictionaries Greek-Language.com – Information on the history of the Greek language, application of modern Linguistics to the study of Greek, and tools for learning Greek Free Lessons in Ancient Greek, Bilingual Libraries, Forum A critical survey of websites devoted to Ancient Greek Ancient Greek Tutorials – Berkeley Language Center of the University of California A Digital Tutorial For Ancient Greek Based on White's First Greek Book New Testament Greek Acropolis World News – A summary of the latest world news in Ancient Greek, Juan Coderch, University of St Andrews Classical texts Perseus – Greek and Roman Materials Ancient Greek Texts&quot; &quot;Ancient Greece (Greek: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ἑλλάς\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", romanized: Hellás) was a northeastern Mediterranean civilization, existing from the Greek Dark Ages of the 12th–9th centuries BC to the end of classical antiquity (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    c. AD 600\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), that comprised a loose collection of culturally and linguistically related city-states and other territories—unified only once, for 13 years, under Alexander the Great's empire (336-323 BC). In Western history, the era of classical antiquity was immediately followed by the Early Middle Ages and the Byzantine period.Roughly three centuries after the Late Bronze \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " collapse of Mycenaean Greece, Greek urban poleis began to form in the 8th century BC, ushering in the Archaic period and colonization of the Mediterranean Basin. This was followed by the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of Classical Greece, from the Greco-Persian Wars to the 5th to 4th centuries BC. The conquests of Alexander the Great of Macedon spread Hellenistic civilization from the western Mediterranean to Central Asia. The Hellenistic period ended with the conquest of the eastern Mediterranean world by the Roman Republic, and the annexation of the Roman province of Macedonia in Roman Greece, and later the province of Achaea during the Roman Empire. Classical Greek culture, especially philosophy, had a powerful influence on ancient Rome, which carried a version of it throughout the Mediterranean and much of Europe. For this reason, Classical Greece is generally considered the cradle of Western civilization, the seminal culture from which the modern West derives many of its founding archetypes and ideas in politics, philosophy, science, and art. Chronology Classical antiquity in the Mediterranean region is commonly considered to have begun in the 8th century BC (around the time of the earliest recorded poetry of Homer) and ended in the 6th century AD. Classical antiquity in Greece was preceded by the Greek Dark Ages (c. 1200 – c. 800 BC), archaeologically characterised by the protogeometric and geometric styles of designs on pottery. Following the Dark Ages was the Archaic Period, beginning around the 8th century BC, which saw early developments in Greek culture and society leading to the Classical Period from the Persian invasion of Greece in 480 until the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of Alexander the Great in 323. The Classical Period is characterized by a &quot;&quot;classical&quot;&quot; style, i.e. one which was considered exemplary by later observers, most famously in the Parthenon of Athens. Politically, the Classical Period was dominated by Athens and the Delian League during the 5th century, but displaced by Spartan hegemony during the early 4th century BC, before power shifted to Thebes and the Boeotian League and finally to the League of Corinth led by Macedon. This period was shaped by the Greco-Persian Wars, the Peloponnesian War, and the Rise of Macedon. Following the Classical period was the Hellenistic period (323–146 BC), during which Greek culture and power expanded into the Near and Middle East from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of Alexander until the Roman conquest. Roman Greece is usually counted from the Roman victory over the Corinthians at the Battle of Corinth in 146 BC to the establishment of Byzantium by Constantine as the capital of the Roman Empire in AD 330. Finally, Late Antiquity refers to the period of Christianization during the later 4th to early 6th centuries \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", consummated by the closure of the Academy of Athens by Justinian I in 529. Historiography The historical period of ancient Greece is unique in world history as the first period attested directly in comprehensive, narrative historiography, while earlier ancient history or protohistory is known from much more fragmentary documents such as annals, king lists, and pragmatic epigraphy. Herodotus is widely known as the &quot;&quot;father of history&quot;&quot;: his Histories are eponymous of the entire field. Written between the 450s and 420s BC, Herodotus' work reaches about a century into the past, discussing 6th century historical figures such as Darius I of Persia, Cambyses II and Psamtik III, and alluding to some 8th century persons such as Candaules. The accuracy of Herodotus' works is debated.Herodotus was succeeded by authors such as Thucydides, Xenophon, Demosthenes, Plato and Aristotle. Most were either Athenian or pro-Athenian, which is why far more is known about the history and politics of Athens than of many other cities. Their scope is further limited by a focus on political, military and diplomatic history, ignoring economic and social history. History Archaic period In the 8th century BC, Greece began to emerge from the Dark Ages, which followed the collapse of the Mycenaean civilization. Literacy had been lost and the Mycenaean script forgotten, but the Greeks adopted the Phoenician alphabet, modifying it to create the Greek alphabet. Objects inscribed with Phoenician writing may have been available in Greece from the 9th century BC, but the earliest evidence of Greek writing comes from graffiti on Greek pottery from the mid-8th century. Greece was divided into many small self-governing communities, a pattern largely dictated by its geography: every island, valley and plain is cut off from its neighbors by the sea or mountain ranges.The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lelantine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " War (c. 710 – c. 650 BC) is the earliest documented war of the ancient Greek period. It was fought between the important \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    poleis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (city-states) of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Chalcis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and Eretria over the fertile \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lelantine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " plain of Euboea. Both cities seem to have suffered a decline as a result of the long war, though \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Chalcis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was the nominal victor. A mercantile class arose in the first half of the 7th century BC, shown by the introduction of coinage in about 680 BC. This seems to have introduced tension to many city-states, as their aristocratic regimes were threatened by the new wealth of merchants ambitious for political power. From 650 BC onwards, the aristocracies had to fight to maintain themselves against populist tyrants. A growing population and a shortage of land also seem to have created internal strife between rich and poor in many city-states.  In Sparta, the Messenian Wars resulted in the conquest of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Messenia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and enserfment of the Messenians, beginning in the latter half of the 8th century BC. This was an unprecedented act in ancient Greece, which led to a social revolution in which the subjugated population of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    helots\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " farmed and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    labored\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " for Sparta, whilst every Spartan male citizen became a soldier of the Spartan army permanently in arms. Rich and poor citizens alike were obliged to live and train as soldiers, an equality that defused social conflict. These reforms, attributed to Lycurgus of Sparta, were probably complete by 650 BC. Athens suffered a land and agrarian crisis in the late 7th century BC, again resulting in civil strife. The Archon (chief magistrate) Draco made severe reforms to the law code in 621 BC (hence &quot;&quot;draconian&quot;&quot;), but these failed to quell the conflict. Eventually, the moderate reforms of Solon (594 BC), improving the lot of the poor but firmly entrenching the aristocracy in power, gave Athens some stability. By the 6th century BC, several cities had emerged as dominant in Greek affairs: Athens, Sparta, Corinth, and Thebes. Each of them had brought the surrounding rural areas and smaller towns under their control, and Athens and Corinth had become major maritime and mercantile powers as well. Rapidly increasing population in the 8th and 7th centuries BC had resulted in emigration of many Greeks to form colonies in Magna Graecia (Southern Italy and Sicily), Asia Minor and further afield. The emigration effectively ceased in the 6th century BC by which time the Greek world had, culturally and linguistically, become much larger than the area of present-day Greece. Greek colonies were not politically controlled by their founding cities, although they often retained religious and commercial links with them. The Greek colonies of Sicily, especially Syracuse, were soon drawn into prolonged conflicts with the Carthaginians. These conflicts lasted from 600 BC to 265 BC, when the Roman Republic allied with the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Mamertines\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to fend off the new tyrant of Syracuse, Hiero II, and then the Carthaginians. As a result, Rome became the new dominant power against the fading strength of the Sicilian Greek cities and the fading Carthaginian hegemony. One year later the First Punic War erupted. In this period, Greece and its overseas colonies enjoyed huge economic development in commerce and manufacturing, with rising general prosperity. Some studies estimate that the average Greek household grew fivefold between 800 and 300 BC, indicating a large increase in average income.In the second half of the 6th century BC, Athens fell under the tyranny of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Peisistratos\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " followed by his sons Hippias and Hipparchos. However, in 510 BC, at the instigation of the Athenian aristocrat Cleisthenes, the Spartan king \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cleomenes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " I helped the Athenians overthrow the tyranny. Sparta and Athens promptly turned on each other, at which point Cleomenes I installed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Isagoras\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " as a pro-Spartan archon. Eager to secure Athens' independence from Spartan control, Cleisthenes proposed a political revolution: that all citizens share power, regardless of status, making Athens a &quot;&quot;democracy&quot;&quot;. The democratic enthusiasm of the Athenians swept out Isagoras and threw back the Spartan-led invasion to restore him. The advent of democracy cured many of the social ills of Athens and ushered in the Golden \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". Classical Greece In 499 BC, the Ionian city states under Persian rule rebelled against their Persian-supported tyrant rulers. Supported by troops sent from Athens and Eretria, they advanced as far as Sardis and burnt the city before being driven back by a Persian counterattack. The revolt continued until 494, when the rebelling Ionians were defeated. Darius did not forget that Athens had assisted the Ionian revolt, and in 490 he assembled an armada to retaliate. Though heavily outnumbered, the Athenians—supported by their Plataean allies—defeated the Persian hordes at the Battle of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Marathon\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and the Persian fleet turned tail. Ten years later, a second invasion was launched by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Darius' son Xerxes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The city-states of northern and central Greece submitted to the Persian forces without resistance, but a coalition of 31 Greek city states, including Athens and Sparta, determined to resist the Persian invaders. At the same time, Greek Sicily was invaded by a Carthaginian force. In 480 BC, the first major battle of the invasion was fought at Thermopylae, where a small rearguard of Greeks, led by three hundred Spartans, held a crucial pass guarding the heart of Greece for several days; at the same time Gelon, tyrant of Syracuse, defeated the Carthaginian invasion at the Battle of Himera.The Persians were decisively defeated at sea by a primarily Athenian naval force at the Battle of Salamis, and on land in 479 BC at the Battle of Plataea. The alliance against Persia continued, initially led by the Spartan Pausanias but from 477 by Athens, and by 460 Persia had been driven out of the Aegean. During this long campaign, the Delian League gradually transformed from a defensive alliance of Greek states into an Athenian empire, as Athens' growing naval power intimidated the other league states. Athens ended its campaigns against Persia in 450, after a disastrous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    defeat\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in Egypt in 454, and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of Cimon in action against the Persians on Cyprus in 450.As the Athenian fight against the Persian empire waned, conflict grew between Athens and Sparta. Suspicious of the increasing Athenian power funded by the Delian League, Sparta offered aid to reluctant members of the League to rebel against Athenian domination. These tensions were exacerbated in 462 BC when Athens sent a force to aid Sparta in overcoming a helot revolt, but this aid was rejected by the Spartans. In the 450s, Athens took control of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Boeotia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and won victories over Aegina and Corinth. However, Athens failed to win a decisive victory, and in 447 lost \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Boeotia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " again. Athens and Sparta signed the Thirty Years' Peace in the winter of 446/5, ending the conflict.Despite the treaty, Athenian relations with Sparta declined again in the 430s, and in 431 BC the Peloponnesian War began. The first phase of the war saw a series of fruitless annual invasions of Attica by Sparta, while Athens successfully fought the Corinthian empire in northwest Greece and defended its own empire, despite a plague which killed the leading Athenian statesman Pericles. The war turned after Athenian victories led by Cleon at Pylos and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sphakteria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and Sparta sued for peace, but the Athenians rejected the proposal. The Athenian failure to regain control of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Boeotia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " at \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Delium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and Brasidas' successes in northern Greece in 424 improved Sparta's position after \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sphakteria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". After the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deaths\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of Cleon and Brasidas, the strongest proponents of war on each side, a peace treaty was negoitiated in 421 by the Athenian general Nicias.The peace did not last, however. In 418 BC allied forces of Athens and Argos were defeated by Sparta at Mantinea. In 415 Athens launched an ambitious naval expedition to dominate Sicily; the expedition ended in disaster at the harbor of Syracuse, with almost the entire army killed and the ships destroyed. Soon after the Athenian defeat in Syracuse, Athens' Ionian allies began to rebel against the Delian league, while Persia began to once again involve itself in Greek affairs on the Spartan side. Initially the Athenian position continued relatively strong, with important victories at Cyzicus in 410 and Arginusae in 406. However, in 405 the Spartan Lysander defeated Athens in the Battle of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aegospotami\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and began to blockade Athens' harbour; driven by hunger, Athens sued for peace, agreeing to surrender their fleet and join the Spartan-led Peloponnesian League.Greece thus entered the 4th century BC under a Spartan hegemony, but it was clear from the start that this was weak. A drastically dwindling population meant Sparta was overstretched, and by 395 Athens, Argos, Thebes, and Corinth felt able to challenge Spartan dominance, resulting in the Corinthian War (395–387 BC). Another war of stalemates, it ended with the status quo restored, after the threat of Persian intervention on behalf of the Spartans. The Spartan hegemony lasted another sixteen years, until, when attempting to impose their will on the Thebans, the Spartans were defeated at Leuctra in 371 BC. The Theban general Epaminondas then led Theban troops into the Peloponnese, whereupon other city-states defected from the Spartan cause. The Thebans were thus able to march into Messenia and free the helot population. Deprived of land and its serfs, Sparta declined to a second-rank power. The Theban hegemony thus established was short-lived; at the Battle of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Mantinea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in 362 BC, Thebes lost its key leader, Epaminondas, and much of its manpower, even though they were victorious in battle. In fact, such were the losses to all the great city-states at Mantinea that none could dominate the aftermath. The exhaustion of the Greek heartland coincided with the rise of Macedon, led by Philip II. In twenty years, Philip had unified his kingdom, expanded it north and west at the expense of Illyrian tribes, and then conquered Thessaly and Thrace. His success stemmed from his innovative reforms to the Macedonian army. Phillip intervened repeatedly in the affairs of the southern city-states, culminating in his invasion of 338 BC. Decisively defeating an allied army of Thebes and Athens at the Battle of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Chaeronea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (338 BC), he became de facto hegemon of all of Greece, except Sparta. He compelled the majority of the city-states to join the Hellenic League, allying them to him and imposing peace among them. Philip then entered into war against the Achaemenid Empire but was assassinated by Pausanias of Orestis early in the conflict. Alexander, son and successor of Philip, continued the war. In an unequalled series of campaigns, Alexander defeated Darius III of Persia and completely destroyed the Achaemenid Empire, annexing it to Macedon and earning himself the epithet 'the Great'. When Alexander died in 323 BC, Greek power and influence were at their zenith. However, there had been a fundamental shift away from the fierce independence and classical culture of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    poleis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "—and instead towards the developing Hellenistic culture. Hellenistic Greece The Hellenistic period lasted from 323 BC, the end of the wars of Alexander the Great, to the annexation of Greece by the Roman Republic in 146 BC. Although the establishment of Roman rule did not break the continuity of Hellenistic society and culture, which remained essentially unchanged until the advent of Christianity, it did mark the end of Greek political independence. After the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of Alexander, his empire was, after quite some conflict, divided among his generals, resulting in the Ptolemaic Kingdom (Egypt and adjoining North Africa), the Seleucid Empire (the Levant, Mesopotamia and Persia) and the Antigonid dynasty (Macedonia). In the intervening period, the poleis of Greece were able to wrest back some of their freedom, although still nominally subject to Macedon. During the Hellenistic period, the importance of &quot;&quot;Greece proper&quot;&quot; (the territory of modern Greece) within the Greek-speaking world declined sharply. The great capitals of Hellenistic culture were \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Alexandria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the Ptolemaic Kingdom and Antioch in the Seleucid Empire. The conquests of Alexander had numerous consequences for the Greek city-states. It greatly widened the horizons of the Greeks and led to a steady emigration of the young and ambitious to the new Greek empires in the east. Many Greeks migrated to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Alexandria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", Antioch and the many other new Hellenistic cities founded in Alexander's wake, as far away as present-day Afghanistan and Pakistan, where the Greco-Bactrian Kingdom and the Indo-Greek Kingdom survived until the end of the first century BC. The city-states within Greece formed themselves into two leagues; the Achaean League (including Thebes, Corinth and Argos) and the Aetolian League (including Sparta and Athens). For much of the period until the Roman conquest, these leagues were at war, often participating in the conflicts between the Diadochi (the successor states to Alexander's empire). The Antigonid Kingdom became involved in a war with the Roman Republic in the late 3rd century. Although the First Macedonian War was inconclusive, the Romans, in typical fashion, continued to fight Macedon until it was completely absorbed into the Roman Republic (by 149 BC). In the east, the unwieldy Seleucid Empire gradually disintegrated, although a rump survived until 64 BC, whilst the Ptolemaic Kingdom continued in Egypt until 30 BC when it too was conquered by the Romans. The Aetolian league grew wary of Roman involvement in Greece, and sided with the Seleucids in the Roman–Seleucid War; when the Romans were victorious, the league was effectively absorbed into the Republic. Although the Achaean league outlasted both the Aetolian league and Macedon, it was also soon defeated and absorbed by the Romans in 146 BC, bringing Greek independence to an end. Roman Greece The Greek peninsula came under Roman rule during the 146 BC conquest of Greece after the Battle of Corinth. Macedonia became a Roman province while southern Greece came under the surveillance of Macedonia's prefect; however, some Greek \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    poleis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " managed to maintain a partial independence and avoid taxation. The Aegean islands were added to this territory in 133 BC. Athens and other Greek cities revolted in 88 BC, and the peninsula was crushed by the Roman general Sulla. The Roman civil wars devastated the land even further, until Augustus organized the peninsula as the province of Achaea in 27 BC. Greece was a key eastern province of the Roman Empire, as the Roman culture had long been in fact Greco-Roman. The Greek language served as a lingua franca in the East and in Italy, and many Greek intellectuals such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " would perform most of their work in Rome. Geography Regions The territory of Greece is mountainous, and as a result, ancient Greece consisted of many smaller regions each with its own dialect, cultural peculiarities, and identity. Regionalism and regional conflicts were prominent features of ancient Greece. Cities tended to be located in valleys between mountains, or on coastal plains and dominated a certain area around them. In the south lay the Peloponnese, consisting of the regions of Laconia (southeast), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Messenia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (southwest), Elis (west), Achaia (north), Korinthia (northeast), Argolis (east), and Arcadia (center). These names survive to the present day as regional units of modern Greece, though with somewhat different boundaries. Mainland Greece to the north, nowadays known as Central Greece, consisted of Aetolia and Acarnania in the west, Locris, Doris, and Phocis in the center, while in the east lay \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Boeotia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Attica, and Megaris. Northeast lay Thessaly, while Epirus lay to the northwest. Epirus stretched from the Ambracian Gulf in the south to the Ceraunian mountains and the Aoos river in the north, and consisted of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Chaonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (north), Molossia (center), and Thesprotia (south). In the northeast corner was Macedonia, originally consisting Lower Macedonia and its regions, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Elimeia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Pieria, and Orestis. Around the time of Alexander I of Macedon, the Argead kings of Macedon started to expand into Upper Macedonia, lands inhabited by independent Macedonian tribes like the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lyncestae\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Orestae\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and the Elimiotae and to the West, beyond the Axius river, into Eordaia, Bottiaea, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Mygdonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Almopia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", regions settled by Thracian tribes. To the north of Macedonia lay various non-Greek peoples such as the Paeonians due north, the Thracians to the northeast, and the Illyrians, with whom the Macedonians were frequently in conflict, to the northwest. Chalcidice was settled early on by southern Greek colonists and was considered part of the Greek world, while from the late 2nd millennium BC substantial Greek settlement also occurred on the eastern shores of the Aegean, in Anatolia. Colonies During the Archaic period, the Greek population grew beyond the capacity of the limited arable land of Greece proper, resulting in the large-scale establishment of colonies elsewhere: according to one estimate, the population of the widening area of Greek settlement increased roughly tenfold from 800 BC to 400 BC, from 800,000 to as many as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    7½-10\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " million.From about 750 BC the Greeks began 250 years of expansion, settling colonies in all directions. To the east, the Aegean coast of Asia Minor was colonized first, followed by Cyprus and the coasts of Thrace, the Sea of Marmara and south coast of the Black Sea. Eventually, Greek colonization reached as far northeast as present-day Ukraine and Russia (Taganrog). To the west the coasts of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Illyria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Sicily and Southern Italy were settled, followed by Southern France, Corsica, and even eastern Spain. Greek colonies were also founded in Egypt and Libya. Modern Syracuse, Naples, Marseille and Istanbul had their beginnings as the Greek colonies Syracusae (Συράκουσαι), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Neapolis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (Νεάπολις), Massalia (Μασσαλία) and Byzantion (Βυζάντιον). These colonies played an important role in the spread of Greek influence throughout Europe and also aided in the establishment of long-distance trading networks between the Greek city-states, boosting the economy of ancient Greece. Politics and society Political structure Ancient Greece consisted of several hundred relatively independent city-states (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    poleis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "). This was a situation unlike that in most other contemporary societies, which were either tribal or kingdoms ruling over relatively large territories. Undoubtedly the geography of Greece—divided and sub-divided by hills, mountains, and rivers—contributed to the fragmentary nature of ancient Greece. On the one hand, the ancient Greeks had no doubt that they were &quot;&quot;one people&quot;&quot;; they had the same religion, same basic culture, and same language. Furthermore, the Greeks were very aware of their tribal origins; Herodotus was able to extensively categorise the city-states by tribe. Yet, although these higher-level relationships existed, they seem to have rarely had a major role in Greek politics. The independence of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    poleis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was fiercely defended; unification was something rarely contemplated by the ancient Greeks. Even when, during the second Persian invasion of Greece, a group of city-states allied themselves to defend Greece, the vast majority of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    poleis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " remained neutral, and after the Persian defeat, the allies quickly returned to infighting.Thus, the major peculiarities of the ancient Greek political system were its fragmentary nature (and that this does not particularly seem to have tribal origin), and the particular focus on urban centers within otherwise tiny states. The peculiarities of the Greek system are further evidenced by the colonies that they set up throughout the Mediterranean Sea, which, though they might count a certain Greek polis as their 'mother' (and remain sympathetic to her), were completely independent of the founding city. Inevitably smaller \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    poleis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " might be dominated by larger neighbors, but conquest or direct rule by another city-state appears to have been quite rare. Instead the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    poleis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " grouped themselves into leagues, membership of which was in a constant state of flux. Later in the Classical period, the leagues would become fewer and larger, be dominated by one city (particularly Athens, Sparta and Thebes); and often \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    poleis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " would be compelled to join under threat of war (or as part of a peace treaty). Even after Philip II of Macedon &quot;&quot;conquered&quot;&quot; the heartlands of ancient Greece, he did not attempt to annex the territory, or unify it into a new province, but simply compelled most of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    poleis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to join his own Corinthian League. Government and law Initially many Greek city-states seem to have been petty kingdoms; there was often a city official carrying some residual, ceremonial functions of the king (basileus), e.g., the archon basileus in Athens. However, by the Archaic period and the first historical consciousness, most had already become aristocratic oligarchies. It is unclear exactly how this change occurred. For instance, in Athens, the kingship had been reduced to a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hereditary\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", lifelong chief magistracy (archon) by c. 1050 BC; by 753 BC this had become a decennial, elected archonship; and finally by 683 BC an annually elected archonship. Through each stage more power would have been transferred to the aristocracy as a whole, and away from a single individual. Inevitably, the domination of politics and concomitant aggregation of wealth by small groups of families was apt to cause social unrest in many \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    poleis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". In many cities a tyrant (not in the modern sense of repressive autocracies), would at some point seize control and govern according to their own will; often a populist agenda would help sustain them in power. In a system wracked with class conflict, government by a 'strongman' was often the best solution. Athens fell under a tyranny in the second half of the 6th century BC. When this tyranny was ended, the Athenians founded the world's first democracy as a radical solution to prevent the aristocracy regaining power. A citizens' assembly (the Ecclesia), for the discussion of city policy, had existed since the reforms of Draco in 621 BC; all citizens were permitted to attend after the reforms of Solon (early 6th century), but the poorest citizens could not address the assembly or run for office. With the establishment of the democracy, the assembly became the de jure mechanism of government; all citizens had equal privileges in the assembly. However, non-citizens, such as metics (foreigners living in Athens) or slaves, had no political rights at all. After the rise of democracy in Athens, other city-states founded democracies. However, many retained more traditional forms of government. As so often in other matters, Sparta was a notable exception to the rest of Greece, ruled through the whole period by not one, but two hereditary monarchs. This was a form of diarchy. The Kings of Sparta belonged to the Agiads and the Eurypontids, descendants respectively of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Eurysthenes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and Procles. Both dynasties' founders were believed to be twin sons of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aristodemus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", a Heraclid ruler. However, the powers of these kings were held in check by both a council of elders (the Gerousia) and magistrates specifically appointed to watch over the kings (the Ephors). Social structure Only free, land-owning, native-born men could be citizens entitled to the full protection of the law in a city-state. In most city-states, unlike the situation in Rome, social prominence did not allow special rights. Sometimes families controlled public religious functions, but this ordinarily did not give any extra power in the government. In Athens, the population was divided into four social classes based on wealth. People could change classes if they made more money. In Sparta, all male citizens were called homoioi, meaning &quot;&quot;peers&quot;&quot;. However, Spartan kings, who served as the city-state's dual military and religious leaders, came from two families. Slavery Slaves had no power or status. They had the right to have a family and own property, subject to their master's goodwill and permission, but they had no political rights. By 600 BC chattel slavery had spread in Greece. By the 5th century BC, slaves made up one-third of the total population in some city-states. Between forty and eighty per cent of the population of Classical Athens were slaves. Slaves outside of Sparta almost never revolted because they were made up of too many nationalities and were too scattered to organize. However, unlike later Western culture, the Ancient Greeks did not think in terms of race.Most families owned slaves as household servants and laborers, and even poor families might have owned a few slaves. Owners were not allowed to beat or kill their slaves. Owners often promised to free slaves in the future to encourage slaves to work hard. Unlike in Rome, freedmen did not become citizens. Instead, they were mixed into the population of metics, which included people from foreign countries or other city-states who were officially allowed to live in the state. City-states legally owned slaves. These public slaves had a larger measure of independence than slaves owned by families, living on their own and performing specialized tasks. In Athens, public slaves were trained to look out for counterfeit coinage, while temple slaves acted as servants of the temple's deity and Scythian slaves were employed in Athens as a police force corralling citizens to political functions. Sparta had a special type of slaves called helots. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Helots\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " were Messenians enslaved en masse during the Messenian Wars by the state and assigned to families where they were forced to stay. Helots raised food and did household chores so that women could concentrate on raising strong children while men could devote their time to training as hoplites. Their masters treated them harshly, and helots revolted against their masters several times before in 370/69 BC they won their freedom. Education For most of Greek history, education was private, except in Sparta. During the Hellenistic period, some city-states established public schools. Only wealthy families could afford a teacher. Boys learned how to read, write and quote literature. They also learned to sing and play one musical instrument and were trained as athletes for military service. They studied not for a job but to become an effective citizen. Girls also learned to read, write and do simple arithmetic so they could manage the household. They almost never received education after childhood.Boys went to school at the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of seven, or went to the barracks, if they lived in Sparta. The three types of teachings were: grammatistes for arithmetic, kitharistes for music and dancing, and Paedotribae for sports. Boys from wealthy families attending the private school lessons were taken care of by a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    paidagogos\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", a household slave selected for this task who accompanied the boy during the day. Classes were held in teachers' private houses and included reading, writing, mathematics, singing, and playing the lyre and flute. When the boy became 12 years old the schooling started to include sports such as wrestling, running, and throwing discus and javelin. In Athens, some older youths attended academy for the finer disciplines such as culture, sciences, music, and the arts. The schooling ended at \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " 18, followed by military training in the army usually for one or two years.Only a small number of boys continued their education after childhood, as in the Spartan agoge. A crucial part of a wealthy teenager's education was a mentorship with an elder, which in a few places and times may have included pederasty. The teenager learned by watching his mentor talking about politics in the agora, helping him perform his public duties, exercising with him in the gymnasium and attending symposia with him. The richest students continued their education by studying with famous teachers. Some of Athens' greatest such schools included the Lyceum (the so-called Peripatetic school founded by Aristotle of Stageira) and the Platonic Academy (founded by Plato of Athens). The education system of the wealthy ancient Greeks is also called Paideia. Economy At its economic height in the 5th and 4th centuries BC, the free citizenry of Classical Greece represented perhaps the most prosperous society in the ancient world, some economic historians considering Greece one of the most advanced pre-industrial economies. In terms of wheat, wages reached an estimated 7-12 kg daily for an unskilled worker in urban Athens, 2-3 times the 3.75 kg of an unskilled rural labourer in Roman Egypt, though Greek farm incomes too were on average lower than those available to urban workers.While slave conditions varied widely, the institution served to sustain the incomes of the free citizenry: an estimate of economic development drawn from the latter (or derived from urban incomes alone) is therefore likely to overstate the true overall level despite widespread evidence for high living standards. Warfare At least in the Archaic Period, the fragmentary nature of ancient Greece, with many competing city-states, increased the frequency of conflict but conversely limited the scale of warfare. Unable to maintain professional armies, the city-states relied on their own citizens to fight. This inevitably reduced the potential duration of campaigns, as citizens would need to return to their own professions (especially in the case of, for example, farmers). Campaigns would therefore often be restricted to summer. When battles occurred, they were usually set piece and intended to be decisive. Casualties were slight compared to later battles, rarely amounting to more than five percent of the losing side, but the slain often included the most prominent citizens and generals who led from the front. The scale and scope of warfare in ancient Greece changed dramatically as a result of the Greco-Persian Wars. To fight the enormous armies of the Achaemenid Empire was effectively beyond the capabilities of a single city-state. The eventual triumph of the Greeks was achieved by alliances of city-states (the exact composition changing over time), allowing the pooling of resources and division of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    labor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Although alliances between city-states occurred before this time, nothing on this scale had been seen before. The rise of Athens and Sparta as pre-eminent powers during this conflict led directly to the Peloponnesian War, which saw further development of the nature of warfare, strategy and tactics. Fought between leagues of cities dominated by Athens and Sparta, the increased manpower and financial resources increased the scale and allowed the diversification of warfare. Set-piece battles during the Peloponnesian war proved indecisive and instead there was increased reliance on attritionary strategies, naval battles and blockades and sieges. These changes greatly increased the number of casualties and the disruption of Greek society. Athens owned one of the largest war fleets in ancient Greece. It had over 200 triremes each powered by 170 oarsmen who were seated in 3 rows on each side of the ship. The city could afford such a large fleet—it had over 34,000 oarsmen—because it owned a lot of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    silver\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " mines that were worked by slaves. According to Josiah Ober, Greek city-states faced approximately a one-in-three chance of destruction during the archaic and classical period. Culture Philosophy Ancient Greek philosophy focused on the role of reason and inquiry. In many ways, it had an important influence on modern philosophy, as well as modern science. Clear unbroken lines of influence lead from ancient Greek and Hellenistic philosophers, to medieval Muslim philosophers and Islamic scientists, to the European Renaissance and Enlightenment, to the secular sciences of the modern day. Neither reason nor inquiry began with the ancient Greeks. Defining the difference between the Greek quest for knowledge and the quests of the elder civilizations, such as the ancient Egyptians and Babylonians, has long been a topic of study by theorists of civilization. The first known philosophers of Greece were the pre-Socratics, who attempted to provide naturalistic, non-mythical descriptions of the world. They were followed by Socrates, one of the first philosophers based on Athens during its golden \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " whose ideas, despite being known by second-hand accounts instead of writings of his own, laid the basis of Western philosophy. Socrates' disciple Plato, who wrote The Republic and established a radical difference between ideas and the concrete world, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Plato's disciple Aristotle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", who wrote extensively about nature and ethics, are also immensely influential in Western philosophy to this day. The later Hellenistic philosophy, also originating in Greece, is defined by names such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Antisthenes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (cynicism), Zeno of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Citium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (stoicism) and Plotinus (Neoplatonism). Literature and theatre The earliest Greek literature was poetry and was composed for performance rather than private consumption. The earliest Greek poet known is Homer, although he was certainly part of an existing tradition of oral poetry. Homer's poetry, though it was developed around the same time that the Greeks developed writing, would have been composed orally; the first poet to certainly compose their work in writing was Archilochus, a lyric poet from the mid-seventh century BC. Tragedy developed around the end of the archaic period, taking elements from across the pre-existing genres of late archaic poetry. Towards the beginning of the classical period, comedy began to develop—the earliest date associated with the genre is 486 BC, when a competition for comedy became an official event at the City Dionysia in Athens, though the first preserved ancient comedy is Aristophanes' \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Acharnians\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", produced in 425. Like poetry, Greek prose had its origins in the archaic period, and the earliest writers of Greek philosophy, history, and medical literature all date to the sixth century BC. Prose first emerged as the writing style adopted by the presocratic philosophers Anaximander and Anaximenes—though Thales of Miletus, considered the first Greek philosopher, apparently wrote nothing. Prose as a genre reached maturity in the classical era, and the major Greek prose genres—philosophy, history, rhetoric, and dialogue—developed in this period.The Hellenistic period saw the literary centre of the Greek world move from Athens, where it had been in the classical period, to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Alexandria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". At the same time, other Hellenistic kings such as the Antigonids and the Attalids were patrons of scholarship and literature, turning Pella and Pergamon respectively into cultural centres. It was thanks to this cultural patronage by Hellenistic kings, and especially the Museum at Alexandria, that so much ancient Greek literature has survived. The Library of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Alexandria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", part of the Museum, had the previously-unenvisaged aim of collecting together copies of all known authors in Greek. Almost all of the surviving non-technical Hellenistic literature is poetry, and Hellenistic poetry tended to be highly intellectual, blending different genres and traditions, and avoiding linear narratives. The Hellenistic period also saw a shift in the ways literature was consumed—while in the archaic and classical periods literature had typically been experienced in public performance, in the Hellenistic period it was more commonly read privately. At the same time, Hellenistic poets began to write for private, rather than public, consumption.With Octavian's victory at \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Actium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in 31 BC, Rome began to become a major centre of Greek literature, as important Greek authors such as Strabo and Dionysius of Halicarnassus came to Rome. The period of greatest innovation in Greek literature under Rome was the &quot;&quot;long second century&quot;&quot; from approximately AD 80 to around AD 230. This innovation was especially marked in prose, with the development of the novel and a revival of prominence for display oratory both dating to this period. Music and dance Music was present almost universally in Greek society, from marriages and funerals to religious ceremonies, theatre, folk music and the ballad-like reciting of epic poetry. There are significant fragments of actual Greek musical notation as well as many literary references to ancient Greek music. Greek art depicts musical instruments and dance. The word music derives from the name of the Muses, the daughters of Zeus who were patron goddesses of the arts. Science and technology Ancient Greek mathematics contributed many important developments to the field of mathematics, including the basic rules of geometry, the idea of formal mathematical proof, and discoveries in number theory, mathematical analysis, applied mathematics, and approached close to establishing integral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calculus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The discoveries of several Greek mathematicians, including Pythagoras, Euclid, and Archimedes, are still used in mathematical teaching today. The Greeks developed astronomy, which they treated as a branch of mathematics, to a highly sophisticated level. The first geometrical, three-dimensional models to explain the apparent motion of the planets were developed in the 4th century BC by Eudoxus of Cnidus and Callippus of Cyzicus. Their younger contemporary Heraclides Ponticus proposed that the Earth rotates around its axis. In the 3rd century BC, Aristarchus of Samos was the first to suggest a heliocentric system. Archimedes in his treatise The Sand Reckoner revives Aristarchus' hypothesis that &quot;&quot;the fixed stars and the Sun remain unmoved, while the Earth revolves about the Sun on the circumference of a circle&quot;&quot;. Otherwise, only fragmentary descriptions of Aristarchus' idea survive. Eratosthenes, using the angles of shadows created at widely separated regions, estimated the circumference of the Earth with great accuracy. In the 2nd century BC Hipparchus of Nicea made a number of contributions, including the first measurement of precession and the compilation of the first star catalog in which he proposed the modern system of apparent magnitudes. The Antikythera mechanism, a device for calculating the movements of planets, dates from about 80 BC and was the first ancestor of the astronomical computer. It was discovered in an ancient shipwreck off the Greek island of Antikythera, between Kythera and Crete. The device became famous for its use of a differential gear, previously believed to have been invented in the 16th century, and the miniaturization and complexity of its parts, comparable to a clock made in the 18th century. The original mechanism is displayed in the Bronze collection of the National Archaeological Museum of Athens, accompanied by a replica. The ancient Greeks also made important discoveries in the medical field. Hippocrates was a physician of the Classical period, and is considered one of the most outstanding figures in the history of medicine. He is referred to as the &quot;&quot;father of medicine&quot;&quot; in recognition of his lasting contributions to the field as the founder of the Hippocratic school of medicine. This intellectual school revolutionized medicine in ancient Greece, establishing it as a discipline distinct from other fields that it had traditionally been associated with (notably \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    theurgy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and philosophy), thus making medicine a profession. Art and architecture The art of ancient Greece has exercised an enormous influence on the culture of many countries from ancient times to the present day, particularly in the areas of sculpture and architecture. In the West, the art of the Roman Empire was largely derived from Greek models. In the East, Alexander the Great's conquests initiated several centuries of exchange between Greek, Central Asian and Indian cultures, resulting in Greco-Buddhist art, with ramifications as far as Japan. Following the Renaissance in Europe, the humanist aesthetic and the high technical standards of Greek art inspired generations of European artists. Well into the 19th century, the classical tradition derived from Greece dominated the art of the western world. Religion Religion was a central part of ancient Greek life. Though the Greeks of different cities and tribes worshipped similar gods, religious practices were not uniform and the gods were thought of differently in different places. The Greeks were polytheistic, worshipping many gods, but as early as the sixth century BC a pantheon of twelve Olympians began to develop. Greek religion was influenced by the practices of the Greeks' near eastern neighbours at least as early as the archaic period, and by the Hellenistic period this influence was seen in both directions.The most important religious act in ancient Greece was animal sacrifice, most commonly of sheep and goats. Sacrifice was accompanied by public prayer, and prayer and hymns were themselves a major part of ancient Greek religious life. Legacy The civilization of ancient Greece has been immensely influential on language, politics, educational systems, philosophy, science, and the arts. It became the Leitkultur of the Roman Empire to the point of marginalizing native Italic traditions. As \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Horace\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " put it, Graecia capta ferum victorem cepit et \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    artis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " / intulit agresti Latio (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Epistulae\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 2.1.156f.) Captive Greece took captive her uncivilised conqueror and instilled her arts in rustic Latium.Via the Roman Empire, Greek culture came to be foundational to Western culture in general. The Byzantine Empire inherited Classical Greek-Hellenistic culture directly, without Latin intermediation, and the preservation of classical Greek learning in medieval Byzantine tradition further exerted a strong influence on the Slavs and later on the Islamic Golden \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " and the Western European Renaissance. A modern revival of Classical Greek learning took place in the Neoclassicism movement in 18th- and 19th-century Europe and the Americas. Empires, kingdoms and regions Kingdom of Mycenae (c. 1600–c. 1100 BC) Mycenaean Greece (or the Mycenaean civilization) was the last phase of the Bronze \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " in Ancient Greece, spanning the period from approximately \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    1600–1100\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " BC. It represents the first advanced and distinctively Greek civilization in mainland Greece with its palatial states, urban organization, works of art, and writing system. The most prominent site was Mycenae, in the Argolid, after which the culture of this era is named. Other centers of power that emerged included Pylos, Tiryns, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Midea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the Peloponnese, Orchomenos, Thebes, Athens in Central Greece and Iolcos in Thessaly. Mycenaean and Mycenaean-influenced settlements also appeared in Epirus, Macedonia, on islands in the Aegean Sea, on the coast of Asia Minor, the Levant, Cyprus, and Italy. Kingdom of Macedon/Macedonian Empire (808–146 BC) Macedonia (/ˌmæsɪˈdoʊniə/ (About this soundlisten); Ancient Greek: Μακεδονία), also called Macedon (/ˈmæsɪdɒn/), was an ancient kingdom on the periphery of Archaic and Classical Greece, and later the dominant state of Hellenistic Greece. The kingdom was founded and initially ruled by the royal Argead dynasty, which was followed by the Antipatrid and Antigonid dynasties. Home to the ancient Macedonians, the earliest kingdom was centered on the northeastern part of the Greek peninsula, and bordered by Epirus to the west, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Paeonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to the north, Thrace to the east and Thessaly to the south. At the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of Alexander the Great in 323 BC, the Macedonian Empire was the largest polity in the world, spanning over all of Greece, Anatolia, Egypt, Mesopotamia, and Persia. Kingdom of Cyrene (632–30 BC) Cyrenaica was colonized by the Greeks beginning in the 7th century BC when it was known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Kyrenaika\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The first and most important colony was that of Cyrene, established in about 631 BC by colonists from the Greek island of Thera, which they had abandoned because of a severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    famine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Their commander, Aristoteles, took the Libyan name Battos. His dynasty, the Battaid, persisted in spite of severe conflict with Greeks in neighboring cities. Delian League (or Athenian Empire) (478–404 BC) The Delian League, founded in 478 BC, was an association of Greek city-states, with the number of members numbering between 150 and 330 under the leadership of Athens, whose purpose was to continue fighting the Persian Empire after the Greek victory in the Battle of Plataea at the end of the Second Persian invasion of Greece. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bosporan\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Kingdom (438 BC–370 AD) The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bosporan\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Kingdom, also known as the Kingdom of the Cimmerian Bosporus (Greek: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Βασίλειον\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " τοῦ Κιμμερικοῦ Βοσπόρου, Basileion tou \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Kimmerikou\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Bosporou), was an ancient Greco-Scythian state located in eastern Crimea and the Taman Peninsula on the shores of the Cimmerian Bosporus, the present-day Strait of Kerch. It was the first truly 'Hellenistic' state in the sense that a mixed population adopted the Greek language and civilization. Aetolian League (370–189 BC) The Aetolian League (also transliterated as Aitolian League) (Ancient Greek: Κοινὸν τῶν Αἰτωλῶν) was a confederation of tribal communities and cities in ancient Greece centered in Aetolia in central Greece. It was probably established during the early Hellenistic era, in opposition to Macedon and the Achaean League. Two annual meetings were held at Thermika and Panaetolika. The league occupied Delphi from 290 BC and steadily gained territory until, by the end of the 3rd century BC, it controlled the whole of central Greece with the exception of Attica and Boeotia. At its peak, the league's territory included Locris, Malis, Dolopes, parts of Thessaly, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Phocis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and Acarnania. In the latter part of its power, certain Greek city-states joined the Aetolian League such as the Arcadian cities of Mantineia, Tegea, Phigalia and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Kydonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " on Crete. Kingdom of Epirus (330–167 BC) Epirus (/ɪˈpaɪrəs/; Epirote Greek: Ἄπειρος, Ápeiros; Attic Greek: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ἤπειρος\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Ḗpeiros) was an ancient Greek state and kingdom, located in the geographical region of Epirus in the western Balkans. The homeland of the ancient Epirotes was bordered by the Aetolian League to the south, ancient Thessaly and Macedonia to the east, and Illyrian tribes to the north. For a brief period (280–275 BC), the Epirote Greek king Pyrrhus managed to make Epirus a powerful state in the Greek world, comparable to the likes of Macedon and Rome. His armies marched against Rome during an unsuccessful campaign in Italy. Dayuan Kingdom (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    329–160\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " BC) The region of Ferghana was conquered by Alexander the Great in 329 BC and became his most advanced base in Central Asia. He founded (probably by occupying and renaming Cyropolis) the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fortified\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " city of Alexandria Eschate (Lit. &quot;&quot;Alexandria the Furthest&quot;&quot;) in the southwestern part of the Ferghana valley, on the southern bank of the river Syr Darya (ancient Jaxartes), at the location of the modern city of Khujand (also called Khozdent, formerly \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Leninabad\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), in the state of Tajikistan. Alexander built a six-kilometer-long brick wall around the city and, as similarly in the cases of the other cities he founded, had a garrison of his retired veterans and wounded settle there. The whole of Bactria, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Transoxiana\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and the area of Ferghana remained under the control of the Hellenistic Seleucid Empire until 250 BC. The region then wrested independence under the leadership of its Greek governors Diodotus of Bactria, to become the Greco-Bactrian Kingdom. Seleucid Empire (312–63 BC) The Seleucid Empire (/sɪˈljuːsɪd/; Ancient Greek: Βασιλεία τῶν Σελευκιδῶν, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Basileía tōn\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Seleukidōn) was a Hellenistic state in Western Asia that existed from 312 BC to 63 BC. It was founded by Seleucus I Nicator following the division of the Macedonian Empire established by Alexander the Great. After receiving \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Babylonia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in 321 BC, Seleucus expanded his dominions to include much of Alexander's Near Eastern territories, establishing a dynasty that would rule for over two centuries. At its height, the empire spanned Anatolia, Persia, the Levant, Mesopotamia, and what are now Kuwait, Afghanistan, and parts of Turkmenistan. Antigonid dynasty (306–168 BC) The Antigonid dynasty (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    /ænˈtɪɡoʊnɪd/\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "; Greek: Ἀντιγονίδαι) was a dynasty of Hellenistic kings descended from Alexander the Great's general Antigonus I \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Monophthalmus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (&quot;&quot;the One-eyed&quot;&quot;). Ptolemaic Kingdom (305–30 BC) The Ptolemaic Kingdom (/ˌtɒlɪˈmeɪ.ɪk/; Koinē Greek: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Πτολεμαϊκὴ βασιλεία, romanized\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ": Ptolemaïkḕ basileía) was an ancient Hellenistic state based in Egypt. It was founded in 305 BC by Ptolemy I Soter, a companion of Alexander the Great, and lasted until the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of Cleopatra in 30 BC. Ruling for nearly three centuries, the Ptolemies were the longest and final Egyptian dynasty of ancient origin. Kingdom of Pontus (281 BC–62 AD) The Kingdom of Pontus (Ancient Greek: Βασιλεία τοῦ Πόντου, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Basileía toû Póntou\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") was a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hellenistic-era\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " kingdom, centered in the historical region of Pontus and ruled by the Mithridatic dynasty of Persian origin, which may have been directly related to Darius the Great and the Achaemenid dynasty. The kingdom was proclaimed by Mithridates I in 281 BC and lasted until its conquest by the Roman Republic in 63 BC. The Kingdom of Pontus reached its largest extent under Mithridates VI the Great, who conquered Colchis, Cappadocia, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bithynia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the Greek colonies of the Tauric Chersonesos, and for a brief time the Roman province of Asia. After a long struggle with Rome in the Mithridatic Wars, Pontus was defeated. The western part of it was incorporated into the Roman Republic as the province Bithynia et Pontus; the eastern half survived as a client kingdom until 62 AD. Kingdom of Pergamon (282–133 BC) The Attalid dynasty (/ˈætəlɪd/; Koinē Greek: Δυναστεία των Ατταλιδών, romanized: Dynasteía ton Attalidón) was a Hellenistic dynasty that ruled the city of Pergamon in Asia Minor after the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of Lysimachus, a general of Alexander the Great. The kingdom was a rump state that had been left after the collapse of the Lysimachian Empire. One of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lysimachus' lieutenants\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Philetaerus, took control of the city in 282 BC. The later Attalids were descended from his father and expanded the city into a kingdom. Achaean League (256–146 BC) The Achaean League (Greek: Κοινὸν τῶν Ἀχαιῶν, Koinon ton Akhaion &quot;&quot;League of Achaeans&quot;&quot;) was a Hellenistic-era confederation of Greek city-states on the northern and central Peloponnese. The league was named after the region of Achaea in the northwestern Peloponnese, which formed its original core. The first league was formed in the fifth century BC. The second Achaean League was established in 280 BC. As a rival of Antigonid Macedon and an ally of Rome, the league played a major role in the expansion of the Roman Republic into Greece. This process eventually led to the League's conquest and dissolution by the Romans in 146 BC. The League represents the most successful attempt by the Greek city-states to develop a form of federalism, which balanced the need for collective action with the desire for local autonomy. Through the writings of the Achaean statesman Polybius, this structure has had an influence on the constitution of the United States and other modern federal states. Greco-Bactrian Kingdom (250–125 BC) The Greco-Bactrian Kingdom was, along with the Indo-Greek Kingdom, the easternmost part of the Hellenistic world, covering Bactria and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sogdiana\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in Central Asia from 256 to 125 BC. It was centered on the north of present-day Afghanistan. The expansion of the Greco-Bactrians into present-day eastern Afghanistan and Pakistan from 180 BC established the Indo-Greek Kingdom, which was to last until around AD 10. Indo-Greek Kingdom (180 BC–10 AD) The Indo-Greek Kingdom or Graeco-Indian Kingdom, and historically known as Yavanarajya (Kingdom of Yavanas), was a Hellenistic kingdom spanning modern-day Afghanistan and the classical circumscriptions of the Punjab region of the Indian subcontinent (northern Pakistan and northwestern India), which existed during the last two centuries BC and was ruled by more than thirty kings, often conflicting with one another. See also Outline of ancient Greece Outline of ancient Egypt Outline of ancient Rome Outline of classical studies Classical demography History of science in classical antiquity Regions in Greco-Roman antiquity Notes References Notes Bibliography Bowersock, G.W. (1985). &quot;&quot;The literature of the Empire&quot;&quot;.  In Easterling, P.E.; Knox, Bernard M.W. (eds.). The Cambridge History of Classical Literature. Cambridge: Cambridge University Press. Bremmer, Jan M. (2007). &quot;&quot;Greek Normative Animal Sacrifice&quot;&quot;.  In Ogden, Daniel (ed.). A Companion to Greek Religion. Blackwell. Bulloch, A.W. (1985). &quot;&quot;Hellenistic Poetry&quot;&quot;.  In Easterling, P.E.; Knox, Bernard M.W. (eds.). The Cambridge History of Classical Literature. Cambridge: Cambridge University Press. Dowden, Ken (2007). &quot;&quot;Olympian Gods, Olympian Pantheon&quot;&quot;.  In Ogden, Daniel (ed.). A Companion to Greek Religion. Blackwell. Furley, William D. (2007). &quot;&quot;Prayers and Hymns&quot;&quot;.  In Ogden, Daniel (ed.). A Companion to Greek Religion. Blackwell. Handley, E.W. (1985). &quot;&quot;Comedy&quot;&quot;.  In Easterling, P.E.; Knox, Bernard M.W. (eds.). The Cambridge History of Classical Literature. Cambridge: Cambridge University Press. Hornblower, Simon (2011). The Greek World: 479–323 BC (4 ed.). Abingdon: Routledge. Kirk, G.S. (1985). &quot;&quot;Homer&quot;&quot;.  In Easterling, P.E.; Knox, Bernard M.W. (eds.). The Cambridge History of Classical Literature. Cambridge: Cambridge University Press. König, Jason (2016). &quot;&quot;Literature in the Roman World&quot;&quot;.  In Hose, Martin; Schenker, David (eds.). A Companion to Greek Literature. John Wiley &amp; Sons. Martin, Thomas R. (2013). Ancient Greece: From Prehistoric to Hellenistic Times (2 ed.). New Haven: Yale University Press. McGlew, James (2016). &quot;&quot;Literature in the Classical \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of Greece&quot;&quot;.  In Hose, Martin; Schenker, David (eds.). A Companion to Greek Literature. John Wiley &amp; Sons. Mori, Anatole (2016). &quot;&quot;Literature in the Hellenistic World&quot;&quot;.  In Hose, Martin; Schenker, David (eds.). A Companion to Greek Literature. John Wiley &amp; Sons. Noegel, Scott B. (2007). &quot;&quot;Greek Religion and the Ancient Near East&quot;&quot;.  In Ogden, Daniel (ed.). A Companion to Greek Religion. Blackwell. Ogden, Daniel (2007). &quot;&quot;Introduction&quot;&quot;.  In Ogden, Daniel (ed.). A Companion to Greek Religion. Blackwell. Power, Timothy (2016). &quot;&quot;Literature in the Archaic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       "&quot;&quot;.  In Hose, Martin; Schenker, David (eds.). A Companion to Greek Literature. John Wiley &amp; Sons. Shapiro, H.A. (2007). &quot;&quot;Introduction&quot;&quot;.  In Shapiro, H.A. (ed.). The Cambridge Companion to Archaic Greece. Cambridge: Cambridge University Press. Further reading Shanks, Michael (1996). Classical Archaeology of Greece. London: Routledge. ISBN 0-203-17197-7. Brock, Roger, and Stephen Hodkinson, eds. 2000. Alternatives to Athens: Varieties of political organization and community in ancient Greece. Oxford and New York: Oxford Univ. Press. Cartledge, Paul, Edward E. Cohen, and Lin Foxhall. 2002. Money, labour and land: Approaches to the economies of ancient Greece. London and New York: Routledge. Cohen, Edward. 1992. Athenian economy and society: A banking perspective. Princeton, NJ: Princeton Univ. Press. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hurwit\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Jeffrey. 1987. The art and culture of early Greece, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    1100–480\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " B.C. Ithaca, NY: Cornell Univ. Press. Kinzl, Konrad, ed. 2006. A companion to the Classical Greek world. Oxford and Malden, MA: Blackwell. Morris, Ian, ed. 1994. Classical Greece: Ancient histories and modern archaeologies. Cambridge, UK, and New York: Cambridge Univ. Press. Pomeroy, Sarah, Stanley M. Burstein, Walter Donlan, and Jennifer Tolbert Roberts. 2008. Ancient Greece: A political, social, and cultural history. 2d ed. New York: Oxford Univ. Press. Rhodes, Peter J. 2006. A history of the Classical Greek world: 478–323 BC. Blackwell History of the Ancient World. Malden, MA: Blackwell. Whitley, James. 2001. The archaeology of ancient Greece. Cambridge, UK, and New York: Cambridge Univ. Press. External links The Canadian Museum of Civilization—Greece Secrets of the Past Ancient Greece website from the British Museum Economic history of ancient Greece The Greek currency history Limenoscope, an ancient Greek ports database The Ancient Theatre Archive, Greek and Roman theatre architecture Illustrated Greek History, Dr. Janice Siegel, Department of Classics, Hampden–Sydney College, Virginia&quot; &quot;Andreas Vesalius (; 31 December 1514 – 15 October 1564) was a 16th-century anatomist, physician, and author of one of the most influential books on human anatomy, De Humani Corporis Fabrica Libri Septem (On the fabric of the human body in seven books). Vesalius is often referred to as the founder of modern human anatomy. He was born in Brussels, which was then part of the Habsburg Netherlands. He was a professor at the University of Padua (1537–1542) and later became Imperial physician at the court of Emperor Charles V. Andreas Vesalius is the Latinized form of the Dutch Andries van Wesel. It was a common practice among European scholars in his time to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Latinize\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " their names. His name is also given as Andrea Vesalius, André Vésale, Andrea Vesalio, Andreas Vesal, André Vesalio and Andre Vesale. Early life and education Vesalius was born as Andries van Wesel to his father Anders van Wesel and mother Isabel Crabbe on 31 December 1514 in Brussels, which was then part of the Habsburg Netherlands. His great grandfather, Jan van Wesel, probably born in Wesel, received a medical degree from the University of Pavia and taught medicine at the University of Leuven. His grandfather, Everard van Wesel, was the Royal Physician of Emperor Maximilian, while his father, Anders van Wesel, served as apothecary to Maximilian, and later valet de chambre to his successor Charles V. Anders encouraged his son to continue in the family tradition and enrolled him in the Brethren of the Common Life in Brussels to learn Greek and Latin prior to learning medicine, according to standards of the era.In 1528 Vesalius entered the University of Leuven (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pedagogium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Castrense) taking arts, but when his father was appointed as the Valet de Chambre in 1532, he decided instead to pursue a career in the military at the University of Paris, where he relocated in 1533. There he studied the theories of Galen under the auspices of Johann Winter von Andernach, Jacques \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Dubois (Jacobus Sylvius) and Jean Fernel\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It was during this time that he developed an interest in anatomy, and he was often found examining excavated bones in the charnel houses at the Cemetery of the Innocents. Vesalius was forced to leave Paris in 1536 owing to the opening of hostilities between the Holy Roman Empire and France and returned to the University of Leuven. He completed his studies there and graduated the following year. His doctoral thesis, Paraphrasis in nonum librum Rhazae medici Arabis clarissimi ad regem Almansorem, de \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    affectuum singularum corporis partium curatione\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", was a commentary on the ninth book of Rhazes. Medical career and accomplishments On the day of his graduation he was immediately offered the chair of surgery and anatomy (explicator chirurgiae) at the University of Padua. He also guest-lectured at the University of Bologna and the University of Pisa. Prior to taking up his position in Padua, Vesalius traveled through Italy, and assisted the future Pope Paul IV and Ignatius of Loyola to heal those afflicted by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    leprosy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In Venice in 1542, he met the illustrator Johan van Calcar, a student of Titian. It was with van Calcar that Vesalius published his first anatomical text, Tabulae Anatomicae \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sex\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", in 1538. Previously these topics had been taught primarily from reading classical texts, mainly \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", followed by an animal dissection by a barber–surgeon whose work was directed by the lecturer. No attempt was made to confirm Galen's claims, which were considered unassailable. Vesalius, in contrast, performed dissection as the primary teaching tool, handling the actual work himself and urging students to perform dissection themselves. He considered hands-on direct observation to be the only reliable resource. Vesalius created detailed illustrations of anatomy for students in the form of six large woodcut posters. When he found that some of them were being widely copied, he published them all in 1538 under the title Tabulae anatomicae \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sex\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". He followed this in 1539 with an updated version of Winter's anatomical handbook, Institutiones anatomicae. In 1539 he also published his Venesection Epistle on bloodletting. This was a popular treatment for almost any illness, but there was some debate about where to take the blood from. The classical Greek procedure, advocated by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", was to collect blood from a site near the location of the illness. However, the Muslim and medieval practice was to draw a smaller amount of blood from a distant location. Vesalius' pamphlet generally supported \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen's view\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", but with qualifications that rejected the infiltration of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In 1541 while in Bologna, Vesalius discovered that all of Galen's research had to be restricted to animals; since dissection had been banned in ancient Rome. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " had dissected Barbary macaques instead, which he considered structurally closest to man. Even though \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " produced many errors due to the anatomical material available to him, he was a qualified examiner, but his research was weakened by stating his findings philosophically, so his findings were based on religious precepts rather than science. Vesalius contributed to the new Giunta edition of Galen's collected works and began to write his own anatomical text based on his own research. Until Vesalius pointed out Galen's substitution of animal for human anatomy, it had gone unnoticed and had long been the basis of studying human anatomy. However, some people still chose to follow \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and resented Vesalius for calling attention to the difference. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " had assumed that arteries carried the purest blood to higher organs such as the brain and lungs from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " of the heart, while veins carried blood to the lesser organs such as the stomach from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". In order for this theory to be correct, some kind of opening was needed to interconnect the ventricles, and Galen claimed to have found them. So paramount was Galen's authority that for 1400 years a succession of anatomists had claimed to find these holes, until Vesalius admitted he could not find them. Nonetheless, he did not venture to dispute \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on the distribution of blood, being unable to offer any other solution, and so supposed that it diffused through the unbroken partition between the ventricles.Other famous examples of Vesalius disproving \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen's assertions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " were his discoveries that the lower jaw (mandible) was composed of only one bone, not two (which \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " had assumed based on animal dissection) and that humans lack the rete mirabile, a network of blood vessels at the base of the brain that is found in sheep and other ungulates. In 1543, Vesalius conducted a public dissection of the body of Jakob Karrer von Gebweiler, a notorious \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    felon\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from the city of Basel, Switzerland. He assembled and articulated the bones, finally donating the skeleton to the University of Basel. This preparation (&quot;&quot;The Basel Skeleton&quot;&quot;) is Vesalius' only well-preserved skeletal preparation, and also the world's oldest surviving anatomical preparation. It is still displayed at the Anatomical Museum of the University of Basel.In the same year Vesalius took residence in Basel to help Johannes Oporinus publish the seven-volume De humani \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    corporis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " fabrica (On the fabric of the human body), a groundbreaking work of human anatomy that he dedicated to Charles V. Many believe it was illustrated by Titian's pupil Jan Stephen van Calcar, but evidence is lacking, and it is unlikely that a single artist created all 273 illustrations in a period of time so short. At about the same time he published an abridged edition for students, Andrea Vesalii \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    suorum\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " de humani \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    corporis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " fabrica librorum epitome, and dedicated it to Philip II of Spain, the son of the Emperor. That work, now collectively referred to as the Fabrica of Vesalius, was groundbreaking in the history of medical publishing and is considered to be a major step in the development of scientific medicine. Because of this, it marks the establishment of anatomy as a modern descriptive science.Though Vesalius' work was not the first such work based on actual dissection, nor even the first work of this era, the production quality, highly detailed and intricate plates, and the likelihood that the artists who produced it were clearly present in person at the dissections made it an instant classic. Pirated editions were available almost immediately, an event Vesalius acknowledged in a printer's note would happen. Vesalius was 28 years old when the first edition of Fabrica was published. Imperial physician and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Soon after publication, Vesalius was invited to become imperial physician to the court of Emperor Charles V. He informed the Venetian Senate that he would leave his post at Padua, which prompted Duke Cosimo I de' Medici to invite him to move to the expanding university in Pisa, which he declined. Vesalius took up the offered position in the imperial court, where he had to deal with other physicians who mocked him for being a mere barber surgeon instead of an academic working on the respected basis of theory. In the 1540s, shortly after entering in service of the emperor, Vesalius married Anne van Hamme, from Vilvorde, Belgium. They had one daughter, named Anne, who died in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    1588.Over\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " the next eleven years Vesalius traveled with the court, treating injuries caused in battle or tournaments, performing postmortems, administering medication, and writing private letters addressing specific medical questions. During these years he also wrote the Epistle on the China root, a short text on the properties of a medical plant whose efficacy he doubted, as well as a defense of his anatomical findings. This elicited a new round of attacks on his work that called for him to be punished by the emperor. In 1551, Charles V commissioned an inquiry in Salamanca to investigate the religious implications of his methods. Although Vesalius' work was cleared by the board, the attacks continued. Four years later one of his main detractors and one-time professors, Jacobus Sylvius, published an article that claimed that the human body itself had changed since \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " had studied it. After the abdication of Emperor Charles V, Vesalius continued at court in great favor with his son Philip II, who rewarded him with a pension for life by making him a count palatine. In 1555 he published a revised edition of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    De humani corporis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " fabrica. In 1564 Vesalius went on a pilgrimage to the Holy Land, some said, in penance after being accused of dissecting a living body. He sailed with the Venetian fleet under James Malatesta via Cyprus. When he reached Jerusalem he received a message from the Venetian senate requesting him again to accept the Paduan professorship, which had become vacant on the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of his friend and pupil Fallopius. After struggling for many days with adverse winds in the Ionian Sea, he was shipwrecked on the island of Zakynthos. Here he soon died, in such debt that a benefactor kindly paid for his funeral. At the time of his \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " he was 49 years of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". He was buried somewhere on the island of Zakynthos (Zante).For some time, it was assumed that Vesalius's pilgrimage was due to the pressures imposed on him by the Inquisition. Today, this assumption is generally considered to be without foundation and is dismissed by modern biographers. It appears the story was spread by Hubert Languet, a diplomat under Emperor Charles V and then under the Prince of Orange, who claimed in 1565 that Vesalius had performed an autopsy on an aristocrat in Spain while the heart was still beating, leading to the Inquisition's condemning him to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The story went on to claim that Philip II had the sentence commuted to a pilgrimage. That story re-surfaced several times, until it was more recently revised. The decision to undertake the pilgrimage was likely just a pretext to leave the Spanish court. Its lifestyle did not please him and he longed to continue his research. Given that he could not get rid of his royal service by resignation, he managed to escape asking for the permission to go to Jerusalem. Publications De Humani Corporis Fabrica In 1543, Vesalius asked Johannes Oporinus to publish the book De Humani Corporis Fabrica Libri Septem (On the fabric of the human body in seven books), a groundbreaking work of human anatomy he dedicated to Charles V and which many believe was illustrated by Titian's pupil Jan Stephen van Calcar. About the same time he published another version of his great work, entitled De Humani Corporis Fabrica Librorum Epitome (Abridgement of the On the fabric of the human body) more commonly known as the Epitome, with a stronger focus on illustrations than on text, so as to help readers, including medical students, to easily understand his findings. The actual text of the Epitome was an abridged form of his work in the Fabrica, and the organization of the two books was quite varied. He dedicated it to Philip II of Spain, son of the Emperor.The Fabrica emphasized the priority of dissection and what has come to be called the &quot;&quot;anatomical&quot;&quot; view of the body, seeing human internal functioning as a result of an essentially corporeal structure filled with organs arranged in three-dimensional space. His book contains drawings of several organs on two leaves. This allows for the creation of three-dimensional diagrams by cutting out the organs and pasting them on flayed figures. This was in stark contrast to many of the anatomical models used previously, which had strong Galenic/Aristotelean elements, as well as elements of astrology. Although modern anatomical texts had been published by Mondino and Berenger, much of their work was clouded by reverence for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and Arabian doctrines. Besides the first good description of the sphenoid bone, he showed that the sternum consists of three portions and the sacrum of five or six, and described accurately the vestibule in the interior of the temporal bone. He not only verified Estienne's observations on the valves of the hepatic veins, but also described the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vena azygos\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and discovered the canal which passes in the fetus between the umbilical vein and the vena cava, since named the ductus venosus. He described the omentum and its connections with the stomach, the spleen and the colon; gave the first correct views of the structure of the pylorus; observed the small size of the caecal appendix in man; gave the first good account of the mediastinum and pleura and the fullest description of the anatomy of the brain up to that time. He did not understand the inferior recesses, and his account of the nerves is confused by regarding the optic as the first pair, the third as the fifth, and the fifth as the seventh. In this work, Vesalius also becomes the first person to describe mechanical ventilation. It is largely this achievement that has resulted in Vesalius being incorporated into the Australian and New Zealand College of Anaesthetists college arms and crest. Excerpts When I undertake the dissection of a human pelvis I pass a stout rope tied like a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    noose\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " beneath the lower jaw and through the zygomas up to the top of the head... The lower end of the noose I run through a pulley fixed to a beam in the room so that I may raise or lower the cadaver as it hangs there or turn around in any direction to suit my purpose; ... You must take care not to put the noose around the neck, unless some of the muscles connected to the occipital bone have already been cut away. Other publications In 1538, Vesalius wrote Epistola, docens venam axillarem dextri cubiti in dolore \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    laterali secandam\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (A letter, teaching that in cases of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the side, the axillary vein of the right elbow be cut), commonly known as the Venesection Letter, which demonstrated a revived venesection, a classical procedure in which blood was drawn near the site of the ailment.  He sought to locate the precise site for venesection in pleurisy within the framework of the classical method.  The real significance of the book is his attempt to support his arguments by the location and continuity of the venous system from his observations rather than appeal to earlier published works.  With this novel approach to the problem of venesection, Vesalius posed the then striking hypothesis that anatomical dissection might be used to test speculation. In 1546, three years after the Fabrica, he wrote his Epistola rationem modumque propinandi radicis Chynae decocti, commonly known as the Epistle on the China Root. Ostensibly an appraisal of a popular but ineffective treatment for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gout\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    syphilis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and stone, this work is especially important as a continued polemic against Galenism and a reply to critics in the camp of his former professor Jacobus Sylvius, now an obsessive detractor. In February 1561, Vesalius was given a copy of Gabriele Fallopio's Observationes anatomicae, friendly additions and corrections to the Fabrica. Before the end of the year Vesalius composed a cordial reply, Anatomicarum Gabrielis Fallopii observationum examen, generally referred to as the Examen. In this work he recognizes in Fallopio a true equal in the science of dissection he had done so much to create. Vesalius' reply to Fallopio was published in May 1564, a month after Vesalius' \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on the Greek island of Zante (now called Zakynthos). Scientific findings Skeletal system Vesalius believed the skeletal system to be the framework of the human body.  It was in this opening chapter or book of De fabrica that Vesalius made several of his strongest claims against \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen's theories\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and writings which he had put in his anatomy books. In his extensive study of the skull, Vesalius claimed that the mandible consisted of one bone, whereas \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " had thought it to be two separate bones. He accurately described the vestibule in the interior of the temporal bone of the skull. In Galen's observation of the ape, he had discovered that their sternum consisted of seven parts which he assumed also held true for humans.  Vesalius discovered that the human sternum consisted of only three parts. He also disproved the common belief that men had one rib fewer than women and noted that the fibula and tibia bones of the leg were indeed larger than the humerus bone of the arm, unlike Galen's original findings. Muscular system Vesalius' most impressive contribution to the study of the muscular system may be the illustrations that accompany the text in De fabrica, which would become known as the &quot;&quot;muscle men&quot;&quot;.  He describes the source and position of each muscle of the body and provides information on their respective operation. Vascular and circulatory systems Vesalius' work on the vascular and circulatory systems was his greatest contribution to modern medicine. In his dissections of the heart, Vesalius became convinced that Galen's claims of a porous Interventricular septum were false. This fact was previously described by Michael Servetus, a fellow of Vesalius, but never reached the public, for it was written down in the &quot;&quot;Manuscript of Paris&quot;&quot;, in 1546, and published later in his Christianismi Restitutio (1553), a book regarded as heretical by the Inquisition. Only three copies survived, but these remained hidden for decades, the rest having been burned shortly after publication. In the second edition Vesalius published that the septum was indeed waterproof, discovering (and naming), the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to explain the blood flow. Vesalius believed that cardiac systole is synchronous with the arterial pulse. He not only verified Estienne's findings on the valves of the hepatic veins, but also described the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    azygos vein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and discovered the canal which passes into the fetus between the umbilical vein and vena cava. Nervous system Vesalius defined a nerve as the mode of transmitting sensation and motion and thus refuted his contemporaries' claims that ligaments, tendons and aponeuroses were three types of nerve units. He believed that the brain and the nervous system are the center of the mind and emotion in contrast to the common Aristotelian belief that the heart was the center of the body. He correspondingly believed that nerves themselves do not originate from the heart, but from the brain—facts already experimentally proved by Herophilus and Erasistratus in the classical era, but suppressed after the adoption of Aristotelianism by the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Catholic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Church in the middle ages. Upon studying the optic nerve, Vesalius came to the conclusion that nerves were not hollow. Abdominal organs In De fabrica, he corrected an earlier claim he made in Tabulae about the right kidney being set higher than the left.  Vesalius claimed that the kidneys were not a filter device for urine to pass through, but rather that the kidneys serve to filter blood as well, and that excretions from the kidneys travelled through the ureters to the bladder. He described the omentum, and its connections with the stomach, the spleen and the colon gave the first correct views of the structure of the pylorus. He also observed the small size of the caecal appendix in man and gave the first good account of the mediastinum and pleura. Vesalius admitted that due to a lack of pregnant cadavers he was unable to come to a significant understanding of the reproductive organs.  However, he did find that the uterus had been falsely identified as having two distinct sections. Heart Through his work with muscles, Vesalius believed that a criterion for muscles was their voluntary motion.  On this claim, he deduced that the heart was not a true muscle due to the obvious involuntary nature of its motion. He identified two chambers and two atria. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " was considered a continuation of the inferior and superior venae cavae, and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " was considered a continuation of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary vein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". He also addressed the controversial issue of the heart being the centre of the soul.  He wished to avoid drawing any conclusions due to possible conflict with contemporary religious beliefs. Against \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen's theory\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and many beliefs he also discovered that there was no hole in the septum or heart. Other achievements Vesalius disproved Galen's assertion that men have more \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    teeth\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " than women. Vesalius introduced the notion of induction of the extraction of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    empyema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " through surgical means. Due to his impressive study of the human skull and the variations in its features he is said to have been responsible for the launch of the study of physical anthropology. Vesalius always encouraged his students to check their findings, and even his own findings, so that they could better understand the structure of the human body. In addition to his continual efforts to study anatomy he also worked on medicinal remedies and came to such conclusions as treating \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    syphilis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chinaroot\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Vesalius claimed that medicine had three aspects: drugs, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ", and 'the use of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hands'—mainly\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " suggesting surgery and the knowledge of anatomy and physiology gained through dissection. Vesalius was a supporter of 'parallel dissections' in which an animal cadaver and a human cadaver are dissected simultaneously in order to demonstrate the anatomical differences and thus correct Galenic errors. Scientific and historical impact The influence of Vesalius' plates representing the partial dissections of the human figure posing in a landscape setting is apparent in the anatomical plates prepared by the Baroque painter Pietro da Cortona (1596–1669), who executed anatomical plates with figures in dramatic poses, most of them with architectural or landscape backdrops.During the 20th century, the American artist, Jacob Lawrence created his Vesalius Suite based on the anatomical drawings of Andreas Vesalius. See also References Sources Dear, Peter. Revolutionizing the Sciences: European Knowledge and Its Ambitions, 1500–1700. Princeton: Princeton \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    UP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", 2001. Debus, Allen, ed. Vesalius. Who's Who in the World of Science: From Antiquity to Present. 1st ed. Hanibal: Western Co., 1968. O'Malley, CD. Andreas Vesalius of Brussels, 1514–1564.  Berkeley: University of California Press, 1964. Porter, Roy, ed. Vesalius. The Biographical Dictionary of Scientists. 2nd Ed. New York: Oxford University P, 1994. Saunders, JB de \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and O'Malley, Charles D. The Illustrations from the Works of Andreas Vesalius of Brussels.  New York: Dover, 1973 [reprint]. &quot;&quot;Vesalius.&quot;&quot; Encyclopedia Americana. 1992. Vesalius, Andreas. On the Fabric of the Human Body, translated by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    W. F. Richardson and J. B.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Carman. 5 vols. San Francisco and Novato: Norman Publishing, 1998–2009. The Fabric of the human Body, Translated by Daniel H. Harrison and Malcolm H. Hast. Basel: Karger Publishing, 2013. Garrison, Daniel H. Vesalius: The China Root Epistle. A New Translation and Critical Edition. New York: Cambridge University Press, 2014. Williams, Trevor, ed. Vesalius. A Biographical Dictionary of Scientists. 3rd Ed. New York: John Wiley and Sons, 1982. External links Andreae Vesalii \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bruxellensis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Dе humani corporis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " fabrica libri septem, Basileae 1543 Anatomia 1522–1867: Anatomical Plates from the Thomas Fisher Rare Book Library Bibliography van Andreas Vesalius Vesalius's « Anatomies » Introduction by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Jacqueline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Vons Places and memories related to Andreas Vesalius Play on Vesalius Translating Vesalius Ars Anatomica collection at University of Edinburgh image service (includes Vesalius's De Humanis Corporis Fabrica) Turning the Pages: a virtual copy of Vesalius's De Humanis Corporis Fabrica. From the U.S. National Library of Medicine. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    De humani corporis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " fabrica. Epitome coloured and complete with manekin at Cambridge Digital Library Texts digitized by the Bibliothèque interuniversitaire de santé; see its digital library Medic@. Vesalius four centuries later by John F. Fulton. Logan Clendening lecture on the history and philosophy of medicine, University of Kansas, 1950. Full-text PDF. Andreas Vesalius, VESALIUS project. Information about the new DVD &quot;&quot;De Humani Corporis Fabrica&quot;&quot; produced by Health Science Library of the St. Anna Hospital in Ferrara – Italy. Vesalius College in Brussels TV report on 500th birthday Vesalius by tvbrussel De Humani Corporis Fabrica Libri Septem (1543) – full digital facsimile at Linda Hall Library Vesalius at 500 – digital exhibition from the University of Missouri Libraries Andreas Vesalius at the Mathematics Genealogy Project&quot; &quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", also known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or pressure, usually due to insufficient blood flow to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (myocardium). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is usually due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obstruction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spasm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the arteries that supply blood to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Other causes include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abnormal heart rhythms\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The main mechanism of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery obstruction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as part of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The term derives from the Latin angere (&quot;&quot;to strangle&quot;&quot;) and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pectus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (&quot;&quot;chest&quot;&quot;), and can therefore be translated as &quot;&quot;a strangling feeling in the chest&quot;&quot;. There is a weak relationship between severity of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and degree of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deprivation in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", where there can be severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with little or no risk of a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       ") and a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       " can occur without \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In some cases, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be quite severe. In the early 20th century this was a known sign of impending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  However, given current medical therapies, the outlook has improved substantially. People with an average \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of 62 years, who have moderate to severe degrees of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (grading by classes II, III, and IV) have a five-year survival rate of approximately \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    92%.Worsening angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " attacks, sudden-onset \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " at rest, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " lasting more than 15 minutes are symptoms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (usually grouped with similar conditions as the acute coronary syndrome). As these may precede a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       ", they require urgent medical attention and are, in general, treated similarly to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Classification Stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Also known as 'effort \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "', this refers to the classic type of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " related to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". A typical presentation of stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is that of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest discomfort\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Symptoms</span>\n",
       "</mark>\n",
       " and associated symptoms precipitated by some activity (running, walking, etc.) with minimal or non-existent symptoms at rest or after administration of sublingual \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nitroglycerin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Symptoms typically abate several minutes after activity and recur when activity resumes. In this way, stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be thought of as being similar to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    intermittent claudication\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " symptoms. Other recognized precipitants of stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " include cold weather, heavy meals, and emotional \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Unstable angina Unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    UA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") (also &quot;&quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    crescendo angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "&quot;&quot;; this is a form of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute coronary syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") is defined as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that changes or worsens.It has at least one of these three features: it occurs at rest (or with minimal exertion), usually lasting more than 10 minutes it is severe and of new-onset (i.e., within the prior 4–6 weeks) it occurs with a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    crescendo\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " pattern (i.e., distinctly more severe, prolonged, or frequent than before).UA may occur unpredictably at rest, which may be a serious indicator of an impending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       ". What differentiates stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (other than symptoms) is the pathophysiology of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The pathophysiology of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the reduction of coronary flow due to transient \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    platelet aggregation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on apparently normal endothelium, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery spasms\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or coronary \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The process starts with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", progresses through \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inflammation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to yield an active unstable plaque, which undergoes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and results in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute myocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which, if not reversed, results in cell \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    necrosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). Studies show that 64% of all unstable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anginas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " occur between 22:00 and 08:00 when patients are at rest.In stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the developing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atheroma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is protected with a fibrous cap. This cap may rupture in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", allowing blood clots to precipitate and further decrease the area of the coronary vessel's lumen. This explains why, in many cases, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " develops independently of activity. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiac syndrome X\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiac syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " X, sometimes known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    microvascular angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is characterized by angina-like \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", in the context of normal epicardial coronary arteries (the largest vessels on the surface of the heart, prior to significant branching) on angiography. The original definition of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " X also mandated that ischemic changes on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " (despite normal coronary arteries) were displayed, as shown on cardiac \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " tests. The primary cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " X is unknown, but factors apparently involved are endothelial dysfunction and reduced flow (perhaps due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spasm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") in the tiny &quot;&quot;resistance&quot;&quot; blood vessels of the heart. Since \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    microvascular angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is not characterized by major \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arterial blockages\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", it is harder to recognize and diagnose. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Microvascular angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was previously considered a rather benign condition, but more recent data has changed this attitude. Studies, including the Women's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Syndrome Evaluation (WISE), suggest that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    microvascular angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is part of the pathophysiology of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemic heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", perhaps explaining the higher rates of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in women than in men, as well as their predilection towards \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute coronary syndromes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the absence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obstructive coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Signs and symptoms \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be quite painful, but many patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " complain of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest discomfort\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Symptoms</span>\n",
       "</mark>\n",
       " rather than actual \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ": the discomfort is usually described as a pressure, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heaviness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tightness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", squeezing, burning, or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    choking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " sensation. Apart from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest discomfort\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", anginal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pains\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may also be experienced in the epigastrium (upper central abdomen), back, neck area, jaw, or shoulders. This is explained by the concept of referred \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and is because the spinal level that receives visceral sensation from the heart simultaneously receives cutaneous sensation from parts of the skin specified by that spinal nerve's dermatome, without an ability to discriminate the two. Typical locations for referred \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are arms (often inner left arm), shoulders, and neck into the jaw. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is typically precipitated by exertion or emotional \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". It is exacerbated by having a full stomach and by cold temperatures. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be accompanied by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", sweating, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in some cases. In this case, the pulse rate and the blood pressure increases. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " lasting only a few seconds is normally not \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (such as precordial catch syndrome). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Myocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " comes about when the myocardium (the heart muscle) receives insufficient blood and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to function normally either because of increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " demand by the myocardium or because of decreased supply to the myocardium. This inadequate perfusion of blood and the resulting reduced delivery of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and nutrients are directly correlated to blocked or narrowed blood vessels. Some experience &quot;&quot;autonomic symptoms&quot;&quot; (related to increased activity of the autonomic nervous system) such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vomiting\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pallor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Major risk factors for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " include cigarette \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", high \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", sedentary lifestyle, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    family history\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    premature heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". A variant form of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina—Prinzmetal's angina—\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "occurs in patients with normal coronary arteries or insignificant \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It is believed caused by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spasms\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the artery. It occurs more in younger women.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Coital angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", also known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina d'amour\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " subsequent to sexual intercourse.  It is generally rare, except in patients with severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Cause Major risk factors Routine counseling of adults to advise them to improve their \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " and increase their physical activity has not been found to significantly alter behavior and thus is not recommended. Conditions that exacerbate or provoke \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " One study found that smokers with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " had a significantly increased level of sympathetic nerve activity when compared to those without. This is in addition to increases in blood pressure, heart rate, and peripheral vascular resistance associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nicotine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which may lead to recurrent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " attacks. In addition, the Centers for Disease Control and Prevention (CDC) reports that the risk of CHD (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Coronary heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PVD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Peripheral vascular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") is reduced within 1–2 years of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " cessation. In another study, it was found that, after one year, the prevalence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " men under 60 after an initial attack was 40% less in those having quit \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " compared to those that continued.  Studies have found that there are short-term and long-term benefits to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " cessation. Other medical problems \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Esophageal disorders Gastroesophageal reflux disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GERD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hyperthyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Hypoxemia Profound \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Uncontrolled \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Other cardiac problems \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bradyarrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hypertrophic cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Tachyarrhythmia \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Valvular heart diseaseMyocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can result from: a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    reduction of blood flow\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to the heart that can be caused by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spasm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute occlusion\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (by an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    embolus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") of the heart's arteries. resistance of the blood vessels. This can be caused by narrowing of the blood vessels; a decrease in radius. Blood flow is proportional to the radius of the artery to the fourth power. reduced oxygen-carrying capacity of the blood, due to several factors such as a decrease in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " tension and hemoglobin concentration. This decreases the ability of hemoglobin to carry \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to myocardial tissue.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the most common cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (narrowing of the blood vessels) of the heart's arteries and, hence, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Some people with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " have normal or minimal narrowing of heart arteries; in these patients, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vasospasm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a more likely cause for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", sometimes in the context of Prinzmetal\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    's angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and syndrome X. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Myocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " also can be the result of factors affecting blood composition, such as the reduced oxygen-carrying capacity of blood, as seen with severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (low number of red blood cells), or long-term \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Pathophysiology \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " results when there is an imbalance between the heart's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " demand and supply. This imbalance can result from an increase in demand (e.g., during \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ") without a proportional increase in supply (e.g., due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obstruction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the coronary arteries). However, the pathophysiology of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in females varies significantly as compared to males. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Non-obstructive coronary disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is more common in females. Diagnosis \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " should be suspected in people presenting tight, dull, or heavy \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest discomfort\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Symptoms</span>\n",
       "</mark>\n",
       " that is: Retrosternal or left-sided, radiating to the left arm, neck, jaw, or back. Associated with exertion or emotional \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " and relieved within several minutes by rest. Precipitated by cold weather or a meal.Some people present with atypical symptoms, including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or epigastric discomfort, or burning. These atypical symptoms are particularly likely in older people, women, and those with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anginal pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is not usually sharp or stabbing or influenced by respiration. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Antacids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and simple analgesics do not usually relieve the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". If \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest discomfort\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Symptoms</span>\n",
       "</mark>\n",
       " (of whatever site) is precipitated by exertion, relieved by rest, and relieved by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glyceryl trinitrate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the likelihood of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is increased.In \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " patients momentarily not feeling any \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", an electrocardiogram (ECG) is typically normal unless there have been other cardiac problems in the past. During periods of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or elevation of the ST segment may be observed. To elicit these changes, an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " ECG test (&quot;&quot;treadmill test&quot;&quot;) may be performed, during which the patient exercises to his/her maximum ability before \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatigue\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " intervenes; if characteristic ECG changes are documented (typically more than 1 mm of flat or downsloping ST \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), the test is considered diagnostic for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Even constant monitoring of the blood pressure and the pulse rate can lead to some conclusions regarding \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " test is also useful in looking for other markers of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ": blood pressure response (or lack thereof, in particular, a drop in systolic blood pressure), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dysrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and chronotropic response. Other alternatives to a standard \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " test include a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thallium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " scintigram or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sestamibi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " scintigram (in patients unable to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " enough for the treadmill tests, e.g., due to asthma or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arthritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or in whom the ECG is too abnormal at rest) or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " echocardiography. In patients in whom such noninvasive testing is diagnostic, a coronary angiogram is typically performed to identify the nature of the coronary lesion, and whether this would be a candidate for angioplasty, coronary artery bypass graft (CABG), treatment only with medication, or other treatments. In hospitalized patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (or the newer term of &quot;&quot;high-risk \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute coronary syndromes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "&quot;&quot;), those with resting ischaemic ECG changes or those with raised cardiac enzymes such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    troponin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may undergo coronary angiography directly. Treatment \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " occurs as a result of coronary blood flow insufficiency in the face of increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " demand. The principal goal in the prevention and relief of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is to limit the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " requirement of the heart so it can meet the inaqedate \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " supply derived through the blood supplied from the stenosed or constricted arteries. The main goals of treatment in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are relief of symptoms, slowing progression of the disease, and reduction of future events, especially \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attacks\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Beta blockers (e.g., \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carvedilol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    metoprolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    propranolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") have a large body of evidence in morbidity and mortality benefits (fewer symptoms, less disability and longer life) and short-acting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nitroglycerin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " medications have been used since 1879 for symptomatic relief of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". There are differing course of treatments for the patient depending on the type of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " the patient has. However, this second can provide a brief overview of the types of medications provided for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and the purpose by which they are prescribed. Beta blockers, specifically B1 adrenergic blockers without intrinsic sympathomimetic activity are the most preferred for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " treatment out of B1 selective and non-selective as well as B1 ISA agents. B1 blockers are \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardioselective\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " blocking agents such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nevibolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Atenolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Metoprolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bisoprolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which result in blocking \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cAMP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the heart muscle cells. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cAMP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " which plays a vital role in phosphorylating the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ryanodine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " receptor and LTCC will usually increase \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ca+2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels in the heart muscle cells, which will then result in contraction is blocked. Therefore, B1 blockade decreases the HR and contraction of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", making it need less \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " demand.  An important thing to note is that the B1 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardioselective\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " blockers are \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardioselective\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and not cardio specific. This means that if the beta-adrenergic antagonist is prescribed in higher doses, it can lose the selectivity aspect and begin causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from B2 adrenergic stimulation of smooth muscle cells.  This is why in therapy for patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the vasodilatory organonitrates complement the use of B-blockers when prescribed the use of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The preference for Beta-1 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardioselective\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " blockers is for B1 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardioselective\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " blockers without instrinsic sympathetic activity. Beta blockers with intrinsic sympathetic activity will still do the beta blockade of the heart muscle cells and have a decreased ionotrophic and chronotropic effect, but this effect will be to a lesser extent than if the beta blocker did not have the instrinsic sympathetic activity. A common \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    beta-blocker\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ISA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " prescribed for the treatment of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Acebutolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".    Non-selective beta-adrenergic antagonists will yield the same action on B1 receptors, however will also act on B2 receptors. These medications, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Propranolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nadolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", act on B1 receptors on smooth muscle cells as well. B1 blockade occurs in the smooth muscle cells. Specifically \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cAMP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is responsible for inhibiting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Light Kinase, the enzyme responsible for acting on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Actin-Myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The inhibition of B1 will result in decreased levels of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cAMP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " which will lead to increased levels of  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Light Chain Kinase in the smooth muscle cells, the enzyme responsible for acting on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Actin-Myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and leading to contraction of the smooth muscle cell. This increased contraction of the smooth muscle cell from B1 blockade is not desirable since it explains the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that may arise with patients taking that medication.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blockers act to decrease the heart's workload, and thus its requirement for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " by blocking the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels of the heart muscle cell. With decreased intracellular \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the calcium-troponin complex does not form in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and it does not contract, therefore reducing the need for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  The other class of medication that can be used to treat \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are the organic nitrates. Organic nitrates are used extensively to treat \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". They improve coronary blood flow of the coronary arteries (arteries which supply blood to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") by reversing and preventing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vasospasm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which increases the blood flow to the heart, improving perfusion and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " delivery to the heart associated with the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". These drugs also reduce systemic vascular resistance, of both \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    veins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and arteries but the veins to a greater extent. The decrease in the resistance of the arteries and veins decreases the myocardial \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " demand, which also reduces myocardial \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " demand.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nitroglycerin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is a potent vasodilator that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    decreases myocardial oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " demand by decreasing the heart's workload. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nitroglycerin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " should not be given if certain inhibitors such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sildenafil\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tadalafil\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vardenafil\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " have been taken within the previous 12 hours as the combination of the two could cause a serious drop in blood pressure. Treatments for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are balloon angioplasty, in which the balloon is inserted at the end of a catheter and inflated to widen the arterial lumen. Stents to maintain the arterial widening are often used at the same time. Coronary bypass surgery involves bypassing constricted arteries with venous grafts. This is much more invasive than angioplasty. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blockers (such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nifedipine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adalat\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amlodipine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    isosorbide mononitrate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nicorandil\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are vasodilators commonly used in chronic stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". A new therapeutic class, called If inhibitor, has recently been made available: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ivabradine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " provides heart rate reduction without affecting contractility leading to major \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anti-ischemic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and antianginal efficacy. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are also vasodilators with both symptomatic and prognostic benefit. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Statins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are the most frequently used \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lipid/cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " modifiers, which probably also stabilize existing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atheromatous\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " plaque. Low-dose \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aspirin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " decreases the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       " in patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic stable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and was part of standard treatment. However, in patients without established \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiovascular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the increase in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hemorrhagic stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " offsets any benefits and it is no longer advised unless the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is very high.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " is also a very good long-term treatment for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (but only particular regimens – gentle and sustained \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " rather than intense short bursts), probably working by complex mechanisms such as improving blood pressure and promoting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery collateralisation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Though sometimes used by patients, evidence does not support the use of traditional Chinese herbal products (THCP) for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Identifying and treating risk factors for further \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a priority in patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". This means testing for elevated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and other fats in the blood, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       "), and encouraging \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " cessation and weight optimization. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blocker \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nifedipine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " prolongs cardiovascular event- and procedure-free survival in patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". New overt heart failures were reduced by 29% compared to placebo; however, the mortality rate difference between the two groups was statistically insignificant. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Microvascular angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in women Women with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " often have either no or atypical symptoms, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anxiety\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    weakness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatigue\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Additionally, many women with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are found to have \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", yet no evidence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obstructive coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on cardiac catheterization. Evidence is accumulating that nearly half of women with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " suffer from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary microvascular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a condition often called \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    microvascular angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (MVA). Small intramyocardial arterioles constrict in MVA causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemic pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that is less predictable than with typical epicardial \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CAD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). The pathophysiology is complex and still being elucidated, but there is strong evidence that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    endothelial dysfunction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", decreased endogenous vasodilators, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inflammation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", changes in adipokines, and platelet activation are contributing factors. The diagnosis of MVA may require catheterization during which there is an assessment of the microcirculatory response to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adenosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acetylcholine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and measurement of coronary and fractional flow reserve. New techniques include positron emission tomography (PET) scanning, cardiac magnetic resonance imaging (MRI), and transthoracic Doppler echocardiography. Managing MVA can be challenging, for example, women with this condition have less \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary microvascular dilation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in response to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nitrates\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " than do those without MVA. Women with MVA often have traditional risk factors for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CAD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obesity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dyslipidemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Aggressive interventions to reduce modifiable risk factors are an important component of management, especially \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " cessation, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " management. The combination of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    non-nitrate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " vasodilators, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blockers and angiotensin-converting enzyme (ACE) inhibitors along with HMG-CoA reductase inhibitors (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    statins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), also is effective in many women, and new drugs, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ranolazine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ivabradine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", have shown promise in the treatment of MVA. Other approaches include spinal cord stimulators, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adenosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " receptor blockade, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    psychiatric\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " intervention. Suspected \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Hospital admission for people with the following symptoms is recommended, as they may have \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ": \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " at rest (which may occur at night), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on minimal exertion, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that seems to progress rapidly despite increasing medical treatment. All people with suspected \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " should be urgently referred to a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " evaluation service, for confirmation of the diagnosis and assessment of the severity of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Epidemiology As of 2010, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemic heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " affects approximately 112 million people (1.6% of the population) being slightly more common in men than women (1.7% to 1.5%).In the United States, 10.2 million are estimated to experience \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with approximately 500,000 new cases occurring each year. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is more often the presenting symptom of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in women than in men. The prevalence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " rises with increasing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", with a mean \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of onset of 62.3 years. After five years post-onset, 4.8% of individuals with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " subsequently died from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Men with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " were found to have an increased risk of subsequent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " related \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " than women. Similar figures apply in the remainder of the Western world. All forms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are much less-common in the Third World, as its risk factors are much more common in Western and Westernized countries; it could, therefore, be termed a disease of affluence. History The condition was named &quot;&quot;hritshoola&quot;&quot; in ancient India and was described by Sushruta (6th century BC).The first clinical description of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was by a British physician Dr. William Heberden in 1768. References External links Treatment of stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " recommendations for patients in layman's terms British Heart Foundation - \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CVD</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CVD</span>\n",
       "</mark>\n",
       " Pectoris Animation Video 3D Guidelines on the management of stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " - European Society of Cardiology Heart Attack and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Statistics by American Heart Association: Final 2006 statistics for the United States&quot; &quot;Angiography or arteriography is a medical imaging technique used to visualize the inside, or lumen, of blood vessels and organs of the body, with particular interest in the arteries, veins, and the heart chambers. This is traditionally done by injecting a radio-opaque contrast agent into the blood vessel and imaging using X-ray based techniques such as fluoroscopy. The word itself comes from the Greek words ἀγγεῖον angeion 'vessel' and γράφειν \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    graphein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 'to write, record'. The film or image of the blood vessels is called an angiograph, or more commonly an angiogram. Though the word can describe both an arteriogram and a venogram, in everyday usage the terms angiogram and arteriogram are often used synonymously, whereas the term venogram is used more precisely.The term angiography has been applied to radionuclide angiography and newer vascular imaging techniques such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CO2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " angiography, CT angiography and MR angiography. The term \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    isotope\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " angiography has also been used, although this more correctly is referred to as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    isotope\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " perfusion scanning. History The technique was first developed in 1927 by the Portuguese physician and neurologist Egas Moniz at the University of Lisbon to provide contrasted X-ray cerebral angiography in order to diagnose several kinds of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nervous diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tumors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arteriovenous malformations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Moniz is recognized as the pioneer in this field. He performed the first cerebral angiogram in Lisbon in 1927, and Reynaldo dos Santos performed the first aortogram in the same city in 1929. In fact, many current angiography techniques were developed by the Portuguese at the University of Lisbon. For example, in 1932, Lopo de Carvalho performed the first pulmonary angiogram via venous puncture of the superior member; in 1948 the first cavogram was performed by Sousa Pereira. Radial access technique for angiography can be traced back to 1953, where Eduardo Pereira first cannulated the radial artery to perform a coronary angiogram. With the introduction of the Seldinger technique in 1953, the procedure became markedly safer as no sharp introductory devices needed to remain inside the vascular lumen. Technique Depending on the type of angiogram, access to the blood vessels is gained most commonly through the femoral artery, to look at the left side of the heart and at the arterial system; or the jugular or femoral vein, to look at the right side of the heart and at the venous system.  Using a system of guide wires and catheters, a type of contrast agent (which shows up by absorbing the X-rays), is added to the blood to make it visible on the X-ray images. The X-ray images taken may either be still, displayed on an image intensifier or film, or motion images.  For all structures except the heart, the images are usually taken using a technique called digital subtraction angiography or DSA. Images in this case are usually taken at 2–3 frames per second, which allows the interventional radiologist to evaluate the flow of the blood through a vessel or vessels.  This technique &quot;&quot;subtracts&quot;&quot; the bones and other organs so only the vessels filled with contrast agent can be seen.  The heart images are taken at 15–30 frames per second, not using a subtraction technique.  Because DSA requires the patient to remain motionless, it cannot be used on the heart.    Both these techniques enable the interventional radiologist or cardiologist to see \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (blockages or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    narrowings\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") inside the vessel which may be inhibiting the flow of blood and causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". After the procedure has been completed, if the femoral technique is applied, the site of arterial entry is either manually compressed, stapled shut, or sutured in order to prevent access-site complications. Uses Coronary angiography One of the most common angiograms performed is to visualize the blood in the coronary arteries. A long, thin, flexible tube called a catheter is used to administer the X-ray contrast agent at the desired area to be visualized. The catheter is threaded into an artery in the forearm, and the tip is advanced through the arterial system into the major coronary artery.  X-ray images of the transient radiocontrast distribution within the blood flowing inside the coronary arteries allows visualization of the size of the artery openings. The presence or absence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atheroma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " within the walls of the arteries cannot be clearly determined. Coronary angiography can visualize \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or narrowing of the blood vessel. The degree of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be determined by comparing the width of the lumen of narrowed segments of blood vessel with wider segments of adjacent vessel.To detect \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a CT scan is more satisfactory than an MRI scan. The sensitivity and specificity between CT and MRI were (97.2 percent and 87.4 percent) and (87.1 percent and 70.3 percent), respectively. Therefore, CT (mainly multislice CT) is more accepted, more widely available, more favored by patients, and more economic. Moreover, CT requires shorter breath-hold time than MRI. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Fluorescein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " angiography \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Fluorescein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " angiography is a medical procedure in which a fluorescent dye is injected into the bloodstream. The dye highlights the blood vessels in the back of the eye so they can be photographed. This test is often used to manage eye disorders. OCT angiography Optical coherence tomography (OCT) is a technology using near-infrared light to image the eye, in particular penetrate the retina to view the micro-structure behind the retinal surface. ocular OCT angiography (OCTA) is a method leveraging OCT technology to assess the vascular health of the retina. Microangiography Microangiography is commonly used to visualize tiny blood vessels. Neuro-vascular angiography Another increasingly common angiographic procedure is neuro-vascular digital subtraction angiography in order to visualise the arterial and venous supply to the brain. Intervention work such as coil-embolisation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aneurysms\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and AVM gluing can also be performed. Peripheral angiography Angiography is also commonly performed to identify vessels narrowing in patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    leg claudication\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cramps\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", caused by reduced blood flow down the legs and to the feet; in patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    renal stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (which commonly causes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ") and can be used in the head to find and repair \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". These are all done routinely through the femoral artery, but can also be performed through the brachial or axillary (arm) artery.  Any stenoses found may be treated by the use of balloon angioplasty, stenting, or atherectomy. Post mortem CT angiography for medicolegal cases Post mortem CT angiography for medicolegal cases is a method initially developed by the Virtopsy group. Originating from that project, both \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    watery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and oily solutions have been evaluated. While oily solutions require special deposition equipment to collect waste water, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    watery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " solutions seem to be regarded as less problematic. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Watery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " solutions also were documented to enhance post mortem CT tissue differentiation whereas oily solutions were not. Conversely, oily solutions seem to only minimally disturb ensuing toxicological analysis, while \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    watery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " solutions may significantly impede toxicological analysis, thus requiring blood sample preservation before post mortem CT angiography. Complications After an angiogram, a sudden \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shock\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can cause a little \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " at the surgery area, but \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attacks\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    strokes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " usually don't occur, as they may in bypass surgery. Cerebral angiography Major complications in cerebral angiography such as in digital subtraction angiography or contrast MRI are also rare but include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    allergic reaction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to the anaesthetic other medication or the contrast medium, blockage or damage to one of the access veins in the leg, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pseudoaneurysm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " at the puncture site; or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    embolism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " formation. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bruising\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " at the site where the contrast is injected are minor complications, delayed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can also occur but is rare. Additional risks The contrast medium that is used usually produces a sensation of warmth lasting only a few seconds, but may be felt in a greater degree in the area of injection. If the patient is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    allergic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to the contrast medium, much more serious side effects are inevitable; however, with new contrast agents the risk of a severe reaction is less than one in 80,000 examinations. Additionally, damage to blood vessels can occur at the site of puncture/injection, and anywhere along the vessel during passage of the catheter. If digital subtraction angiography is used instead, the risks are considerably reduced because the catheter does not need to be passed as far into the blood vessels; thus lessening the chances of damage or blockage. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Antibiotic prophylaxis may given in those procedures that are not clean, or clean procedures that results in generation of infarcted or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    necrotic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " tissues such as embolisation. Routine diagnostic angiography is often considered a clean procedure. Prophylaxis is also given to prevent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from infected space into blood stream. See also References External links RadiologyInfo for patients: Angiography procedures Cardiac Catheterization from Angioplasty.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Org C-Arms\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " types Several types of C-Arms Coronary CT angiography by Eugene Lin&quot; &quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", also known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or pressure, usually due to insufficient blood flow to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (myocardium). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is usually due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obstruction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spasm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the arteries that supply blood to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Other causes include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abnormal heart rhythms\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The main mechanism of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery obstruction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as part of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The term derives from the Latin angere (&quot;&quot;to strangle&quot;&quot;) and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pectus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (&quot;&quot;chest&quot;&quot;), and can therefore be translated as &quot;&quot;a strangling feeling in the chest&quot;&quot;. There is a weak relationship between severity of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and degree of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " deprivation in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", where there can be severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with little or no risk of a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       ") and a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       " can occur without \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In some cases, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be quite severe. In the early 20th century this was a known sign of impending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  However, given current medical therapies, the outlook has improved substantially. People with an average \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of 62 years, who have moderate to severe degrees of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (grading by classes II, III, and IV) have a five-year survival rate of approximately \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    92%.Worsening angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " attacks, sudden-onset \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " at rest, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " lasting more than 15 minutes are symptoms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (usually grouped with similar conditions as the acute coronary syndrome). As these may precede a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       ", they require urgent medical attention and are, in general, treated similarly to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Classification Stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Also known as 'effort \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "', this refers to the classic type of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " related to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". A typical presentation of stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is that of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest discomfort\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Symptoms</span>\n",
       "</mark>\n",
       " and associated symptoms precipitated by some activity (running, walking, etc.) with minimal or non-existent symptoms at rest or after administration of sublingual \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nitroglycerin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Symptoms typically abate several minutes after activity and recur when activity resumes. In this way, stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be thought of as being similar to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    intermittent claudication\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " symptoms. Other recognized precipitants of stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " include cold weather, heavy meals, and emotional \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Unstable angina Unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    UA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") (also &quot;&quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    crescendo angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "&quot;&quot;; this is a form of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute coronary syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") is defined as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that changes or worsens.It has at least one of these three features: it occurs at rest (or with minimal exertion), usually lasting more than 10 minutes it is severe and of new-onset (i.e., within the prior 4–6 weeks) it occurs with a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    crescendo\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " pattern (i.e., distinctly more severe, prolonged, or frequent than before).UA may occur unpredictably at rest, which may be a serious indicator of an impending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       ". What differentiates stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (other than symptoms) is the pathophysiology of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The pathophysiology of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the reduction of coronary flow due to transient \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    platelet aggregation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on apparently normal endothelium, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery spasms\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or coronary \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The process starts with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", progresses through \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inflammation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to yield an active unstable plaque, which undergoes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and results in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute myocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which, if not reversed, results in cell \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    necrosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). Studies show that 64% of all unstable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anginas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " occur between 22:00 and 08:00 when patients are at rest.In stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the developing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atheroma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is protected with a fibrous cap. This cap may rupture in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", allowing blood clots to precipitate and further decrease the area of the coronary vessel's lumen. This explains why, in many cases, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " develops independently of activity. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiac syndrome X\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiac syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " X, sometimes known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    microvascular angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is characterized by angina-like \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", in the context of normal epicardial coronary arteries (the largest vessels on the surface of the heart, prior to significant branching) on angiography. The original definition of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " X also mandated that ischemic changes on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " (despite normal coronary arteries) were displayed, as shown on cardiac \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " tests. The primary cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " X is unknown, but factors apparently involved are endothelial dysfunction and reduced flow (perhaps due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spasm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") in the tiny &quot;&quot;resistance&quot;&quot; blood vessels of the heart. Since \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    microvascular angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is not characterized by major \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arterial blockages\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", it is harder to recognize and diagnose. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Microvascular angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was previously considered a rather benign condition, but more recent data has changed this attitude. Studies, including the Women's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Syndrome Evaluation (WISE), suggest that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    microvascular angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is part of the pathophysiology of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemic heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", perhaps explaining the higher rates of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in women than in men, as well as their predilection towards \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute coronary syndromes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the absence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obstructive coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Signs and symptoms \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be quite painful, but many patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " complain of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest discomfort\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Symptoms</span>\n",
       "</mark>\n",
       " rather than actual \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ": the discomfort is usually described as a pressure, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heaviness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tightness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", squeezing, burning, or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    choking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " sensation. Apart from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest discomfort\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", anginal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pains\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may also be experienced in the epigastrium (upper central abdomen), back, neck area, jaw, or shoulders. This is explained by the concept of referred \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and is because the spinal level that receives visceral sensation from the heart simultaneously receives cutaneous sensation from parts of the skin specified by that spinal nerve's dermatome, without an ability to discriminate the two. Typical locations for referred \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are arms (often inner left arm), shoulders, and neck into the jaw. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is typically precipitated by exertion or emotional \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". It is exacerbated by having a full stomach and by cold temperatures. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be accompanied by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", sweating, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in some cases. In this case, the pulse rate and the blood pressure increases. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " lasting only a few seconds is normally not \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (such as precordial catch syndrome). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Myocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " comes about when the myocardium (the heart muscle) receives insufficient blood and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to function normally either because of increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " demand by the myocardium or because of decreased supply to the myocardium. This inadequate perfusion of blood and the resulting reduced delivery of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and nutrients are directly correlated to blocked or narrowed blood vessels. Some experience &quot;&quot;autonomic symptoms&quot;&quot; (related to increased activity of the autonomic nervous system) such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vomiting\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pallor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Major risk factors for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " include cigarette \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", high \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", sedentary lifestyle, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    family history\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    premature heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". A variant form of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina—Prinzmetal's angina—\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "occurs in patients with normal coronary arteries or insignificant \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It is believed caused by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spasms\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the artery. It occurs more in younger women.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Coital angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", also known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina d'amour\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " subsequent to sexual intercourse.  It is generally rare, except in patients with severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Cause Major risk factors Routine counseling of adults to advise them to improve their \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " and increase their physical activity has not been found to significantly alter behavior and thus is not recommended. Conditions that exacerbate or provoke \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " One study found that smokers with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " had a significantly increased level of sympathetic nerve activity when compared to those without. This is in addition to increases in blood pressure, heart rate, and peripheral vascular resistance associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nicotine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which may lead to recurrent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " attacks. In addition, the Centers for Disease Control and Prevention (CDC) reports that the risk of CHD (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Coronary heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PVD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Peripheral vascular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") is reduced within 1–2 years of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " cessation. In another study, it was found that, after one year, the prevalence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " men under 60 after an initial attack was 40% less in those having quit \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " compared to those that continued.  Studies have found that there are short-term and long-term benefits to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " cessation. Other medical problems \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Esophageal disorders Gastroesophageal reflux disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GERD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hyperthyroidism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Hypoxemia Profound \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Uncontrolled \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Other cardiac problems \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bradyarrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hypertrophic cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Tachyarrhythmia \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Valvular heart diseaseMyocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can result from: a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    reduction of blood flow\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to the heart that can be caused by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spasm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute occlusion\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (by an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    embolus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") of the heart's arteries. resistance of the blood vessels. This can be caused by narrowing of the blood vessels; a decrease in radius. Blood flow is proportional to the radius of the artery to the fourth power. reduced oxygen-carrying capacity of the blood, due to several factors such as a decrease in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " tension and hemoglobin concentration. This decreases the ability of hemoglobin to carry \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to myocardial tissue.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the most common cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (narrowing of the blood vessels) of the heart's arteries and, hence, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Some people with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " have normal or minimal narrowing of heart arteries; in these patients, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vasospasm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a more likely cause for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", sometimes in the context of Prinzmetal\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    's angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and syndrome X. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Myocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " also can be the result of factors affecting blood composition, such as the reduced oxygen-carrying capacity of blood, as seen with severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (low number of red blood cells), or long-term \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Pathophysiology \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " results when there is an imbalance between the heart's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " demand and supply. This imbalance can result from an increase in demand (e.g., during \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ") without a proportional increase in supply (e.g., due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obstruction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the coronary arteries). However, the pathophysiology of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in females varies significantly as compared to males. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Non-obstructive coronary disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is more common in females. Diagnosis \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " should be suspected in people presenting tight, dull, or heavy \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest discomfort\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Symptoms</span>\n",
       "</mark>\n",
       " that is: Retrosternal or left-sided, radiating to the left arm, neck, jaw, or back. Associated with exertion or emotional \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " and relieved within several minutes by rest. Precipitated by cold weather or a meal.Some people present with atypical symptoms, including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or epigastric discomfort, or burning. These atypical symptoms are particularly likely in older people, women, and those with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anginal pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is not usually sharp or stabbing or influenced by respiration. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Antacids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and simple analgesics do not usually relieve the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". If \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest discomfort\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Symptoms</span>\n",
       "</mark>\n",
       " (of whatever site) is precipitated by exertion, relieved by rest, and relieved by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glyceryl trinitrate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the likelihood of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is increased.In \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " patients momentarily not feeling any \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", an electrocardiogram (ECG) is typically normal unless there have been other cardiac problems in the past. During periods of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or elevation of the ST segment may be observed. To elicit these changes, an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " ECG test (&quot;&quot;treadmill test&quot;&quot;) may be performed, during which the patient exercises to his/her maximum ability before \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatigue\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " intervenes; if characteristic ECG changes are documented (typically more than 1 mm of flat or downsloping ST \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), the test is considered diagnostic for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Even constant monitoring of the blood pressure and the pulse rate can lead to some conclusions regarding \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " test is also useful in looking for other markers of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ": blood pressure response (or lack thereof, in particular, a drop in systolic blood pressure), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dysrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and chronotropic response. Other alternatives to a standard \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " test include a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thallium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " scintigram or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sestamibi\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " scintigram (in patients unable to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " enough for the treadmill tests, e.g., due to asthma or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arthritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or in whom the ECG is too abnormal at rest) or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " echocardiography. In patients in whom such noninvasive testing is diagnostic, a coronary angiogram is typically performed to identify the nature of the coronary lesion, and whether this would be a candidate for angioplasty, coronary artery bypass graft (CABG), treatment only with medication, or other treatments. In hospitalized patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (or the newer term of &quot;&quot;high-risk \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute coronary syndromes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "&quot;&quot;), those with resting ischaemic ECG changes or those with raised cardiac enzymes such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    troponin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may undergo coronary angiography directly. Treatment \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " occurs as a result of coronary blood flow insufficiency in the face of increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " demand. The principal goal in the prevention and relief of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is to limit the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " requirement of the heart so it can meet the inaqedate \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " supply derived through the blood supplied from the stenosed or constricted arteries. The main goals of treatment in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are relief of symptoms, slowing progression of the disease, and reduction of future events, especially \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attacks\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Beta blockers (e.g., \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carvedilol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    metoprolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    propranolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") have a large body of evidence in morbidity and mortality benefits (fewer symptoms, less disability and longer life) and short-acting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nitroglycerin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " medications have been used since 1879 for symptomatic relief of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". There are differing course of treatments for the patient depending on the type of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " the patient has. However, this second can provide a brief overview of the types of medications provided for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and the purpose by which they are prescribed. Beta blockers, specifically B1 adrenergic blockers without intrinsic sympathomimetic activity are the most preferred for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " treatment out of B1 selective and non-selective as well as B1 ISA agents. B1 blockers are \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardioselective\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " blocking agents such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nevibolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Atenolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Metoprolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Bisoprolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which result in blocking \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cAMP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the heart muscle cells. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cAMP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " which plays a vital role in phosphorylating the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ryanodine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " receptor and LTCC will usually increase \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ca+2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels in the heart muscle cells, which will then result in contraction is blocked. Therefore, B1 blockade decreases the HR and contraction of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", making it need less \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " demand.  An important thing to note is that the B1 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardioselective\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " blockers are \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardioselective\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and not cardio specific. This means that if the beta-adrenergic antagonist is prescribed in higher doses, it can lose the selectivity aspect and begin causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from B2 adrenergic stimulation of smooth muscle cells.  This is why in therapy for patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the vasodilatory organonitrates complement the use of B-blockers when prescribed the use of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The preference for Beta-1 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardioselective\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " blockers is for B1 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardioselective\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " blockers without instrinsic sympathetic activity. Beta blockers with intrinsic sympathetic activity will still do the beta blockade of the heart muscle cells and have a decreased ionotrophic and chronotropic effect, but this effect will be to a lesser extent than if the beta blocker did not have the instrinsic sympathetic activity. A common \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    beta-blocker\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ISA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " prescribed for the treatment of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Acebutolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".    Non-selective beta-adrenergic antagonists will yield the same action on B1 receptors, however will also act on B2 receptors. These medications, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Propranolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nadolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", act on B1 receptors on smooth muscle cells as well. B1 blockade occurs in the smooth muscle cells. Specifically \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cAMP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is responsible for inhibiting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Light Kinase, the enzyme responsible for acting on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Actin-Myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The inhibition of B1 will result in decreased levels of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cAMP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " which will lead to increased levels of  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Light Chain Kinase in the smooth muscle cells, the enzyme responsible for acting on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Actin-Myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and leading to contraction of the smooth muscle cell. This increased contraction of the smooth muscle cell from B1 blockade is not desirable since it explains the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that may arise with patients taking that medication.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blockers act to decrease the heart's workload, and thus its requirement for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " by blocking the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels of the heart muscle cell. With decreased intracellular \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the calcium-troponin complex does not form in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle cell\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and it does not contract, therefore reducing the need for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  The other class of medication that can be used to treat \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are the organic nitrates. Organic nitrates are used extensively to treat \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". They improve coronary blood flow of the coronary arteries (arteries which supply blood to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") by reversing and preventing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vasospasm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which increases the blood flow to the heart, improving perfusion and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " delivery to the heart associated with the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". These drugs also reduce systemic vascular resistance, of both \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    veins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and arteries but the veins to a greater extent. The decrease in the resistance of the arteries and veins decreases the myocardial \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " demand, which also reduces myocardial \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " demand.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nitroglycerin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is a potent vasodilator that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    decreases myocardial oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " demand by decreasing the heart's workload. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nitroglycerin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " should not be given if certain inhibitors such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sildenafil\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tadalafil\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vardenafil\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " have been taken within the previous 12 hours as the combination of the two could cause a serious drop in blood pressure. Treatments for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are balloon angioplasty, in which the balloon is inserted at the end of a catheter and inflated to widen the arterial lumen. Stents to maintain the arterial widening are often used at the same time. Coronary bypass surgery involves bypassing constricted arteries with venous grafts. This is much more invasive than angioplasty. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blockers (such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nifedipine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adalat\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amlodipine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    isosorbide mononitrate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nicorandil\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are vasodilators commonly used in chronic stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". A new therapeutic class, called If inhibitor, has recently been made available: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ivabradine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " provides heart rate reduction without affecting contractility leading to major \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anti-ischemic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and antianginal efficacy. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are also vasodilators with both symptomatic and prognostic benefit. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Statins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are the most frequently used \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lipid/cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " modifiers, which probably also stabilize existing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atheromatous\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " plaque. Low-dose \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aspirin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " decreases the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       " in patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic stable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and was part of standard treatment. However, in patients without established \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiovascular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the increase in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hemorrhagic stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " offsets any benefits and it is no longer advised unless the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is very high.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " is also a very good long-term treatment for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (but only particular regimens – gentle and sustained \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " rather than intense short bursts), probably working by complex mechanisms such as improving blood pressure and promoting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery collateralisation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Though sometimes used by patients, evidence does not support the use of traditional Chinese herbal products (THCP) for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Identifying and treating risk factors for further \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a priority in patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". This means testing for elevated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and other fats in the blood, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       "), and encouraging \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " cessation and weight optimization. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blocker \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nifedipine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " prolongs cardiovascular event- and procedure-free survival in patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". New overt heart failures were reduced by 29% compared to placebo; however, the mortality rate difference between the two groups was statistically insignificant. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Microvascular angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in women Women with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " often have either no or atypical symptoms, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anxiety\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    weakness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatigue\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Additionally, many women with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are found to have \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", yet no evidence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obstructive coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on cardiac catheterization. Evidence is accumulating that nearly half of women with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " suffer from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary microvascular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a condition often called \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    microvascular angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (MVA). Small intramyocardial arterioles constrict in MVA causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemic pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that is less predictable than with typical epicardial \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CAD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). The pathophysiology is complex and still being elucidated, but there is strong evidence that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    endothelial dysfunction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", decreased endogenous vasodilators, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inflammation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", changes in adipokines, and platelet activation are contributing factors. The diagnosis of MVA may require catheterization during which there is an assessment of the microcirculatory response to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adenosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acetylcholine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and measurement of coronary and fractional flow reserve. New techniques include positron emission tomography (PET) scanning, cardiac magnetic resonance imaging (MRI), and transthoracic Doppler echocardiography. Managing MVA can be challenging, for example, women with this condition have less \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary microvascular dilation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in response to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nitrates\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " than do those without MVA. Women with MVA often have traditional risk factors for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CAD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obesity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dyslipidemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Aggressive interventions to reduce modifiable risk factors are an important component of management, especially \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " cessation, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " management. The combination of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    non-nitrate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " vasodilators, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blockers and angiotensin-converting enzyme (ACE) inhibitors along with HMG-CoA reductase inhibitors (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    statins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), also is effective in many women, and new drugs, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ranolazine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ivabradine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", have shown promise in the treatment of MVA. Other approaches include spinal cord stimulators, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adenosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " receptor blockade, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    psychiatric\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " intervention. Suspected \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Hospital admission for people with the following symptoms is recommended, as they may have \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ": \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " at rest (which may occur at night), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " on minimal exertion, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that seems to progress rapidly despite increasing medical treatment. All people with suspected \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " should be urgently referred to a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " evaluation service, for confirmation of the diagnosis and assessment of the severity of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Epidemiology As of 2010, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemic heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " affects approximately 112 million people (1.6% of the population) being slightly more common in men than women (1.7% to 1.5%).In the United States, 10.2 million are estimated to experience \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with approximately 500,000 new cases occurring each year. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is more often the presenting symptom of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in women than in men. The prevalence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " rises with increasing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", with a mean \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of onset of 62.3 years. After five years post-onset, 4.8% of individuals with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " subsequently died from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Men with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " were found to have an increased risk of subsequent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " related \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " than women. Similar figures apply in the remainder of the Western world. All forms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are much less-common in the Third World, as its risk factors are much more common in Western and Westernized countries; it could, therefore, be termed a disease of affluence. History The condition was named &quot;&quot;hritshoola&quot;&quot; in ancient India and was described by Sushruta (6th century BC).The first clinical description of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was by a British physician Dr. William Heberden in 1768. References External links Treatment of stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " recommendations for patients in layman's terms British Heart Foundation - \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CVD</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CVD</span>\n",
       "</mark>\n",
       " Pectoris Animation Video 3D Guidelines on the management of stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " - European Society of Cardiology Heart Attack and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Statistics by American Heart Association: Final 2006 statistics for the United States&quot; &quot;The Annual Review of Medicine is a peer-reviewed medical journal that publishes review articles about all aspects of medicine. It was established in 1950. Its longest-serving editors have been William \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    P.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Creger (1974–1993)\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    C. Thomas Caskey (2001–2019\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ").  The current editor is Mary E. Klotman. As of 2021, Journal Citation Reports gives the journal a 2020 impact factor of 13.739, ranking it sixth of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    140\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " titles in the category &quot;&quot;Medicine, Research &amp; Experimental&quot;&quot;. History The first volume of the journal was published in 1950 by the nonprofit publishing company Annual Reviews. It noted that the more &quot;&quot;active&quot;&quot; areas of medicine would be covered in each volume, while other subdisciplines would be covered every two or three years. Its first editor was Windsor C. Cutting. In 1996, it was one of the first Annual Reviews journals to be published electronically. Editors of volumes Dates indicate publication years in which someone was credited as a lead editor or co-editor of a journal volume. The planning process for a volume begins well before the volume appears, so appointment to the position of lead editor generally occurred prior to the first year shown here. An editor who has retired or died may be credited as a lead editor of a volume that they helped to plan, even if it is published after their retirement or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Abstracting and indexing The journal is abstracted and indexed in: References External links Official website&quot; &quot;Animals (also called Metazoa) are multicellular, eukaryotic organisms in the biological kingdom Animalia. With few exceptions, animals consume organic material, breathe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", are able to move, can reproduce sexually, and go through an ontogenetic stage in which their body consists of a hollow sphere of cells, the blastula, during embryonic development. Over 1.5 million living animal species have been described—of which around 1 million are insects—but it has been estimated there are over 7 million animal species in total. Animals range in length from 8.5 micrometres (0.00033 in) to 33.6 metres (110 ft). They have complex interactions with each other and their environments, forming intricate food webs. The scientific study of animals is known as zoology. Most living animal species are in Bilateria, a clade whose members have a bilaterally symmetric body plan. The Bilateria include the protostomes, containing invertebrates such as nematodes, arthropods, and molluscs, and the deuterostomes, containing the echinoderms and the chordates, the latter including the vertebrates. Life forms interpreted as early animals were present in the Ediacaran biota of the late Precambrian. Many modern animal phyla became clearly established in the fossil record as marine species during the Cambrian explosion, which began around 542 million years ago. 6,331 groups of genes common to all living animals have been identified; these may have arisen from a single common ancestor that lived 650 million years ago. Historically, Aristotle divided animals into those with blood and those without. Carl Linnaeus created the first hierarchical biological classification for animals in 1758 with his Systema Naturae, which Jean-Baptiste Lamarck expanded into 14 phyla by 1809. In 1874, Ernst Haeckel divided the animal kingdom into the multicellular Metazoa (now synonymous for Animalia) and the Protozoa, single-celled organisms no longer considered animals. In modern times, the biological classification of animals relies on advanced techniques, such as molecular phylogenetics, which are effective at demonstrating the evolutionary relationships between taxa. Humans make use of many animal species, such as for food (including meat, milk, and eggs), for materials (such as leather and wool), as pets, and as working animals including for transport. Dogs have been used in hunting, as have birds of prey, while many terrestrial and aquatic animals were hunted for sports. Nonhuman animals have appeared in art from the earliest times and are featured in mythology and religion. Etymology The word animal comes from the Latin animalis, meaning 'having breath', 'having soul' or 'living being'. The biological definition includes all members of the kingdom Animalia. In colloquial usage, the term animal is often used to refer only to nonhuman animals. Characteristics Animals have several characteristics that set them apart from other living things. Animals are eukaryotic and multicellular. Unlike plants and algae, which produce their own nutrients animals are heterotrophic, feeding on organic material and digesting it internally. With very few exceptions, animals respire aerobically. All animals are motile (able to spontaneously move their bodies) during at least part of their life cycle, but some animals, such as sponges, corals, mussels, and barnacles, later become sessile. The blastula is a stage in embryonic development that is unique to animals, (though it has been lost in some) allowing cells to be differentiated into specialised tissues and organs. Structure All animals are composed of cells, surrounded by a characteristic extracellular matrix composed of collagen and elastic glycoproteins. During development, the animal extracellular matrix forms a relatively flexible framework upon which cells can move about and be reorganised, making the formation of complex structures possible. This may be calcified, forming structures such as shells, bones, and spicules. In contrast, the cells of other multicellular organisms (primarily algae, plants, and fungi) are held in place by cell walls, and so develop by progressive growth. Animal cells uniquely possess the cell junctions called tight junctions, gap junctions, and desmosomes.With few exceptions—in particular, the sponges and placozoans—animal bodies are differentiated into tissues. These include muscles, which enable locomotion, and nerve tissues, which transmit signals and coordinate the body. Typically, there is also an internal digestive chamber with either one opening (in Ctenophora, Cnidaria, and flatworms) or two openings (in most bilaterians). Reproduction and development Nearly all animals make use of some form of sexual reproduction. They produce haploid gametes by meiosis; the smaller, motile gametes are spermatozoa and the larger, non-motile gametes are ova. These fuse to form zygotes, which develop via mitosis into a hollow sphere, called a blastula. In sponges, blastula larvae swim to a new location, attach to the seabed, and develop into a new sponge. In most other groups, the blastula  undergoes more complicated rearrangement. It first invaginates to form a gastrula with a digestive chamber and two separate germ layers, an external ectoderm and an internal endoderm. In most cases, a third germ layer, the mesoderm, also develops between them. These germ layers then differentiate to form tissues and organs.Repeated instances of mating with a close relative during sexual reproduction generally leads to inbreeding \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " within a population due to the increased prevalence of harmful \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    recessive traits\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Animals have evolved numerous mechanisms for avoiding close inbreeding. Some animals are capable of asexual reproduction, which often results in a genetic clone of the parent. This may take place through fragmentation; budding, such as in Hydra and other cnidarians; or parthenogenesis, where fertile eggs are produced without mating, such as in aphids. Ecology Animals are categorised into ecological groups depending on how they obtain or consume organic material, including carnivores, herbivores, omnivores, detritivores, and parasites. Interactions between animals form complex food webs. In carnivorous or omnivorous species, predation is a consumer-resource interaction where a predator feeds on another organism (called its prey). Selective pressures imposed on one another lead to an evolutionary arms race between predator and prey, resulting in various anti-predator adaptations. Almost all multicellular predators are animals. Some consumers use multiple methods; for example, in parasitoid wasps, the larvae feed on the hosts' living tissues, killing them in the process, but the adults primarily consume nectar from flowers. Other animals may have very specific feeding behaviours, such as hawksbill sea turtles primarily eating sponges. Most animals rely on the biomass and energy produced by plants through photosynthesis. Herbivores eat plant material directly, while carnivores, and other animals on higher trophic levels typically acquire it indirectly by eating other animals. Animals oxidize carbohydrates, lipids, proteins, and other biomolecules to unlock the chemical energy of molecular \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which allows the animal to grow and to sustain biological processes such as locomotion. Animals living close to hydrothermal vents and cold seeps on the dark sea floor consume organic matter of archaea and bacteria produced in these locations through chemosynthesis (by oxidizing inorganic compounds, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hydrogen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " sulfide).Animals originally evolved in the sea. Lineages of arthropods colonised land around the same time as land plants, probably between 510 and 471 million years ago during the Late Cambrian or Early Ordovician. Vertebrates such as the lobe-finned fish Tiktaalik started to move on to land in the late Devonian, about 375 million years ago. Animals occupy virtually all of earth's habitats and microhabitats, including salt water, hydrothermal vents, fresh water, hot springs, swamps, forests, pastures, deserts, air, and the interiors of animals, plants, fungi and rocks. Animals are however not particularly heat tolerant; very few of them can survive at constant temperatures above 50 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    °\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "C (122 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    °\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "F). Only very few species of animals (mostly nematodes) inhabit the most extreme cold deserts of continental Antarctica. Diversity Size The blue whale (Balaenoptera musculus) is the largest animal that has ever lived, weighing up to 190 tonnes and measuring up to 33.6 metres (110 ft) long. The largest extant terrestrial animal is the African bush elephant (Loxodonta africana), weighing up to 12.25 tonnes and measuring up to 10.67 metres (35.0 ft) long. The largest terrestrial animals that ever lived were titanosaur sauropod dinosaurs such as Argentinosaurus, which may have weighed as much as 73 tonnes. Several animals are microscopic; some Myxozoa (obligate parasites within the Cnidaria) never grow larger than 20 µm, and one of the smallest species (Myxobolus shekel) is no more than 8.5 µm when fully grown. Numbers and habitats The following table lists estimated numbers of described extant species for the animal groups with the largest numbers of species, along with their principal habitats (terrestrial, fresh water, and marine), and free-living or parasitic ways of life. Species estimates shown here are based on numbers described scientifically; much larger estimates have been calculated based on various means of prediction, and these can vary wildly. For instance, around 25,000–27,000 species of nematodes have been described, while published estimates of the total number of nematode species include 10,000–20,000; 500,000; 10 million; and 100 million. Using patterns within the taxonomic hierarchy, the total number of animal species—including those not yet described—was calculated to be about 7.77 million in 2011. Evolutionary origin The first fossils that might represent animals appear in the 665-million-year-old rocks of the Trezona Formation of South Australia. These fossils are interpreted as most probably being early sponges.Animals are found as long ago as the Ediacaran biota, towards the end of the Precambrian, and possibly somewhat earlier. It had long been doubted whether these life-forms included animals, but the discovery of the animal lipid \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in fossils of Dickinsonia establishes their nature. Animals are thought to have originated under low-oxygen conditions, suggesting that they were capable of living entirely by anaerobic respiration, but as they became specialized for aerobic metabolism they became fully dependent on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in their environments. Many animal phyla first appear in the fossil record during the Cambrian explosion, starting about 542 million years ago, in beds such as the Burgess shale. Extant phyla in these rocks include molluscs, brachiopods, onychophorans, tardigrades, arthropods, echinoderms and hemichordates, along with numerous now-extinct forms such as the predatory Anomalocaris. The apparent suddenness of the event may however be an artefact of the fossil record, rather than showing that all these animals appeared simultaneously.Some palaeontologists have suggested that animals appeared much earlier than the Cambrian explosion, possibly as early as 1 billion years ago. Trace fossils such as tracks and burrows found in the Tonian period may indicate the presence of triploblastic worm-like animals, roughly as large (about 5 mm wide) and complex as earthworms. However, similar tracks are produced today by the giant single-celled protist Gromia sphaerica, so the Tonian trace fossils may not indicate early animal evolution. Around the same time, the layered mats of microorganisms called stromatolites decreased in diversity, perhaps due to grazing by newly evolved animals. Phylogeny Animals are monophyletic, meaning they are derived from a common ancestor. Animals are sister to the Choanoflagellata, with which they form the Choanozoa. The most basal animals, the Porifera, Ctenophora, Cnidaria, and Placozoa, have body plans that lack bilateral symmetry. Their relationships are still disputed; the sister group to all other animals could be the Porifera or the Ctenophora, both of which lack hox genes, important in body plan development.These genes are found in the Placozoa and the higher animals, the Bilateria. 6,331 groups of genes common to all living animals have been identified; these may have arisen from a single common ancestor that lived 650 million years ago in the Precambrian. 25 of these are novel core gene groups, found only in animals; of those, 8 are for essential components of the Wnt and TGF-beta signalling pathways which may have enabled animals to become multicellular by providing a pattern for the body's system of axes (in three dimensions), and another 7 are for transcription factors including homeodomain proteins involved in the control of development.The phylogenetic tree (of major lineages only) indicates approximately how many millions of years ago (mya) the lineages split. Non-bilateria Several animal phyla lack bilateral symmetry. Among these, the sponges (Porifera) probably diverged first, representing the oldest animal phylum. Sponges lack the complex organization found in most other animal phyla; their cells are differentiated, but in most cases not organised into distinct tissues. They typically feed by drawing in water through pores.The Ctenophora (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    comb jellies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") and Cnidaria (which includes jellyfish, sea anemones, and corals) are radially symmetric and have digestive chambers with a single opening, which serves as both mouth and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Animals in both phyla have distinct tissues, but these are not organised into organs. They are diploblastic, having only two main germ layers, ectoderm and endoderm. The tiny placozoans are similar, but they do not have a permanent digestive chamber. Bilateria The remaining animals, the great majority—comprising some 29 phyla and over a million species—form a clade, the Bilateria. The body is triploblastic, with three well-developed germ layers, and their tissues form distinct organs. The digestive chamber has two openings, a mouth and an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and there is an internal body cavity, a coelom or pseudocoelom. Animals with this bilaterally symmetric body plan and a tendency to move in one direction have a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    head end (anterior)\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and a tail end (posterior) as well as a back (dorsal) and a belly (ventral); therefore they also have a left side and a right side.Having a front end means that this part of the body encounters stimuli, such as food, favouring \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cephalisation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the development of a head with sense organs and a mouth. Many bilaterians have a combination of circular muscles that constrict the body, making it longer, and an opposing set of longitudinal muscles, that shorten the body; these enable soft-bodied animals with a hydrostatic skeleton to move by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    peristalsis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". They also have a gut that extends through the basically cylindrical body from mouth to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Many bilaterian phyla have primary larvae which swim with cilia and have an apical organ containing sensory cells. However, there are exceptions to each of these characteristics; for example, adult echinoderms are radially symmetric (unlike their larvae), while some parasitic worms have extremely simplified body structures.Genetic studies have considerably changed zoologists' understanding of the relationships within the Bilateria. Most appear to belong to two major lineages, the protostomes and the deuterostomes. The basalmost bilaterians are the Xenacoelomorpha. Protostomes and deuterostomes Protostomes and deuterostomes differ in several ways. Early in development, deuterostome embryos undergo radial cleavage during cell division, while many protostomes (the Spiralia) undergo spiral cleavage. Animals from both groups possess a complete \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    digestive tract\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", but in protostomes the first opening of the embryonic gut develops into the mouth, and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " forms secondarily. In deuterostomes, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " forms first while the mouth develops secondarily. Most protostomes have schizocoelous development, where cells simply fill in the interior of the gastrula to form the mesoderm. In deuterostomes, the mesoderm forms by enterocoelic pouching, through \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    invagination of the endoderm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".The main deuterostome phyla are the Echinodermata and the Chordata. Echinoderms are exclusively marine and include starfish, sea urchins, and sea cucumbers. The chordates are dominated by the vertebrates (animals with backbones), which consist of fishes, amphibians, reptiles, birds, and mammals. The deuterostomes also include the Hemichordata (acorn worms). Ecdysozoa The Ecdysozoa are protostomes, named after their shared trait of ecdysis, growth by moulting. They include the largest animal phylum, the Arthropoda, which contains insects, spiders, crabs, and their kin. All of these have a body divided into repeating segments, typically with paired appendages. Two smaller phyla, the Onychophora and Tardigrada, are close relatives of the arthropods and share these traits. The ecdysozoans also include the Nematoda or roundworms, perhaps the second largest animal phylum. Roundworms are typically microscopic, and occur in nearly every environment where there is water; some are important parasites. Smaller phyla related to them are the Nematomorpha or horsehair worms, and the Kinorhyncha, Priapulida, and Loricifera. These groups have a reduced coelom, called a pseudocoelom. Spiralia The Spiralia are a large group of protostomes that develop by spiral cleavage in the early embryo. The Spiralia's phylogeny has been disputed, but it contains a large clade, the superphylum Lophotrochozoa, and smaller groups of phyla such as the Rouphozoa which includes the gastrotrichs and the flatworms. All of these are grouped as the Platytrochozoa, which has a sister group, the Gnathifera, which includes the rotifers.The Lophotrochozoa includes the molluscs, annelids, brachiopods, nemerteans, bryozoa and entoprocts. The molluscs, the second-largest animal phylum by number of described species, includes snails, clams, and squids, while the annelids are the segmented worms, such as earthworms, lugworms, and leeches. These two groups have long been considered close relatives because they share trochophore larvae. History of classification In the classical era, Aristotle divided animals, based on his own observations, into those with blood (roughly, the vertebrates) and those without. The animals were then arranged on a scale from man (with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood, 2 legs\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", rational soul) down through the live-bearing tetrapods (with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood, 4 legs\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", sensitive soul) and other groups such as crustaceans (no blood, many legs, sensitive soul) down to spontaneously-generating creatures like sponges (no blood, no legs, vegetable soul). Aristotle was uncertain whether sponges were animals, which in his system ought to have sensation, appetite, and locomotion, or plants, which did not: he knew that sponges could sense touch, and would contract if about to be pulled off their rocks, but that they were rooted like plants and never moved about.In 1758, Carl Linnaeus created the first hierarchical classification in his Systema Naturae. In his original scheme, the animals were one of three kingdoms, divided into the classes of Vermes, Insecta, Pisces, Amphibia, Aves, and Mammalia. Since then the last four have all been subsumed into a single phylum, the Chordata, while his Insecta (which included the crustaceans and arachnids) and Vermes have been renamed or broken up. The process was begun in 1793 by Jean-Baptiste de Lamarck, who called the Vermes une espèce de chaos (a chaotic mess) and split the group into three new phyla, worms, echinoderms, and polyps (which contained corals and jellyfish). By 1809, in his Philosophie Zoologique, Lamarck had created 9 phyla apart from vertebrates (where he still had 4 phyla: mammals, birds, reptiles, and fish) and molluscs, namely cirripedes, annelids, crustaceans, arachnids, insects, worms, radiates, polyps, and infusorians.In his 1817 Le Règne Animal, Georges Cuvier used comparative anatomy to group the animals into four embranchements (&quot;&quot;branches&quot;&quot; with different body plans, roughly corresponding to phyla), namely vertebrates, molluscs, articulated animals (arthropods and annelids), and zoophytes (radiata) (echinoderms, cnidaria and other forms). This division into four was followed by the embryologist Karl Ernst von Baer in 1828, the zoologist Louis Agassiz in 1857, and the comparative anatomist Richard Owen in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    1860.In\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 1874, Ernst Haeckel divided the animal kingdom into two subkingdoms: Metazoa (multicellular animals, with five phyla: coelenterates, echinoderms, articulates, molluscs, and vertebrates) and Protozoa (single-celled animals), including a sixth animal phylum, sponges. The protozoa were later moved to the former kingdom Protista, leaving only the Metazoa as a synonym of Animalia. In human culture Practical uses The human population exploits a large number of other animal species for food, both of domesticated livestock species in animal husbandry and, mainly at sea, by hunting wild species. Marine fish of many species are caught commercially for food. A smaller number of species are farmed commercially. Humans and their livestock make up more than 90% of the biomass of all terrestrial vertebrates, and almost as much as all insects combined.Invertebrates including cephalopods, crustaceans, and bivalve or gastropod molluscs are hunted or farmed for food.Chickens, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cattle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", sheep, pigs, and other animals are raised as livestock for meat across the world. Animal fibres such as wool are used to make \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    textiles\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", while animal sinews have been used as lashings and bindings, and leather is widely used to make shoes and other items. Animals have been hunted and farmed for their fur to make items such as coats and hats. Dyestuffs including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carmine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (cochineal), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shellac\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    kermes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " have been made from the bodies of insects. Working animals including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cattle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and horses have been used for work and transport from the first days of agriculture.Animals such as the fruit fly Drosophila melanogaster serve a major role in science as experimental models. Animals have been used to create vaccines since their discovery in the 18th century. Some medicines such as the cancer drug \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Yondelis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are based on toxins or other molecules of animal origin. People have used hunting dogs to help chase down and retrieve animals, and birds of prey to catch birds and mammals, while tethered cormorants have been used to catch fish. Poison dart frogs have been used to poison the tips of blowpipe darts. A wide variety of animals are kept as pets, from invertebrates such as tarantulas and octopuses, insects including praying mantises, reptiles such as snakes and chameleons, and birds including canaries, parakeets, and parrots all finding a place. However, the most kept pet species are mammals, namely dogs, cats, and rabbits. There is a tension between the role of animals as companions to humans, and their existence as individuals with rights of their own. A wide variety of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    terrestrial and aquatic animals\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are hunted for sport. In art Animals have been the subjects of art from the earliest times, both historical, as in Ancient Egypt, and prehistoric, as in the cave paintings at Lascaux. Major animal paintings include Albrecht Dürer's 1515 The Rhinoceros, and George Stubbs's c. 1762 horse portrait Whistlejacket.Insects, birds and mammals play roles in literature and film, such as in giant bug movies. Animals including insects and mammals feature in mythology and religion. In both Japan and Europe, a butterfly was seen as the personification of a person's soul, while the scarab beetle was sacred in ancient Egypt. Among the mammals, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cattle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", deer, horses, lions, bats, bears, and wolves are the subjects of myths and worship. The signs of the Western and Chinese \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    zodiacs\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are based on animals. See also Animal attacks Animal coloration Ethology Fauna List of animal names Lists of organisms by population Notes References External links Tree of Life Project Animal Diversity Web – University of Michigan's database of animals ARKive – multimedia database of endangered/protected species&quot; &quot;The Anopheles gambiae complex consists of at least seven morphologically indistinguishable  species of mosquitoes in the genus Anopheles. The complex was recognised in the 1960s and includes the most important vectors of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    malaria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in sub-Saharan Africa, particularly of the most dangerous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    malaria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " parasite, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Plasmodium falciparum\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It is one of the most efficient \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    malaria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " vectors known. The An. gambiae mosquito additionally transmits \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Wuchereria bancrofti\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " which causes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Lymphatic filariasis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a symptom of which is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    elephantiasis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Discovery and elements The Anopheles gambiae complex or Anopheles gambiae sensu lato was recognized as a species complex only in the 1960s. The A. gambiae complex consists of: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anopheles arabiensis Anopheles bwambae Anopheles melas Anopheles merus Anopheles quadriannulatus Anopheles gambiae sensu stricto Anopheles coluzzii Anopheles\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " amharicusThe individual species of the complex are morphologically difficult to distinguish from each other, although it is possible for larvae and adult females. The species exhibit different \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    behavioural traits\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". For example, Anopheles quadriannulatus is both a saltwater and mineralwater species. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    A. melas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and A. merus are saltwater species, while the remainder are freshwater species.Anopheles quadriannulatus generally takes its blood meal from animals (zoophilic), whereas Anopheles gambiae sensu \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stricto\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " generally feeds on humans, i.e. is considered anthropophilic.  Identification to the individual species level using the molecular methods of Scott et al. (1993) can have important implications in subsequent control measures. Anopheles gambiae in the strict sense An. gambiae s.s. has been discovered to be currently in a state of diverging into two different species—the Mopti (M) and Savannah (S) strains—though as of 2007, the two strains are still considered to be a single species. The An. gambiae s.s. genome has been sequenced three times, once for the M strain, once for the S strain, and once for a hybrid strain. Currently, ~90 miRNA have been predicted in the literature (38 miRNA officially listed in miRBase) for An. gambiae s.s. based upon conserved sequences to miRNA found in Drosophila. The mechanism of species recognition appears to be sounds emitted by the wings and identified by Johnston's organ. Fecundity Fecundity of A. gambiae depends on the detoxification of reactive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " species (ROS) by catalase.  Reduction in catalase activity significantly reduces reproductive output of female mosquitoes, indicating that catalase plays a central role in protecting oocytes and early embryos from ROS damage. Historical note An. gambiae invaded northeastern Brazil in 1930, which led to a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    malaria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " epidemic in 1938/1939. The Brazilian government assisted by the Rockefeller Foundation in a programme spearheaded by Fred Soper eradicated these mosquitoes from this area. This effort was modeled on the earlier success in eradication of Aedes aegypti as part of the yellow fever control program. The exact species involved in this epidemic has been identified as An. arabiensis. References External links &quot;&quot;Anopheles gambiae&quot;&quot;. VectorBase. View the anoGam1 genome assembly in the UCSC Genome Browser. DiArk&quot; &quot;The anterior cardiac veins (or anterior veins of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ") comprise a variable number of small vessels, usually between two and five, which collect blood from the front of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and open into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       "; the right marginal vein frequently opens into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", and is therefore sometimes regarded as belonging to this group. Unlike most cardiac veins, they do not end in the coronary sinus. Instead, these veins drain directly into the anterior wall of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". References  == External links ==&quot; &quot;The anterior interventricular sulcus  (or anterior longitudinal sulcus) is one of two grooves that separates the ventricles of the heart, the other being the posterior interventricular sulcus. The anterior interventricular sulcus is situated on the sternocostal surface of the heart, close to its left margin. The anterior interventricular branch of the left coronary artery runs in the sulcus along with the great \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac vein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". References This article incorporates text in the public domain from page 527 of the 20th edition of Gray's Anatomy (1918) External links thoraxlesson4 at The Anatomy Lesson by Wesley Norman (Georgetown University) (image only) Anatomy photo:20:st-1102 at the SUNY Downstate Medical Center&quot; &quot;The anterior interventricular sulcus  (or anterior longitudinal sulcus) is one of two grooves that separates the ventricles of the heart, the other being the posterior interventricular sulcus. The anterior interventricular sulcus is situated on the sternocostal surface of the heart, close to its left margin. The anterior interventricular branch of the left coronary artery runs in the sulcus along with the great \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac vein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". References This article incorporates text in the public domain from page 527 of the 20th edition of Gray's Anatomy (1918) External links thoraxlesson4 at The Anatomy Lesson by Wesley Norman (Georgetown University) (image only) Anatomy photo:20:st-1102 at the SUNY Downstate Medical Center&quot; &quot;Anticuchos (singular anticucho, Quechua 'Anti \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Kuchu\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "', Anti: 'Eastern region of the Andes' or 'Eastern native ethnicities', \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Kuchu\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ": 'Cut'; Quechua for '\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anti-style cuts', 'Eastern-style cuts')\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are popular and inexpensive meat dishes that originated in the Andes during the pre-Columbian era, specifically in the Antisuyu region of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Tawantinsuyu\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (Inca Empire). The modern dish was adapted during the colonial era between the 16th and 19th centuries and can now be found in Peru. Anticuchos can be found on street-carts and street food stalls (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anticucheras\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "). The meat may be marinated in vinegar and spices (such as cumin, ají pepper and garlic). While anticuchos can be made of any type of meat, the most popular are made of beef heart (anticuchos de corazón). Anticuchos usually come with a boiled potato  at the end of the skewer. A similar dish, shish kebab, is found in Mediterranean cuisine. In Peru, anticuchos are linked to the procession of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Señor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " de los Milagros. History Although Anticuchos are of Pre-Columbian origin, modern \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anticuchos\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can be traced as far back as the 16th century, when they were first encountered by the Spanish conquistadors. It was at this time that European ingredients such as garlic were added, and beef began to replace the traditional llama that was used at the time of the Inca Empire. It was a popular dish among the inhabitants of the Inca Empire, and it is currently popular throughout most South American countries. Americanized versions of anticuchos are sometimes made of non-organ meats. According to the text file from the National Library in Lima (Peru), it is believed that the term comes from the Quechua antikuchu (anti: 'East' + kuchu: 'cut' or uchu: 'porridge, mix'). The writer Erika Fetzer mentions that according to tradition, anticuchos were prepared with meat and flame. The Spanish strung the meat on sticks as skewers. The Spaniards also brought enslaved blacks, which were established in Lima and the coast of southern Chico de la \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ciudad de los\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Reyes of the Vice-royalty of Peru. They adopted this dish. In those days the Spanish dismissed offal as food for slaves, using non-offal meats out of the desire to have a dish that was more attractive to them. The presently used recipe, with its traditional flavor, specifically uses beef heart. In Peru, the tradition continues with the traditional name and ingredients; anticuchos are consumed by all social classes of Peru, and is especially popular as a street food. Peruvian Ricardo Palma's speeches, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Tradiciones\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Peruanos were published in 1833, mention the sale of anticuchos at 3 in the afternoon. Anticuchos in the Andes Cooking Traditional anticuchos are made with beef chunks of about 5 × 5 cm, roasted on a metal skewer about 40 cm (16 in) long and 3 × 3 mm in diameter. Anticuchos are commonly prepared with different types of beef and to a lesser extent with chicken, usually cut into pieces of 2 x 2 cm, threaded on a skewer of no more than 30 cm (12 in) long, with pieces of vienna sausage and vegetables such as onions, peppers, carrots and mushrooms alternated on the skewer, just like cooking meat on a barbecue (asado). Usually they're seasoned with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    salt\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to taste and sometimes with vinegar or lemon juice. A popular dressing is a sauce made from garlic, onion and chopped cilantro, vinegar, lemon juice and beer, which is spread onto the anticuchos with a sprig of parsley. Anticuchos are usually not the main course of a meal, but rather an accompaniment to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    grilled meats\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " along with other side dishes such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    choripanes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", potatoes, sausages and salads. Variants include smaller sticks of wood; those 15 cm or less are called &quot;&quot;meat skewers.&quot;&quot; Peru Anticuchos are part of traditional Peruvian cuisine. The greatest consumption in Peru is in July, during the celebration of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Fiestas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Patrias (Independence day) in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fondas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and BBQs. Bolivia In Bolivia, anticuchos are made with heart meat (commonly beef or chicken), accompanied with roast potatoes and a type of peanut sauce. See also List of meat dishes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Şiş\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " kebap References External links Peru Taste - Anticuchos&quot; &quot;An antimineralocorticoid, also known as a mineralocorticoid receptor antagonist (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    MCRA\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " antagonist, is a diuretic drug which antagonizes the action of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " at mineralocorticoid receptors. This group of drugs is often used as adjunctive therapy, in combination with other drugs, for the management of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the first member of the class, is also used in the management of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperaldosteronism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Conn's syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") and female \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hirsutism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (due to additional \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    antiandrogen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " actions). Most antimineralocorticoids, including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", are steroidal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spirolactones\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Finerenone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is a nonsteroidal antimineralocorticoid. Medical uses Mineralocorticoid receptor antagonists are diuretic drugs that work primarily on the kidneys. They decrease \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " reabsorption which leads to increased water excretion by the kidneys. By regulating water excretion, mineralocorticoid receptor antagonists lower blood pressure and reduce fluid around the heart which can be very beneficial in some cardiovascular conditions. Mineralocorticoid receptor antagonists have been used for many clinical conditions in the cardiovascular system. It has proven beneficial for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diseases like primary aldosteronism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", primary and resistant \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic kidney disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". They are often used with other medications, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors or beta blockers.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Adverse effects Increased urination is a commonly reported side effect, particularly during the initial phase following treatment initiation; this is mostly transient and tends to reduce with sustained treatment. Common side effects for antimineralocorticoid medications include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nausea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vomiting\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stomach cramps\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diarrhoea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Clinically significant \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperkalemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is possible, and warrants serum \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " monitoring on a periodic basis. The pathophysiology of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperkalemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is that antimineralocorticoid medications reduce \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    K\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") excretion. Mechanism of action \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is a mineralocorticoid which is synthesized in the adrenal glands. When \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is secreted from the adrenal glands, it binds to the mineralocorticoid receptor in the renal tubule cell and forms a complex.  This complex enhances transcription of specific DNA segments in the nucleus, leading to the formation of two protein transporters, Na+/K+ ATPase pump at the basolateral membrane and Na+ channel called ENaC, located at the apical membrane of the renal tubule cell. These protein transporters increase \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " reabsorption and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " excretion in the distal tubule and the collecting duct of the kidneys. This helps the body to maintain normal volume and electrolyte balance, increasing the blood pressure. Mineralocorticoid receptor antagonists decrease the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " effect by binding to the mineralocorticoid receptor inhibiting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". This leads to higher levels of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in serum and increased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " excretion, resulting in decreased body fluid and lower blood pressure. List of Mineralocorticoid receptor antagonists Pharmacokinetics When comparing the pharmacokinetic properties of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    eplerenone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", it is clear that the two drugs differ. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has shorter half-life (t1/2 = 1.3-1.4 hours) than \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    eplerenone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (t1/2 = 4-6 hours). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Eplerenone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " goes through rapid metabolism by the liver to inactive metabolites (t1/2 = 4-6 hours). However, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is metabolized to three active metabolites, which give it prolonged activity (13.8 – 16. 5 hours). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has a long half-life and is excreted 47-51% through kidneys. Patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic kidney disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " therefore require close monitoring when taking the drug. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is also eliminated through feces (35-41%). The excretion of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    eplerenone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is 67% through kidneys and 32% through feces. The information about excretion plays a critical role when determining the appropriate doses for patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    renal and/or hepatic dysfunction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It is very important to adjust the doses for patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    renal dysfunction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " because if they fail to eliminate the drug through their kidneys it could accumulate in the body, causing high concentration of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the blood. Structure-activity relationship \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Eplerenone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " competitively block the binding of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to the mineralocorticoid receptor and hindering the reabsorption of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chloride ions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The activity of mineralocorticoid antagonists is dependent on the presence of a y-lactone ring on the C-17 position. The C-7 position is also important for activity as substituents there sterically hinder the interaction of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    C-7-unsubstituted\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " agonists such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Eplerenone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is a newer drug that was developed as a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " analog with reduced adverse effects. In addition to the y-lactone ring and the substituent on C-7, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    eplerenone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has a 9α,11α-epoxy group. This group is believed to be the reason why \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    eplerenone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " has a 20-40-fold lower affinity for the mineralocorticoid receptor than \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".Despite the nonsteroidal nature of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    finerenone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " which yields a different lipophilicity and polarity profile for this compound, finerenone's affinity toward mineralocorticoid receptors is equal to that of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and 500 times that of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    eplerenone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", hinting that the steroidal core component of most antimineralocorticoids is not essential for mineralocorticoid receptor affinity. History The main goal of the identification of the first \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " antagonists, which happened during the 1950s, was to identify inhibitors of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " activity. In those times, the main use of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was recognized as the control of renal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and the excretion of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".Hans Selye, a Hungarian-Canadian endocrinologist, studied the effects of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " antagonists on rats and found that the use of one of the first \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " antagonists, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", protected them from aldosterone-induced \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac necrosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The same year, 1959, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was launched as a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium-sparing\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " diuretic. It became clear years later that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " antagonists inhibit a specific receptor protein. This protein has high affinity for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " but also for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cortisol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in humans and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    corticosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in mice and rats. For this reason, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " antagonists were called mineralocorticoid receptor antagonists.There have been three major waves in the pharmaceutical industry when it comes to research and development of mineralocorticoid receptor antagonists: The first wave took place within Searle Laboratories. This company identified, shortly after the purification of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aldosterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    steroid-based spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " as the first \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anti-mineralocorticoid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The second wave was all about discovering much more specific steroidal anti-mineralocorticoids. The main active companies were Searle, Ciba-Geigy, Roussel Uclaf and Schering AG.Around 50 years after Selye’s work, several pharmaceutical companies began drug discovery programs. Their goal was to discover novel non-steroidal mineralocorticoid receptor antagonists for use as efficacious and safe drugs with the pharmacodynamics and pharmacokinetics well defined. Their goal was to use these candidates for a broad spectrum of diseases. This was essentially the third wave. The first mineralocorticoid receptor antagonists were all discovered and identified by in vivo experiments whereas the identification of novel non-steroidal mineralocorticoid receptor antagonists were done with high-throughput screening of millions of chemical compounds in various pharmaceutical companies. Examples Members of this class in clinical use include: Widespread use \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " — the first and most widely used member of this class \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Eplerenone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " — much more selective than \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spironolactone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " on target, but somewhat less potent and efficacious Uncommon use (to date) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Canrenone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium canrenoate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " — very limited use Finerenone — nonsteroidal and more potent and selective than either \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    eplerenone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spironolactoneSome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " drugs also have antimineralocorticoid effects secondary to their main mechanism of actions. Examples include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    progesterone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    drospirenone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gestodene\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    benidipine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". See also \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Potassium-sparing diuretic Mineralocorticoid Corticosteroid Antiglucocorticoid References External links Aldosterone+Antagonists at the US National Library of Medicine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Medical Subject Headings (MeSH) MeSH list of agents 82000451&quot; &quot;An antiplatelet drug (antiaggregant), also known as a platelet agglutination inhibitor or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    platelet aggregation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " inhibitor, is a member of a class of pharmaceuticals that decrease \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    platelet aggregation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and inhibit \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " formation. They are effective in the arterial circulation where anticoagulants have little effect.They are widely used in primary and secondary prevention of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombotic cerebrovascular or cardiovascular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Antiplatelet therapy with one or more of these drugs decreases the ability of blood clots to form by interfering with the platelet activation process in primary hemostasis. Antiplatelet drugs can reversibly or irreversibly inhibit the process involved in platelet activation resulting in decreased tendency of platelets to adhere to one another and to damaged blood vessels' endothelium. Choice A 2006 review states: &quot;&quot;...low-dose \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aspirin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " increases the risk of major \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " 2-fold compared with placebo. However, the annual incidence of major \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " due to low-dose \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aspirin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is modest—only 1.3 patients per thousand higher than what is observed with placebo treatment. Treatment of approximately 800 patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    low-dose aspirin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " annually for cardiovascular prophylaxis will result in only 1 additional major \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " episode.&quot;&quot; Dual antiplatelet therapy Often a combination of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aspirin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " plus an ADP/P2Y inhibitor (such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    clopidogrel\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    prasugrel\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ticagrelor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", or another) is used in order to obtain greater effectiveness than with either agent alone. This is known as &quot;&quot;dual antiplatelet therapy&quot;&quot; (or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DAPT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "). Classification The class of antiplatelet drugs include: Irreversible cyclooxygenase inhibitors \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aspirin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Triflusal (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Disgren\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adenosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " diphosphate (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ADP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") receptor inhibitors Cangrelor (Kengreal) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Clopidogrel\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Plavix\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Prasugrel\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "  (Effient) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ticagrelor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Brilinta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ticlopidine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ticlid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") Phosphodiesterase inhibitors \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cilostazol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (Pletaal) Protease-activated receptor-1 (PAR-1) antagonists \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Vorapaxar\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (Zontivity) Glycoprotein IIB/IIIA inhibitors (intravenous use only) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Abciximab\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ReoPro\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Eptifibatide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Integrilin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Tirofiban\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aggrastat\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adenosine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " reuptake inhibitors \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Dipyridamole\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Persantine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Thromboxane\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " inhibitors \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Thromboxane\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " synthase inhibitors \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Thromboxane\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " receptor antagonists Terutroban Usage Prevention and treatment of arterial \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Prevention and treatment of arterial \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is essential in patients with certain medical conditions whereby the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thromboembolism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may result in disastrous consequences such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary embolism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Patients who require the use of antiplatelet drugs are: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with or without \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", any heart surgery (especially prosthetic replacement heart valve), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Coronary Heart Disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as stable \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       ", patients with coronary stent, Peripheral Vascular Disease/Peripheral Arterial Disease and apical/ventricular/mural \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Treatment of established arterial \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " includes the use of antiplatelet drugs and thrombolytic therapy. Antiplatelet drugs alter the platelet activation at the site of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vascular damage\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " crucial to the development of arterial \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aspirin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Triflusal\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " irreversibly inhibits the enzyme COX, resulting in reduced platelet production of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    TXA2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thromboxane\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " - powerful vasoconstrictor that lowers cyclic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AMP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and initiates the platelet release reaction). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Dipyridamole\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " inhibits platelet phosphodiesterase, causing an increase in cyclic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    AMP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " with potentiation of the action of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PGI2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " – opposes actions of TXA2 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Clopidogrel\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " affects the ADP-dependent activation of IIb/IIIa complex Glycoprotein IIb/IIIa receptor antagonists block a receptor on the platelet for fibrinogen and von Willebrand factor. 3 classes: Murine-human chimeric antibodies (e.g., \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abciximab\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") Synthetic peptides (e.g., \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    eptifibatide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") Synthetic non-peptides (e.g., \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tirofiban\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Epoprostenol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    prostacyclin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " that is used to inhibit \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    platelet aggregation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " during renal dialysis (with or without \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heparin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") and is also used in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    primary pulmonary hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Management in the perioperative period Antiplatlet therapy may increase the risk of a bleed during surgery, however, stopping therapy may increase the risk of other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombotic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " problems including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". When considering these medications and the risk-benefit ratio in the perioperative period, one must consider the risk of stopping the medication and a clot forming versus the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " during or after the surgery if medication is continued. A 2018 Cochrane Review that included five randomized controlled trials found low-certainity evidence to suggest that continuing or discontinuing antiplatelet therapy for a non-cardiac surgery does not make a difference in mortality, major bleeds that require surgery, or ischaemic events. The same review found that continuing or discontinuing therapy also did not have a big difference on the incidence of bleeds requiring a blood transfusion (moderate certainity evidence). In patients with truly time-sensitive diseases (defined in the 2014 ACC/AHA guidelines as needing to proceed in 2–6 weeks), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DAPT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can be stopped 3 (three) months (90 days) after a coronary stent is placed if postponing surgery any longer would result in significant morbidity. Examples of these types of surgeries include some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cancer\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " surgery and possibly some orthopedic surgery (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    non-urgent/emergent fracture\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " management). Preferably 6 to 12 months of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DAPT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " should be continued in patients having elective surgery. Bare metal stents required at least one month of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DAPT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Balloon angioplasty in the preoperative period - patients can proceed to surgery two weeks after the procedure. CABG: Patients may proceed with surgery as soon as they are healed from the coronary artery bypass procedure and they do not need any specific amount of time on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DAPT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Dental management of patients on antiplatelet drugs Dentists should be aware of the risk of prolonged \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " time in patients taking antiplatelet drugs when planning dental treatments that are likely to cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Therefore, it is important for dentists to know how to assess patient's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " risk and how to manage them. Assess \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " risk Identify the likelihood and risk of dental treatment causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " complications. Drug \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    toxicity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Antiplatelet drugs effect may be affected by patient's medications, current medical conditions, food and supplements taken. Antiplatelet drugs effect may be increased or decreased. An increase in antiplatelet effect would increase the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and results in prolonged or excessive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". A decrease in antiplatelet effect would reduce the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and potentially increase the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thromboembolic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " risk. Drug \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    toxicity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " also may increased when multiple antiplatelet drugs are used. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gastrointestinal bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a common adverse event seen in many patients. Medications Medications that may increase antiplatelet drugs effect: NSAIDS (e.g.: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aspirin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ibuprofen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diclofenac\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Naproxen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") Cytotoxic drugs or drugs associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bone marrow suppression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (e.g.: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Leflunamide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hydroxychloroquine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Adalimumab\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Infliximab\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Etanercept\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sulfasalazine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Penicillamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ",      Gold, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Methotrexate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Azathioprine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Mycophenolate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") Other anticoagulants or antiplatelet drugs Drugs affecting the nervous system (e.g.: Selective \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    serotonin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " reuptake inhibitors (SSRIs))Medications that may decrease antiplatelet drugs effect: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Carbamazepine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Erythromycin \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Fluconazole\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " OmeprazoleUsage of NSAIDS as part of dental management of patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vascular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " should be discouraged as NSAIDS has antiplatelet effect. Instead, simple analgesics such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Paracetamol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Co-codamol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " should be of first choice. If NSAIDS is required, dentist should be aware of the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and minimise treatment length. Medical conditions Medical conditions that may increase antiplatelet drugs effect:\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Chronic kidney failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    liver disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    haematological malignancy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", recent or current chemotherapy, advanced \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", mild forms of inherited \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bleeding disorders\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    haemophilia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", Von \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Willebrand's disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    idiopathic thrombocytopenic purpura\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Food and supplements Food and supplements that may increase antiplatelet drugs' effect:St. John's Wort, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ginkgo biloba\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Garlic Oral antiplatelet drugs available in the UK See also Anticoagulant drug \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nitrophorin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Thrombolytic drug  == References ==&quot; &quot;Anubis or Inpu, Anpu in Ancient Egyptian \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    (;\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Ancient Greek: Ἄνουβις, Egyptian: inpw, Coptic: ⲁⲛⲟⲩⲡ Anoup) is the Greek name of the god of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mummification\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", embalming, the afterlife, cemeteries, tombs, and the Underworld, in ancient Egyptian religion, usually depicted as a canine or a man with a canine head. Archeologists have identified Anubis's sacred animal as an Egyptian canid, the African golden wolf. The African wolf was formerly called the &quot;&quot;African golden jackal&quot;&quot;, until a 2015 genetic analysis updated the taxonomy and the common name for the species. As a result, Anubis is often referred to as having a &quot;&quot;jackal&quot;&quot; head, but this &quot;&quot;jackal&quot;&quot; is now more properly called a &quot;&quot;wolf&quot;&quot;. Like many ancient \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Egyptian deities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", Anubis assumed different roles in various contexts. Depicted as a protector of graves as early as the First Dynasty (c. 3100 – c. 2890 BC), Anubis was also an embalmer. By the Middle Kingdom (c. 2055–1650 BC) he was replaced by Osiris in his role as lord of the underworld. One of his prominent roles was as a god who ushered souls into the afterlife. He attended the weighing scale during the &quot;&quot;Weighing of the Heart&quot;&quot;, in which it was determined whether a soul would be allowed to enter the realm of the dead. Despite being one of the most ancient and &quot;&quot;one of the most frequently depicted and mentioned gods&quot;&quot; in the Egyptian pantheon, Anubis played almost no role in Egyptian myths.Anubis was depicted in black, a color that symbolized regeneration, life, the soil of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nile\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " River, and the discoloration of the corpse after embalming. Anubis is associated with his brother \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Wepwawet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", another Egyptian god portrayed with a dog's head or in canine form, but with grey or white fur. Historians assume that the two figures were eventually combined. Anubis' female counterpart is Anput. His daughter is the serpent goddess \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Kebechet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Name \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Anubis' name jnpw\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was possibly pronounced [a.ˈna.pʰa(w)], based on Coptic Anoup and the Akkadian transcription 𒀀𒈾𒉺⟨a-na-pa⟩ in the name &lt;ri-a-na-pa&gt; &quot;&quot;Reanapa&quot;&quot; that appears in Amarna letter EA 315. However, this transcription may also be interpreted as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rˁ-nfr\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", a name similar to that of Prince Ranefer of the Fourth Dynasty. History In Egypt's Early Dynastic period (c. 3100 – c. 2686 BC), Anubis was portrayed in full animal form, with a &quot;&quot;jackal&quot;&quot; head and body. A jackal god, probably Anubis, is depicted in stone inscriptions from the reigns of Hor-Aha, Djer, and other pharaohs of the First Dynasty. Since Predynastic Egypt, when the dead were buried in shallow graves, jackals had been strongly associated with cemeteries because they were scavengers which uncovered human bodies and ate their flesh. In the spirit of &quot;&quot;fighting like with like,&quot;&quot; a jackal was chosen to protect the dead, because &quot;&quot;a common problem (and cause of concern) must have been the digging up of bodies, shortly after burial, by jackals and other wild dogs which lived on the margins of the cultivation.&quot;&quot;In the Old Kingdom, Anubis was the most important god of the dead. He was replaced in that role by Osiris during the Middle Kingdom (2000–1700 BC). In the Roman era, which started in 30 BC, tomb paintings depict him holding the hand of deceased persons to guide them to Osiris.The parentage of Anubis varied between \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myths\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", times and sources. In early mythology, he was portrayed as a son of Ra. In the Coffin Texts, which were written in the First Intermediate Period (c. 2181–2055 BC), Anubis is the son of either the cow goddess Hesat or the cat-headed Bastet. Another tradition depicted him as the son of Ra and Nephthys. The Greek Plutarch (c. 40–120 AD) stated that Anubis was the illegitimate son of Nephthys and Osiris, but that he was adopted by Osiris's wife Isis: For when Isis found out that Osiris loved her sister and had  relations with her in mistaking her sister for herself, and when she saw a proof of it in the form of a garland of clover that he had left to Nephthys - she was looking for a baby, because Nephthys abandoned it at once after it had been born for fear of Seth; and when Isis found the baby helped by the dogs which with great difficulties lead her there, she raised him and he became her guard and ally by the name of Anubis. George Hart sees this story as an &quot;&quot;attempt to incorporate the independent deity Anubis into the Osirian pantheon.&quot;&quot; An Egyptian papyrus from the Roman period (30–380 AD) simply called Anubis the &quot;&quot;son of Isis.&quot;&quot;In Nubia, Anubis was seen as the husband of his mother Nephthys.In the Ptolemaic period (350–30 BC), when Egypt became a Hellenistic kingdom ruled by Greek pharaohs, Anubis was merged with the Greek god Hermes, becoming Hermanubis. The two gods were considered similar because they both guided souls to the afterlife. The center of this cult was in uten-ha/Sa-ka/ Cynopolis, a place whose Greek name means &quot;&quot;city of dogs.&quot;&quot; In Book XI of The Golden Ass by Apuleius, there is evidence that the worship of this god was continued in Rome through at least the 2nd century. Indeed, Hermanubis also appears in the alchemical and hermetical literature of the Middle Ages and the Renaissance. Although the Greeks and Romans typically scorned Egyptian animal-headed gods as bizarre and primitive (Anubis was mockingly called &quot;&quot;Barker&quot;&quot; by the Greeks), Anubis was sometimes associated with Sirius in the heavens and Cerberus and Hades in the underworld. In his dialogues, Plato often has Socrates utter oaths &quot;&quot;by the dog&quot;&quot; (Greek: kai me ton kuna), &quot;&quot;by the dog of Egypt&quot;&quot;, and &quot;&quot;by the dog, the god of the Egyptians&quot;&quot;, both for emphasis and to appeal to Anubis as an arbiter of truth in the underworld. Roles Protector of tombs In contrast to real wolves, Anubis was a protector of graves and cemeteries. Several epithets attached to his name in Egyptian texts and inscriptions referred to that role. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Khenty-Amentiu\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which means &quot;&quot;foremost of the westerners&quot;&quot; and was also the name of a different canine funerary god, alluded to his protecting function because the dead were usually buried on the west bank of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nile\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". He took other names in connection with his funerary role, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tpy-ḏw.f\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (Tepy-djuef) &quot;&quot;He who is upon his mountain&quot;&quot; (i.e. keeping guard over tombs from above) and nb-t3-ḏsr (Neb-ta-djeser) &quot;&quot;Lord of the sacred land&quot;&quot;, which designates him as a god of the desert necropolis.The Jumilhac papyrus recounts another tale where Anubis protected the body of Osiris from Set. Set attempted to attack the body of Osiris by transforming himself into a leopard. Anubis stopped and subdued Set, however, and he branded Set's skin with a hot \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    iron\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " rod. Anubis then flayed Set and wore his skin as a warning against evil-doers who would desecrate the tombs of the dead. Priests who attended to the dead wore leopard skin in order to commemorate Anubis' victory over Set. The legend of Anubis branding the hide of Set in leopard form was used to explain how the leopard got its spots.Most ancient tombs had prayers to Anubis carved on them. Embalmer As jmy-wt (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Imiut\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Imiut\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " fetish) &quot;&quot;He who is in the place of embalming&quot;&quot;, Anubis was associated with mummification. He was also called ḫnty zḥ-nṯr &quot;&quot;He who presides over the god's booth&quot;&quot;, in which &quot;&quot;booth&quot;&quot; could refer either to the place where embalming was carried out or the pharaoh's burial chamber.In the Osiris myth, Anubis helped Isis to embalm Osiris. Indeed, when the Osiris myth emerged, it was said that after Osiris had been killed by Set, Osiris's organs were given to Anubis as a gift. With this connection, Anubis became the patron god of embalmers; during the rites of mummification, illustrations from the Book of the Dead often show a wolf-mask-wearing priest supporting the upright mummy. Guide of souls By the late pharaonic era (664–332 BC), Anubis was often depicted as guiding individuals across the threshold from the world of the living to the afterlife. Though a similar role was sometimes performed by the cow-headed Hathor, Anubis was more commonly chosen to fulfill that function. Greek writers from the Roman period of Egyptian history designated that role as that of &quot;&quot;psychopomp&quot;&quot;, a Greek term meaning &quot;&quot;guide of souls&quot;&quot; that they used to refer to their own god Hermes, who also played that role in Greek religion. Funerary art from that period represents Anubis guiding either men or women dressed in Greek clothes into the presence of Osiris, who by then had long replaced Anubis as ruler of the underworld. Weighing of the heart One of the roles of Anubis was as the &quot;&quot;Guardian of the Scales.&quot;&quot; The critical scene depicting the weighing of the heart, in the Book of the Dead,  shows Anubis performing a measurement that determined whether the person was worthy of entering the realm of the dead (the underworld, known as Duat). By weighing the heart of a deceased person against Ma'at (or &quot;&quot;truth&quot;&quot;), who was often represented as an ostrich feather, Anubis dictated the fate of souls. Souls heavier than a feather would be devoured by Ammit, and souls lighter than a feather would ascend to a heavenly existence. Portrayal in art Anubis was one of the most frequently represented deities in ancient Egyptian art. He is depicted in royal tombs as early as the First Dynasty. The god is typically treating a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    king's corpse\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", providing sovereign to mummification rituals and funerals, or standing with fellow gods at the Weighing of the Heart of the Soul in the Hall of Two Truths. One of his most popular representations is of him, with the body of a man and the head of a jackal with pointed ears, standing or kneeling, holding a gold scale while a heart of the soul is being weighed against Ma'at's white truth feather.In the early dynastic period, he was depicted in animal form, as a black canine. Anubis's distinctive black color did not represent the animal, rather it had several symbolic meanings. It represented &quot;&quot;the discolouration of the corpse after its treatment with natron and the smearing of the wrappings with a resinous substance during mummification.&quot;&quot; Being the color of the fertile silt of the River \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nile\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", to Egyptians, black also symbolized fertility and the possibility of rebirth in the afterlife. In the Middle Kingdom, Anubis was often portrayed as a man with the head of a jackal. An extremely rare depiction of him in fully human form was found in the tomb of Ramesses II in Abydos.Anubis is often depicted wearing a ribbon and holding a nḫ3ḫ3 &quot;&quot;flail&quot;&quot; in the crook of his arm. Another of Anubis's attributes was the jmy-wt or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    imiut\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " fetish, named for his role in embalming.In funerary contexts, Anubis is shown either attending to a deceased person's mummy or sitting atop a tomb protecting it. New Kingdom tomb-seals also depict Anubis sitting atop the nine bows that symbolize his domination over the enemies of Egypt. Gallery Worship Although he does not appear in many \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myths\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", he was extremely popular with Egyptians and those of other cultures. The Greeks linked him to their god Hermes, the god who guided the dead to the afterlife. The pairing was later known as Hermanubis. Anubis was heavily worshipped because, despite modern beliefs, he gave the people hope. People marveled in the guarantee that their body would be respected at \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", their soul would be protected and justly judged.Anubis had male priests who sported wood masks with the god's likeness when performing rituals. His cult center was at Cynopolis in Upper Egypt but memorials were built everywhere and he was universally revered in every part of the nation. In popular culture In popular and media culture, Anubis is often falsely portrayed as the sinister god of the dead. He gained popularity during the 20th and 21st centuries through books, video games, and movies where artists would give him evil powers and a dangerous army. Despite his nefarious reputation, his image is still the most recognizable of the Egyptian gods and replicas of his statues and paintings remain popular. See also Anubias Egyptian mythology in popular culture Animal mummy#Miscellaneous animals Abatur-Mandaean uthra who weighs the souls of the dead to determine their fate. References Bibliography Armour, Robert A. (2001), Gods and Myths of Ancient Egypt, Cairo, Egypt: American University in Cairo Press Blackwood, Russell; Crossett, John; Long, Herbert (1962), &quot;&quot;Gorgias 482b&quot;&quot;, The Classical Journal, 57 (7): 318–19, JSTOR 3295283. Conder, Claude Reignier (trans.) (1894) [1893], The Tell Amarna Tablets (Second ed.), London: Published for the Committee of the Palestine Exploration Fund by A.P. Watt, ISBN 9781414701561. Coulter, Charles Russell; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Turner\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", Patricia (2000), Encyclopedia of Ancient Deities, Jefferson (NC) and London: McFarland, ISBN 978-0-7864-0317-2. Faulkner, Raymond O.; Andrews, Carol; Wasserman, James (2008), The Egyptian Book of the Dead: The Book of Going Forth by Day, Chronicle Books, ISBN 978-0-8118-6489-3. Fischer, Henry George (1968), Dendera in the Third Millennium B. C., \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Down\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to the Theban Domination of Upper Egypt, London: J.J. Augustin. Freeman, Charles (1997), The Legacy of Ancient Egypt, New York: Facts on File, ISBN 978-0-816-03656-1. Gryglewski, Ryszard \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    W.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (2002), &quot;&quot;Medical and Religious Aspects of Mummification in Ancient Egypt&quot;&quot; (PDF), Organon, 31 (31): 128–48, PMID 15017968. Hart, George (1986), A Dictionary of Egyptian Gods and Goddesses, London: Routledge &amp; Kegan Paul, ISBN 978-0-415-34495-1. Hoerber, Robert G. (1963), &quot;&quot;The Socratic Oath 'By the Dog'&quot;&quot;, The Classical Journal, 58 (6): 268–69, JSTOR 3293989. Johnston, Sarah Iles (general ed.) (2004), Religions of the Ancient World: A Guide, Cambridge, MA: Belknap Press|isbn=978-0-674-01517-3|postscript=.}} Kinsley, David (1989), The Goddesses' Mirror: Visions of the Divine from East and West, Albany (NY): State University of New York Press, ISBN 978-0-88706-835-5|postscript=. (paperback).\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    }} Lapp\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Günther\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (1986), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Die Opferformel des\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Alten Reiches: unter Berücksichtigung einiger späterer Formen [The offering formula of the Old Kingdom: considering a few later forms], Mainz am Rhein: Zabern, ISBN 978-3805308724. Leprohon, Ronald J. (1990), &quot;&quot;The Offering Formula in the First Intermediate Period&quot;&quot;, The Journal of Egyptian Archaeology, 76: 163–64, doi:10.1177/030751339007600115, JSTOR 3822017, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    S2CID\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 192258122. Peacock, David (2000), &quot;&quot;The Roman Period&quot;&quot;,  in Shaw, Ian (ed.), The Oxford History of Ancient Egypt, Oxford University Press, ISBN 978-0-19-815034-3. Riggs, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Christina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (2005), The Beautiful Burial in Roman Egypt: Art, Identity, and Funerary Religion, Oxford and New York: Oxford University Press Wilkinson, Richard H. (2003), The Complete Gods and Goddesses of Ancient Egypt, London: Thames &amp; Hudson, ISBN 978-0-500-05120-7. Wilkinson, Toby A. H. (1999), Early Dynastic Egypt, London: Routledge \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Zandee, Jan (1960)\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as an Enemy: According to Ancient Egyptian Conceptions, Brill Archive, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    GGKEY\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ":A7N6PJCAF5Q Further reading Duquesne, Terence (2005). The Jackal Divinities of Egypt I. Darengo Publications. ISBN 978-1-871266-24-5. El-Sadeek, Wafaa; Abdel Razek, Sabah (2007). Anubis, Upwawet, and Other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Deities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ": Personal Worship and Official Religion in Ancient Egypt. American University in Cairo Press. ISBN 9789774372315. Grenier, J.-C. (1977). Anubis \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    alexandrin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " et romain (in French). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    E. J. Brill\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". ISBN 9789004049178. External links  Media related to Anubis at Wikimedia Commons  The dictionary definition of Anubis at Wiktionary&quot; &quot;The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " ( ay-OR-tə) is the main and largest artery in the human body, originating from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " of the heart and extending down to the abdomen, where it splits into two smaller arteries (the common iliac arteries). The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " distributes oxygenated blood to all parts of the body through the systemic circulation. Structure Sections In anatomical sources, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is usually divided into sections.One way of classifying a part of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is by anatomical compartment, where the thoracic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " (or thoracic portion of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ") runs from the heart to the diaphragm. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " then continues downward as the abdominal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " (or abdominal portion of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ") from the diaphragm to the aortic bifurcation. Another system divides the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " with respect to its course and the direction of blood flow. In this system, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " starts as the ascending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", travels superiorly from the heart, and then makes a hairpin turn known as the aortic arch. Following the aortic arch, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " then travels inferiorly as the descending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The descending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " has two parts. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " begins to descend in the thoracic cavity and is consequently known as the thoracic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". After the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " passes through the diaphragm, it is known as the abdominal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " ends by dividing into two major blood vessels, the common iliac arteries and a smaller midline vessel, the median sacral artery.: 18 Ascending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " The ascending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " begins at the opening of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " of the heart. It runs through a common pericardial sheath with the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary trunk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". These two blood vessels twist around each other, causing the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to start out posterior to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary trunk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", but end by twisting to its right and anterior side.: 191, 204  The transition from ascending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to aortic arch is at the pericardial reflection on the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".: Plate 211 At the root of the ascending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", the lumen has three small pockets between the cusps of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the wall of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", which are called the aortic sinuses or the sinuses of Valsalva. The left aortic sinus contains the origin of the left coronary artery and the right aortic sinus likewise gives rise to the right coronary artery. Together, these two arteries supply the heart. The posterior aortic sinus does not give rise to a coronary artery. For this reason the left, right and posterior aortic sinuses are also called left-coronary, right-coronary and non-coronary sinuses.: 191 Aortic arch The aortic arch loops over the left \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the bifurcation of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary trunk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", to which it remains connected by the ligamentum arteriosum, a remnant of the fetal circulation that is obliterated a few days after birth. In addition to these blood vessels, the aortic arch crosses the left main bronchus. Between the aortic arch and the pulmonary trunk is a network of autonomic nerve fibers, the cardiac plexus or aortic plexus. The left vagus nerve, which passes anterior to the aortic arch, gives off a major branch, the recurrent laryngeal nerve, which loops under the aortic arch just lateral to the ligamentum arteriosum. It then runs back to the neck. The aortic arch has three major branches: from proximal to distal, they are the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    brachiocephalic trunk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the left common carotid artery, and the left subclavian artery. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    brachiocephalic trunk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " supplies the right side of the head and neck as well as the right arm and chest wall, while the latter two together supply the left side of the same regions. The aortic arch ends, and the descending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " begins at the level of the intervertebral disc between the fourth and fifth thoracic vertebrae.: 209 Thoracic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " The thoracic descending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " gives rise to the intercostal and subcostal arteries, as well as to the superior and inferior left bronchial arteries and variable branches to the esophagus, mediastinum, and pericardium. Its lowest pair of branches are the superior phrenic arteries, which supply the diaphragm, and the subcostal arteries for the twelfth rib.: 195 Abdominal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " The abdominal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " begins at the aortic hiatus of the diaphragm at the level of the twelfth thoracic vertebra. It gives rise to lumbar and musculophrenic arteries, renal and middle suprarenal arteries, and visceral arteries (the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    celiac trunk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the superior mesenteric artery and the inferior mesenteric artery). It ends in a bifurcation into the left and right common iliac arteries. At the point of the bifurcation, there also springs a smaller branch, the median sacral artery.: 331 Development The ascending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " develops from the outflow tract, which initially starts as a single tube connecting the heart with the aortic arches (which will form the great arteries) in early development but is then separated into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary trunk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The aortic arches start as five pairs of symmetrical arteries connecting the heart with the dorsal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", and then undergo a significant remodelling to form the final asymmetrical structure of the great arteries, with the 3rd pair of arteries contributing to the common carotids, the right 4th forming the base and middle part of the right subclavian artery and the left 4th being the central part of the aortic arch. The smooth \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle of the great arteries\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and the population of cells that form the aorticopulmonary septum that separates the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is derived from cardiac neural crest. This contribution of the neural crest to the great artery smooth muscle is unusual as most smooth muscle is derived from mesoderm. In fact the smooth muscle within the abdominal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is derived from mesoderm, and the coronary arteries, which arise just above the semilunar valves, possess smooth \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle of mesodermal\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " origin. A failure of the aorticopulmonary septum to divide the great vessels results in persistent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    truncus arteriosus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Microanatomy The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is an elastic artery, and as such is quite distensible. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " consists of a heterogeneous mixture of smooth \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle, nerves\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", intimal cells, endothelial cells, fibroblast-like cells, and a complex extracellular matrix. The vascular wall consists of several layers known as the tunica externa, tunica media, and tunica intima. The thickness of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " requires an extensive network of tiny blood vessels called vasa vasorum, which feed the tunica externa and tunica media outer layers of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The aortic arch contains baroreceptors and chemoreceptors that relay information concerning blood pressure and blood pH and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels to the medulla oblongata of the brain. This information is processed by the brain and the autonomic nervous system mediates the homeostatic responses. Within the tunica media, smooth muscle and the extracellular matrix are quantitatively the largest components of the aortic vascular wall. The fundamental unit of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is the elastic lamella, which consists of smooth muscle and elastic matrix. The medial layer of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " consist of concentric musculoelastic layers (the elastic lamella) in mammals. The smooth muscle component does not dramatically alter the diameter of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " but rather serves to increase the stiffness and viscoelasticity of the aortic wall when activated. The elastic matrix dominates the biomechanical properties of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The elastic matrix forms lamellae, consisting of elastic fibers, collagens (predominately type III), proteoglycans, and glycoaminoglycans. Variation Variations may occur in the location of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", and the way in which arteries branch off the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", normally on the left side of the body, may be found on the right in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dextrocardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", in which the heart is found on the right, or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    situs inversus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", in which the location of all organs are flipped.: 188 Variations in the branching of individual arteries may also occur. For example, the left vertebral artery may arise from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", instead of the left common carotid artery.: 188 In \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    patent ductus arteriosus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital disorder\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the fetal ductus arteriosis fails to close, leaving an open vessel connecting the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to the proximal descending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Function The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " supplies all of the systemic circulation, which means that the entire body, except for the respiratory zone of the lung, receives its blood from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Broadly speaking, branches from the ascending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " supply the heart; branches from the aortic arch supply the head, neck, and arms; branches from the thoracic descending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " supply the chest (excluding the heart and the respiratory zone of the lung); and branches from the abdominal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " supply the abdomen. The pelvis and legs get their blood from the common iliac arteries. Blood flow and velocity The pulsatile nature of blood flow creates a pulse wave that is propagated down the arterial tree, and at bifurcations reflected waves rebound to return to semilunar valves and the origin of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". These return waves create the dicrotic notch displayed in the aortic pressure curve during the cardiac cycle as these reflected waves push on the aortic semilunar valve. With \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta stiffens\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such that the pulse wave is propagated faster and reflected waves return to the heart faster before the semilunar valve closes, which raises the blood pressure. The stiffness of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is associated with a number of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diseases and pathologies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and noninvasive measures of the pulse wave velocity are an independent indicator of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Measuring the pulse wave velocity (invasively and non-invasively) is a means of determining arterial stiffness. Maximum aortic velocity may be noted as Vmax or less commonly as AoVmax. Mean arterial pressure (MAP) is highest in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", and the MAP decreases across the circulation from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to arteries to arterioles to capillaries to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    veins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " back to atrium. The difference between aortic and right atrial pressure accounts for blood flow in the circulation. When the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " contracts to force blood into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " expands. This stretching gives the potential energy that will help maintain blood pressure during diastole, as during this time the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " contracts passively. This Windkessel effect of the great elastic arteries has important biomechanical implications. The elastic recoil helps conserve the energy from the pumping heart and smooth out the pulsatile nature created by the heart. Aortic pressure is highest at the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and becomes less pulsatile and lower pressure as blood vessels divide into arteries, arterioles, and capillaries such that flow is slow and smooth for gases and nutrient exchange. Clinical significance Aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aneurysm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " – \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mycotic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", bacterial (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    syphilis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), senile, genetic, associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valvular heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coarctation – pre-ductal\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", post-ductal Aortic dissection Aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Abdominal aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aneurysm Aortitis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inflammation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " that can be seen in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    trauma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infections\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    autoimmune disease Atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ehlers–Danlos syndrome Marfan syndrome Trauma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    traumatic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " aortic rupture, most often thoracic and distal to the left subclavian artery and often quickly fatal Transposition of the great vessels, see also dextro-Transposition of the great arteries and levo-Transposition of the great arteries Other animals All amniotes have a broadly similar arrangement to that of humans, albeit with a number of individual variations. In fish, however, there are two separate vessels referred to as aortas. The ventral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " carries de-oxygenated blood from the heart to the gills; part of this vessel forms the ascending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " in tetrapods (the remainder forms the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       "). A second, dorsal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " carries oxygenated blood from the gills to the rest of the body and is homologous with the descending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " of tetrapods. The two aortas are connected by a number of vessels, one passing through each of the gills. Amphibians also retain the fifth connecting vessel, so that the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " has two parallel arches. History The word \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " stems from the Late Latin \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " from Classical Greek aortē (ἀορτή), from aeirō, &quot;&quot;I lift, raise&quot;&quot; (ἀείρω) This term was first applied by Aristotle when describing the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and describes accurately how it seems to be &quot;&quot;suspended&quot;&quot; above the heart.The function of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is documented in the Talmud, where it is noted as one of three major vessels entering or leaving the heart, and where \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    perforation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is linked to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". References External links  The dictionary definition of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " at Wiktionary  Media related to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " at Wikimedia Commons&quot; &quot;The aortic bodies are one of several small clusters of peripheral chemoreceptors located along the aortic arch. They are important in measuring partial pressures of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the blood, and blood pH. Structure The aortic bodies are collections of chemoreceptors present on the aortic arch. Most are located above the aortic arch, while some are located on the posterior side of the aortic arch between it and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " below. They consist of glomus cells and sustentacular cells.Some sources equate the &quot;&quot;aortic bodies&quot;&quot; and &quot;&quot;paraaortic bodies&quot;&quot;, while other sources explicitly distinguish between the two. When a distinction is made, the &quot;&quot;aortic bodies&quot;&quot; are chemoreceptors which regulate the circulatory system, while the &quot;&quot;paraaortic bodies&quot;&quot; are the chromaffin cells which manufacture \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    catecholamines\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Function The aortic bodies measure changes in blood pressure and the composition of arterial blood flowing past it. These changes may include: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " partial pressure. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " partial pressure. pH (indirectly affected by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " concentration).They are particularly sensitive to changes in pH. Aortic bodies are more sensitive detectors of total arterial blood \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " content than the carotid body chemoreceptors, which are more sensitive detectors of the partial pressure of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the arterial blood.The aortic bodies give feedback to the medulla oblongata, specifically to the dorsal respiratory group, via the afferent branches of the vagus nerve (cranial nerve X). The medulla oblongata, in turn, regulates breathing and blood pressure. Clinical significance A \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    paraganglioma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", also known as a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chemodectoma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", is a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tumor\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that may involve an aortic body.Swelling can also occur. See also Carotid body Control of respiration Peripheral chemoreceptors  == References ==&quot; &quot;Central aortic blood pressure (CAP or CASP) is the blood pressure at the root of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Studies have shown the importance of central aortic pressure and its implications in assessing the efficacy of antihypertensive treatment with respect to cardiovascular risk factors. The traditional method of measuring blood pressure in the arms has been shown to underestimate the efficacy of medications such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amlodipine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and overestimate the efficacy of those like \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atenolol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". A clinical trial demonstrated that different medications for lowering blood pressure have different effects on the central aortic pressure and blood flow characteristics, despite producing similar branchial blood pressure readings. The study also indicated that the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CAP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is a better independent predictor of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiovascular and kidney outcomes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". References Further reading CAFE - The Conduit Artery Functional Endpoint Study Lehmann ED (February 2001). &quot;&quot;Where is the evidence that radial artery tonometry can be used with a generalised transfer function to accurately and non-invasively predict central aortic blood pressure?&quot;&quot;. Journal of Human \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". 15 (2): 145–6. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    doi:10.1038/sj.jhh.1001126\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". PMID 11317196. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Williams B\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", Lacy \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    PS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Thom SM,  et al. (March 2006). &quot;&quot;Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study&quot;&quot;. Circulation. 113 (9): 1213–25. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    doi:10.1161/CIRCULATIONAHA.105.595496\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". PMID 16476843. Roman MJ, Devereux RB, Kizer JR,  et al. (July 2007). &quot;&quot;Central pressure more strongly relates to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    vascular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and outcome than does brachial pressure: the Strong Heart Study&quot;&quot;. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". 50 (1): 197–203. CiteSeerX 10.1.1.486.1588. doi:10.1161/HYPERTENSIONAHA.107.089078. PMID 17485598. McGhee BH, Bridges EJ (April 2002). &quot;&quot;Monitoring arterial blood pressure: what you may not know&quot;&quot;. Critical Care Nurse. 22 (2): 60–4, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    66–70\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", 73 passim. PMID 11961944.&quot; &quot;An aortic sinus, also known as a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sinus of Valsalva\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", is one of the anatomic dilations of the ascending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", which occurs just above the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". These widenings are between the wall of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and each of the three cusps of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Structure There are generally three aortic sinuses, one anterior and two posterior sinuses. These give rise to coronary arteries: The left posterior aortic sinus gives rise to the left coronary artery. The anterior aortic sinus gives rise to the right coronary artery. The right posterior aortic sinus usually gives rise to no vessels, and is often known as the non-coronary sinus.The aortic sinuses are typically more prominent than the pulmonary sinuses. Clinical significance If the coronary arteries arise from the wrong aortic sinuses, this can put the heart's ventricles at risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". This is often only discovered when a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       " has already occurred, usually before the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of 20 and during \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ". Names Each aortic sinus can also be referred to as the sinus of Valsalva, the sinus of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Morgagni\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the sinus of Mehta, the sinus of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Otto\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or Petit's sinus. See also \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aneurysm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sinus of Valsalva References External links Anatomy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    photo:20:29\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "-0108 at the SUNY Downstate Medical Center - &quot;&quot;Heart: The Aortic Valve and Aortic Sinuses&quot;&quot;&quot; &quot;The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is a valve in the heart of humans and most other animals, located between the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". It is one of the four valves of the heart and one of the two semilunar valves, the other being the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " normally has three cusps or leaflets, although in 1–2% of the population it is found to congenitally have two leaflets. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is the last structure in the heart the blood travels through before stopping the flow through the systemic circulation. Structure The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " normally has three cusps however there is some discrepancy in their naming. They may be called the left coronary, right coronary and non-coronary cusp. Some sources also advocate they be named as a left, right and posterior cusp. Anatomists have traditionally named them the left posterior (origin of left coronary), anterior (origin of the right coronary) and right posterior.The three cusps, when the valve is closed, contain a sinus called an aortic sinus or sinus of Valsalva. In two of these cusps, the origin of the coronary arteries are found. The width of the sinuses in cross-section is wider than the left ventricular outflow tract as well as wider than the ascending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The junction of the sinuses with the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is called the sinotubular junction. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is located posterior to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the commissure where the anterior two cusps join together points toward the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". It is these two sinuses that contain the origin of the coronary arteries. In the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " known as transposition of the great arteries, these two valves are reversed (the anterior valve is the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ") and the origin of the coronaries still follows this &quot;&quot;rule&quot;&quot; that the origins are in the sinuses facing the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The term &quot;&quot;semilunar&quot;&quot; refers to an approximate half-moon shape of the valve leaflets. Function When the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " contracts (systole), pressure rises in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". When the pressure in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " rises above the pressure in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " opens, allowing blood to exit the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". When ventricular systole ends, pressure in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " rapidly drops. When the pressure in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " decreases, the momentum of the vortex at the outlet of the valve forces the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to close. The closure of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " contributes the A2 component of the second heart sound (S2). Insufficiency Closure of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " permits maintaining high pressures in the systemic circulation while reducing pressure in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to permit blood flow from the lungs to fill the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Abrupt loss of function\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " results in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute aortic insufficiency\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and loss in the normal diastolic blood pressure resulting in a wide pulse pressure and bounding pulses. The endocardium perfuses during diastole and so \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    acute aortic insufficiency\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can reduce perfusion of the heart. Consequently, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary edema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can develop. Slowly worsening aortic insufficiency results in a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic insufficiency\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " which permits the heart to compensate (unlike acute insufficiency). This compensation is through \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and return to normal filling pressures. Stenosis Inadequate opening of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", often through \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcification\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", results in higher flow velocities through the valve and larger pressure gradients. Diagnosis of aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is contingent upon quantification of this gradient. This condition also results in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Clinical significance A normally functioning valve permits normal physiology and dysfunction of the valve results in left \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Dysfunctional aortic valves often\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " present as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " by non-specific symptoms such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatigue\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", low energy, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shortness of breath\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with exertion. Common causes of aortic regurgitation include vasodilation of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", previous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rheumatic fever\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infective endocarditis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    degeneration of the aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Marfan's syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can also be caused by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rheumatic fever\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    degenerative calcification\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The most common \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital heart defect\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the bicuspid \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " (fusion of two cusps together) commonly found in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Turner syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Once diagnosed, the two options are to repair or replace the valve. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " repair \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " repair or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " reconstruction describes the reconstruction of both form and function of the native and dysfunctioning \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Most frequently it is applied for the treatment of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic regurgitation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It can also become necessary for the treatment of aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aneurysm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or less frequently for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " replacement Replacement of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is done by replacing the native valve with a prosthetic valve. Traditionally, this has been a surgical procedure (surgical AVR or SAVR) but a non-surgical option called transcatheter \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " replacement (TAVR) or TAVI transcatheter \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " implantation delivers a prosthetic valve through a catheter. The choice between SAVR and TAVR often relies on the open-heart surgical risk and indications for other open heart surgeries (etc., coronary bypass, other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valve dysfunction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). The Bentall procedure is a type of surgical procedure when the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", aortic root, and ascending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " are replaced in a single operation. There are two basic types of artificial heart valve: mechanical and tissue. Mechanical valves are made of metal and have evolved over time (&quot;&quot;ball and cage&quot;&quot;, &quot;&quot;bileaflet&quot;&quot;). Mechanical valves require lifelong anticoagulation to avoid forming blood clots on the valves that can lead to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    embolism\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " often resulting in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". These tend to be favored in younger individuals as they typically last longer than tissue valves. The shape of these valves do not mimic normal heart valves. Tissue heart valves are usually made from animal tissues, either animal heart valve tissue or animal pericardial tissue, and commonly porcine. The tissue is pretreated by removing antigens to prevent rejection and to prevent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcification\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". These valves tend to model after normal valves by having leaflets that form cusps and sinuses.There are alternatives to animal tissue valves. In some cases, a human \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " can be implanted. These are called homografts. Homograft valves are donated by patients and recovered after the patient expires. The durability of homograft valves is probably the same as for porcine tissue valves. Another procedure for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " replacement is the Ross procedure (after Donald Ross) or pulmonary autograft. The Ross procedure involves going to surgery to have the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " removed and replacing it with the patient's own \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". A pulmonary homograft (a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " taken from a cadaver) or a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valvular prothesis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is then used to replace the patient's own \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The first minimally invasive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " surgery took place at the Cleveland Clinic in 1996. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Endocarditis Endocarditis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection of the heart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and this often results in vegetations growing on valves. While it is possible for it to affect the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", it is not the most likely spot. Evaluation Evaluation of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " can be done with several modalities. Auscultation with a stethoscope is quick and easy. It contributes the A2 component to the second heart sound and changes with inspiration (&quot;&quot;splitting&quot;&quot;) Transthoracic echocardiography (TTE) is used as the first test because it is non-invasive. Using TTE, the degree of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insufficiency\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be quantified to grade the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valve dysfunction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Transesophageal echocardiography is less often used for aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " &amp; \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insufficiency\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " because the angle between the probe and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is not optimal (the best window is a transgastric view). MRI and CT can be used to evaluate the valve, but much less commonly than TTE. Quantification of the maximum velocity through the valve, the area of the opening of the valve, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcification\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", morphology (tricuspid, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bicuspid, unicuspid)\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and size of the valve (annulus, sinuses, sinotubular junction) are common parameters when evaluating the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Invasive measurement of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " can be done during a cardiac catheterization in which the pressure in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " can be measured simultaneously. Additional images References External links Anatomy figure: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    20:07\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "-02 at Human Anatomy Online, SUNY Downstate Medical Center&quot; &quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " area calculation is an indirect method of determining the area of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " area). The calculated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " orifice area is currently one of the measures for evaluating the severity of aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". A valve area of less than 1.0 cm2 is considered to be severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".There are many ways to calculate the valve area of aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  The most commonly used methods involve measurements taken during echocardiography. For interpretation of these values, the area is generally divided by the body surface area, to arrive at the patient's optimal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " orifice area. Planimetry Planimetry is the tracing out of the opening of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " in a still image obtained during echocardiographic acquisition during ventricular systole, when the valve is supposed to be open.  While this method directly measures the valve area, the image may be difficult to obtain due to artifacts during echocardiography, and the measurements are dependent on the technician who has to manually trace the perimeter of the open \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Because of these reasons, planimetry of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is not routinely performed. The continuity equation The continuity equation states that the flow in one area must equal the flow in a second area if there are no shunts between the two areas.  In practical terms, the flow from the left ventricular outflow tract (LVOT) is compared to the flow at the level of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". In echocardiography the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " area is calculated using the velocity time integral (VTI) which is the most accurate method and preferred.  The flow through the LVOT, or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LV stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume (in cm3), can be calculated by measuring the LVOT diameter (in cm), squaring that value, multiplying the value by 0.78540 (which is π/4) giving a cross sectional area of the LVOT (in cm2) and multiplying that value by the LVOT VTI (in cm), measured on the spectral Doppler display using pulsed-wave Doppler.  From these, it is easy to calculate the area (in cm2) of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " by simply dividing the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LV stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume (in cm3) by the AV VTI (in cm) measured on the spectral Doppler display using continuous-wave Doppler.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume = 0.785(π/4) x Diameter2 x VTI of LVOT Cross sectional area of LVOT = 0.785(π/4) x LVOT \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diameter2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "                                                Aortic Valve Area (in cm                                   2                                        )                  =                                                                                    LVOT diameter                                                     2                                               ⋅               0.78540               ⋅                                LVOT VTI                                                        Aortic Valve VTI                                                  {\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    \\displaystyle {\\text{Aortic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Valve Area (in cm}}^{2}{\\text{)}}={{\\text{LVOT diameter}}^{2}\\cdot 0.78540\\cdot {\\text{LVOT VTI}} \\over {\\text{Aortic Valve VTI}}}}    The weakest aspect of this calculation is the variability in measurement of LVOT area, because it involves squaring the LVOT dimension. Therefore, it is crucial for the sonographer to take great care in measuring the LVOT diameter.The measurement using echocardiogram may be inaccurate in cases of Aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    subvalvular stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", because there is not a uniform diameter, as assumed during echocardiogram.  The viewpoint of the echocardiogram may distort the true diameter of the LVOT in some patients.  For verification purposes of the obtained valve area using echocardiogram and doppler measures, especially if the obtained valve area is in the range requiring surgery and cardiac output is low, the Gold standard of left heart catheterization for true hemodynamics should be obtained for validation using the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gorlin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " formula, so patient does not go for unneeded surgery. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gorlin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " equation The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gorlin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " equation states that the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " area is equal to the flow through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " during ventricular systole divided by the systolic pressure gradient across the valve times a constant.  The flow across the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is calculated by taking the cardiac output (measured in liters per minute) and dividing it by the heart rate (to give output per cardiac cycle) and then dividing it by the systolic ejection period measured in seconds per beat (to give flow per ventricular contraction).                                                Valve Area (in cm                                   2                                        )                  =                                                                 Cardiac Output                               (                                                   ml                   min                                               )                                                          Heart rate                               (                                                   beats                   min                                               )               ⋅                                Systolic ejection period (s)                              ⋅               44.3               ⋅                                                   mean Gradient (mmHg)                                                                                  {\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    \\displaystyle {\\text{Valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Area (in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cm}}^{2}{\\text{)}}={\\frac {{\\text{Cardiac Output }}({\\frac {\\text{ml}}{\\text{min}}})}{{\\text{Heart rate }}({\\frac {\\text{beats}}{\\text{min}}})\\cdot {\\text{Systolic ejection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " period (s)}}\\cdot 44.3\\cdot {\\sqrt {\\text{mean Gradient (mmHg)}}}}}}    The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gorlin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " equation is related to flow across the valve.  Because of this, the valve area may be erroneously calculated as stenotic if the flow across the valve is low (i.e. if the cardiac output is low).  The measurement of the true gradient is accomplished by temporarily increasing the cardiac output by the infusion of positive inotropic agents, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dobutamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The Hakki equation The Hakki equation is a simplification of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gorlin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " equation, relying on the observation that in most cases, the numerical value of                                   heart rate (bpm)                  ⋅                    systolic ejection period (s)                  ⋅         44.3         ≈         1000                 {\\displaystyle {\\text{heart rate \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    (bpm)}}\\cdot {\\text{systolic ejection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " period (s)}}\\cdot 44.3\\approx 1000}   . The resulting simplified formula is:                                                Aortic Valve area (in cm                                   2                                        )                  ≈                                                                 Cardiac Output                              (                                                   litre                   min                                               )                                         Peak to Peak Gradient (mmHg)                                                  {\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    \\displaystyle {\\text{Aortic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Valve area (in cm}}^{2}{\\text{)}}\\approx {\\frac {{\\text{Cardiac Output}}({\\frac {\\text{litre}}{\\text{min}}})}{\\sqrt {\\text{Peak to Peak Gradient (mmHg)}}}}} The Agarwal-Okpara-Bao equation The Agarwal-Okpara-Bao equation is a new form of AVA evaluation equation named after Ramesh K. Agarwal, Emmanuel c Okpara, and Guangyu Bao. It was derived from curve fitting of CFD simulation results and 80 clinical data obtained by Minners, Allgeier, Gohlke-Baerwolf, Kienzle, Neumann, and Jander  using a multi-objective genetic algorithm. The comparison of the results calculated from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Gorlin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Equation, Agarwal-Okpara-Bao Equation, and clinical data is shown in the figures on the right.                                                Valve Area (in cm                                   2                                        )                  =                                 (0.83                                   2                             +                                                                                    Q (                                                                                                 m                       l                                                                 m                       i                       n                                                                          )                              60                                                          0.35                               ⋅                                                   mean Gradient (dynes/cm2)                                                                                                  )                                   0.5                             −                    0.87                          {\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    \\displaystyle {\\text{Valve Area\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cm}}^{2}{\\text{)}}={\\text{(0.83}}^{2}+{\\frac {\\frac {{\\text{Q (}}{\\frac {ml}{min}})}{\\text{60}}}{{\\text{0.35 }}\\cdot {\\sqrt {\\text{mean Gradient (dynes/cm2)}}}}}{\\text{)}}^{\\text{0.5}}-{\\text{0.87}}}     == References\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ==&quot; &quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CVD</span>\n",
       "</mark>\n",
       " (AS or AoS) is the narrowing  of the exit of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " of the heart (where the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " begins), such that problems result. It may occur at the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " as well as above and below this level. It typically gets worse over time. Symptoms often come on gradually with a decreased ability to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " often occurring first. If \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    loss of consciousness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or heart related \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " occur due to AS the outcomes are worse. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Loss of consciousness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " typically occurs with standing or exercising. Signs of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shortness of breath\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " especially when lying down, at night, or with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ", and swelling of the legs. Thickening of the valve without narrowing is known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic sclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Causes include being born with a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bicuspid aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rheumatic fever\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; a normal valve may also harden over the decades. A bicuspid \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " affects about one to two percent of the population. As of 2014 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rheumatic heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " mostly occurs in the developing world. Risk factors are similar to those of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", high \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and being male. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " usually has three leaflets and is located between the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " of the heart, and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". AS typically results in a heart murmur. Its severity can be divided into mild, moderate, severe, and very severe, distinguishable by ultrasound scan of the heart.Aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is typically followed using repeated ultrasound scans. Once it has become severe, treatment primarily involves valve replacement surgery, with transcatheter \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " replacement (TAVR) being an option in some who are at high risk from surgery. Valves may either be mechanical or bioprosthetic, with each having risks and benefits. Another less invasive procedure, balloon aortic valvuloplasty (BAV), may result in benefit, but for only a few months. Complications such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be treated in the same way as in those with mild to moderate AS. In those with severe disease a number of medications should be avoided, including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nitroglycerin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and some beta blockers. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nitroprusside\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    phenylephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may be used in those with decompensated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " depending on the blood pressure.Aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the most common \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valvular heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the developed world. It affects about 2% of people who are over 65 years of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". Estimated rates were not known in most of the developing world as of 2014. In those who have symptoms, without repair the chance of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " at five years is about 50% and at 10 years is about 90%. Aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was first described by French physician Lazare \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Rivière\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in 1663. Signs and symptoms Symptoms related to aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " depend on the degree of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Most people with mild to moderate aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " do not have symptoms. Symptoms usually present in individuals with severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", though they may also occur in those with mild to moderate aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The three main symptoms of aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    loss of consciousness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", anginal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shortness of breath\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with activity or other symptoms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shortness of breath\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " while lying flat, episodes of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shortness of breath\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " at night, or swollen legs and feet. It may also be accompanied by the characteristic &quot;&quot;Dresden china&quot;&quot; appearance of pallor with a light flush. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CVD</span>\n",
       "</mark>\n",
       " in setting of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " also increases the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In people with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the 5-year mortality rate is 50% if the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is not replaced.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the setting of AS occurs due to left \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (LVH) that is caused by the constant production of increased pressure required to overcome the pressure gradient caused by the AS. While the muscular layer of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " thickens, the arteries that supply the muscle do not get significantly longer or bigger, so the muscle may not receive enough blood supply to meet its \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " requirement. This \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may first be evident during \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " when the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " requires increased blood supply to compensate for the increased workload.  The individual may complain of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anginal chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with exertion. At this stage, a cardiac \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " test with imaging may be suggestive of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Eventually, however, the heart muscle will require more blood supply at rest than can be supplied by the coronary artery branches. At this point there may be signs of ventricular strain pattern (ST segment \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and T wave inversion) on the EKG, suggesting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    subendocardial ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    subendocardium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is the region that is most susceptible to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " because it is the most distant from the epicardial coronary arteries. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Syncope Syncope\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fainting\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " spells) from aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valve stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is usually \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exertional\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In the setting of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " it increases the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In people with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    syncope\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the three-year mortality rate is 50% if the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is not replaced.It is unclear why \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CVD</span>\n",
       "</mark>\n",
       " causes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    syncope\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". One theory is that severe AS produces a nearly fixed cardiac output. When a person with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " exercises, their peripheral vascular resistance will decrease as the blood vessels of the skeletal muscles dilate to allow the muscles to receive more blood to allow them to do more work. This decrease in peripheral vascular resistance is normally compensated for by an increase in the cardiac output.  Since people with severe AS cannot increase their cardiac output, the blood pressure falls and the person will faint due to decreased blood perfusion to the brain.A second theory is that during \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " the high pressures generated in the hypertrophied \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " cause a vasodepressor response, which causes a secondary peripheral vasodilation that, in turn, causes decreased blood flow to the brain resulting in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    loss of consciousness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Indeed, in aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", because of the fixed obstruction to blood flow out from the heart, it may be impossible for the heart to increase its output to offset peripheral vasodilation.A third mechanism may sometimes be operative. Due to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " in aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", including the consequent inability of the coronary arteries to adequately supply blood to the myocardium (see &quot;&quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CVD</span>\n",
       "</mark>\n",
       "&quot;&quot; below), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abnormal heart rhythms\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may develop. These can lead to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    syncope\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Finally, in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcific aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " at least, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcification\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in and around the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " can progress and extend to involve the electrical conduction system of the heart. If that occurs, the result may be \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart block\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a potentially lethal condition of which \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    syncope\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be a symptom. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Congestive heart failure Congestive heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CHF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") carries a grave prognosis in people with AS. People with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CHF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " attributable to AS have a 2-year mortality rate of 50% if the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is not replaced. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    CHF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the setting of AS is due to a combination of left \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fibrosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    systolic dysfunction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (a decrease in the ejection fraction) and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diastolic dysfunction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (elevated filling pressure of the LV). Associated symptoms In \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heyde's syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gastrointestinal bleeding\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiodysplasia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the colon. Recent research has shown that the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " causes a form of von \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Willebrand disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " by breaking down its associated coagulation factor (factor VIII-associated antigen, also called von Willebrand factor), due to increased turbulence around the stenotic valve. Complications Notwithstanding the foregoing, the American Heart Association has recently changed its recommendations regarding antibiotic prophylaxis for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    endocarditis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Specifically, as of 2007 it is recommended that such prophylaxis should be limited only to those with prosthetic heart valves, those with previous episode(s) of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    endocarditis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and those with certain types of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Since the stenosed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " may limit the heart's output, people with aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are at risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    syncope\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and dangerously low blood pressure should they use any of a number of medications for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiovascular diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that often coexist with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Examples include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nitroglycerin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nitrates\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    terazosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hytrin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hydralazine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Note that all of these substances lead to peripheral vasodilation. Under normal circumstances, in the absence of aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the heart is able to increase its output and thereby offset the effect of the dilated blood vessels. In some cases of aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", however, due to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    obstruction of blood flow\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " out of the heart caused by the stenosed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", cardiac output cannot be increased. Low blood pressure or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    syncope\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may ensue. Causes Aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is most commonly caused by age-related progressive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcification\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (&gt;50% of cases), with a mean \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of 65 to 70 years. Another major cause of aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcification of a\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital bicuspid aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or, more rarely, a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital unicuspid aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Those with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unicuspid aortic valves typically\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " need intervention when very young, often as a newborn. While those with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital bicuspid aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " make up 30-40% of those presenting during adulthood and typically presenting earlier (ages 40+ to 50+) than those with tricuspid aortic valves (65+).Acute \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rheumatic fever\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " post-inflammatory is the cause of less than 10% of cases. Rare causes of aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Fabry disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    systemic lupus erythematosus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Paget disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood uric acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " levels, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Pathophysiology The human \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " normally consists of three cusps or leaflets and has an opening of 3.0-4.0 square centimeters. When the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " contracts, it forces blood through the valve into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and subsequently to the rest of the body. When the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " expands again, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " closes and prevents the blood in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " from flowing backward (regurgitation) into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". In aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the opening of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " becomes narrowed or constricted (stenotic) (e.g., due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcification\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). Degenerative (the most common variety), and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bicuspid aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " both begin with damage to endothelial cells from increased mechanical \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Inflammation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is thought to be involved in the earlier stages of the pathogenesis of AS and its associated risk factors are known to promote the deposition of LDL \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lipoprotein(a\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), a highly damaging substance, into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", causing significant damage and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " over time.As a consequence of this \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " must generate a higher pressure with each contraction to effectively move blood forward into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Initially, the LV generates this increased pressure by thickening its muscular walls (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). The type of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " most commonly seen in AS is known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    concentric hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", in which the walls of the LV are (approximately) equally thickened. In the later stages, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " dilates, the wall thins, and the systolic function deteriorates (resulting in impaired ability to pump blood forward). Morris and Innasimuthu et al. showed that different coronary anatomy is associated with different \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valve diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Research was in progress in 2010 to see if different coronary anatomy might lead to turbulent flow at the level of valves leading to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inflammation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and degeneration. Diagnosis Aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is most often diagnosed when it is asymptomatic and can sometimes be detected during routine examination of the heart and circulatory system. Good evidence exists to demonstrate that certain characteristics of the peripheral pulse can rule in the diagnosis. In particular, there may be a slow and/or sustained upstroke of the arterial pulse, and the pulse may be of low volume. This is sometimes referred to as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulsus parvus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " et tardus. There may also be a noticeable delay between the first heart sound (on auscultation) and the corresponding pulse in the carotid artery (so-called 'apical-carotid delay'). In a similar manner, there may be a delay between the appearance of each pulse in the brachial artery (in the arm) and the radial artery (in the wrist).The first heart sound may be followed by a sharp ejection sound (&quot;&quot;ejection click&quot;&quot;) best heard at the lower left sternal border and the apex, and, thus, appear to be &quot;&quot;split&quot;&quot;. The ejection sound, caused by the impact of left ventricular outflow against the partially fused \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " leaflets, is more commonly associated with a mobile bicuspid \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " than an immobile calcified \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The intensity of this sound does not vary with respiration, which helps distinguish it from the ejection click produced by a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenotic pulmonary valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which will diminish slightly in intensity during inspiration.An easily heard systolic, crescendo-decrescendo (i.e., 'ejection') murmur is heard loudest at the upper right sternal border, at the 2nd right intercostal space, and radiates to the carotid arteries bilaterally. The murmur increases with squatting and decreases with standing and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    isometric muscular contraction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as the Valsalva maneuver, which helps distinguish it from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertrophic obstructive cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    HOCM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). The murmur is louder during expiration but is also easily heard during inspiration. The more severe the degree of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the later the peak occurs in the crescendo-decrescendo of the murmur.The second heart sound (A2) tends to become decreased and softer as the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CVD</span>\n",
       "</mark>\n",
       " becomes more severe. This is a result of the increasing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcification of the valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " preventing it from &quot;&quot;snapping&quot;&quot; shut and producing a sharp, loud sound. Due to increases in left ventricular pressure from the stenotic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", over time the ventricle may \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", resulting in diastolic dysfunction. As a result, there may be a fourth heart sound due to the stiff ventricle. With continued increases in ventricular pressure, dilatation of the ventricle will occur, and a third heart sound may be manifest.Finally, aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " often co-exists with some degree of aortic insufficiency (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic regurgitation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). Hence, the physical exam in aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may also reveal signs of the latter, for example, an early diastolic decrescendo murmur. Indeed, when both \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valve abnormalities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are present, the expected findings of either may be modified or may not even be present. Rather, new signs that reflect the presence of simultaneous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    insufficiency\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", e.g., pulsus bisferiens, emerge.According to a meta-analysis, the most useful findings for ruling in aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the clinical setting were slow rate of rise of the carotid pulse (positive likelihood ratio ranged 2.8–130 across studies), mid to late peak intensity of the murmur (positive likelihood ratio, 8.0–101), and decreased intensity of the second heart sound (positive likelihood ratio, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    3.1–50).Other\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " peripheral signs include: sustained, heaving apex beat, which is not displaced unless \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    systolic dysfunction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " has developed A precordial thrill narrowed pulse pressure Electrocardiogram Although aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " does not lead to any specific findings on the electrocardiogram (ECG), it still often leads to a number of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    electrocardiographic abnormalities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". ECG manifestations of left \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (LVH) are common in aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and arise as a result of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " having placed a chronically \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high-pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " load on the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " (with LVH being the expected response to chronic pressure loads on the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " no matter what the cause).As noted above, the calcification process that occurs in aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can progress to extend beyond the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and into the electrical conduction system of the heart. Evidence of this phenomenon may rarely include ECG patterns characteristic of certain types of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart block\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as Left \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bundle branch block\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Heart catheterization Cardiac chamber catheterization provides a definitive diagnosis, indicating severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in valve area of &lt;1.0 cm2 (normally about 3 cm2). It can directly measure the pressure on both sides of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The pressure gradient may be used as a decision point for treatment. It is useful in symptomatic people before surgery. The standard for diagnosis of aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is non-invasive testing with echocardiography. Cardiac catheterization is reserved for cases in which there is a discrepancy between the clinical picture and non-invasive testing, due to risks inherent to crossing the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Echocardiogram Echocardiogram (heart ultrasound) is the best non-invasive way to evaluate the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " anatomy and function. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " area can be calculated non-invasively using echocardiographic flow velocities. Using the velocity of the blood through the valve, the pressure gradient across the valve can be calculated by the continuity equation or using the modified Bernoulli's equation: Gradient = 4(velocity)² mmHg A normal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " has a gradient of only a few mmHg. A decreased valvular area causes increased pressure gradient, and these parameters are used to classify and grade the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as mild, moderate or severe. The pressure gradient can be abnormally low in the presence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", co-existent aortic regurgitation and also \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischaemic heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (disease related to the decreased blood supply and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischemia).Echocardiogram\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may also show \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricular hypertrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", thickened and immobile \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", and dilated aortic root. However, it may appear deceptively normal in acute cases. Chest \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    X-ray A chest\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " X-ray can also assist in the diagnosis and provide clues as to the severity of the disease, showing the degree of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcification of the valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and in a chronic condition, an enlarged \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and atrium. Management Treatment is generally not necessary in people without symptoms. In moderate cases echocardiography is performed every 1–2 years to monitor the progression, possibly complemented with a cardiac \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " test. In severe cases, echocardiography is performed every 3–6 months. In both moderate and mild cases, the person should immediately make a revisit or be admitted for inpatient care if any new related symptoms appear. There are no therapeutic options currently available to treat people with aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valve stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; however, studies have indicated that the disease occurs as a result of active cellular processes, suggesting that targeting these processes may lead to viable therapeutic approaches. Medication The effect of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    statins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " on the progression of AS is unclear. The latest trials do not show any benefit in slowing AS progression, but did demonstrate a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    decrease in ischemic cardiovascular\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " events.In general, medical therapy has relatively poor efficacy in treating aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  However, it may be useful to manage commonly coexisting conditions that correlate with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ": Any \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is generally treated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    beta-blockers\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Drug</span>\n",
       "</mark>\n",
       " and/or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " blockers. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nitrates\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are contraindicated due to their potential to cause profound \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypotension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Any \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is treated aggressively, but caution must be taken in administering \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    beta-blockers\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Drug</span>\n",
       "</mark>\n",
       ". Any \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is generally treated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    digoxin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and diuretics, and, if not contraindicated, cautious administration of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".While observational studies demonstrated an association between lowered \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    statins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and decreased progression, a randomized clinical trial published in 2005 failed to find any effect on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcific aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". A 2007 study did find a slowing of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CVD</span>\n",
       "</mark>\n",
       " with the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    statin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " rosuvastatin. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " repair \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " repair or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " reconstruction describes the reconstruction of both form and function of the native and dysfunctioning \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Most frequently it is applied for the treatment of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic regurgitation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". It can also become necessary for the treatment of an aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aneurysm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", less frequently for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " replacement In adults, symptomatic severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " usually requires \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " replacement (AVR). While AVR has been the standard of care for aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " for several decades, as of 2016 \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " replacement approaches include open heart surgery, minimally invasive cardiac surgery (MICS) and minimally invasive catheter-based (percutaneous) \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " replacement. However, surgical \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " replacement is well-studied, and generally has a good and well-established longer-term prognosis.A diseased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is most commonly replaced using a surgical procedure with either a mechanical or a tissue valve. The procedure is done either in an open-heart surgical procedure or, in a smaller but growing number of cases, a minimally invasive cardiac surgery (MICS) procedure. Transcatheter \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " replacement Globally more than 250,000 people have received transcatheter \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " replacement (TAVR). For people who are not candidates for surgical valve replacement and most patients who are older than 75, TAVR may be a suitable alternative. Balloon valvuloplasty For infants and children, balloon valvuloplasty, where a balloon is inflated to stretch the valve and allow greater flow, may also be effective. In adults, however, it is generally ineffective, as the valve tends to return to a stenosed state. The surgeon will make a small incision at the top of the person's leg and proceed to insert the balloon into the artery. The balloon is then advanced up to the valve and is inflated to stretch the valve open. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart failure Acute decompensated heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " due to AS may be temporarily managed by an intra-aortic balloon pump while pending surgery. In those with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nitroprusside\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may be carefully used. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Phenylephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may be used in those with very low blood pressure. Prognosis If untreated, severe symptomatic aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " carries a poor prognosis with a 2-year mortality rate of 50-60% and a 3-year survival rate of less than 30%. Prognosis after \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " replacement for people who are younger than 65 is about five years less than that of the general population; for people older than 65 it is about the same. Epidemiology Approximately 2% of people over the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of 65, 3% of people over \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " 75, and 4% percent of people over \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " 85 have aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valve stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The prevalence is increasing with the aging population in North America and Europe.Risk factors known to influence disease progression of AS include lifestyle habits similar to those of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", advanced \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", being male, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hyperlipidemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes mellitus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", cigarette \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    metabolic syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    end-stage kidney disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". History Aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was first described by French physician Lazare \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Rivière\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in 1663. Research People on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bisphosphonates\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " were found in a 2010 study to have less progression of aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and some regressed. This finding led to multiple trials, ongoing as of 2012. Subsequent research failed to confirm the initial positive result. References External links Aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " at Curlie Bonow, Robert O.; Brown, Alan S.; Gillam, Linda D.; Kapadia, Samir R.; Kavinsky, Clifford J.; Lindman, Brian R.; Mack, Michael J.; Thourani, Vinod H. (October 2017). &quot;&quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " 2017 Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis&quot;&quot;. Journal of the American College of Cardiology. 70 (20): 2566–2598. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    doi:10.1016/j.jacc.2017.09.018\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". PMID 29054308.&quot; &quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (lit. 'ruling reptiles') is a clade of diapsids, with birds and crocodilians as the only living representatives. Archosaurs are broadly classified as reptiles, in the cladistic sense of term which includes birds. Extinct archosaurs include non-avian dinosaurs, pterosaurs, and extinct relatives of crocodilians. Modern paleontologists define \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as a crown group that includes the most recent common ancestor of living birds and crocodilians, and all of its descendants. The base of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " splits into two clades: Pseudosuchia, which includes crocodilians and their extinct relatives, and Avemetatarsalia, which includes birds and their extinct relatives (such as non-avian dinosaurs and pterosaurs).Older definitions of the group \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " rely on shared morphological characteristics, such as an antorbital fenestra in the skull, serrated teeth, and an upright stance. Some extinct reptiles, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    proterosuchids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and euparkeriids, possessed these features yet originated prior to the split between the crocodilian and bird lineages. The older morphological definition of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " nowadays roughly corresponds to Archosauriformes, a group named to encompass crown-group archosaurs and their close relatives. The oldest true archosaur fossils are known from the Early Triassic period, though the first archosauriforms and archosauromorphs (reptiles closer to archosaurs than to lizards or other lepidosaurs) appeared in the Permian. Archosaurs quickly diversified in the aftermath of the Permian-Triassic mass extinction (~252 Ma), becoming the largest and most ecologically dominant terrestrial vertebrates from the Middle Triassic period up until the K-Pg mass extinction (~66 Ma). Birds and several crocodyliform lineages were the only archosaurs to survive the K-Pg extinction, rediversifying in the subsequent Cenozoic era. Birds in particular have become among the most species-rich groups of terrestrial vertebrates in the present day. Distinguishing characteristics Archosaurs can traditionally be distinguished from other tetrapods on the basis of several synapomorphies, or shared characteristics, which were present in their last common ancestor. Many of these characteristics appeared prior to the origin of the clade \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", as they were present in archosauriforms such as Proterosuchus and Euparkeria, which were outside the crown group.The most obvious features include teeth set in deep sockets, antorbital and mandibular fenestrae (openings in front of the eyes and in the jaw, respectively), and a pronounced fourth trochanter (a prominent ridge on the femur). Being set in sockets, the teeth were less likely to be torn loose during feeding. This feature is responsible for the name &quot;&quot;thecodont&quot;&quot; (meaning &quot;&quot;socket teeth&quot;&quot;), which early paleontologists applied to many Triassic archosaurs. Additionally, non-muscular cheek and lip tissue appear in various forms throughout the clade, with all living archosaurs lacking non-muscular lips, unlike most non-avian saurischian dinosaurs. Some archosaurs, such as birds, are secondarily toothless. Antorbital fenestrae reduced the weight of the skull, which was relatively large in early archosaurs, rather like that of modern crocodilians. Mandibular fenestrae may also have reduced the weight of the jaw in some forms. The fourth trochanter provides a large site for the attachment of muscles on the femur. Stronger muscles allowed for erect gaits in early archosaurs, and may also be connected with the ability of the archosaurs or their immediate ancestors to survive the catastrophic Permian-Triassic extinction event. Origins Archosaurs are a subgroup of archosauriforms, which themselves are a subgroup of archosauromorphs. Both the oldest archosauromorph (Protorosaurus speneri) and the oldest archosauriform (Archosaurus rossicus) lived in the late Permian. The oldest true archosaurs appeared during the Olenekian stage (247-251 Ma) of the Early Triassic. A few fragmentary fossils of large carnivorous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    crocodilian-line\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " archosaurs (informally termed &quot;&quot;rauisuchians&quot;&quot;) are known from this stage. These include Scythosuchus and Tsylmosuchus (both of which have been found in Russia), as well as the Xilousuchus, a ctenosauriscid from China. The oldest known fossils of bird-line archosaurs are from the Anisian stage (247-242 Ma) of Tanzania, and include Asilisaurus (an early silesaurid), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Teleocrater\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (an aphanosaur), and Nyasasaurus (a possible early dinosaur). Archosaur takeover in the Triassic Synapsids are a clade that includes mammals and their extinct ancestors. The latter group, which are often referred to as mammal-like reptiles but should be termed protomammals, stem mammals, or basal synapsids because they are not true reptiles by modern cladistic classification, were the dominant land vertebrates throughout the Permian, but most perished in the Permian–Triassic extinction event. Very few large synapsids survived the event, and one form, Lystrosaurus (a herbivorous dicynodont), attained a widespread distribution soon after the extinction. Instead, archosaurs and other archosauriforms quickly became the dominant land vertebrates in the early Triassic. Fossils from before the mass extinction have only been found around the Equator, but after the event fossils can be found all over the world. The three most commonly suggested explanations for this are: Archosaurs made more rapid progress towards erect limbs than synapsids, and this gave them greater stamina by avoiding Carrier's constraint. An objection to this explanation is that archosaurs became dominant while they still had sprawling or semi-erect limbs, similar to those of Lystrosaurus and other synapsids. Archosaurs have more efficient respiratory systems featuring unidirectional air flow. Dr. Peter Ward suggests this may have proven advantageous in a suspected drop in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels at the end of the Permian. The Early Triassic was predominantly arid, because most of the Earth's land was concentrated in the supercontinent Pangaea. Archosaurs were probably better at conserving water than early synapsids because: Modern diapsids (lizards, snakes, crocodilians, birds) excrete \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    uric acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which can be excreted as a paste, resulting in low water loss as opposed to a more dilute urine. It is reasonable to suppose that archosaurs (the ancestors of crocodilians, dinosaurs and pterosaurs) also excreted \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    uric acid\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and therefore were good at conserving water. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aglandular (glandless)\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " skins of diapsids would also have helped to conserve water. Modern mammals excrete \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    urea\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", which requires a relatively high urinary rate to keep it from leaving the urine by diffusion in the kidney tubules. Their skins also contain many glands, which also lose water. Assuming that early synapsids had similar features, e.g., as argued by the authors of Palaeos, they were at a disadvantage in a mainly arid world. The same well-respected site points out that &quot;&quot;for much of Australia's Plio-Pleistocene history, where conditions were probably similar, the largest terrestrial predators were not mammals but gigantic varanid lizards (Megalania) and land crocs.&quot;&quot;However, this theory has been questioned, since it implies synapsids were necessarily less advantaged in water retention, that synapsid decline coincides with climate changes or archosaur diversity (neither of which tested) and the fact that desert dwelling mammals are as well adapted in this department as archosaurs, and some cynodonts like Trucidocynodon were large sized predators. A study favors competition amidst mammaliaforms as the main explanation for Mesozoic mammals being small. Main forms Since the 1970s, scientists have classified archosaurs mainly on the basis of their ankles. The earliest archosaurs had &quot;&quot;primitive mesotarsal&quot;&quot; ankles: the astragalus and calcaneum were fixed to the tibia and fibula by sutures and the joint bent about the contact between these bones and the foot. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pseudosuchia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " appeared early in the Triassic. In their ankles, the astragalus was joined to the tibia by a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    suture\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and the joint rotated round a peg on the astragalus which fitted into a socket in the calcaneum. Early &quot;&quot;crurotarsans&quot;&quot; still walked with sprawling limbs, but some later crurotarsans developed fully erect limbs. Modern crocodilians are crurotarsans that can walk with their limbs sprawling or erect depending on speed of locomotion.Euparkeria and the Ornithosuchidae had &quot;&quot;reversed crurotarsal&quot;&quot; ankles, with a peg on the calcaneum and socket on the astragalus. The earliest fossils of Avemetatarsalia (&quot;&quot;bird ankles&quot;&quot;) appear in the Anisian \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " of the Middle Triassic. Most Ornithodirans had &quot;&quot;advanced mesotarsal&quot;&quot; ankles. This form of ankle incorporated a very large astragalus and very small calcaneum, and could only move in one plane, like a simple hinge. This arrangement, which was only suitable for animals with erect limbs, provided more stability when the animals were running. The earliest avemetatarsalians, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Teleocrater\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and Asilisaurus, retained &quot;&quot;primitive mesotarsal&quot;&quot; ankles. The ornithodirans differed from other archosaurs in other ways: they were lightly built and usually small, their necks were long and had an S-shaped curve, their skulls were much more lightly built, and many ornithodirans were completely bipedal. The archosaurian fourth trochanter on the femur may have made it easier for ornithodirans to become bipeds, because it provided more leverage for the thigh muscles. In the late Triassic, the ornithodirans diversified to produce dinosaurs and pterosaurs. Classification Modern classification \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is normally defined as a crown group, which means that it only includes descendants of the last common ancestors of its living representatives. In the case of archosaurs, these are birds and crocodilians. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is within the larger clade Archosauriformes, which includes some close relatives of archosaurs, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    proterochampsids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and euparkeriids. These relatives are often referred to as archosaurs despite being placed outside of the crown group \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in a more basal position within Archosauriformes. Historically, many archosauriforms were described as archosaurs, including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    proterosuchids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and erythrosuchids, based on the presence of an antorbital fenestra. While many researchers prefer to treat \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as an unranked clade, some continue to assign it a traditional biological rank. Traditionally, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " has been treated as a Superorder, though a few 21st century researchers have assigned it to different ranks including Division and Class. History of classification \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as a term was first coined by American paleontologist Edward Drinker Cope in 1869, and included a wide range of taxa including dinosaurs, crocodilians, thecodonts, sauropterygians (which may be related to turtles), rhynchocephalians (a group that according to Cope included rhynchosaurs, which nowadays are considered to be more basal archosauromorphs, and tuataras, which are lepidosaurs), and anomodonts, which are now considered synapsids. It was not until 1986 that \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was defined as a crown-clade, restricting its use to more derived taxa. Cope's term was a Greek-Latin hybrid intended to refer to the cranial arches, but has later also been understood as &quot;&quot;leading reptiles&quot;&quot; or &quot;&quot;ruling reptiles&quot;&quot; by association with Greek ἀρχός &quot;&quot;leader, ruler&quot;&quot;.The term &quot;&quot;thecodont&quot;&quot;, now considered an obsolete term, was first used by the English paleontologist Richard Owen in 1859 to describe Triassic archosaurs, and it became widely used in the 20th century. Thecodonts were considered the &quot;&quot;basal stock&quot;&quot; from which the more advanced archosaurs descended. They did not possess features seen in later avian and crocodilian lines, and therefore were considered more primitive and ancestral to the two groups. With the cladistic revolution of the 1980s and 90s, in which cladistics became the most widely used method of classifying organisms, thecodonts were no longer considered a valid grouping. Because they are considered a &quot;&quot;basal stock&quot;&quot;, thecodonts are paraphyletic, meaning that they form a group that does not include all descendants of its last common ancestor: in this case, the more derived crocodilians and birds are excluded from &quot;&quot;Thecodontia&quot;&quot; as it was formerly understood. The description of the basal ornithodires Lagerpeton and Lagosuchus in the 1970s provided evidence that linked thecodonts with dinosaurs, and contributed to the disuse of the term &quot;&quot;Thecodontia&quot;&quot;, which many cladists consider an artificial grouping.With the identification of &quot;&quot;crocodilian normal&quot;&quot; and &quot;&quot;crocodilian reversed&quot;&quot; ankles by Sankar Chatterjee in 1978, a basal split in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was identified. Chatterjee considered these two groups to be Pseudosuchia with the &quot;&quot;normal&quot;&quot; ankle and Ornithosuchidae with the &quot;&quot;reversed&quot;&quot; ankle. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ornithosuchids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " were thought to be ancestral to dinosaurs at this time. In 1979, A.R.I. Cruickshank identified the basal split and thought that the crurotarsan ankle developed independently in these two groups, but in opposite ways. Cruickshank also thought that the development of these ankle types progressed in each group to allow advanced members to have semi-erect (in the case of crocodilians) or erect (in the case of dinosaurs) gaits. Phylogeny In many phylogenetic analyses, archosaurs have been shown to be a monophyletic grouping, thus forming a true clade. One of the first studies of archosaur phylogeny was authored by French paleontologist Jacques Gauthier in 1986. Gauthier split \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " into Pseudosuchia, the crocodilian line, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ornithosuchia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the dinosaur and pterosaur line. Pseudosuchia was defined as all archosaurs more closely related to crocodiles, while \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ornithosuchia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " was defined as all archosaurs more closely related to birds. Proterochampsids, erythrosuchids, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    proterosuchids\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " fell successively outside \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the resulting tree. Below is the cladogram from Gauthier (1986): In 1988, paleontologists Michael Benton and J.M. Clark produced a new tree in a phylogenetic study of basal archosaurs. As in Gauthier's tree, Benton and Clark's revealed a basal split within \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". They referred to the two groups as Crocodylotarsi and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ornithosuchia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Crocodylotarsi was defined as an apomorphy-based taxon based on the presence of a &quot;&quot;crocodile-normal&quot;&quot; ankle joint (considered to be the defining apomorphy of the clade). Gauthier's Pseudosuchia, by contrast, was a stem-based taxon. Unlike Gauthier's tree, Benton and Clark's places Euparkeria outside \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ornithosuchia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and outside the crown group \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " altogether.The clades Crurotarsi and Ornithodira were first used together in 1990 by paleontologist Paul Sereno and A.B. Arcucci in their phylogenetic study of archosaurs. They were the first to erect the clade Crurotarsi, while Ornithodira was named by Gauthier in 1986. Crurotarsi and Ornithodira replaced Pseudosuchia and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ornithosuchia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", respectively, as the monophyly of both of these clades were questioned. Sereno and Arcucci incorporated archosaur features other than ankle types in their analyses, which resulted in a different tree than previous analyses. Below is a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cladogram\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " based on Sereno (1991), which is similar to the one produced by Sereno and Arcucci: Ornithodira and Crurotarsi are both node-based clades, meaning that they are defined to include the last common ancestor of two or more taxa and all of its descendants. Ornithodira includes the last common ancestor of pterosaurs and dinosaurs (which include birds), while Crurotarsi includes the last common ancestor of living crocodilians and three groups of Triassic archosaurs: ornithosuchids, aetosaurs, and phytosaurs. These clades are not equivalent to &quot;&quot;bird-line&quot;&quot; and &quot;&quot;crocodile-line&quot;&quot; archosaurs, which would be \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    branch-based\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " clades defined as all taxa more closely related to one living group (either birds or crocodiles) than the other. Benton proposed the name Avemetatarsalia in 1999 to include all bird-line archosaurs (under his definition, all archosaurs more closely related to dinosaurs than to crocodilians). His analysis of the small Triassic archosaur Scleromochlus placed it within bird-line archosaurs but outside Ornithodira, meaning that Ornithodira was no longer equivalent to bird-line archosaurs. Below is a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cladogram\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " modified from Benton (2004) showing this phylogeny: In Sterling Nesbitt's 2011 monograph on early archosaurs, a phylogenetic analysis found strong support for phytosaurs falling outside \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Many subsequent studies supported this phylogeny. Because Crurotarsi is defined by the inclusion of phytosaurs, the placement of phytosaurs outside \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " means that Crurotarsi must include all of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Nesbitt reinstated Pseudosuchia as a clade name for crocodile-line archosaurs, using it as a stem-based taxon. Below is a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cladogram\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " modified from Nesbitt (2011): Extinction and survival Crocodylomorphs, pterosaurs and dinosaurs survived the Triassic–Jurassic extinction event about 200 million years ago, but other archosaurs had become extinct at or prior to the Triassic-Jurassic boundary. Non-avian dinosaurs and pterosaurs perished in the Cretaceous–Paleogene extinction event, which occurred approximately 66 million years ago, but crown-group birds (the only remaining dinosaur group) and many crocodyliforms survived. Both are descendants of archosaurs, and are therefore archosaurs themselves under phylogenetic taxonomy. Crocodilians (which include all modern crocodiles, alligators, and gharials) and birds flourish today in the Holocene. It is generally agreed that birds have the most species of all terrestrial vertebrates. Archosaur lifestyle \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hip joints\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and locomotion Like the early tetrapods, early archosaurs had a sprawling gait because their hip sockets faced sideways, and the knobs at the tops of their femurs were in line with the femur. In the early to middle Triassic, some archosaur groups developed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hip joints\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that allowed (or required) a more erect gait. This gave them greater stamina, because it avoided Carrier's constraint, i.e. they could run and breathe easily at the same time. There were two main types of joint which allowed erect legs: The hip sockets faced sideways, but the knobs on the femurs were at right angles to the rest of the femur, which therefore pointed downwards. Dinosaurs evolved from archosaurs with this hip arrangement. The hip sockets faced downwards and the knobs on the femurs were in line with the femur. This &quot;&quot;pillar-erect&quot;&quot; arrangement appears to have evolved independently in various archosaur lineages, for example it was common in &quot;&quot;Rauisuchia&quot;&quot; (non-crocodylomorph paracrocodylomorphs) and also appeared in some aetosaurs.It has been pointed out that an upright stance requires more energy, so it may indicate a higher metabolism and a higher body temperature. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " Most were large predators, but members of various lines diversified into other niches. Aetosaurs were herbivores and some developed extensive armor. A few crocodyliforms were herbivores, e.g., Simosuchus, Phyllodontosuchus. The large crocodyliform Stomatosuchus may have been a filter feeder. Sauropodomorphs and ornithischian dinosaurs were herbivores with diverse adaptations for feeding biomechanics. Land, water and air Archosaurs are mainly portrayed as land animals, but: Many phytosaurs and crocodyliforms dominated the rivers and swamps and even invaded the seas (e.g., the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    teleosaurs\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", Metriorhynchidae and Dyrosauridae). The Metriorhynchidae were rather dolphin-like, with paddle-like forelimbs, a tail \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fluke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and smooth, unarmoured skins. Two clades of ornithodirans, the pterosaurs and the birds, dominated the air after becoming adapted to a volant lifestyle. Metabolism The metabolism of archosaurs is still a controversial topic. They certainly evolved from cold-blooded ancestors, and the surviving non-dinosaurian archosaurs, crocodilians, are cold-blooded. But crocodilians have some features which are normally associated with a warm-blooded metabolism because they improve the animal's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " supply: 4-chambered hearts. Both birds and mammals have 4-chambered hearts, which completely separate the flows of oxygenated and de-oxygenated blood. Non-crocodilian reptiles have 3-chambered hearts, which are less efficient because they let the two flows mix and thus send some de-oxygenated blood out to the body instead of to the lungs. Modern crocodilians' hearts are 4-chambered, but are smaller relative to body size and run at lower pressure than those of modern birds and mammals. They also have a pulmonary bypass, which makes them functionally 3-chambered when under water, conserving \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". a secondary \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which allows the animal to eat and breathe at the same time. a hepatic piston mechanism for pumping the lungs. This is different from the lung-pumping mechanisms of mammals and birds, but similar to what some researchers claim to have found in some dinosaurs.Historically there has been uncertainty as to why natural selection favored the development of these features, which are very important for active warm-blooded creatures, but of little apparent use to cold-blooded aquatic ambush predators that spend the vast majority of their time floating in water or lying on river banks. Paleontological evidence shows that the ancestors of living crocodilians were active and endothermic (warm-blooded). Some experts believe that their archosaur ancestors were warm-blooded as well. This is likely because feather-like filaments evolved to cover the whole body and were capable of providing thermal insulation. Physiological, anatomical, and developmental features of the crocodilian heart support the paleontological evidence and show that the lineage reverted to ectothermy when it invaded the aquatic, ambush predator niche. Crocodilian embryos develop fully 4-chambered hearts at an early stage. Modifications to the growing heart form a pulmonary bypass shunt that includes the left aortic arch, which originates from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", the foramen of Panizza between the left and right aortic arches, and the cog‐tooth valve at the base of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The shunt is used during diving to make the heart function as 3-chambered heart, providing the crocodilian with the neurally controlled shunting used by ectotherms. The researchers concluded that the ancestors of living crocodilians had fully 4-chambered hearts, and were therefore warm-blooded, before they reverted to a cold-blooded or ectothermic metabolism. The authors also provide other evidence for endothermy in stem archosaurs. It is reasonable to suggest that later crocodilians developed the pulmonary bypass shunt as they became cold-blooded, aquatic, and less active. If the crocodilian ancestors and other Triassic archosaurs were warm-blooded, this would help to resolve some evolutionary puzzles: The earliest crocodylomorphs, e.g., Terrestrisuchus, were slim, leggy \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    terrestrial predators\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " whose build suggests a fairly active lifestyle, which requires a fairly fast metabolism. And some other crurotarsan archosaurs appear to have had erect limbs, while those of rauisuchians are very poorly adapted for any other posture. Erect limbs are advantageous for active animals because they avoid Carrier's constraint, but disadvantageous for more sluggish animals because they increase the energy costs of standing up and lying down. If early archosaurs were completely cold-blooded and (as seems most likely) dinosaurs were at least fairly warm-blooded, dinosaurs would have had to evolve warm-blooded metabolisms in less than half the time it took for synapsids to do the same. Respiratory system A recent study of the lungs of Alligator mississippiensis (the American alligator) has shown that the airflow through them is unidirectional, moving in the same direction during inhalation and exhalation. This is also seen in birds and many non-avian dinosaurs, which have air sacs to further aid in respiration. Both birds and alligators achieve unidirectional air flow through the presence of parabronchi, which are responsible for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " exchange. The study has found that in alligators, air enters through the second bronchial branch, moves through the parabronchi, and exits through the first bronchial branch. Unidirectional airflow in both birds and alligators suggests that this type of respiration was present at the base of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and retained by both dinosaurs and non-dinosaurian archosaurs, such as aetosaurs, &quot;&quot;rauisuchians&quot;&quot; (non-crocodylomorph paracrocodylomorphs), crocodylomorphs, and pterosaurs. The use of unidirectional airflow in the lungs of archosaurs may have given the group an advantage over synapsids, which had lungs where air moved tidally in and out through a network of bronchi that terminated in alveoli, which were cul-de-sacs. The better efficiency in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " transfer seen in archosaur lungs may have been advantageous during the times of low atmospheric \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " which are thought to have existed during the Mesozoic. Reproduction Most (if not all) archosaurs are oviparous. Birds and crocodilians lay hard-shelled eggs, as did extinct dinosaurs, and crocodylomorphs. Hard-shelled eggs are present in both dinosaurs and crocodilians, which has been used as an explanation for the absence of viviparity or ovoviviparity in archosaurs. However, both pterosaurs and baurusuchids have soft-shelled eggs, implying that hard shells are not a plesiomorphic condition. The pelvic anatomy of Cricosaurus and other metriorhynchids and fossilized embryos belonging to the non-archosaur archosauromorph Dinocephalosaurus, together suggest that the lack of viviparity among archosaurs may be a consequence of lineage-specific restrictions.Archosaurs are ancestrally superprecocial as evidenced in various dinosaurs, pterosaurs, and crocodylomorphs. However, parental care did evolve independently multiple times in crocodilians, dinosaurs, and aetosaurs. In most such species the animals bury their eggs and rely on temperature-dependent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sex\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " determination. The notable exception are Neornithes which incubate their eggs and rely on genetic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sex\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " determination – a trait that might have given them a survival advantage over other dinosaurs. See also 2021 in archosaur paleontology References Sources Benton, M. J. (2004). Vertebrate Paleontology (3rd ed.). Blackwell Science. Carroll, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    R. L. (1988)\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Vertebrate Paleontology and Evolution'. New York: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    W.\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " H. Freeman. ISBN 9780716718222. External links UCMP Paleos reviews the messy history of archosaur phylogeny (family tree) and has an excellent image of the various archosaur ankle types. Mikko's Phylogeny Archive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Archosauria\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "&quot; &quot;The heart is a muscular organ in most animals, which pumps blood through the blood vessels of the circulatory system. The pumped blood carries \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and nutrients to the body, while carrying metabolic waste such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to the lungs. In humans, the heart is approximately the size of a closed fist and is located between the lungs, in the middle compartment of the chest.In humans, other mammals, and birds, the heart is divided into four chambers: upper left and right atria and lower left and right ventricles. Commonly the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and ventricle are referred together as the right heart and their left counterparts as the left heart. Fish, in contrast, have two chambers, an atrium and a ventricle, while reptiles have three chambers. In a healthy heart blood flows one way through the heart due to heart valves, which prevent backflow. The heart is enclosed in a protective sac, the pericardium, which also contains a small amount of fluid. The wall of the heart is made up of three layers: epicardium, myocardium, and endocardium.The heart pumps blood with a rhythm determined by a group of pacemaker cells in the sinoatrial node. These generate a current that causes contraction of the heart, traveling through the atrioventricular node and along the conduction system of the heart. The heart receives blood low in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " from the systemic circulation, which enters the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " from the superior and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inferior venae cavae\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and passes to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". From here it is pumped into the pulmonary circulation, through the lungs where it receives \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and gives off \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Oxygenated blood then returns to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", passes through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and is pumped out through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to the systemic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    circulation−where\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is used and metabolized to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart beats\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " at a resting rate close to 72 beats per minute. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " temporarily increases the rate, but lowers resting heart rate in the long term, and is good for heart health.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiovascular diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (CVD) are the most common cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " globally as of 2008, accounting for 30% of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deaths\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Of these more than three-quarters are a result of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Risk factors include: \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", being overweight, little \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ", high \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", and poorly controlled \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", among others. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiovascular diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " frequently do not have symptoms or may cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shortness of breath\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Diagnosis of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is often done by the taking of a medical history, listening to the heart-sounds with a stethoscope, ECG, echocardiogram, and ultrasound. Specialists who focus on \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diseases of the heart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are called cardiologists, although many specialties of medicine may be involved in treatment. Structure Location and shape The human heart is situated in the mediastinum, at the level of thoracic vertebrae T5-T8. A double-membraned sac called the pericardium surrounds the heart and attaches to the mediastinum. The back surface of the heart lies near the vertebral column, and the front surface sits behind the sternum and rib cartilages. The upper part of the heart is the attachment point for several large blood vessels—the venae cavae, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary trunk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The upper part of the heart is located at the level of the third costal cartilage. The lower tip of the heart, the apex, lies to the left of the sternum (8 to 9 cm from the midsternal line) between the junction of the fourth and fifth ribs near their articulation with the costal cartilages.The largest part of the heart is usually slightly offset to the left side of the chest (though occasionally it may be offset to the right) and is felt to be on the left because the left heart is stronger and larger, since it pumps to all body parts. Because the heart is between the lungs, the left lung is smaller than the right lung and has a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac notch\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in its border to accommodate the heart. The heart is cone-shaped, with its base positioned upwards and tapering down to the apex. An adult heart has a mass of 250–350 grams (9–12 oz). The heart is often described as the size of a fist: 12 cm (5 in) in length, 8 cm (3.5 in) wide, and 6 cm (2.5 in) in thickness, although this description is disputed, as the heart is likely to be slightly larger. Well-trained athletes can have much larger hearts due to the effects of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " on the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", similar to the response of skeletal muscle. Chambers The heart has four chambers, two upper atria, the receiving chambers, and two lower ventricles, the discharging chambers. The atria open into the ventricles via the atrioventricular valves, present in the atrioventricular septum. This distinction is visible also on the surface of the heart as the coronary sulcus. There is an ear-shaped structure in the upper \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " called the right atrial appendage, or auricle, and another in the upper \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", the left atrial appendage. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " together are sometimes referred to as the right heart. Similarly, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " together are sometimes referred to as the left heart. The ventricles are separated from each other by the interventricular septum, visible on the surface of the heart as the anterior longitudinal sulcus and the posterior interventricular sulcus.The cardiac skeleton is made of dense connective tissue and this gives structure to the heart. It forms the atrioventricular septum, which separates the atria from the ventricles, and the fibrous rings, which serve as bases for the four heart valves. The cardiac skeleton also provides an important boundary in the heart's electrical conduction system since collagen cannot conduct electricity. The interatrial septum separates the atria, and the interventricular septum separates the ventricles. The interventricular septum is much thicker than the interatrial septum since the ventricles need to generate greater pressure when they contract. Valves The heart has four valves, which separate its chambers. One valve lies between each atrium and ventricle, and one valve rests at the exit of each ventricle.The valves between the atria and ventricles are called the atrioventricular valves. Between the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tricuspid valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tricuspid valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " has three cusps, which connect to chordae tendinae and three papillary muscles named the anterior, posterior, and septal muscles, after their relative positions. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " lies between the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". It is also known as the bicuspid valve due to its having two cusps, an anterior and a posterior cusp. These cusps are also attached via chordae tendinae to two papillary muscles projecting from the ventricular wall.The papillary muscles extend from the walls of the heart to valves by cartilaginous connections called chordae tendinae. These muscles prevent the valves from falling too far back when they close. During the relaxation phase of the cardiac cycle, the papillary muscles are also relaxed and the tension on the chordae tendineae is slight. As the heart chambers contract, so do the papillary muscles. This creates tension on the chordae tendineae, helping to hold the cusps of the atrioventricular valves in place and preventing them from being blown back into the atria. Two additional semilunar valves sit at the exit of each of the ventricles. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is located at the base of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". This has three cusps which are not attached to any papillary muscles. When the ventricle relaxes blood flows back into the ventricle from the artery and this flow of blood fills the pocket-like valve, pressing against the cusps which close to seal the valve. The semilunar \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is at the base of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and also is not attached to papillary muscles. This too has three cusps which close with the pressure of the blood flowing back from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Right heart The right heart consists of two chambers, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", separated by a valve, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tricuspid valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " receives blood almost continuously from the body's two major \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    veins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the superior and inferior venae cavae. A small amount of blood from the coronary circulation also drains into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " via the coronary sinus, which is immediately above and to the middle of the opening of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inferior vena cava\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In the wall of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is an oval-shaped \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " known as the fossa ovalis, which is a remnant of an opening in the fetal heart known as the foramen ovale. Most of the internal surface of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is smooth, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the fossa ovalis is medial, and the anterior surface has prominent ridges of pectinate muscles, which are also present in the right atrial appendage.The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is connected to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " by the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tricuspid valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The walls of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " are lined with trabeculae carneae, ridges of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " covered by endocardium. In addition to these muscular ridges, a band of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", also covered by endocardium, known as the moderator band reinforces the thin walls of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and plays a crucial role in cardiac conduction. It arises from the lower part of the interventricular septum and crosses the interior space of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to connect with the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inferior papillary muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " tapers into the pulmonary trunk, into which it ejects blood when contracting. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary trunk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " branches into the left and right pulmonary arteries that carry the blood to each lung. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " lies between the right heart and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary trunk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Left heart The left heart has two chambers: the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", separated by the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " receives oxygenated blood back from the lungs via one of the four pulmonary veins. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " has an outpouching called the left atrial appendage. Like the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is lined by pectinate muscles. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is connected to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " by the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is much thicker as compared with the right, due to the greater force needed to pump blood to the entire body. Like the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", the left also has trabeculae carneae, but there is no moderator band. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " pumps blood to the body through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Two small openings above the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " carry blood to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; the left coronary artery is above the left cusp of the valve,  and the right coronary artery is above the right cusp. Wall The heart wall is made up of three layers: the inner endocardium, middle myocardium and outer epicardium. These are surrounded by a double-membraned sac called the pericardium. The innermost layer of the heart is called the endocardium. It is made up of a lining of simple squamous epithelium and covers heart chambers and valves. It is continuous with the endothelium of the veins and arteries of the heart, and is joined to the myocardium with a thin layer of connective tissue. The endocardium, by secreting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    endothelins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", may also play a role in regulating the contraction of the myocardium. The middle layer of the heart wall is the myocardium, which is the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle—a\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " layer of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    involuntary striated muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " tissue surrounded by a framework of collagen. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " pattern is elegant and complex, as the muscle cells swirl and spiral around the chambers of the heart, with the outer muscles forming a figure 8 pattern around the atria and around the bases of the great vessels and the inner muscles, forming a figure 8 around the two ventricles and proceeding toward the apex. This complex swirling pattern allows the heart to pump blood more effectively.There are two types of cells in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ": muscle cells which have the ability to contract easily, and pacemaker cells of the conducting system. The muscle cells make up the bulk (99%) of cells in the atria and ventricles. These contractile cells are connected by intercalated discs which allow a rapid response to impulses of action potential from the pacemaker cells. The intercalated discs allow the cells to act as a syncytium and enable the contractions that pump blood through the heart and into the major arteries. The pacemaker cells make up 1% of cells and form the conduction system of the heart. They are generally much smaller than the contractile cells and have few myofibrils which gives them limited contractibility. Their function is similar in many respects to neurons. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiac muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " tissue has autorhythmicity, the unique ability to initiate a cardiac action potential at a fixed rate—spreading the impulse rapidly from cell to cell to trigger the contraction of the entire heart.There are specific proteins expressed in cardiac muscle cells. These are mostly associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscle contraction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and bind with actin, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tropomyosin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and troponin. They include MYH6, ACTC1, TNNI3, CDH2 and PKP2. Other proteins expressed are MYH7 and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    LDB3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " that are also expressed in skeletal muscle. Pericardium The pericardium is the sac that surrounds the heart. The tough outer surface of the pericardium is called the fibrous membrane. This is lined by a double inner membrane called the serous membrane that produces pericardial fluid to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lubricate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " the surface of the heart. The part of the serous membrane attached to the fibrous membrane is called the parietal pericardium, while the part of the serous membrane attached to the heart is known as the visceral pericardium. The pericardium is present in order to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    lubricate\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " its movement against other structures within the chest, to keep the heart's position stabilised within the chest, and to protect the heart from \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Coronary circulation Heart tissue, like all cells in the body, needs to be supplied with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", nutrients and a way of removing metabolic wastes. This is achieved by the coronary circulation, which includes arteries, veins, and lymphatic vessels. Blood flow through the coronary vessels occurs in peaks and troughs relating to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle's relaxation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or contraction.Heart tissue receives blood from two arteries which arise just above the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". These are the left main coronary artery and the right coronary artery. The left main coronary artery splits shortly after leaving the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " into two vessels, the left anterior descending and the left circumflex artery. The left anterior descending artery supplies heart tissue and the front, outer side, and septum of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". It does this by branching into smaller arteries—diagonal and septal branches. The left circumflex supplies the back and underneath of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The right coronary artery supplies the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", and lower posterior sections of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The right coronary artery also supplies blood to the atrioventricular node (in about 90% of people) and the sinoatrial node (in about 60% of people). The right coronary artery runs in a groove at the back of the heart and the left anterior descending artery runs in a groove at the front. There is significant variation between people in the anatomy of the arteries that supply the heart  The arteries divide at their furthest reaches into smaller branches that join together at the edges of each arterial distribution.The coronary sinus is a large vein that drains into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", and receives most of the venous drainage of the heart. It receives blood from the great \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac vein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (receiving the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and both ventricles), the posterior cardiac vein (draining the back of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       "), the middle cardiac vein (draining the bottom of the left and right ventricles), and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    small cardiac veins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The anterior cardiac veins drain the front of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and drain directly into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".Small lymphatic networks called plexuses exist beneath each of the three layers of the heart. These networks collect into a main left and a main right trunk, which travel up the groove between the ventricles that exists on the heart's surface, receiving smaller vessels as they travel up. These vessels then travel into the atrioventricular groove, and receive a third vessel which drains the section of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " sitting on the diaphragm. The left vessel joins with this third vessel, and travels along the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", ending in the inferior tracheobronchial node. The right vessel travels along the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the part of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " sitting on the diaphragm. It usually then travels in front of the ascending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and then ends in a brachiocephalic node. Nerve supply The heart receives nerve signals from the vagus nerve and from nerves arising from the sympathetic trunk. These nerves act to influence, but not control, the heart rate. Sympathetic nerves also influence the force of heart contraction. Signals that travel along these nerves arise from two paired cardiovascular centres in the medulla oblongata. The vagus nerve of the parasympathetic nervous system acts to decrease the heart rate, and nerves from the sympathetic trunk act to increase the heart rate. These nerves form a network of nerves that lies over the heart called the cardiac plexus.The vagus nerve is a long, wandering nerve that emerges from the brainstem and provides parasympathetic stimulation to a large number of organs in the thorax and abdomen, including the heart. The nerves from the sympathetic trunk emerge through the T1-T4 thoracic ganglia and travel to both the sinoatrial and atrioventricular nodes, as well as to the atria and ventricles. The ventricles are more richly innervated by sympathetic fibers than parasympathetic fibers. Sympathetic stimulation causes the release of the neurotransmitter \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    norepinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (also known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    noradrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") at the neuromuscular junction of the cardiac nerves. This shortens the repolarization period, thus speeding the rate of depolarization and contraction, which results in an increased heart rate. It opens chemical or ligand-gated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ion channels, allowing an influx of positively charged ions. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Norepinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " binds to the beta–1 receptor. Development The heart is the first functional organ to develop and starts to beat and pump blood at about three weeks into embryogenesis. This early start is crucial for subsequent embryonic and prenatal development. The heart derives from splanchnopleuric mesenchyme in the neural plate which forms the cardiogenic region. Two endocardial tubes form here that fuse to form a primitive heart tube known as the tubular heart. Between the third and fourth week, the heart tube lengthens, and begins to fold to form an S-shape within the pericardium. This places the chambers and major vessels into the correct alignment for the developed heart. Further development will include the formation of the septa and the valves and the remodeling of the heart chambers. By the end of the fifth week, the septa are complete, and by the ninth week, the heart valves are complete.Before the fifth week, there is an opening in the fetal heart known as the foramen ovale. The foramen ovale allowed blood in the fetal heart to pass directly from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", allowing some blood to bypass the lungs. Within seconds after birth, a flap of tissue known as the septum primum that previously acted as a valve closes the foramen ovale and establishes the typical cardiac circulation pattern. A \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    depression\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the surface of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " remains where the foramen ovale was, called the fossa ovalis. The embryonic heart begins beating at around 22 days after conception (5 weeks after the last normal menstrual period, LMP). It starts to beat at a rate near to the mother's which is about 75–80 beats per minute (bpm). The embryonic heart rate then accelerates and reaches a peak rate of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    165–185\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " bpm early in the early 7th week (early 9th week after the LMP). After 9 weeks (start of the fetal stage) it starts to decelerate, slowing to around 145 (±25) bpm at birth. There is no difference in female and male heart rates before birth. Physiology Blood flow The heart functions as a pump in the circulatory system to provide a continuous flow of blood throughout the body. This circulation consists of the systemic circulation to and from the body and the pulmonary circulation to and from the lungs. Blood in the pulmonary circulation exchanges \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the lungs through the process of respiration. The systemic circulation then transports \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to the body and returns \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and relatively deoxygenated blood to the heart for transfer to the lungs.The right heart collects deoxygenated blood from two large \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    veins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", the superior and inferior venae cavae. Blood collects in the right and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " continuously. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    superior vena cava\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " drains blood from above the diaphragm and empties into the upper back part of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inferior vena cava drains the blood\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from below the diaphragm and empties into the back part of the atrium below the opening for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    superior vena cava\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Immediately above and to the middle of the opening of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    inferior vena cava\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the opening of the thin-walled coronary sinus. Additionally, the coronary sinus returns deoxygenated blood from the myocardium to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The blood collects in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". When the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " contracts, the blood is pumped through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tricuspid valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". As the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " contracts, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tricuspid valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " closes and the blood is pumped into the pulmonary trunk through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary trunk\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " divides into pulmonary arteries and progressively smaller arteries throughout the lungs, until it reaches capillaries. As these pass by alveoli \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is exchanged for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". This happens through the passive process of diffusion. In the left heart, oxygenated blood is returned to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " via the pulmonary veins. It is then pumped into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " for systemic circulation. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is a large artery that branches into many smaller arteries, arterioles, and ultimately capillaries. In the capillaries, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and nutrients from blood are supplied to body cells for metabolism, and exchanged for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and waste products. Capillary blood, now deoxygenated, travels into venules and veins that ultimately collect in the superior and inferior vena cavae, and into the right heart. Cardiac cycle The cardiac cycle refers to the sequence of events in which the heart contracts and relaxes with every heartbeat. The period of time during which the ventricles contract, forcing blood out into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and main \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", is known as systole, while the period during which the ventricles relax and refill with blood is known as diastole. The atria and ventricles work in concert, so in systole when the ventricles are contracting, the atria are relaxed and collecting blood. When the ventricles are relaxed in diastole, the atria contract to pump blood to the ventricles. This coordination ensures blood is pumped efficiently to the body.At the beginning of the cardiac cycle, the ventricles are relaxing. As they do so, they are filled by blood passing through the open \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral and tricuspid valves\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". After the ventricles have completed most of their filling, the atria contract, forcing further blood into the ventricles and priming the pump. Next, the ventricles start to contract. As the pressure rises within the cavities of the ventricles, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral and tricuspid valves\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are forced shut. As the pressure within the ventricles rises further, exceeding the pressure with the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and pulmonary arteries, the aortic and pulmonary valves open. Blood is ejected from the heart, causing the pressure within the ventricles to fall. Simultaneously, the atria refill as blood flows into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " through the superior and inferior vena cavae, and into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " through the pulmonary veins. Finally, when the pressure within the ventricles falls below the pressure within the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and pulmonary arteries, the aortic and pulmonary valves close. The ventricles start to relax, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    mitral and tricuspid valves\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " open, and the cycle begins again. Cardiac output Cardiac output (CO) is a measurement of the amount of blood pumped by each ventricle (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume) in one minute. This is calculated by multiplying the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume (SV) by the beats per minute of the heart rate (HR). So that: CO = SV x HR. The cardiac output is normalized to body size through body surface area and is called the cardiac index. The average cardiac output, using an average \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume of about 70mL, is 5.25 L/min, with a normal range of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    4.0–8.0\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " L/min. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume is normally measured using an echocardiogram and can be influenced by the size of the heart, physical and mental condition of the individual, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sex\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", contractility, duration of contraction, preload and afterload.Preload refers to the filling pressure of the atria at the end of diastole, when the ventricles are at their fullest. A main factor is how long it takes the ventricles to fill: if the ventricles contract more frequently, then there is less time to fill and the preload will be less. Preload can also be affected by a person's blood volume. The force of each contraction of the heart muscle is proportional to the preload, described as the Frank-Starling mechanism. This states that the force of contraction is directly proportional to the initial length of muscle fiber, meaning a ventricle will contract more forcefully, the more it is stretched.Afterload, or how much pressure the heart must generate to eject blood at systole, is influenced by vascular resistance. It can be influenced by narrowing of the heart valves (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") or contraction or relaxation of the peripheral blood vessels.The strength of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " contractions controls the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume. This can be influenced positively or negatively by agents termed inotropes. These agents can be a result of changes within the body, or be given as drugs as part of treatment for a medical disorder, or as a form of life support, particularly in intensive care units. Inotropes that increase the force of contraction are &quot;&quot;positive&quot;&quot; inotropes, and include sympathetic agents such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    adrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    noradrenaline\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dopamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". &quot;&quot;Negative&quot;&quot; inotropes decrease the force of contraction and include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blockers. Electrical conduction The normal rhythmical heart beat, called sinus rhythm, is established by the heart's own pacemaker, the sinoatrial node (also known as the sinus node or the SA node). Here an electrical signal is created that travels through the heart, causing the heart muscle to contract. The sinoatrial node is found in the upper part of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " near to the junction with the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    superior vena cava\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The electrical signal generated by the sinoatrial node travels through the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " in a radial way that is not completely understood. It travels to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " via Bachmann's bundle, such that the muscles of the left and right atria contract together. The signal then travels to the atrioventricular node. This is found at the bottom of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " in the atrioventricular septum—the boundary between the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The septum is part of the cardiac skeleton, tissue within the heart that the electrical signal cannot pass through, which forces the signal to pass through the atrioventricular node only. The signal then travels along the bundle of His to left and right bundle branches through to the ventricles of the heart. In the ventricles the signal is carried by specialized tissue called the Purkinje fibers which then transmit the electric charge to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Heart rate The normal resting heart rate is called the sinus rhythm, created and sustained by the sinoatrial node, a group of pacemaking cells found in the wall of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". Cells in the sinoatrial node do this by creating an action potential. The cardiac action potential is created by the movement of specific electrolytes into and out of the pacemaker cells. The action potential then spreads to nearby cells.When the sinoatrial cells are resting, they have a negative charge on their membranes. However a rapid influx of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions causes the membrane's charge to become positive. This is called depolarisation and occurs spontaneously. Once the cell has a sufficiently high charge, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels close and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions then begin to enter the cell, shortly after which \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " begins to leave it. All the ions travel through ion channels in the membrane of the sinoatrial cells. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " start to move out of and into the cell only once it has a sufficiently high charge, and so are called voltage-gated. Shortly after this, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels close and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels open, allowing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " to leave the cell. This causes the cell to have a negative resting charge and is called repolarization. When the membrane potential reaches approximately −60 mV, the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channels close and the process may begin again.The ions move from areas where they are concentrated to where they are not. For this reason \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " moves into the cell from outside, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " moves from within the cell to outside the cell. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " also plays a critical role. Their influx through slow channels means that the sinoatrial cells have a prolonged &quot;&quot;plateau&quot;&quot; phase when they have a positive charge. A part of this is called the absolute refractory period. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " ions also combine with the regulatory protein troponin C in the troponin complex to enable contraction of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and separate from the protein to allow relaxation.The adult resting heart rate ranges from 60 to 100 bpm. The resting heart rate of a newborn can be 129 beats per minute (bpm) and this gradually decreases until maturity. An athlete's heart rate can be lower than 60 bpm. During \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " the rate can be 150 bpm with maximum rates reaching from 200 to 220 bpm. Influences The normal sinus rhythm of the heart, giving the resting heart rate, is influenced by a number of factors. The cardiovascular centres in the brainstem control the sympathetic and parasympathetic influences to the heart through the vagus nerve and sympathetic trunk. These cardiovascular centres receive input from a series of receptors including baroreceptors, sensing stretch the stretching of blood vessels and chemoreceptors, sensing the amount of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " in the blood and its pH. Through a series of reflexes these help regulate and sustain blood flow.Baroreceptors are stretch receptors located in the aortic sinus, carotid bodies, the venae cavae, and other locations, including pulmonary vessels and the right side of the heart itself. Baroreceptors fire at a rate determined by how much they are stretched, which is influenced by blood pressure, level of physical activity, and the relative distribution of blood. With increased pressure and stretch, the rate of baroreceptor firing increases, and the cardiac centers decrease sympathetic stimulation and increase parasympathetic stimulation. As pressure and stretch decrease, the rate of baroreceptor firing decreases, and the cardiac centers increase sympathetic stimulation and decrease parasympathetic stimulation. There is a similar reflex, called the atrial reflex or Bainbridge reflex, associated with varying rates of blood flow to the atria. Increased venous return stretches the walls of the atria where specialized baroreceptors are located. However, as the atrial baroreceptors increase their rate of firing and as they stretch due to the increased blood pressure, the cardiac center responds by increasing sympathetic stimulation and inhibiting parasympathetic stimulation to increase heart rate. The opposite is also true. Chemoreceptors present in the carotid body or adjacent to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " in an aortic body respond to the blood's oxygen, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " levels. Low \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or high \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " will stimulate firing of the receptors.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " and fitness levels, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", body temperature, basal metabolic rate, and even a person's emotional state can all affect the heart rate. High levels of the hormones \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    norepinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and thyroid hormones can increase the heart rate. The levels of electrolytes including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    potassium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can also influence the speed and regularity of the heart rate; low blood \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", low blood pressure and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dehydration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may increase it. Clinical significance \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diseases Cardiovascular diseases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", which include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diseases of the heart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", are the leading cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " worldwide. The majority of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiovascular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is noncommunicable and related to lifestyle and other factors, becoming more prevalent with ageing. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a major cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", accounting for an average of 30% of all \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deaths\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in 2008, globally. This rate varies from a lower 28% to a high 40% in high-income countries. Doctors that specialise in the heart are called cardiologists. Many other medical professionals are involved in treating \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diseases of the heart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", including doctors, cardiothoracic surgeons, intensivists, and allied health practitioners including physiotherapists and dieticians. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ischaemic heart disease Coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", also known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischaemic heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", is caused by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "—a build-up of fatty material along the inner walls of the arteries. These \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatty deposits\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerotic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " plaques narrow the coronary arteries, and if severe may reduce blood flow to the heart. If a narrowing (or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") is relatively minor then the patient may not experience any symptoms. Severe \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    narrowings\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " during \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " or even at rest. The thin covering of an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerotic\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " plaque can rupture, exposing the fatty centre to the circulating blood. In this case a clot or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    thrombus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can form, blocking the artery, and restricting blood flow to an area of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " causing a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart attack\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       ") or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    unstable angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In the worst case this may cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac arrest\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a sudden and utter loss of output from the heart. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Obesity\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", uncontrolled \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and high \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can all increase the risk of developing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coronary artery disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart failure Heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is defined as a condition in which the heart is unable to pump enough blood to meet the demands of the body. Patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may experience \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " especially when lying flat, as well as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ankle swelling\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    peripheral oedema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is the end result of many \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diseases affecting the heart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", but is most commonly associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischaemic heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valvular heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ". Less common causes include various \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiomyopathies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is frequently associated with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    weakness of the heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the ventricles (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    systolic heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), but can also be seen in patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that is strong but stiff (diastolic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Complications</span>\n",
       "</mark>\n",
       "). The condition may affect the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " (causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    predominantly breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " (causing predominantly swelling of the legs and an elevated jugular venous pressure), or both ventricles. Patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are at higher risk of developing dangerous heart rhythm disturbances or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiomyopathies Cardiomyopathies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are diseases affecting the muscle of the heart. Some cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abnormal thickening of the heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertrophic cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), some cause the heart to abnormally expand and weaken (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dilated cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), some cause the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to become stiff and unable to fully relax between contractions (restrictive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") and some make the heart prone to abnormal heart rhythms (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmogenic cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). These conditions are often genetic and can be inherited, but some such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dilated cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be caused by damage from toxins such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    alcohol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiomyopathies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertrophic cardiomopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are linked to a higher risk of sudden \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", particularly in athletes. Many \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiomyopathies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can lead to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the later stages of the disease. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Valvular heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Healthy heart valves allow blood to flow easily in one direction, but prevent it from flowing in the other direction. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diseased\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " heart valves may have a narrow opening and therefore restrict the flow of blood in the forward direction (referred to as a stenotic valve), or may allow blood to leak in the reverse direction (referred to as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valvular regurgitation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Valvular heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", blackouts, or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", but may be asymptomatic and only detected on a routine examination by hearing abnormal heart sounds or a heart murmur. In the developed world, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valvular heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is most commonly caused by degeneration secondary to old \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ", but may also be caused by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infection of the heart valves\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    endocarditis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). In some parts of the world rheumatic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is a major cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valvular heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", typically leading to mitral or aortic \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and caused by the body's immune system reacting to a streptococcal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    throat infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiac arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " While in the healthy heart, waves of electrical impulses originate in the sinus node before spreading to the rest of the atria, the atrioventricular node, and finally the ventricles (referred to as a normal sinus rhythm), this normal rhythm can be disrupted. Abnormal heart rhythms or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be asymptomatic or may cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", blackouts, or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Some types of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " increase the long term risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " cause the heart to beat abnormally slowly, referred to as a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradyarrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". This may be caused by an abnormally slow sinus node or damage within the cardiac conduction system (heart block). In other \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " the heart may beat abnormally rapidly, referred to as a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachyarrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". These \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can take many forms and can originate from different structures within the heart—some arise from the atria (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial flutter\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), some from the atrioventricular node (e.g. AV nodal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    re-entrant tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") whilst others arise from the ventricles (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). Some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tachyarrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are caused by scarring within the heart (e.g. some forms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), others by an irritable focus (e.g. focal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), while others are caused by additional abnormal conduction tissue that has been present since birth (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Wolff-Parkinson-White syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). The most dangerous form of heart racing is \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", in which the ventricles quiver rather than contract, and which if untreated is rapidly fatal. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pericardial disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " The sac which surrounds the heart, called the pericardium, can become inflamed in a condition known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pericarditis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". This condition typically causes \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that may spread to the back, and is often caused by a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    viral infection\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    glandular fever\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", cytomegalovirus, or coxsackievirus). Fluid can build up within the pericardial sac, referred to as a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pericardial effusion\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Pericardial effusions\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " often occur secondary to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pericarditis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    kidney failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tumours\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and frequently do not cause any symptoms. However, large effusions or effusions which accumulate rapidly can compress the heart in a condition known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac tamponade\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and potentially fatal low blood pressure. Fluid can be removed from the pericardial space for diagnosis or to relieve \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    tamponade\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " using a syringe in a procedure called \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pericardiocentesis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Congenital heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Some people are born with hearts that are abnormal and these abnormalities are known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital heart defects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". They may range from the relatively minor (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    patent foramen ovale\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", arguably a variant of normal) to serious \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    life-threatening abnormalities\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypoplastic left heart syndrome\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). Common abnormalities include those that affect the heart muscle that separates the two side of the heart (a &quot;&quot;hole in the heart&quot;&quot; - e.g., \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular septal defect\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). Other defects include those affecting the heart valves (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital aortic stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), or the main blood vessels that lead from the heart (e.g. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    coarctation of the aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). More complex syndromes are seen that affect more than one part of the heart (e.g. Tetralogy of Fallot). Some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital heart defects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " allow blood that is low in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " that would normally be returned to the lungs to instead be pumped back to the rest of the body. These are known as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cyanotic congenital heart defects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and are often more serious. Major \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital heart defects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are often picked up in childhood, shortly after birth, or even before a child is born (e.g. transposition of the great arteries), causing \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    breathlessness\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and a lower rate of growth. More minor forms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may remain undetected for many years and only reveal themselves in adult life (e.g., \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial septal defect\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "). Diagnosis \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is diagnosed by the taking of a medical history, a cardiac examination, and further investigations, including blood tests, echocardiograms, ECGs and imaging. Other invasive procedures such as cardiac catheterisation can also play a role. Examination The cardiac examination includes inspection, feeling the chest with the hands (palpation) and listening with a stethoscope (auscultation). It involves assessment of signs that may be visible on a person's hands (such as splinter haemorrhages), joints and other areas. A person's pulse is taken, usually at the radial artery near the wrist, in order to assess for the rhythm and strength of the pulse. The blood pressure is taken, using either a manual or automatic sphygmomanometer or using a more invasive measurement from within the artery. Any elevation of the jugular venous pulse is noted. A person's chest is felt for any transmitted vibrations from the heart, and then listened to with a stethoscope. Heart sounds Typically, healthy hearts have only two audible heart sounds, called S1 and S2. The first heart sound S1, is the sound created by the closing of the atrioventricular valves during ventricular contraction and is normally described as &quot;&quot;lub&quot;&quot;. The second heart sound, S2, is the sound of the semilunar valves closing during ventricular diastole and is described as &quot;&quot;dub&quot;&quot;. Each sound consists of two components, reflecting the slight difference in time as the two valves close. S2 may split into two distinct sounds, either as a result of inspiration or different \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valvular or cardiac problems\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Additional heart sounds may also be present and these give rise to gallop rhythms. A third heart sound, S3 usually indicates an increase in ventricular blood volume. A fourth heart sound S4 is referred to as an atrial gallop and is produced by the sound of blood being forced into a stiff ventricle. The combined presence of S3 and S4 give a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    quadruple\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " gallop.\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart murmurs\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are abnormal heart sounds which can be either related to disease or benign, and there are several kinds. There are normally two heart sounds, and abnormal heart sounds can either be extra sounds, or &quot;&quot;murmurs&quot;&quot; related to the flow of blood between the sounds. Murmurs are graded by volume, from 1 (the quietest), to 6 (the loudest), and evaluated by their relationship to the heart sounds, position in the cardiac cycle, and additional features such as their radiation to other sites, changes with a person's position, the frequency of the sound as determined by the side of the stethoscope by which they are heard, and site at which they are heard loudest. Murmurs may be caused by damaged heart valves or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    congenital heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular septal defects\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or may be heard in normal hearts. A different type of sound, a pericardial friction rub can be heard in cases of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pericarditis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " where the inflamed membranes can \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rub\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " together. Blood tests Blood tests play an important role in the diagnosis and treatment of many cardiovascular conditions. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Troponin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is a sensitive biomarker for a heart with insufficient blood supply. It is released 4–6 hours after injury, and usually peaks at about 12–24 hours. Two tests of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    troponin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are often taken—one at the time of initial presentation, and another within 3–6 hours, with either a high level or a significant rise being diagnostic. A test for brain natriuretic peptide (BNP) can be used to evaluate for the presence of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and rises when there is increased demand on the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". These tests are considered biomarkers because they are highly specific for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Testing for the MB form of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    creatine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " kinase provides information about the heart's blood supply, but is used less frequently because it is less specific and sensitive.Other blood tests are often taken to help understand a person's general health and risk factors that may contribute to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". These often include a full blood count investigating for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anaemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and basic metabolic panel that may reveal any disturbances in electrolytes. A coagulation screen is often required to ensure that the right level of anticoagulation is given. Fasting lipids and fasting blood glucose (or an HbA1c level) are often ordered to evaluate a person's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cholesterol\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " status, respectively. Electrocardiogram Using surface electrodes on the body, it is possible to record the electrical activity of the heart. This tracing of the electrical signal is the electrocardiogram (ECG) or (EKG). An ECG is a bedside test and involves the placement of ten leads on the body. This produces a &quot;&quot;12 lead&quot;&quot; ECG (three extra leads are calculated mathematically, and one lead is a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ground).There\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are five prominent features on the ECG: the P wave (atrial depolarisation), the QRS complex (ventricular depolarisation) and the T wave (ventricular repolarisation). As the heart cells contract, they create a current that travels through the heart. A downward deflection on the ECG implies cells are becoming more positive in charge (&quot;&quot;depolarising&quot;&quot;) in the direction of that lead, whereas an upward inflection implies cells are becoming more negative (&quot;&quot;repolarising&quot;&quot;) in the direction of the lead. This depends on the position of the lead, so if a wave of depolarising moved from left to right, a lead on the left would show a negative deflection, and a lead on the right would show a positive deflection. The ECG is a useful tool in detecting \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rhythm disturbances\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and in detecting insufficient blood supply to the heart. Sometimes abnormalities are suspected, but not immediately visible on the ECG. Testing when exercising can be used to provoke an abnormality, or an ECG can be worn for a longer period such as a 24-hour Holter monitor if a suspected \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    rhythm abnormality\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is not present at the time of assessment. Imaging Several imaging methods can be used to assess the anatomy and function of the heart, including ultrasound (echocardiography), angiography, CT scans, MRI and PET. An echocardiogram is an ultrasound of the heart used to measure the heart's function, assess for \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    valve disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and look for any abnormalities. Echocardiography can be conducted by a probe on the chest (&quot;&quot;transthoracic&quot;&quot;) or by a probe in the esophagus (&quot;&quot;transoesophageal&quot;&quot;). A typical echocardiography report will include information about the width of the valves noting any \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", whether there is any backflow of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    blood (regurgitation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") and information about the blood volumes at the end of systole and diastole, including an ejection fraction, which describes how much blood is ejected from the left and right ventricles after systole. Ejection fraction can then be obtained by dividing the volume ejected by the heart (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume) by the volume of the filled heart (end-diastolic volume). Echocardiograms can also be conducted under circumstances when the body is more stressed, in order to examine for signs of lack of blood supply. This cardiac \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " test involves either direct \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ", or where this is not possible, injection of a drug such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dobutamine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".CT scans, chest X-rays and other forms of imaging can help evaluate the heart's size, evaluate for signs of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary oedema\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and indicate whether there is fluid around the heart. They are also useful for evaluating the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", the major blood vessel which leaves the heart. Treatment \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Diseases affecting the heart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be treated by a variety of methods including lifestyle modification, drug treatment, and surgery. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ischaemic heart disease Narrowings of the coronary arteries (ischaemic heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") are treated to relieve symptoms of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chest pain\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " caused by a partially narrowed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    artery (angina pectoris\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), to minimise \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle damage\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " when an artery is completely occluded (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), or to prevent a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocardial infarction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " from occurring. Medications to improve \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angina\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " symptoms include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nitroglycerin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", beta blockers, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blockers, while preventative treatments include \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    antiplatelets\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aspirin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    statins\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", lifestyle measures such as stopping \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    smoking\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    weight loss\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and treatment of risk factors such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    high blood pressure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diabetes\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".In addition to using medications, narrowed heart arteries can be treated by expanding the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    narrowings\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or redirecting the flow of blood to bypass an obstruction. This may be performed using a percutaneous coronary intervention, during which \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    narrowings\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be expanded by passing small balloon-tipped wires into the coronary arteries, inflating the balloon to expand the narrowing, and sometimes leaving behind a metal scaffold known as a stent to keep the artery open.If the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    narrowings\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in coronary arteries are unsuitable for treatment with a percutaneous coronary intervention, open surgery may be required. A coronary artery bypass graft can be performed, whereby a blood vessel from another part of the body (the saphenous vein, radial artery, or internal mammary artery) is used to redirect blood from a point before the narrowing (typically the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ") to a point beyond the obstruction. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Valvular heart disease Diseased heart valves\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " that have become abnormally narrow or abnormally leaky may require surgery. This is traditionally performed as an open surgical procedure to replace the damaged heart valve with a tissue or metallic prosthetic valve. In some circumstances, the tricuspid or mitral valves can be repaired surgically, avoiding the need for a valve replacement. Heart valves can also be treated percutaneously, using techniques that share many similarities with percutaneous coronary intervention. Transcatheter \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aortic valve\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " replacement is increasingly used for patients consider very high risk for open valve replacement. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Cardiac arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Abnormal heart rhythms (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") can be treated using antiarrhythmic drugs. These may work by manipulating the flow of electrolytes across the cell membrane (such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blockers, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    sodium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " channel blockers, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    amiodarone\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    digoxin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), or modify the autonomic nervous system's effect on the heart (beta blockers and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atropine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "). In some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " which increase the risk of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", this risk can be reduced using anticoagulants such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    warfarin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " or novel oral anticoagulants.If medications fail to control an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", another treatment option may be catheter ablation. In these procedures, wires are passed from a vein or artery in the leg to the heart to find the abnormal area of tissue that is causing the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". The abnormal tissue can be intentionally damaged, or ablated, by heating or freezing to prevent further heart rhythm disturbances. Whilst the majority of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " can be treated using minimally invasive catheter techniques, some \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (particularly \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atrial fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") can also be treated using open or thoracoscopic surgery, either at the time of other cardiac surgery or as a standalone procedure. A cardioversion, whereby an electric \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shock\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is used to stun the heart out of an abnormal rhythm, may also be used. Cardiac devices in the form of pacemakers or implantable defibrillators may also be required to treat \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Pacemakers, comprising a small battery powered generator implanted under the skin and one or more leads that extend to the heart, are most commonly used to treat abnormally slow heart rhythms. Implantable defibrillators are used to treat serious life-threatening rapid heart rhythms. These devices monitor the heart, and if dangerous heart racing is detected can automatically deliver a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shock\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " to restore the heart to a normal rhythm. Implantable defibrillators are most commonly used in patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiomyopathies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or inherited \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " syndromes. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " As well as addressing the underlying cause for a patient's \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (most commonly \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ischaemic heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), the mainstay of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " treatment is with medication. These include drugs to prevent fluid from accumulating in the lungs by increasing the amount of urine a patient produces (diuretics), and drugs that attempt to preserve the pumping function of the heart (beta blockers, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors and mineralocorticoid receptor antagonists).In\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " some patients with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a specialised pacemaker known as cardiac resynchronisation therapy can be used to improve the heart's pumping efficiency. These devices are frequently combined with a defibrillator. In very severe cases of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", a small pump called a ventricular assist device may be implanted which supplements the heart's own pumping ability. In the most severe cases, a cardiac transplant may be considered. History Ancient Humans have known about the heart since ancient times, although its precise function and anatomy were not clearly understood. From the primarily religious views of earlier societies towards the heart, ancient Greeks are considered to have been the primary seat of scientific understanding of the heart in the ancient world. Aristotle considered the heart to be the organ responsible for creating blood; Plato considered the heart as the source of circulating blood and Hippocrates noted blood circulating cyclically from the body through the heart to the lungs. Erasistratos (304–250 BCE) noted the heart as a pump, causing dilation of blood vessels, and noted that arteries and veins both radiate from the heart, becoming progressively smaller with distance, although he believed they were filled with air and not blood. He also discovered the heart valves.The Greek physician Galen (2nd century CE) knew blood vessels carried blood and identified venous (dark red) and arterial (brighter and thinner) blood, each with distinct and separate functions. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", noting the heart as the hottest organ in the body, concluded that it provided heat to the body. The heart did not pump blood around, the heart's motion sucked blood in during diastole and the blood moved by the pulsation of the arteries themselves. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen believed the arterial blood\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " was created by venous blood passing from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to the right through 'pores' between the ventricles. Air from the lungs passed from the lungs via the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " to the left side of the heart and created arterial blood.These ideas went unchallenged for almost a thousand years. Pre-modern The earliest descriptions of the coronary and pulmonary circulation systems can be found in the Commentary on Anatomy in Avicenna's Canon, published in 1242 by Ibn al-Nafis. In his manuscript, al-Nafis wrote that blood passes through the pulmonary circulation instead of moving from the right to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " as previously believed by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". His work was later translated into Latin by Andrea Alpago.In Europe, the teachings of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " continued to dominate the academic community and his doctrines were adopted as the official canon of the Church. Andreas Vesalius questioned some of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen's beliefs of the heart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    De humani corporis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " fabrica (1543), but his \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    magnum\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " opus was interpreted as a challenge to the authorities and he was subjected to a number of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    attacks\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Michael Servetus wrote in Christianismi Restitutio (1553) that blood flows from one side of the heart to the other via the lungs. Modern A breakthrough in understanding the flow of blood through the heart and body came with the publication of De Motu Cordis (1628) by the English physician William Harvey. Harvey's book completely describes the systemic circulation and the mechanical force of the heart, leading to an overhaul of the Galenic doctrines. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Otto\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Frank (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    1865–1944\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ") was a German physiologist; among his many published works are detailed studies of this important heart relationship. Ernest Starling (1866–1927) was an important English physiologist who also studied the heart. Although they worked largely independently, their combined efforts and similar conclusions have been recognized in the name &quot;&quot;Frank–Starling mechanism&quot;&quot;.Although Purkinje fibers and the bundle of His were discovered as early as the 19th century, their specific role in the electrical conduction system of the heart remained unknown until Sunao Tawara published his monograph, titled Das Reizleitungssystem des Säugetierherzens, in 1906. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Tawara's discovery of the atrioventricular\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " node prompted Arthur Keith and Martin Flack to look for similar structures in the heart, leading to their discovery of the sinoatrial node several months later. These structures form the anatomical basis of the electrocardiogram, whose inventor, Willem Einthoven, was awarded the Nobel Prize in Medicine or Physiology in 1924.The first successful heart transplantation was performed in 1967 by the South African surgeon Christiaan Barnard at Groote Schuur Hospital in Cape Town. This marked an important milestone in cardiac surgery, capturing the attention of both the medical profession and the world at large. However, long-term survival rates of patients were initially very low. Louis Washkansky, the first recipient of a donated heart, died 18 days after the operation while other patients did not survive for more than a few weeks. The American surgeon Norman Shumway has been credited for his efforts to improve transplantation techniques, along with pioneers Richard Lower, Vladimir Demikhov and Adrian Kantrowitz. As of March 2000, more than 55,000 heart transplantations have been performed worldwide.By the middle of the 20th century, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " had surpassed \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    infectious disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " as the leading cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the United States, and it is currently the leading cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    deaths\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " worldwide. Since 1948, the ongoing Framingham Heart Study has shed light on the effects of various influences on the heart, including \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    diet\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       ", and common medications such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aspirin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Although the introduction of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACE inhibitors\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and beta blockers has improved the management of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    chronic heart failure\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", the disease continues to be an enormous medical and societal burden, with 30 to 40% of patients dying within a year of receiving the diagnosis. Society and culture Symbolism As one of the vital organs, the heart was long identified as the center of the entire body, the seat of life, or emotion, or reason, will, intellect, purpose or the mind. The heart is an emblematic symbol in many religions, signifying &quot;&quot;truth, conscience or moral courage in many religions—the temple or throne of God in Islamic and Judeo-Christian thought; the divine centre, or atman, and the third eye of transcendent wisdom in Hinduism; the diamond of purity and essence of the Buddha; the Taoist centre of understanding.&quot;&quot;In the Hebrew Bible, the word for heart, lev, is used in these meanings, as the seat of emotion, the mind, and referring to the anatomical organ. It is also connected in function and symbolism to the stomach.An important part of the concept of the soul in Ancient Egyptian religion was thought to be the heart, or ib. The ib or metaphysical heart was believed to be formed from one drop of blood from the child's mother's heart, taken at conception. To ancient Egyptians, the heart was the seat of emotion, thought, will, and intention. This is evidenced by Egyptian expressions which incorporate the word ib, such as Awi-ib for &quot;&quot;happy&quot;&quot; (literally, &quot;&quot;long of heart&quot;&quot;), Xak-ib for &quot;&quot;estranged&quot;&quot; (literally, &quot;&quot;truncated of heart&quot;&quot;). In Egyptian religion, the heart was the key to the afterlife. It was conceived as surviving \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in the nether world, where it gave evidence for, or against, its possessor. It was thought that the heart was examined by Anubis and a variety of deities during the Weighing of the Heart ceremony. If the heart weighed more than the feather of Maat, which symbolized the ideal standard of behavior. If the scales balanced, it meant the heart's possessor had lived a just life and could enter the afterlife; if the heart was heavier, it would be devoured by the monster Ammit.The Chinese character for &quot;&quot;heart&quot;&quot;, 心, derives from a comparatively realistic depiction of a heart (indicating the heart chambers) in seal script. The Chinese word \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    xīn\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " also takes the metaphorical meanings of &quot;&quot;mind&quot;&quot;, &quot;&quot;intention&quot;&quot;, or &quot;&quot;core&quot;&quot;. In Chinese medicine, the heart is seen as the center of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    神\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " shén &quot;&quot;spirit, consciousness&quot;&quot;. The heart is associated with the small intestine, tongue, governs the six organs and five viscera, and belongs to fire in the five elements.The Sanskrit word for heart is hṛd or hṛdaya, found in the oldest surviving Sanskrit text, the Rigveda. In Sanskrit, it may mean both the anatomical object and &quot;&quot;mind&quot;&quot; or &quot;&quot;soul&quot;&quot;, representing the seat of emotion. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Hrd\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may be a cognate of the word for heart in Greek, Latin, and English.Many classical philosophers and scientists, including Aristotle, considered the heart the seat of thought, reason, or emotion, often disregarding the brain as contributing to those functions. The identification of the heart as the seat of emotions in particular is due to the Roman physician \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Galen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", who also located the seat of the passions in the liver, and the seat of reason in the brain.The heart also played a role in the Aztec system of belief. The most common form of human sacrifice practiced by the Aztecs was heart-extraction. The Aztec believed that the heart (tona) was both the seat of the individual and a fragment of the Sun's heat (istli). To this day, the Nahua consider the Sun to be a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart-soul (tona-tiuh):\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " &quot;&quot;round, hot, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulsating&quot;&quot;.In\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " Catholicism, there has been a long tradition of veneration of the heart, stemming from worship of the wounds of Jesus Christ which gained prominence from the mid sixteenth century. This tradition influenced the development of the medieval Christian devotion to the Sacred Heart of Jesus and the parallel veneration of the Immaculate Heart of Mary, made popular by John Eudes.The expression of a broken heart is a cross-cultural reference to grief for a lost one or to unfulfilled romantic love. The notion of &quot;&quot;Cupid's arrows&quot;&quot; is ancient, due to Ovid, but while Ovid describes Cupid as wounding his victims with his arrows, it is not made explicit that it is the heart that is wounded. The familiar iconography of Cupid shooting little heart symbols is a Renaissance theme that became tied to Valentine's day. Food Animal hearts are widely consumed as food. As they are almost entirely muscle, they are high in protein. They are often included in dishes with other offal, for example in the pan-Ottoman kokoretsi. Chicken hearts are considered to be giblets, and are often grilled on skewers; examples of this are Japanese hāto yakitori, Brazilian churrasco de coração, and Indonesian chicken heart satay. They can also be pan-fried, as in Jerusalem mixed grill. In Egyptian cuisine, they can be used, finely chopped, as part of stuffing for chicken. Many recipes combined them with other giblets, such as the Mexican pollo en menudencias and the Russian ragu iz kurinyikh potrokhov.The hearts of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    beef, pork,\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and mutton can generally be interchanged in recipes. As heart is a hard-working muscle, it makes for &quot;&quot;firm and rather dry&quot;&quot; meat, so is generally slow-cooked. Another way of dealing with toughness is to julienne the meat, as in Chinese stir-fried heart.Beef heart may be \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    grilled or braised\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". In the Peruvian \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    anticuchos de corazón, barbecued beef\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " hearts are grilled after being tenderized through long marination in a \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    spice\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and vinegar mixture. An Australian recipe for &quot;&quot;mock goose&quot;&quot; is actually \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    braised stuffed beef heart\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".Pig \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart is stewed,\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " poached, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    braised\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or made into sausage. The Balinese oret is a sort of blood sausage made with pig heart and blood. A French recipe for cœur de porc à l'orange is made of braised heart with an orange sauce. Other animals Vertebrates The size of the heart varies among the different animal groups, with hearts in vertebrates ranging from those of the smallest mice (12 mg) to the blue whale (600 kg). In vertebrates, the heart lies in the middle of the ventral part of the body, surrounded by a pericardium. which in some fish may be connected to the peritoneum.The SA node is found in all amniotes but not in more primitive vertebrates. In these animals, the muscles of the heart are relatively continuous, and the sinus venosus coordinates the beat, which passes in a wave through the remaining chambers. Indeed, since the sinus venosus is incorporated into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " in amniotes, it is likely homologous with the SA node. In teleosts, with their vestigial sinus venosus, the main centre of coordination is, instead, in the atrium. The rate of heartbeat varies enormously between different species, ranging from around 20 beats per minute in codfish to around 600 in hummingbirds and up to 1200 bpm in the ruby-throated hummingbird. Double circulatory systems Adult amphibians and most reptiles have a double circulatory system, meaning a circulatory system divided into arterial and venous parts. However, the heart itself is not completely separated into two sides. Instead, it is separated into three chambers—two atria and one ventricle. Blood returning from both the systemic circulation and the lungs is returned, and blood is pumped simultaneously into the systemic circulation and the lungs. The double system allows blood to circulate to and from the lungs which deliver oxygenated blood directly to the heart.In reptiles, the heart is usually situated around the middle of the thorax, and in snakes, usually between the junction of the upper first and second third. There is a heart with three chambers: two atria and one ventricle. The form and function of these hearts are different than mammalian hearts due to the fact that snakes have an elongated body, and thus are affected by different environmental factors. In particular, the snake's heart relative to the position in their body has been influenced greatly by gravity. Therefore, snakes that are larger in size tend to have a higher blood pressure due to gravitational change. This results in the heart being located in different regions of the body that is relative to the snake's body length. The ventricle is incompletely separated into two-halves by a wall (septum), with a considerable gap near the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    pulmonary artery\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and aortic openings. In most reptilian species, there appears to be little, if any, mixing between the bloodstreams, so the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " receives, essentially, only oxygenated blood. The exception to this rule is crocodiles, which have a four-chambered heart.In the heart of lungfish, the septum extends partway into the ventricle. This allows for some degree of separation between the de-oxygenated bloodstream destined for the lungs and the oxygenated stream that is delivered to the rest of the body. The absence of such a division in living amphibian species may be partly due to the amount of respiration that occurs through the skin; thus, the blood returned to the heart through the venae cavae is already partially oxygenated. As a result, there may be less need for a finer division between the two bloodstreams than in lungfish or other tetrapods. Nonetheless, in at least some species of amphibian, the spongy nature of the ventricle does seem to maintain more of a separation between the bloodstreams. Also, the original valves of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    conus arteriosus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " have been replaced by a spiral valve that divides it into two parallel parts, thereby helping to keep the two bloodstreams separate. Full division Archosaurs (crocodilians and birds) and mammals show complete separation of the heart into two pumps for a total of four heart chambers; it is thought that the four-chambered heart of archosaurs evolved independently from that of mammals. In crocodilians, there is a small opening, the foramen of Panizza, at the base of the arterial trunks and there is some degree of mixing between the blood in each side of the heart, during a dive underwater; thus, only in birds and mammals are the two streams of blood—those to the pulmonary and systemic circulations—permanently kept entirely separate by a physical barrier. Fish Fish have what is often described as a two-chambered heart, consisting of one atrium to receive blood and one ventricle to pump it. However, the fish heart has entry and exit compartments that may be called chambers, so it is also sometimes described as three-chambered or four-chambered, depending on what is counted as a chamber. The atrium and ventricle are sometimes considered &quot;&quot;true chambers&quot;&quot;, while the others are considered &quot;&quot;accessory chambers&quot;&quot;.Primitive fish have a four-chambered heart, but the chambers are arranged sequentially so that this primitive heart is quite unlike the four-chambered hearts of mammals and birds. The first chamber is the sinus venosus, which collects deoxygenated blood from the body through the hepatic and cardinal veins. From here, blood flows into the atrium and then to the powerful muscular ventricle where the main pumping action will take place. The fourth and final chamber is the conus arteriosus, which contains several valves and sends blood to the ventral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The ventral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " delivers blood to the gills where it is oxygenated and flows, through the dorsal \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", into the rest of the body. (In tetrapods, the ventral \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " has divided in two; one half forms the ascending \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", while the other forms the pulmonary artery).In the adult fish, the four chambers are not arranged in a straight row but instead form an S-shape, with the latter two chambers lying above the former two. This relatively simple pattern is found in cartilaginous fish and in the ray-finned fish. In teleosts, the conus arteriosus is very small and can more accurately be described as part of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " rather than of the heart proper. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    conus arteriosus\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is not present in any amniotes, presumably having been absorbed into the ventricles over the course of evolution. Similarly, while the sinus venosus is present as a vestigial structure in some reptiles and birds, it is otherwise absorbed into the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right atrium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and is no longer distinguishable. Invertebrates Arthropods and most mollusks have an open circulatory system. In this system, deoxygenated blood collects around the heart in cavities (sinuses). This blood slowly permeates the heart through many small one-way channels. The heart then pumps the blood into the hemocoel, a cavity between the organs. The heart in arthropods is typically a muscular tube that runs the length of the body, under the back and from the base of the head. Instead of blood the circulatory fluid is haemolymph which carries the most commonly used respiratory pigment, copper-based haemocyanin as the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " transporter. Haemoglobin is only used by a few arthropods.In some other invertebrates such as earthworms, the circulatory system is not used to transport \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and so is much reduced, having no veins or arteries and consisting of two connected tubes. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " travels by diffusion and there are five \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    small muscular\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " vessels that connect these vessels that contract at the front of the animals that can be thought of as &quot;&quot;hearts&quot;&quot;.Squids and other cephalopods have two &quot;&quot;gill hearts&quot;&quot; also known as branchial hearts, and one &quot;&quot;systemic heart&quot;&quot;. The branchial hearts have two atria and one ventricle each, and pump to the gills, whereas the systemic heart pumps to the body. Only the chordates (including vertebrates) and the hemichordates have a central &quot;&quot;heart&quot;&quot;, which is a vesicle formed from the thickening of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aorta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and contracts to pump blood. This suggests a presence of it in the last common ancestor of these groups (may have been lost in the echinoderms). Additional images Notes References This article incorporates text from the CC-BY book: OpenStax College,  Anatomy &amp; Physiology. OpenStax CNX. 30 Jul 2014. Bibliography Hall, John (2011). Guyton and Hall textbook of medical physiology (12th ed.). Philadelphia: Saunders/Elsevier. ISBN 978-1-4160-4574-8. Longo, Dan; Fauci, Anthony; Kasper, Dennis; Hauser, Stephen; Jameson, J.; Loscalzo, Joseph (2011). Harrison's Principles of Internal Medicine (18 ed.). McGraw-Hill Professional. ISBN 978-0-07-174889-6. Susan Standring; Neil R. Borley;  et al., eds. (2008). Gray's anatomy : the anatomical basis of clinical practice (40th ed.). London: Churchill Livingstone. ISBN 978-0-8089-2371-8. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Nicki R. Colledge\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "; Brian R. Walker; Stuart H. Ralston, eds. (2010). Davidson's principles and practice of medicine (21st ed.). Edinburgh: Churchill Livingstone/Elsevier. ISBN 978-0-7020-3085-7. External links What Is the Heart? – NIH Atlas of Human Cardiac Anatomy Dissection review of the anatomy of the Human Heart including vessels, internal and external features Prenatal human heart development Animal hearts: fish, squid The Heart, BBC Radio 4 interdisciplinary discussion with David Wootton, Fay Bound Alberti &amp; Jonathan Sawday (In Our Time, 1 June 2006) &quot;&quot;Heart&quot;&quot; . Encyclopædia Britannica. 13 (11th ed.). 1911. pp. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    129–134\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".&quot; &quot;An arteriole is a small-diameter blood vessel in the microcirculation that extends and branches out from an artery and leads to capillaries.Arterioles have muscular walls (usually only one to two layers of smooth muscle cells) and are the primary site of vascular resistance. The greatest change in blood pressure and velocity of blood flow occurs at the transition of arterioles to capillaries. Structure Microanatomy In a healthy vascular system the endothelium lines all blood-contacting surfaces, including arteries, arterioles, veins, venules, capillaries, and heart chambers.  This healthy condition is promoted by the ample production of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nitric oxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " by the endothelium, which requires a biochemical reaction regulated by a complex balance of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    polyphenols\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", various \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nitric oxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " synthase enzymes and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    L-arginine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". In addition there is direct electrical and chemical communication via gap junctions between the endothelial cells and the vascular smooth muscle. Physiology Blood pressure Blood pressure in the arteries supplying the body is a result of the work needed to pump the cardiac output (the flow of blood pumped by the heart) through the vascular resistance, sometimes termed total peripheral resistance. An increase in the tunica media to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    luminal\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " diameter ratio has been observed in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertensive\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " arterioles (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arteriolosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") as the vascular wall thickens and/or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    luminal\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " diameter decreases. The up and down fluctuation of the arterial blood pressure is due to the pulsatile nature of the cardiac output and determined by the interaction of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stroke\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " volume versus the volume and elasticity of the major arteries. The decreased velocity of flow in the capillaries increases the blood pressure, due to Bernoulli's principle. This induces \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    gas\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and nutrients to move from the blood to the cells, due to the lower osmotic pressure outside the capillary. The opposite process occurs when the blood leaves the capillaries and enters the venules, where the blood pressure drops due to an increase in flow rate. Arterioles receive autonomic nervous system innervation and respond to various circulating hormones in order to regulate their diameter. Retinal vessels lack a functional sympathetic innervation. Stretch Further local responses to stretch, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", pH, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " also influence arteriolar tone. Generally, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    norepinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    epinephrine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (hormones produced by sympathetic nerves and the adrenal gland medulla) are vasoconstrictive acting on alpha 1-adrenergic receptors. However, the arterioles of skeletal muscle, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    cardiac muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and pulmonary circulation vasodilate in response to these hormones when they act on beta-adrenergic receptors. Generally, stretch and high \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " tension increase tone, and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    carbon dioxide\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and low pH promote vasodilation. Pulmonary arterioles are a noteworthy exception as they vasodilate in response to high \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    oxygen\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Brain arterioles are particularly sensitive to pH with reduced pH promoting vasodilation. A number of hormones influence arteriole tone such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    angiotensin II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (vasoconstrictive), endothelin (vasoconstrictive), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    bradykinin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (vasodilation), atrial natriuretic peptide (vasodilation), and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    prostacyclin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (vasodilation). Clinical significance Arteriole diameters decrease with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    age\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       " and with exposure to air pollution. Disease Any pathology which constricts blood flow, such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stenosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", will increase total peripheral resistance and lead to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Arteriosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Arteriolosclerosis is the term specifically used for the hardening of arteriole walls. This can be due to decreased elastic production from fibrinogen, associated with ageing, or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    hypertension\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " or pathological conditions such as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    atherosclerosis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Arteritis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " Medication The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    muscular contraction\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of arterioles is targeted by drugs that lower blood pressure (antihypertensives), for example the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dihydropyridines\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nifedipine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    nicardipine\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), which block the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    calcium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " conductance in the muscular layer of the arterioles, causing relaxation. This decreases the resistance to flow into peripheral vascular beds, lowering overall systemic pressure. Metarterioles A &quot;&quot;metarteriole&quot;&quot; is an arteriole which bypasses capillary circulation. See also Surface chemistry of microvasculature Venule Microcirculation  == References ==&quot; &quot;\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Arrhythmogenic cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "), \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmogenic right ventricular dysplasia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ARVD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), or \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmogenic right ventricular cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ARVC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       "), is an inherited \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is caused by genetic defects of the parts of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    heart muscle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (also called myocardium or cardiac muscle) known as desmosomes, areas on the surface of heart muscle cells which link the cells together. The desmosomes are composed of several proteins, and many of those proteins can have harmful mutations. The disease is a type of non-ischemic cardiomyopathy that primarily involves the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ", though cases of exclusive \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " have been reported.  It is characterized by hypokinetic areas involving the free wall of the ventricle, with fibrofatty replacement of the myocardium, with associated \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " often originating in the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ". The nomenclature \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ARVD\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is currently thought to be inappropriate and misleading as \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " does not involve \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dysplasia of the ventricular wall\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". Cases of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " originating from the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " led to the abandonment of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    name ARVC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " can be found in association with diffuse palmoplantar \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    keratoderma\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", and woolly hair, in an autosomal recessive condition called \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Naxos disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", because this genetic abnormality can also affect the integrity of the superficial layers of the skin most exposed to pressure \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    stress\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Causes</span>\n",
       "</mark>\n",
       ".: 513 ACM is an important cause of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " in children and young adults.  It is seen predominantly in males, and 30–50% of cases have a familial distribution. Signs and symptoms Those affected by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmogenic cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may not have any symptoms at all despite having significant abnormalities in the structure of their hearts. If symptoms do occur, the initial presentation is often due to abnormal heart rhythms (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") which in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmogenic cardiomyopathy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may take the form of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    palpitations\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", or blackouts. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Sudden death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may be the first presentation of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " without any preceding symptoms.  These symptoms often occur during adolescence and early adulthood, but signs of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " may rarely be seen in infants. As ACM progresses, the muscle tissue within the ventricles may dilate and weaken. The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " typically weakens first, leading to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatigue\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ankle swelling\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  In the later stages of the disease in which both ventricles are involved \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    shortness of breath\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " may develop, especially when lying flat.The first clinical signs of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " are usually during adolescence and early adulthood.  However, rarely, signs of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " have been demonstrated in infants. Genetics \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is usually inherited in an autosomal dominant pattern, with variable expression. Only 30% to 50% of individuals affected by \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " will test positive to one of the known genetic mutations in chromosomal loci associated with the disease. Novel studies showed that mutations (point mutations) in genes encoding for desmosomal proteins (see intercalated disc) are the main causatives for the development of this disease. Recently it has been shown, that mutations in the desmin \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DES\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " gene could cause \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ". Desmin is an intermediate filament protein, which is linked to the desmosomes. Different \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    DES\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " mutations cause an \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    abnormal aggregation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of desmin and associated proteins. The penetrance is 20–35% in general, but significantly higher in Italy.  Seven gene loci have been implicated in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ".  It is unclear whether the pathogenesis varies with the different loci involved.  Standard genetic screening test are currently tested and evaluated in different state of the art cardiovascular research centres and hospitals. Types include: Pathogenesis The pathogenesis of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " is largely unknown.  Apoptosis (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    programmed cell death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") appears to play a large role.  It was previously thought that only the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is involved, but recent cohorts have shown many cases of left \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    biventricular disease\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  The disease process starts in the subepicardial region and works its way towards the endocardial surface, leading to transmural involvement (possibly accounting for the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aneurysmal dilatation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " of the ventricles).  Residual myocardium is confined to the subendocardial region and the trabeculae of the ventricles.  These trabeculae may become hypertrophied. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Aneurysmal dilatation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is seen in 50% of cases at autopsy.  It usually occurs in the diaphragmatic, apical, and infundibular regions (known as the triangle of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    dysplasia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ").  The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is involved in 50–67% of individuals.  If the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " is involved, it is usually late in the course of disease, and confers a poor prognosis. There are two pathological patterns seen in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Fatty infiltration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fibro-fatty infiltration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Fatty infiltration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " The first, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatty infiltration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", is confined to the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".  This involves a partial or near-complete substitution of myocardium with \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatty\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " tissue without wall thinning.  It involves predominantly the apical and infundibular regions of the RV.  The \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    left ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       " and ventricular septum are usually spared.  No inflammatory infiltrates are seen in \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatty infiltration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ".  There is evidence of myocyte (myocardial cell) degeneration and \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    death\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " seen in 50% of cases of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fatty infiltration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Fibro-fatty infiltration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " The second, \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    fibro-fatty infiltration\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ", involves replacement of myocytes with fibrofatty tissue.  A patchy \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    myocarditis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is involved in up to 2/3 of cases, with inflammatory infiltrates (mostly T cells) seen on microscopy.  \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Myocardial atrophy\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is due to injury and apoptosis.  This leads to thinning of the RV free wall (to &lt; 3 mm thickness) Myocytes are replaced with fibrofatty tissue.  The regions preferentially involved include the RV inflow tract, the RV outflow tract, and the RV apex.  However, the LV free wall may be involved in some cases.  Involvement of the ventricular septum is rare.  The areas involved are prone to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    aneurysm\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " formation. The Role of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " Recently, some studies have identified strenuous \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    exercise\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Prevention</span>\n",
       "</mark>\n",
       " as a novel risk for accelerated progression of the disease. One retrospective study on 301 patients conclusively demonstrated that the subpopulations participating in strenuous physical activity (professional athletes for example) had an earlier onset of symptoms and earlier mortality compared to other populations. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ventricular arrhythmias Ventricular arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " due to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ACM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       " typically arise from the diseased \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    right ventricle\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">Parts of the human heart</span>\n",
       "</mark>\n",
       ".  The type of \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    arrhythmia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " ranges from frequent \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    premature ventricular complexes (PVCs\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       ") to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular tachycardia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (VT) to \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular fibrillation\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " (\n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    VF\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CHEMICAL</span>\n",
       "</mark>\n",
       "). While the initiating factor of the \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    ventricular arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " is unclear, it may be due to triggered activity or reentry. \n",
       "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
       "    Ventricular arrhythmias\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DISEASE</span>\n",
       "</mark>\n",
       " are usually exercise-related, suggesting that they are sensitive t</div></span>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "html=displacy.render(doc_ner1,style=\"ent\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "html=displacy.render(doc_ner2,style=\"ent\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "html=displacy.render(doc_ner3,style=\"ent\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "html=displacy.render(doc_ner4,style=\"ent\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#Label's and Entities added to source , target and relations list\n",
    "\n",
    "docs=[doc_ner1,doc_ner2,doc_ner3,doc_ner4]\n",
    "for doc in docs:\n",
    "    for ents in doc.ents:\n",
    "        sources.append(ents)\n",
    "        targets.append(ents.label_)\n",
    "        relations.append('NER')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "doc_stanza = nlp_stanza(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#print both here"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "texts =[[]]\n",
    "ners =[[]]\n",
    "i=0\n",
    "for sent in doc_stanza.ents:\n",
    "    text=[]\n",
    "    ner=[]\n",
    "    for token in sent.tokens:\n",
    "        text.append(token.text)\n",
    "        ner.append(token.ner)\n",
    "    texts.append(text)\n",
    "    ners.append(ner)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "pattern = [['B-PROBLEM', 'I-PROBLEM', 'E-PROBLEM'],['B-TREATMENT', 'I-TREATMENT', 'E-TREATMENT'],['B-TEST', 'I-TEST', 'E-TEST']]\n",
    "sources1 =[]\n",
    "relations1 = []\n",
    "targets1 =[]\n",
    "for val in ners:\n",
    "    if val in pattern:\n",
    "        if texts[ners.index(val)][0] not in sources1:\n",
    "            sources1.append(texts[ners.index(val)][0])\n",
    "            relations1.append(texts[ners.index(val)][1])\n",
    "            targets1.append(texts[ners.index(val)][2]) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "for i in range(len(sources1)):\n",
    "    sources.append(sources1[i])\n",
    "    targets.append(targets1[i])\n",
    "    relations.append(relations1[i])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df=pd.DataFrame({'source-node':sources,'target-node':targets,'relation':relations})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NER               28659\n",
       "include             400\n",
       "such_as             337\n",
       "abbreviated-as      166\n",
       "other               108\n",
       "have                 92\n",
       "has                  69\n",
       "used                 54\n",
       "had                  41\n",
       "found                36\n",
       "is                   32\n",
       "contains             24\n",
       "cause                23\n",
       "believed             23\n",
       "performed            22\n",
       "developed            22\n",
       "increases            19\n",
       "form                 19\n",
       "shown                19\n",
       "causes               19\n",
       "includes             18\n",
       "involves             18\n",
       "included             17\n",
       "treated              17\n",
       "increase             17\n",
       "considered           16\n",
       "means                16\n",
       "result               14\n",
       "decreases            14\n",
       "published            13\n",
       "began                13\n",
       "appears              13\n",
       "See                  13\n",
       "are                  13\n",
       "allow                13\n",
       "called               13\n",
       "made                 13\n",
       "provides             12\n",
       "use                  12\n",
       "discovered           12\n",
       "receives             12\n",
       "took                 12\n",
       "continued            12\n",
       "require              12\n",
       "said                 12\n",
       "make                 12\n",
       "occurs               12\n",
       "required             12\n",
       "suggested            11\n",
       "taken                11\n",
       "Name: relation, dtype: int64"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['relation'].value_counts()[:50]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>source-node</th>\n",
       "      <th>target-node</th>\n",
       "      <th>relation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>waste</td>\n",
       "      <td>carbon dioxide</td>\n",
       "      <td>such_as</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>They</td>\n",
       "      <td>MYH6</td>\n",
       "      <td>include</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>They</td>\n",
       "      <td>ACTC1</td>\n",
       "      <td>include</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>They</td>\n",
       "      <td>TNNI3</td>\n",
       "      <td>include</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>They</td>\n",
       "      <td>CDH2</td>\n",
       "      <td>include</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  source-node     target-node relation\n",
       "0       waste  carbon dioxide  such_as\n",
       "1        They            MYH6  include\n",
       "2        They           ACTC1  include\n",
       "3        They           TNNI3  include\n",
       "4        They            CDH2  include"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "Knowledge_graph=nx.from_pandas_edgelist(df, 'source-node', 'target-node', edge_attr=True, create_using=nx.MultiDiGraph())\n",
    "for n in Knowledge_graph.nodes():\n",
    "    Knowledge_graph.nodes[n]['color'] = 'red' if n in df['source-node'] else 'skyblue'\n",
    "\n",
    "plt.figure(figsize=(20,20))\n",
    "colors = [node[1]['color'] for node in Knowledge_graph.nodes(data=True)]\n",
    "pos = nx.spring_layout(Knowledge_graph)\n",
    "nx.draw(Knowledge_graph, with_labels=True, node_color=colors, edge_cmap=plt.cm.Blues, pos = pos)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "interpreter": {
   "hash": "c6e4e9f98eb68ad3b7c296f83d20e6de614cb42e90992a65aa266555a3137d0d"
  },
  "kernelspec": {
   "display_name": "Python 3.9.6 64-bit ('base': conda)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.6"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
